--
-- PostgreSQL database dump
--

-- Dumped from database version 14.10
-- Dumped by pg_dump version 14.10

SET statement_timeout = 0;
SET lock_timeout = 0;
SET idle_in_transaction_session_timeout = 0;
SET client_encoding = 'UTF8';
SET standard_conforming_strings = on;
SELECT pg_catalog.set_config('search_path', '', false);
SET check_function_bodies = false;
SET xmloption = content;
SET client_min_messages = warning;
SET row_security = off;

--
-- Name: event_crf_initial_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.event_crf_initial_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
			pk INTEGER;
			entity_name_value TEXT;
			
        BEGIN
            IF (TG_OP = 'INSERT') THEN
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Status';
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id )
		                    VALUES (pk, '41', now(), NEW.owner_id, 'event_crf', NEW.event_crf_id, entity_name_value,'2', NEW.status_id, NEW.event_crf_id );
				RETURN NULL;
            END IF;
        RETURN NULL;
        END;
        $$;


ALTER FUNCTION public.event_crf_initial_trigger() OWNER TO clinica;

--
-- Name: event_crf_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.event_crf_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
			pk INTEGER;
			entity_name_value TEXT;
		BEGIN
			IF (TG_OP = 'UPDATE') THEN
				IF(OLD.status_id <> NEW.status_id) THEN
				/*---------------*/
				/*Event CRF status changed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Status';

				IF(OLD.status_id = '1' AND NEW.status_id = '2') THEN
				    IF (NEW.electronic_signature_status) THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id,study_event_id, event_crf_version_id )
		                    VALUES (pk, '14', now(), NEW.update_id, 'event_crf', NEW.event_crf_id, entity_name_value, OLD.status_id, NEW.status_id, NEW.event_crf_id, NEW.study_event_id ,NEW.crf_version_id);
		            ELSE
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id)
		                    VALUES (pk, '8', now(), NEW.update_id, 'event_crf', NEW.event_crf_id, entity_name_value, OLD.status_id, NEW.status_id, NEW.event_crf_id , NEW.study_event_id ,NEW.crf_version_id);
		            END IF;
				ELSIF (OLD.status_id = '1' AND NEW.status_id = '4') THEN
				    IF (NEW.electronic_signature_status) THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id)
		                    VALUES (pk, '15', now(), NEW.update_id, 'event_crf', NEW.event_crf_id, entity_name_value, OLD.status_id, NEW.status_id, NEW.event_crf_id , NEW.study_event_id ,NEW.crf_version_id);
		            ELSE
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id)
		                    VALUES (pk, '10', now(), NEW.update_id, 'event_crf', NEW.event_crf_id, entity_name_value, OLD.status_id, NEW.status_id, NEW.event_crf_id , NEW.study_event_id ,NEW.crf_version_id);
		            END IF;
				ELSIF (OLD.status_id = '4' AND NEW.status_id = '2') THEN
		    		IF (NEW.electronic_signature_status) THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id)
		                    VALUES (pk, '16', now(), NEW.update_id, 'event_crf', NEW.event_crf_id, entity_name_value, OLD.status_id, NEW.status_id, NEW.event_crf_id , NEW.study_event_id ,NEW.crf_version_id);
				    ELSE
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id)
		                    VALUES (pk, '11', now(), NEW.update_id, 'event_crf', NEW.event_crf_id, entity_name_value, OLD.status_id, NEW.status_id, NEW.event_crf_id , NEW.study_event_id ,NEW.crf_version_id);
				    END IF;
                 				ELSIF ( NEW.status_id = '11') THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id)
		                    VALUES (pk, '40', now(), NEW.update_id, 'event_crf', NEW.event_crf_id, entity_name_value, OLD.status_id, NEW.status_id, NEW.event_crf_id , NEW.study_event_id ,NEW.crf_version_id);

				END IF;
				/*---------------*/
				END IF;

				IF(OLD.date_interviewed <> NEW.date_interviewed) THEN
				/*---------------*/
				/*Event CRF date interviewed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Date interviewed';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id)
					VALUES (pk, '9', now(), NEW.update_id, 'event_crf', NEW.event_crf_id, entity_name_value, OLD.date_interviewed, NEW.date_interviewed, NEW.event_crf_id , NEW.study_event_id ,NEW.crf_version_id);
				/*---------------*/
				END IF;

				IF((OLD.interviewer_name <> NEW.interviewer_name) AND (OLD.interviewer_name <> '')) THEN
				/*---------------*/
				/*Event CRF interviewer name*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Interviewer Name';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id)
					VALUES (pk, '9', now(), NEW.update_id, 'event_crf', NEW.event_crf_id, entity_name_value, OLD.interviewer_name, NEW.interviewer_name, NEW.event_crf_id , NEW.study_event_id ,NEW.crf_version_id);
				/*---------------*/
				END IF;

				IF(OLD.sdv_status <> NEW.sdv_status) THEN
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'EventCRF SDV Status';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id)
					VALUES (pk, '32', now(), NEW.sdv_update_id, 'event_crf', NEW.event_crf_id, entity_name_value, (select case when OLD.sdv_status is true then 'TRUE' else 'FALSE' end),
					(select case when NEW.sdv_status is true then 'TRUE' else 'FALSE' end), NEW.event_crf_id , NEW.study_event_id ,NEW.crf_version_id);
				/*---------------*/
				END IF;
			RETURN NULL;  /*return values ignored for 'after' triggers*/
			END IF;
		END;
		$$;


ALTER FUNCTION public.event_crf_trigger() OWNER TO clinica;

--
-- Name: event_crf_version_change_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.event_crf_version_change_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
			pk INTEGER;
			crf_old_name TEXT;
			crf_new_name TEXT;
			
		BEGIN
			IF (TG_OP = 'UPDATE') THEN
				IF(OLD.crf_version_id <> NEW.crf_version_id) THEN
				 /*---------------*/

				    SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				   SELECT INTO crf_old_name cf.name FROM crf_version cf WHERE cf.crf_version_id = OLD.crf_version_id;
				    SELECT INTO crf_new_name cf.name FROM crf_version cf WHERE cf.crf_version_id = NEW.crf_version_id;
				    
				    
				    
				    
					INSERT INTO audit_log_event(  
					audit_id, 
					audit_date,  
					audit_table,  
					user_id ,
					entity_id ,
					entity_name ,
					audit_log_event_type_id ,
					old_value ,
					new_value ,
					event_crf_id ,
					study_event_id
					 )
				
					VALUES (
					pk, 
					now(),
					'event_crf',
					NEW.update_id,
					OLD.event_crf_id, 
					'CRF version',
					'33',
					crf_old_name, 
					crf_new_name,
					OLD.event_crf_id,
					OLD.study_event_id
					);
				/*---------------*/
				END IF;
				RETURN NULL;  /*return values ignored for 'after' triggers*/
			END IF;
		RETURN NULL;  /*return values ignored for 'after' triggers*/
		END;
		$$;


ALTER FUNCTION public.event_crf_version_change_trigger() OWNER TO clinica;

--
-- Name: event_definition_crf_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.event_definition_crf_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
            pk INTEGER;
            se_id INTEGER;
            cv_id INTEGER;
            entity_name_value TEXT;
            BEGIN
                IF (TG_OP = 'UPDATE') THEN
                    IF(OLD.status_id <> NEW.status_id) THEN
                        /*---------------*/
                        /*Event CRF status changed*/
                        SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                        SELECT INTO entity_name_value 'Status';
                        IF(NEW.status_id = '5') THEN
                            SELECT INTO se_id se.study_event_id FROM study_event se WHERE se.study_event_definition_id = NEW.study_event_definition_id;
                            SELECT INTO cv_id ec.crf_version_id FROM event_crf ec, study_event se WHERE se.study_event_definition_id = NEW.study_event_definition_id and ec.study_event_id = se.study_event_id;

                            INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, study_event_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id, event_crf_version_id)
                                        VALUES (pk, '13',se_id, now(), NEW.update_id, 'event_definition_crf', NEW.event_definition_crf_id, entity_name_value, OLD.status_id, NEW.status_id, NEW.event_definition_crf_id, cv_id);
                        END IF;
                    END IF;
                    RETURN NULL;  /*return values ignored for 'after' triggers*/
                END IF;
            END;
        $$;


ALTER FUNCTION public.event_definition_crf_trigger() OWNER TO clinica;

--
-- Name: fix_duplicates_in_study_defs(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.fix_duplicates_in_study_defs() RETURNS void
    LANGUAGE plpgsql
    AS $$DECLARE
		    maxOrdinal INTEGER DEFAULT 1;
		    mviews RECORD;
		    mviews2 RECORD;
		
		    BEGIN
			FOR mviews2 in select ordinal, count(*) as cnt from study_event_definition sed group by ordinal
				LOOP
				IF mviews2.cnt > 1 THEN
		
					FOR mviews in select study_event_definition_id as sid from study_event_definition sed order by sed.study_event_definition_id
						LOOP
						UPDATE study_event_definition set ordinal = maxOrdinal where study_event_definition_id = mviews.sid;
						
						maxOrdinal := maxOrdinal + 1;
			
						END LOOP;
					EXIT;
				END IF;
				END LOOP;
		    END;
		    $$;


ALTER FUNCTION public.fix_duplicates_in_study_defs() OWNER TO clinica;

--
-- Name: fix_rule_referencing_cross_study(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.fix_rule_referencing_cross_study() RETURNS void
    LANGUAGE plpgsql
    AS $$DECLARE
		    
		     newExpressionId INTEGER DEFAULT 0;
		     newRuleId INTEGER DEFAULT 0;
		     mviews RECORD;
		
		    BEGIN
		
		    FOR mviews in select r.rule_expression_id as rrule_expression_id, rs.study_id as rsstudy_id, rsr.rule_id as rsrrule_id, rsr.id as rsrid  from rule_set rs, rule r,rule_set_rule rsr where  rsr.rule_set_id = rs.id and rule_id = r.id and  rs.study_id != r.study_id 
		    LOOP
		        newExpressionId := NEXTVAL('rule_expression_id_seq');
		        newRuleId := NEXTVAL('rule_id_seq');
		        INSERT INTO rule_expression select newExpressionId,value,context,owner_id,date_created,date_updated,update_id,status_id,0 from rule_expression where id = mviews.rrule_expression_id;
		        INSERT INTO rule SELECT newRuleId,name,description,oc_oid,enabled,newExpressionId,owner_id,date_created,date_updated,update_id,status_id,0,mviews.rsstudy_id FROM rule WHERE id = mviews.rsrrule_id ;
		        UPDATE rule_set_rule rsr set rule_id = newRuleId where rsr.id = mviews.rsrid;
		    END LOOP;
		
		    END;
		    $$;


ALTER FUNCTION public.fix_rule_referencing_cross_study() OWNER TO clinica;

--
-- Name: global_subject_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.global_subject_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
			pk INTEGER;
			entity_name_value TEXT;
		BEGIN
			IF (TG_OP = 'INSERT') THEN
				/*---------------*/
				 /*Subject created*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id)
					VALUES (pk, '5', now(), NEW.owner_id, 'subject', NEW.subject_id);
				RETURN NULL; /*return values ignored for 'after' triggers*/
				/*---------------*/
			ELSIF (TG_OP = 'UPDATE') THEN
				IF(OLD.status_id <> NEW.status_id) THEN
				/*---------------*/
				 /*Subject status changed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Status';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
					VALUES (pk, '6', now(), NEW.update_id, 'subject', NEW.subject_id, entity_name_value, OLD.status_id, NEW.status_id);
				/*---------------*/
				END IF;
		
				IF(OLD.unique_identifier <> NEW.unique_identifier) THEN
				/*---------------*/
				/*Subject value changed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Person ID';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
					VALUES (pk, '7', now(), NEW.update_id, 'subject', NEW.subject_id, entity_name_value, OLD.unique_identifier, NEW.unique_identifier);
				/*---------------*/
				END IF;
		
				IF(OLD.date_of_birth <> NEW.date_of_birth) THEN
				/*---------------*/
				 /*Subject value changed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Date of Birth';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
					VALUES (pk, '7', now(), NEW.update_id, 'subject', NEW.subject_id, entity_name_value, OLD.date_of_birth, NEW.date_of_birth);
				/*---------------*/
				END IF;
		
		        IF(OLD.gender <> NEW.gender) THEN
		   		/*---------------*/
		   		/*Subject value changed*/
		   		SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		   		SELECT INTO entity_name_value 'Gender';
		   		INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
				VALUES (pk, '7', now(), NEW.update_id, 'subject', NEW.subject_id, entity_name_value, OLD.gender, NEW.gender);
		   		/*---------------*/
		   		END IF;
				
			RETURN NULL;  /*return values ignored for 'after' triggers*/
			END IF;
		END;
		$$;


ALTER FUNCTION public.global_subject_trigger() OWNER TO clinica;

--
-- Name: item_data_initial_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.item_data_initial_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
            pk INTEGER;
            entity_name_value TEXT;
            std_evnt_id INTEGER;
            crf_version_id INTEGER;
        BEGIN
            IF (TG_OP = 'INSERT' and length(NEW.value)>0) THEN
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value item.name FROM item WHERE item.item_id = NEW.item_id;
		        SELECT INTO std_evnt_id ec.study_event_id FROM event_crf ec WHERE ec.event_crf_id = NEW.event_crf_id;
		        SELECT INTO crf_version_id ec.crf_version_id FROM event_crf ec WHERE ec.event_crf_id = NEW.event_crf_id;
		        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, reason_for_change, new_value, event_crf_id, study_event_id, event_crf_version_id ,item_data_repeat_key)
		                VALUES (pk, '1', now(), NEW.owner_id, 'item_data', NEW.item_data_id, entity_name_value, 'initial value', NEW.value, NEW.event_crf_id, std_evnt_id, crf_version_id , NEW.ordinal);
				RETURN NULL;
            END IF;
        RETURN NULL;
        END;
        $$;


ALTER FUNCTION public.item_data_initial_trigger() OWNER TO clinica;

--
-- Name: item_data_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.item_data_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
            pk INTEGER;
            entity_name_value TEXT;
            status INTEGER;
            std_evnt_id INTEGER;
            crf_version_id INTEGER;
        BEGIN
                SELECT INTO status status_id FROM event_crf WHERE event_crf_id = OLD.event_crf_id;
                SELECT INTO std_evnt_id ec.study_event_id FROM event_crf ec WHERE ec.event_crf_id = OLD.event_crf_id;
                SELECT INTO crf_version_id ec.crf_version_id FROM event_crf ec WHERE ec.event_crf_id = OLD.event_crf_id;
        
            IF (TG_OP = 'DELETE') THEN
                /*---------------*/
                 /*Item data deleted (by deleting an event crf)*/
                SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                SELECT INTO entity_name_value item.name FROM item WHERE item.item_id = OLD.item_id;
                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, event_crf_id, study_event_id, event_crf_version_id)
                        VALUES (pk, '13', now(), OLD.update_id, 'item_data', OLD.item_data_id, entity_name_value, OLD.value, OLD.event_crf_id, std_evnt_id, crf_version_id);
                RETURN NULL; --return values ignored for 'after' triggers
            ELSIF (TG_OP = 'UPDATE') THEN
        
                IF(OLD.value <> NEW.value and status=11) THEN
                /*---------------*/
                 /*Item data updated*/
                SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                SELECT INTO entity_name_value item.name FROM item WHERE item.item_id = NEW.item_id;
                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id ,study_event_id, event_crf_version_id,item_data_repeat_key)
                    VALUES (pk, '13', now(), NEW.update_id, 'item_data', NEW.item_data_id, entity_name_value, OLD.value, NEW.value, NEW.event_crf_id ,std_evnt_id, crf_version_id , NEW.ordinal);
                DELETE FROM rule_action_run_log where item_data_id = NEW.item_data_id;  
                /*---------------*/
                ELSEIF(OLD.value <> NEW.value) THEN
                /*---------------*/
                 /*Item data updated*/
                SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                SELECT INTO entity_name_value item.name FROM item WHERE item.item_id = NEW.item_id;
                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value, event_crf_id,study_event_id, event_crf_version_id,item_data_repeat_key)
                    VALUES (pk, '1', now(), NEW.update_id, 'item_data', NEW.item_data_id, entity_name_value, OLD.value, NEW.value, NEW.event_crf_id,std_evnt_id, crf_version_id , NEW.ordinal);
                DELETE FROM rule_action_run_log where item_data_id = NEW.item_data_id;  
                /*---------------*/
                END IF;
                RETURN NULL;  /*return values ignored for 'after' triggers*/
            END IF;
        RETURN NULL;  /*return values ignored for 'after' triggers*/
        END;
        $$;


ALTER FUNCTION public.item_data_trigger() OWNER TO clinica;

--
-- Name: populate_ssid_in_didm_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.populate_ssid_in_didm_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$
        BEGIN
            update dn_item_data_map  set study_subject_id = 
            (
                select DISTINCT se.study_subject_id from study_event se, event_crf ec, item_data id where 
                id.event_crf_id = ec.event_crf_id and ec.study_event_id = se.study_event_id and id.item_data_id = dn_item_data_map.item_data_id
            ) where study_subject_id is null;
        RETURN NULL;    
        END;
        $$;


ALTER FUNCTION public.populate_ssid_in_didm_trigger() OWNER TO clinica;

--
-- Name: repeating_item_data_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.repeating_item_data_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
		 pk INTEGER;
		 entity_name_value TEXT;
		 std_evnt_id INTEGER;
		 crf_version_id INTEGER;
		 validator_id INTEGER;
		 event_crf_status_id INTEGER;
		
		
		BEGIN
		 IF (TG_OP = 'INSERT') THEN
		  /*---------------*/ 
		  SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		  SELECT INTO entity_name_value item.name FROM item WHERE item.item_id = NEW.item_id;
		        SELECT INTO std_evnt_id ec.study_event_id FROM event_crf ec WHERE ec.event_crf_id = NEW.event_crf_id;
		        SELECT INTO crf_version_id ec.crf_version_id FROM event_crf ec WHERE ec.event_crf_id = NEW.event_crf_id;
		 SELECT INTO validator_id ec.validator_id FROM event_crf ec WHERE ec.event_crf_id = NEW.event_crf_id;
		 SELECT INTO event_crf_status_id ec.status_id FROM event_crf ec WHERE ec.event_crf_id = NEW.event_crf_id;
		 
		        IF (NEW.status_id = '2' AND NEW.ordinal > 1 AND validator_id > 0 AND event_crf_status_id  = '4') THEN  /*DDE*/
		          
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, new_value, event_crf_id, study_event_id, event_crf_version_id)
		                VALUES (pk, '30', now(), NEW.owner_id, 'item_data', NEW.item_data_id, entity_name_value, NEW.value, NEW.event_crf_id, std_evnt_id, crf_version_id);
		        ELSE 
		          IF(NEW.status_id ='2' AND NEW.ordinal > 1  AND event_crf_status_id  = '2') THEN /*ADE*/
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, new_value, event_crf_id, study_event_id, event_crf_version_id)
		                VALUES (pk, '30', now(), NEW.owner_id, 'item_data', NEW.item_data_id, entity_name_value, NEW.value, NEW.event_crf_id, std_evnt_id, crf_version_id);
		          END IF;
		       END IF;
		  RETURN NULL;  /*return values ignored for 'after' triggers*/
		 
		 END IF;
		RETURN NULL;  /*return values ignored for 'after' triggers*/
		END; $$;


ALTER FUNCTION public.repeating_item_data_trigger() OWNER TO clinica;

--
-- Name: study_event_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.study_event_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
            pk INTEGER;
        BEGIN
            IF (TG_OP = 'INSERT') THEN
                SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                IF(NEW.subject_event_status_id = '1') THEN
                    INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                    VALUES (pk, '17', now(), NEW.owner_id, 'study_event', NEW.study_event_id, 'Status','0', NEW.subject_event_status_id);
                END IF;
            END IF;
        
            IF (TG_OP = 'UPDATE') THEN
                IF(OLD.subject_event_status_id <> NEW.subject_event_status_id) THEN
                    SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                    IF(NEW.subject_event_status_id = '1') THEN
                        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                        VALUES (pk, '17', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
                    ELSIF(NEW.subject_event_status_id = '3') THEN
                        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                        VALUES (pk, '18', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
                    ELSIF(NEW.subject_event_status_id = '4') THEN
                        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                        VALUES (pk, '19', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
                    ELSIF(NEW.subject_event_status_id = '5') THEN
                        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                        VALUES (pk, '20', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
                    ELSIF(NEW.subject_event_status_id = '6') THEN
                        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                        VALUES (pk, '21', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
                    ELSIF(NEW.subject_event_status_id = '7') THEN
                        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                        VALUES (pk, '22', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
                    ELSIF(NEW.subject_event_status_id = '8') THEN
                        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                        VALUES (pk, '31', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
                    END IF;
                END IF;
                IF(OLD.status_id <> NEW.status_id) THEN
                    IF(NEW.status_id = '5' or NEW.status_id = '1') THEN
                        SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                        VALUES (pk, '23', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.status_id, NEW.status_id);
                    END IF;
                END IF;
                IF(OLD.date_start <> NEW.date_start) THEN
                    SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                    INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                    VALUES (pk, '24', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Start date', OLD.date_start, NEW.date_start);
                END IF;
                IF(OLD.date_end <> NEW.date_end) THEN
                    SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                    INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                    VALUES (pk, '25', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'End date', OLD.date_end, NEW.date_end);
                END IF;
                IF(OLD.location <> NEW.location) THEN
                    SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
                    INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
                    VALUES (pk, '26', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Location', OLD.location, NEW.location);
                END IF;
                RETURN NULL;  /*return values ignored for 'after' triggers*/
            END IF;
            RETURN NULL;
        END;$$;


ALTER FUNCTION public.study_event_trigger() OWNER TO clinica;

--
-- Name: study_event_trigger_new(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.study_event_trigger_new() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
			pk INTEGER;
		BEGIN
			IF (TG_OP = 'INSERT') THEN
		        SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		        IF(NEW.subject_event_status_id = '1') THEN
		            INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		            VALUES (pk, '17', now(), NEW.owner_id, 'study_event', NEW.study_event_id, 'Status','0', NEW.subject_event_status_id);
		        END IF;
		    END IF;
		
			IF (TG_OP = 'UPDATE') THEN
				IF(OLD.subject_event_status_id <> NEW.subject_event_status_id) THEN
		            SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		            IF(NEW.subject_event_status_id = '1') THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		                VALUES (pk, '17', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
		            ELSIF(NEW.subject_event_status_id = '3') THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		                VALUES (pk, '18', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
		            ELSIF(NEW.subject_event_status_id = '4') THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		                VALUES (pk, '19', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
		            ELSIF(NEW.subject_event_status_id = '5') THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		                VALUES (pk, '20', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
		            ELSIF(NEW.subject_event_status_id = '6') THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		                VALUES (pk, '21', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
		            ELSIF(NEW.subject_event_status_id = '7') THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		                VALUES (pk, '22', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
		            ELSIF(NEW.subject_event_status_id = '8') THEN
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		                VALUES (pk, '31', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.subject_event_status_id, NEW.subject_event_status_id);
				    END IF;
			    END IF;
		        IF(OLD.status_id <> NEW.status_id) THEN
		            IF(NEW.status_id = '5' and OLD.status_id = '1') THEN
		                SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		                VALUES (pk, '23', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.status_id, NEW.status_id);
		            END IF;
		            IF(OLD.status_id = '5' and NEW.status_id = '1') THEN
		                SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		                INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		                VALUES (pk, '35', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Status', OLD.status_id, NEW.status_id);
		            END IF;
		        END IF;
		        IF(OLD.date_start <> NEW.date_start) THEN
		            SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		            INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		            VALUES (pk, '24', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Start date', OLD.date_start, NEW.date_start);
		        END IF;
		        IF(OLD.date_end <> NEW.date_end) THEN
		            SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		            INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		            VALUES (pk, '25', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'End date', OLD.date_end, NEW.date_end);
		        END IF;
		        IF(OLD.location <> NEW.location) THEN
		            SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		            INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		            VALUES (pk, '26', now(), NEW.update_id, 'study_event', NEW.study_event_id, 'Location', OLD.location, NEW.location);
		        END IF;
		    	RETURN NULL;  /*return values ignored for 'after' triggers*/
			END IF;
			RETURN NULL;
		END;$$;


ALTER FUNCTION public.study_event_trigger_new() OWNER TO clinica;

--
-- Name: study_subject_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.study_subject_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
			pk INTEGER;
			entity_name_value TEXT;
		    old_unique_identifier TEXT;
		    new_unique_identifier TEXT;
		
		BEGIN
			IF (TG_OP = 'INSERT') THEN
				/*---------------*/
				 /*Study subject created*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id)
					VALUES (pk, '2', now(), NEW.owner_id, 'study_subject', NEW.study_subject_id);
				RETURN NULL; /*return values ignored for 'after' triggers*/
				/*---------------*/
			ELSIF (TG_OP = 'UPDATE') THEN
				IF(OLD.status_id <> NEW.status_id) THEN
				 /*---------------*/
				/*Study subject status changed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Status';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
					VALUES (pk, '3', now(), NEW.update_id, 'study_subject', NEW.study_subject_id, entity_name_value, OLD.status_id, NEW.status_id);
				/*---------------*/
				END IF;
		
				IF(OLD.label <> NEW.label) THEN
				/*---------------*/
				 /*Study subject value changed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Study Subject ID';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
					VALUES (pk, '4', now(), NEW.update_id, 'study_subject', NEW.study_subject_id, entity_name_value, OLD.label, NEW.label);
				/*---------------*/
				END IF;
		
				IF(OLD.secondary_label <> NEW.secondary_label) THEN
				/*---------------*/
				/*Study subject value changed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Secondary Subject ID';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
					VALUES (pk, '4', now(), NEW.update_id, 'study_subject', NEW.study_subject_id, entity_name_value, OLD.secondary_label, NEW.secondary_label);
				/*---------------*/
				END IF;
		
				IF(OLD.enrollment_date <> NEW.enrollment_date) THEN
				/*---------------*/
				/*Study subject value changed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Enrollment Date';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
					VALUES (pk, '4', now(), NEW.update_id, 'study_subject', NEW.study_subject_id, entity_name_value, OLD.enrollment_date, NEW.enrollment_date);
				 /*---------------*/
				END IF;

				IF(OLD.time_zone <> NEW.time_zone) THEN
				/*---------------*/
				/*Study subject value changed*/
				SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
				SELECT INTO entity_name_value 'Time Zone';
				INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
					VALUES (pk, '4', now(), NEW.update_id, 'study_subject', NEW.study_subject_id, entity_name_value, OLD.time_zone, NEW.time_zone);
				 /*---------------*/
				END IF;

	
		        IF(OLD.study_id <> NEW.study_id) THEN
		         /*---------------*/
		         /*Subject reassigned*/
		        SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
		        SELECT INTO entity_name_value 'Study id';
		        SELECT INTO old_unique_identifier study.unique_identifier FROM study study WHERE study.study_id = OLD.study_id;
		        SELECT INTO new_unique_identifier study.unique_identifier FROM study study WHERE study.study_id = NEW.study_id;
		        INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
		            VALUES (pk, '27', now(), NEW.update_id, 'study_subject', NEW.study_subject_id, entity_name_value, old_unique_identifier, new_unique_identifier);
		        /*---------------*/
		        END IF;
		
				RETURN NULL;  /*return values ignored for 'after' triggers*/
			END IF;
		END;
		$$;


ALTER FUNCTION public.study_subject_trigger() OWNER TO clinica;

--
-- Name: subject_group_assignment_trigger(); Type: FUNCTION; Schema: public; Owner: clinica
--

CREATE FUNCTION public.subject_group_assignment_trigger() RETURNS trigger
    LANGUAGE plpgsql
    AS $$DECLARE
            pk INTEGER;
            group_name TEXT;
            old_group_name TEXT;
            new_group_name TEXT;
            study_group_class_name TEXT;
            BEGIN
            IF (TG_OP = 'INSERT') THEN
            SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
            SELECT INTO group_name sg.name FROM study_group sg WHERE sg.study_group_id = NEW.study_group_id;
            SELECT INTO study_group_class_name sgc.name FROM study_group sg join study_group_class sgc ON sg.study_group_class_id = sgc.study_group_class_id WHERE sg.study_group_id = NEW.study_group_id ;
            INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
            VALUES (pk, '28', now(), NEW.owner_id, 'subject_group_map', NEW.study_subject_id, study_group_class_name,'', group_name);
            END IF;
            IF (TG_OP = 'UPDATE') THEN
            IF(OLD.study_group_id <> NEW.study_group_id) THEN
            SELECT INTO pk NEXTVAL('audit_log_event_audit_id_seq');
            SELECT INTO old_group_name sg.name FROM study_group sg WHERE sg.study_group_id = OLD.study_group_id;
            SELECT INTO new_group_name sg.name FROM study_group sg WHERE sg.study_group_id = NEW.study_group_id;
            SELECT INTO study_group_class_name sgc.name FROM study_group sg join study_group_class sgc ON sg.study_group_class_id = sgc.study_group_class_id WHERE sg.study_group_id = NEW.study_group_id ;
            INSERT INTO audit_log_event(audit_id, audit_log_event_type_id, audit_date, user_id, audit_table, entity_id, entity_name, old_value, new_value)
            VALUES (pk, '29', now(), NEW.update_id, 'subject_group_map', NEW.study_subject_id, study_group_class_name,old_group_name, new_group_name);
            END IF;
            RETURN NULL;  /*return values ignored for 'after' triggers*/
            END IF;
            RETURN NULL;
            END;$$;


ALTER FUNCTION public.subject_group_assignment_trigger() OWNER TO clinica;

SET default_tablespace = '';

SET default_table_access_method = heap;

--
-- Name: archived_dataset_file; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.archived_dataset_file (
    archived_dataset_file_id integer NOT NULL,
    name character varying(255),
    dataset_id integer,
    export_format_id integer,
    file_reference character varying(1000),
    run_time integer,
    file_size integer,
    date_created timestamp(6) without time zone,
    owner_id integer
);


ALTER TABLE public.archived_dataset_file OWNER TO clinica;

--
-- Name: archived_dataset_file_archived_dataset_file_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.archived_dataset_file_archived_dataset_file_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.archived_dataset_file_archived_dataset_file_id_seq OWNER TO clinica;

--
-- Name: archived_dataset_file_archived_dataset_file_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.archived_dataset_file_archived_dataset_file_id_seq OWNED BY public.archived_dataset_file.archived_dataset_file_id;


--
-- Name: audit_event; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.audit_event (
    audit_id integer NOT NULL,
    audit_date timestamp without time zone NOT NULL,
    audit_table character varying(500) NOT NULL,
    user_id integer,
    entity_id integer,
    reason_for_change character varying(1000),
    action_message character varying(4000)
);


ALTER TABLE public.audit_event OWNER TO clinica;

--
-- Name: audit_event_audit_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.audit_event_audit_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.audit_event_audit_id_seq OWNER TO clinica;

--
-- Name: audit_event_audit_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.audit_event_audit_id_seq OWNED BY public.audit_event.audit_id;


--
-- Name: audit_event_context; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.audit_event_context (
    audit_id integer,
    study_id integer,
    subject_id integer,
    study_subject_id integer,
    role_name character varying(200),
    event_crf_id integer,
    study_event_id integer,
    study_event_definition_id integer,
    crf_id integer,
    crf_version_id integer,
    study_crf_id integer,
    item_id integer
);


ALTER TABLE public.audit_event_context OWNER TO clinica;

--
-- Name: audit_event_values; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.audit_event_values (
    audit_id integer,
    column_name character varying(255),
    old_value character varying(2000),
    new_value character varying(2000)
);


ALTER TABLE public.audit_event_values OWNER TO clinica;

--
-- Name: audit_log_event; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.audit_log_event (
    audit_id integer NOT NULL,
    audit_date timestamp without time zone NOT NULL,
    audit_table character varying(500) NOT NULL,
    user_id integer,
    entity_id integer,
    entity_name character varying(500),
    reason_for_change character varying(1000),
    audit_log_event_type_id integer,
    old_value character varying(2000),
    new_value character varying(2000),
    event_crf_id integer,
    study_event_id integer,
    event_crf_version_id integer,
    item_data_repeat_key character varying(4000)
);


ALTER TABLE public.audit_log_event OWNER TO clinica;

--
-- Name: audit_log_event_audit_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.audit_log_event_audit_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.audit_log_event_audit_id_seq OWNER TO clinica;

--
-- Name: audit_log_event_audit_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.audit_log_event_audit_id_seq OWNED BY public.audit_log_event.audit_id;


--
-- Name: audit_log_event_type; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.audit_log_event_type (
    audit_log_event_type_id integer NOT NULL,
    name character varying(255)
);


ALTER TABLE public.audit_log_event_type OWNER TO clinica;

--
-- Name: audit_log_event_type_audit_log_event_type_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.audit_log_event_type_audit_log_event_type_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.audit_log_event_type_audit_log_event_type_id_seq OWNER TO clinica;

--
-- Name: audit_log_event_type_audit_log_event_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.audit_log_event_type_audit_log_event_type_id_seq OWNED BY public.audit_log_event_type.audit_log_event_type_id;


--
-- Name: audit_user_login; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.audit_user_login (
    id integer NOT NULL,
    user_name character varying(255),
    user_account_id integer,
    login_attempt_date timestamp without time zone,
    login_status_code integer,
    version integer,
    details character varying(255)
);


ALTER TABLE public.audit_user_login OWNER TO clinica;

--
-- Name: audit_user_login_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.audit_user_login_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.audit_user_login_id_seq OWNER TO clinica;

--
-- Name: audit_user_login_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.audit_user_login_id_seq OWNED BY public.audit_user_login.id;


--
-- Name: authorities; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.authorities (
    id integer NOT NULL,
    username character varying(50) NOT NULL,
    authority character varying(50) NOT NULL,
    version integer
);


ALTER TABLE public.authorities OWNER TO clinica;

--
-- Name: authorities_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.authorities_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.authorities_id_seq OWNER TO clinica;

--
-- Name: authorities_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.authorities_id_seq OWNED BY public.authorities.id;


--
-- Name: completion_status; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.completion_status (
    completion_status_id integer NOT NULL,
    status_id integer,
    name character varying(255),
    description character varying(1000)
);


ALTER TABLE public.completion_status OWNER TO clinica;

--
-- Name: completion_status_completion_status_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.completion_status_completion_status_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.completion_status_completion_status_id_seq OWNER TO clinica;

--
-- Name: completion_status_completion_status_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.completion_status_completion_status_id_seq OWNED BY public.completion_status.completion_status_id;


--
-- Name: configuration; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.configuration (
    id integer NOT NULL,
    key character varying(255),
    value character varying(255),
    description character varying(512),
    version integer
);


ALTER TABLE public.configuration OWNER TO clinica;

--
-- Name: configuration_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.configuration_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.configuration_id_seq OWNER TO clinica;

--
-- Name: configuration_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.configuration_id_seq OWNED BY public.configuration.id;


--
-- Name: crf; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.crf (
    crf_id integer NOT NULL,
    status_id integer,
    name character varying(255),
    description character varying(2048),
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    oc_oid character varying(40) NOT NULL,
    source_study_id integer
);


ALTER TABLE public.crf OWNER TO clinica;

--
-- Name: crf_crf_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.crf_crf_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.crf_crf_id_seq OWNER TO clinica;

--
-- Name: crf_crf_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.crf_crf_id_seq OWNED BY public.crf.crf_id;


--
-- Name: crf_version; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.crf_version (
    crf_version_id integer NOT NULL,
    crf_id integer NOT NULL,
    name character varying(255),
    description character varying(4000),
    revision_notes character varying(255),
    status_id integer,
    date_created date,
    date_updated date,
    owner_id integer,
    update_id integer,
    oc_oid character varying(40) NOT NULL,
    xform text,
    xform_name character varying(255)
);


ALTER TABLE public.crf_version OWNER TO clinica;

--
-- Name: crf_version_crf_version_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.crf_version_crf_version_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.crf_version_crf_version_id_seq OWNER TO clinica;

--
-- Name: crf_version_crf_version_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.crf_version_crf_version_id_seq OWNED BY public.crf_version.crf_version_id;


--
-- Name: crf_version_media; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.crf_version_media (
    crf_version_media_id integer NOT NULL,
    crf_version_id integer NOT NULL,
    name character varying(255) NOT NULL,
    path character varying(4000) NOT NULL
);


ALTER TABLE public.crf_version_media OWNER TO clinica;

--
-- Name: crf_version_media_crf_version_media_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.crf_version_media_crf_version_media_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.crf_version_media_crf_version_media_id_seq OWNER TO clinica;

--
-- Name: crf_version_media_crf_version_media_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.crf_version_media_crf_version_media_id_seq OWNED BY public.crf_version_media.crf_version_media_id;


--
-- Name: databasechangelog; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.databasechangelog (
    id character varying(255) NOT NULL,
    author character varying(255) NOT NULL,
    filename character varying(255) NOT NULL,
    dateexecuted timestamp without time zone NOT NULL,
    orderexecuted integer NOT NULL,
    exectype character varying(10) NOT NULL,
    md5sum character varying(35),
    description character varying(255),
    comments character varying(255),
    tag character varying(255),
    liquibase character varying(20),
    contexts character varying(255),
    labels character varying(255),
    deployment_id character varying(10)
);


ALTER TABLE public.databasechangelog OWNER TO clinica;

--
-- Name: databasechangeloglock; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.databasechangeloglock (
    id integer NOT NULL,
    locked boolean NOT NULL,
    lockgranted timestamp without time zone,
    lockedby character varying(255)
);


ALTER TABLE public.databasechangeloglock OWNER TO clinica;

--
-- Name: dataset; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dataset (
    dataset_id integer NOT NULL,
    study_id integer,
    status_id integer,
    name character varying(255),
    description character varying(2000),
    sql_statement text,
    num_runs integer,
    date_start date,
    date_end date,
    date_created date,
    date_updated date,
    date_last_run date,
    owner_id integer,
    approver_id integer,
    update_id integer,
    show_event_location boolean DEFAULT false,
    show_event_start boolean DEFAULT false,
    show_event_end boolean DEFAULT false,
    show_subject_dob boolean DEFAULT false,
    show_subject_gender boolean DEFAULT false,
    show_event_status boolean DEFAULT false,
    show_subject_status boolean DEFAULT false,
    show_subject_unique_id boolean DEFAULT false,
    show_subject_age_at_event boolean DEFAULT false,
    show_crf_status boolean DEFAULT false,
    show_crf_version boolean DEFAULT false,
    show_crf_int_name boolean DEFAULT false,
    show_crf_int_date boolean DEFAULT false,
    show_group_info boolean DEFAULT false,
    show_disc_info boolean DEFAULT false,
    odm_metadataversion_name character varying(255),
    odm_metadataversion_oid character varying(255),
    odm_prior_study_oid character varying(255),
    odm_prior_metadataversion_oid character varying(255),
    show_secondary_id boolean DEFAULT false,
    dataset_item_status_id integer
);


ALTER TABLE public.dataset OWNER TO clinica;

--
-- Name: dataset_crf_version_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dataset_crf_version_map (
    dataset_id integer,
    event_definition_crf_id integer
);


ALTER TABLE public.dataset_crf_version_map OWNER TO clinica;

--
-- Name: dataset_dataset_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dataset_dataset_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dataset_dataset_id_seq OWNER TO clinica;

--
-- Name: dataset_dataset_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dataset_dataset_id_seq OWNED BY public.dataset.dataset_id;


--
-- Name: dataset_filter_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dataset_filter_map (
    dataset_id integer,
    filter_id integer,
    ordinal integer
);


ALTER TABLE public.dataset_filter_map OWNER TO clinica;

--
-- Name: dataset_item_status; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dataset_item_status (
    dataset_item_status_id integer NOT NULL,
    name character varying(50),
    description character varying(255)
);


ALTER TABLE public.dataset_item_status OWNER TO clinica;

--
-- Name: dataset_item_status_dataset_item_status_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dataset_item_status_dataset_item_status_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dataset_item_status_dataset_item_status_id_seq OWNER TO clinica;

--
-- Name: dataset_item_status_dataset_item_status_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dataset_item_status_dataset_item_status_id_seq OWNED BY public.dataset_item_status.dataset_item_status_id;


--
-- Name: dataset_study_group_class_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dataset_study_group_class_map (
    dataset_id integer NOT NULL,
    study_group_class_id integer NOT NULL
);


ALTER TABLE public.dataset_study_group_class_map OWNER TO clinica;

--
-- Name: dc_computed_event; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dc_computed_event (
    dc_summary_event_id integer NOT NULL,
    dc_event_id integer NOT NULL,
    item_target_id integer,
    summary_type character varying(255)
);


ALTER TABLE public.dc_computed_event OWNER TO clinica;

--
-- Name: dc_computed_event_dc_summary_event_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dc_computed_event_dc_summary_event_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dc_computed_event_dc_summary_event_id_seq OWNER TO clinica;

--
-- Name: dc_computed_event_dc_summary_event_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dc_computed_event_dc_summary_event_id_seq OWNED BY public.dc_computed_event.dc_summary_event_id;


--
-- Name: dc_event; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dc_event (
    dc_event_id integer NOT NULL,
    decision_condition_id integer,
    ordinal integer NOT NULL,
    type character varying(256) NOT NULL
);


ALTER TABLE public.dc_event OWNER TO clinica;

--
-- Name: dc_event_dc_event_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dc_event_dc_event_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dc_event_dc_event_id_seq OWNER TO clinica;

--
-- Name: dc_event_dc_event_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dc_event_dc_event_id_seq OWNED BY public.dc_event.dc_event_id;


--
-- Name: dc_primitive; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dc_primitive (
    dc_primitive_id integer NOT NULL,
    decision_condition_id integer,
    item_id integer,
    dynamic_value_item_id integer,
    comparison character varying(3) NOT NULL,
    constant_value character varying(4000)
);


ALTER TABLE public.dc_primitive OWNER TO clinica;

--
-- Name: dc_primitive_dc_primitive_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dc_primitive_dc_primitive_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dc_primitive_dc_primitive_id_seq OWNER TO clinica;

--
-- Name: dc_primitive_dc_primitive_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dc_primitive_dc_primitive_id_seq OWNED BY public.dc_primitive.dc_primitive_id;


--
-- Name: dc_section_event; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dc_section_event (
    dc_event_id integer NOT NULL,
    section_id integer NOT NULL
);


ALTER TABLE public.dc_section_event OWNER TO clinica;

--
-- Name: dc_section_event_dc_event_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dc_section_event_dc_event_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dc_section_event_dc_event_id_seq OWNER TO clinica;

--
-- Name: dc_section_event_dc_event_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dc_section_event_dc_event_id_seq OWNED BY public.dc_section_event.dc_event_id;


--
-- Name: dc_send_email_event; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dc_send_email_event (
    dc_event_id integer NOT NULL,
    to_address character varying(1000) NOT NULL,
    subject character varying(1000),
    body character varying(4000)
);


ALTER TABLE public.dc_send_email_event OWNER TO clinica;

--
-- Name: dc_send_email_event_dc_event_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dc_send_email_event_dc_event_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dc_send_email_event_dc_event_id_seq OWNER TO clinica;

--
-- Name: dc_send_email_event_dc_event_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dc_send_email_event_dc_event_id_seq OWNED BY public.dc_send_email_event.dc_event_id;


--
-- Name: dc_substitution_event; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dc_substitution_event (
    dc_event_id integer NOT NULL,
    item_id integer,
    value character varying(1000) NOT NULL
);


ALTER TABLE public.dc_substitution_event OWNER TO clinica;

--
-- Name: dc_substitution_event_dc_event_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dc_substitution_event_dc_event_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dc_substitution_event_dc_event_id_seq OWNER TO clinica;

--
-- Name: dc_substitution_event_dc_event_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dc_substitution_event_dc_event_id_seq OWNED BY public.dc_substitution_event.dc_event_id;


--
-- Name: dc_summary_item_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dc_summary_item_map (
    dc_summary_event_id integer,
    item_id integer,
    ordinal integer
);


ALTER TABLE public.dc_summary_item_map OWNER TO clinica;

--
-- Name: decision_condition; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.decision_condition (
    decision_condition_id integer NOT NULL,
    crf_version_id integer,
    status_id integer,
    label character varying(1000) NOT NULL,
    comments character varying(3000) NOT NULL,
    quantity integer NOT NULL,
    type character varying(3) NOT NULL,
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer
);


ALTER TABLE public.decision_condition OWNER TO clinica;

--
-- Name: decision_condition_decision_condition_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.decision_condition_decision_condition_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.decision_condition_decision_condition_id_seq OWNER TO clinica;

--
-- Name: decision_condition_decision_condition_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.decision_condition_decision_condition_id_seq OWNED BY public.decision_condition.decision_condition_id;


--
-- Name: discrepancy_note; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.discrepancy_note (
    discrepancy_note_id integer NOT NULL,
    description character varying(2040),
    discrepancy_note_type_id integer,
    resolution_status_id integer,
    detailed_notes character varying(1000),
    date_created timestamp with time zone,
    owner_id integer,
    parent_dn_id integer,
    entity_type character varying(30),
    study_id integer,
    assigned_user_id integer
);


ALTER TABLE public.discrepancy_note OWNER TO clinica;

--
-- Name: discrepancy_note_discrepancy_note_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.discrepancy_note_discrepancy_note_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.discrepancy_note_discrepancy_note_id_seq OWNER TO clinica;

--
-- Name: discrepancy_note_discrepancy_note_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.discrepancy_note_discrepancy_note_id_seq OWNED BY public.discrepancy_note.discrepancy_note_id;


--
-- Name: discrepancy_note_type; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.discrepancy_note_type (
    discrepancy_note_type_id integer NOT NULL,
    name character varying(50),
    description character varying(255)
);


ALTER TABLE public.discrepancy_note_type OWNER TO clinica;

--
-- Name: discrepancy_note_type_discrepancy_note_type_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.discrepancy_note_type_discrepancy_note_type_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.discrepancy_note_type_discrepancy_note_type_id_seq OWNER TO clinica;

--
-- Name: discrepancy_note_type_discrepancy_note_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.discrepancy_note_type_discrepancy_note_type_id_seq OWNED BY public.discrepancy_note_type.discrepancy_note_type_id;


--
-- Name: dn_age_days; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.dn_age_days AS
 SELECT dn.discrepancy_note_id,
        CASE
            WHEN (dn.resolution_status_id = ANY (ARRAY[1, 2, 3])) THEN date_part('day'::text, (CURRENT_TIMESTAMP - ( SELECT cdn.date_created
               FROM public.discrepancy_note cdn
              WHERE (cdn.discrepancy_note_id = ( SELECT max(idn.discrepancy_note_id) AS max
                       FROM public.discrepancy_note idn
                      WHERE (idn.parent_dn_id = dn.discrepancy_note_id))))))
            ELSE (NULL::integer)::double precision
        END AS days,
        CASE
            WHEN (dn.resolution_status_id = 4) THEN date_part('day'::text, (( SELECT cdn.date_created
               FROM public.discrepancy_note cdn
              WHERE (cdn.discrepancy_note_id = ( SELECT max(idn.discrepancy_note_id) AS max
                       FROM public.discrepancy_note idn
                      WHERE (idn.parent_dn_id = dn.discrepancy_note_id)))) - dn.date_created))
            WHEN (dn.resolution_status_id = ANY (ARRAY[1, 2, 3])) THEN date_part('day'::text, (CURRENT_TIMESTAMP - dn.date_created))
            ELSE (NULL::integer)::double precision
        END AS age
   FROM public.discrepancy_note dn
  WHERE (dn.parent_dn_id IS NULL);


ALTER TABLE public.dn_age_days OWNER TO clinica;

--
-- Name: dn_event_crf_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dn_event_crf_map (
    event_crf_id integer,
    discrepancy_note_id integer,
    column_name character varying(255)
);


ALTER TABLE public.dn_event_crf_map OWNER TO clinica;

--
-- Name: dn_item_data_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dn_item_data_map (
    item_data_id integer,
    discrepancy_note_id integer,
    column_name character varying(255),
    study_subject_id integer,
    activated boolean DEFAULT true
);


ALTER TABLE public.dn_item_data_map OWNER TO clinica;

--
-- Name: dn_study_event_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dn_study_event_map (
    study_event_id integer,
    discrepancy_note_id integer,
    column_name character varying(255)
);


ALTER TABLE public.dn_study_event_map OWNER TO clinica;

--
-- Name: dn_study_subject_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dn_study_subject_map (
    study_subject_id integer,
    discrepancy_note_id integer,
    column_name character varying(255)
);


ALTER TABLE public.dn_study_subject_map OWNER TO clinica;

--
-- Name: dn_subject_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dn_subject_map (
    subject_id integer,
    discrepancy_note_id integer,
    column_name character varying(255)
);


ALTER TABLE public.dn_subject_map OWNER TO clinica;

--
-- Name: dyn_item_form_metadata; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dyn_item_form_metadata (
    id integer NOT NULL,
    item_form_metadata_id integer,
    item_id integer,
    crf_version_id integer,
    show_item boolean DEFAULT true,
    event_crf_id integer,
    version integer,
    item_data_id integer,
    passed_dde integer DEFAULT 0
);


ALTER TABLE public.dyn_item_form_metadata OWNER TO clinica;

--
-- Name: dyn_item_form_metadata_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dyn_item_form_metadata_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dyn_item_form_metadata_id_seq OWNER TO clinica;

--
-- Name: dyn_item_form_metadata_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dyn_item_form_metadata_id_seq OWNED BY public.dyn_item_form_metadata.id;


--
-- Name: dyn_item_group_metadata; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.dyn_item_group_metadata (
    id integer NOT NULL,
    item_group_metadata_id integer,
    item_group_id integer,
    show_group boolean DEFAULT true,
    event_crf_id integer,
    version integer,
    passed_dde integer DEFAULT 0
);


ALTER TABLE public.dyn_item_group_metadata OWNER TO clinica;

--
-- Name: dyn_item_group_metadata_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.dyn_item_group_metadata_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.dyn_item_group_metadata_id_seq OWNER TO clinica;

--
-- Name: dyn_item_group_metadata_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.dyn_item_group_metadata_id_seq OWNED BY public.dyn_item_group_metadata.id;


--
-- Name: event_crf; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.event_crf (
    event_crf_id integer NOT NULL,
    study_event_id integer,
    crf_version_id integer,
    date_interviewed date,
    interviewer_name character varying(255),
    completion_status_id integer,
    status_id integer,
    annotations character varying(4000),
    date_completed timestamp without time zone,
    validator_id integer,
    date_validate date,
    date_validate_completed timestamp without time zone,
    validator_annotations character varying(4000),
    validate_string character varying(256),
    owner_id integer,
    date_created timestamp with time zone,
    study_subject_id integer,
    date_updated timestamp with time zone,
    update_id integer,
    electronic_signature_status boolean DEFAULT false,
    sdv_status boolean DEFAULT false NOT NULL,
    old_status_id integer DEFAULT 1,
    sdv_update_id integer DEFAULT 0
);


ALTER TABLE public.event_crf OWNER TO clinica;

--
-- Name: event_crf_event_crf_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.event_crf_event_crf_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.event_crf_event_crf_id_seq OWNER TO clinica;

--
-- Name: event_crf_event_crf_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.event_crf_event_crf_id_seq OWNED BY public.event_crf.event_crf_id;


--
-- Name: event_crf_flag; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.event_crf_flag (
    id integer NOT NULL,
    path character varying(255),
    tag_id integer,
    flag_workflow_id integer,
    owner_id integer,
    update_id integer,
    date_created timestamp with time zone,
    date_updated timestamp with time zone
);


ALTER TABLE public.event_crf_flag OWNER TO clinica;

--
-- Name: event_crf_flag_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.event_crf_flag_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.event_crf_flag_id_seq OWNER TO clinica;

--
-- Name: event_crf_flag_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.event_crf_flag_id_seq OWNED BY public.event_crf_flag.id;


--
-- Name: event_crf_flag_workflow; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.event_crf_flag_workflow (
    id integer NOT NULL,
    workflow_id character varying(255),
    workflow_status character varying(255),
    owner_id integer,
    update_id integer,
    date_created timestamp with time zone,
    date_updated timestamp with time zone
);


ALTER TABLE public.event_crf_flag_workflow OWNER TO clinica;

--
-- Name: event_crf_flag_workflow_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.event_crf_flag_workflow_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.event_crf_flag_workflow_id_seq OWNER TO clinica;

--
-- Name: event_crf_flag_workflow_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.event_crf_flag_workflow_id_seq OWNED BY public.event_crf_flag_workflow.id;


--
-- Name: event_definition_crf; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.event_definition_crf (
    event_definition_crf_id integer NOT NULL,
    study_event_definition_id integer,
    study_id integer,
    crf_id integer,
    required_crf boolean,
    double_entry boolean,
    require_all_text_filled boolean,
    decision_conditions boolean,
    null_values character varying(255),
    default_version_id integer,
    status_id integer,
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    ordinal integer,
    electronic_signature boolean DEFAULT false,
    hide_crf boolean DEFAULT false,
    source_data_verification_code integer,
    selected_version_ids character varying(150),
    parent_id integer,
    participant_form boolean DEFAULT false,
    allow_anonymous_submission boolean DEFAULT false,
    submission_url character varying(255)
);


ALTER TABLE public.event_definition_crf OWNER TO clinica;

--
-- Name: event_definition_crf_event_definition_crf_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.event_definition_crf_event_definition_crf_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.event_definition_crf_event_definition_crf_id_seq OWNER TO clinica;

--
-- Name: event_definition_crf_event_definition_crf_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.event_definition_crf_event_definition_crf_id_seq OWNED BY public.event_definition_crf.event_definition_crf_id;


--
-- Name: event_definition_crf_item_tag; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.event_definition_crf_item_tag (
    id integer NOT NULL,
    path character varying(255),
    tag_id integer,
    active boolean,
    owner_id integer,
    update_id integer,
    date_created timestamp with time zone,
    date_updated timestamp with time zone
);


ALTER TABLE public.event_definition_crf_item_tag OWNER TO clinica;

--
-- Name: event_definition_crf_item_tag_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.event_definition_crf_item_tag_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.event_definition_crf_item_tag_id_seq OWNER TO clinica;

--
-- Name: event_definition_crf_item_tag_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.event_definition_crf_item_tag_id_seq OWNED BY public.event_definition_crf_item_tag.id;


--
-- Name: event_definition_crf_tag; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.event_definition_crf_tag (
    id integer NOT NULL,
    path character varying(255),
    tag_id integer,
    active boolean,
    owner_id integer,
    update_id integer,
    date_created timestamp with time zone,
    date_updated timestamp with time zone
);


ALTER TABLE public.event_definition_crf_tag OWNER TO clinica;

--
-- Name: event_definition_crf_tag_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.event_definition_crf_tag_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.event_definition_crf_tag_id_seq OWNER TO clinica;

--
-- Name: event_definition_crf_tag_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.event_definition_crf_tag_id_seq OWNED BY public.event_definition_crf_tag.id;


--
-- Name: export_format; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.export_format (
    export_format_id integer NOT NULL,
    name character varying(255),
    description character varying(1000),
    mime_type character varying(255)
);


ALTER TABLE public.export_format OWNER TO clinica;

--
-- Name: export_format_export_format_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.export_format_export_format_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.export_format_export_format_id_seq OWNER TO clinica;

--
-- Name: export_format_export_format_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.export_format_export_format_id_seq OWNED BY public.export_format.export_format_id;


--
-- Name: filter; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.filter (
    filter_id integer NOT NULL,
    name character varying(255),
    description character varying(2000),
    sql_statement text,
    status_id integer,
    date_created date,
    date_updated date,
    owner_id integer NOT NULL,
    update_id integer
);


ALTER TABLE public.filter OWNER TO clinica;

--
-- Name: filter_crf_version_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.filter_crf_version_map (
    filter_id integer,
    crf_version_id integer
);


ALTER TABLE public.filter_crf_version_map OWNER TO clinica;

--
-- Name: filter_filter_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.filter_filter_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.filter_filter_id_seq OWNER TO clinica;

--
-- Name: filter_filter_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.filter_filter_id_seq OWNED BY public.filter.filter_id;


--
-- Name: group_class_types; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.group_class_types (
    group_class_type_id integer NOT NULL,
    name character varying(255),
    description character varying(1000)
);


ALTER TABLE public.group_class_types OWNER TO clinica;

--
-- Name: group_class_types_group_class_type_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.group_class_types_group_class_type_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.group_class_types_group_class_type_id_seq OWNER TO clinica;

--
-- Name: group_class_types_group_class_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.group_class_types_group_class_type_id_seq OWNED BY public.group_class_types.group_class_type_id;


--
-- Name: item; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.item (
    item_id integer NOT NULL,
    name character varying(255),
    description character varying(4000),
    units character varying(64),
    phi_status boolean,
    item_data_type_id integer,
    item_reference_type_id integer,
    status_id integer,
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    oc_oid character varying(40) NOT NULL
);


ALTER TABLE public.item OWNER TO clinica;

--
-- Name: item_data; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.item_data (
    item_data_id integer NOT NULL,
    item_id integer NOT NULL,
    event_crf_id integer,
    status_id integer,
    value character varying(4000),
    date_created date,
    date_updated date,
    owner_id integer,
    update_id integer,
    ordinal integer,
    old_status_id integer,
    deleted boolean DEFAULT false
);


ALTER TABLE public.item_data OWNER TO clinica;

--
-- Name: item_data_flag; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.item_data_flag (
    id integer NOT NULL,
    path character varying(255),
    tag_id integer,
    flag_workflow_id integer,
    owner_id integer,
    update_id integer,
    date_created timestamp with time zone,
    date_updated timestamp with time zone
);


ALTER TABLE public.item_data_flag OWNER TO clinica;

--
-- Name: item_data_flag_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.item_data_flag_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.item_data_flag_id_seq OWNER TO clinica;

--
-- Name: item_data_flag_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.item_data_flag_id_seq OWNED BY public.item_data_flag.id;


--
-- Name: item_data_flag_workflow; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.item_data_flag_workflow (
    id integer NOT NULL,
    workflow_id character varying(255),
    workflow_status character varying(255),
    owner_id integer,
    update_id integer,
    date_created timestamp with time zone,
    date_updated timestamp with time zone
);


ALTER TABLE public.item_data_flag_workflow OWNER TO clinica;

--
-- Name: item_data_flag_workflow_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.item_data_flag_workflow_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.item_data_flag_workflow_id_seq OWNER TO clinica;

--
-- Name: item_data_flag_workflow_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.item_data_flag_workflow_id_seq OWNED BY public.item_data_flag_workflow.id;


--
-- Name: item_data_item_data_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.item_data_item_data_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.item_data_item_data_id_seq OWNER TO clinica;

--
-- Name: item_data_item_data_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.item_data_item_data_id_seq OWNED BY public.item_data.item_data_id;


--
-- Name: item_data_type; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.item_data_type (
    item_data_type_id integer NOT NULL,
    code character varying(20),
    name character varying(255),
    definition character varying(1000),
    reference character varying(1000)
);


ALTER TABLE public.item_data_type OWNER TO clinica;

--
-- Name: item_data_type_item_data_type_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.item_data_type_item_data_type_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.item_data_type_item_data_type_id_seq OWNER TO clinica;

--
-- Name: item_data_type_item_data_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.item_data_type_item_data_type_id_seq OWNED BY public.item_data_type.item_data_type_id;


--
-- Name: item_form_metadata; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.item_form_metadata (
    item_form_metadata_id integer NOT NULL,
    item_id integer NOT NULL,
    crf_version_id integer,
    header character varying(2000),
    subheader character varying(240),
    parent_id integer,
    parent_label character varying(120),
    column_number integer,
    page_number_label character varying(5),
    question_number_label character varying(20),
    left_item_text character varying(4000),
    right_item_text character varying(2000),
    section_id integer NOT NULL,
    decision_condition_id integer,
    response_set_id integer NOT NULL,
    regexp character varying(1000),
    regexp_error_msg character varying(255),
    ordinal integer NOT NULL,
    required boolean,
    default_value character varying(4000),
    response_layout character varying(255),
    width_decimal character varying(10),
    show_item boolean DEFAULT true
);


ALTER TABLE public.item_form_metadata OWNER TO clinica;

--
-- Name: item_form_metadata_item_form_metadata_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.item_form_metadata_item_form_metadata_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.item_form_metadata_item_form_metadata_id_seq OWNER TO clinica;

--
-- Name: item_form_metadata_item_form_metadata_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.item_form_metadata_item_form_metadata_id_seq OWNED BY public.item_form_metadata.item_form_metadata_id;


--
-- Name: item_group; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.item_group (
    item_group_id integer NOT NULL,
    name character varying(255),
    crf_id integer NOT NULL,
    status_id integer,
    date_created date,
    date_updated date,
    owner_id integer,
    update_id integer,
    oc_oid character varying(40) NOT NULL
);


ALTER TABLE public.item_group OWNER TO clinica;

--
-- Name: item_group_item_group_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.item_group_item_group_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.item_group_item_group_id_seq OWNER TO clinica;

--
-- Name: item_group_item_group_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.item_group_item_group_id_seq OWNED BY public.item_group.item_group_id;


--
-- Name: item_group_metadata; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.item_group_metadata (
    item_group_metadata_id integer NOT NULL,
    item_group_id integer NOT NULL,
    header character varying(255),
    subheader character varying(255),
    layout character varying(100),
    repeat_number integer,
    repeat_max integer,
    repeat_array character varying(255),
    row_start_number integer,
    crf_version_id integer NOT NULL,
    item_id integer NOT NULL,
    ordinal integer NOT NULL,
    borders integer,
    show_group boolean DEFAULT true,
    repeating_group boolean DEFAULT true NOT NULL
);


ALTER TABLE public.item_group_metadata OWNER TO clinica;

--
-- Name: item_group_metadata_item_group_metadata_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.item_group_metadata_item_group_metadata_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.item_group_metadata_item_group_metadata_id_seq OWNER TO clinica;

--
-- Name: item_group_metadata_item_group_metadata_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.item_group_metadata_item_group_metadata_id_seq OWNED BY public.item_group_metadata.item_group_metadata_id;


--
-- Name: item_item_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.item_item_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.item_item_id_seq OWNER TO clinica;

--
-- Name: item_item_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.item_item_id_seq OWNED BY public.item.item_id;


--
-- Name: item_reference_type; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.item_reference_type (
    item_reference_type_id integer NOT NULL,
    name character varying(255),
    description character varying(1000)
);


ALTER TABLE public.item_reference_type OWNER TO clinica;

--
-- Name: item_reference_type_item_reference_type_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.item_reference_type_item_reference_type_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.item_reference_type_item_reference_type_id_seq OWNER TO clinica;

--
-- Name: item_reference_type_item_reference_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.item_reference_type_item_reference_type_id_seq OWNED BY public.item_reference_type.item_reference_type_id;


--
-- Name: measurement_unit; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.measurement_unit (
    id integer NOT NULL,
    oc_oid character varying(40) NOT NULL,
    name character varying(100) NOT NULL,
    description character varying(255),
    version integer
);


ALTER TABLE public.measurement_unit OWNER TO clinica;

--
-- Name: measurement_unit_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.measurement_unit_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.measurement_unit_id_seq OWNER TO clinica;

--
-- Name: measurement_unit_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.measurement_unit_id_seq OWNED BY public.measurement_unit.id;


--
-- Name: null_value_type; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.null_value_type (
    null_value_type_id integer NOT NULL,
    code character varying(20),
    name character varying(255),
    definition character varying(1000),
    reference character varying(1000)
);


ALTER TABLE public.null_value_type OWNER TO clinica;

--
-- Name: null_value_type_null_value_type_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.null_value_type_null_value_type_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.null_value_type_null_value_type_id_seq OWNER TO clinica;

--
-- Name: null_value_type_null_value_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.null_value_type_null_value_type_id_seq OWNED BY public.null_value_type.null_value_type_id;


--
-- Name: oc_qrtz_blob_triggers; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_blob_triggers (
    trigger_name character varying(200) NOT NULL,
    trigger_group character varying(200) NOT NULL,
    blob_data bytea
);


ALTER TABLE public.oc_qrtz_blob_triggers OWNER TO clinica;

--
-- Name: oc_qrtz_calendars; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_calendars (
    calendar_name character varying(200) NOT NULL,
    sched_name character varying(120) DEFAULT 'TestScheduler'::character varying NOT NULL,
    calendar bytea
);


ALTER TABLE public.oc_qrtz_calendars OWNER TO clinica;

--
-- Name: oc_qrtz_cron_triggers; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_cron_triggers (
    trigger_name character varying(200) NOT NULL,
    trigger_group character varying(200) NOT NULL,
    cron_expression character varying(120) NOT NULL,
    time_zone_id character varying(80),
    sched_name character varying(120) DEFAULT 'TestScheduler'::character varying NOT NULL
);


ALTER TABLE public.oc_qrtz_cron_triggers OWNER TO clinica;

--
-- Name: oc_qrtz_fired_triggers; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_fired_triggers (
    entry_id character varying(95) NOT NULL,
    trigger_name character varying(200) NOT NULL,
    trigger_group character varying(200) NOT NULL,
    instance_name character varying(200) NOT NULL,
    fired_time bigint NOT NULL,
    priority integer NOT NULL,
    state character varying(16) NOT NULL,
    job_name character varying(200),
    job_group character varying(200),
    is_stateful boolean,
    requests_recovery boolean,
    sched_name character varying(120) DEFAULT 'TestScheduler'::character varying NOT NULL,
    is_nonconcurrent boolean,
    is_update_data boolean,
    sched_time bigint NOT NULL
);


ALTER TABLE public.oc_qrtz_fired_triggers OWNER TO clinica;

--
-- Name: oc_qrtz_job_details; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_job_details (
    job_name character varying(200) NOT NULL,
    job_group character varying(200) NOT NULL,
    description character varying(250),
    job_class_name character varying(250) NOT NULL,
    is_durable boolean NOT NULL,
    requests_recovery boolean NOT NULL,
    sched_name character varying(120) DEFAULT 'TestScheduler'::character varying NOT NULL,
    is_nonconcurrent boolean,
    is_update_data boolean,
    job_data bytea
);


ALTER TABLE public.oc_qrtz_job_details OWNER TO clinica;

--
-- Name: oc_qrtz_job_listeners; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_job_listeners (
    job_name character varying(200) NOT NULL,
    job_group character varying(200) NOT NULL,
    job_listener character varying(200) NOT NULL
);


ALTER TABLE public.oc_qrtz_job_listeners OWNER TO clinica;

--
-- Name: oc_qrtz_locks; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_locks (
    lock_name character varying(40) NOT NULL,
    sched_name character varying(120) DEFAULT 'TestScheduler'::character varying NOT NULL
);


ALTER TABLE public.oc_qrtz_locks OWNER TO clinica;

--
-- Name: oc_qrtz_paused_trigger_grps; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_paused_trigger_grps (
    trigger_group character varying(200) NOT NULL,
    sched_name character varying(120) DEFAULT 'TestScheduler'::character varying NOT NULL
);


ALTER TABLE public.oc_qrtz_paused_trigger_grps OWNER TO clinica;

--
-- Name: oc_qrtz_scheduler_state; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_scheduler_state (
    instance_name character varying(200) NOT NULL,
    last_checkin_time bigint NOT NULL,
    checkin_interval bigint NOT NULL,
    sched_name character varying(120) DEFAULT 'TestScheduler'::character varying NOT NULL
);


ALTER TABLE public.oc_qrtz_scheduler_state OWNER TO clinica;

--
-- Name: oc_qrtz_simple_triggers; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_simple_triggers (
    trigger_name character varying(200) NOT NULL,
    trigger_group character varying(200) NOT NULL,
    repeat_count bigint NOT NULL,
    repeat_interval bigint NOT NULL,
    times_triggered bigint NOT NULL,
    sched_name character varying(120) DEFAULT 'TestScheduler'::character varying NOT NULL
);


ALTER TABLE public.oc_qrtz_simple_triggers OWNER TO clinica;

--
-- Name: oc_qrtz_trigger_listeners; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_trigger_listeners (
    trigger_name character varying(200) NOT NULL,
    trigger_group character varying(200) NOT NULL,
    trigger_listener character varying(200) NOT NULL
);


ALTER TABLE public.oc_qrtz_trigger_listeners OWNER TO clinica;

--
-- Name: oc_qrtz_triggers; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.oc_qrtz_triggers (
    trigger_name character varying(200) NOT NULL,
    trigger_group character varying(200) NOT NULL,
    job_name character varying(200) NOT NULL,
    job_group character varying(200) NOT NULL,
    description character varying(250),
    next_fire_time bigint,
    prev_fire_time bigint,
    priority integer,
    trigger_state character varying(16) NOT NULL,
    trigger_type character varying(8) NOT NULL,
    start_time bigint NOT NULL,
    end_time bigint,
    calendar_name character varying(200),
    misfire_instr smallint,
    sched_name character varying(120) DEFAULT 'TestScheduler'::character varying NOT NULL,
    job_data bytea
);


ALTER TABLE public.oc_qrtz_triggers OWNER TO clinica;

--
-- Name: openclinica_version; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.openclinica_version (
    id integer NOT NULL,
    name character varying(255),
    build_number character varying(1000),
    version integer,
    update_timestamp timestamp without time zone
);


ALTER TABLE public.openclinica_version OWNER TO clinica;

--
-- Name: openclinica_version_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.openclinica_version_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.openclinica_version_id_seq OWNER TO clinica;

--
-- Name: openclinica_version_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.openclinica_version_id_seq OWNED BY public.openclinica_version.id;


--
-- Name: privilege; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.privilege (
    priv_id integer NOT NULL,
    priv_name character varying(50),
    priv_desc character varying(2000)
);


ALTER TABLE public.privilege OWNER TO clinica;

--
-- Name: privilege_priv_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.privilege_priv_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.privilege_priv_id_seq OWNER TO clinica;

--
-- Name: privilege_priv_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.privilege_priv_id_seq OWNED BY public.privilege.priv_id;


--
-- Name: resolution_status; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.resolution_status (
    resolution_status_id integer NOT NULL,
    name character varying(50),
    description character varying(255)
);


ALTER TABLE public.resolution_status OWNER TO clinica;

--
-- Name: resolution_status_resolution_status_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.resolution_status_resolution_status_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.resolution_status_resolution_status_id_seq OWNER TO clinica;

--
-- Name: resolution_status_resolution_status_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.resolution_status_resolution_status_id_seq OWNED BY public.resolution_status.resolution_status_id;


--
-- Name: response_set; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.response_set (
    response_set_id integer NOT NULL,
    response_type_id integer,
    label character varying(80),
    options_text character varying(4000),
    options_values character varying(4000),
    version_id integer
);


ALTER TABLE public.response_set OWNER TO clinica;

--
-- Name: response_set_response_set_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.response_set_response_set_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.response_set_response_set_id_seq OWNER TO clinica;

--
-- Name: response_set_response_set_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.response_set_response_set_id_seq OWNED BY public.response_set.response_set_id;


--
-- Name: response_type; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.response_type (
    response_type_id integer NOT NULL,
    name character varying(255),
    description character varying(1000)
);


ALTER TABLE public.response_type OWNER TO clinica;

--
-- Name: response_type_response_type_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.response_type_response_type_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.response_type_response_type_id_seq OWNER TO clinica;

--
-- Name: response_type_response_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.response_type_response_type_id_seq OWNED BY public.response_type.response_type_id;


--
-- Name: role_privilege_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.role_privilege_map (
    role_id integer NOT NULL,
    priv_id integer NOT NULL,
    priv_value character varying(50)
);


ALTER TABLE public.role_privilege_map OWNER TO clinica;

--
-- Name: rule; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule (
    id integer NOT NULL,
    name character varying(255),
    description character varying(255),
    oc_oid character varying(40),
    enabled boolean,
    rule_expression_id integer NOT NULL,
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    status_id integer,
    version integer,
    study_id integer
);


ALTER TABLE public.rule OWNER TO clinica;

--
-- Name: rule_action; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_action (
    id integer NOT NULL,
    rule_set_rule_id integer NOT NULL,
    action_type integer NOT NULL,
    expression_evaluates_to boolean NOT NULL,
    message character varying(2040),
    email_to character varying(255),
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    status_id integer,
    version integer,
    rule_action_run_id integer,
    oc_oid_reference character varying(4000),
    email_subject character varying(1020)
);


ALTER TABLE public.rule_action OWNER TO clinica;

--
-- Name: rule_action_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_action_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_action_id_seq OWNER TO clinica;

--
-- Name: rule_action_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_action_id_seq OWNED BY public.rule_action.id;


--
-- Name: rule_action_property; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_action_property (
    id integer NOT NULL,
    rule_action_id integer,
    oc_oid character varying(512),
    value character varying(512),
    version integer,
    rule_expression_id integer,
    property character varying(4000)
);


ALTER TABLE public.rule_action_property OWNER TO clinica;

--
-- Name: rule_action_property_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_action_property_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_action_property_id_seq OWNER TO clinica;

--
-- Name: rule_action_property_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_action_property_id_seq OWNED BY public.rule_action_property.id;


--
-- Name: rule_action_run; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_action_run (
    id integer NOT NULL,
    administrative_data_entry boolean,
    initial_data_entry boolean,
    double_data_entry boolean,
    import_data_entry boolean,
    batch boolean,
    version integer,
    not_started boolean,
    scheduled boolean,
    data_entry_started boolean,
    complete boolean,
    skipped boolean,
    stopped boolean
);


ALTER TABLE public.rule_action_run OWNER TO clinica;

--
-- Name: rule_action_run_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_action_run_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_action_run_id_seq OWNER TO clinica;

--
-- Name: rule_action_run_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_action_run_id_seq OWNED BY public.rule_action_run.id;


--
-- Name: rule_action_run_log; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_action_run_log (
    id integer NOT NULL,
    action_type integer,
    item_data_id integer,
    value character varying(4000),
    rule_oc_oid character varying(40),
    version integer
);


ALTER TABLE public.rule_action_run_log OWNER TO clinica;

--
-- Name: rule_action_run_log_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_action_run_log_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_action_run_log_id_seq OWNER TO clinica;

--
-- Name: rule_action_run_log_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_action_run_log_id_seq OWNED BY public.rule_action_run_log.id;


--
-- Name: rule_action_stratification_factor; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_action_stratification_factor (
    id integer NOT NULL,
    rule_action_id integer,
    version integer,
    rule_expression_id integer
);


ALTER TABLE public.rule_action_stratification_factor OWNER TO clinica;

--
-- Name: rule_action_stratification_factor_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_action_stratification_factor_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_action_stratification_factor_id_seq OWNER TO clinica;

--
-- Name: rule_action_stratification_factor_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_action_stratification_factor_id_seq OWNED BY public.rule_action_stratification_factor.id;


--
-- Name: rule_expression; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_expression (
    id integer NOT NULL,
    value character varying(2040) NOT NULL,
    context integer NOT NULL,
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    status_id integer,
    version integer
);


ALTER TABLE public.rule_expression OWNER TO clinica;

--
-- Name: rule_expression_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_expression_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_expression_id_seq OWNER TO clinica;

--
-- Name: rule_expression_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_expression_id_seq OWNED BY public.rule_expression.id;


--
-- Name: rule_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_id_seq OWNER TO clinica;

--
-- Name: rule_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_id_seq OWNED BY public.rule.id;


--
-- Name: rule_set; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_set (
    id integer NOT NULL,
    rule_expression_id integer NOT NULL,
    study_event_definition_id integer,
    crf_id integer,
    crf_version_id integer,
    study_id integer NOT NULL,
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    status_id integer,
    version integer,
    item_id integer,
    item_group_id integer,
    run_schedule boolean DEFAULT false,
    run_time character varying(255)
);


ALTER TABLE public.rule_set OWNER TO clinica;

--
-- Name: rule_set_audit; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_set_audit (
    id integer NOT NULL,
    rule_set_id integer NOT NULL,
    date_updated date,
    updater_id integer,
    status_id integer,
    version integer
);


ALTER TABLE public.rule_set_audit OWNER TO clinica;

--
-- Name: rule_set_audit_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_set_audit_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_set_audit_id_seq OWNER TO clinica;

--
-- Name: rule_set_audit_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_set_audit_id_seq OWNED BY public.rule_set_audit.id;


--
-- Name: rule_set_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_set_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_set_id_seq OWNER TO clinica;

--
-- Name: rule_set_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_set_id_seq OWNED BY public.rule_set.id;


--
-- Name: rule_set_rule; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_set_rule (
    id integer NOT NULL,
    rule_set_id integer NOT NULL,
    rule_id integer NOT NULL,
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    status_id integer,
    version integer
);


ALTER TABLE public.rule_set_rule OWNER TO clinica;

--
-- Name: rule_set_rule_audit; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.rule_set_rule_audit (
    id integer NOT NULL,
    rule_set_rule_id integer NOT NULL,
    date_updated date,
    updater_id integer,
    status_id integer,
    version integer
);


ALTER TABLE public.rule_set_rule_audit OWNER TO clinica;

--
-- Name: rule_set_rule_audit_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_set_rule_audit_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_set_rule_audit_id_seq OWNER TO clinica;

--
-- Name: rule_set_rule_audit_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_set_rule_audit_id_seq OWNED BY public.rule_set_rule_audit.id;


--
-- Name: rule_set_rule_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.rule_set_rule_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.rule_set_rule_id_seq OWNER TO clinica;

--
-- Name: rule_set_rule_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.rule_set_rule_id_seq OWNED BY public.rule_set_rule.id;


--
-- Name: scd_item_metadata; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.scd_item_metadata (
    id integer NOT NULL,
    scd_item_form_metadata_id integer,
    control_item_form_metadata_id integer,
    control_item_name character varying(255),
    option_value character varying(500),
    message character varying(3000),
    version integer
);


ALTER TABLE public.scd_item_metadata OWNER TO clinica;

--
-- Name: scd_item_metadata_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.scd_item_metadata_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.scd_item_metadata_id_seq OWNER TO clinica;

--
-- Name: scd_item_metadata_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.scd_item_metadata_id_seq OWNED BY public.scd_item_metadata.id;


--
-- Name: section; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.section (
    section_id integer NOT NULL,
    crf_version_id integer NOT NULL,
    status_id integer,
    label character varying(2000),
    title character varying(2000),
    subtitle character varying(2000),
    instructions character varying(2000),
    page_number_label character varying(5),
    ordinal integer,
    parent_id integer,
    date_created date,
    date_updated date,
    owner_id integer NOT NULL,
    update_id integer,
    borders integer
);


ALTER TABLE public.section OWNER TO clinica;

--
-- Name: section_section_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.section_section_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.section_section_id_seq OWNER TO clinica;

--
-- Name: section_section_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.section_section_id_seq OWNED BY public.section.section_id;


--
-- Name: status; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.status (
    status_id integer NOT NULL,
    name character varying(255),
    description character varying(1000)
);


ALTER TABLE public.status OWNER TO clinica;

--
-- Name: status_status_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.status_status_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.status_status_id_seq OWNER TO clinica;

--
-- Name: status_status_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.status_status_id_seq OWNED BY public.status.status_id;


--
-- Name: study; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study (
    study_id integer NOT NULL,
    parent_study_id integer,
    unique_identifier character varying(30),
    secondary_identifier character varying(255),
    name character varying(255),
    summary character varying(255),
    date_planned_start date,
    date_planned_end date,
    date_created date,
    date_updated date,
    owner_id integer,
    update_id integer,
    type_id integer,
    status_id integer,
    principal_investigator character varying(255),
    facility_name character varying(255),
    facility_city character varying(255),
    facility_state character varying(20),
    facility_zip character varying(64),
    facility_country character varying(64),
    facility_recruitment_status character varying(60),
    facility_contact_name character varying(255),
    facility_contact_degree character varying(255),
    facility_contact_phone character varying(255),
    facility_contact_email character varying(255),
    protocol_type character varying(30),
    protocol_description character varying(1000),
    protocol_date_verification date,
    phase character varying(30),
    expected_total_enrollment integer,
    sponsor character varying(255),
    collaborators character varying(1000),
    medline_identifier character varying(255),
    url character varying(255),
    url_description character varying(255),
    conditions character varying(500),
    keywords character varying(255),
    eligibility character varying(500),
    gender character varying(30),
    age_max character varying(3),
    age_min character varying(3),
    healthy_volunteer_accepted boolean,
    purpose character varying(64),
    allocation character varying(64),
    masking character varying(30),
    control character varying(30),
    assignment character varying(30),
    endpoint character varying(64),
    interventions character varying(1000),
    duration character varying(30),
    selection character varying(30),
    timing character varying(30),
    official_title character varying(255),
    results_reference boolean,
    oc_oid character varying(40) NOT NULL,
    old_status_id integer DEFAULT 1,
    mail_notification character varying(255) DEFAULT 'DISABLED'::character varying NOT NULL,
    contact_email character varying(255)
);


ALTER TABLE public.study OWNER TO clinica;

--
-- Name: study_event; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_event (
    study_event_id integer NOT NULL,
    study_event_definition_id integer,
    study_subject_id integer,
    location character varying(2000),
    sample_ordinal integer,
    date_start timestamp without time zone,
    date_end timestamp without time zone,
    owner_id integer,
    status_id integer,
    date_created timestamp with time zone,
    date_updated timestamp with time zone,
    update_id integer,
    subject_event_status_id integer,
    start_time_flag boolean,
    end_time_flag boolean
);


ALTER TABLE public.study_event OWNER TO clinica;

--
-- Name: study_event_definition; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_event_definition (
    study_event_definition_id integer NOT NULL,
    study_id integer,
    name character varying(2000),
    description character varying(2000),
    repeating boolean,
    type character varying(20),
    category character varying(2000),
    owner_id integer,
    status_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    ordinal integer,
    oc_oid character varying(40) NOT NULL
);


ALTER TABLE public.study_event_definition OWNER TO clinica;

--
-- Name: study_event_definition_study_event_definition_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_event_definition_study_event_definition_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_event_definition_study_event_definition_id_seq OWNER TO clinica;

--
-- Name: study_event_definition_study_event_definition_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_event_definition_study_event_definition_id_seq OWNED BY public.study_event_definition.study_event_definition_id;


--
-- Name: study_event_study_event_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_event_study_event_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_event_study_event_id_seq OWNER TO clinica;

--
-- Name: study_event_study_event_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_event_study_event_id_seq OWNED BY public.study_event.study_event_id;


--
-- Name: study_group; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_group (
    study_group_id integer NOT NULL,
    name character varying(255),
    description character varying(1000),
    study_group_class_id integer
);


ALTER TABLE public.study_group OWNER TO clinica;

--
-- Name: study_group_class; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_group_class (
    study_group_class_id integer NOT NULL,
    name character varying(30),
    study_id integer,
    owner_id integer,
    date_created date,
    group_class_type_id integer,
    status_id integer,
    date_updated date,
    update_id integer,
    subject_assignment character varying(30)
);


ALTER TABLE public.study_group_class OWNER TO clinica;

--
-- Name: study_group_class_study_group_class_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_group_class_study_group_class_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_group_class_study_group_class_id_seq OWNER TO clinica;

--
-- Name: study_group_class_study_group_class_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_group_class_study_group_class_id_seq OWNED BY public.study_group_class.study_group_class_id;


--
-- Name: study_group_study_group_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_group_study_group_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_group_study_group_id_seq OWNER TO clinica;

--
-- Name: study_group_study_group_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_group_study_group_id_seq OWNED BY public.study_group.study_group_id;


--
-- Name: study_module_status; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_module_status (
    id integer NOT NULL,
    study_id integer,
    study integer DEFAULT 1,
    crf integer DEFAULT 1,
    event_definition integer DEFAULT 1,
    subject_group integer DEFAULT 1,
    rule integer DEFAULT 1,
    site integer DEFAULT 1,
    users integer DEFAULT 1,
    version integer,
    date_created date,
    date_updated date,
    owner_id integer,
    update_id integer,
    status_id integer
);


ALTER TABLE public.study_module_status OWNER TO clinica;

--
-- Name: study_module_status_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_module_status_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_module_status_id_seq OWNER TO clinica;

--
-- Name: study_module_status_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_module_status_id_seq OWNED BY public.study_module_status.id;


--
-- Name: study_parameter; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_parameter (
    study_parameter_id integer NOT NULL,
    handle character varying(50),
    name character varying(50),
    description character varying(255),
    default_value character varying(50),
    inheritable boolean DEFAULT true,
    overridable boolean
);


ALTER TABLE public.study_parameter OWNER TO clinica;

--
-- Name: study_parameter_study_parameter_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_parameter_study_parameter_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_parameter_study_parameter_id_seq OWNER TO clinica;

--
-- Name: study_parameter_study_parameter_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_parameter_study_parameter_id_seq OWNED BY public.study_parameter.study_parameter_id;


--
-- Name: study_parameter_value; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_parameter_value (
    study_parameter_value_id integer NOT NULL,
    study_id integer,
    value character varying(50),
    parameter character varying(50)
);


ALTER TABLE public.study_parameter_value OWNER TO clinica;

--
-- Name: study_parameter_value_study_parameter_value_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_parameter_value_study_parameter_value_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_parameter_value_study_parameter_value_id_seq OWNER TO clinica;

--
-- Name: study_parameter_value_study_parameter_value_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_parameter_value_study_parameter_value_id_seq OWNED BY public.study_parameter_value.study_parameter_value_id;


--
-- Name: study_study_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_study_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_study_id_seq OWNER TO clinica;

--
-- Name: study_study_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_study_id_seq OWNED BY public.study.study_id;


--
-- Name: study_subject; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_subject (
    study_subject_id integer NOT NULL,
    label character varying(30),
    secondary_label character varying(30),
    subject_id integer,
    study_id integer,
    status_id integer,
    enrollment_date date,
    date_created timestamp with time zone,
    date_updated timestamp with time zone,
    owner_id integer,
    update_id integer,
    oc_oid character varying(40) NOT NULL,
    time_zone character varying(255) DEFAULT ''::character varying
);


ALTER TABLE public.study_subject OWNER TO clinica;

--
-- Name: study_subject_study_subject_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_subject_study_subject_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_subject_study_subject_id_seq OWNER TO clinica;

--
-- Name: study_subject_study_subject_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_subject_study_subject_id_seq OWNED BY public.study_subject.study_subject_id;


--
-- Name: study_type; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_type (
    study_type_id integer NOT NULL,
    name character varying(255),
    description character varying(1000)
);


ALTER TABLE public.study_type OWNER TO clinica;

--
-- Name: study_type_study_type_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.study_type_study_type_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.study_type_study_type_id_seq OWNER TO clinica;

--
-- Name: study_type_study_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.study_type_study_type_id_seq OWNED BY public.study_type.study_type_id;


--
-- Name: study_user_role; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.study_user_role (
    role_name character varying(40),
    study_id integer,
    status_id integer,
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    user_name character varying(40)
);


ALTER TABLE public.study_user_role OWNER TO clinica;

--
-- Name: subject; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.subject (
    subject_id integer NOT NULL,
    father_id integer,
    mother_id integer,
    status_id integer,
    date_of_birth date,
    gender character(1),
    unique_identifier character varying(255),
    date_created timestamp with time zone,
    owner_id integer,
    date_updated timestamp with time zone,
    update_id integer,
    dob_collected boolean
);


ALTER TABLE public.subject OWNER TO clinica;

--
-- Name: subject_event_status; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.subject_event_status (
    subject_event_status_id integer NOT NULL,
    name character varying(255),
    description character varying(1000)
);


ALTER TABLE public.subject_event_status OWNER TO clinica;

--
-- Name: subject_event_status_subject_event_status_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.subject_event_status_subject_event_status_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.subject_event_status_subject_event_status_id_seq OWNER TO clinica;

--
-- Name: subject_event_status_subject_event_status_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.subject_event_status_subject_event_status_id_seq OWNED BY public.subject_event_status.subject_event_status_id;


--
-- Name: subject_group_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.subject_group_map (
    subject_group_map_id integer NOT NULL,
    study_group_class_id integer,
    study_subject_id integer,
    study_group_id integer,
    status_id integer,
    owner_id integer,
    date_created date,
    date_updated date,
    update_id integer,
    notes character varying(255)
);


ALTER TABLE public.subject_group_map OWNER TO clinica;

--
-- Name: subject_group_map_subject_group_map_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.subject_group_map_subject_group_map_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.subject_group_map_subject_group_map_id_seq OWNER TO clinica;

--
-- Name: subject_group_map_subject_group_map_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.subject_group_map_subject_group_map_id_seq OWNED BY public.subject_group_map.subject_group_map_id;


--
-- Name: subject_subject_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.subject_subject_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.subject_subject_id_seq OWNER TO clinica;

--
-- Name: subject_subject_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.subject_subject_id_seq OWNED BY public.subject.subject_id;


--
-- Name: tag; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.tag (
    id integer NOT NULL,
    tag_name character varying(255),
    workflow character varying(255),
    owner_id integer,
    update_id integer,
    date_created timestamp with time zone,
    date_updated timestamp with time zone
);


ALTER TABLE public.tag OWNER TO clinica;

--
-- Name: tag_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.tag_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.tag_id_seq OWNER TO clinica;

--
-- Name: tag_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.tag_id_seq OWNED BY public.tag.id;


--
-- Name: usage_statistics_data; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.usage_statistics_data (
    id integer NOT NULL,
    param_key character varying(255),
    param_value character varying(1000),
    update_timestamp timestamp without time zone,
    version integer
);


ALTER TABLE public.usage_statistics_data OWNER TO clinica;

--
-- Name: usage_statistics_data_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.usage_statistics_data_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.usage_statistics_data_id_seq OWNER TO clinica;

--
-- Name: usage_statistics_data_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.usage_statistics_data_id_seq OWNED BY public.usage_statistics_data.id;


--
-- Name: user_account; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.user_account (
    user_id integer NOT NULL,
    user_name character varying(64),
    passwd character varying(255),
    first_name character varying(50),
    last_name character varying(50),
    email character varying(120),
    active_study integer,
    institutional_affiliation character varying(255),
    status_id integer,
    owner_id integer,
    date_created date,
    date_updated date,
    date_lastvisit timestamp without time zone,
    passwd_timestamp date,
    passwd_challenge_question character varying(64),
    passwd_challenge_answer character varying(255),
    phone character varying(64),
    user_type_id integer,
    update_id integer,
    enabled boolean DEFAULT true NOT NULL,
    account_non_locked boolean DEFAULT true NOT NULL,
    lock_counter integer DEFAULT 0 NOT NULL,
    run_webservices boolean DEFAULT false NOT NULL,
    access_code character varying(64),
    time_zone character varying(255) DEFAULT ''::character varying,
    enable_api_key boolean DEFAULT false,
    api_key character varying(255),
    authtype character varying(255) DEFAULT 'STANDARD'::character varying NOT NULL,
    authsecret character varying(255)
);


ALTER TABLE public.user_account OWNER TO clinica;

--
-- Name: user_account_user_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.user_account_user_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.user_account_user_id_seq OWNER TO clinica;

--
-- Name: user_account_user_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.user_account_user_id_seq OWNED BY public.user_account.user_id;


--
-- Name: user_role; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.user_role (
    role_id integer NOT NULL,
    role_name character varying(50) NOT NULL,
    parent_id integer,
    role_desc character varying(2000)
);


ALTER TABLE public.user_role OWNER TO clinica;

--
-- Name: user_role_role_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.user_role_role_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.user_role_role_id_seq OWNER TO clinica;

--
-- Name: user_role_role_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.user_role_role_id_seq OWNED BY public.user_role.role_id;


--
-- Name: user_type; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.user_type (
    user_type_id integer NOT NULL,
    user_type character varying(50)
);


ALTER TABLE public.user_type OWNER TO clinica;

--
-- Name: user_type_user_type_id_seq; Type: SEQUENCE; Schema: public; Owner: clinica
--

CREATE SEQUENCE public.user_type_user_type_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.user_type_user_type_id_seq OWNER TO clinica;

--
-- Name: user_type_user_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: clinica
--

ALTER SEQUENCE public.user_type_user_type_id_seq OWNED BY public.user_type.user_type_id;


--
-- Name: versioning_map; Type: TABLE; Schema: public; Owner: clinica
--

CREATE TABLE public.versioning_map (
    crf_version_id integer,
    item_id integer
);


ALTER TABLE public.versioning_map OWNER TO clinica;

--
-- Name: view_dn_stats; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_dn_stats AS
 SELECT dn.discrepancy_note_id,
        CASE
            WHEN ((dn.resolution_status_id = 1) OR (dn.resolution_status_id = 2) OR (dn.resolution_status_id = 3)) THEN date_part('day'::text, (CURRENT_TIMESTAMP - totals.date_updated))
            ELSE (NULL::integer)::double precision
        END AS days,
        CASE
            WHEN ((dn.resolution_status_id = 1) OR (dn.resolution_status_id = 2) OR (dn.resolution_status_id = 3)) THEN date_part('day'::text, (CURRENT_TIMESTAMP - dn.date_created))
            WHEN (dn.resolution_status_id = 4) THEN date_part('day'::text, (totals.date_updated - dn.date_created))
            ELSE (NULL::integer)::double precision
        END AS age,
    totals.total_notes,
    dn.date_created,
    totals.date_updated
   FROM public.discrepancy_note dn,
    ( SELECT dn1.parent_dn_id,
            max(dn1.date_created) AS date_updated,
            count(dn1.discrepancy_note_id) AS total_notes
           FROM public.discrepancy_note dn1
          GROUP BY dn1.parent_dn_id) totals
  WHERE (((dn.parent_dn_id IS NULL) OR (dn.parent_dn_id = 0)) AND (dn.discrepancy_note_id = totals.parent_dn_id));


ALTER TABLE public.view_dn_stats OWNER TO clinica;

--
-- Name: view_dn_event_crf; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_dn_event_crf AS
 SELECT s.study_id,
    s.parent_study_id,
    ( SELECT event_definition_crf.hide_crf
           FROM public.event_definition_crf
          WHERE ((event_definition_crf.study_event_definition_id = sed.study_event_definition_id) AND ((event_definition_crf.study_id = s.study_id) OR (event_definition_crf.study_id = s.parent_study_id)) AND (event_definition_crf.crf_id = c.crf_id) AND ((event_definition_crf.parent_id = 0) OR (event_definition_crf.parent_id IS NULL)))) AS study_hide_crf,
    ( SELECT event_definition_crf.hide_crf
           FROM public.event_definition_crf
          WHERE ((event_definition_crf.study_event_definition_id = sed.study_event_definition_id) AND (event_definition_crf.study_id = s.study_id) AND (event_definition_crf.crf_id = c.crf_id) AND ((event_definition_crf.parent_id <> 0) OR (event_definition_crf.parent_id IS NOT NULL)))) AS site_hide_crf,
    dn.discrepancy_note_id,
    map.event_crf_id AS entity_id,
    map.column_name,
    ss.study_subject_id,
    ss.label,
    ss.status_id AS ss_status_id,
    dn.discrepancy_note_type_id,
    dn.resolution_status_id,
    s.unique_identifier AS site_id,
    ds.date_created,
    ds.date_updated,
    ds.days,
    ds.age,
    sed.name AS event_name,
    se.date_start,
    c.name AS crf_name,
    ec.status_id,
    NULL::integer AS item_id,
    map.column_name AS entity_name,
        CASE
            WHEN ((map.column_name)::text = 'date_interviewed'::text) THEN to_char((ec.date_interviewed)::timestamp with time zone, 'YYYY-MM-DD'::text)
            WHEN ((map.column_name)::text = 'interviewer_name'::text) THEN (ec.interviewer_name)::text
            ELSE btrim(''::text)
        END AS value,
    dn.entity_type,
    dn.description,
    dn.detailed_notes,
    ds.total_notes,
    ua.first_name,
    ua.last_name,
    ua.user_name,
    ua2.first_name AS owner_first_name,
    ua2.last_name AS owner_last_name,
    ua2.user_name AS owner_user_name
   FROM (((((((((((public.dn_event_crf_map map
     JOIN public.discrepancy_note dn ON (((dn.discrepancy_note_id = map.discrepancy_note_id) AND ((dn.entity_type)::text = 'eventCrf'::text) AND ((dn.parent_dn_id IS NULL) OR (dn.parent_dn_id = 0)))))
     JOIN public.view_dn_stats ds ON ((dn.discrepancy_note_id = ds.discrepancy_note_id)))
     JOIN public.user_account ua2 ON ((dn.owner_id = ua2.user_id)))
     JOIN public.event_crf ec ON ((map.event_crf_id = ec.event_crf_id)))
     JOIN public.study_event se ON ((ec.study_event_id = se.study_event_id)))
     JOIN public.crf_version cv ON ((ec.crf_version_id = cv.crf_version_id)))
     JOIN public.study_event_definition sed ON ((se.study_event_definition_id = sed.study_event_definition_id)))
     JOIN public.crf c ON ((cv.crf_id = c.crf_id)))
     JOIN public.study_subject ss ON ((se.study_subject_id = ss.study_subject_id)))
     JOIN public.study s ON ((ss.study_id = s.study_id)))
     LEFT JOIN public.user_account ua ON ((dn.assigned_user_id = ua.user_id)));


ALTER TABLE public.view_dn_event_crf OWNER TO clinica;

--
-- Name: view_dn_item_data; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_dn_item_data AS
 SELECT s.study_id,
    s.parent_study_id,
    ( SELECT event_definition_crf.hide_crf
           FROM public.event_definition_crf
          WHERE ((event_definition_crf.study_event_definition_id = sed.study_event_definition_id) AND ((event_definition_crf.study_id = s.study_id) OR (event_definition_crf.study_id = s.parent_study_id)) AND (event_definition_crf.crf_id = c.crf_id) AND ((event_definition_crf.parent_id = 0) OR (event_definition_crf.parent_id IS NULL)))) AS study_hide_crf,
    ( SELECT event_definition_crf.hide_crf
           FROM public.event_definition_crf
          WHERE ((event_definition_crf.study_event_definition_id = sed.study_event_definition_id) AND (event_definition_crf.study_id = s.study_id) AND (event_definition_crf.crf_id = c.crf_id) AND ((event_definition_crf.parent_id <> 0) OR (event_definition_crf.parent_id IS NOT NULL)))) AS site_hide_crf,
    dn.discrepancy_note_id,
    map.item_data_id AS entity_id,
    map.column_name,
    ss.study_subject_id,
    ss.label,
    ss.status_id AS ss_status_id,
    dn.discrepancy_note_type_id,
    dn.resolution_status_id,
    s.unique_identifier AS site_id,
    ds.date_created,
    ds.date_updated,
    ds.days,
    ds.age,
    sed.name AS event_name,
    se.date_start,
    c.name AS crf_name,
    ec.status_id,
    i.item_id,
    i.name AS entity_name,
    id.value,
    dn.entity_type,
    dn.description,
    dn.detailed_notes,
    ds.total_notes,
    ua.first_name,
    ua.last_name,
    ua.user_name,
    ua2.first_name AS owner_first_name,
    ua2.last_name AS owner_last_name,
    ua2.user_name AS owner_user_name
   FROM (((((((((((((public.dn_item_data_map map
     JOIN public.discrepancy_note dn ON (((dn.discrepancy_note_id = map.discrepancy_note_id) AND ((dn.entity_type)::text = 'itemData'::text) AND ((dn.parent_dn_id IS NULL) OR (dn.parent_dn_id = 0)))))
     JOIN public.view_dn_stats ds ON ((dn.discrepancy_note_id = ds.discrepancy_note_id)))
     JOIN public.user_account ua2 ON ((dn.owner_id = ua2.user_id)))
     JOIN public.item_data id ON ((map.item_data_id = id.item_data_id)))
     JOIN public.item i ON ((id.item_id = i.item_id)))
     JOIN public.event_crf ec ON ((id.event_crf_id = ec.event_crf_id)))
     JOIN public.study_event se ON ((ec.study_event_id = se.study_event_id)))
     JOIN public.crf_version cv ON ((ec.crf_version_id = cv.crf_version_id)))
     JOIN public.study_event_definition sed ON ((se.study_event_definition_id = sed.study_event_definition_id)))
     JOIN public.crf c ON ((cv.crf_id = c.crf_id)))
     JOIN public.study_subject ss ON ((se.study_subject_id = ss.study_subject_id)))
     JOIN public.study s ON ((ss.study_id = s.study_id)))
     LEFT JOIN public.user_account ua ON ((dn.assigned_user_id = ua.user_id)))
  WHERE (map.study_subject_id = ss.study_subject_id);


ALTER TABLE public.view_dn_item_data OWNER TO clinica;

--
-- Name: view_dn_study_event; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_dn_study_event AS
 SELECT s.study_id,
    s.parent_study_id,
    false AS study_hide_crf,
    false AS site_hide_crf,
    dn.discrepancy_note_id,
    map.study_event_id AS entity_id,
    map.column_name,
    ss.study_subject_id,
    ss.label,
    ss.status_id AS ss_status_id,
    dn.discrepancy_note_type_id,
    dn.resolution_status_id,
    s.unique_identifier AS site_id,
    ds.date_created,
    ds.date_updated,
    ds.days,
    ds.age,
    sed.name AS event_name,
    se.date_start,
    btrim(''::text) AS crf_name,
    0 AS status_id,
    NULL::integer AS item_id,
    map.column_name AS entity_name,
        CASE
            WHEN ((map.column_name)::text = 'start_date'::text) THEN to_char(se.date_start, 'YYYY-MM-DD'::text)
            WHEN ((map.column_name)::text = 'end_date'::text) THEN to_char(se.date_end, 'YYYY-MM-DD'::text)
            WHEN ((map.column_name)::text = 'location'::text) THEN (se.location)::text
            ELSE btrim(''::text)
        END AS value,
    dn.entity_type,
    dn.description,
    dn.detailed_notes,
    ds.total_notes,
    ua.first_name,
    ua.last_name,
    ua.user_name,
    ua2.first_name AS owner_first_name,
    ua2.last_name AS owner_last_name,
    ua2.user_name AS owner_user_name
   FROM ((((((((public.dn_study_event_map map
     JOIN public.discrepancy_note dn ON (((dn.discrepancy_note_id = map.discrepancy_note_id) AND ((dn.entity_type)::text = 'studyEvent'::text) AND ((dn.parent_dn_id IS NULL) OR (dn.parent_dn_id = 0)))))
     JOIN public.view_dn_stats ds ON ((dn.discrepancy_note_id = ds.discrepancy_note_id)))
     JOIN public.user_account ua2 ON ((dn.owner_id = ua2.user_id)))
     JOIN public.study_event se ON ((map.study_event_id = se.study_event_id)))
     JOIN public.study_subject ss ON ((se.study_subject_id = ss.study_subject_id)))
     JOIN public.study s ON ((ss.study_id = s.study_id)))
     JOIN public.study_event_definition sed ON ((se.study_event_definition_id = sed.study_event_definition_id)))
     LEFT JOIN public.user_account ua ON ((dn.assigned_user_id = ua.user_id)));


ALTER TABLE public.view_dn_study_event OWNER TO clinica;

--
-- Name: view_dn_study_subject; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_dn_study_subject AS
 SELECT s.study_id,
    s.parent_study_id,
    false AS study_hide_crf,
    false AS site_hide_crf,
    dn.discrepancy_note_id,
    map.study_subject_id AS entity_id,
    map.column_name,
    ss.study_subject_id,
    ss.label,
    ss.status_id AS ss_status_id,
    dn.discrepancy_note_type_id,
    dn.resolution_status_id,
    s.unique_identifier AS site_id,
    ds.date_created,
    ds.date_updated,
    ds.days,
    ds.age,
    btrim(''::text) AS event_name,
    NULL::timestamp with time zone AS date_start,
    btrim(''::text) AS crf_name,
    0 AS status_id,
    NULL::integer AS item_id,
    map.column_name AS entity_name,
    to_char((ss.enrollment_date)::timestamp with time zone, 'YYYY-MM-DD'::text) AS value,
    dn.entity_type,
    dn.description,
    dn.detailed_notes,
    ds.total_notes,
    ua.first_name,
    ua.last_name,
    ua.user_name,
    ua2.first_name AS owner_first_name,
    ua2.last_name AS owner_last_name,
    ua2.user_name AS owner_user_name
   FROM ((((((public.dn_study_subject_map map
     JOIN public.discrepancy_note dn ON (((dn.discrepancy_note_id = map.discrepancy_note_id) AND ((dn.entity_type)::text = 'studySub'::text) AND ((dn.parent_dn_id IS NULL) OR (dn.parent_dn_id = 0)))))
     JOIN public.view_dn_stats ds ON ((dn.discrepancy_note_id = ds.discrepancy_note_id)))
     JOIN public.user_account ua2 ON ((dn.owner_id = ua2.user_id)))
     JOIN public.study_subject ss ON ((map.study_subject_id = ss.study_subject_id)))
     JOIN public.study s ON ((ss.study_id = s.study_id)))
     LEFT JOIN public.user_account ua ON ((dn.assigned_user_id = ua.user_id)));


ALTER TABLE public.view_dn_study_subject OWNER TO clinica;

--
-- Name: view_dn_subject; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_dn_subject AS
 SELECT s.study_id,
    s.parent_study_id,
    false AS study_hide_crf,
    false AS site_hide_crf,
    dn.discrepancy_note_id,
    map.subject_id AS entity_id,
    map.column_name,
    ss.study_subject_id,
    ss.label,
    ss.status_id AS ss_status_id,
    dn.discrepancy_note_type_id,
    dn.resolution_status_id,
    s.unique_identifier AS site_id,
    ds.date_created,
    ds.date_updated,
    ds.days,
    ds.age,
    btrim(''::text) AS event_name,
    NULL::timestamp with time zone AS date_start,
    btrim(''::text) AS crf_name,
    0 AS status_id,
    NULL::integer AS item_id,
    map.column_name AS entity_name,
        CASE
            WHEN ((map.column_name)::text = 'unique_identifier'::text) THEN (su.unique_identifier)::text
            WHEN ((map.column_name)::text = 'gender'::text) THEN (su.gender)::text
            WHEN ((map.column_name)::text = 'date_of_birth'::text) THEN to_char((su.date_of_birth)::timestamp with time zone, 'YYYY-MM-DD'::text)
            ELSE btrim(''::text)
        END AS value,
    dn.entity_type,
    dn.description,
    dn.detailed_notes,
    ds.total_notes,
    ua.first_name,
    ua.last_name,
    ua.user_name,
    ua2.first_name AS owner_first_name,
    ua2.last_name AS owner_last_name,
    ua2.user_name AS owner_user_name
   FROM (((((((public.dn_subject_map map
     JOIN public.discrepancy_note dn ON (((dn.discrepancy_note_id = map.discrepancy_note_id) AND ((dn.entity_type)::text = 'subject'::text) AND ((dn.parent_dn_id IS NULL) OR (dn.parent_dn_id = 0)))))
     JOIN public.view_dn_stats ds ON ((dn.discrepancy_note_id = ds.discrepancy_note_id)))
     JOIN public.user_account ua2 ON ((dn.owner_id = ua2.user_id)))
     JOIN public.subject su ON ((map.subject_id = su.subject_id)))
     JOIN public.study_subject ss ON ((su.subject_id = ss.subject_id)))
     JOIN public.study s ON ((ss.study_id = s.study_id)))
     LEFT JOIN public.user_account ua ON ((dn.assigned_user_id = ua.user_id)));


ALTER TABLE public.view_dn_subject OWNER TO clinica;

--
-- Name: view_discrepancy_note; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_discrepancy_note AS
 SELECT view_dn_item_data.study_id,
    view_dn_item_data.parent_study_id,
    view_dn_item_data.study_hide_crf,
    view_dn_item_data.site_hide_crf,
    view_dn_item_data.discrepancy_note_id,
    view_dn_item_data.entity_id,
    view_dn_item_data.column_name,
    view_dn_item_data.study_subject_id,
    view_dn_item_data.label,
    view_dn_item_data.ss_status_id,
    view_dn_item_data.discrepancy_note_type_id,
    view_dn_item_data.resolution_status_id,
    view_dn_item_data.site_id,
    view_dn_item_data.date_created,
    view_dn_item_data.date_updated,
    view_dn_item_data.days,
    view_dn_item_data.age,
    view_dn_item_data.event_name,
    view_dn_item_data.date_start,
    view_dn_item_data.crf_name,
    view_dn_item_data.status_id,
    view_dn_item_data.item_id,
    view_dn_item_data.entity_name,
    view_dn_item_data.value,
    view_dn_item_data.entity_type,
    view_dn_item_data.description,
    view_dn_item_data.detailed_notes,
    view_dn_item_data.total_notes,
    view_dn_item_data.first_name,
    view_dn_item_data.last_name,
    view_dn_item_data.user_name,
    view_dn_item_data.owner_first_name,
    view_dn_item_data.owner_last_name,
    view_dn_item_data.owner_user_name
   FROM public.view_dn_item_data
UNION ALL
 SELECT view_dn_event_crf.study_id,
    view_dn_event_crf.parent_study_id,
    view_dn_event_crf.study_hide_crf,
    view_dn_event_crf.site_hide_crf,
    view_dn_event_crf.discrepancy_note_id,
    view_dn_event_crf.entity_id,
    view_dn_event_crf.column_name,
    view_dn_event_crf.study_subject_id,
    view_dn_event_crf.label,
    view_dn_event_crf.ss_status_id,
    view_dn_event_crf.discrepancy_note_type_id,
    view_dn_event_crf.resolution_status_id,
    view_dn_event_crf.site_id,
    view_dn_event_crf.date_created,
    view_dn_event_crf.date_updated,
    view_dn_event_crf.days,
    view_dn_event_crf.age,
    view_dn_event_crf.event_name,
    view_dn_event_crf.date_start,
    view_dn_event_crf.crf_name,
    view_dn_event_crf.status_id,
    view_dn_event_crf.item_id,
    view_dn_event_crf.entity_name,
    view_dn_event_crf.value,
    view_dn_event_crf.entity_type,
    view_dn_event_crf.description,
    view_dn_event_crf.detailed_notes,
    view_dn_event_crf.total_notes,
    view_dn_event_crf.first_name,
    view_dn_event_crf.last_name,
    view_dn_event_crf.user_name,
    view_dn_event_crf.owner_first_name,
    view_dn_event_crf.owner_last_name,
    view_dn_event_crf.owner_user_name
   FROM public.view_dn_event_crf
UNION ALL
 SELECT view_dn_study_event.study_id,
    view_dn_study_event.parent_study_id,
    view_dn_study_event.study_hide_crf,
    view_dn_study_event.site_hide_crf,
    view_dn_study_event.discrepancy_note_id,
    view_dn_study_event.entity_id,
    view_dn_study_event.column_name,
    view_dn_study_event.study_subject_id,
    view_dn_study_event.label,
    view_dn_study_event.ss_status_id,
    view_dn_study_event.discrepancy_note_type_id,
    view_dn_study_event.resolution_status_id,
    view_dn_study_event.site_id,
    view_dn_study_event.date_created,
    view_dn_study_event.date_updated,
    view_dn_study_event.days,
    view_dn_study_event.age,
    view_dn_study_event.event_name,
    view_dn_study_event.date_start,
    view_dn_study_event.crf_name,
    view_dn_study_event.status_id,
    view_dn_study_event.item_id,
    view_dn_study_event.entity_name,
    view_dn_study_event.value,
    view_dn_study_event.entity_type,
    view_dn_study_event.description,
    view_dn_study_event.detailed_notes,
    view_dn_study_event.total_notes,
    view_dn_study_event.first_name,
    view_dn_study_event.last_name,
    view_dn_study_event.user_name,
    view_dn_study_event.owner_first_name,
    view_dn_study_event.owner_last_name,
    view_dn_study_event.owner_user_name
   FROM public.view_dn_study_event
UNION ALL
 SELECT view_dn_study_subject.study_id,
    view_dn_study_subject.parent_study_id,
    view_dn_study_subject.study_hide_crf,
    view_dn_study_subject.site_hide_crf,
    view_dn_study_subject.discrepancy_note_id,
    view_dn_study_subject.entity_id,
    view_dn_study_subject.column_name,
    view_dn_study_subject.study_subject_id,
    view_dn_study_subject.label,
    view_dn_study_subject.ss_status_id,
    view_dn_study_subject.discrepancy_note_type_id,
    view_dn_study_subject.resolution_status_id,
    view_dn_study_subject.site_id,
    view_dn_study_subject.date_created,
    view_dn_study_subject.date_updated,
    view_dn_study_subject.days,
    view_dn_study_subject.age,
    view_dn_study_subject.event_name,
    view_dn_study_subject.date_start,
    view_dn_study_subject.crf_name,
    view_dn_study_subject.status_id,
    view_dn_study_subject.item_id,
    view_dn_study_subject.entity_name,
    view_dn_study_subject.value,
    view_dn_study_subject.entity_type,
    view_dn_study_subject.description,
    view_dn_study_subject.detailed_notes,
    view_dn_study_subject.total_notes,
    view_dn_study_subject.first_name,
    view_dn_study_subject.last_name,
    view_dn_study_subject.user_name,
    view_dn_study_subject.owner_first_name,
    view_dn_study_subject.owner_last_name,
    view_dn_study_subject.owner_user_name
   FROM public.view_dn_study_subject
UNION ALL
 SELECT view_dn_subject.study_id,
    view_dn_subject.parent_study_id,
    view_dn_subject.study_hide_crf,
    view_dn_subject.site_hide_crf,
    view_dn_subject.discrepancy_note_id,
    view_dn_subject.entity_id,
    view_dn_subject.column_name,
    view_dn_subject.study_subject_id,
    view_dn_subject.label,
    view_dn_subject.ss_status_id,
    view_dn_subject.discrepancy_note_type_id,
    view_dn_subject.resolution_status_id,
    view_dn_subject.site_id,
    view_dn_subject.date_created,
    view_dn_subject.date_updated,
    view_dn_subject.days,
    view_dn_subject.age,
    view_dn_subject.event_name,
    view_dn_subject.date_start,
    view_dn_subject.crf_name,
    view_dn_subject.status_id,
    view_dn_subject.item_id,
    view_dn_subject.entity_name,
    view_dn_subject.value,
    view_dn_subject.entity_type,
    view_dn_subject.description,
    view_dn_subject.detailed_notes,
    view_dn_subject.total_notes,
    view_dn_subject.first_name,
    view_dn_subject.last_name,
    view_dn_subject.user_name,
    view_dn_subject.owner_first_name,
    view_dn_subject.owner_last_name,
    view_dn_subject.owner_user_name
   FROM public.view_dn_subject;


ALTER TABLE public.view_discrepancy_note OWNER TO clinica;

--
-- Name: view_item_data_toolkit; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_item_data_toolkit AS
 SELECT DISTINCT id.item_data_id,
        CASE
            WHEN (s.parent_study_id IS NULL) THEN 0
            ELSE s.parent_study_id
        END AS parent_study_id,
    s.study_id,
    ss.label AS study_subject_id,
    ss.oc_oid AS ss_oid,
    sed.name AS study_event_defn,
    sed.oc_oid AS sed_oid,
    se.sample_ordinal AS event_ordinal,
    c.name AS crf_name,
    c.oc_oid AS crf_oid,
    ig.name AS group_name,
    ig.oc_oid AS group_oid,
    id.ordinal AS group_ordinal,
    i.oc_oid AS item_oid,
    ifm.left_item_text,
    id.value,
    ec.event_crf_id,
    ec.status_id AS event_crf_status_id
   FROM (((((((((((public.item_data id
     JOIN public.item i ON ((id.item_id = i.item_id)))
     JOIN public.item_form_metadata ifm ON ((ifm.item_id = i.item_id)))
     JOIN public.event_crf ec ON ((id.event_crf_id = ec.event_crf_id)))
     JOIN public.study_subject ss ON ((ss.study_subject_id = ec.study_subject_id)))
     JOIN public.study s ON ((s.study_id = ss.study_id)))
     JOIN public.crf_version cv ON ((ec.crf_version_id = cv.crf_version_id)))
     JOIN public.crf c ON ((c.crf_id = cv.crf_id)))
     JOIN public.item_group_metadata igm ON ((igm.item_id = id.item_id)))
     JOIN public.item_group ig ON ((ig.item_group_id = igm.item_group_id)))
     JOIN public.study_event se ON ((se.study_event_id = ec.study_event_id)))
     JOIN public.study_event_definition sed ON ((sed.study_event_definition_id = se.study_event_definition_id)))
  ORDER BY id.item_data_id;


ALTER TABLE public.view_item_data_toolkit OWNER TO clinica;

--
-- Name: view_item_data_toolkit_filtered; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_item_data_toolkit_filtered AS
 SELECT DISTINCT view.item_data_id,
    view.parent_study_id,
    view.study_id,
    view.study_subject_id,
    view.ss_oid,
    view.study_event_defn,
    view.sed_oid,
    view.event_ordinal,
    view.crf_name,
    view.crf_oid,
    view.group_name,
    view.group_oid,
    view.group_ordinal,
    view.item_oid,
    view.left_item_text,
    view.value,
    view.event_crf_id,
    view.event_crf_status_id,
    edci_tag.path,
    edc_tag.tag_id,
    idfw.workflow_status AS item_data_workflow_status
   FROM ((((((public.view_item_data_toolkit view
     JOIN public.event_definition_crf_tag edc_tag ON (((edc_tag.path)::text = (((view.sed_oid)::text || '.'::text) || (view.crf_oid)::text))))
     LEFT JOIN public.event_definition_crf_item_tag edci_tag ON ((((edci_tag.path)::text = (((((((view.sed_oid)::text || '.'::text) || (view.crf_oid)::text) || '.'::text) || (view.group_oid)::text) || '.'::text) || (view.item_oid)::text)) AND (edci_tag.active = true) AND (edci_tag.tag_id = edc_tag.tag_id))))
     LEFT JOIN public.item_data_flag id_flag ON (((id_flag.path)::text = (((((((((((((view.ss_oid)::text || '.'::text) || (view.sed_oid)::text) || '.'::text) || (view.event_ordinal)::text) || '.'::text) || (view.crf_oid)::text) || '.'::text) || (view.group_oid)::text) || '.'::text) || (view.group_ordinal)::text) || '.'::text) || (view.item_oid)::text))))
     LEFT JOIN public.event_crf_flag ec_flag ON ((((ec_flag.path)::text = (((((((view.ss_oid)::text || '.'::text) || (view.sed_oid)::text) || '.'::text) || (view.event_ordinal)::text) || '.'::text) || (view.crf_oid)::text)) AND (ec_flag.tag_id = edc_tag.tag_id))))
     LEFT JOIN public.item_data_flag_workflow idfw ON ((idfw.id = id_flag.flag_workflow_id)))
     LEFT JOIN public.event_crf_flag_workflow ecfw ON ((ecfw.id = ec_flag.flag_workflow_id)))
  ORDER BY view.event_crf_id;


ALTER TABLE public.view_item_data_toolkit_filtered OWNER TO clinica;

--
-- Name: view_site_hidden_event_definition_crf; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_site_hidden_event_definition_crf AS
 SELECT edc.event_definition_crf_id,
    edc.hide_crf,
    edc.study_id,
    se.study_event_id,
    cv.crf_version_id
   FROM ((public.event_definition_crf edc
     JOIN public.study_event se ON (((edc.study_event_definition_id = se.study_event_definition_id) AND (NOT (edc.event_definition_crf_id IN ( SELECT event_definition_crf.parent_id
           FROM public.event_definition_crf
          WHERE ((event_definition_crf.parent_id IS NOT NULL) OR (event_definition_crf.parent_id <> 0))))))))
     JOIN public.crf_version cv ON ((edc.crf_id = cv.crf_id)));


ALTER TABLE public.view_site_hidden_event_definition_crf OWNER TO clinica;

--
-- Name: view_study_hidden_event_definition_crf; Type: VIEW; Schema: public; Owner: clinica
--

CREATE VIEW public.view_study_hidden_event_definition_crf AS
 SELECT edc.event_definition_crf_id,
    edc.hide_crf,
    edc.study_id,
    se.study_event_id,
    cv.crf_version_id
   FROM ((public.event_definition_crf edc
     JOIN public.study_event se ON (((edc.study_event_definition_id = se.study_event_definition_id) AND (edc.parent_id IS NULL))))
     JOIN public.crf_version cv ON ((edc.crf_id = cv.crf_id)));


ALTER TABLE public.view_study_hidden_event_definition_crf OWNER TO clinica;

--
-- Name: archived_dataset_file archived_dataset_file_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.archived_dataset_file ALTER COLUMN archived_dataset_file_id SET DEFAULT nextval('public.archived_dataset_file_archived_dataset_file_id_seq'::regclass);


--
-- Name: audit_event audit_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_event ALTER COLUMN audit_id SET DEFAULT nextval('public.audit_event_audit_id_seq'::regclass);


--
-- Name: audit_log_event audit_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_log_event ALTER COLUMN audit_id SET DEFAULT nextval('public.audit_log_event_audit_id_seq'::regclass);


--
-- Name: audit_log_event_type audit_log_event_type_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_log_event_type ALTER COLUMN audit_log_event_type_id SET DEFAULT nextval('public.audit_log_event_type_audit_log_event_type_id_seq'::regclass);


--
-- Name: audit_user_login id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_user_login ALTER COLUMN id SET DEFAULT nextval('public.audit_user_login_id_seq'::regclass);


--
-- Name: authorities id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.authorities ALTER COLUMN id SET DEFAULT nextval('public.authorities_id_seq'::regclass);


--
-- Name: completion_status completion_status_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.completion_status ALTER COLUMN completion_status_id SET DEFAULT nextval('public.completion_status_completion_status_id_seq'::regclass);


--
-- Name: configuration id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.configuration ALTER COLUMN id SET DEFAULT nextval('public.configuration_id_seq'::regclass);


--
-- Name: crf crf_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf ALTER COLUMN crf_id SET DEFAULT nextval('public.crf_crf_id_seq'::regclass);


--
-- Name: crf_version crf_version_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf_version ALTER COLUMN crf_version_id SET DEFAULT nextval('public.crf_version_crf_version_id_seq'::regclass);


--
-- Name: crf_version_media crf_version_media_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf_version_media ALTER COLUMN crf_version_media_id SET DEFAULT nextval('public.crf_version_media_crf_version_media_id_seq'::regclass);


--
-- Name: dataset dataset_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset ALTER COLUMN dataset_id SET DEFAULT nextval('public.dataset_dataset_id_seq'::regclass);


--
-- Name: dataset_item_status dataset_item_status_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset_item_status ALTER COLUMN dataset_item_status_id SET DEFAULT nextval('public.dataset_item_status_dataset_item_status_id_seq'::regclass);


--
-- Name: dc_computed_event dc_summary_event_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_computed_event ALTER COLUMN dc_summary_event_id SET DEFAULT nextval('public.dc_computed_event_dc_summary_event_id_seq'::regclass);


--
-- Name: dc_event dc_event_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_event ALTER COLUMN dc_event_id SET DEFAULT nextval('public.dc_event_dc_event_id_seq'::regclass);


--
-- Name: dc_primitive dc_primitive_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_primitive ALTER COLUMN dc_primitive_id SET DEFAULT nextval('public.dc_primitive_dc_primitive_id_seq'::regclass);


--
-- Name: dc_section_event dc_event_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_section_event ALTER COLUMN dc_event_id SET DEFAULT nextval('public.dc_section_event_dc_event_id_seq'::regclass);


--
-- Name: dc_send_email_event dc_event_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_send_email_event ALTER COLUMN dc_event_id SET DEFAULT nextval('public.dc_send_email_event_dc_event_id_seq'::regclass);


--
-- Name: dc_substitution_event dc_event_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_substitution_event ALTER COLUMN dc_event_id SET DEFAULT nextval('public.dc_substitution_event_dc_event_id_seq'::regclass);


--
-- Name: decision_condition decision_condition_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.decision_condition ALTER COLUMN decision_condition_id SET DEFAULT nextval('public.decision_condition_decision_condition_id_seq'::regclass);


--
-- Name: discrepancy_note discrepancy_note_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.discrepancy_note ALTER COLUMN discrepancy_note_id SET DEFAULT nextval('public.discrepancy_note_discrepancy_note_id_seq'::regclass);


--
-- Name: discrepancy_note_type discrepancy_note_type_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.discrepancy_note_type ALTER COLUMN discrepancy_note_type_id SET DEFAULT nextval('public.discrepancy_note_type_discrepancy_note_type_id_seq'::regclass);


--
-- Name: dyn_item_form_metadata id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dyn_item_form_metadata ALTER COLUMN id SET DEFAULT nextval('public.dyn_item_form_metadata_id_seq'::regclass);


--
-- Name: dyn_item_group_metadata id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dyn_item_group_metadata ALTER COLUMN id SET DEFAULT nextval('public.dyn_item_group_metadata_id_seq'::regclass);


--
-- Name: event_crf event_crf_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf ALTER COLUMN event_crf_id SET DEFAULT nextval('public.event_crf_event_crf_id_seq'::regclass);


--
-- Name: event_crf_flag id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf_flag ALTER COLUMN id SET DEFAULT nextval('public.event_crf_flag_id_seq'::regclass);


--
-- Name: event_crf_flag_workflow id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf_flag_workflow ALTER COLUMN id SET DEFAULT nextval('public.event_crf_flag_workflow_id_seq'::regclass);


--
-- Name: event_definition_crf event_definition_crf_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf ALTER COLUMN event_definition_crf_id SET DEFAULT nextval('public.event_definition_crf_event_definition_crf_id_seq'::regclass);


--
-- Name: event_definition_crf_item_tag id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf_item_tag ALTER COLUMN id SET DEFAULT nextval('public.event_definition_crf_item_tag_id_seq'::regclass);


--
-- Name: event_definition_crf_tag id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf_tag ALTER COLUMN id SET DEFAULT nextval('public.event_definition_crf_tag_id_seq'::regclass);


--
-- Name: export_format export_format_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.export_format ALTER COLUMN export_format_id SET DEFAULT nextval('public.export_format_export_format_id_seq'::regclass);


--
-- Name: filter filter_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.filter ALTER COLUMN filter_id SET DEFAULT nextval('public.filter_filter_id_seq'::regclass);


--
-- Name: group_class_types group_class_type_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.group_class_types ALTER COLUMN group_class_type_id SET DEFAULT nextval('public.group_class_types_group_class_type_id_seq'::regclass);


--
-- Name: item item_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item ALTER COLUMN item_id SET DEFAULT nextval('public.item_item_id_seq'::regclass);


--
-- Name: item_data item_data_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data ALTER COLUMN item_data_id SET DEFAULT nextval('public.item_data_item_data_id_seq'::regclass);


--
-- Name: item_data_flag id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data_flag ALTER COLUMN id SET DEFAULT nextval('public.item_data_flag_id_seq'::regclass);


--
-- Name: item_data_flag_workflow id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data_flag_workflow ALTER COLUMN id SET DEFAULT nextval('public.item_data_flag_workflow_id_seq'::regclass);


--
-- Name: item_data_type item_data_type_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data_type ALTER COLUMN item_data_type_id SET DEFAULT nextval('public.item_data_type_item_data_type_id_seq'::regclass);


--
-- Name: item_form_metadata item_form_metadata_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_form_metadata ALTER COLUMN item_form_metadata_id SET DEFAULT nextval('public.item_form_metadata_item_form_metadata_id_seq'::regclass);


--
-- Name: item_group item_group_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group ALTER COLUMN item_group_id SET DEFAULT nextval('public.item_group_item_group_id_seq'::regclass);


--
-- Name: item_group_metadata item_group_metadata_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group_metadata ALTER COLUMN item_group_metadata_id SET DEFAULT nextval('public.item_group_metadata_item_group_metadata_id_seq'::regclass);


--
-- Name: item_reference_type item_reference_type_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_reference_type ALTER COLUMN item_reference_type_id SET DEFAULT nextval('public.item_reference_type_item_reference_type_id_seq'::regclass);


--
-- Name: measurement_unit id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.measurement_unit ALTER COLUMN id SET DEFAULT nextval('public.measurement_unit_id_seq'::regclass);


--
-- Name: null_value_type null_value_type_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.null_value_type ALTER COLUMN null_value_type_id SET DEFAULT nextval('public.null_value_type_null_value_type_id_seq'::regclass);


--
-- Name: openclinica_version id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.openclinica_version ALTER COLUMN id SET DEFAULT nextval('public.openclinica_version_id_seq'::regclass);


--
-- Name: privilege priv_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.privilege ALTER COLUMN priv_id SET DEFAULT nextval('public.privilege_priv_id_seq'::regclass);


--
-- Name: resolution_status resolution_status_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.resolution_status ALTER COLUMN resolution_status_id SET DEFAULT nextval('public.resolution_status_resolution_status_id_seq'::regclass);


--
-- Name: response_set response_set_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.response_set ALTER COLUMN response_set_id SET DEFAULT nextval('public.response_set_response_set_id_seq'::regclass);


--
-- Name: response_type response_type_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.response_type ALTER COLUMN response_type_id SET DEFAULT nextval('public.response_type_response_type_id_seq'::regclass);


--
-- Name: rule id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule ALTER COLUMN id SET DEFAULT nextval('public.rule_id_seq'::regclass);


--
-- Name: rule_action id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action ALTER COLUMN id SET DEFAULT nextval('public.rule_action_id_seq'::regclass);


--
-- Name: rule_action_property id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action_property ALTER COLUMN id SET DEFAULT nextval('public.rule_action_property_id_seq'::regclass);


--
-- Name: rule_action_run id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action_run ALTER COLUMN id SET DEFAULT nextval('public.rule_action_run_id_seq'::regclass);


--
-- Name: rule_action_run_log id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action_run_log ALTER COLUMN id SET DEFAULT nextval('public.rule_action_run_log_id_seq'::regclass);


--
-- Name: rule_action_stratification_factor id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action_stratification_factor ALTER COLUMN id SET DEFAULT nextval('public.rule_action_stratification_factor_id_seq'::regclass);


--
-- Name: rule_expression id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_expression ALTER COLUMN id SET DEFAULT nextval('public.rule_expression_id_seq'::regclass);


--
-- Name: rule_set id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_set ALTER COLUMN id SET DEFAULT nextval('public.rule_set_id_seq'::regclass);


--
-- Name: rule_set_audit id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_set_audit ALTER COLUMN id SET DEFAULT nextval('public.rule_set_audit_id_seq'::regclass);


--
-- Name: rule_set_rule id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_set_rule ALTER COLUMN id SET DEFAULT nextval('public.rule_set_rule_id_seq'::regclass);


--
-- Name: rule_set_rule_audit id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_set_rule_audit ALTER COLUMN id SET DEFAULT nextval('public.rule_set_rule_audit_id_seq'::regclass);


--
-- Name: scd_item_metadata id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.scd_item_metadata ALTER COLUMN id SET DEFAULT nextval('public.scd_item_metadata_id_seq'::regclass);


--
-- Name: section section_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.section ALTER COLUMN section_id SET DEFAULT nextval('public.section_section_id_seq'::regclass);


--
-- Name: status status_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.status ALTER COLUMN status_id SET DEFAULT nextval('public.status_status_id_seq'::regclass);


--
-- Name: study study_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study ALTER COLUMN study_id SET DEFAULT nextval('public.study_study_id_seq'::regclass);


--
-- Name: study_event study_event_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event ALTER COLUMN study_event_id SET DEFAULT nextval('public.study_event_study_event_id_seq'::regclass);


--
-- Name: study_event_definition study_event_definition_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event_definition ALTER COLUMN study_event_definition_id SET DEFAULT nextval('public.study_event_definition_study_event_definition_id_seq'::regclass);


--
-- Name: study_group study_group_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_group ALTER COLUMN study_group_id SET DEFAULT nextval('public.study_group_study_group_id_seq'::regclass);


--
-- Name: study_group_class study_group_class_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_group_class ALTER COLUMN study_group_class_id SET DEFAULT nextval('public.study_group_class_study_group_class_id_seq'::regclass);


--
-- Name: study_module_status id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_module_status ALTER COLUMN id SET DEFAULT nextval('public.study_module_status_id_seq'::regclass);


--
-- Name: study_parameter study_parameter_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_parameter ALTER COLUMN study_parameter_id SET DEFAULT nextval('public.study_parameter_study_parameter_id_seq'::regclass);


--
-- Name: study_parameter_value study_parameter_value_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_parameter_value ALTER COLUMN study_parameter_value_id SET DEFAULT nextval('public.study_parameter_value_study_parameter_value_id_seq'::regclass);


--
-- Name: study_subject study_subject_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_subject ALTER COLUMN study_subject_id SET DEFAULT nextval('public.study_subject_study_subject_id_seq'::regclass);


--
-- Name: study_type study_type_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_type ALTER COLUMN study_type_id SET DEFAULT nextval('public.study_type_study_type_id_seq'::regclass);


--
-- Name: subject subject_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject ALTER COLUMN subject_id SET DEFAULT nextval('public.subject_subject_id_seq'::regclass);


--
-- Name: subject_event_status subject_event_status_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject_event_status ALTER COLUMN subject_event_status_id SET DEFAULT nextval('public.subject_event_status_subject_event_status_id_seq'::regclass);


--
-- Name: subject_group_map subject_group_map_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject_group_map ALTER COLUMN subject_group_map_id SET DEFAULT nextval('public.subject_group_map_subject_group_map_id_seq'::regclass);


--
-- Name: tag id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.tag ALTER COLUMN id SET DEFAULT nextval('public.tag_id_seq'::regclass);


--
-- Name: usage_statistics_data id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.usage_statistics_data ALTER COLUMN id SET DEFAULT nextval('public.usage_statistics_data_id_seq'::regclass);


--
-- Name: user_account user_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.user_account ALTER COLUMN user_id SET DEFAULT nextval('public.user_account_user_id_seq'::regclass);


--
-- Name: user_role role_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.user_role ALTER COLUMN role_id SET DEFAULT nextval('public.user_role_role_id_seq'::regclass);


--
-- Name: user_type user_type_id; Type: DEFAULT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.user_type ALTER COLUMN user_type_id SET DEFAULT nextval('public.user_type_user_type_id_seq'::regclass);


--
-- Data for Name: archived_dataset_file; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.archived_dataset_file (archived_dataset_file_id, name, dataset_id, export_format_id, file_reference, run_time, file_size, date_created, owner_id) FROM stdin;
\.


--
-- Data for Name: audit_event; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.audit_event (audit_id, audit_date, audit_table, user_id, entity_id, reason_for_change, action_message) FROM stdin;
\.


--
-- Data for Name: audit_event_context; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.audit_event_context (audit_id, study_id, subject_id, study_subject_id, role_name, event_crf_id, study_event_id, study_event_definition_id, crf_id, crf_version_id, study_crf_id, item_id) FROM stdin;
\.


--
-- Data for Name: audit_event_values; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.audit_event_values (audit_id, column_name, old_value, new_value) FROM stdin;
\.


--
-- Data for Name: audit_log_event; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.audit_log_event (audit_id, audit_date, audit_table, user_id, entity_id, entity_name, reason_for_change, audit_log_event_type_id, old_value, new_value, event_crf_id, study_event_id, event_crf_version_id, item_data_repeat_key) FROM stdin;
1	2023-12-02 17:21:32.984812	subject	1	1	\N	\N	5	\N	\N	\N	\N	\N	\N
2	2023-12-02 17:21:32.996902	study_subject	1	1	\N	\N	2	\N	\N	\N	\N	\N	\N
\.


--
-- Data for Name: audit_log_event_type; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.audit_log_event_type (audit_log_event_type_id, name) FROM stdin;
1	Item data value updated
2	Study subject created
3	Study subject status changed
4	Study subject value changed
5	Subject created
6	Subject status changed
7	Subject global value changed
8	Event CRF marked complete
9	Event CRF properties changed
12	Item data status changed
13	Item data deleted
17	Study Event scheduled
18	Study Event data entry started
19	Study Event completed
20	Study Event stopped
21	Study Event skipped
22	Study Event locked
23	Study Event removed
24	Study Event start date changed
25	Study Event end date changed
26	Study Event location changed
27	Subject Site Assignment
28	Subject Group Assignment
29	Subject Group changed
30	Item data inserted for repeating row
31	Study Event signed
14	Event CRF complete with password
15	Event CRF Initial Data Entry complete with password
16	Event CRF Double Data Entry complete with password
10	Event CRF Initial Data Entry complete
11	Event CRF Double Data Entry complete
32	EventCRF SDV Status
35	Study Event restored
33	Change CRF version
40	event_crf_deleted
41	event_crf_started
\.


--
-- Data for Name: audit_user_login; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.audit_user_login (id, user_name, user_account_id, login_attempt_date, login_status_code, version, details) FROM stdin;
1	root	1	2023-12-02 09:38:30.324	1	0	\N
2	root	1	2023-12-02 10:39:31.374	4	0	\N
3	root	1	2023-12-02 17:11:17.733	1	0	\N
4	root	1	2023-12-02 17:25:14.235	4	0	\N
5	root	1	2023-12-02 17:25:14.248	4	0	\N
6	root	1	2023-12-02 17:25:34.261	1	0	\N
7	root	1	2023-12-02 17:28:55.21	4	0	\N
8	root	1	2023-12-02 17:28:55.215	4	0	\N
9	admin	4	2023-12-02 17:29:00.4	1	0	\N
10	admin	4	2023-12-02 17:29:39.819	4	0	\N
11	admin	4	2023-12-02 17:29:39.827	4	0	\N
12	admin	4	2023-12-02 17:29:47.306	1	0	\N
13	admin	4	2023-12-02 17:31:53.76	4	0	\N
14	admin	4	2023-12-02 17:31:53.768	4	0	\N
15	admin	4	2023-12-02 17:32:13.373	1	0	\N
16	admin	4	2023-12-02 18:33:36.797	4	0	\N
17	admin	4	2023-12-02 19:51:31.374	1	0	\N
18	admin	4	2023-12-02 19:53:58.892	4	0	\N
19	admin	4	2023-12-02 19:53:58.898	4	0	\N
20	root	1	2023-12-02 19:54:05.922	1	0	\N
21	root	1	2023-12-02 19:54:42.321	4	0	\N
22	root	1	2023-12-02 19:54:42.334	4	0	\N
23	root	1	2023-12-03 03:28:06.719	2	0	\N
24	root	1	2023-12-03 03:28:16.36	2	0	\N
25	admin	4	2023-12-03 03:29:05.441	1	0	\N
26	admin	4	2023-12-03 04:35:43.498	4	0	\N
27	admin	4	2023-12-03 05:48:25.076	1	0	\N
28	admin	4	2023-12-03 06:00:23.317	1	0	\N
29	admin	4	2023-12-03 06:49:45.335	4	0	\N
30	admin	4	2023-12-03 07:09:45.641	4	0	\N
31	admin	4	2023-12-03 08:22:02.228	1	0	\N
32	admin	4	2023-12-03 09:22:47.399	4	0	\N
33	admin	4	2023-12-03 23:20:53.846	1	0	\N
34	admin	4	2023-12-04 00:36:03.883	4	0	\N
35	admin	4	2023-12-04 01:47:10.374	1	0	\N
36	admin	4	2023-12-04 03:04:08.272	4	0	\N
37	admin	4	2023-12-04 03:39:29.482	1	0	\N
38	admin	4	2023-12-04 04:40:11.686	4	0	\N
39	admin	4	2023-12-04 07:17:06.264	1	0	\N
40	admin	4	2023-12-04 08:24:18.942	4	0	\N
41	admin	4	2023-12-04 13:19:30.587	1	0	\N
42	Admin	\N	2023-12-04 13:29:15.88	2	0	\N
43	admin	4	2023-12-04 13:29:29.228	1	0	\N
44	admin	4	2023-12-04 14:20:32.604	4	0	\N
45	admin	4	2023-12-04 14:27:53.118	1	0	\N
46	admin	4	2023-12-04 14:30:32.936	4	0	\N
47	admin	4	2023-12-04 15:32:34.887	4	0	\N
48	admin	4	2023-12-04 15:43:30.588	1	0	\N
49	admin	4	2023-12-04 16:35:21.908	1	0	\N
50	admin	4	2023-12-04 16:49:37.292	4	0	\N
51	admin	4	2023-12-04 17:32:42.562	1	0	\N
52	admin	4	2023-12-04 18:25:40.272	4	0	\N
53	admin	4	2023-12-04 18:33:40.552	4	0	\N
54	admin	4	2023-12-05 00:51:02.487	2	0	\N
55	admin	4	2023-12-05 00:51:36.491	2	0	\N
56	admin	4	2023-12-05 00:52:42.553	1	0	\N
57	admin	4	2023-12-05 00:56:39.033	1	0	\N
58	admin	4	2023-12-05 01:52:56.349	4	0	\N
59	admin	4	2023-12-05 01:57:56.529	4	0	\N
60	root	1	2023-12-05 03:26:22.381	2	0	\N
61	admin	4	2023-12-05 03:34:13.941	1	0	\N
62	admin	4	2023-12-05 04:35:01.67	4	0	\N
63	admin	4	2023-12-05 05:40:09.366	1	0	\N
64	admin	4	2023-12-05 06:41:06.105	4	0	\N
65	admin	4	2023-12-05 06:55:20.548	1	0	\N
66	admin	4	2023-12-05 08:41:10.072	4	0	\N
67	admin	4	2023-12-05 09:00:57.58	1	0	\N
68	admin	4	2023-12-05 09:04:59.871	1	0	\N
69	admin	4	2023-12-05 09:29:30.767	4	0	\N
70	admin	4	2023-12-05 09:29:30.779	4	0	\N
71	admin	4	2023-12-05 09:30:08.103	1	0	\N
72	admin	4	2023-12-05 09:48:28.326	4	0	\N
73	admin	4	2023-12-05 09:48:28.342	4	0	\N
74	admin	4	2023-12-05 09:48:56.481	1	0	\N
75	admin	4	2023-12-05 10:31:13.733	4	0	\N
76	admin	4	2023-12-05 11:39:16.242	4	0	\N
77	admin	4	2023-12-05 12:10:40.889	1	0	\N
78	admin	4	2023-12-05 12:35:02.97	1	0	\N
79	admin	4	2023-12-05 12:35:56.787	4	0	\N
80	admin	4	2023-12-05 12:35:56.807	4	0	\N
81	admin	4	2023-12-05 12:36:15.881	1	0	\N
82	admin	4	2023-12-05 12:36:34.834	4	0	\N
83	admin	4	2023-12-05 12:36:34.87	4	0	\N
84	admin	4	2023-12-05 12:37:21.736	1	0	\N
85	admin	4	2023-12-05 12:39:48.289	4	0	\N
86	admin	4	2023-12-05 12:39:48.306	4	0	\N
87	admin	4	2023-12-05 12:40:01.543	1	0	\N
88	admin	4	2023-12-05 12:49:19.031	4	0	\N
89	admin	4	2023-12-05 12:49:19.041	4	0	\N
90	admin	4	2023-12-05 12:49:39.332	1	0	\N
91	admin	4	2023-12-05 13:21:18.893	4	0	\N
92	admin	4	2023-12-05 13:21:18.905	4	0	\N
93	admin	4	2023-12-05 13:21:32.806	1	0	\N
94	admin	4	2023-12-05 13:21:45.789	4	0	\N
95	admin	4	2023-12-05 13:21:45.799	4	0	\N
96	admin	4	2023-12-05 13:22:05.267	1	0	\N
97	admin	4	2023-12-05 13:26:27.488	4	0	\N
98	admin	4	2023-12-05 13:26:27.497	4	0	\N
99	admin	4	2023-12-05 13:26:41.432	1	0	\N
100	admin	4	2023-12-05 13:27:00.647	4	0	\N
101	admin	4	2023-12-05 13:27:00.661	4	0	\N
102	admin	4	2023-12-05 13:27:32.779	1	0	\N
103	admin	4	2023-12-05 13:28:45.288	4	0	\N
104	admin	4	2023-12-05 13:28:45.295	4	0	\N
105	admin	4	2023-12-05 13:29:01.035	1	0	\N
106	admin	4	2023-12-05 13:45:46.555	4	0	\N
107	admin	4	2023-12-05 13:45:46.59	4	0	\N
108	admin	4	2023-12-05 13:46:01.34	1	0	\N
109	admin	4	2023-12-05 13:58:31.796	1	0	\N
110	admin	4	2023-12-05 14:12:11.79	4	0	\N
111	admin	4	2023-12-05 14:12:11.802	4	0	\N
112	admin	4	2023-12-05 14:12:27.984	1	0	\N
113	admin	4	2023-12-05 14:25:59.313	4	0	\N
114	admin	4	2023-12-05 14:25:59.323	4	0	\N
115	admin	4	2023-12-05 14:26:23.839	1	0	\N
116	admin	4	2023-12-05 14:39:38.85	4	0	\N
117	admin	4	2023-12-05 14:39:38.858	4	0	\N
118	admin	4	2023-12-05 14:40:07.5	1	0	\N
119	admin	4	2023-12-05 14:40:18.428	4	0	\N
120	admin	4	2023-12-05 14:40:18.435	4	0	\N
121	admin	4	2023-12-05 14:40:40.262	1	0	\N
122	admin	4	2023-12-05 14:40:55.514	4	0	\N
123	admin	4	2023-12-05 14:40:55.521	4	0	\N
124	admin	4	2023-12-05 14:41:03.713	1	0	\N
125	admin	4	2023-12-05 14:41:06.365	4	0	\N
126	admin	4	2023-12-05 14:41:06.372	4	0	\N
127	admin	4	2023-12-05 14:49:17.613	4	0	\N
128	admin	4	2023-12-05 14:49:17.623	4	0	\N
129	admin	4	2023-12-05 14:49:24.064	1	0	\N
130	admin	4	2023-12-05 14:56:42.851	1	0	\N
131	admin	4	2023-12-05 15:45:24.335	4	0	\N
132	admin	4	2023-12-05 15:50:24.527	4	0	\N
133	admin	4	2023-12-05 16:12:25.597	4	0	\N
134	admin	4	2023-12-05 16:38:49.964	1	0	\N
135	admin	4	2023-12-05 16:59:39.875	1	0	\N
136	admin	4	2023-12-05 17:02:47.645	4	0	\N
137	admin	4	2023-12-05 17:02:47.656	4	0	\N
138	admin	4	2023-12-05 17:02:57.071	1	0	\N
139	admin	4	2023-12-05 17:03:01.368	4	0	\N
140	admin	4	2023-12-05 17:03:01.377	4	0	\N
141	admin	4	2023-12-05 17:03:14.505	1	0	\N
142	admin	4	2023-12-05 17:03:14.578	4	0	\N
143	admin	4	2023-12-05 17:03:14.585	4	0	\N
144	admin	4	2023-12-05 17:03:22.877	1	0	\N
145	admin	4	2023-12-05 17:03:29.768	4	0	\N
146	admin	4	2023-12-05 17:03:29.775	4	0	\N
147	admin	4	2023-12-05 17:03:45.238	1	0	\N
148	admin	4	2023-12-05 17:03:56.168	4	0	\N
149	admin	4	2023-12-05 17:03:56.174	4	0	\N
150	admin	4	2023-12-05 17:06:21.019	1	0	\N
151	admin	4	2023-12-05 17:13:25.551	4	0	\N
152	admin	4	2023-12-05 17:13:25.583	4	0	\N
153	root	1	2023-12-05 17:13:35.503	1	0	\N
154	root	1	2023-12-05 17:16:50.364	4	0	\N
155	root	1	2023-12-05 17:16:50.384	4	0	\N
156	root	1	2023-12-05 17:41:14.374	1	0	\N
157	admin	4	2023-12-05 18:04:29.39	4	0	\N
158	admin	4	2023-12-05 18:35:04.967	1	0	\N
159	root	1	2023-12-05 19:00:31.286	4	0	\N
160	admin	4	2023-12-05 19:37:32.79	4	0	\N
161	root	1	2023-12-05 19:57:29.146	2	0	\N
162	root	1	2023-12-05 19:57:52.219	2	0	\N
163	admin	4	2023-12-05 20:02:53.565	1	0	\N
164	admin	4	2023-12-05 20:04:05.266	1	0	\N
165	admin	4	2023-12-05 20:04:56.549	4	0	\N
166	admin	4	2023-12-05 20:04:56.565	4	0	\N
167	admin	4	2023-12-05 20:05:18.58	1	0	\N
168	admin	4	2023-12-05 20:21:36.678	4	0	\N
169	admin	4	2023-12-05 20:21:36.695	4	0	\N
170	admin	4	2023-12-05 20:22:10.424	1	0	\N
171	admin	4	2023-12-05 21:06:31.31	1	0	\N
172	admin	4	2023-12-05 21:07:36.092	4	0	\N
173	admin	4	2023-12-05 21:30:36.744	4	0	\N
174	admin	4	2023-12-05 22:08:37.748	4	0	\N
175	admin	4	2023-12-05 23:35:45.157	1	0	\N
176	admin	4	2023-12-06 00:59:43.044	4	0	\N
177	admin	4	2023-12-06 01:47:13.21	1	0	\N
178	admin	4	2023-12-06 04:02:48.151	4	0	\N
179	admin	4	2023-12-06 06:33:05.509	1	0	\N
180	admin	4	2023-12-06 08:33:52.547	4	0	\N
181	admin	4	2023-12-06 08:43:04.81	1	0	\N
182	admin	4	2023-12-06 10:52:54.403	4	0	\N
183	Claudia	\N	2023-12-06 11:02:10.932	2	0	\N
184	Claudia	\N	2023-12-06 11:02:37.089	2	0	\N
185	root	1	2023-12-06 11:06:13.108	1	0	\N
186	ctrepte	\N	2023-12-06 12:12:54.886	2	0	\N
187	claudia	5	2023-12-06 12:13:08.945	1	0	\N
188	root	1	2023-12-06 12:52:56.09	4	0	\N
189	claudia	5	2023-12-06 13:26:56.487	4	0	\N
190	root	1	2023-12-06 13:38:25.17	2	0	\N
191	root	1	2023-12-06 13:38:35.264	2	0	\N
192	admin_reliatec	\N	2023-12-06 13:46:34.709	2	0	\N
193	admin_reliatec	\N	2023-12-06 13:46:47.394	2	0	\N
194	admin_reliatec	\N	2023-12-06 14:05:36.927	2	0	\N
195	admin	4	2023-12-06 15:44:49.909	1	0	\N
196	admin	4	2023-12-06 16:48:18.035	1	0	\N
197	admin	4	2023-12-06 16:49:58.779	4	0	\N
198	admin	4	2023-12-06 17:13:30.662	1	0	\N
199	root	1	2023-12-06 17:14:27.805	1	0	\N
200	root	1	2023-12-06 17:16:14.899	4	0	\N
201	root	1	2023-12-06 17:16:14.905	4	0	\N
202	admin	4	2023-12-06 17:37:35.848	4	0	\N
203	admin	4	2023-12-06 17:37:35.854	4	0	\N
204	admin	4	2023-12-06 17:39:05.238	1	0	\N
205	admin	4	2023-12-06 18:14:59.839	4	0	\N
206	admin	4	2023-12-06 18:57:00.311	4	0	\N
207	admin	4	2023-12-06 18:58:21.651	1	0	\N
208	admin	4	2023-12-06 19:43:03.766	1	0	\N
209	admin	4	2023-12-06 19:52:42.841	4	0	\N
210	admin	4	2023-12-06 19:52:42.85	4	0	\N
211	admin	4	2023-12-06 19:53:31.105	1	0	\N
212	admin	4	2023-12-06 20:08:01.871	4	0	\N
213	admin	4	2023-12-06 20:08:01.896	4	0	\N
214	admin	4	2023-12-06 20:08:18.081	1	0	\N
215	admin	4	2023-12-06 20:12:57.474	4	0	\N
216	admin	4	2023-12-06 20:12:57.482	4	0	\N
217	admin	4	2023-12-06 20:13:25.709	1	0	\N
218	admin	4	2023-12-06 20:44:10.301	1	0	\N
219	admin	4	2023-12-06 20:50:31.634	4	0	\N
220	admin	4	2023-12-06 20:50:31.641	4	0	\N
221	admin	4	2023-12-06 20:50:48.793	1	0	\N
222	admin	4	2023-12-06 20:53:19.759	4	0	\N
223	admin	4	2023-12-06 20:53:19.765	4	0	\N
224	admin	4	2023-12-06 20:53:30.491	1	0	\N
225	admin	4	2023-12-06 21:06:18.015	4	0	\N
226	admin	4	2023-12-06 21:06:18.028	4	0	\N
227	admin	4	2023-12-06 21:06:31.53	1	0	\N
228	admin	4	2023-12-06 21:24:12.835	4	0	\N
229	admin	4	2023-12-06 21:24:12.845	4	0	\N
230	admin	4	2023-12-06 21:55:04.868	4	0	\N
231	admin	4	2023-12-06 22:17:58.737	1	0	\N
232	admin	4	2023-12-06 22:37:09.318	1	0	\N
233	admin	4	2023-12-06 22:46:19.705	4	0	\N
234	admin	4	2023-12-06 22:46:19.716	4	0	\N
235	admin	4	2023-12-06 22:46:46.346	2	0	\N
236	admin	4	2023-12-06 22:46:46.778	2	0	\N
237	admin	4	2023-12-06 22:47:48.556	1	0	\N
238	admin	4	2023-12-06 22:58:06.849	4	0	\N
239	admin	4	2023-12-06 23:38:08.29	4	0	\N
240	admin	4	2023-12-07 00:10:09.111	4	0	\N
241	admin	4	2023-12-07 03:00:50.608	1	0	\N
242	admin	4	2023-12-07 04:06:16.43	4	0	\N
243	admin	4	2023-12-07 07:54:29.05	2	0	\N
244	admin	4	2023-12-07 07:54:48.61	1	0	\N
245	admin	4	2023-12-07 09:13:23.352	4	0	\N
246	admin	4	2023-12-07 11:01:02.575	1	0	\N
247	admin	4	2023-12-07 12:55:25.921	4	0	\N
248	admin	4	2023-12-07 16:22:28.639	1	0	\N
249	admin	4	2023-12-07 19:46:30.348	4	0	\N
250	admin	4	2023-12-07 19:52:01.222	1	0	\N
251	admin	4	2023-12-07 20:36:24.93	1	0	\N
252	admin	4	2023-12-07 21:02:31.179	4	0	\N
253	admin	4	2023-12-07 21:36:31.791	4	0	\N
254	cdctestuser	6	2023-12-07 22:51:48.258	1	0	\N
255	cdctestuser	6	2023-12-07 22:55:05.08	4	0	\N
256	cdctestuser	6	2023-12-07 22:55:05.093	4	0	\N
257	cdctestuser	6	2023-12-07 22:55:18.626	1	0	\N
258	root	1	2023-12-07 22:55:32.202	2	0	\N
259	admin	4	2023-12-07 23:01:35.714	2	0	\N
260	admin	4	2023-12-07 23:07:49.038	1	0	\N
261	admin	4	2023-12-07 23:44:28.368	1	0	\N
262	admin	4	2023-12-07 23:44:54.116	4	0	\N
263	admin	4	2023-12-07 23:44:54.12	4	0	\N
264	admin	4	2023-12-07 23:45:16.893	4	0	\N
265	admin	4	2023-12-07 23:45:16.898	4	0	\N
266	admin	4	2023-12-07 23:45:32.14	1	0	\N
267	admin	4	2023-12-07 23:51:34.215	1	0	\N
268	admin	4	2023-12-07 23:51:48.459	1	0	\N
269	admin	4	2023-12-07 23:51:48.465	4	0	\N
270	cdctestuser	6	2023-12-07 23:55:34.669	4	0	\N
271	admin	4	2023-12-08 00:45:35.536	4	0	\N
272	admin	4	2023-12-08 01:18:36.085	4	0	\N
273	admin	4	2023-12-08 02:26:30.883	1	0	\N
274	cdctestuser	6	2023-12-08 02:53:46.029	1	0	\N
275	admin	4	2023-12-08 02:57:30.85	1	0	\N
276	admin	4	2023-12-08 02:58:11.402	4	0	\N
277	admin	4	2023-12-08 02:58:11.408	4	0	\N
278	admin	4	2023-12-08 03:27:02.195	1	0	\N
279	cdctestuser	6	2023-12-08 03:54:39.103	4	0	\N
280	admin	4	2023-12-08 03:57:39.152	4	0	\N
281	admin	4	2023-12-08 04:54:40.048	4	0	\N
282	admin	4	2023-12-08 09:17:54.391	1	0	\N
283	admin	4	2023-12-08 09:53:17.395	1	0	\N
284	admin	4	2023-12-08 10:25:17.877	4	0	\N
285	admin	4	2023-12-08 10:25:17.892	4	0	\N
286	admin	4	2023-12-08 10:25:30.582	1	0	\N
287	admin	4	2023-12-08 11:09:46.851	4	0	\N
288	admin	4	2023-12-08 11:39:47.587	4	0	\N
289	admin	4	2023-12-08 11:52:48.184	1	0	\N
290	admin	4	2023-12-08 11:54:24.144	1	0	\N
291	admin	4	2023-12-08 11:54:36.673	4	0	\N
292	admin	4	2023-12-08 11:54:36.681	4	0	\N
293	admin	4	2023-12-08 11:54:42.989	1	0	\N
294	admin	4	2023-12-08 11:54:43.049	4	0	\N
295	admin	4	2023-12-08 11:54:43.054	4	0	\N
296	admin	4	2023-12-08 11:55:22.131	1	0	\N
297	admin	4	2023-12-08 11:55:30.725	4	0	\N
298	admin	4	2023-12-08 11:55:30.739	4	0	\N
299	admin	4	2023-12-08 11:55:43.471	2	0	\N
300	admin	4	2023-12-08 11:55:43.901	2	0	\N
301	admin	4	2023-12-08 11:55:50.253	1	0	\N
302	admin	4	2023-12-08 11:55:51.033	4	0	\N
303	admin	4	2023-12-08 11:55:51.04	4	0	\N
304	admin	4	2023-12-08 11:56:13.829	1	0	\N
305	admin	4	2023-12-08 11:56:30.769	4	0	\N
306	admin	4	2023-12-08 11:56:30.776	4	0	\N
307	admin	4	2023-12-08 11:57:11.57	1	0	\N
308	admin	4	2023-12-08 11:57:13.703	4	0	\N
309	admin	4	2023-12-08 11:57:13.714	4	0	\N
310	admin	4	2023-12-08 11:57:30.269	1	0	\N
311	admin	4	2023-12-08 12:41:21.242	4	0	\N
312	admin	4	2023-12-08 12:41:21.261	4	0	\N
313	admin	4	2023-12-08 12:41:27.83	1	0	\N
314	admin	4	2023-12-08 12:41:28.424	1	0	\N
315	admin	4	2023-12-08 12:41:28.429	4	0	\N
316	admin	4	2023-12-08 12:58:49.366	4	0	\N
317	root	1	2023-12-08 13:13:37.156	1	0	\N
318	root	1	2023-12-08 13:13:56.343	4	0	\N
319	root	1	2023-12-08 13:13:56.349	4	0	\N
320	root	1	2023-12-08 13:41:56.02	1	0	\N
321	admin	4	2023-12-08 13:51:50.37	4	0	\N
322	root	1	2023-12-08 15:37:52.129	4	0	\N
323	admin	4	2023-12-08 16:50:58.152	1	0	\N
324	admin	4	2023-12-08 16:55:52.856	1	0	\N
325	root	1	2023-12-08 17:46:47.434	1	0	\N
326	 cdctestuser	\N	2023-12-08 17:47:10.067	2	0	\N
327	root	1	2023-12-08 17:49:40.331	4	0	\N
328	root	1	2023-12-08 17:49:40.338	4	0	\N
329	cdctestuser	6	2023-12-08 17:49:52.12	1	0	\N
330	cdctestuser	6	2023-12-08 17:49:57.683	4	0	\N
331	cdctestuser	6	2023-12-08 17:49:57.688	4	0	\N
332	admin	4	2023-12-08 17:51:54.803	4	0	\N
333	cdctestuser	6	2023-12-08 18:05:47.649	1	0	\N
334	cdctestuser	6	2023-12-08 18:07:31.925	4	0	\N
335	cdctestuser	6	2023-12-08 18:07:31.93	4	0	\N
336	cdctestuser	6	2023-12-08 18:07:38.676	1	0	\N
337	admin	4	2023-12-08 18:41:55.78	4	0	\N
338	cdctestuser	6	2023-12-08 19:10:56.603	4	0	\N
339	admin	4	2023-12-08 20:25:49.657	1	0	\N
340	admin	4	2023-12-08 21:25:59.98	4	0	\N
341	admin	4	2023-12-08 23:26:54.811	1	0	\N
342	admin	4	2023-12-09 00:28:04.918	4	0	\N
343	admin	4	2023-12-09 04:32:52.113	1	0	\N
344	admin	4	2023-12-09 06:20:12.748	4	0	\N
345	admin	4	2023-12-09 08:08:29.465	1	0	\N
346	admin	4	2023-12-09 09:10:15.396	4	0	\N
347	admin	4	2023-12-09 13:20:25.391	1	0	\N
348	admin	4	2023-12-09 15:33:23.181	4	0	\N
349	admin	4	2023-12-09 16:31:18.782	1	0	\N
350	admin	4	2023-12-09 18:29:28.011	4	0	\N
351	admin	4	2023-12-09 19:24:10.225	1	0	\N
352	admin	4	2023-12-09 23:48:37.312	4	0	\N
353	admin	4	2023-12-10 01:09:07.366	1	0	\N
354	admin	4	2023-12-10 01:52:10.915	1	0	\N
355	admin	4	2023-12-10 02:11:41.412	4	0	\N
356	admin	4	2023-12-10 03:17:43.704	4	0	\N
357	admin	4	2023-12-10 06:06:24.44	1	0	\N
358	admin	4	2023-12-10 07:29:57.508	1	0	\N
359	admin	4	2023-12-10 07:38:06.74	4	0	\N
360	admin	4	2023-12-10 07:38:06.748	4	0	\N
361	admin	4	2023-12-10 07:39:45.926	1	0	\N
362	admin	4	2023-12-10 08:30:34.013	4	0	\N
363	admin	4	2023-12-10 11:20:36.013	4	0	\N
364	admin	4	2023-12-10 13:04:40.856	1	0	\N
365	admin	4	2023-12-10 15:11:38.384	4	0	\N
366	admin	4	2023-12-10 23:21:25.277	1	0	\N
367	admin	4	2023-12-11 00:24:21.745	1	0	\N
368	admin	4	2023-12-11 00:24:53.663	4	0	\N
369	admin	4	2023-12-11 01:28:53.469	1	0	\N
370	admin	4	2023-12-11 01:38:54.825	4	0	\N
371	admin	4	2023-12-11 02:30:56.249	4	0	\N
372	admin	4	2023-12-11 05:57:19.019	1	0	\N
373	admin	4	2023-12-11 07:08:03.887	4	0	\N
374	admin	4	2023-12-11 09:37:23.657	1	0	\N
375	admin	4	2023-12-11 11:17:09.663	4	0	\N
376	admin	4	2023-12-11 11:31:12.521	1	0	\N
377	admin	4	2023-12-11 11:56:09.82	1	0	\N
378	admin	4	2023-12-11 12:48:12.14	4	0	\N
379	admin	4	2023-12-11 12:58:42.291	1	0	\N
380	admin	4	2023-12-11 13:16:13.019	4	0	\N
381	admin	4	2023-12-11 13:54:16.409	1	0	\N
382	admin	4	2023-12-11 14:14:41.98	4	0	\N
383	admin	4	2023-12-11 14:14:42.003	4	0	\N
384	admin	4	2023-12-11 14:16:34.305	1	0	\N
385	admin	4	2023-12-11 14:25:28.309	4	0	\N
386	admin	4	2023-12-11 14:25:28.315	4	0	\N
387	admin	4	2023-12-11 14:25:47.362	1	0	\N
388	admin	4	2023-12-11 14:33:42.603	4	0	\N
389	admin	4	2023-12-11 14:33:42.616	4	0	\N
390	admin	4	2023-12-11 15:08:06.27	1	0	\N
391	admin	4	2023-12-11 15:27:15.892	4	0	\N
392	root	1	2023-12-11 15:36:42.884	1	0	\N
393	admin	4	2023-12-11 16:11:10.716	4	0	\N
394	admin	4	2023-12-11 16:11:10.732	4	0	\N
395	admin	4	2023-12-11 16:11:23.9	1	0	\N
396	admin	4	2023-12-11 16:58:49.374	4	0	\N
397	admin	4	2023-12-11 16:58:49.381	4	0	\N
398	claudia	5	2023-12-11 16:58:55.906	1	0	\N
399	root	1	2023-12-11 17:29:18.278	4	0	\N
400	claudia	5	2023-12-11 17:59:18.781	4	0	\N
401	claudia	5	2023-12-11 18:22:52.479	1	0	\N
402	root	1	2023-12-11 18:29:15.133	1	0	\N
403	root	1	2023-12-11 19:37:20.367	4	0	\N
404	claudia	5	2023-12-11 20:08:20.873	4	0	\N
405	admin	4	2023-12-11 20:24:12.205	1	0	\N
406	admin	4	2023-12-11 20:31:55.532	1	0	\N
407	admin	4	2023-12-11 20:31:55.545	4	0	\N
408	admin	4	2023-12-12 01:35:26.806	4	0	\N
409	admin	4	2023-12-12 03:01:48.369	1	0	\N
410	admin	4	2023-12-12 04:04:28.629	4	0	\N
411	admin	4	2023-12-12 06:10:35.708	1	0	\N
412	admin	4	2023-12-12 09:13:32.216	4	0	\N
413	admin	4	2023-12-12 13:29:24.376	1	0	\N
414	admin	4	2023-12-12 15:51:41.115	4	0	\N
415	admin	4	2023-12-12 16:47:00.534	1	0	\N
416	admin	4	2023-12-12 16:47:06.558	1	0	\N
417	admin	4	2023-12-12 16:47:06.57	4	0	\N
418	admin	4	2023-12-12 16:53:56.486	1	0	\N
419	root	1	2023-12-12 16:55:22.571	1	0	\N
420	admin	4	2023-12-12 17:17:44.615	4	0	\N
421	admin	4	2023-12-12 17:56:45.821	4	0	\N
422	root	1	2023-12-12 18:18:46.571	4	0	\N
423	admin	4	2023-12-12 20:34:25.391	1	0	\N
424	admin	4	2023-12-12 21:40:53.082	4	0	\N
425	admin	4	2023-12-12 22:50:08.897	1	0	\N
426	admin	4	2023-12-13 01:10:59.551	4	0	\N
427	admin	4	2023-12-13 01:17:45.834	1	0	\N
428	admin	4	2023-12-13 02:19:01.907	4	0	\N
429	admin	4	2023-12-13 10:59:23.383	1	0	\N
430	admin	4	2023-12-13 13:31:23.404	4	0	\N
431	admin	4	2023-12-13 13:49:03.664	1	0	\N
432	admin	4	2023-12-13 14:51:25.621	4	0	\N
433	admin	4	2023-12-13 17:44:47.907	1	0	\N
434	claudia	5	2023-12-13 18:32:55.542	1	0	\N
435	admin	4	2023-12-13 18:48:31.236	4	0	\N
436	claudia	5	2023-12-13 19:43:32.409	4	0	\N
437	admin	4	2023-12-13 21:23:40.746	1	0	\N
438	admin	4	2023-12-13 22:36:36.61	4	0	\N
439	admin	4	2023-12-13 23:03:00.354	1	0	\N
440	admin	4	2023-12-14 00:08:39.019	4	0	\N
441	admin	4	2023-12-14 06:30:38.986	2	0	\N
442	admin	4	2023-12-14 06:30:54.443	2	0	\N
443	claudia	5	2023-12-14 10:02:19.591	1	0	\N
444	study38admin@mailinator.com	\N	2023-12-14 10:22:47.605	2	0	\N
445	Afeez	\N	2023-12-14 10:23:07.828	2	0	\N
446	admin	4	2023-12-14 10:23:32.401	2	0	\N
447	study38admin@mailinator.com	\N	2023-12-14 10:24:49.061	2	0	\N
448	admin	4	2023-12-14 10:26:43.612	2	0	\N
449	Afeez	\N	2023-12-14 10:27:05.86	2	0	\N
450	admin	4	2023-12-14 10:27:25.399	1	0	\N
451	claudia	5	2023-12-14 10:43:13.551	4	0	\N
452	claudia	5	2023-12-14 10:43:13.566	4	0	\N
453	admin	4	2023-12-14 13:32:59.806	4	0	\N
454	admin	4	2023-12-14 14:04:17.321	1	0	\N
455	admin	4	2023-12-14 16:02:02.482	4	0	\N
456	admin	4	2023-12-14 17:05:11.077	1	0	\N
457	admin	4	2023-12-14 18:40:06.845	4	0	\N
458	admin	4	2023-12-14 18:42:31.841	2	0	\N
459	admin	4	2023-12-14 19:32:54.472	2	0	\N
460	admin 	\N	2023-12-14 19:33:24.193	2	0	\N
461	admin	4	2023-12-14 19:33:29.798	2	0	\N
462	admin	4	2023-12-14 23:29:20.793	1	0	\N
463	admin	4	2023-12-15 00:48:17.383	4	0	\N
464	admin	4	2023-12-15 03:01:47.089	2	0	\N
465	admin	4	2023-12-15 09:38:11.946	1	0	\N
466	admin	4	2023-12-15 11:00:13.222	4	0	\N
467	admin	4	2023-12-15 11:00:33.431	1	0	\N
468	admin	4	2023-12-15 11:00:38.166	1	0	\N
469	admin	4	2023-12-15 11:00:38.178	4	0	\N
470	admin	4	2023-12-15 11:00:49.349	1	0	\N
471	admin	4	2023-12-15 12:01:36.177	4	0	\N
472	admin	4	2023-12-15 13:50:38.674	4	0	\N
473	root	1	2023-12-15 17:50:39.752	1	0	\N
474	root	1	2023-12-15 17:52:16.41	4	0	\N
475	root	1	2023-12-15 17:52:16.42	4	0	\N
476	admin	4	2023-12-15 17:52:24.228	2	0	\N
477	root	1	2023-12-15 17:52:37.381	1	0	\N
478	root	1	2023-12-15 17:52:46.149	4	0	\N
479	root	1	2023-12-15 17:52:46.156	4	0	\N
480	admin2	7	2023-12-15 17:52:56.324	2	0	\N
481	root	1	2023-12-15 17:53:04.147	1	0	\N
482	root	1	2023-12-15 18:54:46.616	4	0	\N
483	admin	4	2023-12-15 21:08:12.26	1	0	\N
484	admin	4	2023-12-15 22:08:52.021	4	0	\N
485	admin	4	2023-12-16 14:25:16.164	1	0	\N
486	admin	4	2023-12-16 15:50:23.539	4	0	\N
487	admin	4	2023-12-16 21:58:42.036	1	0	\N
488	admin	4	2023-12-16 21:58:42.439	1	0	\N
489	admin	4	2023-12-16 22:29:35.234	4	0	\N
490	admin	4	2023-12-16 23:16:36.68	4	0	\N
491	admin	4	2023-12-17 03:24:11.774	2	0	\N
492	edenilson	8	2023-12-17 06:22:51.242	1	0	\N
493	edenilson	8	2023-12-17 07:31:51.625	4	0	\N
494	admin	4	2023-12-17 10:40:09.797	1	0	\N
495	admin	4	2023-12-17 12:21:59.986	4	0	\N
496	edenilson	8	2023-12-17 18:09:52.136	1	0	\N
497	edenilson	8	2023-12-17 19:12:13.629	4	0	\N
498	edenilson	8	2023-12-17 19:26:13.541	1	0	\N
499	admin	4	2023-12-17 20:03:29.774	1	0	\N
500	edenilson	8	2023-12-17 20:30:16.381	4	0	\N
501	admin	4	2023-12-17 21:06:17.641	4	0	\N
502	admin	4	2023-12-18 09:32:05.108	1	0	\N
503	admin	4	2023-12-18 10:40:45.295	4	0	\N
504	admin	4	2023-12-18 11:07:52.096	1	0	\N
505	admin	4	2023-12-18 12:22:47.841	4	0	\N
506	admin	4	2023-12-18 12:42:39.659	1	0	\N
507	admin	4	2023-12-18 15:40:55.469	4	0	\N
508	admin	4	2023-12-18 15:57:35.954	1	0	\N
509	claudia	5	2023-12-18 17:41:57.682	1	0	\N
510	claudia	5	2023-12-18 17:43:38.303	4	0	\N
511	claudia	5	2023-12-18 17:43:38.308	4	0	\N
512	admin	4	2023-12-18 18:40:00.533	4	0	\N
513	admin	4	2023-12-18 20:38:30.803	2	0	\N
514	admin	4	2023-12-18 21:00:13.119	1	0	\N
515	admin	4	2023-12-18 23:41:09.786	4	0	\N
516	admin	4	2023-12-19 08:33:59.599	1	0	\N
517	admin	4	2023-12-19 11:05:17.16	1	0	\N
518	admin	4	2023-12-19 11:13:19.721	4	0	\N
519	admin	4	2023-12-19 12:09:20.54	4	0	\N
520	admin	4	2023-12-19 12:31:15.868	1	0	\N
521	admin	4	2023-12-19 13:33:21.88	4	0	\N
522	admin	4	2023-12-19 16:03:00.318	1	0	\N
523	root	1	2023-12-19 16:22:49.934	1	0	\N
524	josue	9	2023-12-19 16:28:14.672	1	0	\N
525	admin	4	2023-12-19 17:25:26.114	4	0	\N
526	josue	9	2023-12-19 17:53:26.436	4	0	\N
527	root	1	2023-12-19 18:02:26.576	4	0	\N
528	admin	4	2023-12-19 18:21:08.352	1	0	\N
529	admin	4	2023-12-19 19:36:27.632	4	0	\N
530	josue	9	2023-12-19 20:22:32.479	2	0	\N
531	josue	9	2023-12-19 20:22:47.725	1	0	\N
532	admin	4	2023-12-19 20:52:54.164	1	0	\N
533	josue	9	2023-12-19 21:23:29.146	4	0	\N
534	josue	9	2023-12-19 22:11:07.382	1	0	\N
535	admin	4	2023-12-19 22:15:29.917	4	0	\N
536	admin	4	2023-12-19 22:28:48.858	1	0	\N
537	josue	9	2023-12-19 23:12:30.596	4	0	\N
538	admin	4	2023-12-20 00:03:31.164	4	0	\N
539	edenilson	8	2023-12-20 06:52:10.542	1	0	\N
540	edenilson	8	2023-12-20 08:28:47.535	4	0	\N
541	admin	4	2023-12-20 11:49:32.539	1	0	\N
542	admin	4	2023-12-20 13:36:56.576	4	0	\N
543	josue	9	2023-12-20 16:57:52.854	1	0	\N
544	claudia	5	2023-12-20 17:28:14.126	1	0	\N
545	josue	9	2023-12-20 18:01:04.89	4	0	\N
546	claudia	5	2023-12-20 18:46:40.671	4	0	\N
547	claudia	5	2023-12-20 18:46:40.68	4	0	\N
548	admin	4	2023-12-20 20:54:12.007	1	0	\N
549	josue	9	2023-12-20 20:55:16.336	1	0	\N
550	josue	9	2023-12-20 22:13:09.801	4	0	\N
551	admin	4	2023-12-21 00:59:11.767	4	0	\N
552	josue	9	2023-12-21 02:27:12.509	1	0	\N
553	josue	9	2023-12-21 04:45:14.807	4	0	\N
554	admin	4	2023-12-21 10:18:54.082	1	0	\N
555	admin	4	2023-12-21 12:58:24.472	4	0	\N
556	admin	4	2023-12-21 14:46:55.742	1	0	\N
557	root	1	2023-12-21 17:25:52.556	1	0	\N
558	root	1	2023-12-21 17:38:00.797	4	0	\N
559	root	1	2023-12-21 17:38:00.809	4	0	\N
560	admin	4	2023-12-21 18:42:29.716	4	0	\N
561	admin	4	2023-12-21 20:10:03.549	1	0	\N
562	josue	9	2023-12-21 21:07:32.779	1	0	\N
563	josue	9	2023-12-21 22:35:32.915	4	0	\N
564	admin	4	2023-12-22 01:10:34.973	4	0	\N
565	otmar	10	2023-12-22 05:25:39.759	1	0	\N
566	otmar	10	2023-12-22 05:25:45.011	4	0	\N
567	otmar	10	2023-12-22 05:25:45.024	4	0	\N
568	admin	4	2023-12-22 08:47:28.044	1	0	\N
569	admin	4	2023-12-22 12:36:53.017	4	0	\N
570	admin	4	2023-12-22 14:58:34.761	1	0	\N
571	admin	4	2023-12-22 15:01:10.642	1	0	\N
572	admin	4	2023-12-22 15:01:10.77	4	0	\N
573	admin	4	2023-12-22 17:21:02.71	4	0	\N
574	admin	4	2023-12-22 17:26:19.018	1	0	\N
575	admin	4	2023-12-22 18:27:05.257	4	0	\N
576	admin	4	2023-12-22 21:05:30.029	1	0	\N
577	admin	4	2023-12-22 21:05:30.428	1	0	\N
578	admin	4	2023-12-22 21:36:11.26	4	0	\N
579	admin	4	2023-12-22 22:53:13.081	4	0	\N
580	admin	4	2023-12-23 00:41:37.118	1	0	\N
581	admin	4	2023-12-23 01:42:15.476	4	0	\N
582	admin	4	2023-12-23 13:45:09.041	1	0	\N
583	admin	4	2023-12-23 15:45:28.212	4	0	\N
584	admin	4	2023-12-23 17:40:26.05	1	0	\N
585	admin	4	2023-12-23 17:40:27.418	1	0	\N
586	admin	4	2023-12-23 17:40:27.434	4	0	\N
587	admin	4	2023-12-23 18:59:33.979	4	0	\N
588	admin	4	2023-12-23 19:09:23.637	1	0	\N
589	admin	4	2023-12-23 21:41:36.718	4	0	\N
590	admin	4	2023-12-23 22:08:28.667	1	0	\N
591	admin	4	2023-12-24 01:50:39.748	4	0	\N
\.


--
-- Data for Name: authorities; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.authorities (id, username, authority, version) FROM stdin;
1	root	ROLE_USER	1
2	psinha	ROLE_USER	0
3	psinha1	ROLE_USER	0
4	admin	ROLE_USER	0
5	claudia	ROLE_USER	0
6	cdctestuser	ROLE_USER	0
7	admin2	ROLE_USER	0
8	edenilson	ROLE_USER	0
9	josue	ROLE_USER	0
10	otmar	ROLE_USER	0
\.


--
-- Data for Name: completion_status; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.completion_status (completion_status_id, status_id, name, description) FROM stdin;
1	1	completion status	place filler for completion status
\.


--
-- Data for Name: configuration; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.configuration (id, key, value, description, version) FROM stdin;
1	user.lock.switch	FALSE	You can enable/disable the User Locking functionality by setting the value to TRUE/FALSE	0
2	user.lock.allowedFailedConsecutiveLoginAttempts	3	You can configure the number of allowed Failed Consecutive Login Attempts before Locking the system	0
3	pwd.chars.min	8	Password minimum length	0
4	pwd.chars.max	-1	Password maximum length	0
5	pwd.chars.case.lower	false	Whether the password must contain lowercase letters	0
6	pwd.chars.case.upper	false	Whether the password must contain upper case letters	0
7	pwd.chars.digits	false	Whether the password must contain digits	0
8	pwd.chars.specials	false	Whether the password must special character	0
9	pwd.expiration.days	360	Number of days after a password expires	0
10	pwd.change.required	1	If the user is required to change their password after the first login	0
\.


--
-- Data for Name: crf; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.crf (crf_id, status_id, name, description, owner_id, date_created, date_updated, update_id, oc_oid, source_study_id) FROM stdin;
2	1	S38_AE_FollowUp	intial version	4	2023-12-03	2023-12-03	4	F_S38_AE_FOLLO	3
71	5	S38_TSPK_TBDrugSparceSpecimenCollection	intial version	4	2023-12-10	2023-12-11	4	F_S38_TSPK_TBD	3
90	1	38_EN_EnrollmentForm	intial version	4	2023-12-19	2023-12-19	4	F_38_EN_ENROLL	3
8	1	S38_NE_NonEnrollmentForm	intial version	4	2023-12-05	2023-12-05	4	F_S38_NE_NONEN	3
92	5	38_AE_FollowUp	intial version	4	2023-12-19	2023-12-19	4	F_38_AE_FOLLOW	3
12	1	S38_TSPK_screening	1st draft of TB Drug Sparse PK Screening/Eligibility Form	4	2023-12-05	2023-12-05	4	F_S38_TSPK_SCR	3
13	1	S38_IPK_screening	1st draft of TB Drug Intensive PK Screening/Eligibility Form	4	2023-12-05	2023-12-05	4	F_S38_IPK_SCRE	3
73	5	T1_TF_IGNORETESTSHEET	Ignore this test form	4	2023-12-10	2023-12-11	4	F_T1_TF_IGNORE	3
28	5	S38_CM	1st draft of Concomitant Medication Form	4	2023-12-05	2023-12-05	4	F_S38_CM	3
66	1	S38_CM_ConcomitantMedicationForm	1st draft of Concomitant Medication Form	4	2023-12-09	2023-12-09	4	F_S38_CM_CONCO	3
32	5	S38_DR	1st draft of TB Drug Dose Record Form	4	2023-12-05	2023-12-05	4	F_S38_DR	3
30	5	S38_CM v2	1st draft of Concomitant Medication Form	4	2023-12-05	2023-12-09	4	F_S38_CMV2	3
33	5	S38_DR v2	1st draft of TB Drug Dose Record Form	4	2023-12-05	2023-12-05	4	F_S38_DRV2	3
3	1	S38_FU_EvaluationForm	intial version	4	2023-12-03	2023-12-11	4	F_S38_FU_EVALU	3
69	1	S38_DR_DrugDoseRecordForm	1st draft of TB Drug Dose Record Form	4	2023-12-09	2023-12-09	4	F_S38_DR_DRUGD	3
44	1	S38_BH_FutureResearchBloodShippingForm	initial version	4	2023-12-06	2023-12-06	4	F_S38_BH_FUTUR	3
35	5	S38_DR v3	1st draft of TB Drug Dose Record Form	4	2023-12-05	2023-12-09	4	F_S38_DRV3	3
1	1	S38_AE_AdverseEvents	intial version	4	2023-12-03	2023-12-06	4	F_S38_AE_ADVER	3
70	1	S38_PG_PharmacogenomicBloodSampleForm	1st draft of Pharmacogenomic Blood Sample Form	4	2023-12-09	2023-12-09	4	F_S38_PG_PHARM	3
65	5	S38_FC_Follow-upCompletionV1.0	initial version	4	2023-12-08	2023-12-11	4	F_S38_FC_FOLLO	3
59	1	S38_FRB_FutureResearchBloodSFB	intial version	4	2023-12-07	2023-12-07	4	F_S38_FRB_FUTU	3
99	1	38_HX_HistoryForm	intial version	4	2023-12-22	2023-12-24	4	F_38_HX_HISTOR	3
63	1	S38_PossiblePoorTreatmentForm	Initial version	4	2023-12-07	2023-12-07	4	F_S38_POSSIBLE	3
80	1	S38_TSPK_DrugSparceSpecimenCollection	intial version	4	2023-12-11	2023-12-14	4	F_S38_TSPK_DRU	3
58	5	S38_TC_TreatmentChangeForm	Initial version	4	2023-12-06	2023-12-18	4	F_S38_TC_TREAT_1438	3
85	1	S38_TG_TreatmentChangeForm	First version	4	2023-12-18	2023-12-18	4	F_S38_TG_TREAT	3
9	1	S38_TC_TreatmentCompletion	intial version	4	2023-12-05	2023-12-18	4	F_S38_TC_TREAT	3
84	5	38_TX_Treatment_Evaluation_Form	intial version	8	2023-12-17	2023-12-18	4	F_38_TX_TREATM	3
25	5	S38_PG	1st draft of Pharmacogenomic Blood Sample Form	4	2023-12-05	2023-12-10	4	F_S38_PG	3
96	1	38_IPK_TB_Drug-IntensivePKSpecimenCollectionForm	Second version	4	2023-12-21	2023-12-22	4	F_38_IPK_TB_DR_8108	3
87	1	38_TX_TreatmentEvaluationForm	initial version	4	2023-12-18	2023-12-18	4	F_38_TX_TREATM_5386	3
6	5	S38_DE_NotificationOfDeathForm	intial version	4	2023-12-04	2023-12-22	4	F_S38_DE_NOTIF	3
76	5	S38_FC_Follow-upCompletion	Second version	4	2023-12-10	2023-12-10	4	F_S38_FC_FOLLO_4879	3
79	1	S38_FC_FollowupCompletion	Third version	4	2023-12-10	2023-12-10	4	F_S38_FC_FOLLO_2392	3
82	5	S38_PKS_ShippingFormForTB	intial version	4	2023-12-12	2023-12-18	4	F_S38_PKS_SHIP	3
98	1	38_DE_NotificationOfDeathForm	intial version	4	2023-12-22	2023-12-22	4	F_38_DE_NOTIFI	3
7	5	S38_HX_HistoryForm	intial version	4	2023-12-04	2023-12-22	4	F_S38_HX_HISTO	3
88	1	38_PKS_ShippingFormForTB	intial version	4	2023-12-18	2023-12-19	4	F_38_PKS_SHIPP	3
5	5	S38_EN_EnrollmentForm	intial version	4	2023-12-04	2023-12-19	4	F_S38_EN_ENROL	3
93	1	38_AF_FollowUp	intial version	4	2023-12-19	2023-12-20	4	F_38_AF_FOLLOW	3
94	5	38_IPK_TB_DrugIntensivePKSpecimenCollectionForm	intial version	8	2023-12-20	2023-12-21	4	F_38_IPK_TB_DR	3
\.


--
-- Data for Name: crf_version; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.crf_version (crf_version_id, crf_id, name, description, revision_notes, status_id, date_created, date_updated, owner_id, update_id, oc_oid, xform, xform_name) FROM stdin;
3	2	v1.0	intial version	ct 12-Dic-2023	1	2023-12-03	\N	4	\N	F_S38_AE_FOLLO_V10_347	\N	\N
4	3	v1.0	intial version	ct 11-Nov-2023	1	2023-12-03	\N	4	\N	F_S38_FU_EVALU_V10	\N	\N
93	80	v2.0	Second version	ct 04-Dic-2023	1	2023-12-14	\N	4	\N	F_S38_TSPK_DRU_V20_6915	\N	\N
10	8	v1.0	intial version	ct 04-Dic-2023	1	2023-12-05	\N	4	\N	F_S38_NE_NONEN_V10	\N	\N
12	12	V0.1	1st draft of TB Drug Sparse PK Screening/Eligibility Form	none	1	2023-12-05	\N	4	\N	F_S38_TSPK_SCR_V01	\N	\N
13	12	V0.2	1st draft of TB Drug Sparse PK Screening/Eligibility Form	none	1	2023-12-05	\N	4	\N	F_S38_TSPK_SCR_V02	\N	\N
14	12	V0.3	1st draft of TB Drug Sparse PK Screening/Eligibility Form	none	1	2023-12-05	\N	4	\N	F_S38_TSPK_SCR_V03	\N	\N
15	13	V0.1	1st draft of TB Drug Intensive PK Screening/Eligibility Form	none	1	2023-12-05	\N	4	\N	F_S38_IPK_SCRE_V01	\N	\N
25	58	v1.0	Initial version	none	7	2023-12-06	2023-12-18	4	4	F_S38_TC_TREAT_1438_V10	\N	\N
33	58	v2.0	Second version	none	7	2023-12-07	2023-12-18	4	4	F_S38_TC_TREAT_1438_V20	\N	\N
17	28	V0.1	1st draft of Concomitant Medication Form	none	7	2023-12-05	2023-12-05	4	4	F_S38_CM_V01	\N	\N
34	58	v3.0	Third version	none	7	2023-12-07	2023-12-18	4	4	F_S38_TC_TREAT_1438_V30	\N	\N
36	58	v4.0	Fourth version	none	7	2023-12-07	2023-12-18	4	4	F_S38_TC_TREAT_1438_V40	\N	\N
19	32	V0.1	1st draft of TB Drug Dose Record Form	none	7	2023-12-05	2023-12-05	4	4	F_S38_DR_V01	\N	\N
95	85	v1.0	First version	none	1	2023-12-18	\N	4	\N	F_S38_TG_TREAT_V10	\N	\N
20	33	V0.1	1st draft of TB Drug Dose Record Form	none	7	2023-12-05	2023-12-05	4	4	F_S38_DRV2_V01	\N	\N
96	9	v1.0	intial version	ct 04-Dic-2023	1	2023-12-18	\N	4	\N	F_S38_TC_TREAT_V10_2263	\N	\N
22	44	v1.0	initial version	none	1	2023-12-06	\N	4	\N	F_S38_BH_FUTUR_V10	\N	\N
23	1	v2.0	small corrections done by Lucio Montero	ct 06-Dec-2023	1	2023-12-06	\N	4	\N	F_S38_AE_ADVER_V20	\N	\N
24	44	v2.0	Second Version	none	1	2023-12-06	\N	4	\N	F_S38_BH_FUTUR_V20	\N	\N
26	1	v1.0	intial version	ct 11-Nov-2023	1	2023-12-06	\N	4	\N	F_S38_AE_ADVER_V10_2930	\N	\N
94	84	v1.0	intial version	ct 11-Nov-2023	7	2023-12-17	2023-12-18	8	4	F_38_TX_TREATM_V10	\N	\N
99	87	v1.0	initial version	ct 11-Nov-2023	1	2023-12-18	\N	4	\N	F_38_TX_TREATM_5386_V10	\N	\N
32	59	v1.0	intial version	ct 04-Dic-2023	1	2023-12-07	\N	4	\N	F_S38_FRB_FUTU_V10	\N	\N
35	63	v1.0	Initial version	none	1	2023-12-07	\N	4	\N	F_S38_POSSIBLE_V10	\N	\N
101	87	v2.0	Second version	ct 11-Nov-2023	1	2023-12-18	\N	4	\N	F_38_TX_TREATM_5386_V20_6507	\N	\N
81	82	v1.0	intial version	ct 04-Dic-2023	7	2023-12-12	2023-12-18	4	4	F_S38_PKS_SHIP_V10	\N	\N
40	3	v2.0	Second version	ct 11-Nov-2023	1	2023-12-09	\N	4	\N	F_S38_FU_EVALU_V20	\N	\N
41	66	v7.0	1st draft of Concomitant Medication Form	none	1	2023-12-09	\N	4	\N	F_S38_CM_CONCO_V70	\N	\N
18	30	V0.1	1st draft of Concomitant Medication Form	none	7	2023-12-05	2023-12-09	4	4	F_S38_CMV2_V01	\N	\N
27	30	V0.2	1st draft of Concomitant Medication Form	none	7	2023-12-06	2023-12-09	4	4	F_S38_CMV2_V02	\N	\N
28	30	V0.3	1st draft of Concomitant Medication Form	none	7	2023-12-06	2023-12-09	4	4	F_S38_CMV2_V03	\N	\N
29	30	V0.5	1st draft of Concomitant Medication Form	none	7	2023-12-06	2023-12-09	4	4	F_S38_CMV2_V05	\N	\N
30	30	V0.6	1st draft of Concomitant Medication Form	none	7	2023-12-06	2023-12-09	4	4	F_S38_CMV2_V06	\N	\N
31	30	V0.7	1st draft of Concomitant Medication Form	none	7	2023-12-06	2023-12-09	4	4	F_S38_CMV2_V07	\N	\N
42	69	v1.0	1st draft of TB Drug Dose Record Form	none	1	2023-12-09	\N	4	\N	F_S38_DR_DRUGD_V10	\N	\N
21	35	V0.1	1st draft of TB Drug Dose Record Form	none	7	2023-12-05	2023-12-09	4	4	F_S38_DRV3_V01	\N	\N
43	70	v1.0	1st draft of Pharmacogenomic Blood Sample Form	none	1	2023-12-09	\N	4	\N	F_S38_PG_PHARM_V10	\N	\N
105	88	v1.0	intial version	ct 04-Dic-2023	5	2023-12-18	2023-12-19	4	4	F_38_PKS_SHIPP_V10_1418	\N	\N
107	88	v2.0	second version	ct 04-Dic-2023	1	2023-12-19	\N	4	\N	F_38_PKS_SHIPP_V20_7666	\N	\N
6	5	v1.0	intial version	ct 11-Nov-2023	7	2023-12-04	2023-12-19	4	4	F_S38_EN_ENROL_V10	\N	\N
65	5	v1.1	intial version	ct 11-Nov-2023	7	2023-12-11	2023-12-19	5	4	F_S38_EN_ENROL_V11	\N	\N
109	90	v1.0	intial version	ct 11-Nov-2023	1	2023-12-19	\N	4	\N	F_38_EN_ENROLL_V10_2365	\N	\N
110	92	v1.0	intial version	ct 12-Dic-2023	7	2023-12-19	2023-12-19	4	4	F_38_AE_FOLLOW_V10	\N	\N
16	25	V0.1	1st draft of Pharmacogenomic Blood Sample Form	none	7	2023-12-05	2023-12-10	4	4	F_S38_PG_V01	\N	\N
60	76	v2.0	Second version	ct 11-Nov-2023	7	2023-12-10	2023-12-10	4	4	F_S38_FC_FOLLO_4879_V20_7116	\N	\N
61	79	v3.0	Third version	NONE	1	2023-12-10	\N	4	\N	F_S38_FC_FOLLO_2392_V30	\N	\N
62	71	v1.0	intial version	ct 04-Dic-2023	7	2023-12-11	2023-12-11	4	4	F_S38_TSPK_TBD_V10_4387	\N	\N
63	80	v1.0	intial version	ct 04-Dic-2023	1	2023-12-11	\N	4	\N	F_S38_TSPK_DRU_V10	\N	\N
64	3	v2.1	Second version	ct 11-Nov-2023	1	2023-12-11	\N	4	\N	F_S38_FU_EVALU_V21	\N	\N
37	65	v1.0	initial version	ct 11-Nov-2023	7	2023-12-08	2023-12-11	4	4	F_S38_FC_FOLLO_V10	\N	\N
126	93	v1.0	intial version	ct 12-Dic-2023	1	2023-12-20	\N	4	\N	F_38_AF_FOLLOW_V10	\N	\N
117	94	v1.0	intial version	ct 11-Nov-2023	7	2023-12-20	2023-12-21	8	4	F_38_IPK_TB_DR_V10	\N	\N
135	96	v2.0	Second version	ct 11-Nov-2023	1	2023-12-22	\N	4	\N	F_38_IPK_TB_DR_8108_V20	\N	\N
7	6	v1.0	intial version	ct 11-Nov-2023	7	2023-12-04	2023-12-22	4	4	F_S38_DE_NOTIF_V10	\N	\N
137	98	v1.0	intial version	None	1	2023-12-22	\N	4	\N	F_38_DE_NOTIFI_V10_9807	\N	\N
9	7	v1.0	intial version	ct 04-Dic-2023	7	2023-12-04	2023-12-22	4	4	F_S38_HX_HISTO_V10_298	\N	\N
148	99	v1.0	intial version	None	1	2023-12-24	\N	4	\N	F_38_HX_HISTOR_V10	\N	\N
\.


--
-- Data for Name: crf_version_media; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.crf_version_media (crf_version_media_id, crf_version_id, name, path) FROM stdin;
\.


--
-- Data for Name: databasechangelog; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.databasechangelog (id, author, filename, dateexecuted, orderexecuted, exectype, md5sum, description, comments, tag, liquibase, contexts, labels, deployment_id) FROM stdin;
1235684743487-0	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:46.719021	1	MARK_RAN	8:ab25015b9763c27a512455fd43e39225	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-1	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:46.80246	2	EXECUTED	8:75a39ee2d45f42b135de71a20df62f99	createTable tableName=archived_dataset_file		\N	3.6.3	\N	\N	1509384775
1235684743487-2	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:46.817784	3	EXECUTED	8:49b4819aff026a99d7b0548b35a63029	createTable tableName=audit_event		\N	3.6.3	\N	\N	1509384775
1235684743487-3	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:46.876468	4	EXECUTED	8:e6ca531ef9cf0d8470e3c3522188681e	createTable tableName=audit_event_context		\N	3.6.3	\N	\N	1509384775
1235684743487-4	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:46.886475	5	EXECUTED	8:9c124592d17e2b5323b66d8f57fce7bb	createTable tableName=audit_event_values		\N	3.6.3	\N	\N	1509384775
1235684743487-5	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:46.913508	6	EXECUTED	8:9f2b8689687ef7713897c1e1a70d2ebb	createTable tableName=audit_log_event		\N	3.6.3	\N	\N	1509384775
235684743487-5-1	kkrumlian	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:46.916593	7	EXECUTED	8:d41d8cd98f00b204e9800998ecf8427e	empty		\N	3.6.3	\N	\N	1509384775
235684743487-5-2	kkrumlian	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:46.919963	8	EXECUTED	8:d41d8cd98f00b204e9800998ecf8427e	empty		\N	3.6.3	\N	\N	1509384775
1235684743487-6	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:46.982523	9	EXECUTED	8:c8aaae0e324a03884b11808d0a3cde5a	createTable tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-7	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.027979	10	EXECUTED	8:a18936418bedba4bd41ea351b1b708ae	createTable tableName=completion_status		\N	3.6.3	\N	\N	1509384775
1235684743487-8	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.179813	11	EXECUTED	8:5752fe8b7dd5e1783bb76bd76c490802	createTable tableName=crf		\N	3.6.3	\N	\N	1509384775
1235684743487-9	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.202761	12	EXECUTED	8:b41359e661d830286a984c2f679a5eff	createTable tableName=crf_version		\N	3.6.3	\N	\N	1509384775
1235684743487-10	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.235956	13	EXECUTED	8:7b916bf555eb847232bf3efaa86fa8b9	createTable tableName=dataset		\N	3.6.3	\N	\N	1509384775
235684743487-10-1	kkrumlian	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.241521	14	MARK_RAN	8:d8766ca6237d3decdca44ccf02bdef1c	dropTable tableName=dataset		\N	3.6.3	\N	\N	1509384775
1235684743487-10-2	kkrumlian	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.24851	15	MARK_RAN	8:1b54ec543794fafb7ff7964387119446	createTable tableName=dataset		\N	3.6.3	\N	\N	1509384775
235684743487-10-3	kkrumlian	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.252216	16	EXECUTED	8:d41d8cd98f00b204e9800998ecf8427e	empty		\N	3.6.3	\N	\N	1509384775
1235684743487-11	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.286842	17	EXECUTED	8:716041754b974828255bda16ea669d11	createTable tableName=dataset_crf_version_map		\N	3.6.3	\N	\N	1509384775
1235684743487-12	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.296131	18	EXECUTED	8:d6bee076c68d62eb732673ddbc79dd7f	createTable tableName=dataset_filter_map		\N	3.6.3	\N	\N	1509384775
1235684743487-13	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.301443	19	EXECUTED	8:892e0f42c612ab48a5206fa037a2bb91	createTable tableName=dataset_study_group_class_map		\N	3.6.3	\N	\N	1509384775
1235684743487-14	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.316929	20	EXECUTED	8:4a35282487e39f3a325524434811c046	createTable tableName=dc_computed_event		\N	3.6.3	\N	\N	1509384775
1235684743487-15	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.336017	21	EXECUTED	8:a8fd5ee2012102fd3234847b83641e7c	createTable tableName=dc_event		\N	3.6.3	\N	\N	1509384775
1235684743487-16	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.353459	22	EXECUTED	8:1990e4185c7f9cec46537630326be9a5	createTable tableName=dc_primitive		\N	3.6.3	\N	\N	1509384775
1235684743487-17	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.371425	23	EXECUTED	8:9a8bebb42e0debb2fc1b2de24200d6da	createTable tableName=dc_section_event		\N	3.6.3	\N	\N	1509384775
1235684743487-18	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.415859	24	EXECUTED	8:8c969997fa8e40d4542098613ff67a49	createTable tableName=dc_send_email_event		\N	3.6.3	\N	\N	1509384775
1235684743487-19	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.434761	25	EXECUTED	8:8bbc5d421ecd3dd45ab8d0488f7a485a	createTable tableName=dc_substitution_event		\N	3.6.3	\N	\N	1509384775
1235684743487-20	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.445274	26	EXECUTED	8:e807da47d9cc06a2a9c816aac801f92c	createTable tableName=dc_summary_item_map		\N	3.6.3	\N	\N	1509384775
1235684743487-21	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.466151	27	EXECUTED	8:4bbb389a038a945cb3142d4b3671ba6f	createTable tableName=decision_condition		\N	3.6.3	\N	\N	1509384775
1235684743487-22	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.48967	28	EXECUTED	8:0aaecfd2fd709f91f68591fa83fc74c2	createTable tableName=discrepancy_note		\N	3.6.3	\N	\N	1509384775
1235684743487-23	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.500909	29	EXECUTED	8:31310632aa0deef8374e1cd8d7e73a3c	createTable tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
1235684743487-24	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.51104	30	EXECUTED	8:6be4537297bbe3747a7e98a51fade90e	createTable tableName=dn_event_crf_map		\N	3.6.3	\N	\N	1509384775
1235684743487-25	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.518237	31	EXECUTED	8:48159a10319361e1e90e129f0f52ce79	createTable tableName=dn_item_data_map		\N	3.6.3	\N	\N	1509384775
1235684743487-26	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.534074	32	EXECUTED	8:035750d8678ba7939eee438990f32d4e	createTable tableName=dn_study_event_map		\N	3.6.3	\N	\N	1509384775
1235684743487-27	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.549478	33	EXECUTED	8:e6f36347e7556c0199ebcffba5beddba	createTable tableName=dn_study_subject_map		\N	3.6.3	\N	\N	1509384775
1235684743487-28	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.558975	34	EXECUTED	8:267b1a7b9b07b3270a8804a1dd614c41	createTable tableName=dn_subject_map		\N	3.6.3	\N	\N	1509384775
1235684743487-29	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.578458	35	EXECUTED	8:2d84bebb30d70d421d1197bdc1705387	createTable tableName=event_crf		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-9	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.195349	649	EXECUTED	8:4927977153d185a78f84ba1a1693eded	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-30	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.593734	36	EXECUTED	8:2be7d7e16cf465e30b846e2bf74aa7eb	createTable tableName=event_definition_crf		\N	3.6.3	\N	\N	1509384775
1235684743487-31	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.606866	37	EXECUTED	8:1e2af57ca0f9ced0278d26e2790b431c	createTable tableName=export_format		\N	3.6.3	\N	\N	1509384775
1235684743487-32	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.621752	38	EXECUTED	8:55d1a0d13871f0676c9a5c4448fdaa40	createTable tableName=filter		\N	3.6.3	\N	\N	1509384775
235684743487-32-1	kkrumlian	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.626768	39	MARK_RAN	8:87c8e9f28f945994770a175f3b8e0013	dropTable tableName=filter		\N	3.6.3	\N	\N	1509384775
1235684743487-32-2	kkrumlian	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.642799	40	MARK_RAN	8:8eefa9b88de32fd8e47025a96639e581	createTable tableName=filter		\N	3.6.3	\N	\N	1509384775
235684743487-32-3	kkrumlian	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.646631	41	EXECUTED	8:d41d8cd98f00b204e9800998ecf8427e	empty		\N	3.6.3	\N	\N	1509384775
1235684743487-33	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.654669	42	EXECUTED	8:018ea6822999ec08141725648cfea144	createTable tableName=filter_crf_version_map		\N	3.6.3	\N	\N	1509384775
1235684743487-34	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.669507	43	EXECUTED	8:04da53a11a50fbe807fa49a1f0ffd8ad	createTable tableName=group_class_types		\N	3.6.3	\N	\N	1509384775
1235684743487-35	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.684578	44	EXECUTED	8:6d31529ee3e474eb66d78a31b811016e	createTable tableName=item		\N	3.6.3	\N	\N	1509384775
1235684743487-36	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.697303	45	EXECUTED	8:0e9e3ba564cde91d75a7f20a092ee8c8	createTable tableName=item_data		\N	3.6.3	\N	\N	1509384775
1235684743487-37	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.710411	46	EXECUTED	8:ebe81e192653b298f701edc92367aa6b	createTable tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-38	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.725427	47	EXECUTED	8:1c5c5fdff357490dc09aa9ad1fc30568	createTable tableName=item_form_metadata		\N	3.6.3	\N	\N	1509384775
1235684743487-39	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.73386	48	EXECUTED	8:84dd9d291ae82748723d7fd844087b49	createTable tableName=item_group		\N	3.6.3	\N	\N	1509384775
1235684743487-40	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.746875	49	EXECUTED	8:e936a01433322af590ebb00e0e0fc303	createTable tableName=item_group_metadata		\N	3.6.3	\N	\N	1509384775
1235684743487-41	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.76742	50	EXECUTED	8:4ef33c18136abe6ddcd3591af18ee37b	createTable tableName=item_reference_type		\N	3.6.3	\N	\N	1509384775
1235684743487-42	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.787622	51	EXECUTED	8:fd8ea095a7baae4d540dd2081d065fa6	createTable tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-43	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.796571	52	EXECUTED	8:72de38d0e7169c4267e753a20dcccf93	createTable tableName=openclinica_version		\N	3.6.3	\N	\N	1509384775
1235684743487-43-1	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.802614	53	EXECUTED	8:8847950fab7e2d659fc66dcf92cefd90	dropTable tableName=openclinica_version		\N	3.6.3	\N	\N	1509384775
1235684743487-43-2	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.813357	54	EXECUTED	8:833753787ac14466b353f539ce90238f	createTable tableName=openclinica_version		\N	3.6.3	\N	\N	1509384775
1235684743487-44	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.829684	55	EXECUTED	8:745c69632162820f47500b11c05288cf	createTable tableName=privilege		\N	3.6.3	\N	\N	1509384775
1235684743487-45	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.848546	56	EXECUTED	8:eb07c228ab5b72825d03cae934b41950	createTable tableName=resolution_status		\N	3.6.3	\N	\N	1509384775
1235684743487-46	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.87924	57	EXECUTED	8:b9a79994580cd4422d6022fecb518241	createTable tableName=response_set		\N	3.6.3	\N	\N	1509384775
1235684743487-47	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.898094	58	EXECUTED	8:69e4ab85f9ba73ce29e52204101b8767	createTable tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-48	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.905331	59	EXECUTED	8:02349b735c8bd4315f5f70e486b57669	createTable tableName=role_privilege_map		\N	3.6.3	\N	\N	1509384775
1235684743487-49	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.917543	60	EXECUTED	8:e94661e26f8f4e232c902bf412491665	createTable tableName=rule		\N	3.6.3	\N	\N	1509384775
1235684743487-50	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.932918	61	EXECUTED	8:4d43f401f214e8dbdc71b21ff641ce66	createTable tableName=rule_action		\N	3.6.3	\N	\N	1509384775
1235684743487-51	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.957147	62	EXECUTED	8:a75751c1a5d9e2b4dc21e540a37ba02b	createTable tableName=rule_expression		\N	3.6.3	\N	\N	1509384775
1235684743487-52	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.975738	63	EXECUTED	8:6bb306d331ebc9747a96d1aa098d243e	createTable tableName=rule_set		\N	3.6.3	\N	\N	1509384775
1235684743487-53	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.987236	64	EXECUTED	8:e2183a822e74b12f6069ac8398b9563f	createTable tableName=rule_set_audit		\N	3.6.3	\N	\N	1509384775
1235684743487-54	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:47.998114	65	EXECUTED	8:ba4f18774b25e7c98660e99487298807	createTable tableName=rule_set_rule		\N	3.6.3	\N	\N	1509384775
1235684743487-55	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.007619	66	EXECUTED	8:99a91a5e5707b2d5977481754fe18e40	createTable tableName=rule_set_rule_audit		\N	3.6.3	\N	\N	1509384775
1235684743487-56	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.029089	67	EXECUTED	8:28477b753c6af013056e638153ba9cfa	createTable tableName=section		\N	3.6.3	\N	\N	1509384775
1235684743487-57	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.049873	68	EXECUTED	8:c632c95c12844ce9810157ca9d794013	createTable tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-58	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.073862	69	EXECUTED	8:01a9d4c2532042b4d1ca9512c0995ff2	createTable tableName=study		\N	3.6.3	\N	\N	1509384775
1235684743487-59	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.097298	70	EXECUTED	8:e3d52deaeba5943a11b26aaa79f9f2d3	createTable tableName=study_event		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-10	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.224252	650	EXECUTED	8:a8c26dc25a1a70477230778778cf7e29	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-60	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.109	71	EXECUTED	8:42ce85748e6cdddf8c081ec010a2c7b4	createTable tableName=study_event_definition		\N	3.6.3	\N	\N	1509384775
1235684743487-61	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.119982	72	EXECUTED	8:cea6d977d3b25f4950ebbb645e5f8573	createTable tableName=study_group		\N	3.6.3	\N	\N	1509384775
1235684743487-62	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.128749	73	EXECUTED	8:f47b05c54b386104a4cc6f81cb935bb7	createTable tableName=study_group_class		\N	3.6.3	\N	\N	1509384775
1235684743487-63	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.142179	74	EXECUTED	8:9e9b1efe1656d50b5c850c104d3ff3c2	createTable tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-64	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.149397	75	EXECUTED	8:fe55faffdce6be6e45efb3672b44e946	createTable tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-65	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.164359	76	EXECUTED	8:ebcf3983b1a57b1d46093611ebfa6513	createTable tableName=study_subject		\N	3.6.3	\N	\N	1509384775
1235684743487-66	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.17455	77	EXECUTED	8:fdab9fa2cf68b2da6a36e7d66edb2c49	createTable tableName=study_type		\N	3.6.3	\N	\N	1509384775
1235684743487-67	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.179143	78	EXECUTED	8:8b27f270993dcbcc4094c8d411c6166c	createTable tableName=study_user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-68	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.187664	79	EXECUTED	8:b0d42edba5a604eeb32ba5da9880f078	createTable tableName=subject		\N	3.6.3	\N	\N	1509384775
1235684743487-69	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.197065	80	EXECUTED	8:72c7fe9c277ebb3defb253e170de147a	createTable tableName=subject_event_status		\N	3.6.3	\N	\N	1509384775
1235684743487-70	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.203703	81	EXECUTED	8:628b4b8e306ce2564b6dea49d49132ec	createTable tableName=subject_group_map		\N	3.6.3	\N	\N	1509384775
1235684743487-71	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.216986	82	EXECUTED	8:f4b01066342a49a8be7a3e2f95f72106	createTable tableName=user_account		\N	3.6.3	\N	\N	1509384775
1235684743487-72	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.227846	83	EXECUTED	8:4291a7048736ea6723c12f628dfe1d39	createTable tableName=user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-73	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.236052	84	EXECUTED	8:d92d0f26fc468dacc64359201c20eb6e	createTable tableName=user_type		\N	3.6.3	\N	\N	1509384775
1235684743487-74	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.242623	85	EXECUTED	8:2e6ca64cd8aa2b00c6098d8559e909a5	createTable tableName=versioning_map		\N	3.6.3	\N	\N	1509384775
1236014212860-75	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.25085	86	EXECUTED	8:4ab35ba894e54fb7148c2ee7ec6f832d	addUniqueConstraint constraintName=uniq_crf_oc_oid, tableName=crf		\N	3.6.3	\N	\N	1509384775
1236014212860-76	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.260236	87	EXECUTED	8:783a5821fb76be57e88002f66823ffb4	addUniqueConstraint constraintName=uniq_crf_version_oc_oid, tableName=crf_version		\N	3.6.3	\N	\N	1509384775
1236014212860-77	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.266109	88	EXECUTED	8:9f2a1e391446c400213d0d8acac17b4c	addUniqueConstraint constraintName=uniq_item_oc_oid, tableName=item		\N	3.6.3	\N	\N	1509384775
1236014212860-78	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.27403	89	EXECUTED	8:40944b0affe1fd427daaf881d093f3fd	addUniqueConstraint constraintName=uniq_item_group_oc_oid, tableName=item_group		\N	3.6.3	\N	\N	1509384775
1236014212860-79	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.279444	90	EXECUTED	8:f11877e6e1e49a3bfadc9ff6317861e6	addUniqueConstraint constraintName=uniq_study_oid, tableName=study		\N	3.6.3	\N	\N	1509384775
1236014212860-80	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.284146	91	EXECUTED	8:3302762b35aef789a3e545fa1c9ed1bc	addUniqueConstraint constraintName=uniq_study_event_def_oid, tableName=study_event_definition		\N	3.6.3	\N	\N	1509384775
1236014212860-81	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.291271	92	EXECUTED	8:2cb89cd4186ac5900cb4c77d6b2e4c66	addUniqueConstraint constraintName=study_parameter_handle_key, tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1236014212860-82	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.29834	93	EXECUTED	8:9185d3a333e95f3e1e23749b7e8f6091	addUniqueConstraint constraintName=uniq_study_subject_oid, tableName=study_subject		\N	3.6.3	\N	\N	1509384775
1235684743487-83	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.306069	94	EXECUTED	8:3c6808fef162c99c4ee14d189894c160	createIndex indexName=i_audit_event_audit_table, tableName=audit_event		\N	3.6.3	\N	\N	1509384775
1235684743487-84	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.313895	95	EXECUTED	8:ba4302cf79ecccad8e75c3f44bdc5707	createIndex indexName=i_audit_event_entity_id, tableName=audit_event		\N	3.6.3	\N	\N	1509384775
1235684743487-85	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.321361	96	EXECUTED	8:48e0f7ab89b7ad305384814debdd0353	createIndex indexName=i_audit_event_user_id, tableName=audit_event		\N	3.6.3	\N	\N	1509384775
1235684743487-86	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.329317	97	EXECUTED	8:c895f39d0f76c1f237753e8832c7c7f5	createIndex indexName=i_audit_event_context_study_id, tableName=audit_event_context		\N	3.6.3	\N	\N	1509384775
1235684743487-87	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.336022	98	EXECUTED	8:c0a6cedf52e0a75e4e6af69b53ca3ed9	createIndex indexName=i_item_name, tableName=item		\N	3.6.3	\N	\N	1509384775
1235684743487-88	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.344828	99	EXECUTED	8:11a1057cca90d2825f51464a96d05c9f	createIndex indexName=i_itm_form_metadata_crf_ver_id, tableName=item_form_metadata		\N	3.6.3	\N	\N	1509384775
1235684743487-89	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.349446	100	EXECUTED	8:0f7e7aeeda60ad7f973aa8a0aa502084	createIndex indexName=i_section_ordinal, tableName=section		\N	3.6.3	\N	\N	1509384775
1235684743487-90	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.356501	101	EXECUTED	8:b56eaf9079785a7eaec8a2081eebd3d5	createIndex indexName=i_section_parent_id, tableName=section		\N	3.6.3	\N	\N	1509384775
1235684743487-91	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.363417	102	EXECUTED	8:7f61eccf7e49507bf0d51d3ef5f007b0	createIndex indexName=i_study_user_role_user_name, tableName=study_user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-92	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.372133	103	EXECUTED	8:02055e8e8fa822ea0ef8464316fba5b5	createIndex indexName=i_user_account_user_name, tableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-93	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.380387	104	EXECUTED	8:5a145d60e11ca5662d15a117de10da15	addForeignKeyConstraint baseTableName=archived_dataset_file, constraintName=fk_archived_reference_dataset, referencedTableName=dataset		\N	3.6.3	\N	\N	1509384775
1236014212860-94	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.387597	105	EXECUTED	8:b5f86b242cad93583fd6b362279d2068	addForeignKeyConstraint baseTableName=archived_dataset_file, constraintName=fk_archived_reference_export_f, referencedTableName=export_format		\N	3.6.3	\N	\N	1509384775
1236014212860-95	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.395721	106	EXECUTED	8:82c4abeb6e25ca6728ab834b9368dfc3	addForeignKeyConstraint baseTableName=audit_event_context, constraintName=fk_audit_ev_reference_audit_ev, referencedTableName=audit_event		\N	3.6.3	\N	\N	1509384775
1236014212860-96	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.403175	107	EXECUTED	8:a8dfd8c64577d36fe846aeede9fa9458	addForeignKeyConstraint baseTableName=audit_event_values, constraintName=fk_audit_lo_ref_audit_lo, referencedTableName=audit_event		\N	3.6.3	\N	\N	1509384775
1236014212860-97	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.410348	108	EXECUTED	8:784d7819df2f9e6fcea9911ebe283d45	addForeignKeyConstraint baseTableName=completion_status, constraintName=fk_completi_fk_comple_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-98	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.417689	109	EXECUTED	8:2cf3e9e321dae21d9f78b335b9f491dc	addForeignKeyConstraint baseTableName=crf, constraintName=fk_crf_crf_user_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-99	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.425496	110	EXECUTED	8:04c1af1eb42ff752ab61795c0e13b4c9	addForeignKeyConstraint baseTableName=crf, constraintName=fk_crf_fk_crf_fk_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-100	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.436126	111	EXECUTED	8:17b3dc3f2f1d2538eb9f8467b2b5b3af	addForeignKeyConstraint baseTableName=crf_version, constraintName=fk_versioni_reference_instrume, referencedTableName=crf		\N	3.6.3	\N	\N	1509384775
1236014212860-101	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.448974	112	EXECUTED	8:2b2a7dd1be174b5c352feedd8c5a7503	addForeignKeyConstraint baseTableName=crf_version, constraintName=fk_crf_vers_crf_versi_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-102	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.459559	113	EXECUTED	8:5ead911e261260224ee47acc5f71e2f1	addForeignKeyConstraint baseTableName=crf_version, constraintName=fk_crf_vers_fk_crf_ve_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-103	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.469394	114	EXECUTED	8:694029fd735da7a447331470dc56e85e	addForeignKeyConstraint baseTableName=dataset, constraintName=fk_dataset_fk_datase_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-104	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.477914	115	EXECUTED	8:a6214b160a99ba3eb9a53631a4289f42	addForeignKeyConstraint baseTableName=dataset, constraintName=fk_dataset_fk_datase_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-105	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.48585	116	EXECUTED	8:484f5148d76803addac6a31237e38b78	addForeignKeyConstraint baseTableName=dataset, constraintName=fk_dataset_fk_datase_study, referencedTableName=study		\N	3.6.3	\N	\N	1509384775
1236014212860-106	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.494213	117	EXECUTED	8:422792896040cc10697e6ac344c9607d	addForeignKeyConstraint baseTableName=dataset_crf_version_map, constraintName=fk_dataset_crf_ref_dataset, referencedTableName=dataset		\N	3.6.3	\N	\N	1509384775
1236014212860-107	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.500737	118	EXECUTED	8:33c9842f4c7133a1d757a77ef34ee4a6	addForeignKeyConstraint baseTableName=dataset_crf_version_map, constraintName=fk_dataset__ref_event_event_de, referencedTableName=event_definition_crf		\N	3.6.3	\N	\N	1509384775
1236014212860-108	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.508595	119	EXECUTED	8:c42e81434e0fed5ba3dcee85d604fcab	addForeignKeyConstraint baseTableName=dataset_filter_map, constraintName=fk_dataset_reference_dataset, referencedTableName=dataset		\N	3.6.3	\N	\N	1509384775
1236014212860-109	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.514859	120	EXECUTED	8:72a8561a4743867ec8e9d1650d05f90e	addForeignKeyConstraint baseTableName=dataset_filter_map, constraintName=fk_dataset_reference_filter, referencedTableName=filter		\N	3.6.3	\N	\N	1509384775
1236014212860-110	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.522068	121	EXECUTED	8:0d91bae01ba8d23c57145e268fc3e7e5	addForeignKeyConstraint baseTableName=dataset_study_group_class_map, constraintName=fk_dataset_study_ref_dataset, referencedTableName=dataset		\N	3.6.3	\N	\N	1509384775
1236014212860-111	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.529496	122	EXECUTED	8:c2ab431561bbd588ad05a01a1120b001	addForeignKeyConstraint baseTableName=dataset_study_group_class_map, constraintName=fk_dataset_ref_study_grp_class, referencedTableName=study_group_class		\N	3.6.3	\N	\N	1509384775
1236014212860-112	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.537328	123	EXECUTED	8:6bec0f5e3b4a1a748b4b99907f3f4b09	addForeignKeyConstraint baseTableName=dc_computed_event, constraintName=fk_dc_compu_fk_dc_com_dc_event, referencedTableName=dc_event		\N	3.6.3	\N	\N	1509384775
1236014212860-113	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.550484	124	EXECUTED	8:e0c5684bc4c492532cc5c80c378190f0	addForeignKeyConstraint baseTableName=dc_event, constraintName=fk_dc_event_fk_dc_eve_decision, referencedTableName=decision_condition		\N	3.6.3	\N	\N	1509384775
1236014212860-114	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.565869	125	EXECUTED	8:e5df907a87c0a2c471e386f798ab5f0c	addForeignKeyConstraint baseTableName=dc_primitive, constraintName=fk_dc_primi_fk_dc_pri_decision, referencedTableName=decision_condition		\N	3.6.3	\N	\N	1509384775
1236014212860-115	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.582112	126	EXECUTED	8:6d3e2ee63fe4e3782c04b0209da8ee3d	addForeignKeyConstraint baseTableName=dc_primitive, constraintName=fk_dc_primi_fk_dc_pri_item, referencedTableName=item		\N	3.6.3	\N	\N	1509384775
1236014212860-116	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.591941	127	EXECUTED	8:ad93c0a42a057e6af75bdbc1246ad543	addForeignKeyConstraint baseTableName=dc_primitive, constraintName=fk_dc_primi_fk_item_i_item, referencedTableName=item		\N	3.6.3	\N	\N	1509384775
1236014212860-117	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.597803	128	EXECUTED	8:108c87221c029437cc89bdb6ba088df9	addForeignKeyConstraint baseTableName=dc_section_event, constraintName=fk_dc_secti_fk_dc_sec_dc_event, referencedTableName=dc_event		\N	3.6.3	\N	\N	1509384775
1236014212860-118	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.608285	129	EXECUTED	8:da8faf0f2dd00016b538c10a781e1202	addForeignKeyConstraint baseTableName=dc_send_email_event, constraintName=fk_dc_send__dc_send_e_dc_event, referencedTableName=dc_event		\N	3.6.3	\N	\N	1509384775
1236014212860-119	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.617978	130	EXECUTED	8:117084b2919e8b2dfd55e7a433e1c171	addForeignKeyConstraint baseTableName=dc_substitution_event, constraintName=fk_dc_subst_fk_dc_sub_dc_event, referencedTableName=dc_event		\N	3.6.3	\N	\N	1509384775
1236014212860-120	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.626831	131	EXECUTED	8:7cd87e39f571ebb40515e24d186afcb5	addForeignKeyConstraint baseTableName=dc_substitution_event, constraintName=fk_dc_subst_fk_dc_sub_item, referencedTableName=item		\N	3.6.3	\N	\N	1509384775
1236014212860-121	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.63501	132	EXECUTED	8:7a837085d8d722840cd2e81ad995913e	addForeignKeyConstraint baseTableName=dc_summary_item_map, constraintName=fk_dc_summa_fk_dc_sum_dc_compu, referencedTableName=dc_computed_event		\N	3.6.3	\N	\N	1509384775
1236014212860-122	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.641602	133	EXECUTED	8:ccf0c6dd73dd7dea0d8584a950e1612d	addForeignKeyConstraint baseTableName=dc_summary_item_map, constraintName=fk_dc_summa_fk_dc_sum_item, referencedTableName=item		\N	3.6.3	\N	\N	1509384775
1236014212860-123	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.65068	134	EXECUTED	8:f5ef89e27a8fd3489cd19bb3323869f6	addForeignKeyConstraint baseTableName=decision_condition, constraintName=fk_decision_fk_decisi_crf_vers, referencedTableName=crf_version		\N	3.6.3	\N	\N	1509384775
1236014212860-124	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.659849	135	EXECUTED	8:033e7d8806cff79e26978f9e46663fb9	addForeignKeyConstraint baseTableName=decision_condition, constraintName=fk_decision_fk_decisi_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-125	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.668752	136	EXECUTED	8:fbec8420757bd6febf7b891591385fad	addForeignKeyConstraint baseTableName=decision_condition, constraintName=fk_decision_fk_decisi_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-126	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.677762	137	EXECUTED	8:fa3804dbde9a11cbacd5944b5a734ece	addForeignKeyConstraint baseTableName=discrepancy_note, constraintName=dn_discrepancy_note_type_id_fk, referencedTableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
1236014212860-127	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.687637	138	EXECUTED	8:55673da64417f38ab8b610b94648c66f	addForeignKeyConstraint baseTableName=discrepancy_note, constraintName=discrepancy_note_owner_id_fkey, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-128	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.695523	139	EXECUTED	8:54f7b2226f1eeb82d86fa2222d55deb4	addForeignKeyConstraint baseTableName=discrepancy_note, constraintName=dn_resolution_status_id_fkey, referencedTableName=resolution_status		\N	3.6.3	\N	\N	1509384775
1236014212860-129	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.70388	140	EXECUTED	8:beeaa6ccf41466caf49907830aef8fe4	addForeignKeyConstraint baseTableName=discrepancy_note, constraintName=discrepancy_note_study_id_fkey, referencedTableName=study		\N	3.6.3	\N	\N	1509384775
1236014212860-130	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.71308	141	EXECUTED	8:b3f322258d3e85fa30c0a796efbe459c	addForeignKeyConstraint baseTableName=dn_event_crf_map, constraintName=dn_event_crf_map_dn_id_fkey, referencedTableName=discrepancy_note		\N	3.6.3	\N	\N	1509384775
1236014212860-131	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.722561	142	EXECUTED	8:5886303880158c7f2a89457fdbb90814	addForeignKeyConstraint baseTableName=dn_event_crf_map, constraintName=dn_evnt_crf_map_evnt_crf_id_fk, referencedTableName=event_crf		\N	3.6.3	\N	\N	1509384775
1236014212860-132	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.731944	143	EXECUTED	8:8716b7587d36ee9bec873a558eb461aa	addForeignKeyConstraint baseTableName=dn_item_data_map, constraintName=dn_item_data_map_dn_id_fkey, referencedTableName=discrepancy_note		\N	3.6.3	\N	\N	1509384775
1236014212860-133	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.742981	144	EXECUTED	8:1a63ed8be239f846d65b860cd92709d5	addForeignKeyConstraint baseTableName=dn_item_data_map, constraintName=dn_itm_data_map_itm_data_id_fk, referencedTableName=item_data		\N	3.6.3	\N	\N	1509384775
1236014212860-134	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.752361	145	EXECUTED	8:758b09cd1c0a94e87010214d6c7d4f3b	addForeignKeyConstraint baseTableName=dn_study_event_map, constraintName=dn_study_event_map_dn_id_fkey, referencedTableName=discrepancy_note		\N	3.6.3	\N	\N	1509384775
1236014212860-135	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.758985	146	EXECUTED	8:a3ce6f519bc224196a0a2c3345b66c20	addForeignKeyConstraint baseTableName=dn_study_event_map, constraintName=dn_sem_study_event_id_fkey, referencedTableName=study_event		\N	3.6.3	\N	\N	1509384775
1236014212860-136	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.767275	147	EXECUTED	8:b7717ef377c43720c3966af36d256228	addForeignKeyConstraint baseTableName=dn_study_subject_map, constraintName=dn_study_subject_map_dn_id_fk, referencedTableName=discrepancy_note		\N	3.6.3	\N	\N	1509384775
1236014212860-137	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.777651	148	EXECUTED	8:6cc6e4bd76416ebfc33951427c38127c	addForeignKeyConstraint baseTableName=dn_study_subject_map, constraintName=dn_ssm_study_subject_id_fkey, referencedTableName=study_subject		\N	3.6.3	\N	\N	1509384775
1236014212860-138	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.785578	149	EXECUTED	8:abe22b5d100781a8c52ff8bd788758b5	addForeignKeyConstraint baseTableName=dn_subject_map, constraintName=dn_subject_map_dn_id_fkey, referencedTableName=discrepancy_note		\N	3.6.3	\N	\N	1509384775
1236014212860-139	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.792092	150	EXECUTED	8:5aff82860bcfc18039b2b6d92f90feaa	addForeignKeyConstraint baseTableName=dn_subject_map, constraintName=dn_subject_map_subject_id_fkey, referencedTableName=subject		\N	3.6.3	\N	\N	1509384775
1236014212860-140	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.79743	151	EXECUTED	8:db489a71831699a5021ab34b53d58c2f	addForeignKeyConstraint baseTableName=event_crf, constraintName=fk_event_cr_fk_event__completi, referencedTableName=completion_status		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-11	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.306681	651	EXECUTED	8:29f51fb38b19723cf40131acd6d60611	sql		\N	3.6.3	\N	\N	1509384775
1236014212860-141	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.802914	152	EXECUTED	8:708fc4cc3ab8c497c81e8042db324e40	addForeignKeyConstraint baseTableName=event_crf, constraintName=fk_subject_referenc_instrument, referencedTableName=crf_version		\N	3.6.3	\N	\N	1509384775
1236014212860-142	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.810086	153	EXECUTED	8:eff93ffb371dfd3875b78f46bd3e32ed	addForeignKeyConstraint baseTableName=event_crf, constraintName=fk_event_cr_fk_event__user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-143	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.820543	154	EXECUTED	8:3ba8c51488856a55c85213d4061c84c2	addForeignKeyConstraint baseTableName=event_crf, constraintName=fk_event_cr_fk_event__status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-144	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.832961	155	EXECUTED	8:71e2e06369e952fd52005a36be6ffeb7	addForeignKeyConstraint baseTableName=event_crf, constraintName=fk_event_cr_fk_event__study_ev, referencedTableName=study_event		\N	3.6.3	\N	\N	1509384775
1236014212860-145	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.849361	156	EXECUTED	8:586e39df8fb012f72b98e0836983a7a4	addForeignKeyConstraint baseTableName=event_crf, constraintName=fk_event_cr_reference_study_su, referencedTableName=study_subject		\N	3.6.3	\N	\N	1509384775
1236014212860-146	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.860953	157	EXECUTED	8:b737a81c6355360025707405fd3dcac2	addForeignKeyConstraint baseTableName=event_definition_crf, constraintName=fk_study_inst_reference, referencedTableName=crf		\N	3.6.3	\N	\N	1509384775
1236014212860-147	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.866983	158	EXECUTED	8:9c71a0de20af02fef329d5287b901ba4	addForeignKeyConstraint baseTableName=event_definition_crf, constraintName=fk_versioning_study_inst, referencedTableName=crf_version		\N	3.6.3	\N	\N	1509384775
1236014212860-148	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.876884	159	EXECUTED	8:14ceb6fe4cb45b90fbe76520a89ccc02	addForeignKeyConstraint baseTableName=event_definition_crf, constraintName=fk_event_de_study_crf_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-149	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.883533	160	EXECUTED	8:127e91df58164417384bbf7ff8746bf1	addForeignKeyConstraint baseTableName=event_definition_crf, constraintName=fk_event_de_fk_study__status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-150	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.890968	161	EXECUTED	8:ed672069caab041c0c31f5c931c8441a	addForeignKeyConstraint baseTableName=event_definition_crf, constraintName=fk_event_de_reference_study_ev, referencedTableName=study_event_definition		\N	3.6.3	\N	\N	1509384775
1236014212860-151	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.899175	162	EXECUTED	8:02ce5e1e247373da2db3dd81845e5f71	addForeignKeyConstraint baseTableName=event_definition_crf, constraintName=fk_study_reference_instrument, referencedTableName=study		\N	3.6.3	\N	\N	1509384775
1236014212860-152	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.906317	163	EXECUTED	8:d2a67fe9543a3a16f9b17766efc35356	addForeignKeyConstraint baseTableName=filter, constraintName=fk_filter_fk_query__user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-153	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.913576	164	EXECUTED	8:c0fd1fd8b9af591af681b77e51b0632b	addForeignKeyConstraint baseTableName=filter, constraintName=fk_filter_fk_query__status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-154	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.921641	165	EXECUTED	8:b962255cfd5c5f2309ffb5b2316360c1	addForeignKeyConstraint baseTableName=filter_crf_version_map, constraintName=fk_filter_c_reference_crf_vers, referencedTableName=crf_version		\N	3.6.3	\N	\N	1509384775
1236014212860-155	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.928784	166	EXECUTED	8:270af0a70dbbff1dfb4eaa71c3400308	addForeignKeyConstraint baseTableName=filter_crf_version_map, constraintName=fk_filter_c_reference_filter, referencedTableName=filter		\N	3.6.3	\N	\N	1509384775
1236014212860-156	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.935883	167	EXECUTED	8:4ad2b50832012ba7f7fc24bd18dc11ef	addForeignKeyConstraint baseTableName=item, constraintName=fk_item_fk_item_i_item_dat, referencedTableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1236014212860-157	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.942921	168	EXECUTED	8:7f42e9a4d91aeadcfbbc6863dce306d3	addForeignKeyConstraint baseTableName=item, constraintName=fk_item_fk_item_f_item_ref, referencedTableName=item_reference_type		\N	3.6.3	\N	\N	1509384775
1236014212860-158	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.952137	169	EXECUTED	8:e46042a5f6e62591a2d0e5d64b6eb6f9	addForeignKeyConstraint baseTableName=item, constraintName=fk_item_fk_item_u_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-159	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.957878	170	EXECUTED	8:aaad7f001ba309a386f68f02deaa781e	addForeignKeyConstraint baseTableName=item, constraintName=fk_item_fk_item_s_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-160	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.965922	171	EXECUTED	8:2434665aa599a819cb6915aa78778562	addForeignKeyConstraint baseTableName=item_data, constraintName=fk_item_reference_subject, referencedTableName=event_crf		\N	3.6.3	\N	\N	1509384775
1236014212860-161	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.973873	172	EXECUTED	8:acbc118b8dcb46b241ddd76b6bc3ce48	addForeignKeyConstraint baseTableName=item_data, constraintName=fk_answer_reference_item, referencedTableName=item		\N	3.6.3	\N	\N	1509384775
1236014212860-162	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.98018	173	EXECUTED	8:2758521afabdc918a6db68e681b4cdd7	addForeignKeyConstraint baseTableName=item_data, constraintName=fk_item_dat_fk_item_d_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-163	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.985192	174	EXECUTED	8:a3e53d1177d299765bda5423bf27fd79	addForeignKeyConstraint baseTableName=item_data, constraintName=fk_item_dat_fk_item_d_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-164	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:48.992688	175	EXECUTED	8:93357942e32539f39e92a7ce1430d76b	addForeignKeyConstraint baseTableName=item_form_metadata, constraintName=fk_item_id, referencedTableName=item		\N	3.6.3	\N	\N	1509384775
1236014212860-165	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.001272	176	EXECUTED	8:f4d83e1c13de54eee4ea263e1f4804d8	addForeignKeyConstraint baseTableName=item_form_metadata, constraintName=fk_rs_id, referencedTableName=response_set		\N	3.6.3	\N	\N	1509384775
1236014212860-166	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.011337	177	EXECUTED	8:5239a0205a65d65df485f6656e86b362	addForeignKeyConstraint baseTableName=item_form_metadata, constraintName=fk_sec_id, referencedTableName=section		\N	3.6.3	\N	\N	1509384775
1236014212860-167	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.019341	178	EXECUTED	8:416e1853b6d2db27a844d88ac9b6410f	addForeignKeyConstraint baseTableName=item_group, constraintName=fk_item_group_crf, referencedTableName=crf		\N	3.6.3	\N	\N	1509384775
1236014212860-168	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.027401	179	EXECUTED	8:14e51438b573b62b7cdb6c06497f52c4	addForeignKeyConstraint baseTableName=item_group, constraintName=fk_item_gro_fk_item_g_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-169	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.040581	180	EXECUTED	8:5e1d6d162faa991093126c25c6372753	addForeignKeyConstraint baseTableName=item_group, constraintName=fk_item_gro_fk_item_g_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-170	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.04859	181	EXECUTED	8:bb780d7900ecce72c99c0f739f62a6f3	addForeignKeyConstraint baseTableName=item_group_metadata, constraintName=fk_crf_metadata, referencedTableName=crf_version		\N	3.6.3	\N	\N	1509384775
1236014212860-171	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.057496	182	EXECUTED	8:50cdb140076c819efd86fed58248024e	addForeignKeyConstraint baseTableName=item_group_metadata, constraintName=fk_item_group, referencedTableName=item_group		\N	3.6.3	\N	\N	1509384775
1236014212860-172	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.063466	183	EXECUTED	8:0d6e32d61569810923d3aaad5252d0b6	addForeignKeyConstraint baseTableName=item_group_metadata, constraintName=fk_item, referencedTableName=item		\N	3.6.3	\N	\N	1509384775
1236014212860-173	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.073752	184	EXECUTED	8:7196bafac32a9de08ecc5737aead0c9e	addForeignKeyConstraint baseTableName=response_set, constraintName=fk_response_fk_respon_response, referencedTableName=response_type		\N	3.6.3	\N	\N	1509384775
1236014212860-174	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.080432	185	EXECUTED	8:67b67df0bf7ccf00b923aaf14cb471cc	addForeignKeyConstraint baseTableName=role_privilege_map, constraintName=fk_priv_id, referencedTableName=privilege		\N	3.6.3	\N	\N	1509384775
1236014212860-175	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.08765	186	EXECUTED	8:b5961da7020d64c5e931affd118db504	addForeignKeyConstraint baseTableName=role_privilege_map, constraintName=fk_role_id, referencedTableName=user_role		\N	3.6.3	\N	\N	1509384775
1236014212860-176	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.095074	187	EXECUTED	8:95ac34cbaff8c35abdcd76fff87645bf	addForeignKeyConstraint baseTableName=section, constraintName=fk_section_version, referencedTableName=crf_version		\N	3.6.3	\N	\N	1509384775
1236014212860-177	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.104187	188	EXECUTED	8:763024d732b00c0bf587dac5b4522c60	addForeignKeyConstraint baseTableName=section, constraintName=fk_section_fk_sectio_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-178	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.115448	189	EXECUTED	8:fa0533582aa989548754d26cfe9ab79f	addForeignKeyConstraint baseTableName=section, constraintName=fk_section_fk_sectio_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-179	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.123853	190	EXECUTED	8:658584378cf05f956fabf3251b6d2030	addForeignKeyConstraint baseTableName=study, constraintName=fk_study_fk_study__user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-180	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.13197	191	EXECUTED	8:b026736c60bd4a8061e6b87f74d5c5d5	addForeignKeyConstraint baseTableName=study, constraintName=PROJECT_IS_CONTAINED_WITHIN_PA, referencedTableName=study		\N	3.6.3	\N	\N	1509384775
1236014212860-181	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.147382	192	EXECUTED	8:40c509d963ba8550383cb96e8a51ed71	addForeignKeyConstraint baseTableName=study, constraintName=fk_study_fk_study__status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-182	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.158107	193	EXECUTED	8:b225e2b2c8a493540da1c6e8a55e0180	addForeignKeyConstraint baseTableName=study, constraintName=fk_study_type, referencedTableName=study_type		\N	3.6.3	\N	\N	1509384775
1236014212860-183	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.166395	194	EXECUTED	8:a547c33f2a87cfda82ba69e2b0880c3c	addForeignKeyConstraint baseTableName=study_event, constraintName=fk_study_ev_fk_study__user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-184	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.176658	195	EXECUTED	8:fba528a262b0ad6f688fff651b7c806e	addForeignKeyConstraint baseTableName=study_event, constraintName=fk_study_ev_fk_study__status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-185	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.187401	196	EXECUTED	8:37d2af747ca09dbc4896c8d9baf905ab	addForeignKeyConstraint baseTableName=study_event, constraintName=fk_study_ev_fk_study__study_ev, referencedTableName=study_event_definition		\N	3.6.3	\N	\N	1509384775
1236014212860-186	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.196055	197	EXECUTED	8:8a268e6d14026d111d531680dcabcb01	addForeignKeyConstraint baseTableName=study_event, constraintName=fk_study_ev_reference_study_su, referencedTableName=study_subject		\N	3.6.3	\N	\N	1509384775
1236014212860-187	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.204484	198	EXECUTED	8:daa94b0109ec79110712f8cabddeb5e8	addForeignKeyConstraint baseTableName=study_event_definition, constraintName=fk_study_ev_fk_studye_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-188	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.212593	199	EXECUTED	8:d319fba9e1c911f3b44d698101780001	addForeignKeyConstraint baseTableName=study_event_definition, constraintName=fk_study_ev_fk_studye_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-189	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.218654	200	EXECUTED	8:ffb58bfdba7a2a915364641868ced2bc	addForeignKeyConstraint baseTableName=study_event_definition, constraintName=FK_STUDY_EV_FK_STUDY__STUDY, referencedTableName=study		\N	3.6.3	\N	\N	1509384775
1236014212860-190	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.226239	201	EXECUTED	8:5e397541082c45334d23b2522663380b	addForeignKeyConstraint baseTableName=study_group, constraintName=fk_group_class_study_group, referencedTableName=study_group_class		\N	3.6.3	\N	\N	1509384775
1235684743487-115	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.66118	266	MARK_RAN	8:a75887dad929337403ff840c552fff79	sql		\N	3.6.3	\N	\N	1509384775
1236014212860-191	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.233226	202	EXECUTED	8:ba5fc8c611acf6cab75249a869685adc	addForeignKeyConstraint baseTableName=study_group_class, constraintName=fk_study_gr_fk_study__group_ty, referencedTableName=group_class_types		\N	3.6.3	\N	\N	1509384775
1236014212860-192	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.243934	203	EXECUTED	8:e0e5474a511c4bc3283bbf9eae8f3278	addForeignKeyConstraint baseTableName=study_group_class, constraintName=fk_study_gr_fk_study__user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-193	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.254533	204	EXECUTED	8:76a9959a7f912c02fe495059d374bedd	addForeignKeyConstraint baseTableName=study_group_class, constraintName=fk_study_gr_fk_study__status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-194	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.266502	205	EXECUTED	8:5b1a123b41b42294fb7c49590a965f62	addForeignKeyConstraint baseTableName=study_parameter_value, constraintName=study_param_value_param_fkey, referencedTableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1236014212860-195	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.276458	206	EXECUTED	8:90d2cd232a5877273732af59eeb5724a	addForeignKeyConstraint baseTableName=study_parameter_value, constraintName=study_param_value_study_id_fk, referencedTableName=study		\N	3.6.3	\N	\N	1509384775
1236014212860-196	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.287202	207	EXECUTED	8:0f4bb01382b2693f900c2b12f5642ed5	addForeignKeyConstraint baseTableName=study_subject, constraintName=fk_study_su_fk_study__user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-197	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.295632	208	EXECUTED	8:d950507bf627a6cd6df4cda151da915f	addForeignKeyConstraint baseTableName=study_subject, constraintName=fk_study_su_fk_study__status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-198	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.303207	209	EXECUTED	8:5faf573679909033c358825fb1221686	addForeignKeyConstraint baseTableName=study_subject, constraintName=fk_project__reference_study2, referencedTableName=study		\N	3.6.3	\N	\N	1509384775
1236014212860-199	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.30817	210	EXECUTED	8:0c6146baee4bf1ab070c6c2274d9b53e	addForeignKeyConstraint baseTableName=study_subject, constraintName=fk_study_reference_subject, referencedTableName=subject		\N	3.6.3	\N	\N	1509384775
1236014212860-200	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.313829	211	EXECUTED	8:bc8f4605f0be91009762750f7e2de0ec	addForeignKeyConstraint baseTableName=study_user_role, constraintName=fk_study_us_study_use_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-201	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.320285	212	EXECUTED	8:5300222041ea79d3c20f7d34be7810c5	addForeignKeyConstraint baseTableName=study_user_role, constraintName=fk_study_us_fk_study__status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-202	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.328176	213	EXECUTED	8:a8c1c485c719e872e90a19a7fc9c8249	addForeignKeyConstraint baseTableName=study_user_role, constraintName=fk_person_role_study_id, referencedTableName=study		\N	3.6.3	\N	\N	1509384775
1236014212860-203	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.338084	214	EXECUTED	8:cc245ff4851d9bda30393dfaf70a45a8	addForeignKeyConstraint baseTableName=subject, constraintName=HAS_FATHER, referencedTableName=subject		\N	3.6.3	\N	\N	1509384775
1236014212860-204	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.345223	215	EXECUTED	8:c65aa2c1c0e5b399cc91416e9320bff3	addForeignKeyConstraint baseTableName=subject, constraintName=HAS_MOTHER, referencedTableName=subject		\N	3.6.3	\N	\N	1509384775
1236014212860-205	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.351858	216	EXECUTED	8:c19643b8fee32b180fd3e17a2098a54f	addForeignKeyConstraint baseTableName=subject, constraintName=fk_subject_fk_subjec_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-206	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.359015	217	EXECUTED	8:7cb70adc9fb9eb3646e97085a76b5c70	addForeignKeyConstraint baseTableName=subject, constraintName=fk_subject_fk_subjec_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-207	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.366942	218	EXECUTED	8:c4327ab0cf4dba9394fa8d769485b56c	addForeignKeyConstraint baseTableName=subject_group_map, constraintName=fk_subject__fk_sub_gr_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-208	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.376787	219	EXECUTED	8:4675a4ed5a4494748cb6c96cc4620b73	addForeignKeyConstraint baseTableName=subject_group_map, constraintName=fk_subject__fk_subjec_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-209	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.384678	220	EXECUTED	8:dcd61b3af42dd54b5005db1ac3817b2c	addForeignKeyConstraint baseTableName=subject_group_map, constraintName=fk_subject__fk_subjec_study_gr, referencedTableName=study_group_class		\N	3.6.3	\N	\N	1509384775
1236014212860-210	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.392537	221	EXECUTED	8:26b87f20cabf9d776441cae4541b3c85	addForeignKeyConstraint baseTableName=subject_group_map, constraintName=fk_subject__fk_subjec_group_ro, referencedTableName=study_group		\N	3.6.3	\N	\N	1509384775
1236014212860-211	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.4002	222	EXECUTED	8:e00b9266b75630dcda467bfa0e38f29b	addForeignKeyConstraint baseTableName=subject_group_map, constraintName=fk_subject__subject_g_study_su, referencedTableName=study_subject		\N	3.6.3	\N	\N	1509384775
1236014212860-212	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.407173	223	EXECUTED	8:b4ea0f0888616c020449a7f668275866	addForeignKeyConstraint baseTableName=user_account, constraintName=fk_user_acc_fk_user_f_user_acc, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1236014212860-213	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.412892	224	EXECUTED	8:5670df208d3f80311b55312381fcdcf5	addForeignKeyConstraint baseTableName=user_account, constraintName=fk_user_acc_status_re_status, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
1236014212860-214	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.41894	225	EXECUTED	8:e443b38ca43d7f66603caad35f73aef6	addForeignKeyConstraint baseTableName=user_account, constraintName=fk_user_acc_ref_user__user_typ, referencedTableName=user_type		\N	3.6.3	\N	\N	1509384775
1236014212860-215	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.424456	226	EXECUTED	8:a8c0325992bf1c8c5203d6935e9b1a23	addForeignKeyConstraint baseTableName=versioning_map, constraintName=fk_versioni_fk_versio_crf_vers, referencedTableName=crf_version		\N	3.6.3	\N	\N	1509384775
1236014212860-216	pgawade (generated)	migration/2.5/changeLogCreateTables.xml	2023-12-02 09:29:49.429784	227	EXECUTED	8:8fcbdd127ad819b84f765818ce66cbc3	addForeignKeyConstraint baseTableName=versioning_map, constraintName=fk_versioni_fk_versio_item, referencedTableName=item		\N	3.6.3	\N	\N	1509384775
1235684743487-358	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.440687	228	EXECUTED	8:b8e68de4d2d9162edf55c108fc2f92fd	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-359	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.449476	229	EXECUTED	8:e492bba351691f46cf5d3b4ca3541535	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-360	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.456554	230	EXECUTED	8:e20b2c3a817a2fa7e2876994f84c8fa0	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-361	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.46539	231	EXECUTED	8:546d7f5229badfc53a98861303be6164	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-362	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.477438	232	EXECUTED	8:6f1b401f214247a8ab064702a71e47c9	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-363	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.493906	233	EXECUTED	8:f2738be0a0b626c2505c5ea830c10077	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-364	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.506037	234	EXECUTED	8:f7de76bd05378289d1ba8efe5be6390e	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-365	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.514196	235	EXECUTED	8:1aa66d188d2fea929ea6d2a36798d514	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-366	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.519114	236	EXECUTED	8:fe141d6b17e807e11aebef61816ce663	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-367	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.528511	237	EXECUTED	8:f902670329ff6dbeb67fbe094f5a4140	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-368	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.534976	238	EXECUTED	8:19ddc561cc9b4b06bdc8e67bce13b383	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-369	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.541398	239	EXECUTED	8:a0670abc6cc8b73f07b78c70e3c7a1a0	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-370	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.54772	240	EXECUTED	8:95a771dbd88b01b8537376a041a9e474	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-371	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.555529	241	EXECUTED	8:6593180872df00c572effc89a3c1e092	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-93	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.562351	242	MARK_RAN	8:6ed7e18af5415d38f0aaea6fd814a8e9	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-94	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.569773	243	MARK_RAN	8:7079d556d3e42461500fb1cd0720fc50	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-95	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.575869	244	MARK_RAN	8:274be231b79fe6546b438180b1f4a517	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-96	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.585249	245	MARK_RAN	8:34eb9f3bb37b5fb4de0765f73a32d397	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-97	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.589294	246	MARK_RAN	8:ac345c5e9effa5e3bdfc7c0e8ad488f6	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-155	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.598246	247	MARK_RAN	8:c52952721682d0b710565dbc9e8a3bed	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-98	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.603722	248	MARK_RAN	8:eb1286ec8b7387d61e57176b31338450	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-99	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.606412	249	MARK_RAN	8:c46b27579042ffbd8081dacef97ce7d9	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-100	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.609359	250	MARK_RAN	8:10fc09edcc2097dd2e21624a7f443a49	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-101	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.611705	251	MARK_RAN	8:1a4a683639c966868cc4462133f5f4bd	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-102	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.614109	252	MARK_RAN	8:d88b2dfb38699046bbe01d2c36e0bd74	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-103	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.617542	253	MARK_RAN	8:da3e02bd109d2eba7a3478b8ddcd8f35	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-104	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.621114	254	MARK_RAN	8:3e3db750b9e3f1c7732f21beeab2075e	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-105	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.623875	255	MARK_RAN	8:aa740982a69b037d71a14abf86309c9e	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-106	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.62799	256	MARK_RAN	8:7474ffca613a9b8bf866e9fefba51a9d	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-107	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.631246	257	MARK_RAN	8:17e93919e8c6775504b3fce227d7167e	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-108	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.634596	258	MARK_RAN	8:3cc11789d6bd4f8a62f55ca7d96eedbd	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-109	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.637732	259	MARK_RAN	8:b19884d5119e575cdd05aa8912ed703d	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-110	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.643049	260	MARK_RAN	8:9b73bd57d023dc187a14704a81217960	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-111	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.647183	261	MARK_RAN	8:a869d6ebacc872a45b63d9b8f31b3e94	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-112	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.649704	262	MARK_RAN	8:ccdb56856b01f716423f899b7640621c	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-113	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.65324	263	MARK_RAN	8:a8d67d2d4865df30a749b045698babdf	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-380	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.656705	264	MARK_RAN	8:68c0bba17f8a8d7f15ebbbba4df1b16a	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-114	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.659129	265	MARK_RAN	8:6d5839d126b6b8077664ac915a2e2ffe	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-116	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.666949	267	MARK_RAN	8:a9a25772fc0cac4ffb62649e33ef596b	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-117	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.670934	268	MARK_RAN	8:26a826cac4bd650f87fc29b96f260b73	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-118	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.674625	269	MARK_RAN	8:f44d995a17b91ffa608dd0696cb29dee	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-119	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.681965	270	MARK_RAN	8:0e5a1f7decad7c9bd02b9a2e727d2134	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-120	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.686686	271	MARK_RAN	8:9adc90e9a658bd23dd07c27fd6abec7c	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-388	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.691214	272	MARK_RAN	8:50c0d4e159dd41dec4a54e68b7946575	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-121	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.694457	273	MARK_RAN	8:65fc4e704d667f5ec1b2f51b723dcd7a	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-122	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.69779	274	MARK_RAN	8:59dafac03ddf130c67ca3a58c628ca15	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-123	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.701147	275	MARK_RAN	8:8cb55c0265c69074f04edc3cbcbf630b	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-124	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.704116	276	MARK_RAN	8:0250fecbdb17b84ecf4f051c4dbd6d86	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-125	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.7073	277	MARK_RAN	8:7a1a26da141cf35b38013a4afc23ec76	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-126	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.710492	278	MARK_RAN	8:49129a7a3458d7e2fd210d764898d8a6	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-127	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.715584	279	MARK_RAN	8:49a644cd4014584605ba9e487902ade9	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-128	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.719294	280	MARK_RAN	8:81bfe156bd8738bc76a26e616a3cd0fa	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-129	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.72319	281	MARK_RAN	8:94e6cffb6db80079b8597174e0acec81	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-130	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.726397	282	MARK_RAN	8:71e6286fa0f831b7f64225ed5ff64e09	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-131	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.728833	283	MARK_RAN	8:5e88ad64f206b6ea1f322d827b865da7	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-132	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.731199	284	MARK_RAN	8:5e292e6216ba161ca20928d62a6abf9d	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-133	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.733951	285	MARK_RAN	8:baca8fceba5b0b6107ace237dc70f846	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-134	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.737443	286	MARK_RAN	8:8cc148883c2c59822f39b8646e6a5237	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-135	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.741916	287	MARK_RAN	8:881151f70f9a6bef716f65de23446105	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-136	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.746683	288	MARK_RAN	8:da691c1f251c8dad3eab02afcc637055	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-137	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.750125	289	MARK_RAN	8:4a51efd714a3413ece8aa17a68567280	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-138	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.754397	290	MARK_RAN	8:ef04b4a2e298c2d80ebfbab8cfa48a05	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-139	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.765286	291	MARK_RAN	8:d718966d59bf951ede52c3f1e9861c48	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-140	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.768954	292	MARK_RAN	8:e8f54d473f28d89ae92923aeff63e233	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-141	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.772318	293	MARK_RAN	8:68b1e195994272784aae1fc0b89350c7	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-142	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.775491	294	MARK_RAN	8:b952246da098df2b91f2b6914a543165	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-143	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.779729	295	MARK_RAN	8:0ba81ba39c9f9b329ec0fde7d01d6af5	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-144	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.782631	296	MARK_RAN	8:3328f6be87fb7e248a03945c855ba584	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-145	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.785433	297	MARK_RAN	8:41d82d3e97b2be939ae80e45320f7687	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-146	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.788003	298	MARK_RAN	8:a2d57cc7a9498b013e6771fd4755586d	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-147	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.790992	299	MARK_RAN	8:8182bcefe02ef55616c0e6ecfa96d007	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-148	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.794246	300	MARK_RAN	8:1258d24ffa5e818b12ec9cad771ae351	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-149	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.79724	301	MARK_RAN	8:99ae1825232d2c13150be1cc07cad917	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-150	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.799762	302	MARK_RAN	8:9d4df8e91729916cdd091cf112bc82ed	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-151	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.802551	303	MARK_RAN	8:a1e88d711b3deff36e0708ffc5d9a506	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-152	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.805393	304	MARK_RAN	8:b4044b08328e755b92db5332f17d76c0	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-373	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.809457	305	MARK_RAN	8:fa63a466def347227491c42729ac1a68	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-374	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.812595	306	MARK_RAN	8:f6bd4a186f2281ca7124f0660fcfa1b6	sql		\N	3.6.3	\N	\N	1509384775
1236096695424-291	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.815059	307	MARK_RAN	8:f450dc954965c2c457bbf16ff2a4a169	createSequence sequenceName=ARCHIVED_DATASET_FILE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-292	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.818297	308	MARK_RAN	8:46051e8fd8efd31769a4cdd9d6b37963	createSequence sequenceName=AUDIT_EVENT_VAL_AUDIT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-293	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.823983	309	MARK_RAN	8:751580644ff46893101c672a1cce8e58	createSequence sequenceName=AUDIT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-294	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.829227	310	MARK_RAN	8:fec67954d4b0df0cc8790349bb65946a	createSequence sequenceName=AUDIT_LOG_EVENT_AUDIT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-295	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.831704	311	MARK_RAN	8:5bc1df8a708533fa7fc056f72e0c9adc	createSequence sequenceName=AUDIT_LOG_EVENT_TYPE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-296	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.834171	312	MARK_RAN	8:5a8032c49d578adb14d1b977149274a4	createSequence sequenceName=COMPLETION_STATUS_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-297	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.836421	313	MARK_RAN	8:0453004e649f53534d26040306ce0d46	createSequence sequenceName=CRF_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-298	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.83956	314	MARK_RAN	8:6cc9397f759d53261f3446c9200fbd2e	createSequence sequenceName=CRF_VERSION_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-299	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.843598	315	MARK_RAN	8:3e0c57739e7748ad7011ac40536f0712	createSequence sequenceName=DATASET_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-300	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.846955	316	MARK_RAN	8:cb55b07359d980f0e95ad53154b29afc	createSequence sequenceName=DC_EVENT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-301	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.85025	317	MARK_RAN	8:50b1a3171db1d5b09dbdfa84b10be3d0	createSequence sequenceName=DC_PRIMITIVE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-302	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.853116	318	MARK_RAN	8:0743ea4ca2a0ac8529a272a4dd63d427	createSequence sequenceName=DC_SECTION_EVENT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-303	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.85914	319	MARK_RAN	8:4218c5c80c433bc0eb09c07fccbe42b5	createSequence sequenceName=DC_SEND_EMAIL_EVENT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-304	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.862055	320	MARK_RAN	8:1327eb1eb1bc141e67eabfccb7ee1d13	createSequence sequenceName=DC_SUBSTITUTION_EVENT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-305	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.864708	321	MARK_RAN	8:ace13022fb6d87acb02e51e7980c1e13	createSequence sequenceName=DC_SUMMARY_EVENT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-306	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.870262	322	MARK_RAN	8:29ce5f97186e2761f4326ba274142a80	createSequence sequenceName=DECISION_CONDITION_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-307	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.872623	323	MARK_RAN	8:21b2863b40865e7c309223a4f00ce0b6	createSequence sequenceName=DISCREPANCY_NOTE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-308	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.874795	324	MARK_RAN	8:c9075bb86d85f84b4bdcf45a52a8eee8	createSequence sequenceName=DISCREPANCY_NOTE_TYPE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-309	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.876962	325	MARK_RAN	8:53e3bfa37d009c91267c553cb95c9920	createSequence sequenceName=EVENT_CRF_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-310	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.879516	326	MARK_RAN	8:a8b80c54bfd747a79784f83e70791f61	createSequence sequenceName=EVENT_DEFINITION_CRF_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-311	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.882091	327	MARK_RAN	8:099c378b2925fea90f45845fd53e4a78	createSequence sequenceName=EXPORT_FORMAT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-312	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.885748	328	MARK_RAN	8:2c26eeea393c6b8d86d17526f2d1cbdd	createSequence sequenceName=FILTER_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-313	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.888951	329	MARK_RAN	8:f21ab24ca9730ba5c52e0d9ab29cc282	createSequence sequenceName=GROUP_CLASS_TYPE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-314	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.891786	330	MARK_RAN	8:fcb6d90c25a6cc5f306ebe26307cc5fa	createSequence sequenceName=ITEM_DATA_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-315	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.896802	331	MARK_RAN	8:2db69a3e1d6ef2bf80deca40af4174f2	createSequence sequenceName=ITEM_DATA_TYPE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-316	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.899202	332	MARK_RAN	8:fb011b418ffcfd38f745959bd9ab56c6	createSequence sequenceName=ITEM_FORM_METADATA_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-317	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.901008	333	MARK_RAN	8:6d0e86d957a101ed0bd035193299ef39	createSequence sequenceName=ITEM_GROUP_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-318	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.903028	334	MARK_RAN	8:c13a33eb69c73df25833ec2be8ee82c7	createSequence sequenceName=ITEM_GROUP_METADATA_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-319	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.907227	335	MARK_RAN	8:6de055922443a3c12ab5dbe970627f5d	createSequence sequenceName=ITEM_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-320	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.90966	336	MARK_RAN	8:b2e8fba8a593e996ac24224590ce5578	createSequence sequenceName=ITEM_REFERENCE_TYPE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-321	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.911708	337	MARK_RAN	8:7437f48c5b56544b8b0d2374f37b7572	createSequence sequenceName=NULL_VALUE_TYPE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-322	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.915976	338	MARK_RAN	8:9860e704669fec84d7a088738a6de9ce	createSequence sequenceName=PRIV_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-323	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.920551	339	MARK_RAN	8:3c70fa00c20743c4041a8ed17b7019d6	createSequence sequenceName=RESOLUTION_STATUS_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-324	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.924455	340	MARK_RAN	8:87f6621ee901dadd85c450cd346468fc	createSequence sequenceName=RESPONSE_SET_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-325	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.931877	341	MARK_RAN	8:f4f691bae3d0276abca4b8d2fc0281c2	createSequence sequenceName=RESPONSE_TYPE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-326	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.933594	342	MARK_RAN	8:24235070e4bfc01d9ef42df7edbe71ea	createSequence sequenceName=ROLE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-327	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.935177	343	MARK_RAN	8:cce95af06dcf0bc3ac0859e4175c4c23	createSequence sequenceName=RULE_ACTION_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-328	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.93679	344	MARK_RAN	8:735a7c365758a1d922c40600f6ddc78c	createSequence sequenceName=RULE_EXPRESSION_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-329	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.938375	345	MARK_RAN	8:19ab601b1ccf43ec62316608ebf28e33	createSequence sequenceName=RULE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-330	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.940784	346	MARK_RAN	8:a124b8e229866cc7db2abb9b31428c50	createSequence sequenceName=RULE_SET_AUDIT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-331	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.946121	347	MARK_RAN	8:301f109c6b899a751e7ec566fe86326b	createSequence sequenceName=RULE_SET_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-332	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.949002	348	MARK_RAN	8:e377deeb9c7cb140a9c9890d9b165247	createSequence sequenceName=RULE_SET_RULE_AUDIT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-333	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.954628	349	MARK_RAN	8:ffaaafe304ba9f7bb7a532e12ae0ead3	createSequence sequenceName=RULE_SET_RULE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-334	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.958001	350	MARK_RAN	8:aaad01bccc4359f30f1195c430dfb3cc	createSequence sequenceName=SECTION_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-335	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.960538	351	MARK_RAN	8:ab40618e2313804a2847ce0290bd9583	createSequence sequenceName=STATUS_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-336	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.962648	352	MARK_RAN	8:6d2953e5129dd8e252719d3acfe6b99e	createSequence sequenceName=STUDY_EVENT_DEFINITION_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-337	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.965148	353	MARK_RAN	8:1e23ba7713289c1599df1311cedb9b57	createSequence sequenceName=STUDY_EVENT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-338	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.967298	354	MARK_RAN	8:086eb6fdfe2f22a3ab519cf9df0e819e	createSequence sequenceName=STUDY_GROUP_CLASS_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-339	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.970114	355	MARK_RAN	8:a44ea87deb51446da07ce738fa51c475	createSequence sequenceName=STUDY_GROUP_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-340	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.972967	356	MARK_RAN	8:74bbed9512633ea6e641c4a643b52fdd	createSequence sequenceName=STUDY_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-341	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.975337	357	MARK_RAN	8:a4a733f72269890feb6230e4188b8e9a	createSequence sequenceName=STUDY_PARAMETER_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-342	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.977469	358	MARK_RAN	8:c138043618eaab923c8d0b28c0ca95a3	createSequence sequenceName=STUDY_PARAMETER_VALUE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-343	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.97941	359	MARK_RAN	8:2d21a92a2dd3dc6e0520f08dbaa321d8	createSequence sequenceName=STUDY_SUBJECT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-344	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.981468	360	MARK_RAN	8:6e150d9d34650119793c939fb7711f55	createSequence sequenceName=STUDY_TYPE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-345	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.983908	361	MARK_RAN	8:54019e54403cea853e8c5dda29e824d6	createSequence sequenceName=SUBJECT_EVENT_STATUS_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-346	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.98736	362	MARK_RAN	8:50056459f6c199fe020f519c219bbe22	createSequence sequenceName=SUBJECT_GROUP_MAP_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-347	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.991404	363	MARK_RAN	8:11852c0910e095f9a2f386907d15a008	createSequence sequenceName=SUBJECT_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-348	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.994254	364	MARK_RAN	8:9def6fcc2b62b90fb5084cfc512d6ac4	createSequence sequenceName=USER_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-349	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:49.998442	365	MARK_RAN	8:c5787b151c94a84a6a24123e3c4af1b7	createSequence sequenceName=USER_TYPE_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-350	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:50.001795	366	MARK_RAN	8:9648255423283ac79ea119d74dfefcbe	createSequence sequenceName=USAGE_STATISTICS_DATA_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1236096695424-351	pgawade (generated)	migration/2.5/changeLogCreateFunctions.xml	2023-12-02 09:29:50.005111	367	MARK_RAN	8:a1ff029fb778ce1a43907168c3c1ef97	createSequence sequenceName=OPENCLINICA_VERSION_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1235684743487-217	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.013847	368	EXECUTED	8:f9bcc0a9e34cd3a7bc8574452ebb2084	insert tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-218	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.018775	369	EXECUTED	8:4a4dcbaf3df122c20637633cdd60302e	insert tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-219	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.026361	370	EXECUTED	8:53188602c5fe66d9090d7963a7d5a29e	insert tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-220	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.032019	371	EXECUTED	8:e114aa055dd251c2330f360afa08f9ad	insert tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-221	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.039444	372	EXECUTED	8:5d7203fa1daef39eaefe7b504033fde3	insert tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-222	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.044797	373	EXECUTED	8:71a95dc36e0b2d86ebd563d8f8202631	insert tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-223	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.051093	374	EXECUTED	8:453867bd02ebe3aab16692ac13ca631d	insert tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-224	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.061749	375	EXECUTED	8:56e944d178da8633366e2171ea9fb2d3	insert tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-225	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.070081	376	EXECUTED	8:a7afda9833f2bbb6e7f335f9aad7520f	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-226	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.078098	377	EXECUTED	8:f7849dda0c0131d521c544d21f5e78d5	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-227	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.085377	378	EXECUTED	8:c9e2f82b22766f03288e0a1285aeb992	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-228	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.097214	379	EXECUTED	8:e9262fc73f6197d8a5e0456b4c6666c2	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-229	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.113872	380	EXECUTED	8:1544ffd2c832fbad4c652a9f6e29c0e5	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-230	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.125975	381	EXECUTED	8:d465c89f1aaf8070873913d792eeb7ea	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-231	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.132018	382	EXECUTED	8:ef1bd6ffad08208290e07ad2a9eb4cb5	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-232	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.140229	383	EXECUTED	8:0ad7754f6394e20eff685b5dc68ade42	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-233	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.146543	384	EXECUTED	8:cbb911df6407e26140509dfb789dafbc	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-234	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.160029	385	EXECUTED	8:298c81244a8401c3c16f7d493a55b8af	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-235	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.167493	386	EXECUTED	8:ad119a1c53c2e5bfc5dab73d9470fc55	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-237	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.178128	387	EXECUTED	8:86116daa91eb038f13d1e2ed26c73ffd	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-238	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.189068	388	EXECUTED	8:bcafddbcd00e606beaf6209691d42ae4	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-239	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.195905	389	EXECUTED	8:9b8b442f9baccb1b1bfb68f8cb99582d	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-240	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.201015	390	EXECUTED	8:5d61f82c6e01bbdd2fed3991d08c5afe	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-241	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.207271	391	EXECUTED	8:af04c6bbcbada633adfd8b37a168ff46	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-242	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.21174	392	EXECUTED	8:ece323c835e27d9f6e4357328db560fa	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-243	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.215819	393	EXECUTED	8:37887199bcda62329b58a359ef9bd030	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-244	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.220615	394	EXECUTED	8:40f23046cd2a4fbb367df3945ce9fe3e	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-245	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.230392	395	EXECUTED	8:85a4040883337100cbaee0ef5a9b9da9	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-246	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.236131	396	EXECUTED	8:8765ea2e549f82e1af0ebe489b3cbc6d	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-247	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.241599	397	EXECUTED	8:9f4114e0513bf879cf88e8b2e1f3b3d0	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-248	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.258593	398	EXECUTED	8:60e4322ed5300c22802f50f2f8692dc2	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-249	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.262799	399	EXECUTED	8:7afd71c14b14bd96bb929ad2c4bda03f	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-250	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.267524	400	EXECUTED	8:3110a3a4da9b95ea0e6055d9ea50c992	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-251	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.272757	401	EXECUTED	8:22bac96fac58913b28a2fcb2593fc272	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-252	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.278305	402	EXECUTED	8:0443bdebc29725c327ff14b2ef58ff5d	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-253	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.281547	403	EXECUTED	8:bd2ccca635527d870f9cbef1d83624be	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-254	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.285292	404	EXECUTED	8:1a203659a9d1b9d5b3a2c6dd7d5b3c16	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-255	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.290925	405	EXECUTED	8:9c9a507a6a17d10796918b4e90a176f2	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
1235684743487-256	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.29512	406	EXECUTED	8:7d5de7c41a8abe493b1cb703bb573b26	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-7	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.165748	647	EXECUTED	8:332540fbc218622298ae9a66170ad084	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-257	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.299704	407	EXECUTED	8:ea020a68aa2dc2e5a91040a042f494af	insert tableName=subject_event_status		\N	3.6.3	\N	\N	1509384775
1235684743487-258	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.305155	408	EXECUTED	8:40a0e3e1429f0974919583a70383a558	insert tableName=subject_event_status		\N	3.6.3	\N	\N	1509384775
1235684743487-259	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.310369	409	EXECUTED	8:7f3b4df912792f2c6a064e954a5a4c27	insert tableName=subject_event_status		\N	3.6.3	\N	\N	1509384775
1235684743487-260	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.316304	410	EXECUTED	8:587de459368e957e1d26ea52d2a4efc9	insert tableName=subject_event_status		\N	3.6.3	\N	\N	1509384775
1235684743487-261	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.32108	411	EXECUTED	8:c4280f9be3ae0a1325ff222d04f3b869	insert tableName=subject_event_status		\N	3.6.3	\N	\N	1509384775
1235684743487-262	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.324998	412	EXECUTED	8:6bcfb3988b8a742f36ae1ac34664ec5c	insert tableName=subject_event_status		\N	3.6.3	\N	\N	1509384775
1235684743487-263	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.328174	413	EXECUTED	8:ba0f1ffa4b518dd35a760066c124090a	insert tableName=subject_event_status		\N	3.6.3	\N	\N	1509384775
1235684743487-264	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.331028	414	EXECUTED	8:52daed60dd6e08bea8771f0e05f989fa	insert tableName=subject_event_status		\N	3.6.3	\N	\N	1509384775
1235684743487-265	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.334968	415	EXECUTED	8:a74d90c0de4199e192ad0abe82744c6f	insert tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-266	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.339593	416	EXECUTED	8:816daeb98044de9d75843f281be36f0c	insert tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-267	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.344404	417	EXECUTED	8:9ca78dc1d4f210a6a39292528755eb9c	insert tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-268	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.34863	418	EXECUTED	8:d5262bb385867b8d77621a36167f8c49	insert tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-269	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.353964	419	EXECUTED	8:d03b46e2090bd53de739e0ba62c7f242	insert tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-270	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.360082	420	EXECUTED	8:4b2262e5985684a44344599800689b6b	insert tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-271	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.365656	421	EXECUTED	8:cb6069e67980874b9fb0d6a023da5e34	insert tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-272	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.377197	422	EXECUTED	8:ea8a07ca02148056a5a5b429b78c0544	insert tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-273	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.383522	423	EXECUTED	8:0b62ba6956395d6c24e5c409b5c8ecd5	insert tableName=response_type		\N	3.6.3	\N	\N	1509384775
1235684743487-274	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.389762	424	EXECUTED	8:27274b9bb65ff8c60fa89656dbe73a4e	insert tableName=user_type		\N	3.6.3	\N	\N	1509384775
1235684743487-275	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.395953	425	EXECUTED	8:c89e895eb241cf188089bc58795b19a1	insert tableName=user_type		\N	3.6.3	\N	\N	1509384775
1235684743487-276	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.400731	426	EXECUTED	8:3df9aa9f27c7f3317e6b23fb9d2df245	insert tableName=user_type		\N	3.6.3	\N	\N	1509384775
1235684743487-277	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.408015	427	EXECUTED	8:4b3252e9c7dd5f4fa56c3e722b91f34e	insert tableName=study_type		\N	3.6.3	\N	\N	1509384775
1235684743487-278	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.411932	428	EXECUTED	8:fa34ea59d1a40dc0dc8701a8b1aede39	insert tableName=study_type		\N	3.6.3	\N	\N	1509384775
1235684743487-279	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.41817	429	EXECUTED	8:c21473f9e55dce6ef9d0417bcc7a1740	insert tableName=user_account		\N	3.6.3	\N	\N	1509384775
1235684743487-279-1	kkrumlian	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.425074	430	EXECUTED	8:48f3d2a02d2b5b3f07fe64d06e64fdcf	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-279-2	kkrumlian	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.42789	431	MARK_RAN	8:88de093f5891a1813e52b65084df72e9	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-280	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.434401	432	EXECUTED	8:44df87de223658603bb4be7e2173fa15	insert tableName=study		\N	3.6.3	\N	\N	1509384775
1235684743487-280-1	kkrumlian	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.441281	433	EXECUTED	8:c150fe84c2d3d64d9c805cfbfdf5cd59	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-280-2	kkrumlian	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.444992	434	MARK_RAN	8:f836eaaae87e9d012c7e0c26373ef1c5	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-281	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.451308	435	EXECUTED	8:209cb9e2f3838a6cafdebb5f8cc75d3b	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-282	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.465041	436	EXECUTED	8:dd2aac5294454e87b5119c8264ab11da	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-283	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.476409	437	EXECUTED	8:be8a8191cf707054c37942395b430206	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-284	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.482281	438	EXECUTED	8:1f01ac820d92dea074a9d54911c915c4	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-285	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.488419	439	EXECUTED	8:bfc7e4dd92eae4bd3a54165bf491fbff	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-286	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.493694	440	EXECUTED	8:04534d44d0d0bc855a16c433f5e93596	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-287	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.499116	441	EXECUTED	8:14c9d8a0b8d654dbd745b431e4e68c1f	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-288	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.505111	442	EXECUTED	8:acdeccfe1af4771933592bcf1f2db01e	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-289	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.509429	443	EXECUTED	8:5f5a5af81e6d2086e73ab186f9ff3aa7	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-290	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.513708	444	EXECUTED	8:7dcabcfd81d7cce2e99a1d550d071458	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-291	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.517419	445	EXECUTED	8:ac17bb73f550c2920571c0bc8d28c15b	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-292	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.521875	446	EXECUTED	8:d80a11010c3fd7bffd0d539a894b89ef	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-293	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.525893	447	EXECUTED	8:66308d0128564cf7c6adbad33f7daf78	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-294	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.530066	448	EXECUTED	8:4958b28daec50f3726595dec04b3081d	insert tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
1235684743487-295	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.533486	449	EXECUTED	8:24b43e5d5989e458bace23071fef40b2	insert tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
1235684743487-296	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.537179	450	EXECUTED	8:ae9827de2cce13de7122577f73d910df	insert tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
1235684743487-297	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.540736	451	EXECUTED	8:2550843464638524e285f88106a7ab9f	insert tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
1235684743487-298	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.543622	452	EXECUTED	8:ca1bc001b4b432e39f0842bb4be33c12	insert tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
1235684743487-299	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.54751	453	EXECUTED	8:7be1a79ebeef5c84dcc396849379db95	insert tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
1235684743487-300	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.550614	454	EXECUTED	8:a45621f0ea2c8e58565ac2ba04f816cb	insert tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
1235684743487-301	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.555454	455	EXECUTED	8:2ba4be175630b68d80676f8b5a03badf	insert tableName=resolution_status		\N	3.6.3	\N	\N	1509384775
1235684743487-302	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.561971	456	EXECUTED	8:e3642b771f5f0c08c52425402b169723	insert tableName=resolution_status		\N	3.6.3	\N	\N	1509384775
1235684743487-303	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.567858	457	EXECUTED	8:d1fdc06622fe218893f22aab9e59ab4d	insert tableName=resolution_status		\N	3.6.3	\N	\N	1509384775
1235684743487-304	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.574189	458	EXECUTED	8:ee5740298004fc993e0affb4a323d0c8	insert tableName=resolution_status		\N	3.6.3	\N	\N	1509384775
1235684743487-305	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.579535	459	EXECUTED	8:60f7d80b097daeaea3365799dd932fd5	insert tableName=resolution_status		\N	3.6.3	\N	\N	1509384775
1235684743487-306	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.585816	460	EXECUTED	8:7c76d4a70bc31210b1ba197aa8b9ae46	insert tableName=completion_status		\N	3.6.3	\N	\N	1509384775
1235684743487-307	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.590191	461	EXECUTED	8:64bd952f99e585b5c4be5e80a884366e	insert tableName=user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-308	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.595488	462	EXECUTED	8:8e7842ed8f5f9560c4497ef74cc9b5c9	insert tableName=user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-309	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.600856	463	EXECUTED	8:17336df7826bbeda20aea050b1da1042	insert tableName=user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-310	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.606423	464	EXECUTED	8:128d3b27a6fe0810bf40531a7ea6973e	insert tableName=user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-311	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.612735	465	EXECUTED	8:7e9a14b07ef61e8da75d7fddc62b941b	insert tableName=user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-312	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.617718	466	EXECUTED	8:9224207bba3b1a1e109e6791b0757d8e	insert tableName=user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-313	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.622314	467	EXECUTED	8:c5e611840c41d66270556b5338a387cf	insert tableName=export_format		\N	3.6.3	\N	\N	1509384775
1235684743487-314	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.625181	468	EXECUTED	8:45ead64d624b09a680dca9813a150f81	insert tableName=export_format		\N	3.6.3	\N	\N	1509384775
1235684743487-315	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.62799	469	EXECUTED	8:1f23c8ca6c86cf49c5a4cbe588f17618	insert tableName=export_format		\N	3.6.3	\N	\N	1509384775
1235684743487-316	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.630696	470	EXECUTED	8:7f1c6ccf25609442ae0ddc60f10f4128	insert tableName=export_format		\N	3.6.3	\N	\N	1509384775
1235684743487-317	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.633507	471	EXECUTED	8:65f313b47dda8be52016b8f3812b8456	insert tableName=export_format		\N	3.6.3	\N	\N	1509384775
1235684743487-318	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.637678	472	EXECUTED	8:a546e09fec2ee9db2a10eaa5ebf82fc5	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-319	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.641074	473	EXECUTED	8:262a84d747f238c3f1acdf0105ae8c7f	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-320	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.644521	474	EXECUTED	8:0ff146a7c75fc9f0d3d4fd340cfb4205	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-321	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.647879	475	EXECUTED	8:4b12ec962a1e8356e4704420b70ed6dc	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-322	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.651253	476	EXECUTED	8:f2d184ef9d8fa814f005d5fa77b1297e	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-323	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.654733	477	EXECUTED	8:169146d8d330f594874b539f48737a60	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-324	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.659307	478	EXECUTED	8:8d0ed8a2fb1a0f34d7a52e03b12ff7ac	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-325	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.667262	479	EXECUTED	8:daaafa4f843a4d8a0145e8a0a915c480	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-326	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.673911	480	EXECUTED	8:9b6c20024ef03b4a0ba4d4d2b0b368e7	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-327	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.678938	481	EXECUTED	8:481815ce36a11a8f8532a40a75f651ad	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-328	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.682844	482	EXECUTED	8:e9c2b892d4bb0b59a9bb149ba59568a3	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-329	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.687807	483	EXECUTED	8:c29742bd6913484ba63d8ff921600da7	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-330	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.693801	484	EXECUTED	8:da945939879094848ea4532e8ee77fe8	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-331	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.69911	485	EXECUTED	8:f9a58bbee8e985803d0493d1ae797b22	insert tableName=item_reference_type		\N	3.6.3	\N	\N	1509384775
1235684743487-332	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.70485	486	EXECUTED	8:d041ede137a3c6685b187928abe0cc26	insert tableName=study_user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-333	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.710424	487	EXECUTED	8:1a142bd1a10b07307e9f541181892700	insert tableName=study_user_role		\N	3.6.3	\N	\N	1509384775
1235684743487-334	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.714934	488	EXECUTED	8:bc35387c9c6437f767189180820624de	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-335	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.719051	489	EXECUTED	8:21dd8d7859ead96dba6f98636dad20f5	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-336	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.722682	490	EXECUTED	8:676b91e5ceb913f92989f9868f462011	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-337	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.72613	491	EXECUTED	8:28541c93f01a506e86e6a79154337a61	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-338	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.728537	492	EXECUTED	8:b6f46255e2aa21d060e81e21afd5a906	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-339	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.730943	493	EXECUTED	8:3032dfe9ccfc01c717ce23b66d4313b5	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-340	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.733405	494	EXECUTED	8:b2fb167d5eaad51925f102308fc28548	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-341	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.737516	495	EXECUTED	8:47297b04b1485681eb1e2c8a1c9fcab6	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-342	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.740881	496	EXECUTED	8:714e6ddb19db41d35d99ab86a62a857a	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-343	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.744148	497	EXECUTED	8:e87422aacb8444c38b1e41b611b8c297	insert tableName=group_class_types		\N	3.6.3	\N	\N	1509384775
1235684743487-344	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.747187	498	EXECUTED	8:387308eb9df30cfc42878d853135c535	insert tableName=group_class_types		\N	3.6.3	\N	\N	1509384775
1235684743487-345	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.749849	499	EXECUTED	8:be2ebb8042ae1f2f2ae286962fb8f0d0	insert tableName=group_class_types		\N	3.6.3	\N	\N	1509384775
1235684743487-346	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.753858	500	EXECUTED	8:c274f69e37db9f85d71319af244f2f65	insert tableName=group_class_types		\N	3.6.3	\N	\N	1509384775
1235684743487-347	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.757559	501	EXECUTED	8:cdde31d50985e3abdbe973772fd0030e	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-348	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.761831	502	EXECUTED	8:503a68ed687c91558f902190b560e080	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-349	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.765386	503	EXECUTED	8:6a7a30fed44f1f376be2f9be5581630a	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-350	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.773078	504	EXECUTED	8:ecd80b30b46ba049fb8a9eabe742c482	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-351	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.779649	505	EXECUTED	8:bcc787a5029ef66b5fdd2ff517a12dd3	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-352	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.788909	506	EXECUTED	8:5dc067b7456bc80358231f2c5ff4a51b	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-353	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.794063	507	EXECUTED	8:d4eb9505388fe331f2fba5805ce3fce8	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-354	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.798725	508	EXECUTED	8:b20ae90a3f670e0a84f80fe266f238fc	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-355	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.803125	509	EXECUTED	8:7a59105e934791e6bc9bb918e2bc4635	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-356	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.807479	510	EXECUTED	8:bd624454d257dc9712b93f6e30a78d85	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-357	pgawade (generated)	migration/2.5/changeLogDataInsert.xml	2023-12-02 09:29:50.814599	511	EXECUTED	8:56aeaa227a30d58b679d90d8d3c403a5	insert tableName=null_value_type		\N	3.6.3	\N	\N	1509384775
1235684743487-372	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.820906	512	EXECUTED	8:15d6aa224e65fc7e5a878df7f4f87e46	renameColumn newColumnName=id, oldColumnName=rule_id, tableName=rule		\N	3.6.3	\N	\N	1509384775
1235684743487-373	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.827656	513	EXECUTED	8:9a6f25bae89abc11a8eaadda3222deb4	renameTable newTableName=rule_id_seq, oldTableName=rule_rule_id_seq		\N	3.6.3	\N	\N	1509384775
1235684743487-374	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.834917	514	EXECUTED	8:060efc355f68da3bcbb971fc3642bd91	addColumn tableName=rule		\N	3.6.3	\N	\N	1509384775
1235684743487-375	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.840303	515	EXECUTED	8:5ceaedf2b00dcce16a266833a4afb07e	update tableName=rule		\N	3.6.3	\N	\N	1509384775
1235684743487-376	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.844661	516	EXECUTED	8:a0bf6b0e2887df2c10a1d6c6167a00f0	renameColumn newColumnName=id, oldColumnName=rule_action_id, tableName=rule_action		\N	3.6.3	\N	\N	1509384775
1235684743487-377	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.848659	517	EXECUTED	8:e870e4ec39cb550ebb78722e5a6778cd	renameTable newTableName=rule_action_id_seq, oldTableName=rule_action_rule_action_id_seq		\N	3.6.3	\N	\N	1509384775
1235684743487-378	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.856555	518	EXECUTED	8:41d24bd0d56a9b9bfbd31b2de0de5c41	addColumn tableName=rule_action		\N	3.6.3	\N	\N	1509384775
1235684743487-379	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.861771	519	EXECUTED	8:9d7cb58a79b2e769bbcfc8929bfbab6f	update tableName=rule_action		\N	3.6.3	\N	\N	1509384775
1235684743487-380	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.866755	520	EXECUTED	8:2ef080b1a3c199ee038d6d00f07f7a24	renameColumn newColumnName=id, oldColumnName=rule_expression_id, tableName=rule_expression		\N	3.6.3	\N	\N	1509384775
1235684743487-381	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.877134	521	EXECUTED	8:fcff51463679b46efd5d2b6fac05b747	renameTable newTableName=rule_expression_id_seq, oldTableName=rule_expression_rule_expression_id_seq		\N	3.6.3	\N	\N	1509384775
1235684743487-382	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.882671	522	EXECUTED	8:cdadaccb8a79fdb37f76512d693c6c92	addColumn tableName=rule_expression		\N	3.6.3	\N	\N	1509384775
1235684743487-383	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.887547	523	EXECUTED	8:5a260b32bd274d36e7d04d580f0d68ae	update tableName=rule_expression		\N	3.6.3	\N	\N	1509384775
1235684743487-384	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.89281	524	EXECUTED	8:d2bbfdb59bc4c8b3a157fc2c39eb82a3	renameColumn newColumnName=id, oldColumnName=rule_set_id, tableName=rule_set		\N	3.6.3	\N	\N	1509384775
1235684743487-385	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.89748	525	EXECUTED	8:39ddecde39b3a9a8a702721dd9036e84	renameTable newTableName=rule_set_id_seq, oldTableName=rule_set_rule_set_id_seq		\N	3.6.3	\N	\N	1509384775
1235684743487-386	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.901339	526	EXECUTED	8:5dfae0caa8945dfc8c0f47013a0eb574	addColumn tableName=rule_set		\N	3.6.3	\N	\N	1509384775
1235684743487-387	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.904786	527	EXECUTED	8:18e8ff06bf73cab5966d0ba21bcb1716	update tableName=rule_set		\N	3.6.3	\N	\N	1509384775
1235684743487-388	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.908856	528	EXECUTED	8:43ab339face85d20073efdb8cf58a47e	renameColumn newColumnName=id, oldColumnName=rule_set_audit_id, tableName=rule_set_audit		\N	3.6.3	\N	\N	1509384775
1235684743487-389	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.911892	529	EXECUTED	8:f82061ca8544950b56a462759324f451	renameTable newTableName=rule_set_audit_id_seq, oldTableName=rule_set_audit_rule_set_audit_id_seq		\N	3.6.3	\N	\N	1509384775
1235684743487-390	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.915099	530	EXECUTED	8:2d809343230c93e5edf12fe6e1694422	addColumn tableName=rule_set_audit		\N	3.6.3	\N	\N	1509384775
1235684743487-391	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.918145	531	EXECUTED	8:236b0a6385304c4d403b2dedc074e307	update tableName=rule_set_audit		\N	3.6.3	\N	\N	1509384775
1235684743487-392	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.921383	532	EXECUTED	8:e24e894246e3d161e365be7db292364e	renameColumn newColumnName=id, oldColumnName=rule_set_rule_id, tableName=rule_set_rule		\N	3.6.3	\N	\N	1509384775
1235684743487-393	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.924823	533	EXECUTED	8:132ca549755f6fcccc7f42bb89557186	renameTable newTableName=rule_set_rule_id_seq, oldTableName=rule_set_rule_rule_set_rule_id_seq		\N	3.6.3	\N	\N	1509384775
1235684743487-394	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.928654	534	EXECUTED	8:d5c85db0710271b7d2eb076623ef1577	addColumn tableName=rule_set_rule		\N	3.6.3	\N	\N	1509384775
1235684743487-395	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.932982	535	EXECUTED	8:984fd070b3da227a08fd549aa7bf1797	update tableName=rule_set_rule		\N	3.6.3	\N	\N	1509384775
1235684743487-396	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.937021	536	EXECUTED	8:8a7342fb18d8a638761e0a1c55a766e0	renameColumn newColumnName=id, oldColumnName=rule_set_rule_audit_id, tableName=rule_set_rule_audit		\N	3.6.3	\N	\N	1509384775
1235684743487-397	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.941122	537	EXECUTED	8:2f5f89455561282eddc5c9e9adab3ad5	renameTable newTableName=rule_set_rule_audit_id_seq, oldTableName=rule_set_rule_audit_rule_set_rule_audit_id_seq		\N	3.6.3	\N	\N	1509384775
1235684743487-398	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.945149	538	EXECUTED	8:46677b1eab898b7fafafaac8587fca48	addColumn tableName=rule_set_rule_audit		\N	3.6.3	\N	\N	1509384775
1235684743487-399	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.948578	539	EXECUTED	8:63ca8031fe697a1f8bae1519bc99c781	update tableName=rule_set_rule_audit		\N	3.6.3	\N	\N	1509384775
1235684743487-400	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.951316	540	EXECUTED	8:10e4ba5a7fc2e2fe46f1f49d4862412c	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-401	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.955476	541	EXECUTED	8:a555f96d8b1b480484035325fa37affe	insert tableName=item_data_type		\N	3.6.3	\N	\N	1509384775
1235684743487-402	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.96261	542	EXECUTED	8:7b9b1e57a5991cf462767ffe105ada62	createTable tableName=authorities		\N	3.6.3	\N	\N	1509384775
1235684743487-433	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.965067	543	MARK_RAN	8:8c8e59b23bba4362960c50b31a3fa4b0	createSequence sequenceName=AUTHORITIES_ID_SEQ		\N	3.6.3	\N	\N	1509384775
1235684743487-434	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.967672	544	MARK_RAN	8:49f3196750f8b171c0d35c761f948831	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-403	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.982238	545	EXECUTED	8:a8d8fd46e32199a4ab926a3f30a15e8e	createTable tableName=oc_qrtz_blob_triggers		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-8	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.182999	648	EXECUTED	8:4a7f0bf31361f93c0ea0899cb8255aca	sql		\N	3.6.3	\N	\N	1509384775
1235684743487-404	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:50.991359	546	EXECUTED	8:ca8829339b8a65109fea4981e6266ce5	createTable tableName=oc_qrtz_calendars		\N	3.6.3	\N	\N	1509384775
1235684743487-405	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.003284	547	EXECUTED	8:f4b408683ca4b0a4ead9465672cade7c	createTable tableName=oc_qrtz_cron_triggers		\N	3.6.3	\N	\N	1509384775
1235684743487-406	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.016281	548	EXECUTED	8:3eb59d9d8926555ec47349f096ec8b39	createTable tableName=oc_qrtz_fired_triggers		\N	3.6.3	\N	\N	1509384775
1235684743487-407	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.035202	549	EXECUTED	8:e74c826041bc046dc8b99a584744975e	createTable tableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
1235684743487-408	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.048863	550	EXECUTED	8:53dfbc04592790b73f91e1d92bfd36a3	createTable tableName=oc_qrtz_job_listeners		\N	3.6.3	\N	\N	1509384775
1235684743487-409	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.058098	551	EXECUTED	8:9d0af7d72eaa9dd4438e7b530180b3cd	createTable tableName=oc_qrtz_locks		\N	3.6.3	\N	\N	1509384775
1235684743487-410	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.065152	552	EXECUTED	8:69be035b176235db7fe02618f94f6377	createTable tableName=oc_qrtz_paused_trigger_grps		\N	3.6.3	\N	\N	1509384775
1235684743487-411	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.075986	553	EXECUTED	8:24b48571395d1ab4f1aab440af86c59e	createTable tableName=oc_qrtz_scheduler_state		\N	3.6.3	\N	\N	1509384775
1235684743487-412	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.085204	554	EXECUTED	8:587e5baff5ae59e742ccb1359f4585e0	createTable tableName=oc_qrtz_simple_triggers		\N	3.6.3	\N	\N	1509384775
1235684743487-413	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.098503	555	EXECUTED	8:b9f45483b4ef95bcbc246fd15feb84fe	createTable tableName=oc_qrtz_trigger_listeners		\N	3.6.3	\N	\N	1509384775
1235684743487-414	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.112998	556	EXECUTED	8:4387cd4795d644ef3aa2fe8b762c035d	createTable tableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
1235684743487-415	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.119371	557	EXECUTED	8:76427fae1b94796a0cc03f403e482125	insert tableName=authorities		\N	3.6.3	\N	\N	1509384775
1235684743487-416	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.126781	558	EXECUTED	8:d2bd6e738c3640030f207389a4532cc8	insert tableName=oc_qrtz_locks		\N	3.6.3	\N	\N	1509384775
1235684743487-417	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.130716	559	EXECUTED	8:3fbd01f16e6cda42664658f1ff9d35dd	insert tableName=oc_qrtz_locks		\N	3.6.3	\N	\N	1509384775
1235684743487-418	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.13495	560	EXECUTED	8:d4cd6f9c322890bcd736d039ef599769	insert tableName=oc_qrtz_locks		\N	3.6.3	\N	\N	1509384775
1235684743487-419	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.141502	561	EXECUTED	8:80ed0dd9fcf5e833c720518974b464aa	insert tableName=oc_qrtz_locks		\N	3.6.3	\N	\N	1509384775
1235684743487-420	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.146775	562	EXECUTED	8:e7ed12ba832b8c70441cc9616f1ed6b5	insert tableName=oc_qrtz_locks		\N	3.6.3	\N	\N	1509384775
1236021533243-421	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.156845	563	EXECUTED	8:34e5601b66f9e7002ae2776b9f4e9c13	addForeignKeyConstraint baseTableName=oc_qrtz_blob_triggers, constraintName=oc_qrtz_blob_triggers_trg_fkey, referencedTableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
1236021533243-422	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.166667	564	EXECUTED	8:bab305ff414461d3f4e17ebdbfb41dc0	addForeignKeyConstraint baseTableName=oc_qrtz_cron_triggers, constraintName=oc_qrtz_cron_triggers_trg_fkey, referencedTableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
1236021533243-423	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.178068	565	EXECUTED	8:3f58e0a1de1f7418ae06f843a1a61d08	addForeignKeyConstraint baseTableName=oc_qrtz_job_listeners, constraintName=oc_qrtz_job_listeners_job_fkey, referencedTableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
1236021533243-424	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.18711	566	EXECUTED	8:1329e905ba0a765db06a4a79bafca7a8	addForeignKeyConstraint baseTableName=oc_qrtz_simple_triggers, constraintName=oc_qrtz_simple_trigs_trg_fkey, referencedTableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
1236021533243-425	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.201534	567	EXECUTED	8:e561a445f4ceb104aab5146a8fdd256d	addForeignKeyConstraint baseTableName=oc_qrtz_trigger_listeners, constraintName=oc_qrtz_trigger_lsnrs_trg_fkey, referencedTableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
1236021533243-426	pgawade (generated)	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.213759	568	EXECUTED	8:373f2f3b9c350423285b9335ccb92573	addForeignKeyConstraint baseTableName=oc_qrtz_triggers, constraintName=oc_qrtz_triggers_job_name_fkey, referencedTableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
1235684743487-427	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.221747	569	EXECUTED	8:97bbe82a6a49c7fa003a526a5ba7e475	addColumn tableName=event_definition_crf		\N	3.6.3	\N	\N	1509384775
1235684743487-428	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.227481	570	EXECUTED	8:c3394d99fc31c45e31e65e8e243611fc	addColumn tableName=discrepancy_note		\N	3.6.3	\N	\N	1509384775
1235684743487-429	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.233434	571	EXECUTED	8:f3db3f0e4bc71fab1edeff7f9ac7750d	addForeignKeyConstraint baseTableName=discrepancy_note, constraintName=discrepancy_note_asn_u_id_fkey, referencedTableName=user_account		\N	3.6.3	\N	\N	1509384775
1235684743487-430	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.241395	572	EXECUTED	8:bc041580b76a81d2e4ac3dca45d28bbd	insert tableName=study_parameter		\N	3.6.3	\N	\N	1509384775
1235684743487-431	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.246303	573	EXECUTED	8:f66fe500e724db0823af6382a2ffa1ef	insert tableName=study_parameter_value		\N	3.6.3	\N	\N	1509384775
1235684743487-432	pgawade	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.25303	574	EXECUTED	8:64dcb26e8aa2d660cfaa2457279d9ea4	addColumn tableName=item_form_metadata		\N	3.6.3	\N	\N	1509384775
1235684743487-433	kkrumlian	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.261769	575	EXECUTED	8:e36306d501fdc6c80afca4739bc4dd9d	addColumn tableName=crf		\N	3.6.3	\N	\N	1509384775
1235684743487-434	kkrumlian	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.275518	576	EXECUTED	8:06b264dfd1b7f6775664163262271bb4	insert tableName=status		\N	3.6.3	\N	\N	1509384775
1235684743487-435	kkrumlian	migration/3.0/schema_patch_2.5_to_3.0.xml	2023-12-02 09:29:51.288843	577	EXECUTED	8:982029be93be2fa533ad1be53b7bb789	sql		\N	3.6.3	\N	\N	1509384775
2009-03-16-2914-1	ywang	migration/3.0/2009-03-16-2914.xml	2023-12-02 09:29:51.302458	578	EXECUTED	8:30ddd3132cd96bf8fa348b434622fb14	createTable tableName=dataset_item_status		\N	3.6.3	\N	\N	1509384775
2009-03-16-2914-2	ywang	migration/3.0/2009-03-16-2914.xml	2023-12-02 09:29:51.310701	579	EXECUTED	8:39d50b8d748e6c8823033208db8aff3b	insert tableName=dataset_item_status		\N	3.6.3	\N	\N	1509384775
2009-03-16-2914-3	ywang	migration/3.0/2009-03-16-2914.xml	2023-12-02 09:29:51.316142	580	EXECUTED	8:cafa63ee6f8e78c9eb54e0ea829ff3d8	insert tableName=dataset_item_status		\N	3.6.3	\N	\N	1509384775
2009-03-16-2914-4	ywang	migration/3.0/2009-03-16-2914.xml	2023-12-02 09:29:51.327133	581	EXECUTED	8:be8afadfb4f40fef29664f0962fa5b74	insert tableName=dataset_item_status		\N	3.6.3	\N	\N	1509384775
2009-03-16-2914-5	ywang	migration/3.0/2009-03-16-2914.xml	2023-12-02 09:29:51.334617	582	EXECUTED	8:a6d3b864142876e6f0f59eec5d7d8040	addColumn tableName=dataset		\N	3.6.3	\N	\N	1509384775
2009-03-16-2914-6	ywang	migration/3.0/2009-03-16-2914.xml	2023-12-02 09:29:51.344257	583	EXECUTED	8:02358c7a63d25d0db88bbda8ad14cb91	addForeignKeyConstraint baseTableName=dataset, constraintName=dataset_fk_dataset_item_status, referencedTableName=dataset_item_status		\N	3.6.3	\N	\N	1509384775
2009-03-30-NA01-1	kkrumlian	migration/3.0/2009-03-30-NA01.xml	2023-12-02 09:29:51.349508	584	EXECUTED	8:ac755c630059fa59f27ea2c975dd059c	renameColumn newColumnName=source_study_id, oldColumnName=study_id, tableName=crf	Rename Column Name	\N	3.6.3	\N	\N	1509384775
2009-03-30-NA01-2	kkrumlian	migration/3.0/2009-03-30-NA01.xml	2023-12-02 09:29:51.35905	585	EXECUTED	8:a1820970ea7d06729d7587ea075ad360	addForeignKeyConstraint baseTableName=crf, constraintName=fk_source_study_id, referencedTableName=study	Add foreign Key for the source_study_id	\N	3.6.3	\N	\N	1509384775
2009-03-30-3348-1	ywang	migration/3.0/2009-03-30-3348.xml	2023-12-02 09:29:51.365538	586	EXECUTED	8:51786ab81b450276ec05c3647989c29f	addColumn tableName=event_definition_crf	event_definition_crf (source_data_verification_code)	\N	3.6.3	\N	\N	1509384775
2009-03-30-3348-2	ywang	migration/3.0/2009-03-30-3348.xml	2023-12-02 09:29:51.373092	587	EXECUTED	8:daa1dc5cf258afcc00c71c7defa70c71	addColumn tableName=event_definition_crf	event_definition_crf (selected_version_ids)	\N	3.6.3	\N	\N	1509384775
2009-03-30-3348-3	ywang	migration/3.0/2009-03-30-3348.xml	2023-12-02 09:29:51.381619	588	EXECUTED	8:79bbd6043c64056d49cf148181e70bb7	addColumn tableName=event_definition_crf	event_definition_crf (parent_id)	\N	3.6.3	\N	\N	1509384775
2009-03-31-1	ywang	migration/3.0/2009-03-31-3382.xml	2023-12-02 09:29:51.389591	589	EXECUTED	8:dc9523c33f6ffd4312644323add769e4	update tableName=dataset_item_status		\N	3.6.3	\N	\N	1509384775
2009-03-31-2	ywang	migration/3.0/2009-03-31-3382.xml	2023-12-02 09:29:51.395709	590	EXECUTED	8:4110b2ec52ce0d8448f8b59dd80709e5	update tableName=dataset_item_status		\N	3.6.3	\N	\N	1509384775
2009-03-31-3	ywang	migration/3.0/2009-03-31-3382.xml	2023-12-02 09:29:51.401364	591	EXECUTED	8:bd25dfeaba2f76ff8d4ce561eb8954b4	update tableName=dataset_item_status		\N	3.6.3	\N	\N	1509384775
2009-04-02-3397-1	kkrumlian	migration/3.0/2009-04-02-3397.xml	2023-12-02 09:29:51.414161	592	EXECUTED	8:e60bff81e87f6260d2f335851868d712	createTable tableName=audit_user_login	Create a table named audit_user_login	\N	3.6.3	\N	\N	1509384775
2009-04-02-3397-3	kkrumlian	migration/3.0/2009-04-02-3397.xml	2023-12-02 09:29:51.423434	593	EXECUTED	8:c06df55d220be762b82bf23e64296548	addForeignKeyConstraint baseTableName=audit_user_login, constraintName=fk_audit_user_login_id, referencedTableName=user_account	Add foreign Key for user_account_id	\N	3.6.3	\N	\N	1509384775
2009-04-02-3397-4	kkrumlian	migration/3.0/2009-04-02-3397.xml	2023-12-02 09:29:51.431787	594	EXECUTED	8:ddcaed314dcd68a764f1147166a9ab16	addColumn tableName=user_account	Add enabled property to user_account table	\N	3.6.3	\N	\N	1509384775
2009-04-02-3397-5	kkrumlian	migration/3.0/2009-04-02-3397.xml	2023-12-02 09:29:51.440769	595	EXECUTED	8:32b5eaae0fdc3babaa46d4f458ffa383	addColumn tableName=user_account	Add account_non_locked property to user_account table	\N	3.6.3	\N	\N	1509384775
2009-04-02-3397-6	kkrumlian	migration/3.0/2009-04-02-3397.xml	2023-12-02 09:29:51.447954	596	EXECUTED	8:015d2f8abef98a2babbb67b1b002e9fe	addColumn tableName=user_account	Add lock_counter property to user_account table	\N	3.6.3	\N	\N	1509384775
2009-04-02-3397-7	kkrumlian	migration/3.0/2009-04-02-3397.xml	2023-12-02 09:29:51.466862	597	EXECUTED	8:d967e573e74fbe2600f32b5892e9bcd1	createTable tableName=configuration	Create a table named configuration	\N	3.6.3	\N	\N	1509384775
2009-04-02-3397-8	kkrumlian	migration/3.0/2009-04-02-3397.xml	2023-12-02 09:29:51.484253	598	EXECUTED	8:b3914e4541bffd89600146a5605e0b66	createIndex indexName=i_key_index, tableName=configuration	Create an index on table named configuration	\N	3.6.3	\N	\N	1509384775
2009-04-02-3397-10	kkrumlian	migration/3.0/2009-04-02-3397.xml	2023-12-02 09:29:51.507604	599	EXECUTED	8:1f8a960cef55784377ec948612246321	insert tableName=configuration		\N	3.6.3	\N	\N	1509384775
2009-04-02-3397-11	kkrumlian	migration/3.0/2009-04-02-3397.xml	2023-12-02 09:29:51.515005	600	EXECUTED	8:fcab58cc8cc38419e2e3d15267cfc081	insert tableName=configuration		\N	3.6.3	\N	\N	1509384775
2009-04-10-3120-1	sshamim	migration/3.0/2009-04-10-3120.xml	2023-12-02 09:29:51.529794	601	EXECUTED	8:0fd84cfdae98c29dabee1ea347242a23	createTable tableName=study_module_status	Create a table named study_module_status	\N	3.6.3	\N	\N	1509384775
2009-04-10-3120-2	sshamim	migration/3.0/2009-04-10-3120.xml	2023-12-02 09:29:51.539787	602	EXECUTED	8:f07e656cd9c33ac1d2c39ebfbd8c6627	addForeignKeyConstraint baseTableName=study_module_status, constraintName=fk_study_module_study_id, referencedTableName=study	Add foreign Key for study_id column	\N	3.6.3	\N	\N	1509384775
2009-04-29-3349-1	bwperry	migration/3.0/2009-04-29-3349.xml	2023-12-02 09:29:51.549719	603	EXECUTED	8:59bdb5da15a8e2560b53a7baa2c80efe	addColumn tableName=event_crf	Add sdv_status property to event_crf table	\N	3.6.3	\N	\N	1509384775
2009-05-15-3624-1	ywang	migration/3.0/2009-05-15-3624.xml	2023-12-02 09:29:51.597666	604	EXECUTED	8:f1a8420ee77020302c6b1e8b59831ecb	createTable tableName=measurement_unit	create measurement_unit	\N	3.6.3	\N	\N	1509384775
2009-05-15-3624-3	ywang	migration/3.0/2009-05-15-3624.xml	2023-12-02 09:29:51.609719	605	EXECUTED	8:a18c3450fbfe9cd9f2232e94fb30a105	sql	mapping item.units to measurement_unit.name and oc_oid	\N	3.6.3	\N	\N	1509384775
2009-05-28-3481-1	sshamim	migration/3.0/2009-05-28-3481.xml	2023-12-02 09:29:51.615833	606	EXECUTED	8:7dd65dc75ef12df657cf5032686624b7	insert tableName=status	Insert a record in Status table	\N	3.6.3	\N	\N	1509384775
2009-06-04-3684-1	thickerson	migration/3.0/2009-06-04-3684.xml	2023-12-02 09:29:51.624712	607	EXECUTED	8:89fa12135c4ec50180fa2b62d17b11f5	insert tableName=study_parameter	Insert a new record in the studyParameter table	\N	3.6.3	\N	\N	1509384775
2009-06-08-3628-1	ywang	migration/3.0/2009-06-08-3628.xml	2023-12-02 09:29:51.630676	608	EXECUTED	8:5099b26dd89bf997e999d30f8b051a3e	insert tableName=null_value_type	insert a new record to null_value_type: NPE(not performed)	\N	3.6.3	\N	\N	1509384775
2009-06-10-3260-1	kkrumlian	migration/3.0/2009-06-10-3260.xml	2023-12-02 09:29:51.637343	609	EXECUTED	8:279236a00b2511c104a85c8ef4ba5916	update tableName=discrepancy_note	update discrepancy_note set entity_type='itemData' where entity_type='ItemData'	\N	3.6.3	\N	\N	1509384775
2009-07-23-3930-1	ywang	migration/3.0/2009-07-23-3930.xml	2023-12-02 09:29:51.651448	610	EXECUTED	8:c327f00db54ec79573e2ce6eac1fa5b8	sql	create or replace event_crf_trigger for event crf sdv status	\N	3.6.3	\N	\N	1509384775
2009-07-23-3930-2	ywang	migration/3.0/2009-07-23-3930.xml	2023-12-02 09:29:51.660435	611	EXECUTED	8:382a966af0df8ef570c928327f4e7906	insert tableName=audit_log_event_type	Insert event crf sdv into audit_log_event_type  table	\N	3.6.3	\N	\N	1509384775
2009-07-24-3648-1	shamim	migration/3.0/2009-07-24-3648.xml	2023-12-02 09:29:51.689844	612	EXECUTED	8:a9ac48925b2c621a63e291b018dc2c05	addColumn tableName=event_crf	Add a column in event_crf table	\N	3.6.3	\N	\N	1509384775
2009-09-10-3599-1	ywang	migration/3.0/2009-09-10-3599.xml	2023-12-02 09:29:51.698493	613	EXECUTED	8:ac7763ad8570d09e65d72aac5ab0ea45	sql	update resolution_status_id for parent note	\N	3.6.3	\N	\N	1509384775
2009-12-01-4439-1	kkrumlian	migration/3.0/2009-12-01-4439.xml	2023-12-02 09:29:51.707852	614	EXECUTED	8:2d23f143be450ec3c4407b6fb2e14c7a	sql	update study protocol_type	\N	3.6.3	\N	\N	1509384775
2009-12-01-4439-2	kkrumlian	migration/3.0/2009-12-01-4439.xml	2023-12-02 09:29:51.714595	615	EXECUTED	8:226444fdc137f3862b1bbf2ee5ef850c	sql	update study protocol_type	\N	3.6.3	\N	\N	1509384775
2009-12-01-4439-3	kkrumlian	migration/3.0/2009-12-01-4439.xml	2023-12-02 09:29:51.727402	616	EXECUTED	8:e425b0198d75274eede7566826e7ef41	sql	update study protocol_type	\N	3.6.3	\N	\N	1509384775
2009-12-11-4502-1	kkrumlian	migration/3.0/2009-12-11-4502.xml	2023-12-02 09:29:51.732853	617	EXECUTED	8:2fe8f14ea68c02df1d0201e845731012	update tableName=study_user_role	update study protocol_type	\N	3.6.3	\N	\N	1509384775
2010-02-16-NA01-1	kkrumlian	migration/3.0/2010-02-16-NA01.xml	2023-12-02 09:29:51.827251	618	EXECUTED	8:c19f3980f3e13d0d8c96223b7b414341	sql	update data in item_data table	\N	3.6.3	\N	\N	1509384775
2010-03-01-4772-2	kkrumlian	migration/3.0/2010-03-01-4772.xml	2023-12-02 09:29:51.840664	619	EXECUTED	8:e1680fefd70639257716f11a35bea6a1	sql	ALTER TABLE dataset ALTER sql_statement TYPE text	\N	3.6.3	\N	\N	1509384775
2010-03-02-4776-1	kkrumlian	migration/3.0/2010-03-02-4776.xml	2023-12-02 09:29:51.854322	620	EXECUTED	8:40c0abda332e3a1cb0bc0127527b9606	update tableName=event_definition_crf	update event_definition_crf	\N	3.6.3	\N	\N	1509384775
2009-03-03-4768-1	sshamim	migration/3.0/2010-03-03-4768.xml	2023-12-02 09:29:51.865698	621	EXECUTED	8:65740d994efcf9661be7b3af14ccaf90	sql	create or replace event_definition_crf_trigger	\N	3.6.3	\N	\N	1509384775
2009-03-03-4768-2	sshamim	migration/3.0/2010-03-03-4768.xml	2023-12-02 09:29:51.873044	622	EXECUTED	8:d9f786242b9f448ed8edb2f2e1c6cdb4	sql		\N	3.6.3	\N	\N	1509384775
2010-03-03-NA01-1	kkrumlian	migration/3.0/2010-03-03-NA01.xml	2023-12-02 09:29:51.880317	623	EXECUTED	8:ea097807f6d63dd22325e92f4244d306	addColumn tableName=dn_item_data_map	Add Study Subject Id column to	\N	3.6.3	\N	\N	1509384775
2010-03-03-NA01-2	kkrumlian	migration/3.0/2010-03-03-NA01.xml	2023-12-02 09:29:51.88991	624	EXECUTED	8:efa0d2816f82c9043e332b2627cc768e	sql	Update Study Subject Id column	\N	3.6.3	\N	\N	1509384775
2010-03-03-NA01-3	kkrumlian	migration/3.0/2010-03-03-NA01.xml	2023-12-02 09:29:51.898632	625	EXECUTED	8:1f980ac52ddd692ed024a49c0e7b1876	sql		\N	3.6.3	\N	\N	1509384775
2010-03-03-NA01-4	kkrumlian	migration/3.0/2010-03-03-NA01.xml	2023-12-02 09:29:51.909951	626	EXECUTED	8:c7e28458175698b65c75c4b0b7f86231	sql		\N	3.6.3	\N	\N	1509384775
2010-03-03-NA01-5	kkrumlian	migration/3.0/2010-03-03-NA01.xml	2023-12-02 09:29:51.917404	627	MARK_RAN	8:337b08aff4b4cd4d229f2fb840587da5	sql		\N	3.6.3	\N	\N	1509384775
2010-03-03-NA01-6	kkrumlian	migration/3.0/2010-03-03-NA01.xml	2023-12-02 09:29:51.922561	628	EXECUTED	8:b51f2a8e72b0a5edb46cec3f1f4649af	update tableName=discrepancy_note	update discrepancy_note table	\N	3.6.3	\N	\N	1509384775
2010-05-31-5009-1	ahamid	migration/3.0/2010-05-31-5009.xml	2023-12-02 09:29:51.92831	629	EXECUTED	8:2ab3fbfcded4e6c9071eae53d6a9ea09	addColumn tableName=study	study (old_status)	\N	3.6.3	\N	\N	1509384775
2010-05-31-5009-3	ahamid	migration/3.0/2010-05-31-5009.xml	2023-12-02 09:29:51.934396	630	EXECUTED	8:9ff1f2d21c30111af68a6aedc3a5d65a	addForeignKeyConstraint baseTableName=study, constraintName=fk_old_status_id, referencedTableName=status		\N	3.6.3	\N	\N	1509384775
2010-05-31-5009-4	ahamid	migration/3.0/2010-05-31-5009.xml	2023-12-02 09:29:51.939751	631	EXECUTED	8:e8701c70ac501a3dc3badcc6e5f0f919	sql		\N	3.6.3	\N	\N	1509384775
2010-05-27-5095-2	kkrumlian	migration/3.0/2010-05-27-5095.xml	2023-12-02 09:29:51.945065	632	EXECUTED	8:a3d4f6a134686de2a380db28dd1bcef4	addColumn tableName=rule_set	Add item_id column to rule_set	\N	3.6.3	\N	\N	1509384775
2010-05-27-5095-3	kkrumlian	migration/3.0/2010-05-27-5095.xml	2023-12-02 09:29:51.955622	633	EXECUTED	8:1512a6a2c8e8bdbd772e11f709a30f9a	sql	Populate item_id with values	\N	3.6.3	\N	\N	1509384775
2010-05-27-5095-5	kkrumlian	migration/3.0/2010-05-27-5095.xml	2023-12-02 09:29:51.96291	634	EXECUTED	8:c8e36211c33c0cbaeed0f1ee077d614e	addColumn tableName=rule_set	Add item_group_id column to rule_set	\N	3.6.3	\N	\N	1509384775
2010-05-27-5095-6	kkrumlian	migration/3.0/2010-05-27-5095.xml	2023-12-02 09:29:51.971871	635	EXECUTED	8:7de250a859bc8cea3e599103d07d7ea8	sql	Populate item_group_id with values	\N	3.6.3	\N	\N	1509384775
2010-07-16-NA01-1	kkrumlian	migration/3.0/2010-07-16-NA01.xml	2023-12-02 09:29:51.978459	636	EXECUTED	8:54f5f2705f14bd70841643699e43c6e4	addColumn tableName=rule	add study_id to rule table	\N	3.6.3	\N	\N	1509384775
2010-07-16-NA01-2	kkrumlian	migration/3.0/2010-07-16-NA01.xml	2023-12-02 09:29:51.98514	637	EXECUTED	8:b903b5bc904bfe9bfca564311ea5c54a	sql	update study_id to rule table	\N	3.6.3	\N	\N	1509384775
2010-07-16-NA01-3	kkrumlian	migration/3.0/2010-07-16-NA01.xml	2023-12-02 09:29:51.993161	638	EXECUTED	8:ebf8cbc988af2ad4f132b5d3af1caf9e	sql	update study_id to rule table	\N	3.6.3	\N	\N	1509384775
2010-07-30-5255-1	thickerson	migration/3.0/2010-07-30-5255.xml	2023-12-02 09:29:52.006077	639	EXECUTED	8:407fcbfaf45fc1141998e36145f3757a	sql	updating ordinals in study event definition table to remove duplicates	\N	3.6.3	\N	\N	1509384775
2010-09-22-5926-1	kkrumlian	migration/3.0/2010-09-22-5926.xml	2023-12-02 09:29:52.021765	640	EXECUTED	8:15e7e80263ea19988d215669e6d8ee12	sql	fix a bug introduced in 3.0.4 that allowed Pdate to store dd-MMM-yyyy instead of mm/dd/yyyy	\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-1	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.037677	641	EXECUTED	8:391d742797292a39ff1cbfd7cfaf0712	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-2	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.046739	642	EXECUTED	8:2dbecf83f6fd1f1469a88b587e14a6cc	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-3	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.070946	643	EXECUTED	8:cbaa5492222d19e505acd32299ed3786	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-4	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.110928	644	EXECUTED	8:93e6f2efe24f7a1d3d4879aaf37ab7ce	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-5	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.1241	645	EXECUTED	8:1613cf2cfe6c637b34cbdc7a4cb131be	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-6	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.146727	646	EXECUTED	8:1b98514ad6862389e2f8e363e365a96d	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-12	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.314925	652	EXECUTED	8:21fea4c9f2cbc980ec7d3ba89f45532d	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-13	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.326342	653	EXECUTED	8:c25ba30ef717e6feb17f1baf3c26cf6d	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-14	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.346645	654	EXECUTED	8:0459dcd96354b26de67811d093edbb4a	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-15	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.356849	655	EXECUTED	8:4c4c480b702eb47143a3c00834a5a8f4	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-16	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.385481	656	EXECUTED	8:6129ff38db913d62b24c97b0e15fa7e4	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-17	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.398196	657	EXECUTED	8:f59222784494d6816daa8a7132bdff67	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-18	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.466042	658	EXECUTED	8:3438c9439f31a41d71d910594825833c	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-19	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.495171	659	EXECUTED	8:c6c6acaf5692fc453a379addb7db6c54	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-20	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.509772	660	EXECUTED	8:ff1effb995283254ae88cfa391dcabaf	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-21	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.518479	661	EXECUTED	8:b8116b6ca3924c71356269774723e11e	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-22	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.525516	662	EXECUTED	8:dfad2fe53ab0a77e9c82beda8f574951	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-23	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.531497	663	EXECUTED	8:e556f8cfeea22ef1a1773f3d695dcd17	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-24	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.539392	664	EXECUTED	8:1e9ad302e79bbbf8056f98c0d4127e6f	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-25	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.551138	665	EXECUTED	8:098dfa90593cad83b8998f06400da527	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-26	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.558963	666	EXECUTED	8:7d86594c7d33a5988910642b4cf5325d	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-27	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.566962	667	EXECUTED	8:c15afac03bf05da47a4d825aacafbe4e	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-28	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.575848	668	EXECUTED	8:ace731973bf0ae7675ad767ea8b891d9	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-29	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.588154	669	EXECUTED	8:a0702cbbd1b76133b57cc00bb49598ed	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-30	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.611292	670	EXECUTED	8:f013aa05f4fcfbe47cc22f09283335f6	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-31	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.621887	671	EXECUTED	8:1e1e59d22efc79063c4279ace74e5402	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-32	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.628951	672	EXECUTED	8:9654279247f97ab258db59b7dc5883d3	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-33	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.63631	673	EXECUTED	8:da961cb9b7ae24b6e0ef3bd823e6c76c	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-34	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.645693	674	EXECUTED	8:43390bfe73c799215cbeed50ff5b8691	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-35	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.654568	675	EXECUTED	8:935f8eb613513c83d9fc044047171823	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-36	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.672137	676	EXECUTED	8:489e78684c403d0673e94b150b5fbcd7	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-37	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.683185	677	EXECUTED	8:5204339ff1c50ccd232a78f8a677630d	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-38	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.694146	678	EXECUTED	8:554c03f28847ea00a82327b1c4aad295	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-39	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.703613	679	EXECUTED	8:d5e6cf3508429d08eeb59747fed382a8	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-40	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.711496	680	EXECUTED	8:a53be88eaf596490867cd65cdf352dad	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-41	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.716844	681	EXECUTED	8:8975e9305c667755d2462eb87467bbcc	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-42	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.730973	682	EXECUTED	8:3dcd43322b172b40ae8080a5e0fceafa	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-43	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.736841	683	EXECUTED	8:0c32f3e54e9bb7e563ddd695a9796e16	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-44	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.74428	684	EXECUTED	8:d09678ff87dee6155c542acc175f816d	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-45	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.751496	685	EXECUTED	8:260343bcd9957a8e8c711e516e79da7e	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-46	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.76415	686	EXECUTED	8:39e43aefefdf151a62786502de8011b7	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-47	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.773331	687	EXECUTED	8:7740869808d9f1c9de73ebd49f21d8cc	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-48	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.783728	688	EXECUTED	8:3c16e0ebbac544ae09113fddbc2093bd	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-49	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.800183	689	EXECUTED	8:03175ca79220dc138ef8e0f9cff290f1	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-50	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.809474	690	EXECUTED	8:1b2d0ea1fdfcd841d572422ce63462db	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-51	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.814899	691	EXECUTED	8:6f47269429f2afe48f91416789f26ed8	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-52	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.820732	692	EXECUTED	8:7b7572bf601bcdb526338c99af874095	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-53	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.827917	693	EXECUTED	8:70155bb5383f102baf189e2b08c0cfa2	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-54	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.832936	694	EXECUTED	8:0d1417c99ae5646d8ce6489a47a1a5a4	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-55	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.839522	695	EXECUTED	8:78ed417d9499da090bd45b89080b2613	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-56	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.846685	696	EXECUTED	8:f7b6f637b3aad7a37353b1d8ad55052c	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-57	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.854822	697	EXECUTED	8:c7d7dc22c5113fef489cb8affdfaa8ad	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-58	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.864185	698	EXECUTED	8:2e21521fee06b91ebf0060e2bf672202	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-59	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.872274	699	EXECUTED	8:38ff087bfbd8aa6b855cfae339d3f6dc	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-60	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.880287	700	EXECUTED	8:67e0b88da9bd8bb0bb9373cd51e8d5c7	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-61	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.889568	701	EXECUTED	8:076ed5317b33d7d8c9d9901d3dafc9a0	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-62	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.898088	702	EXECUTED	8:34063462d1138e22890c06a90898808e	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-63	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.908374	703	EXECUTED	8:63861e05eb5c415288dc9cf89894e3cc	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-64	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.917104	704	EXECUTED	8:6e64695401ce316f78901c936776e675	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-65	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.924633	705	EXECUTED	8:115273b21ff0a9d4bbd67cc778ebd7c4	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-66	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.931129	706	EXECUTED	8:9cfff0870912bac946ff8cff4c077743	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-67	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.939506	707	EXECUTED	8:e8e7551fa69f413ac38489cb55188b22	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-68	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.948618	708	EXECUTED	8:518cbefeedb43eeda5d63bc2204fd1f3	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-69	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.957179	709	EXECUTED	8:61792dd2117bbe3ecec6fde43fa97333	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-70	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.965883	710	EXECUTED	8:d9d9e71c681c3ba8c8701562be4b6753	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-71	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.976808	711	EXECUTED	8:5de3797a9cd3d40eb619588ec56ba4ca	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-72	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:52.991607	712	EXECUTED	8:57ec4c5a46866ed1801486951e3565e1	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-73	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.001846	713	EXECUTED	8:f67821de396521cdd31960927c902623	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-74	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.011772	714	EXECUTED	8:521d56e3f52fab9fa28f7cc87a7ba627	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-75	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.017265	715	EXECUTED	8:41f411d1ac10ca81799ca5fa6d5beb71	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-76	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.023313	716	EXECUTED	8:0c47a53b4005cba8c2b7b3171aa9426a	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-77	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.029624	717	EXECUTED	8:faa5733acf5179e764f925b8f5ee22bf	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-78	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.035116	718	EXECUTED	8:771f03a58331eebfdf769b26c03dad42	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-79	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.03983	719	EXECUTED	8:6fb97905429026716fd154a659dc767b	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-80	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.046453	720	EXECUTED	8:a069270a68b8203e126af13a58b18586	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-81	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.058058	721	EXECUTED	8:0ab76468f6ef1133b00aaebcae032fca	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-82	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.07662	722	EXECUTED	8:9a4f966bfc4f405fa52960516ae1796e	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-83	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.090486	723	EXECUTED	8:6ec9ec82cda84c2de814e22c7baab0b4	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-84	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.106126	724	EXECUTED	8:c54bdaca065bd569f5327e39a4d25ea1	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-85	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.114354	725	EXECUTED	8:b831adc99dc761a39d5c1e18eec87d81	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-86	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.120157	726	EXECUTED	8:08f84ab05085dd66dd5e911ee6dcbf9d	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-87	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.129545	727	EXECUTED	8:000f64bb0e2e3189a933f80cdecf3daa	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-88	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.13681	728	EXECUTED	8:0dc6b3e50f70c1239992c790d9bbb7c9	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-89	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.143897	729	EXECUTED	8:2fd6e5b0b13681ed5062bd865d420fb9	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-90	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.152443	730	EXECUTED	8:12c302f09808699b1be4ced45982c009	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-91	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.174393	731	EXECUTED	8:62268d2d077be6f47474d8e71d387d0d	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-92	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.182574	732	EXECUTED	8:977b19ba3e0169ff05b7216cb0733e33	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-93	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.192319	733	EXECUTED	8:b15de58fb326a575412cef5e3e31d283	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-94	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.205829	734	EXECUTED	8:2567cf17d5ee043f32c294e3b1d7385b	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-95	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.214765	735	EXECUTED	8:984b476d448d79b63f2516f10e617cd6	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-96	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.22243	736	EXECUTED	8:55d517421bf6dfb5f41e2440e61713c1	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-97	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.232023	737	EXECUTED	8:ef2e184f3b95a345cc56b65aa73f865a	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-98	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.244293	738	EXECUTED	8:e583bc3b365788de565a0d9b70ed8182	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-99	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.253849	739	EXECUTED	8:9119ae960a43acf5b525edfa6b632fac	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-100	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.263316	740	EXECUTED	8:7bca9a36d155f48b5d67908e0a196466	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-101	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.271398	741	EXECUTED	8:6f36a6effb2688623d7cfcbd80b0b374	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-102	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.279527	742	EXECUTED	8:204715bf32f32d3b1376a16671a20fae	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-103	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.285786	743	EXECUTED	8:0f3d219bacbba95044661298ed83cbb8	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-104	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.294211	744	EXECUTED	8:6d0530e4ceff6ae31a6ea5f2f7c22140	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-105	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.301349	745	EXECUTED	8:a1db2ba5c65e34538891ffb4d5182015	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-106	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.31024	746	EXECUTED	8:def599481f052728275ec812d179144f	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-107	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.315762	747	EXECUTED	8:9564c0653d640dce49c33f6ff38836ac	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-108	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.325892	748	EXECUTED	8:53fda929e412a5e821fd2c12722a668f	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-109	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.332518	749	EXECUTED	8:a675f733ebf6832f4ea5f1c46a3c402d	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-110	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.340569	750	EXECUTED	8:cf6bdb177d1f8004c0e63dbb5f2634d0	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-111	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.348794	751	EXECUTED	8:0589153753e71c5a0f6503e7bf68ce15	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-112	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.357046	752	EXECUTED	8:0ac1ceef78b325b015ba2f1bcc68794f	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-113	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.365388	753	EXECUTED	8:bbd27c99905c9ac2b8cbaaea7c42c9c6	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-114	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.376474	754	EXECUTED	8:771212fe645da757bbb9ee0281df8922	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-115	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.384195	755	EXECUTED	8:733669f0d4a5585dbe9f8b24079f345b	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-116	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.394443	756	EXECUTED	8:15b491c641d0bb2a1448f0192063c193	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-117	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.401353	757	EXECUTED	8:ca5672d3309b96c6ec8294f60d7d04e7	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-118	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.409742	758	EXECUTED	8:91daa79df2875e1e451c26f517da6fa7	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-119	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.417591	759	EXECUTED	8:0da82a88bf6c804eb3e2785e59038e6a	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-120	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.426821	760	EXECUTED	8:45ef604a7f99eb43c22a045298d0c122	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-121	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.433093	761	EXECUTED	8:559cc22bd4d277d76d26eb4fde44e225	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-122	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.442338	762	EXECUTED	8:d6124a89eabfd54eb6682115a3e6b5b2	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-123	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.447983	763	EXECUTED	8:8dca45d1df1561a99191eccd8be4e9ce	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-124	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.456023	764	EXECUTED	8:5f8fb3ff2b3e7958b86dec0df47fe859	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-125	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.464193	765	EXECUTED	8:2b4990651f4a44d0eca83a0606f40632	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-126	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.473725	766	EXECUTED	8:f5bf4e8f65d41bb14cf8111e2308c177	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-127	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.47939	767	EXECUTED	8:511605968ca65c239e263e14c73c1a2b	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-128	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.486247	768	EXECUTED	8:b21dc8755dd9d3fbcb118fbccfb5aeaa	sql		\N	3.6.3	\N	\N	1509384775
2011-04-08-8840-129	pgawade	migration/amethyst/changeLogCreateIndexes.xml	2023-12-02 09:29:53.495274	769	EXECUTED	8:d842cd6166490fd7cf3f25cb922409c3	sql		\N	3.6.3	\N	\N	1509384775
2010-01-13-4575-1	kkrumlian	migration/amethyst/2010-01-13-4575.xml	2023-12-02 09:29:53.500213	770	EXECUTED	8:bf6db3a5e7ee638bbe3d38b3601fe5d9	addColumn tableName=rule_action	update rule_action add oids column	\N	3.6.3	\N	\N	1509384775
2010-01-13-4575-2	kkrumlian	migration/amethyst/2010-01-13-4575.xml	2023-12-02 09:29:53.523586	771	EXECUTED	8:1b7be94ab5d19d990d614867f0ec3240	createTable tableName=rule_action_run	Create a table named audit_user_login	\N	3.6.3	\N	\N	1509384775
2010-01-13-4575-4	kkrumlian	migration/amethyst/2010-01-13-4575.xml	2023-12-02 09:29:53.530532	772	EXECUTED	8:68b6d746b435bf3672936aeb8aff9981	addColumn tableName=rule_action	update rule_action add rule_action_run_id column	\N	3.6.3	\N	\N	1509384775
2010-01-13-4575-5	kkrumlian	migration/amethyst/2010-01-13-4575.xml	2023-12-02 09:29:53.543544	773	EXECUTED	8:ec1800950c1a002efee3527d308cd0d6	createTable tableName=rule_action_property	Create a table named rule_action_property	\N	3.6.3	\N	\N	1509384775
2010-01-13-4575-7	kkrumlian	migration/amethyst/2010-01-13-4575.xml	2023-12-02 09:29:53.549109	774	EXECUTED	8:9d63bfa0d1c7a0bf75ff34d0023c128e	dropColumn columnName=oids, tableName=rule_action	update rule_action drop oids column	\N	3.6.3	\N	\N	1509384775
2010-01-13-4575-8	kkrumlian	migration/amethyst/2010-01-13-4575.xml	2023-12-02 09:29:53.56336	775	EXECUTED	8:52d4dcace836b74204899c9432b9399c	createTable tableName=rule_action_run_log	Create a table named rule_action_run_log	\N	3.6.3	\N	\N	1509384775
2010-01-13-4575-10	kkrumlian	migration/amethyst/2010-01-13-4575.xml	2023-12-02 09:29:53.573228	776	EXECUTED	8:3a220d5cdb8dc10bc8f09b1ad07eff37	dropColumn columnName=reference, tableName=rule_action_property; addColumn tableName=rule_action_property	Drop/Add Column	\N	3.6.3	\N	\N	1509384775
2011-03-01-4575-1	kkrumlian	migration/amethyst/2011-03-01-4575.xml	2023-12-02 09:29:53.582074	777	EXECUTED	8:3fa5b88359381fea10a35c96c3655260	sql	Add a row to rule_action_run and update rule_action row	\N	3.6.3	\N	\N	1509384775
2010-02-03-4593-1	thickerson	migration/amethyst/2010-02-03-4593.xml	2023-12-02 09:29:53.591661	778	EXECUTED	8:f3edf6cc2da435479910210f50a0344f	addColumn tableName=item_form_metadata	Add a column to item_form_metadata	\N	3.6.3	\N	\N	1509384775
2010-02-03-4593-2	thickerson	migration/amethyst/2010-02-03-4593.xml	2023-12-02 09:29:53.599486	779	EXECUTED	8:cad2a7e0fa14447c0d235c805e576da0	addColumn tableName=item_group_metadata	Add a column to item_group_metadata	\N	3.6.3	\N	\N	1509384775
2010-03-03-4618-1	thickerson	migration/amethyst/2010-03-03-4618.xml	2023-12-02 09:29:53.617059	780	EXECUTED	8:a7f0d32efe351d66a4e640f8ae1dd19a	createTable tableName=dyn_item_form_metadata	Create a table named dynamics_item_form_metadata	\N	3.6.3	\N	\N	1509384775
2010-03-03-4618-2	thickerson	migration/amethyst/2010-03-03-4618.xml	2023-12-02 09:29:53.632779	781	EXECUTED	8:d406591fb92b52dc8141c3d3c1a147a2	createTable tableName=dyn_item_group_metadata	Create a table named dynamics_item_group_metadata	\N	3.6.3	\N	\N	1509384775
2010-03-30-4618-1	thickerson	migration/amethyst/2010-03-30-4618.xml	2023-12-02 09:29:53.643402	782	EXECUTED	8:73ebe6713ee8b9703f7ecef684adbcc0	addColumn tableName=dyn_item_form_metadata	Add a column to dyn_item_form_metadata	\N	3.6.3	\N	\N	1509384775
2010-03-30-4618-2	thickerson	migration/amethyst/2010-03-30-4618.xml	2023-12-02 09:29:53.65411	783	EXECUTED	8:6ad86a5de9928572cced7a6fad04ae4b	addColumn tableName=dyn_item_form_metadata	Add a column to dyn_item_form_metadata: PASSED DDE	\N	3.6.3	\N	\N	1509384775
2010-03-30-4618-3	thickerson	migration/amethyst/2010-03-30-4618.xml	2023-12-02 09:29:53.664657	784	EXECUTED	8:5e864ec6f87ad75cae9046835597fd03	addColumn tableName=dyn_item_group_metadata	Add a column to dyn_item_group_metadata: PASSED DDE	\N	3.6.3	\N	\N	1509384775
2010-05-27-5095-1	kkrumlian	migration/amethyst/2010-05-27-5095.xml	2023-12-02 09:29:53.675541	785	EXECUTED	8:75e81d01081a127ab2d39af601b46040	sql	Change RuleSet so study event definition id can be null	\N	3.6.3	\N	\N	1509384775
2010-07-01-5245-1	ahamid	migration/amethyst/2010-07-01-5245.xml	2023-12-02 09:29:53.690974	786	EXECUTED	8:92432dac7a0b2b8f977709645f95a7b0	sql	CREATE A VIEW	\N	3.6.3	\N	\N	1509384775
2010-07-01-5245-3	ahamid	migration/amethyst/2010-07-01-5245.xml	2023-12-02 09:29:53.703846	787	EXECUTED	8:69643d61a5144e62973df7ab129bc8b3	sql	RECREATE THE VIEW WITH SOME NEW CONDITION	\N	3.6.3	\N	\N	1509384775
2011-05-9305-1	ahamid	migration/amethyst/2011-05-28-9305.xml	2023-12-02 09:29:53.71823	788	MARK_RAN	8:e74c826041bc046dc8b99a584744975e	createTable tableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
2011-05-9305-2	ahamid	migration/amethyst/2011-05-28-9305.xml	2023-12-02 09:29:53.728512	789	MARK_RAN	8:4387cd4795d644ef3aa2fe8b762c035d	createTable tableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
2010-07-07-5429-1	thickerson	migration/amethyst/2010-07-07-5429.xml	2023-12-02 09:29:53.736782	790	EXECUTED	8:b0277c2725cbdf81f8acf4402fb79df8	sql	Change oc_qrtz_job_details class names for EXPORT DATA JOBS	\N	3.6.3	\N	\N	1509384775
2010-07-07-5429-2	thickerson	migration/amethyst/2010-07-07-5429.xml	2023-12-02 09:29:53.743063	791	EXECUTED	8:88fa2b3c9572939125a5b3cab0493ef2	sql	Change oc_qrtz_job_details class names for IMPORT DATA JOBS	\N	3.6.3	\N	\N	1509384775
2010-07-14-5265-1	ahamid	migration/amethyst/2010-07-14-5265.xml	2023-12-02 09:29:53.763132	792	EXECUTED	8:11abfba952ade539a3e6c6455d4dc922	addColumn tableName=item_group_metadata	item_group_metadata (repeating_group)	\N	3.6.3	\N	\N	1509384775
2010-08-19-NA01-1	kkrumlian	migration/amethyst/2010-08-19-NA01.xml	2023-12-02 09:29:53.781728	793	EXECUTED	8:617ba684c33ecbe9a19a02b12a151991	addColumn tableName=user_account	add run webservices column to user_account table	\N	3.6.3	\N	\N	1509384775
2010-05-27-5724	jamuna	migration/amethyst/2010-08-24-5724.xml	2023-12-02 09:29:53.795044	794	EXECUTED	8:30ac2cd4b3a51815929cd01c955e6ca0	dropView viewName=dn_age_days	Dropping the view before changing the  date type	\N	3.6.3	\N	\N	1509384775
2010-05-27-5724-0	jamuna	migration/amethyst/2010-08-24-5724.xml	2023-12-02 09:29:53.821047	795	EXECUTED	8:ed396587a64de457aed01bb8e55d2351	sql	Change data type of created_date to timestamp	\N	3.6.3	\N	\N	1509384775
2010-05-27-5724-2	jamuna	migration/amethyst/2010-08-24-5724.xml	2023-12-02 09:29:53.827857	796	EXECUTED	8:ed396587a64de457aed01bb8e55d2351	sql	Change data type of created_date to timestamp	\N	3.6.3	\N	\N	1509384775
2010-05-27-5724-1	jamuna	migration/amethyst/2010-08-24-5724.xml	2023-12-02 09:29:53.84268	797	EXECUTED	8:c63e2de857b8c94466b6e26a910d41a4	createView viewName=dn_age_days	recreating the view back	\N	3.6.3	\N	\N	1509384775
2010-05-27-5724-3	jamuna	migration/amethyst/2010-08-24-5724.xml	2023-12-02 09:29:53.852634	798	EXECUTED	8:30ac2cd4b3a51815929cd01c955e6ca0	dropView viewName=dn_age_days	Dropping the view before changing the  date type	\N	3.6.3	\N	\N	1509384775
2010-05-27-5724-4	jamuna	migration/amethyst/2010-08-24-5724.xml	2023-12-02 09:29:53.867257	799	EXECUTED	8:c63e2de857b8c94466b6e26a910d41a4	createView viewName=dn_age_days	recreating the view back	\N	3.6.3	\N	\N	1509384775
2010-08-26-5724	jamuna	migration/amethyst/2010-08-26-5724.xml	2023-12-02 09:29:53.875968	800	EXECUTED	8:30ac2cd4b3a51815929cd01c955e6ca0	dropView viewName=dn_age_days	Dropping the view before changing the  date type	\N	3.6.3	\N	\N	1509384775
2010-08-26-5724-2	jamuna	migration/amethyst/2010-08-26-5724.xml	2023-12-02 09:29:53.912938	801	EXECUTED	8:52da625ac87ad262752a02dc867ac92a	sql	Change data type of created_date back to date	\N	3.6.3	\N	\N	1509384775
2010-08-26-5724-1	jamuna	migration/amethyst/2010-08-26-5724.xml	2023-12-02 09:29:53.922691	802	EXECUTED	8:c63e2de857b8c94466b6e26a910d41a4	createView viewName=dn_age_days	recreating the view back	\N	3.6.3	\N	\N	1509384775
2010-08-26-5724-3	jamuna	migration/amethyst/2010-08-26-5724.xml	2023-12-02 09:29:53.92793	803	EXECUTED	8:30ac2cd4b3a51815929cd01c955e6ca0	dropView viewName=dn_age_days	Dropping the view again to create the view without owner name	\N	3.6.3	\N	\N	1509384775
2010-08-26-5724-4	jamuna	migration/amethyst/2010-08-26-5724.xml	2023-12-02 09:29:53.938952	804	EXECUTED	8:c63e2de857b8c94466b6e26a910d41a4	createView viewName=dn_age_days	recreating the view back	\N	3.6.3	\N	\N	1509384775
2010-08-26-5237-1	ahamid	migration/amethyst/2010-08-26-5732.xml	2023-12-02 09:29:53.952171	805	EXECUTED	8:0a6e507cacc04cc4cf77b53a6a1faf4c	insert tableName=study_parameter	Insert a new record in the studyParameter table	\N	3.6.3	\N	\N	1509384775
2010-08-26-5237-2	ahamid	migration/amethyst/2010-08-26-5732.xml	2023-12-02 09:29:53.964806	806	EXECUTED	8:73c971ce18d6b20029ebb0f92ea64e24	sql	Change study_parameter values	\N	3.6.3	\N	\N	1509384775
2010-08-26-5237-3	ahamid	migration/amethyst/2010-08-26-5732.xml	2023-12-02 09:29:53.974812	807	EXECUTED	8:d45e75f2af8a957716dc1ea4ccf6a110	sql	Change study_parameter values	\N	3.6.3	\N	\N	1509384775
2010-10-05-5556-1	thickerson	migration/amethyst/2010-10-05-5556.xml	2023-12-02 09:29:53.994241	808	EXECUTED	8:8ee7e73daaecd12bec656734d496274f	sql	Change data type of created_date to timestamp	\N	3.6.3	\N	\N	1509384775
2010-10-11-5962-1	ywang	migration/amethyst/2010-10-11-5962.xml	2023-12-02 09:29:54.001292	809	EXECUTED	8:dfbadd97abfee9158a8cfb28a14ded6a	sql	Update Resolution Status Ids of Parent DNs As Their Last Child	\N	3.6.3	\N	\N	1509384775
2010-10-11-5962-3	ywang	migration/amethyst/2010-10-11-5962.xml	2023-12-02 09:29:54.013764	810	EXECUTED	8:828196c835b142c5c2fd8b61f9d80b8c	sql	Create or Replace a View DN_DAYS	\N	3.6.3	\N	\N	1509384775
2010-11-24-6084-1-1	kkrumlian	migration/amethyst/2010-11-24-6084.xml	2023-12-02 09:29:54.024055	811	EXECUTED	8:e28ffbac82cdc68287eeaf4456429a7c	sql	Disable item_data triggers	\N	3.6.3	\N	\N	1509384775
2010-11-24-6084-1	kkrumlian	migration/amethyst/2010-11-24-6084.xml	2023-12-02 09:29:54.032998	812	EXECUTED	8:6abad164692d0898f4330db346841446	sql	Change date format for dataype date,pdate (MM/dd/YYYY) to ISO-8601	\N	3.6.3	\N	\N	1509384775
2010-11-24-6084-3	kkrumlian	migration/amethyst/2010-11-24-6084.xml	2023-12-02 09:29:54.054466	813	EXECUTED	8:57da8fa1e8163c0e2735d1f01429450b	sql	Change date format for dataype pdate (MMM-YYYY) to ISO-8601	\N	3.6.3	\N	\N	1509384775
2010-11-24-6084-5	kkrumlian	migration/amethyst/2010-11-24-6084.xml	2023-12-02 09:29:54.063089	814	EXECUTED	8:35fa92cfaedb984b44aa3141ccaad9ef	sql	Disable item_data triggers	\N	3.6.3	\N	\N	1509384775
2010-12-02-6421-1	ahamid	migration/amethyst/2010-12-02-6421.xml	2023-12-02 09:29:54.070169	815	EXECUTED	8:59d1b78348ab866633c676948cd8c9d9	renameColumn newColumnName=old_status_id, oldColumnName=prev_status, tableName=event_crf	Rename Column Name	\N	3.6.3	\N	\N	1509384775
2010-12-02-6421-3	ahamid	migration/amethyst/2010-12-02-6421.xml	2023-12-02 09:29:54.076987	816	EXECUTED	8:84e4ca26f553e64b91812cd77267d66b	sql	Update null values	\N	3.6.3	\N	\N	1509384775
2010-12-02-6421-5	ahamid	migration/amethyst/2010-12-02-6421.xml	2023-12-02 09:29:54.083886	817	EXECUTED	8:939a659fc7bd6b733a2e930ee371ed26	sql	Update null values	\N	3.6.3	\N	\N	1509384775
2010-12-17-NA01-1	kkrumlian	migration/amethyst/2010-12-17-NA01.xml	2023-12-02 09:29:54.092678	818	EXECUTED	8:6f1b401f214247a8ab064702a71e47c9	sql		\N	3.6.3	\N	\N	1509384775
2010-12-17-NA01-2	pgawade (generated)	migration/amethyst/2010-12-17-NA01.xml	2023-12-02 09:29:54.096199	819	MARK_RAN	8:677dba04d819ab8d6157434fed35e35a	sql		\N	3.6.3	\N	\N	1509384775
2010-12-17-NA01-3	pgawade (generated)	migration/amethyst/2010-12-17-NA01.xml	2023-12-02 09:29:54.102582	820	EXECUTED	8:130797b7819393087e39243ea9cabf80	sql		\N	3.6.3	\N	\N	1509384775
2011-02-07-7181-1	ywang	migration/amethyst/2011-02-07-7181.xml	2023-12-02 09:29:54.115418	821	EXECUTED	8:ba229ef7b83a78763994b46d8329914f	createTable tableName=scd_item_metadata	Create table scd_item_metadata	\N	3.6.3	\N	\N	1509384775
2011-02-07-7181-4	ywang	migration/amethyst/2011-02-07-7181.xml	2023-12-02 09:29:54.124367	822	EXECUTED	8:012608ed4f086e90f11d7ac6ef0496f9	addForeignKeyConstraint baseTableName=scd_item_metadata, constraintName=scd_meta_fk_scd_form_meta_id, referencedTableName=item_form_metadata	Add foreign key for scd_item_metadata	\N	3.6.3	\N	\N	1509384775
2011-02-07-7181-5	ywang	migration/amethyst/2011-02-07-7181.xml	2023-12-02 09:29:54.132654	823	EXECUTED	8:24d3cef8f63967ce9fffce32e76ae9f9	addForeignKeyConstraint baseTableName=scd_item_metadata, constraintName=scd_meta_fk_control_meta_id, referencedTableName=item_form_metadata	Add foreign key for scd_item_metadata	\N	3.6.3	\N	\N	1509384775
2011-03-01-6567-1	ywang	migration/amethyst/2011-03-01-6567.xml	2023-12-02 09:29:54.139803	824	EXECUTED	8:cfb03f1f229b7fe824feda948b0e483e	createView viewName=view_item_unit	create temporary view	\N	3.6.3	\N	\N	1509384775
2011-03-01-6567-3	ywang	migration/amethyst/2011-03-01-6567.xml	2023-12-02 09:29:54.145666	825	EXECUTED	8:32149aecbe69fe5b0931107860df9360	sql	insert into measurement_unit.name and oc_oid	\N	3.6.3	\N	\N	1509384775
2011-03-01-6567-5	ywang	migration/amethyst/2011-03-01-6567.xml	2023-12-02 09:29:54.155167	826	EXECUTED	8:b0eb9ad7e51e692a1604e0ffe177af0c	sql	insert into measurement_unit.name and oc_oid	\N	3.6.3	\N	\N	1509384775
2011-03-01-6567-7	ywang	migration/amethyst/2011-03-01-6567.xml	2023-12-02 09:29:54.160896	827	EXECUTED	8:3eb2f063553396a87874ee7cb256ccae	sql	update measurement_unit.oc_oid	\N	3.6.3	\N	\N	1509384775
2011-03-01-6567-9	ywang	migration/amethyst/2011-03-01-6567.xml	2023-12-02 09:29:54.167492	828	EXECUTED	8:08caa4295640b5ed869fd4bca06541b7	dropView viewName=view_item_unit	drop temporary view	\N	3.6.3	\N	\N	1509384775
2011-03-01-7700-1	ahamid	migration/amethyst/2011-03-01-7700.xml	2023-12-02 09:29:54.174097	829	EXECUTED	8:b966f9f4e00f81550600b9ff48d1102d	addColumn tableName=event_crf	update event_crf add sdv_update_id column	\N	3.6.3	\N	\N	1509384775
2011-03-01-7700-2	ahamid	migration/amethyst/2011-03-01-7700.xml	2023-12-02 09:29:54.182084	830	EXECUTED	8:b881d4f8c5d5e15c0c44a5742b43462a	sql	create or replace event_crf_trigger for event crf sdv status	\N	3.6.3	\N	\N	1509384775
2011-03-16-5930-1	ahamid	migration/amethyst/2011-03-16-5930.xml	2023-12-02 09:29:54.18926	831	EXECUTED	8:facaaf6c8674b85522caa002c630b64e	addColumn tableName=item_data	Item_Data (old_status)	\N	3.6.3	\N	\N	1509384775
2011-03-22-8248-1	pgawade	migration/amethyst/2011-03-22-8248.xml	2023-12-02 09:29:54.203403	832	EXECUTED	8:87eeec90e825ade893d965132ebe92b4	createTable tableName=usage_statistics_data		\N	3.6.3	\N	\N	1509384775
2011-04-05-7475-1	jnyayapathi	migration/amethyst/2011-04-05-7475.xml	2023-12-02 09:29:54.209631	833	EXECUTED	8:3a4ab5a073e324acaa159caf40e62176	sql	Change export data jobs trigger status to complete	\N	3.6.3	\N	\N	1509384775
2011-05-03-9430-3	jnyayapathi	migration/amethyst/2011-05-03-9430.xml	2023-12-02 09:29:54.219954	834	EXECUTED	8:2f7ab9a8c08b51899f101b95a91a294b	sql	Add a constraint when no item data rows are present	\N	3.6.3	\N	\N	1509384775
2011-05-20-9703-1	pgawade (generated)	migration/amethyst/2011-05-20-9703.xml	2023-12-02 09:29:54.223941	835	MARK_RAN	8:138782ab24f59f2699316718da2bd39f	sql		\N	3.6.3	\N	\N	1509384775
2011-05-20-9703-2	jnyayapathi	migration/amethyst/2011-05-20-9703.xml	2023-12-02 09:29:54.227106	836	MARK_RAN	8:2c802e760d41bf25e4af3359c6a4fe6c	sql		\N	3.6.3	\N	\N	1509384775
2010-12-17-NA01-3	pgawade (generated)	migration/amethyst/2011-05-20-9703.xml	2023-12-02 09:29:54.233725	837	EXECUTED	8:130797b7819393087e39243ea9cabf80	sql		\N	3.6.3	\N	\N	1509384775
2011-07-27-8874-1	ywang	migration/amethyst/2011-07-27-8874.xml	2023-12-02 09:29:54.240647	838	EXECUTED	8:f3c1cb91f8596e0f514c2dac8fbf62b7	sql	create item_data_initial_trigger()	\N	3.6.3	\N	\N	1509384775
2011-07-27-8874-2	ywang	migration/amethyst/2011-07-27-8874.xml	2023-12-02 09:29:54.247597	839	EXECUTED	8:59d9c4242d7ec5f2da311ae52e9d06de	sql	create trigger item_data_initial	\N	3.6.3	\N	\N	1509384775
2011-07-27-8874-3	ywang	migration/amethyst/2011-07-27-8874.xml	2023-12-02 09:29:54.250545	840	MARK_RAN	8:b2de51574502b3af7e1b2ac919c89edf	sql	create trigger item_data_initial	\N	3.6.3	\N	\N	1509384775
2011-07-27-8874-4	ywang	migration/amethyst/2011-07-27-8874.xml	2023-12-02 09:29:54.254523	841	MARK_RAN	8:d0dbf71a4311f73bde32b3837b4b3706	sql	add procedure item_data_initial_trigger	\N	3.6.3	\N	\N	1509384775
2011-07-27-8874-5	ywang	migration/amethyst/2011-07-27-8874.xml	2023-12-02 09:29:54.258571	842	MARK_RAN	8:dd6b96388e705859095f4f5c9f59eb04	sql	create item_data_initial_trigger	\N	3.6.3	\N	\N	1509384775
2011-08-03-10666-1	ywang	migration/amethyst/2011-08-03-10666.xml	2023-12-02 09:29:54.264675	843	EXECUTED	8:f85a6b03f07e430c4cdcffa7430f822a	insert tableName=response_type	insert new response type	\N	3.6.3	\N	\N	1509384775
2011-09-06-10813-2	pgawade	migration/amethyst/2011-09-06-10813.xml	2023-12-02 09:29:54.275065	844	EXECUTED	8:8775aefa650bbf929a6ec5a05f4be153	sql	update repeating_group column of item_group_metadata for 3.0 to 3.1 migrations on postgres database	\N	3.6.3	\N	\N	1509384775
2011-11-16-11950-1	htaycher (generated)	migration/amethyst/2011-11-16-11950.xml	2023-12-02 09:29:54.27995	845	EXECUTED	8:3c110feb2a634abe59fb200afc9286fc	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
2011-11-16-11950-3	htaycher 	migration/amethyst/2011-11-16-11950.xml	2023-12-02 09:29:54.288663	846	EXECUTED	8:56765057db461a39fffc73707b95700c	sql		\N	3.6.3	\N	\N	1509384775
2011-11-16-11950-4	htaycher 	migration/amethyst/2011-11-16-11950.xml	2023-12-02 09:29:54.295368	847	EXECUTED	8:bc8e1f4e059abc7ae681d52bbfb71394	sql		\N	3.6.3	\N	\N	1509384775
2011-11-16-11950-5	htaycher 	migration/amethyst/2011-11-16-11950.xml	2023-12-02 09:29:54.299737	848	EXECUTED	8:b5380b7c2e916077db6f4aa4121c0880	sql		\N	3.6.3	\N	\N	1509384775
2011-11-16-11950-12	htaycher	migration/amethyst/2011-11-16-11950.xml	2023-12-02 09:29:54.302202	849	MARK_RAN	8:744e52cd3a06dfe5ab0ac13874c1ff67	sql		\N	3.6.3	\N	\N	1509384775
2012-07-01-14506-11	htaycher	migration/amethyst/2012-07-01-14506.xml	2023-12-02 09:29:54.306448	850	EXECUTED	8:75273b46ee39f57c806426577ae92acf	insert tableName=configuration		\N	3.6.3	\N	\N	1509384775
2012-07-01-14506-12	htaycher	migration/amethyst/2012-07-01-14506.xml	2023-12-02 09:29:54.310062	851	EXECUTED	8:da145151e11a3b128b1415f7685538ef	insert tableName=configuration		\N	3.6.3	\N	\N	1509384775
2012-07-01-14506-13	htaycher	migration/amethyst/2012-07-01-14506.xml	2023-12-02 09:29:54.313612	852	EXECUTED	8:c60340c61e66954b1fb90e5b0245cf71	insert tableName=configuration		\N	3.6.3	\N	\N	1509384775
2012-07-01-14506-14	htaycher	migration/amethyst/2012-07-01-14506.xml	2023-12-02 09:29:54.31643	853	EXECUTED	8:d37801bf5ee5bedada99c373a1f5c239	insert tableName=configuration		\N	3.6.3	\N	\N	1509384775
2012-07-01-14506-19	htaycher	migration/amethyst/2012-07-01-14506.xml	2023-12-02 09:29:54.320319	854	EXECUTED	8:87e6a882c8f18c0827065d94820032ec	insert tableName=configuration		\N	3.6.3	\N	\N	1509384775
2012-07-01-14506-15	htaycher	migration/amethyst/2012-07-01-14506.xml	2023-12-02 09:29:54.325633	855	EXECUTED	8:100cf788c14f4b020c3a4ef59f4b1af3	insert tableName=configuration		\N	3.6.3	\N	\N	1509384775
2012-07-01-14506-18	drodrigues	migration/amethyst/2012-07-01-14506.xml	2023-12-02 09:29:54.329407	856	EXECUTED	8:356656c6bd9c16a44dd29f157a0872bb	insert tableName=configuration; insert tableName=configuration		\N	3.6.3	\N	\N	1509384775
2012-07-16-14454-1	htaycher	migration/amethyst/2012-07-16-14454.xml	2023-12-02 09:29:54.332923	857	EXECUTED	8:73c971ce18d6b20029ebb0f92ea64e24	sql	Change study_parameter values	\N	3.6.3	\N	\N	1509384775
2012-07-16-14454-2	htaycher	migration/amethyst/2012-07-16-14454.xml	2023-12-02 09:29:54.336312	858	EXECUTED	8:d45e75f2af8a957716dc1ea4ccf6a110	sql	Change study_parameter values	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-01	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.343729	859	EXECUTED	8:c2d42bec4963adc8207afcf68281181f	sql	View 'view_dn_stats'.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-02	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.350801	860	EXECUTED	8:451205dd5fbd5f0a1a8d6788467b1987	sql	View 'view_study_hidden_event_definition_crf'.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-03	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.359344	861	EXECUTED	8:66be27b053ccba6adb9335e4bd59e9a8	sql	View 'view_site_hidden_event_definition_crf'.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-04	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.384417	862	EXECUTED	8:b2f11b02ecd2127272fbb4b0251a7589	sql	View 'view_dn_item_data'.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-05	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.405401	863	EXECUTED	8:e77a09c93e8b96a9dfcf5ef7a2b2feb3	sql	View 'view_dn_event_crf'.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-06	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.419193	864	EXECUTED	8:102d25d95933bb544daec558d0176cbf	sql	View 'view_dn_study_event'.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-07	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.429902	865	EXECUTED	8:f12bf763b75e0013bad4fa1616435981	sql	View 'view_dn_study_subject'.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-08	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.441384	866	EXECUTED	8:41c3ee6d825d44b35abaa9aa91b6a1f0	sql	View 'view_dn_subject'.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-09	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.46117	867	EXECUTED	8:e5b5ca11f804386758d5df0963c99c65	sql	View 'view_discrepancy_note'.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-10	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.500057	868	EXECUTED	8:7b5d4e32ab7d2fc4aba3d53606e2d831	sql	Indexes for the tables used in the view_discrepancy_notes query.	\N	3.6.3	\N	\N	1509384775
2012-08-29-14122-10-shared	drodrigues	migration/amethyst/2012-08-29-14122.xml	2023-12-02 09:29:54.506594	869	EXECUTED	8:60265f3f14731733638debb0feae942e	sql	Updating wrong entity names in study event mapping	\N	3.6.3	\N	\N	1509384775
2012-08-3-13347-01	drodrigues	migration/amethyst/2012-08-31-13347.xml	2023-12-02 09:29:54.51201	870	EXECUTED	8:10b932faf5e7019e2b1639d0266bf334	sql	Updating wrong case in DISCREPANCY_NOTE.ENTITY_TYPE	\N	3.6.3	\N	\N	1509384775
2013-04-16-MR330-01	jnyayapathi	migration/amethyst/2013-04-16-MR330.xml	2023-12-02 09:29:54.53139	871	EXECUTED	8:941f0bbff6b5b14e1cba5cb49765cb9c	sql	View 'view_dn_item_data'.	\N	3.6.3	\N	\N	1509384775
2013-04-16-MR330-03	jnyayapathi	migration/amethyst/2013-04-16-MR330.xml	2023-12-02 09:29:54.553436	872	EXECUTED	8:a5509e375e96d632c3367190da3c471e	sql	View 'view_dn_item_data'.	\N	3.6.3	\N	\N	1509384775
2013-04-16-MR330-04	jnyayapathi	migration/amethyst/2013-04-16-MR330.xml	2023-12-02 09:29:54.574883	873	EXECUTED	8:ca200af4e1b23ef6eb8e8984ecb75b23	sql	View 'view_dn_event_crf'.	\N	3.6.3	\N	\N	1509384775
2011-10-03-11376-1	htaycher (generated)	migration/customDevelopment/changeLogTypeInsert.xml	2023-12-02 09:29:54.580992	874	EXECUTED	8:2710f3de3a69a217c86ad1c3bb1f4706	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
2011-10-03-11376-3	htaycher 	migration/customDevelopment/changeLogCreateFunction.xml	2023-12-02 09:29:54.587963	875	EXECUTED	8:35e5a39aef9d84ce4c1e79270d7fc88a	sql		\N	3.6.3	\N	\N	1509384775
2011-10-03-11376-2	htaycher 	migration/customDevelopment/changeLogCreateFunction.xml	2023-12-02 09:29:54.593338	876	EXECUTED	8:6ff85bf725ba86b2fea57c553f3a083d	sql		\N	3.6.3	\N	\N	1509384775
2011-11-03-11376-9	htaycher	migration/customDevelopment/changeLogCreateFunction.xml	2023-12-02 09:29:54.596067	877	MARK_RAN	8:783fe47238344c3028c682554d12dcd0	sql		\N	3.6.3	\N	\N	1509384775
2013-07-31-OC-1403-1	jnyayapathi	migration/3.2/2013-07-31-OC-1403.xml	2023-12-02 09:29:54.600072	878	EXECUTED	8:0f4d5b7d764c4937c4996a6a7990d2e2	delete tableName=oc_qrtz_simple_triggers		\N	3.6.3	\N	\N	1509384775
2013-07-31-OC-1403-2	jnyayapathi	migration/3.2/2013-07-31-OC-1403.xml	2023-12-02 09:29:54.603039	879	EXECUTED	8:6cc6a43daf63e683ab2b5f7a2e88421f	delete tableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
2013-10-21-OC-3399-1	jnyayapathi	migration/3.2/2013-10-21-OC-3399.xml	2023-12-02 09:29:54.606458	880	EXECUTED	8:fe0e29973d70741c5eebdda06484d47b	update tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
2013-10-21-OC-3399-2	jnyayapathi	migration/3.2/2013-10-21-OC-3399.xml	2023-12-02 09:29:54.609759	881	EXECUTED	8:f1643e1d1a7f74deb7412779e0d58d5a	update tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
2013-10-21-OC-3399-4	jnyayapathi	migration/3.2/2013-10-21-OC-3399.xml	2023-12-02 09:29:54.615331	882	EXECUTED	8:be20cab74896b9eb0466c6b4ea7252a0	update tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
2013-10-21-OC-3399-5	jnyayapathi	migration/3.2/2013-10-21-OC-3399.xml	2023-12-02 09:29:54.621464	883	EXECUTED	8:8a1f922701e7b320459494895e005941	update tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
2013-10-21-OC-3399-6	jnyayapathi	migration/3.2/2013-10-21-OC-3399.xml	2023-12-02 09:29:54.626381	884	EXECUTED	8:b525f3654f3469919da407347d841510	update tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
2013-10-21-OC-3399-7	jnyayapathi	migration/3.2/2013-10-21-OC-3399.xml	2023-12-02 09:29:54.632028	885	EXECUTED	8:87e0fc14c052ed4a146c56c6e5cf0c45	update tableName=discrepancy_note_type		\N	3.6.3	\N	\N	1509384775
2014-01-03-OC-3442-1	jrousseau	migration/3.2/2014-01-03-OC-3442.xml	2023-12-02 09:29:56.718957	886	EXECUTED	8:4e482a556364c9eb4b921506a1f3d6f9	createIndex indexName=i_versioning_map_item_id, tableName=versioning_map		\N	3.6.3	\N	\N	1509384775
2014-01-03-OC-3442-2	jrousseau	migration/3.2/2014-01-03-OC-3442.xml	2023-12-02 09:29:58.81198	887	EXECUTED	8:09ebbdfdebd47456514ff9ce5acd3add	createIndex indexName=i_versioning_map_crf_version_id, tableName=versioning_map		\N	3.6.3	\N	\N	1509384775
2014-01-15-OC-1276-1	kkrumlian	migration/3.2/2014-01-15-OC-1276.xml	2023-12-02 09:29:58.819362	888	EXECUTED	8:7f8533f7c3b5c1c41becb21c2333d454	sql		\N	3.6.3	\N	\N	1509384775
2014-01-30-OC-4168-1	kkrumlian	migration/3.2/2014-01-30-OC-4168.xml	2023-12-02 09:29:58.82627	889	EXECUTED	8:3977c45136c98d42e681693a6db15a4a	sql		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-1	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:00.811808	890	EXECUTED	8:079bdaaadd3080a72f76de28fbdaf42c	createIndex indexName=i_difm_item_id, tableName=dyn_item_form_metadata		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-2	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:04.054982	891	EXECUTED	8:120f7732ce69a6e5591b0d42b28e1157	createIndex indexName=i_difm_item_form_metadata_id, tableName=dyn_item_form_metadata		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-3	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:06.072629	892	EXECUTED	8:3792ba683074d99bfd04844b02057c54	createIndex indexName=i_difm_event_crf_id, tableName=dyn_item_form_metadata		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-4	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:08.018611	893	EXECUTED	8:c4085ec7f001c3e7c5b14a90656a97c7	createIndex indexName=i_difm_item_data_id, tableName=dyn_item_form_metadata		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-5	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:09.774458	894	EXECUTED	8:206a2a191928c43a2d231c82125030df	createIndex indexName=i_difm_show_item, tableName=dyn_item_form_metadata		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-6	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:11.450154	895	EXECUTED	8:c9b93a0f3712e1859a2dfde2575cc564	createIndex indexName=i_event_crf_study_event_id, tableName=event_crf		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-7	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:13.105906	896	EXECUTED	8:484930b2d4e130fc82ed8036acc4b6a9	createIndex indexName=i_ifm_response_set_id, tableName=item_form_metadata		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-8	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:14.631153	897	EXECUTED	8:b8d5db41d080311a155fdaebb934d718	createIndex indexName=i_ifm_section_id, tableName=item_form_metadata		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-9	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:16.381795	898	EXECUTED	8:4d339959f3467d406fb7fb6bd7435669	createIndex indexName=i_ifm_item_id, tableName=item_form_metadata		\N	3.6.3	\N	\N	1509384775
2014-04-09-OC-5087-10	jrousseau	migration/3.3/2014-04-09-OC-5087.xml	2023-12-02 09:30:18.055526	899	EXECUTED	8:3cb4cca2d1a103ee15cba9ef937faa96	createIndex indexName=i_didm_column_name, tableName=dn_item_data_map		\N	3.6.3	\N	\N	1509384775
2010-04-15-OC-4822-1	jnyayapathi	migration/3.3/2014-04-15-OC-4822.xml	2023-12-02 09:30:18.080418	900	EXECUTED	8:a516ee73b926a575ef8f29db5629c37c	addColumn tableName=rule_action_property	Add Column	\N	3.6.3	\N	\N	1509384775
2010-04-15-OC-4822-2	jnyayapathi	migration/3.3/2014-04-15-OC-4822.xml	2023-12-02 09:30:18.092165	901	EXECUTED	8:993ffa483bdb1b15b07b01491ea074d2	addColumn tableName=rule_action	Add Column	\N	3.6.3	\N	\N	1509384775
2010-04-15-OC-4822-3	jnyayapathi	migration/3.3/2014-04-15-OC-4822.xml	2023-12-02 09:30:18.110616	902	EXECUTED	8:ce204584905c91d2f8c2aaa2e21316c4	addColumn tableName=rule_action_run	Add Column	\N	3.6.3	\N	\N	1509384775
2010-04-15-OC-4822-4	jnyayapathi	migration/3.3/2014-04-15-OC-4822.xml	2023-12-02 09:30:18.129041	903	EXECUTED	8:6bf84faf14c5f3b8dce3c7eba7d5444e	addColumn tableName=rule_action_run	Add Column	\N	3.6.3	\N	\N	1509384775
2010-04-15-OC-4822-5	jnyayapathi	migration/3.3/2014-04-15-OC-4822.xml	2023-12-02 09:30:18.144584	904	EXECUTED	8:64779746be191bb9853fab2f362a5091	addColumn tableName=rule_action_run	Add Column	\N	3.6.3	\N	\N	1509384775
2010-04-15-OC-4822-6	jnyayapathi	migration/3.3/2014-04-15-OC-4822.xml	2023-12-02 09:30:18.157432	905	EXECUTED	8:b32e38e5d18fe92816bbce230f874200	addColumn tableName=rule_action_run	Add Column	\N	3.6.3	\N	\N	1509384775
2010-04-15-OC-4822-7	jnyayapathi	migration/3.3/2014-04-15-OC-4822.xml	2023-12-02 09:30:18.164038	906	EXECUTED	8:3133792dd8e5f6447cb78c93014d4433	addColumn tableName=rule_action_run	Add Column	\N	3.6.3	\N	\N	1509384775
2010-04-15-OC-4822-8	jnyayapathi	migration/3.3/2014-04-15-OC-4822.xml	2023-12-02 09:30:18.170711	907	EXECUTED	8:40250431a09f709ea7b0f772f7659dae	addColumn tableName=rule_action_run	Add Column	\N	3.6.3	\N	\N	1509384775
2014-08-5767	jkeremian	migration/3.4/2014-08-15-5767.xml	2023-12-02 09:30:18.179252	908	EXECUTED	8:15615ff9ff55a410bb19787c48b7f68e	insert tableName=study_parameter	Insert a new record in the studyParameter table	\N	3.6.3	\N	\N	1509384775
2014-08-27-4488_1	jkeremian	migration/3.4/2014-08-27-5985.xml	2023-12-02 09:30:18.236331	909	EXECUTED	8:058431db8373d185983130fcaf99a97a	sql	Change data type of created_date to timestamp	\N	3.6.3	\N	\N	1509384775
2014-08-27-4488_2	jkeremian	migration/3.4/2014-08-27-5985.xml	2023-12-02 09:30:18.318467	910	EXECUTED	8:193b4afabdd371ebfd34d7d60ec2a010	sql	Change data type of updated_date to timestamp	\N	3.6.3	\N	\N	1509384775
2014-08-27-5897_1	jkeremian	migration/3.4/2014-08-29-5897.xml	2023-12-02 09:30:18.408966	911	EXECUTED	8:7ffb96a508b898ce43871365a04c73ec	sql	Change data type of created_date to timestamp	\N	3.6.3	\N	\N	1509384775
2014-08-27-5897_2	jkeremian	migration/3.4/2014-08-29-5897.xml	2023-12-02 09:30:18.426943	912	EXECUTED	8:73a8d7f4245220ba996b9c4761fbdea9	sql	Change data type of updated_date to timestamp	\N	3.6.3	\N	\N	1509384775
2014-09-03-5903_1	jkeremian	migration/3.4/2014-09-03-5903.xml	2023-12-02 09:30:18.453205	913	EXECUTED	8:63367f00ff68796fb61474801e86c7bd	sql	Change data type of created_date to timestamp	\N	3.6.3	\N	\N	1509384775
2014-09-03-5903_2	jkeremian	migration/3.4/2014-09-03-5903.xml	2023-12-02 09:30:18.482153	914	EXECUTED	8:512146d64e6d9776788d59dab4793d03	sql	Change data type of updated_date to timestamp	\N	3.6.3	\N	\N	1509384775
2014-09-03-5904_1	jkeremian	migration/3.4/2014-09-03-5904.xml	2023-12-02 09:30:18.503546	915	EXECUTED	8:9cd77e82a262ea0620f93b7276c532a9	sql	Change data type of created_date to timestamp	\N	3.6.3	\N	\N	1509384775
2014-09-03-5904_2	jkeremian	migration/3.4/2014-09-03-5904.xml	2023-12-02 09:30:18.527586	916	EXECUTED	8:66370afba59153b483f53905578f49d8	sql	Change data type of updated_date to timestamp	\N	3.6.3	\N	\N	1509384775
2014-08-28-5896_1	jkeremian	migration/3.4/2014-08-28-5896.xml	2023-12-02 09:30:18.559513	917	EXECUTED	8:7fcfbcd5fa7a96b390950713282a8b6a	sql	Before Changing data type of created_date to timestamp, we need to drop all Views	\N	3.6.3	\N	\N	1509384775
2014-08-28-5896_2	jkeremian	migration/3.4/2014-08-28-5896.xml	2023-12-02 09:30:18.587063	918	EXECUTED	8:9bf82232c0432770c38eef7c4cb6cf98	sql	Change data type of created_date to timestamp	\N	3.6.3	\N	\N	1509384775
2014-08-28-5896_3	jkeremian	migration/3.4/2014-08-28-5896.xml	2023-12-02 09:30:18.702628	919	EXECUTED	8:21522155bbde92734c81dc3067be65bd	sql	Create All Reviews back by updating date data types	\N	3.6.3	\N	\N	1509384775
2015-01-11-OC-6132-1	jkeremian	migration/3.5/2015-01-11-OC-6132.xml	2023-12-02 09:30:18.711379	920	EXECUTED	8:d3ab969e313cdf7283e48ea594a4c235	addColumn tableName=user_account	Add access_code column to user Account table	\N	3.6.3	\N	\N	1509384775
2015-01-23-5802-1	jkeremian	migration/3.5/2015-01-23-OC-5802.xml	2023-12-02 09:30:18.721866	921	EXECUTED	8:057a990b649a90d0e498745e5a38b0ea	addColumn tableName=event_definition_crf	adding a column in event_definition_crf table	\N	3.6.3	\N	\N	1509384775
2015-04-12-OC-6304-1	jkeremian	migration/3.6/2015-04-12-OC-6304.xml	2023-12-02 09:30:18.731306	922	EXECUTED	8:b2539856ffd2fd75d4255e0945ed5e07	addColumn tableName=dn_item_data_map	adding a column in dn_item_data_map table	\N	3.6.3	\N	\N	1509384775
2015-4-15-6008-1	jkeremian	migration/3.6/2015-04-15-OC-6008.xml	2023-12-02 09:30:18.739318	923	EXECUTED	8:e02713f2108a0fad8831bda00110074f	addColumn tableName=audit_log_event	Add Column item_data_repeat_key in audit_log_event table	\N	3.6.3	\N	\N	1509384775
2015-4-15-6008-2	jkeremian	migration/3.6/2015-04-15-OC-6008.xml	2023-12-02 09:30:18.749277	924	EXECUTED	8:f29e6fcbdd8f62e6bc69c1e64ffce58a	sql		\N	3.6.3	\N	\N	1509384775
2015-4-15-6008-3	jkeremian	migration/3.6/2015-04-15-OC-6008.xml	2023-12-02 09:30:18.758403	925	EXECUTED	8:e3a1326828f259b4070e1ea5c4f8a15d	sql	create item_data_initial_trigger()	\N	3.6.3	\N	\N	1509384775
2015-04-15-OC6413-1	jkeremian	migration/3.6/2015-04-15-OC-6413.xml	2023-12-02 09:30:18.768755	926	EXECUTED	8:5b965d66c18a37abc4035a6a5ac62f5f	sql		\N	3.6.3	\N	\N	1509384775
2015-04-15-OC6413-2	jkeremian	migration/3.6/2015-04-15-OC-6413.xml	2023-12-02 09:30:18.776859	927	EXECUTED	8:48967e6075e3843b24b1eb535fa0caee	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
2015-04-15-OC6413-3	jkeremian	migration/3.6/2015-04-15-OC-6413.xml	2023-12-02 09:30:18.784604	928	EXECUTED	8:1a0ba035666fa5952ba8d225789ff5d7	insert tableName=audit_log_event_type		\N	3.6.3	\N	\N	1509384775
2015-04-15-OC6413-4	jkeremian	migration/3.6/2015-04-15-OC-6413.xml	2023-12-02 09:30:18.792919	929	EXECUTED	8:8b861fad96d137b348711a765911aeb9	insert tableName=status		\N	3.6.3	\N	\N	1509384775
2015-04-15-OC6413-5	jkeremian	migration/3.6/2015-04-15-OC-6413.xml	2023-12-02 09:30:18.801585	930	EXECUTED	8:ecd9aa52cc7eb1ce1c4aec04599f4a4b	sql	create event_crf_initial_trigger()	\N	3.6.3	\N	\N	1509384775
2015-04-15-OC6413-6	jkeremian	migration/3.6/2015-04-15-OC-6413.xml	2023-12-02 09:30:18.811438	931	EXECUTED	8:2dbf99cef4517b5c1448d64b1de099a0	sql		\N	3.6.3	\N	\N	1509384775
2015-05-01-OC-6405-01	jkeremian	migration/3.6/2015-05-01-OC-6405.xml	2023-12-02 09:30:18.81965	932	EXECUTED	8:ea20a524f230e7415a99e69009fab2fb	addColumn tableName=rule_action	adding a email_subject column in rule_action table	\N	3.6.3	\N	\N	1509384775
2015-05-21-OC-5994-01	sdibona	migration/3.6/2015-05-21-OC-5994.xml	2023-12-02 09:30:18.825331	933	EXECUTED	8:d41d8cd98f00b204e9800998ecf8427e	empty	increasing size of column user_name in table study_user_role	\N	3.6.3	\N	\N	1509384775
2015-05-21-OC-5994-02	jkeremian	migration/3.6/2015-05-21-OC-5994.xml	2023-12-02 09:30:18.85724	934	EXECUTED	8:d41d8cd98f00b204e9800998ecf8427e	empty	increasing size of column role_name in table user_role	\N	3.6.3	\N	\N	1509384775
2015-05-21-OC-5994-03	jkeremian	migration/3.6/2015-05-21-OC-5994.xml	2023-12-02 09:30:18.860327	935	EXECUTED	8:d41d8cd98f00b204e9800998ecf8427e	empty	increasing size of column user_name in table authorities	\N	3.6.3	\N	\N	1509384775
2015-05-14-OC-6454-1	jkeremian	migration/3.6/2015-05-14-OC-6454.xml	2023-12-02 09:30:18.865813	936	EXECUTED	8:5ffd89ffe7df94b51797673be0aad1a7	addColumn tableName=rule_set	adding a column in dn_item_data_map table	\N	3.6.3	\N	\N	1509384775
2015-05-14-OC-6454-2	jkeremian	migration/3.6/2015-05-14-OC-6454.xml	2023-12-02 09:30:18.872495	937	EXECUTED	8:e2ac4f59f21be877644e6bfa24f8cbc2	addColumn tableName=user_account	adding a column in dn_item_data_map table	\N	3.6.3	\N	\N	1509384775
2015-05-14-OC-6454-3	jkeremian	migration/3.6/2015-05-14-OC-6454.xml	2023-12-02 09:30:18.876643	938	EXECUTED	8:6d6c4b498b1c85b69eb942ffacf68aef	addColumn tableName=study_subject	adding a column in dn_item_data_map table	\N	3.6.3	\N	\N	1509384775
2015-06-26-OC-6467-01	jkeremian	migration/3.6/2015-05-26-OC-6467.xml	2023-12-02 09:30:18.880841	939	EXECUTED	8:45c839be83953b42cb2c37ff08864450	sql		\N	3.6.3	\N	\N	1509384775
2015-07-09-OC-6551-1	sdibona	migration/3.7/2015-07-09-OC-6551.xml	2023-12-02 09:30:18.884532	940	EXECUTED	8:8182786b34849d8e00fbc69d365a86a9	addColumn tableName=crf_version	adding a column in crf_version	\N	3.6.3	\N	\N	1509384775
2015-07-25-OC-6589-1	sdibona	migration/3.7/2015-07-25-OC-6589.xml	2023-12-02 09:30:18.890519	941	EXECUTED	8:1976debd714e817384aa1b9166359eaa	addColumn tableName=crf_version	adding a column in crf_version	\N	3.6.3	\N	\N	1509384775
2015-07-31-OC-6621-1	sdibona	migration/3.7/2015-07-31-OC-6621.xml	2023-12-02 09:30:18.905115	942	EXECUTED	8:b63c171361d8db0e58b0df9d2b4052b4	createTable tableName=crf_version_media	adding a mapping table for CRF associated media	\N	3.6.3	\N	\N	1509384775
2015-07-31-OC-6621-2	sdibona	migration/3.7/2015-07-31-OC-6621.xml	2023-12-02 09:30:18.912749	943	EXECUTED	8:db043a672fd162d4a9d3a31f972cf30f	addForeignKeyConstraint baseTableName=crf_version_media, constraintName=fk_crf_version_id, referencedTableName=crf_version		\N	3.6.3	\N	\N	1509384775
2015-07-15-6582-1	jkeremian	migration/3.7/2015-07-15-OC-6582.xml	2023-12-02 09:30:18.91818	944	EXECUTED	8:502d2a7b4cb0acc0ca9c76d48535f0b8	addColumn tableName=event_definition_crf	adding allow_anonymous_submission column in event_definition_crf table	\N	3.6.3	\N	\N	1509384775
2015-07-15-6582-2	jkeremian	migration/3.7/2015-07-15-OC-6582.xml	2023-12-02 09:30:18.926427	945	EXECUTED	8:4e55490ad53a2d963ffd9c43c37e7878	addColumn tableName=event_definition_crf	adding submission_url column in event_definition_crf table	\N	3.6.3	\N	\N	1509384775
2015-08-11-6636-1	jkeremian	migration/3.7/2015-08-11-OC-6636.xml	2023-12-02 09:30:18.932549	946	EXECUTED	8:5cfddcca287a4986fc21628d5033184b	addColumn tableName=user_account	adding enable_api_key column in user_account table	\N	3.6.3	\N	\N	1509384775
2015-08-11-6636-2	jkeremian	migration/3.7/2015-08-11-OC-6636.xml	2023-12-02 09:30:18.937546	947	EXECUTED	8:8d42db77b48deddf68221ea3dac4b9b1	addColumn tableName=user_account	adding api_key column in user_account table	\N	3.6.3	\N	\N	1509384775
2015-08-18-OC-2886	sidr	migration/3.7/2015-08-18-OC-2886.xml	2023-12-02 09:30:18.942281	948	EXECUTED	8:0c5ad78510bb0a6d5d5af787d68d5e5a	sql		\N	3.6.3	\N	\N	1509384775
2015-11-17-6829-2	kkrumlian	migration/3.8/2015-11-17-OC-6829.xml	2023-12-02 09:30:18.948467	949	EXECUTED	8:e915d059ad526c4fb0046f677292ddcc	sql		\N	3.6.3	\N	\N	1509384775
2015-11-18-OC-6777-1	sdibona	migration/3.9/2015-11-18-OC-6777.xml	2023-12-02 09:30:18.952875	950	EXECUTED	8:fc604a1c3a0082602830f5b11b55fd7e	addColumn tableName=item_data	adding a column in item_data	\N	3.6.3	\N	\N	1509384775
2015-11-12-OC-6820	jkeremian	migration/3.9/2015-11-12-OC-6820.xml	2023-12-02 09:30:18.959981	951	EXECUTED	8:23c2b0e9b86128e1fe50753c488fdc10	sql	Apply Uniqueness Constraint to Study Event Table	\N	3.6.3	\N	\N	1509384775
2015-11-18-6825-02	jkeremian	migration/3.9/2015-11-18-OC-6825.xml	2023-12-02 09:30:18.972437	952	EXECUTED	8:cbb806c364fc10155c5f05b71c9a322b	createTable tableName=rule_action_stratification_factor	Create a new table named rule_action_factor	\N	3.6.3	\N	\N	1509384775
2015-12-07-OC-6483-01	jkeremian	migration/3.9/2015-12-07-OC-6483.xml	2023-12-02 09:30:18.97893	953	EXECUTED	8:4602049b0ca8aa2eb3ccae26f06e723f	sql	Change character width for Message and Email_subject columns of Rule Action Table	\N	3.6.3	\N	\N	1509384775
2015-12-07-OC-1176-01	jkeremian	migration/3.9/2015-12-07-OC-1176.xml	2023-12-02 09:30:18.984453	954	EXECUTED	8:175e84e17952010f572cb11b6cc8b1f7	sql	Change character width for expression column of Rule_Expression Table	\N	3.6.3	\N	\N	1509384775
2015-12-08-OC-6847	jkeremian	migration/3.9/2015-12-08-OC-6847.xml	2023-12-02 09:30:18.989965	955	EXECUTED	8:29e6117fe42094063cede56c4b04c0be	insert tableName=study_parameter	Insert a new record in the studyParameter table	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-01	jkeremian	migration/3.10/2016-02-05-OC-6963.xml	2023-12-02 09:30:19.000961	956	EXECUTED	8:1536ce0ef6b8a5d504752afd5d4dabfc	sql	Create Table tag	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-02	jkeremian	migration/3.10/2016-02-05-OC-6963.xml	2023-12-02 09:30:19.012796	957	EXECUTED	8:9481bfb9f1b02d75a5bc9478d8162b03	sql	Create Table event_definition_crf_item_tag	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-03	jkeremian	migration/3.10/2016-02-05-OC-6963.xml	2023-12-02 09:30:19.021741	958	EXECUTED	8:dacc7e08803e3d2cc881da0f86aa6e93	sql	Create Table event_definition_crf_tag	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-04	jkeremian	migration/3.10/2016-02-05-OC-6963.xml	2023-12-02 09:30:19.030716	959	EXECUTED	8:7f4c8957ab57b887f446a190c554468f	sql	Create Table item_data_flag	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-05	jkeremian	migration/3.10/2016-02-05-OC-6963.xml	2023-12-02 09:30:19.046812	960	EXECUTED	8:487e0b5ee0752c4a17c30cf0d41a8f8b	sql	Create Table item_data_flag_workflow	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-06	jkeremian	migration/3.10/2016-02-05-OC-6963.xml	2023-12-02 09:30:19.057407	961	EXECUTED	8:6310fa0002f951b112875b51f5f3f797	sql	Create Table event_crf_flag	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-07	jkeremian	migration/3.10/2016-02-05-OC-6963.xml	2023-12-02 09:30:19.076972	962	EXECUTED	8:f975842dad862374c93a530215f8a371	sql	Create Table event_crf_flag_workflow	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-08	jkeremian	migration/3.10/2016-02-05-OC-6963.xml	2023-12-02 09:30:19.098601	963	EXECUTED	8:080d44c1282b7b48506e0305d0942af1	sql	Create View for Item Data Toolkit	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-09	jkeremian	migration/3.10/2016-02-05-OC-6963.xml	2023-12-02 09:30:19.11625	964	EXECUTED	8:7b2a6b9fbfb39e80d50193c94265dae2	sql	Create View for Item Data Toolkit Filtered	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-10	jkeremian	migration/3.10/2016-02-06-OC-6963.xml	2023-12-02 09:30:19.122364	965	EXECUTED	8:45b21f8c3923ce40468e8517671aa8a0	sql	Insert a Row in Tag Table	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-11	jkeremian	migration/3.10/2016-02-06-OC-6963.xml	2023-12-02 09:30:19.126384	966	EXECUTED	8:61d64efe05945b109010bb2deefadc24	sql	Insert a Row in Tag Table	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-12	jkeremian	migration/3.10/2016-02-06-OC-6963.xml	2023-12-02 09:30:19.133526	967	EXECUTED	8:93b8cc501f265c835a4a56e46b892987	sql	Apply Uniqueness Constraint to Event_Definition_Crf_Item_Tag	\N	3.6.3	\N	\N	1509384775
2016-02-05-OC-6963-13	jkeremian	migration/3.10/2016-02-06-OC-6963.xml	2023-12-02 09:30:19.141002	968	EXECUTED	8:168a78e471477a7943a7b1df39e64572	sql	Apply Uniqueness Constraint to Event_Definition_Crf_Tag	\N	3.6.3	\N	\N	1509384775
2016-04-07-7118	dewa	migration/3.11/2016-04-07-OC-7118.xml	2023-12-02 09:30:19.147333	969	EXECUTED	8:0f0bc21e86fe0acde38634d139363807	addColumn tableName=audit_user_login	Add new column details on audit_user_login table	\N	3.6.3	\N	\N	1509384775
2016-08-12-OC-5891-01	jkeremian	migration/3.12/2016-08-12-OC-5891.xml	2023-12-02 09:30:19.181937	970	EXECUTED	8:7fcfbcd5fa7a96b390950713282a8b6a	sql	Before Changing data type of description field in discrepancy_note, we need to drop all Views	\N	3.6.3	\N	\N	1509384775
2016-08-12-OC-5891-02	jkeremian	migration/3.12/2016-08-12-OC-5891.xml	2023-12-02 09:30:19.188491	971	EXECUTED	8:8d4abd31985cce0fffc26f20e92898d7	sql	Change character width for Description column of Discrepancy Note Table	\N	3.6.3	\N	\N	1509384775
2016-08-12-OC-5891-03	jkeremian	migration/3.12/2016-08-12-OC-5891.xml	2023-12-02 09:30:19.285515	972	EXECUTED	8:21522155bbde92734c81dc3067be65bd	sql	Create All Reviews back by updating date data types	\N	3.6.3	\N	\N	1509384775
2016-08-24-7399-1	kkrumlian	migration/3.12/2016-08-24-OC-7399.xml	2023-12-02 09:30:19.290942	973	MARK_RAN	8:d41d8cd98f00b204e9800998ecf8427e	empty	Reverting Fix user_id in audit_log_event when SDV	\N	3.6.3	\N	\N	1509384775
2017-05-23-OC-8124-1	sdibona	migration/3.14/2017-05-23-OC-8124.xml	2023-12-02 09:30:20.753242	974	EXECUTED	8:ef6111b181e893cf09add59d048d0ab1	createIndex indexName=i_digm_item_group_metadata_id, tableName=dyn_item_group_metadata		\N	3.6.3	\N	\N	1509384775
2017-05-23-OC-8124-2	sdibona	migration/3.14/2017-05-23-OC-8124.xml	2023-12-02 09:30:22.261211	975	EXECUTED	8:99fc87a71cd0b811da5bf08fd26908d7	createIndex indexName=i_digm_item_group_id, tableName=dyn_item_group_metadata		\N	3.6.3	\N	\N	1509384775
2017-05-23-OC-8124-3	sdibona	migration/3.14/2017-05-23-OC-8124.xml	2023-12-02 09:30:23.652461	976	EXECUTED	8:02e1084b3a11b9899bfabae782d73e6d	createIndex indexName=i_digm_show_group, tableName=dyn_item_group_metadata		\N	3.6.3	\N	\N	1509384775
2017-05-23-OC-8124-4	sdibona	migration/3.14/2017-05-23-OC-8124.xml	2023-12-02 09:30:25.070705	977	EXECUTED	8:4021f86f758810d4cc25e4973fe609f7	createIndex indexName=i_digm_event_crf_id, tableName=dyn_item_group_metadata		\N	3.6.3	\N	\N	1509384775
2017-06-05-7394-1	sdibona	migration/3.14/2017-06-05-OC-7394.xml	2023-12-02 09:30:25.07977	978	EXECUTED	8:a4239a9cfd4e0179739b251c155aaec3	addUniqueConstraint constraintName=uniq_study_event_crf_version_study_subject, tableName=event_crf	Adding unique constraint to prevent duplicate entries in event_crf	\N	3.6.3	\N	\N	1509384775
2017-07-27-7877-1	sdibona	migration/3.14/2017-07-27-OC-7877.xml	2023-12-02 09:30:25.087249	979	EXECUTED	8:0bccded348ec1e688cd1dea4a5e6fe8c	addUniqueConstraint constraintName=uniq_study_event_def_study_crf, tableName=event_definition_crf	Adding unique constraint to prevent duplicate entries in event_definition_crf	\N	3.6.3	\N	\N	1509384775
1555001321719-1	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.094155	980	EXECUTED	8:87dfc69221fa4cbe7d93d12b8e867b8e	addColumn tableName=oc_qrtz_locks		\N	3.6.3	\N	\N	1509384775
1555001321719-2	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.119719	981	EXECUTED	8:218ba9e53f0276b7ba03f72236cbcc09	dropPrimaryKey tableName=oc_qrtz_locks; addPrimaryKey constraintName=oc_qrtz_locks_pkey, tableName=oc_qrtz_locks		\N	3.6.3	\N	\N	1509384775
1555001321719-3	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.12634	982	EXECUTED	8:0e900d1989e95a954b8b7c61288fd5b6	addColumn tableName=oc_qrtz_paused_trigger_grps		\N	3.6.3	\N	\N	1509384775
1555001321719-4	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.131735	983	EXECUTED	8:ef2e5b9fd97f10f1bade3d60fbc176c6	addColumn tableName=oc_qrtz_calendars		\N	3.6.3	\N	\N	1509384775
1555001321719-5	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.136581	984	EXECUTED	8:618749afc707a132a0ece622e30828bb	addColumn tableName=oc_qrtz_scheduler_state		\N	3.6.3	\N	\N	1509384775
1555001321719-6	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.144214	985	EXECUTED	8:397a0df750a41c9bad6d22b5dd48e724	addColumn tableName=oc_qrtz_cron_triggers		\N	3.6.3	\N	\N	1509384775
1555001321719-7	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.154572	986	EXECUTED	8:e6e75e1ec04f98fbbdeb217312f27b9a	addColumn tableName=oc_qrtz_simple_triggers		\N	3.6.3	\N	\N	1509384775
1555001321719-8	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.159984	987	EXECUTED	8:78b3179b27cd8bf96f6976a72cf0d628	addColumn tableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
1555001321719-9	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.16563	988	EXECUTED	8:292a7208d7aef5a86eaf116f6796070d	addColumn tableName=oc_qrtz_fired_triggers		\N	3.6.3	\N	\N	1509384775
1555001321719-10	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.170142	989	EXECUTED	8:84b34ec5516463d6453da2ab8f4e1dca	addColumn tableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
1555001321719-11	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.17874	990	EXECUTED	8:c5ef242b619939b08baf969d597825b0	addColumn tableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
1555001321719-12	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.184574	991	EXECUTED	8:b9de6e17db596ba63b2f25dbf0b21310	addColumn tableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
1555001321719-13	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.188648	992	EXECUTED	8:3fd6bee9f77a53bffbd33b0155be3521	addColumn tableName=oc_qrtz_fired_triggers		\N	3.6.3	\N	\N	1509384775
1555001321719-14	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.192421	993	EXECUTED	8:329d87589aee864b560fe11561ee1a9e	addColumn tableName=oc_qrtz_fired_triggers		\N	3.6.3	\N	\N	1509384775
1555001321719-15	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.197246	994	EXECUTED	8:476ce1d6efe729ed2804c69f27ec4000	addColumn tableName=oc_qrtz_fired_triggers		\N	3.6.3	\N	\N	1509384775
1555001321719-16	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.201937	995	EXECUTED	8:092debf8f52f5be486cab64ff8da81df	dropColumn tableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
1555001321719-17	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.207175	996	EXECUTED	8:e2260d61b2a55ea9d6ca952623de6c8a	dropColumn tableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
1555001321719-18	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.213329	997	EXECUTED	8:720e7a9fae1985b48c7ff9b3f63097a1	dropColumn tableName=oc_qrtz_fired_triggers		\N	3.6.3	\N	\N	1509384775
1555001321719-19	cha	migration/lc-1.0.0/update_to_spring5.xml	2023-12-02 09:30:25.219595	998	EXECUTED	8:9eadcb0f4e036366584fad350006720a	dropColumn tableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
2020-01-31-alter_oc_qrtz_blob_triggers_blob_data_type_to_bytea	toskrip	migration/lc-1.0.0/qrtz_blob_to_bytea.xml	2023-12-02 09:30:25.227616	999	EXECUTED	8:1bd6c076330bb11a58cb9ea6490b6d05	dropColumn columnName=blob_data, tableName=oc_qrtz_blob_triggers; addColumn tableName=oc_qrtz_blob_triggers		\N	3.6.3	\N	\N	1509384775
2020-01-31-alter_oc_qrtz_calendars_calendar_type_to_bytea	toskrip	migration/lc-1.0.0/qrtz_blob_to_bytea.xml	2023-12-02 09:30:25.235395	1000	EXECUTED	8:0d2e82c9574987293becb8ac95552ac9	dropColumn columnName=calendar, tableName=oc_qrtz_calendars; addColumn tableName=oc_qrtz_calendars		\N	3.6.3	\N	\N	1509384775
2020-01-31-alter_oc_qrtz_job_details_job_data_type_to_bytea	toskrip	migration/lc-1.0.0/qrtz_blob_to_bytea.xml	2023-12-02 09:30:25.243164	1001	EXECUTED	8:e463a842390a021d92fa333031f6cf33	dropColumn columnName=job_data, tableName=oc_qrtz_job_details; addColumn tableName=oc_qrtz_job_details		\N	3.6.3	\N	\N	1509384775
2020-01-31-alter_oc_qrtz_triggers_job_data_type_to_bytea	toskrip	migration/lc-1.0.0/qrtz_blob_to_bytea.xml	2023-12-02 09:30:25.249723	1002	EXECUTED	8:9dfb39e6066e79001fd197ad23120cee	dropColumn columnName=job_data, tableName=oc_qrtz_triggers; addColumn tableName=oc_qrtz_triggers		\N	3.6.3	\N	\N	1509384775
1	thillger	migration/lc-1.2.0/2-fauth.xml	2023-12-02 09:30:25.255426	1003	EXECUTED	8:c6ecb175102d018d149bfae44d467096	addColumn tableName=user_account	Creating new attributes for 2-factor authentication.	\N	3.6.3	\N	\N	1509384775
2	thillger	migration/lc-1.2.0/2-fauth.xml	2023-12-02 09:30:25.267588	1004	EXECUTED	8:677f2208506b163a6f8d28d4f65ad5ad	createIndex indexName=ix1_user_account, tableName=user_account; createIndex indexName=ix2_user_account, tableName=user_account	Creating indexes on 'user_account' for newly created attributes.	\N	3.6.3	\N	\N	1509384775
1	jbley	migration/lc-1.2.0/mail_notification.xml	2023-12-02 09:30:25.273494	1005	EXECUTED	8:8980622c67d3cd6e563ac5148d27c56e	addColumn tableName=study	Creating new attribute for mail notification for login.	\N	3.6.3	\N	\N	1509384775
2	jbley	migration/lc-1.2.0/mail_notification.xml	2023-12-02 09:30:25.280489	1006	EXECUTED	8:c6a37c0cf0997327de243b8a61345fce	createIndex indexName=ix1_study, tableName=study	Creating index on 'study' for newly created attribute.	\N	3.6.3	\N	\N	1509384775
3	thillger	migration/lc-1.2.0/mail_notification.xml	2023-12-02 09:30:25.285618	1007	EXECUTED	8:cd11d12019f45a24105fe031acc8a9f7	addColumn tableName=study	Creating new attribute for contacting purpose in case of mail notifications.	\N	3.6.3	\N	\N	1509384775
\.


--
-- Data for Name: databasechangeloglock; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.databasechangeloglock (id, locked, lockgranted, lockedby) FROM stdin;
1	f	\N	\N
\.


--
-- Data for Name: dataset; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dataset (dataset_id, study_id, status_id, name, description, sql_statement, num_runs, date_start, date_end, date_created, date_updated, date_last_run, owner_id, approver_id, update_id, show_event_location, show_event_start, show_event_end, show_subject_dob, show_subject_gender, show_event_status, show_subject_status, show_subject_unique_id, show_subject_age_at_event, show_crf_status, show_crf_version, show_crf_int_name, show_crf_int_date, show_group_info, show_disc_info, odm_metadataversion_name, odm_metadataversion_oid, odm_prior_study_oid, odm_prior_metadataversion_oid, show_secondary_id, dataset_item_status_id) FROM stdin;
\.


--
-- Data for Name: dataset_crf_version_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dataset_crf_version_map (dataset_id, event_definition_crf_id) FROM stdin;
\.


--
-- Data for Name: dataset_filter_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dataset_filter_map (dataset_id, filter_id, ordinal) FROM stdin;
\.


--
-- Data for Name: dataset_item_status; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dataset_item_status (dataset_item_status_id, name, description) FROM stdin;
1	completed	Data from CRFs Marked Complete
2	non_completed	Data from CRFs not Marked Complete
3	completed_and_non_completed	Data from all Available CRFs 
\.


--
-- Data for Name: dataset_study_group_class_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dataset_study_group_class_map (dataset_id, study_group_class_id) FROM stdin;
\.


--
-- Data for Name: dc_computed_event; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dc_computed_event (dc_summary_event_id, dc_event_id, item_target_id, summary_type) FROM stdin;
\.


--
-- Data for Name: dc_event; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dc_event (dc_event_id, decision_condition_id, ordinal, type) FROM stdin;
\.


--
-- Data for Name: dc_primitive; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dc_primitive (dc_primitive_id, decision_condition_id, item_id, dynamic_value_item_id, comparison, constant_value) FROM stdin;
\.


--
-- Data for Name: dc_section_event; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dc_section_event (dc_event_id, section_id) FROM stdin;
\.


--
-- Data for Name: dc_send_email_event; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dc_send_email_event (dc_event_id, to_address, subject, body) FROM stdin;
\.


--
-- Data for Name: dc_substitution_event; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dc_substitution_event (dc_event_id, item_id, value) FROM stdin;
\.


--
-- Data for Name: dc_summary_item_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dc_summary_item_map (dc_summary_event_id, item_id, ordinal) FROM stdin;
\.


--
-- Data for Name: decision_condition; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.decision_condition (decision_condition_id, crf_version_id, status_id, label, comments, quantity, type, owner_id, date_created, date_updated, update_id) FROM stdin;
\.


--
-- Data for Name: discrepancy_note; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.discrepancy_note (discrepancy_note_id, description, discrepancy_note_type_id, resolution_status_id, detailed_notes, date_created, owner_id, parent_dn_id, entity_type, study_id, assigned_user_id) FROM stdin;
\.


--
-- Data for Name: discrepancy_note_type; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.discrepancy_note_type (discrepancy_note_type_id, name, description) FROM stdin;
1	Failed Validation Check	
2	Annotation	
3	Query	
4	Reason For Change	
5	Not Applicable	
6	Not Applicable	
7	Not Applicable	
\.


--
-- Data for Name: dn_event_crf_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dn_event_crf_map (event_crf_id, discrepancy_note_id, column_name) FROM stdin;
\.


--
-- Data for Name: dn_item_data_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dn_item_data_map (item_data_id, discrepancy_note_id, column_name, study_subject_id, activated) FROM stdin;
\.


--
-- Data for Name: dn_study_event_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dn_study_event_map (study_event_id, discrepancy_note_id, column_name) FROM stdin;
\.


--
-- Data for Name: dn_study_subject_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dn_study_subject_map (study_subject_id, discrepancy_note_id, column_name) FROM stdin;
\.


--
-- Data for Name: dn_subject_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dn_subject_map (subject_id, discrepancy_note_id, column_name) FROM stdin;
\.


--
-- Data for Name: dyn_item_form_metadata; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dyn_item_form_metadata (id, item_form_metadata_id, item_id, crf_version_id, show_item, event_crf_id, version, item_data_id, passed_dde) FROM stdin;
\.


--
-- Data for Name: dyn_item_group_metadata; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.dyn_item_group_metadata (id, item_group_metadata_id, item_group_id, show_group, event_crf_id, version, passed_dde) FROM stdin;
\.


--
-- Data for Name: event_crf; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.event_crf (event_crf_id, study_event_id, crf_version_id, date_interviewed, interviewer_name, completion_status_id, status_id, annotations, date_completed, validator_id, date_validate, date_validate_completed, validator_annotations, validate_string, owner_id, date_created, study_subject_id, date_updated, update_id, electronic_signature_status, sdv_status, old_status_id, sdv_update_id) FROM stdin;
\.


--
-- Data for Name: event_crf_flag; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.event_crf_flag (id, path, tag_id, flag_workflow_id, owner_id, update_id, date_created, date_updated) FROM stdin;
\.


--
-- Data for Name: event_crf_flag_workflow; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.event_crf_flag_workflow (id, workflow_id, workflow_status, owner_id, update_id, date_created, date_updated) FROM stdin;
\.


--
-- Data for Name: event_definition_crf; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.event_definition_crf (event_definition_crf_id, study_event_definition_id, study_id, crf_id, required_crf, double_entry, require_all_text_filled, decision_conditions, null_values, default_version_id, status_id, owner_id, date_created, date_updated, update_id, ordinal, electronic_signature, hide_crf, source_data_verification_code, selected_version_ids, parent_id, participant_form, allow_anonymous_submission, submission_url) FROM stdin;
1	1	3	1	t	f	f	f		23	1	1	2023-12-08	\N	\N	1	f	f	3		\N	f	f	
2	1	3	2	t	f	f	f		3	1	1	2023-12-08	\N	\N	2	f	f	3		\N	f	f	
3	1	3	44	t	f	f	f		22	1	1	2023-12-08	\N	\N	3	f	f	3		\N	f	f	
\.


--
-- Data for Name: event_definition_crf_item_tag; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.event_definition_crf_item_tag (id, path, tag_id, active, owner_id, update_id, date_created, date_updated) FROM stdin;
\.


--
-- Data for Name: event_definition_crf_tag; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.event_definition_crf_tag (id, path, tag_id, active, owner_id, update_id, date_created, date_updated) FROM stdin;
\.


--
-- Data for Name: export_format; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.export_format (export_format_id, name, description, mime_type) FROM stdin;
1	text/plain	Default export format for tab-delimited text	text/plain
2	text/plain	Default export format for comma-delimited text	text/plain
3	application/vnd.ms-excel	Default export format for Excel files	application/vnd.ms-excel
4	text/plain	Default export format for CDISC ODM XML files	text/plain
5	text/plain	Default export format for SAS files	text/plain
\.


--
-- Data for Name: filter; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.filter (filter_id, name, description, sql_statement, status_id, date_created, date_updated, owner_id, update_id) FROM stdin;
\.


--
-- Data for Name: filter_crf_version_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.filter_crf_version_map (filter_id, crf_version_id) FROM stdin;
\.


--
-- Data for Name: group_class_types; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.group_class_types (group_class_type_id, name, description) FROM stdin;
1	Arm	\N
2	Family/Pedigree	\N
3	Demographic	\N
4	Other	\N
\.


--
-- Data for Name: item; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.item (item_id, name, description, units, phi_status, item_data_type_id, item_reference_type_id, status_id, owner_id, date_created, date_updated, update_id, oc_oid) FROM stdin;
507	USUBJID	Participant's ID	38-##-#####	f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_USUBJID
508	AENO	Sequence ID	####	f	7	1	1	4	2023-12-07	\N	\N	I_S38_P_AENO
509	PPTRASM	What has prompted assessment for possible poor treatment response?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_PPTRASM
510	PPTRASPC	Other prompts of assessment for possible poor treatment response.		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_PPTRASPC
511	PPTRRESP	Was the Central Study Clinician contacted at the time a possible poor treatment response was suspected?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_PPTRRESP
512	REPRTDT	Report date	DD-MMM-YYYY	f	9	1	1	4	2023-12-07	\N	\N	I_S38_P_REPRTDT
513	REPRTTYP	Did participant report any changes in antiretroviral or non-TB/non-antiretroviral medications, including over-the-counter drugs since the last study visit?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_REPRTTYP
514	ANTITBUS	Did participant take any drugs with anti-TB activity since the last study visit?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_ANTITBUS
515	CHTXRAY	Was a chest X-ray obtained?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_CHTXRAY
516	EVALABTS	Are new laboratory test results available?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_EVALABTS
517	EVASYWE	Were signs and symptoms assessed and/or weight measured?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_EVASYWE
518	EVASPUC	Was sputum collection attempted (expectorated or induced)?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_EVASPUC
519	EVASPCN	How many specimens were collected?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_EVASPCN
520	EVABIOC	Was a specimen for biomarker analysis collected (i.e., blood)?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_EVABIOC
521	EVAPDIE	Did the participant die?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_EVAPDIE
522	EVAMODS	Were any modifications made to the assigned study TB treatment?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_EVAMODS
523	PPTRIND	Based on information available at the time of initial PR form completion, in the site investigator’s judgment this possible poor treatment response is most likely indicative of which of the following?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_PPTRIND
524	OTHRIND	Other likely indications		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_OTHRIND
525	COMPRMT	What is occurring with the participant to prompt a possible poor treatment response evaluation		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_COMPRMT
526	COMILCO	Specify any concurrent illnesses or conditions present at the time of this visit which might explain the participant’s symptoms and diagnostic findings		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_COMILCO
527	COMCTBT	Document considered or actual changes to TB treatment, TB treatment extension or re-initiation of TB treatment		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_COMCTBT
528	COMANSC	If extrapulmonary TB is suspected, identify the anatomic site(s) (e.g., lymph node, meninges, kidney) and describe the clinical findings		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_COMANSC
529	COMPATH	If applicable, report the pathologic findings from specimens obtained from extrapulmonary sites and provide a copy of the report with the participant’s personal identifiers blacked out to TBTCcrush@cdc.gov:		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_COMPATH
530	COMADD	Additional comments		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_COMADD
531	PRINPIC	PRINT name of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_PRINPIC
532	SIGNPIC	Signature of Principal Investigator or Co-PI:		f	11	1	1	4	2023-12-07	\N	\N	I_S38_P_SIGNPIC
533	PRINPCF	PRINT name of person completing form:		f	5	1	1	4	2023-12-07	\N	\N	I_S38_P_PRINPCF
534	SIGNPCF	Signature of person completing form:		f	11	1	1	4	2023-12-07	\N	\N	I_S38_P_SIGNPCF
535	DATEFRCP	Date Possible Poor Treatment Response Form completed		f	9	1	1	4	2023-12-07	\N	\N	I_S38_P_DATEFRCP
562	PARTID	Participant ID		f	5	1	1	4	2023-12-09	\N	\N	I_S38_C_PARTID_6894
563	NONTBNAME	Name of non-TB and non-antiretroviral medication		f	5	1	1	4	2023-12-09	\N	\N	I_S38_C_NONTBNAME_647
564	NONTBSTDAT	Start date of non-TB and non-antiretroviral medication		f	9	1	1	4	2023-12-09	\N	\N	I_S38_C_NONTBSTDAT_3775
565	NONTBENDAT	End date of non-TB and non-antiretroviral medication		f	9	1	1	4	2023-12-09	\N	\N	I_S38_C_NONTBENDAT_537
566	ANTIRENAME	Name of antiretroviral medication		f	5	1	1	4	2023-12-09	\N	\N	I_S38_C_ANTIRENAME_4611
567	ANTIRESTDAT	Start date of antiretroviral medication		f	9	1	1	4	2023-12-09	\N	\N	I_S38_C_ANTIRESTDAT_5817
568	ANTIREENDAT	End date of antiretroviral medication		f	9	1	1	4	2023-12-09	\N	\N	I_S38_C_ANTIREENDAT_1004
569	COMMENTS	Comments		f	5	1	1	4	2023-12-09	\N	\N	I_S38_C_COMMENTS_9651
570	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-09	\N	\N	I_S38_C_PERSCOMP_1432
309	SEX	Sex		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_SEX
310	BRTHYR	Year of birth	YYYY	f	6	1	1	4	2023-12-05	\N	\N	I_S38_N_BRTHYR
311	BRTHCTRY	Place of birth		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_BRTHCTRY
312	ETHNIC	Ethnicity		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_ETHNIC
313	RACENR	Race		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_RACENR
314	RACEOTH	Race specify Other		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_RACEOTH
315	SCRID	Site Screening Number		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_SCRID
316	NECAT	Reason for Non-Enrollment		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_NECAT
317	RNETERM	No evidence of pulmonary tuberculosis with or without suspected or proven concomitant extrapulmonary tuberculosis outside the central nervous system or bones		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_RNETERM
318	HIV	For participants with HIV		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_HIV
319	ROTHERTERM	Specify Other medical conditions		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_ROTHERTERM
320	NESCAT	Laboratory parameters done at or within 14 days prior to screenin		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_NESCAT
321	NESCATEXP	Experimental Components		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_NESCATEXP
322	NESCATSTU	Study Procedures NESCAT		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_NESCATSTU
323	NESCATDIF	Difficulties or Costs Associated with Study Participation		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_NESCATDIF
324	NESCATOPI	Opinion or Response of Others Stigma		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_NESCATOPI
375	PARTID	Participant ID		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_PARTID
325	NESCATMISC	Miscellaneous STUDY PROCEDURES		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_NESCATMISC
326	NESCATDEC	Site decides not to enroll patient		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_NESCATDEC
327	NCNAME	Form Completion		f	5	1	1	4	2023-12-05	\N	\N	I_S38_N_NCNAME
328	NCDAT	Date Non-enrollment Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_N_NCDAT
1364	BEREFIDDEB	Intensive PK 1E 6hrs post ref. dose TBTC Label Number 2	####6#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDEB_3152
1365	BEREFIDDEA	Intensive PK 1E 6hrs post ref. dose TBTC Label Number 1	####6#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDEA_705
1404	USUBJID	Participant's ID		f	5	1	1	4	2023-12-19	\N	\N	I_38_PK_USUBJID_4468
1366	BEREFIDDAD	Intensive PK 1A Pre ref. dose TBTC Label Number 4	####-1#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDAD_8414
1367	BEREFIDDAC	Intensive PK 1A Pre ref. dose TBTC Label Number 3	####-1#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDAC_282
1368	BEREFIDDAB	Intensive PK 1A Pre ref. dose TBTC Label Number 2	####-1#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDAB_9784
1369	BEORRESC	Extent thawed		f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEORRESC_4264
1370	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-18	\N	\N	I_38_PK_ZCDAT_1704
1371	BEREFIDCCD	Sparse PK 1C 3 hrs post ref. dose TBTC Label Number 4	#### 3 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCCD_4003
1372	BEREFIDDAA	Intensive PK 1A Pre ref. dose TBTC Label Number 1	####-1#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDAA_7007
1373	BEREFIDCCC	Sparse PK 1C 3 hrs post ref. dose TBTC Label Number 3	#### 3 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCCC_6303
1374	BEREFIDDED	Intensive PK 1E 6hrs post ref. dose TBTC Label Number 4	####6#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDED_472
1375	COVAL	Comments		f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_COVAL_1656
1376	BEDURC	Amount of time thawed Unknown		f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEDURC_290
1377	BEREFIDCBA	Sparse PK 1B Right before ref. dose TBTC Label Number 1	#### 0 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCBA_6552
78	ZFSER	Did the initial reportable event become a serious adverse event (SAE)?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFSER_1583
79	ZITERMB	If yes, specify		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZITERMB_401
80	ZFANTC	In the opinion of the investigator, is this an anticipated or unanticipated AE?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFANTC_1878
81	ZFDIFFDX	Is the FINAL reportable adverse event different from the initial event reported on the AE Form?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFDIFFDX_6215
82	ZNTERLB	Were any additional assessment, evaluations or tests done in response to this AE:		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNTERLB_4992
83	TXTDIS	Was study treatment permanently discontinued as a result of this AE?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_TXTDIS_7187
84	AFRESLV	If applicable, specify how long after the onset date did the AE resolved (hours, days, weeks):		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_AFRESLV_9897
85	ZTXTHELD	Was all or any part of study treatment held for any period of time?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZTXTHELD_6750
86	ZFTERM	Details of AE from its corresponding AE Form		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFTERM_6461
87	RPDAT	Date of pregnancy outcome	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_RPDAT_1596
88	AFSUM	Summary of current AE status		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_AFSUM_9918
89	ZFTOXGR	Indicate the maximum toxicity grade during the course of the AE		f	6	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFTOXGR_5860
90	ZFENDAT	Resolution Date/Death Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFENDAT_7955
91	ZFOUT	Status of the AE (check only one and provide date if indicated)		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFOUT_5494
92	ZFREL	In the opinion of the investigator, what is the final attribution to study treatment in causing this AE?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFREL_2197
93	ZNTERMSS	Signs and symptoms assessment		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNTERMSS_6693
94	VISDAT	Date of AE status evaluated	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_VISDAT_6859
95	ZCNAME	Name of person completing form		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCNAME_1894
96	ZCEVAL	Name of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCEVAL_4660
97	ZFSDTH	If yes, indicate type of SAE		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFSDTH_7333
98	ZNTERCE	Clinical evaluations		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNTERCE_7491
99	ZISONAME	Safety officer providing MedDRA code		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZISONAME_6532
100	ZRECH	Was the participant re-challenged with the intention of restarting study treatment?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZRECH_3309
101	RPTEST	Pregnancy outcome		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_RPTEST_7541
102	ZNTERMMB	Sputum or other specimen collected for TB diagnostic workup		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNTERMMB_4352
103	RPTESTCD	were any congenital anomalies present?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_RPTESTCD_262
104	RPORRESC	What was the gestational age at pregnancy outcome?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_RPORRESC_2443
105	SAESTDAT	Date event became an SAE:	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_SAESTDAT_7987
106	SAEDAT	Site awareness date:	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_SAEDAT_3594
107	AFDC	If applicable, specify whether the participant permanently discontinued study treatment because of medical advice or participant decision to discontinue		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_AFDC_4213
108	XATRT	select the study drug(s) to which the AE is attributed		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_XATRT_761
109	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCDAT_7808
110	ZFLLT	Final MedDRA Lower Level Term Description		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFLLT_9674
111	ZFLLTCD	Final MedDRA Lower Level Term Code		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZFLLTCD_8818
1378	BEREFIDDDB	Intensive PK 1D 4hrs post ref. dose TBTC Label Number 2	####4#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDDB_5888
1711	USUBJID	Participant's ID	38 - ## - #####	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_USUBJID
1164	USUBJID	Participant's ID		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_USUBJID
1712	VISIT	Visit or date of blood specimen collection		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_VISIT
1713	VISDAT	Date of Visit	DD-MMM-YYYY	f	9	1	1	8	2023-12-20	\N	\N	I_38_IP_VISDAT
1714	EXSTDATA	Reference Dose & Vomiting (Pre-reference dose A) Date	DD-MMM-YYYY	f	9	1	1	8	2023-12-20	\N	\N	I_38_IP_EXSTDATA
1183	COVAL	Comments		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_COVAL_7006
1184	ZCNAME	Form Completion		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZCNAME_1235
1185	ZCDAT	Date Treatment Evaluation Form Completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-18	\N	\N	I_38_TX_ZCDAT_7235
145	BRTHDAT	Date of birth	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_E_BRTHDAT
146	BRTHCOND	Estimated		f	5	1	1	4	2023-12-04	\N	\N	I_S38_E_BRTHCOND
147	DSSTDAT	Date participant or legal guardian signed informed consent	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_E_DSSTDAT
148	DSSTDATB	Date participant gave assent	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_E_DSSTDATB
149	DSDECOD	NA (e.g., Participant > 18)		f	5	1	1	4	2023-12-04	\N	\N	I_S38_E_DSDECOD
150	HEIGHT	Height		f	7	1	1	4	2023-12-04	\N	\N	I_S38_E_HEIGHT
151	VSORRESU	Height measure		f	5	1	1	4	2023-12-04	\N	\N	I_S38_E_VSORRESU
152	WEIGHT	Weight		f	7	1	1	4	2023-12-04	\N	\N	I_S38_E_WEIGHT
153	VSORRESUW	Weight mesaure		f	5	1	1	4	2023-12-04	\N	\N	I_S38_E_VSORRESUW
154	VSDAT	Date of weight:	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_E_VSDAT
155	MODAT	Date of chest X-ray	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_E_MODAT
156	CAVIT	Any cavitation on chest x-ray		f	5	1	1	4	2023-12-04	\N	\N	I_S38_E_CAVIT
157	XDSTDAT	Scheduled study treatment start date	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_E_XDSTDAT
158	COVAL	Comments		f	5	1	1	4	2023-12-04	\N	\N	I_S38_E_COVAL
159	ZCNAME	PRINT name of person completing form		f	5	1	1	4	2023-12-04	\N	\N	I_S38_E_ZCNAME
160	ZCDAT	Date enrollment form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_E_ZCDAT
161	XDARM	Assigned treatment arm (study kit medications)		f	5	1	1	4	2023-12-04	\N	\N	I_S38_E_XDARM
162	XDDECO	Medication		f	5	1	1	4	2023-12-04	\N	\N	I_S38_E_XDDECO
163	XDDOSU	Dose (mg)		f	7	1	1	4	2023-12-04	\N	\N	I_S38_E_XDDOSU
164	XDDURU	Duration # of weeks		f	6	1	1	4	2023-12-04	\N	\N	I_S38_E_XDDURU
165	DDSTDAT	Date of death	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_D_DDSTDAT
166	PRCDTH	Was (were) the cause(s) of death known?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_PRCDTH
167	DDORRE	If yes, list the primary cause(s) of death		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_DDORRE
168	TBDTH	In the clinician's opinion, TB was (check one):		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_TBDTH
169	TXTDTH	What is the likelihood that study treatment was a factor in the participant's death (check one)?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_TXTDTH
170	ANTCDTH	In the opinion of the investigator, was this an anticipated or unanticipated death?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_ANTCDTH
171	VIOACIND	Was the manner of death violent or accidental?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_VIOACIND
172	AUTOPIND	Was an autopsy performed?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_AUTOPIND
173	PMSPEC	Was a post-mortem specimen collected for microbiological or histological workup?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_PMSPEC
174	PMPEX	Was a post-mortem specimen collected for pathological examination?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_PMPEX
175	PMPEXAFB	If "yes", was the specimen positive for TB?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_PMPEXAFB
176	COVAL	Record Microscopic and histologic details here if Q9a above = "Yes"		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_COVAL
177	ZCEVAL	PRINT name of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_ZCEVAL
178	ZCNAME	Signature of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_ZCNAME
179	ZCNAMEB	Name of person completing QA/QC		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_ZCNAMEB
180	ZCDAT	Date Form QA/QC completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_D_ZCDAT
181	ZCNAMEC	Name of person entering form		f	5	1	1	4	2023-12-04	\N	\N	I_S38_D_ZCNAMEC
182	ZCDATC	Date Form entered	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_D_ZCDATC
341	PARTID2	Second part of participant ID	##-#####	f	5	1	1	4	2023-12-05	\N	\N	I_S38_T_PARTID2
349	PARTID	Participant ID	38-##-#####	f	5	1	1	4	2023-12-05	\N	\N	I_S38_I_PARTID
350	SCRDAT	Screening date	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_I_SCRDAT
351	MINSTYDRGS	Minimum of 14 doses of study drugs		f	5	1	1	4	2023-12-05	\N	\N	I_S38_I_MINSTYDRGS
352	TWOCONSDOS	Two consecutive daily study doses via DOT before reference dose		f	5	1	1	4	2023-12-05	\N	\N	I_S38_I_TWOCONSDOS
353	SEVENBDSMP	Seven blood samples over 24-hours		f	5	1	1	4	2023-12-05	\N	\N	I_S38_I_SEVENBDSMP
354	OUTPAT	Willing to be admitted as out-patient		f	5	1	1	4	2023-12-05	\N	\N	I_S38_I_OUTPAT
348	PARTID	Participant ID	38-##-#####	f	5	1	1	4	2023-12-05	\N	\N	I_S38_T_PARTID
342	SPPKSCRDAT	Sparse PK screening date	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_T_SPPKSCRDAT
343	MINSTYDRGS	Minimum of 14 doses of study drugs		f	5	1	1	4	2023-12-05	\N	\N	I_S38_T_MINSTYDRGS
344	TWOCONSDOS	Two consecutive daily study doses via DOT before reference dose		f	5	1	1	4	2023-12-05	\N	\N	I_S38_T_TWOCONSDOS
345	THREEBDSMP	Three blood samples over 4-hours		f	5	1	1	4	2023-12-05	\N	\N	I_S38_T_THREEBDSMP
346	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-05	\N	\N	I_S38_T_PERSCOMP
347	SPPKCMPDAT	Sparse PK screening form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_T_SPPKCMPDAT
355	HIHEMOGLOB	Hemoglobin ≥ 8 g/dL		f	5	1	1	4	2023-12-05	\N	\N	I_S38_I_HIHEMOGLOB
356	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-05	\N	\N	I_S38_I_PERSCOMP
1715	EXSTTIMA	Reference Dose & Vomiting (Pre-reference dose A) Time	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_EXSTTIMA
1716	EXTMCONDA	Reference Dose & Vomiting (Pre-reference dose A) Estimated		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_EXTMCONDA
1717	CETERMVMA	Reference Dose & Vomiting (Pre-reference dose A) Vomiting		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_CETERMVMA
357	SPPKCMPDAT	Sparse PK screening form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_I_SPPKCMPDAT
369	ALTWOLBLNO	CUID Label Number of Aliquot #2	########	f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_ALTWOLBLNO
370	ALIQSTORDAT	Date aliquots stored locally in freezer	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_P_ALIQSTORDAT
371	ALIQSTORTIM	Time aliquots stored locally in freezer	HH:MM	f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_ALIQSTORTIM
372	COMMENTS	Comments		f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_COMMENTS
373	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_PERSCOMP
374	SPPKCMPDAT	Pharmacogenomics form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_P_SPPKCMPDAT
376	NONTBNAME	Name of non-TB and non-antiretroviral medication		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_NONTBNAME
377	NONTBSTDAT	Start date of non-TB and non-antiretroviral medication		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_NONTBSTDAT
378	NONTBENDAT	End date of non-TB and non-antiretroviral medication		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_NONTBENDAT
379	ANTIRENAME	Name of antiretroviral medication		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_ANTIRENAME
380	ANTIRESTDAT	Start date of antiretroviral medication		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_ANTIRESTDAT
381	ANTIREENDAT	End date of antiretroviral medication		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_ANTIREENDAT
382	COMMENTS	Comments		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_COMMENTS
383	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_PERSCOMP
384	SPPKCMPDAT	Concomitant medication form completed		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_SPPKCMPDAT
536	USUBJID	Participant's ID	38-##-####	f	5	1	1	4	2023-12-07	\N	\N	I_S38_T_USUBJID
571	SPPKCMPDAT	Concomitant medication form completed		f	9	1	1	4	2023-12-09	\N	\N	I_S38_C_SPPKCMPDAT_9138
572	JUNK	Ignore this value -- for formatting only		f	5	1	1	4	2023-12-09	\N	\N	I_S38_C_JUNK_6123
573	JUNK2	Ignore this value -- for formatting only		f	5	1	1	4	2023-12-09	\N	\N	I_S38_C_JUNK2_4072
574	JUNK3	Ignore this value -- for formatting only		f	5	1	1	4	2023-12-09	\N	\N	I_S38_C_JUNK3_8611
575	PARTID	Participant ID		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_PARTID_4102
576	DOSETYPE	Dose Type		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_DOSETYPE_6576
577	FOOD	Food		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_FOOD_8941
578	VOMONEHR	Vomiting within 1 hour		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_VOMONEHR_9655
579	DOSEDAT	Dose Date		f	9	1	1	4	2023-12-09	\N	\N	I_S38_D_DOSEDAT_8618
395	PARTID	Participant ID		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_PARTID
396	DOSETYPE	Dose Type		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_DOSETYPE
397	FOOD	Food		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_FOOD
398	VOMONEHR	Vomiting within 1 hour		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_VOMONEHR
399	DOSEDAT	Dose Date		f	9	1	1	4	2023-12-05	\N	\N	I_S38_D_DOSEDAT
400	MG1	mg 1		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG1
401	MG2	mg 2		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG2
402	MG3	mg 3		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG3
403	MG4	mg 4		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG4
404	MG5	mg 5		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG5
405	MG6	mg 6		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG6
406	ADM	Adm		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_ADM
407	TOLRECHAL	Tolerated re-challenge		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_TOLRECHAL
408	COMMENTS	Comments		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_COMMENTS
409	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_PERSCOMP
410	DRCMPDAT	Concomitant medication form completed		f	9	1	1	4	2023-12-05	\N	\N	I_S38_D_DRCMPDAT
411	PARTID	Participant ID		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_PARTID_1113
412	DOSETYPE	Dose Type		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_DOSETYPE_4222
413	FOOD	Food		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_FOOD_9083
414	VOMONEHR	Vomiting within 1 hour		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_VOMONEHR_436
415	DOSEDAT	Dose Date		f	9	1	1	4	2023-12-05	\N	\N	I_S38_D_DOSEDAT_4846
416	MG1	mg 1		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG1_8983
246	SUCDURUD	Unit		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SUCDURUD_4205
247	PERINEUR	Peripheral neuropathy		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_PERINEUR_6550
248	MHTERM	If yes, please specify the past mental health diagnoses		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTERM_5776
249	BRTHCTRY	Place of birth		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_BRTHCTRY_7429
250	MHBODSYS	specify the system organ class for each extrapulmonary site		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHBODSYS_5670
251	MHTERMART	Has the participant ever been prescribed and taken antiretroviral therapy (ART)?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTERMART_2253
252	TBPRIORTX	Was the participant ever treated for active TB prior to this episode		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_TBPRIORTX_8581
253	CANCER	Cancer		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_CANCER_1844
254	HEPB	Hepatitis B		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_HEPB_4307
255	HEPC	Hepatitis C		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_HEPC_8479
256	MHSTYRCOND	what were the most recent month and year	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_H_MHSTYRCOND_4468
257	ZNTERMCM	Was the participant taking non-TB medications, including over-the-counter drugs, in the 14 days prior to study treatment start date		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_ZNTERMCM_5571
417	MG2	mg 2		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG2_9795
418	MG3	mg 3		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG3_4832
419	MG4	mg 4		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG4_2039
420	MG5	mg 5		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG5_4081
421	MG6	mg 6		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG6_1009
422	ADM	Adm		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_ADM_3084
423	TOLRECHAL	Tolerated re-challenge		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_TOLRECHAL_3942
424	COMMENTS	Comments		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_COMMENTS_341
580	MG1	mg 1		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_MG1_8502
581	MG2	mg 2		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_MG2_4528
258	VISDAT	Visit date	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_H_VISDAT_4804
259	ZNOCCUR	Was the participant taking any antiretroviral therapy in the 14 days prior to study treatment start date		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_ZNOCCUR_679
260	MHSCAT	Past personal mental illness		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHSCAT_5007
261	RCORRFACP	Resident of correctional facility		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_RCORRFACP_7714
262	MHTERMCARDIAC	Specify		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTERMCARDIAC_940
263	EXTRATB	Does participant currently have extrapulmonary TB		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_EXTRATB_5619
264	SUCDURC	Total duration of tobacco use		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SUCDURC_5290
265	DIABETES	Diabetes		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_DIABETES_1713
266	MHTERMTRAUMA	please specify the event(s)		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTERMTRAUMA_688
267	SUDSTXT	Number of cigarettes currently or formerly smoked per day		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SUDSTXT_7378
268	MHREC	Medical records confirming diabetes diagnosis available		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHREC_7122
269	RIDU	Injecting drug use		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_RIDU_2747
270	SUCDURN	Amount		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SUCDURN_247
271	SUCDURCD	Time since participant quit smoking		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SUCDURCD_3445
272	HEPUNK	Hepatitis (Type unknown)		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_HEPUNK_7596
273	SUCDURU	Unit		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SUCDURU_1974
274	LIVER	Liver disease		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_LIVER_9408
275	ZNTERMDR	Was the participant taking pre-study TB treatment in the 6 months prior to study start date and/or drugs with anti-TB activity given for purposes other than treatment of TB in the 30 days prior to study treatment start date		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_ZNTERMDR_7936
276	SCORRESN	Karnofsky score		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SCORRESN_9825
277	ZCDAT	Date History Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-04	\N	\N	I_S38_H_ZCDAT_7553
278	MHTERMCDLS	Has the participant ever had a CD4 cell count below 200 cells/mm3?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTERMCDLS_902
279	ZNTERMART	In what year was ART initiated	YYYY	f	6	1	1	4	2023-12-04	\N	\N	I_S38_H_ZNTERMART_9534
280	COVAL	Comments		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_COVAL_5647
281	OTHERC	Other concomitant diagnoses, including any current/active mental illness or problems		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_OTHERC_1059
282	RALCOHOL	Alcohol use led to problems in relationships		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_RALCOHOL_9205
283	SEX	Sex		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SEX_8550
284	MHSTMOWHO	Month		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHSTMOWHO_2442
285	MHTERMSELF	If yes, please specify the past mental health diagnoses		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTERMSELF_1528
286	CARDIAC	Cardiac conditions		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_CARDIAC_9045
287	SUTRT	Has participant ever smoked tobacco		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SUTRT_7083
288	ETHNIC	Ethnicity		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_ETHNIC_3005
289	MHTRAUMA	Past personal experience of traumatic event(s)		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTRAUMA_9540
290	MHSTYR	Specify diabetes type		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHSTYR_3163
291	MHSTYRWHO	Year	YYYY	f	6	1	1	4	2023-12-04	\N	\N	I_S38_H_MHSTYRWHO_9300
292	ZCNAME	name of person completing form		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_ZCNAME_320
293	MHTERMCHANGE	please specify medication and mental status change		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTERMCHANGE_1487
294	MHCAT	Mental health history		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHCAT_4298
295	RACEOTH	Other		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_RACEOTH_1586
296	RHOMELESS	Homeless		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_RHOMELESS_9661
297	HEPALC	Hepatitis due to alcohol use		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_HEPALC_3260
298	ZNCATAT	Was the participant taking any antidiabetic medications		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_ZNCATAT_4108
299	MHTERMWHO	List WHO Clinical Stage 4 Conditions and provide month and year (e.g., JAN-2021) of onset		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTERMWHO_370
300	CPLTPRTX	Did participant complete prescribed TB treatment?		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_CPLTPRTX_4852
301	MHCHANGE	Unintended mental status changes induced by specific medications or substances		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHCHANGE_2943
302	OTHER	Other		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_OTHER_1676
303	MHSTYRHIV	What year was the participant first documented as HIV-positive		f	6	1	1	4	2023-12-04	\N	\N	I_S38_H_MHSTYRHIV_7143
304	RACENR	Race		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_RACENR_8700
305	RNIDU	Non-injecting drug use		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_RNIDU_3734
306	SUCDURND	Amount		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_SUCDURND_7412
307	MHDIAG	In what year diabetes was diagnosed		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHDIAG_2949
308	MHTERMCANCER	Specify		f	5	1	1	4	2023-12-04	\N	\N	I_S38_H_MHTERMCANCER_1588
358	PARTID	Participant ID	38-##-#####	f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_PARTID
359	STDYEVAL	Study Evaluation		f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_STDYEVAL
360	SEQID	Sequence ID	####	f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_SEQID
361	UNSCHEDDAT	Date of Unscheduled Visit	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_P_UNSCHEDDAT
362	SPECCOLLDAT	Date of specimen collection	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_P_SPECCOLLDAT
363	SPECCOLLTIM	Time of specimen collection	HH:MM	f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_SPECCOLLTIM
364	TOTVOLCOLL	Total Volume Collected	mL	f	7	1	1	4	2023-12-05	\N	\N	I_S38_P_TOTVOLCOLL
365	ALIQMADE	Were any aliquots made		f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_ALIQMADE
366	ALIQONEVOL	Vol of Aliquot 1	mL	f	7	1	1	4	2023-12-05	\N	\N	I_S38_P_ALIQONEVOL
367	ALIQTWOVOL	Vol of Aliquot 2	mL	f	7	1	1	4	2023-12-05	\N	\N	I_S38_P_ALIQTWOVOL
368	ALONELBLNO	CUID Label Number of Aliquot #1	########	f	5	1	1	4	2023-12-05	\N	\N	I_S38_P_ALONELBLNO
425	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_PERSCOMP_3412
426	DRCMPDAT	Concomitant medication form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_D_DRCMPDAT_1458
427	PARTID	Participant ID		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_PARTID_7601
428	DOSETYPE	Dose Type		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_DOSETYPE_6249
429	FOOD	Food		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_FOOD_5513
430	VOMONEHR	Vomiting within 1 hour		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_VOMONEHR_6280
431	DOSEDAT	Dose Date		f	9	1	1	4	2023-12-05	\N	\N	I_S38_D_DOSEDAT_242
432	MG1	mg 1		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG1_3310
433	MG2	mg 2		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG2_7929
434	MG3	mg 3		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG3_9753
435	MG4	mg 4		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG4_4319
436	MG5	mg 5		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG5_5740
437	MG6	mg 6		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_MG6_7040
438	ADM	Adm		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_ADM_1432
439	TOLRECHAL	Tolerated re-challenge		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_TOLRECHAL_4644
440	COMMENTS	Comments		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_COMMENTS_9677
441	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-05	\N	\N	I_S38_D_PERSCOMP_9408
442	DRCMPDAT	Date TB Drug Dose Record Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-05	\N	\N	I_S38_D_DRCMPDAT_7541
537	DSDECOD	Complete study follow-up		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSDECOD
538	DSFURNC	Reason for not completing study follow-up		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSFURNC
539	DSPWCR	Participant withdrew consent		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSPWCR
540	DSPWSR	Specify reason		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSPWSR
541	DSPDIAE	Participant determined ineligible		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSPDIAE
542	DSPDISR	Specify reason		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSPDISR
543	DSPILFU	Participant is lost to follow-up		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSPILFU
544	DSPILSR	Specify reason		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSPILSR
545	DSPOTH	Other		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSPOTH
546	DSPOSR	Specify reason		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_DSPOSR
547	DSDSFU	Date study follow-up ended	DD-MMM-YYYY	f	9	1	1	4	2023-12-08	\N	\N	I_S38_F_DSDSFU
548	BEMODIFY	Storage of blood specimens for pharmacogenomic testing		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_BEMODIFY
549	BEDAT	Storage withdrawal date	DD-MMM-YYYY	f	9	1	1	4	2023-12-08	\N	\N	I_S38_F_BEDAT
550	COREF	Reason for withdrawal of specimen storage		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_COREF
551	BECAT	Storage of blood specimens for future research		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_BECAT
552	BESOBD	Storage withdrawal date	DD-MMM-YYYY	f	9	1	1	4	2023-12-08	\N	\N	I_S38_F_BESOBD
553	CSDCE	Comments		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_CSDCE
554	ZCNAME	Form Completion		f	5	1	1	4	2023-12-08	\N	\N	I_S38_F_ZCNAME_8197
555	ZCDAT	Date Follow-up Completion Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-08	\N	\N	I_S38_F_ZCDAT_1001
21	AESEEN	Was participant seen by an MD, urgent care or ER staff?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_AESEEN
27	ZNCATA	Date of ultrasound	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNCATA
11	ZNOCCURA	Were any non-study medications taken within 7 days of initial presentation of sign(s) or symptoms(s)?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNOCCURA
17	ZIACN	Clinician action taken with regard to study treatment		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZIACN
10	ZIWORSE	Was this event a worsening to grade 3 or higher of sign(s), symptoms or medical condition that was present at screening/baseline?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZIWORSE
6	ZISERA	If yes, indicate type of SAE		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZISERA
18	COREF	Summary of AE		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_COREF
19	AEDOSE	How long, in hours, after the dose immediately before the AE did the signs and symptoms start?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_AEDOSE
1	VISDATRPDAT	Date of site awareness	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_VISDATRPDAT
20	AESS	Did the participant present with signs and symptoms similar to those reported in this AE report, but of lower toxicity grade, prior to this AE?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_AESS
26	ZNCAT	Was an ultrasound done?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNCAT
4	ZITERM	What is the reportable adverse event?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZITERM
2	ZISTDAT	Date of AE onset	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_ZISTDAT
9	ZITOXGR	Indicate the maximum toxicity grade of event by the time of this report		f	6	1	1	4	2023-12-03	\N	\N	I_S38_A_ZITOXGR
582	MG3	mg 3		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_MG3_956
583	MG4	mg 4		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_MG4_8402
584	MG5	mg 5		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_MG5_1366
585	MG6	mg 6		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_MG6_1690
586	ADM	Adm		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_ADM_4480
587	TOLRECHAL	Tolerated re-challenge		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_TOLRECHAL_1181
588	COMMENTS	Comments		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_COMMENTS_974
589	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-09	\N	\N	I_S38_D_PERSCOMP_389
590	DRCMPDAT	Date TB Drug Dose Record Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-09	\N	\N	I_S38_D_DRCMPDAT_7170
591	PARTID	Participant ID	38-##-#####	f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_PARTID_9283
592	STDYEVAL	Study Evaluation		f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_STDYEVAL_1082
593	SEQID	Sequence ID	####	f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_SEQID_8839
594	UNSCHEDDAT	Date of Unscheduled Visit	DD-MMM-YYYY	f	9	1	1	4	2023-12-09	\N	\N	I_S38_P_UNSCHEDDAT_4880
595	SPECCOLLDAT	Date of specimen collection	DD-MMM-YYYY	f	9	1	1	4	2023-12-09	\N	\N	I_S38_P_SPECCOLLDAT_3383
596	SPECCOLLTIM	Time of specimen collection	HH:MM	f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_SPECCOLLTIM_6262
462	TRECHUNSC	Date of Unscheduled visits if any	DD-MMM-YYYY	f	9	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHUNSC
463	SEQIDADEV	Squence ID of Adverse event, if any		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_SEQIDADEV
464	SEQUIDPTR	Squence ID of Possible Poor Treatment Response, if any		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_SEQUIDPTR
465	TRECHADEV	Were there any additional events associated with this treatment change?		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHADEV
466	SEQUIDEVI	Sequence ID of additional adverse event 1, if any		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_SEQUIDEVI
467	SEQUIDEVII	Sequence ID of additional adverse event 2, if any		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_SEQUIDEVII
468	SEQUIDPTRI	Sequence ID of additional Possible Poor Treatment Response, if any.		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_SEQUIDPTRI
469	TRECHREC	Did the Site Investigator recommend a change in TB treatment?		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHREC
470	TRECHTYP	Which change to TB treatment was recommended by the Site Investigator?		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHTYP
471	TRECHOTR	Other change(s) to TB treatment recommended by the Site Investigator		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHOTR
472	TRECHRES	Reasons for recommending TB treatment change		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHRES
478	NREGSTRT	Knowledge of Start date of non-study regimen		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_NREGSTRT
885	MLSTTIM	Time within ± 1 Hour of Dose	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLSTTIM
883	MLDOSTXT	Quantity within ± 1 Hour of Dose		f	6	1	1	4	2023-12-11	\N	\N	I_S38_T_MLDOSTXT
1379	BEREFIDDDA	Intensive PK 1D 4hrs post ref. dose TBTC Label Number 1	####4#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDDA_4672
443	PARTID	Participant's Identification Number		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_PARTID
444	DATEVISIT	Visit or date of blood sample collection		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_DATEVISIT
445	POPTBTR	Possible Poor TB Treatment Response		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_POPTBTR
446	SEQID	Sequence ID		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_SEQID
447	UNSEVISIT	Unscheduled visit	DD-MMM-YYYY	f	9	1	1	4	2023-12-06	\N	\N	I_S38_B_UNSEVISIT
448	SHIPSDATE	Date sample shipped to central storage facility:	DD-MMM-YYYY	f	9	1	1	4	2023-12-06	\N	\N	I_S38_B_SHIPSDATE
449	SHIPSLBL	Label number of shipped sample		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_SHIPSLBL
450	SPECFROZ	Was the specimen frozen prior to shipping?		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_SPECFROZ
451	SPECTHAW	If “yes”, did the specimen thaw before shipping?		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_SPECTHAW
452	THAWTIME	Amount of time thawed		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_THAWTIME
453	THAWTIMES	Specific number of hours or days thawed, if any		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_THAWTIMES
454	THAWEXTN	Extent thawed		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_THAWEXTN
455	COMMNT	Comment		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_COMMNT
456	PRINTNME	PRINT name of person completing form:		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_PRINTNME
457	DATEFRBRF	Date Future Research Blood Form completed:	DD-MMM-YYYY	f	9	1	1	4	2023-12-06	\N	\N	I_S38_B_DATEFRBRF
458	SPECCONCS	Central storage report on Condition of Specimens		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_SPECCONCS
459	SPECCONAL	Analysis laboratory report on Condition of Specimens		f	5	1	1	4	2023-12-06	\N	\N	I_S38_B_SPECCONAL
597	TOTVOLCOLL	Total Volume Collected	mL	f	7	1	1	4	2023-12-09	\N	\N	I_S38_P_TOTVOLCOLL_3008
474	TRECHNIT	Was a change in TB treatment actually initiated?		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHNIT
475	TRECHALTD	If TB treatment wasn't initiated or it is unknown, was an alternative diagnosis established?		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHALTD
598	ALIQMADE	Were any aliquots made		f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_ALIQMADE_104
879	CEXTMCOND	Reference Dose & Vomiting Reference dose Estimated		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CEXTMCOND
1381	BEDURU	Amount of time thawed Unit		f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEDURU_8260
881	MLCAT	Was food consumed ± 1 hour the administration of the reference dose?		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLCAT
1382	BEDURN	Amount of time thawed Amount		f	6	1	1	4	2023-12-18	\N	\N	I_38_PK_BEDURN_9235
1383	ZCNAME	Form Completion		f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_ZCNAME_2423
1384	BEREFIDCBD	Sparse PK 1B Right before ref. dose TBTC Label Number 4	#### 0 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCBD_2129
461	TRECHRPT	Visit for reporting treatment change		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHRPT
1385	BEREFIDCBC	Sparse PK 1B Right before ref. dose TBTC Label Number 3	#### 0 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCBC_9841
922	ZCNAME	PRINT name of person completing form		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ZCNAME
599	ALIQONEVOL	Vol of Aliquot 1	mL	f	7	1	1	4	2023-12-09	\N	\N	I_S38_P_ALIQONEVOL_1903
600	ALIQTWOVOL	Vol of Aliquot 2	mL	f	7	1	1	4	2023-12-09	\N	\N	I_S38_P_ALIQTWOVOL_8844
1386	BEREFIDDDD	Intensive PK 1D 4hrs post ref. dose TBTC Label Number 4	####4#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDDD_4879
460	PARTID	Participant's ID		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_PARTID_7826
874	BEXSTTIM	Reference Dose & Vomiting Pre-reference dose B Time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BEXSTTIM
601	ALONELBLNO	CUID Label Number of Aliquot #1	########	f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_ALONELBLNO_1636
602	ALTWOLBLNO	CUID Label Number of Aliquot #2	########	f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_ALTWOLBLNO_8738
603	ALIQSTORDAT	Date aliquots stored locally in freezer	DD-MMM-YYYY	f	9	1	1	4	2023-12-09	\N	\N	I_S38_P_ALIQSTORDAT_2557
604	ALIQSTORTIM	Time aliquots stored locally in freezer	HH:MM	f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_ALIQSTORTIM_8402
605	COMMENTS	Comments		f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_COMMENTS_2512
606	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-09	\N	\N	I_S38_P_PERSCOMP_1647
607	SPPKCMPDAT	Pharmacogenomics form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-09	\N	\N	I_S38_P_SPPKCMPDAT_2063
870	AEXSTTIM	Reference Dose & Vomiting Pre-reference dose A Time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AEXSTTIM
43	ZISONAMEB	Safety officer determining attribution		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZISONAMEB
40	ZILLT	Initial MedDRA Lower Level Term Description		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZILLT
486	RPMETHODOTH	Other Method		f	5	1	1	4	2023-12-06	\N	\N	I_S38_A_RPMETHODOTH
37	ZNOCCUR	Is this a reportable event?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNOCCUR
30	ZCNAME	Signature of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCNAME
16	ZITXDOS	How many post-enrollment study drug doses were administered prior to the participant initially presenting with sign(s) or symptom(s)?		f	6	1	1	4	2023-12-03	\N	\N	I_S38_A_ZITXDOS
35	ZCNAMEC	Name of person entering form		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCNAMEC
29	ZCEVAL	PRINT name of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCEVAL
33	ZCNAMEB	Name of person completing QA/QC		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCNAMEB
31	ZCNAMEA	Name of person completing form		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCNAMEA
12	ZNTERM	Are results for any of the following evaluations or procedures available for this AE?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNTERM
41	ZISONAME	Safety officer providing MedDRA code		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZISONAME
5	ZISER	Was this a serious adverse event (SAE)?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZISER
14	ZNTERMC	Signs and symptoms assessment		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNTERMC
3	ZIDX	Was a diagnosis assigned?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZIDX
13	ZNTERMB	Clinical evaluations		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNTERMB
23	RPTEST	Date of first day of last menstrual period	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_RPTEST
24	RPTESTCD	Estimated date of delivery	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_RPTESTCD
15	ZNTERMD	Sputum or other specimen collected for TB diagnostic workup		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNTERMD
34	ZCDATB	Date Form QA/QC completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCDATB
36	ZCDATC	Date Form entered	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCDATC
39	ZILLTCD	Initial MedDRA Lower Level Term Code		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZILLTCD
22	AERX	If applicable, list the medications that were prescribed to treat the AE, including doses and frequency:		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_AERX
25	RPMETHOD	What method was used to estimate date of delivery?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_RPMETHOD
38	ZISONAM	Safety Officer determining reportability		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZISONAM
42	ZISOREL	In the opinion of the CDC Safety Officer, what is the attribution to study treatment in causing this AE?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZISOREL
7	ZIREL	what is the attribution to study treatment in causing this AE?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZIREL
8	ZIANTC	is this an anticipated or unanticipated AE?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZIANTC
32	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_A_ZCDAT
28	ZNCATB	Estimated gestational age		f	5	1	1	4	2023-12-03	\N	\N	I_S38_A_ZNCATB
490	VISDAT	Visit or date of blood sample collection		f	9	1	1	4	2023-12-07	\N	\N	I_S38_F_VISDAT_1668
491	SQCEID	Sequence ID		f	6	1	1	4	2023-12-07	\N	\N	I_S38_F_SQCEID
492	VISDATV	Date of visit	DD-MMM-YYYY	f	9	1	1	4	2023-12-07	\N	\N	I_S38_F_VISDATV
493	BLCODA	Blood for future research sampling	DD-MMM-YYYY	f	9	1	1	4	2023-12-07	\N	\N	I_S38_F_BLCODA
494	ACBLCOTI	Actual blood collection time (HH:MM)	HH:MM	f	5	1	1	4	2023-12-07	\N	\N	I_S38_F_ACBLCOTI
495	TOVOCO	Total volume collected	ml	f	7	1	1	4	2023-12-07	\N	\N	I_S38_F_TOVOCO
496	RELANUM	Report the Label Number exactly as written on the label affixed to the tube		f	6	1	1	4	2023-12-07	\N	\N	I_S38_F_RELANUM
497	DATEPAXTW	Date/time PAXGene tube transferred to -20°C freezer:	DD-MMM-YYYY	f	9	1	1	4	2023-12-07	\N	\N	I_S38_F_DATEPAXTW
385	PARTID	Participant ID		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_PARTID_5296
386	NONTBNAME	Name of non-TB and non-antiretroviral medication		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_NONTBNAME_2979
387	NONTBSTDAT	Start date of non-TB and non-antiretroviral medication		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_NONTBSTDAT_1385
388	NONTBENDAT	End date of non-TB and non-antiretroviral medication		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_NONTBENDAT_8921
389	ANTIRENAME	Name of antiretroviral medication		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_ANTIRENAME_86
390	ANTIRESTDAT	Start date of antiretroviral medication		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_ANTIRESTDAT_661
391	ANTIREENDAT	End date of antiretroviral medication		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_ANTIREENDAT_383
392	COMMENTS	Comments		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_COMMENTS_7890
393	PERSCOMP	Person completing form		f	5	1	1	4	2023-12-05	\N	\N	I_S38_C_PERSCOMP_8776
394	SPPKCMPDAT	Concomitant medication form completed		f	9	1	1	4	2023-12-05	\N	\N	I_S38_C_SPPKCMPDAT_5876
487	JUNK	Ignore this value -- for formatting only		f	5	1	1	4	2023-12-06	\N	\N	I_S38_C_JUNK
488	JUNK2	Ignore this value -- for formatting only		f	5	1	1	4	2023-12-06	\N	\N	I_S38_C_JUNK2
498	TIMEPAXTW	Date/time PAXGene	HH:MM	f	5	1	1	4	2023-12-07	\N	\N	I_S38_F_TIMEPAXTW
499	DATEPAXSE	Date/time PAXGene tube transferred to -70°C freezer or below for long term storage:	DD-MMM-YYYY	f	9	1	1	4	2023-12-07	\N	\N	I_S38_F_DATEPAXSE
500	TIMEPAXSE	Date/time PAXGene tube transferred to -70°C	HH:MM	f	5	1	1	4	2023-12-07	\N	\N	I_S38_F_TIMEPAXSE
489	JUNK3	Ignore this value -- for formatting only		f	5	1	1	4	2023-12-06	\N	\N	I_S38_C_JUNK3
501	COVAL	Comments		f	5	1	1	4	2023-12-07	\N	\N	I_S38_F_COVAL_5437
502	NCNAME	Form Completion		f	5	1	1	4	2023-12-07	\N	\N	I_S38_F_NCNAME
503	NCDAT	Date Non-enrollment Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-07	\N	\N	I_S38_F_NCDAT
473	TRECHROTH	Other reasons for recommending TB treatment change		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHROTH
1387	BEREFIDCBB	Sparse PK 1B Right before ref. dose TBTC Label Number 2	#### 0 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCBB_3993
1175	ZNTERMRS	Was sputum collected for RS ratio essay?		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMRS_3213
1176	ZNTERMPG	Was a specimen for pharmacogenomics testing collected?		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMPG_2908
1177	ZNTERMBR	Biomarker analysis collected		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMBR_2279
888	AMLSTTIM	Time Last Meal	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AMLSTTIM
506	TRECHRRT	Visit for reporting treatment change		f	5	1	1	4	2023-12-07	\N	\N	I_S38_T_TRECHRRT
504	TRECHINIT	Was a change in TB treatment actually initiated?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_T_TRECHINIT
505	TRECHALT	If TB treatment wasn't initiated or it is unknown, was an alternative diagnosis established?		f	5	1	1	4	2023-12-07	\N	\N	I_S38_T_TRECHALT
476	TRECHXNIT	If Site Investigator recommended a change in TB treatment, and it was not initiated, what was the reason for not changing treatment?		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHXNIT
477	TRECHMED	Medications included in initial non-study regimen or extension of treatment if TB treatment was changed		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_TRECHMED
479	NREGSDTE	Actual or estimated non-study regimen start date		f	9	1	1	4	2023-12-06	\N	\N	I_S38_T_NREGSDTE
480	COMMNTS	Comments		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_COMMNTS
481	PRINPIC	PRINT name of Principal Investigator or Co-PI:		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_PRINPIC
482	SIGNPIC	Signature of Principal Investigator or Co-PI:		f	11	1	1	4	2023-12-06	\N	\N	I_S38_T_SIGNPIC
483	PRINPCF	PRINT name of person completing form:		f	5	1	1	4	2023-12-06	\N	\N	I_S38_T_PRINPCF
484	SGNPCF	Signature of person completing form:		f	11	1	1	4	2023-12-06	\N	\N	I_S38_T_SGNPCF
485	DATEFRCP	Date Form completed:		f	9	1	1	4	2023-12-06	\N	\N	I_S38_T_DATEFRCP
887	AMLSTDAT	Day Last Meal	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_AMLSTDAT
890	SUOCCUR	Did participant abstain from alcohol for at least 48 hours prior to PK sampling?		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_SUOCCUR
891	BESTAT	Pre-ref dose (t=1) Time point		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BESTAT
889	AMLTMCOND	Estimated Time Last Meal		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AMLTMCOND
892	BETIMA	Pre-ref dose (t=1) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BETIMA
911	BBBESTAT	Right before ref. dose (t=0)		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBBESTAT
1179	ZNTERMIPK	Were tb drug intensive PK specimens collected		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMIPK_1519
1180	ZNTERMPR	Participant is diagnosed as pregnant		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMPR_6380
1181	ZNTERMTM	Were any modifications to the assigned study TB treatment		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMTM_9693
1170	ZNDTERMCE	Clinical evaluations		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNDTERMCE_871
1186	ZNTERMPRA	Participant is diagnosed as pregnant		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMPRA
1182	TXSTATA	Study Treatment		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_TXSTATA
1173	ZNTERMMB	Sputum Collection Attempted		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMMB_7043
1174	ZNORRESN	If yes, how many specimens were collected		f	6	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNORRESN_6485
1187	ZNTERMBRA	Biomarker analysis collected		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMBRA
1171	ZNTERMLB	Were new lab tests ordered		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMLB_1515
1178	ZNTERMTSPK	Were TB drug sparse PK specimen collected?		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMTSPK_1248
1188	ZNTERMIPKA	Were tb drug intensive PK specimens collected		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMIPKA
1165	VISSTAT	Visit Missed		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_VISSTAT_7918
921	COVAL	Comments		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_COVAL
1168	ZNDTERMDR	Did participant take any TB medications?		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNDTERMDR_9742
1189	ZNTERMPGA	Was a specimen for pharmacogenomics testing collected?		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMPGA
1167	ZNVISDAT	Date of visit	DD-MMM-YYYY	f	9	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNVISDAT_3686
1172	ZNTERMSS	Symptoms assessed		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMSS_7525
1169	ZNDTERMCM	Did participant report any changes in antiretroviral or non-TB medications?		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNDTERMCM_5451
1190	ZNTERMRSA	Was sputum collected for RS ratio essay?		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNTERMRSA
113	VISDAT	Date of AE onset	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_F_VISDAT
115	ZNTERMDR	Did participant take any drugs with anti-TB activity		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMDR
116	ZNTERMCE	Were any clinical evaluations		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMCE
118	ZNTERMSS	Were signs and symptoms assessed		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMSS
120	ZNTERMRS	Was sputum collected for RS ratio assay		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMRS
1166	ZNVISIT	Week of evaluation		f	5	1	1	4	2023-12-18	\N	\N	I_38_TX_ZNVISIT_7714
1388	BEREFIDDDC	Intensive PK 1D 4hrs post ref. dose TBTC Label Number 3	####4#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDDC_1350
1389	BEREFIDDCA	Intensive PK 1C 2hrs post ref. dose TBTC Label Number 1	####2#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDCA_7178
1390	BEREFIDDGD	Intensive PK 1G 24 hrs post ref. dose TBTC Label Number 4	####24#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDGD_9487
1391	BEREFIDDGC	Intensive PK 1G 24 hrs post ref. dose TBTC Label Number 3	####24#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDGC_9377
1392	BEREFIDDGB	Intensive PK 1G 24 hrs post ref. dose TBTC Label Number 2	####24#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDGB_1245
1393	BEREFIDDGA	Intensive PK 1G 24 hrs post ref. dose TBTC Label Number 1	####24#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDGA_3802
1395	BEOCCURFR	Specimens Frozen Prior To Shipping		f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEOCCURFR_6605
1396	BEREFIDCAD	Sparse PK 1A Pre ref. dose TBTC Label Number 4	#### -1 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCAD_5164
1397	BEREFIDCAC	Sparse PK 1A Pre ref. dose TBTC Label Number 3	#### -1 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCAC_8993
560	VISITMID	Was the visit missed		f	5	1	1	4	2023-12-09	\N	\N	I_S38_F_VISITMID
112	VISIT	Week/Month of evaluation		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_VISIT
114	ZNTERMCM	Did participant report any changes in antiretroviral or non-TB/non-antiretroviral medications, including over-the-counter drugs?		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMCM
117	ZNTERMLB	Are new laboratory test results available		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMLB
119	ZNTERMMB	Was sputum collection attempted or other specimen collected for AFB work-up		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMMB
561	ZNORRESN	If yes, how many specimens were collected		f	5	1	1	4	2023-12-09	\N	\N	I_S38_F_ZNORRESN
121	ZNTERMPG	Was a specimen for pharmacogenomics testing collected		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMPG
122	ZNTERMBR	Was a specimen for biomarker analysis collected		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMBR
123	ZNTERMTM	Were any modifications made to the assigned study TB treatment		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZNTERMTM
124	COVAL	Comments		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_COVAL
125	ZCNAME	Name of person completing form		f	5	1	1	4	2023-12-03	\N	\N	I_S38_F_ZCNAME
126	ZCDAT	Date Follow-up Evaluation Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-03	\N	\N	I_S38_F_ZCDAT
924	VSORRESUH	Height unit		f	5	1	1	5	2023-12-11	\N	\N	I_S38_E_VSORRESUH
907	AABEREFID	TBTC Label Number at Pre-ref dose (t=1) 1	#### -1 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AABEREFID
1398	BEREFIDDCD	Intensive PK 1C 2hrs post ref. dose TBTC Label Number 4	####2#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDCD_607
1399	BEREFIDCAB	Sparse PK 1A Pre ref. dose TBTC Label Number 2	#### -1 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCAB_5789
1400	BEREFIDDCC	Intensive PK 1C 2hrs post ref. dose TBTC Label Number 3	####2#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDCC_4440
1718	EXSTDATB	Reference Dose & Vomiting (Pre-reference dose B) Date	DD-MMM-YYYY	f	9	1	1	8	2023-12-20	\N	\N	I_38_IP_EXSTDATB
1719	EXSTTIMB	Reference Dose & Vomiting (Pre-reference dose B) Time	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_EXSTTIMB
1720	EXTMCONDB	Reference Dose & Vomiting (Pre-reference dose B) Estimated		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_EXTMCONDB
1721	CETERMVMB	Reference Dose & Vomiting (Pre-reference dose B) Vomiting		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_CETERMVMB
1722	EXSTDATC	Reference Dose & Vomiting (Reference dose) Date	DD-MMM-YYYY	f	9	1	1	8	2023-12-20	\N	\N	I_38_IP_EXSTDATC
1723	EXSTTIMC	Reference Dose & Vomiting (Reference dose) Time	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_EXSTTIMC
1724	EXTMCONDC	Reference Dose & Vomiting (Reference dose) Estimated		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_EXTMCONDC
1725	CETERMVMC	Reference Dose & Vomiting (Reference dose) Vomiting		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_CETERMVMC
923	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_ZCDAT
1726	CEOCCURA	Did participant vomit between PK reference dose administration and last PK specimen collection?		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_CEOCCURA
1727	ESTTIMD	If "yes", provide the date/time vomiting started	DD-MMM-YYYY	f	9	1	1	8	2023-12-20	\N	\N	I_38_IP_ESTTIMD
1728	ESTTIMDT	Time when vomiting started	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_ESTTIMDT
908	ABBEREFID	TBTC Label Number at Pre-ref dose (t=1) 2	#### -1 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ABBEREFID
906	AABESTAT	2a Time point Pre ref. dose (t=-1)		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AABESTAT
909	ACBEREFID	TBTC Label Number at Pre-ref dose (t=1) 3	#### -1 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ACBEREFID
876	BCEOCCUR	Reference Dose & Vomiting Pre-reference dose B Vomiting		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BCEOCCUR
916	CCBESTAT	3 hrs (post ref. dose)		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CCBESTAT
961	BEREFIDDBB	TSPK 1B 1hr post ref. dose TBTC Label Number 2	####1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDBB
962	BEREFIDDBC	TSPK 1B 1hr post ref. dose TBTC Label Number 3	####1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDBC
963	BEREFIDDBD	TSPK 1B 1hr post ref. dose TBTC Label Number 4	####1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDBD
964	BEREFIDDCA	TSPK 1C 2hrs post ref. dose TBTC Label Number 1	####2#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDCA
965	BEREFIDDCB	TSPK 1C 2hrs post ref. dose TBTC Label Number 2	####2#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDCB
966	BEREFIDDCC	TSPK 1C 2hrs post ref. dose TBTC Label Number 3	####2#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDCC
967	BEREFIDDCD	TSPK 1C 2hrs post ref. dose TBTC Label Number 4	####2#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDCD
968	BEREFIDDDA	TSPK 1D 4hrs post ref. dose TBTC Label Number 1	####4#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDDA
886	MLTMCOND	Estimated Time within ± 1 Hour of Dose		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLTMCOND
899	BBETIMC	Right before ref. dose (t=0) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBETIMC
912	BABEREFID	TBTC Label Number at ref. dose (t=0) 1	#### 0 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BABEREFID
903	CBETIMB	3 hrs (post ref. dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBETIMB
913	BBBEREFID	TBTC Label Number at ref. dose (t=0) 2	#### 0 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBBEREFID
969	BEREFIDDDB	TSPK 1D 4hrs post ref. dose TBTC Label Number 2	####4#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDDB
970	BEREFIDDDC	TSPK 1D 4hrs post ref. dose TBTC Label Number 3	####4#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDDC
971	BEREFIDDDD	TSPK 1D 4hrs post ref. dose TBTC Label Number 4	####4#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDDD
972	BEREFIDDEA	TSPK 1E 6hrs post ref. dose TBTC Label Number 1	####6#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDEA
904	CBETIMC	3 hrs (post ref. dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBETIMC
905	CBEOCCUR	3 hrs (post ref. dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBEOCCUR
914	BCBEREFID	TBTC Label Number at ref. dose (t=0) 3	#### 0 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BCBEREFID
1729	MLCAT	Was food consumed ± 1 hour the administration of the reference dose?		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_MLCAT
1730	MLTRT	Food consumed within ± 1 Hour of Dose		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_MLTRT
1731	MLDOSTXT	Quantity within ± 1 Hour of Dose		f	6	1	1	8	2023-12-20	\N	\N	I_38_IP_MLDOSTXT
1732	MLDOSU	Unit within ± 1 Hour of Dose		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_MLDOSU
900	BBEOCCUR	Right before ref. dose (t=0) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBEOCCUR
1733	MLSTTIMA	Time within ± 1 Hour of Dose	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_MLSTTIMA
1734	MLTMCONDA	Estimated Time within ± 1 Hour of Dose		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_MLTMCONDA
1735	MLSTDAT	Day Last Meal	DD-MMM-YYYY	f	9	1	1	8	2023-12-20	\N	\N	I_38_IP_MLSTDAT
1736	MLSTTIMB	Time Last Meal	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_MLSTTIMB
1737	MLTMCONDB	Estimated Time Last Meal		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_MLTMCONDB
1738	SUTRT	Did participant abstain from alcohol for at least 48 hours prior to PK sampling?		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_SUTRT
895	BEOCCUR	Pre-ref dose (t=1) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BEOCCUR
875	BEXTMCOND	Reference Dose & Vomiting Pre-reference dose B Estimated		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BEXTMCOND
1432	COVAL	Comments		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_COVAL_2849
1433	DSSTDAT	Date participant or legal guardian signed informed consent	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_EN_DSSTDAT_1083
1434	XDOCCUR	Was there a successful enrollment submission		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_XDOCCUR_8592
896	BBESTAT	Right before ref. dose (t=0) Time point		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBESTAT
1435	XDTRTA	Medication		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_XDTRTA_2772
869	AEXSTDAT	Reference Dose & Vomiting Pre-reference dose A Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_AEXSTDAT
873	BEXSTDAT	Reference Dose & Vomiting Pre-reference dose B Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_BEXSTDAT
877	CEXSTDAT	Reference Dose & Vomiting Reference dose Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_CEXSTDAT
880	CCEOCCUR	Reference Dose & Vomiting Reference dose Vomiting		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CCEOCCUR
878	CEXSTTIM	Reference Dose & Vomiting Reference dose Time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CEXSTTIM
872	ACEOCCUR	Reference Dose & Vomiting Pre-reference dose A Vomiting		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ACEOCCUR
1436	DSSTDATB	Date participant gave assent	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_EN_DSSTDATB_1442
1437	XDTRT	Medication		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_XDTRT_9626
1438	VISDAT	Enrollment Date		f	9	1	1	4	2023-12-19	\N	\N	I_38_EN_VISDAT_4238
1439	WEIGHT	Weight		f	7	1	1	4	2023-12-19	\N	\N	I_38_EN_WEIGHT_9017
1440	ZCNAME	PRINT name of person completing form		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_ZCNAME_2128
867	VISIT	Visit or date of blood specimen collection		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_VISIT
1441	VSORRESUW	Weight unit		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_VSORRESUW_4171
1442	BRTHCOND	Date of birth estimated		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_BRTHCOND_8062
882	MLTRT	Food consumed within ± 1 Hour of Dose		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLTRT
884	MLDOSU	Unit within ± 1 Hour of Dose		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLDOSU
1443	DSDECOD	Date participant gave assent NA		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_DSDECOD_3149
1444	XDDSTXT	Dose (mg)		f	7	1	1	4	2023-12-19	\N	\N	I_38_EN_XDDSTXT_6420
1445	XDARM	Assigned treatment arm (study kit medications)		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_XDARM_6750
1446	SITEID	Site ID		f	6	1	1	4	2023-12-19	\N	\N	I_38_EN_SITEID_7973
1447	HEIGHT	Height		f	7	1	1	4	2023-12-19	\N	\N	I_38_EN_HEIGHT_1384
1448	XDSTDAT	Scheduled study treatment start date	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_EN_XDSTDAT_8517
1449	CAVIT	Any cavitation on chest x-ray		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_CAVIT_7668
1450	VSORRESUH	Height unit		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_VSORRESUH_8672
1451	XDDURN	Duration # of weeks		f	6	1	1	4	2023-12-19	\N	\N	I_38_EN_XDDURN_6807
1452	MODAT	Date of chest X-ray	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_EN_MODAT_3721
940	VISIT	Visit or date of blood specimen collection		f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_VISIT
941	VISDAT	Date of Visit	DD-MMM-YYYY	f	9	1	1	4	2023-12-12	\N	\N	I_S38_P_VISDAT
942	BEDAT	Date aliquots shipped to analysis laboratory or central storage facility	DD-MMM-YYYY	f	9	1	1	4	2023-12-12	\N	\N	I_S38_P_BEDAT
943	BESCAT	2. Aliquots collected for which type of sampling		f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BESCAT
944	BEREFIDCAA	IPK 1A Pre ref. dose TBTC Label Number 1	####-1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCAA
945	BEREFIDCAB	IPK 1A Pre ref. dose TBTC Label Number 2	####-1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCAB
946	BEREFIDCAC	IPK 1A Pre ref. dose TBTC Label Number 3	####-1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCAC
947	BEREFIDCAD	IPK 1A Pre ref. dose TBTC Label Number 4	####-1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCAD
948	BEREFIDCBA	IPK 1B Right before ref. dose TBTC Label Number 1	####0#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCBA
1453	VSDAT	Date of weight:	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_EN_VSDAT_9134
949	BEREFIDCBB	IPK 1B Right before ref. dose TBTC Label Number 2	####0#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCBB
950	BEREFIDCBC	IPK 1B Right before ref. dose TBTC Label Number 3	####0#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCBC
951	BEREFIDCBD	IPK 1B Right before ref. dose TBTC Label Number 4	####0#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCBD
952	BEREFIDCCA	IPK 1C 3 hrs post ref. dose TBTC Label Number 1	####3#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCCA
953	BEREFIDCCB	IPK 1C 3 hrs post ref. dose TBTC Label Number 2	####3#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCCB
954	BEREFIDCCC	IPK 1C 3 hrs post ref. dose TBTC Label Number 3	####3#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCCC
777	DSTERMCF	Did participant complete study follow-up		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMCF
778	DSTERMOR	Specify reason		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMOR
779	CSDCE	Comments		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_CSDCE_8352
780	DSTERMPR	Specify reason		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMPR
781	BEMODIFY	Storage of blood specimens for pharmacogenomic testing		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_BEMODIFY_2162
782	DSTERMWR	Specify reason		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMWR
783	DSTERMWS	Participant withdrew consent		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMWS
784	DSTERMLF	Participant is lost to follow-up		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMLF
785	BECAT	Storage of blood specimens for future research		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_BECAT_3763
786	COREF	Reason for withdrawal of specimen storage		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_COREF_1086
787	BESOBD	Storage withdrawal date	DD-MMM-YYYY	f	9	1	1	4	2023-12-10	\N	\N	I_S38_F_BESOBD_5564
788	DSDSFU	Date study follow-up ended	DD-MMM-YYYY	f	9	1	1	4	2023-12-10	\N	\N	I_S38_F_DSDSFU_4883
789	BEDAT	Storage withdrawal date	DD-MMM-YYYY	f	9	1	1	4	2023-12-10	\N	\N	I_S38_F_BEDAT_1757
790	USUBJID	Participant's ID	##-##-#####	f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_USUBJID
791	ZCNAME	Form Completion		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_ZCNAME_5876
792	ZCDAT	Date Follow-up Completion Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-10	\N	\N	I_S38_F_ZCDAT_1810
793	DSTERMNS	The primary reason why participant did not complete study follow-up		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMNS
794	DSTERMO	Other		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMO
795	DSTERMPV	Participant determined ineligible after enrollment for reasons other than mycobacteriology (PROTOCOL VIOLATION)		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMPV
796	DSTERMLR	Specify reason		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMLR
797	USUBJID	Participant's ID	##-##-#####	f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_USUBJID_8656
798	DSTERMCF	Did participant complete study follow-up		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMCF_2596
799	DSTERMNS	The primary reason why participant did not complete study follow-up		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMNS_7280
800	DSTERMSR	Specific reason for response to the "primary reason why participant did not complete study follow-up", if any.		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_DSTERMSR
801	DSSTDAT	Date study follow-up ended	DD-MMM-YYYY	f	9	1	1	4	2023-12-10	\N	\N	I_S38_F_DSSTDAT
802	BECATPG	Participant decision for storage of blood specimens for pharmacogenomic testing		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_BECATPG
803	BEDATPG	Storage withdrawal date	DD-MMM-YYYY	f	9	1	1	4	2023-12-10	\N	\N	I_S38_F_BEDATPG
804	PGWDREAS	Reason for withdrawal of specimen storage		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_PGWDREAS
805	BECATFTR	Participant decision for storage of blood specimens for future research		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_BECATFTR
806	BEDATFTR	Storage withdrawal date	DD-MMM-YYYY	f	9	1	1	4	2023-12-10	\N	\N	I_S38_F_BEDATFTR
807	COREFFC	Comments		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_COREFFC
808	ZCNAME	PRINT name of person completing form		f	5	1	1	4	2023-12-10	\N	\N	I_S38_F_ZCNAME_990
809	ZCDAT	Date Follow-up Completion Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-10	\N	\N	I_S38_F_ZCDAT_384
810	AABEREFID	TBTC Label Number 2A 1	####-1#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AABEREFID_4382
811	ABBEREFID	TBTC Label Number 2A 2	####-1#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ABBEREFID_5729
812	AMLSTTIM	Time Last Meal	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AMLSTTIM_5015
813	AMLSTDAT	Day Last Meal	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_AMLSTDAT_2337
814	SUOCCUR	Did participant abstain from alcohol for at least 48 hours prior to PK sampling?		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_SUOCCUR_2311
815	AABESTAT	2a Time point Pre ref. dose (t=-1)		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AABESTAT_8277
816	BESTAT	1A Time point		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BESTAT_9746
817	ACBEREFID	TBTC Label Number 2A 3	####-1#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ACBEREFID_5505
818	ADBEREFID	TBTC Label Number 2A 4	####-1#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ADBEREFID_5675
819	MLSTTIM	Time within + 1 Hour of Dose	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLSTTIM_7692
820	AMLTMCOND	Estimated Time Last Meal		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AMLTMCOND_1064
821	CBBEREFID	TBTC Label Number 2C 2	####3#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBBEREFID_1903
822	MLDOSTXT	Quantity within + 1 Hour of Dose		f	6	1	1	4	2023-12-11	\N	\N	I_S38_T_MLDOSTXT_6649
823	VISDAT	Date of Visit	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_VISDAT_8242
824	CDBEREFID	TBTC Label Number 2C 4	####3#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CDBEREFID_1261
825	BETIMC	1A Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BETIMC_9613
826	BETIMB	1A Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BETIMB_1937
827	CABEREFID	TBTC Label Number 2C 1	####3#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CABEREFID_3038
828	CCBEREFID	TBTC Label Number 2C 3	####3#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CCBEREFID_9132
829	BETIMA	1A Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BETIMA_1061
830	BBETIMA	1B Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBETIMA_7952
831	BBETIMB	1B Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBETIMB_1274
832	CEXTMCOND	Reference Dose & Vomiting Pre-reference dose C Estimated		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CEXTMCOND_9177
833	AEXTMCOND	Reference Dose & Vomiting Pre-reference dose A Estimated		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AEXTMCOND_7766
834	BBBESTAT	Right before ref. dose (t=0)		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBBESTAT_4221
835	BCEOCCUR	Reference Dose & Vomiting Pre-reference dose B Vomiting		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BCEOCCUR_8709
836	CCBESTAT	3 hrs post ref. dose		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CCBESTAT_5086
837	BBESTAT	1B Time point		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBESTAT_5797
838	MLTMCOND	Estimated Time within + 1 Hour of Dose		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLTMCOND_9508
839	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_ZCDAT_6207
840	BBETIMC	1B Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBETIMC_2742
841	COVAL	Comments		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_COVAL_1883
842	BABEREFID	TBTC Label Number 2B 1	####0#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BABEREFID_9634
843	CBETIMB	1C Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBETIMB_9649
844	BBBEREFID	TBTC Label Number 2B 2	####0#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBBEREFID_8234
845	CBETIMC	1C Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBETIMC_2676
846	CBEOCCUR	1C Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBEOCCUR_7559
847	CBESTAT	1C Time point		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBESTAT_502
848	MLCAT	Food Consumed		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLCAT_9288
849	BCBEREFID	TBTC Label Number 2B 3	####0#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BCBEREFID_2702
850	CBETIMA	1C Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBETIMA_8040
851	BDBEREFID	TBTC Label Number 2B 4	####0#	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BDBEREFID_2254
852	ZCNAME	Form Completion		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ZCNAME_4704
853	BEXSTTIM	Reference Dose & Vomiting Pre-reference dose B Time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BEXSTTIM_5728
854	AEXSTTIM	Reference Dose & Vomiting Pre-reference dose A Time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AEXSTTIM_6522
855	AEXSTDAT	Reference Dose & Vomiting Pre-reference dose A Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_AEXSTDAT_2800
856	BEXSTDAT	Reference Dose & Vomiting Pre-reference dose B Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_BEXSTDAT_4566
857	CEXSTDAT	Reference Dose & Vomiting Pre-reference dose C Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_CEXSTDAT_4780
858	CCEOCCUR	Reference Dose & Vomiting Pre-reference dose C Vomiting		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CCEOCCUR_3458
859	CEXSTTIM	Reference Dose & Vomiting Pre-reference dose C Time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CEXSTTIM_2680
860	ACEOCCUR	Reference Dose & Vomiting Pre-reference dose A Vomiting		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ACEOCCUR_5937
861	VISIT	Visit or date of blood specimen collection		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_VISIT_5451
862	MLTRT	Food within + 1 Hour of Dose		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLTRT_8623
863	MLDOSU	Unit within + 1 Hour of Dose		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_MLDOSU_1746
864	BBEOCCUR	1B Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBEOCCUR_9009
865	BEOCCUR	1A Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BEOCCUR_8884
866	BEXTMCOND	Reference Dose & Vomiting Pre-reference dose B Estimated		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BEXTMCOND_9867
910	ADBEREFID	TBTC Label Number at Pre-ref dose (t=1) 4	#### -1 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_ADBEREFID
918	CBBEREFID	TBTC Label Number at 3 hrs (post ref. dose) 2	#### 3 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBBEREFID
1454	BRTHDAT	Date of birth	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_EN_BRTHDAT_6750
920	CDBEREFID	TBTC Label Number at 3 hrs (post ref. dose) 4	#### 3 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CDBEREFID
894	BETIMC	Pre-ref dose (t=1) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BETIMC
893	BETIMB	Pre-ref dose (t=1) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BETIMB
1455	USUBJID	Participant ID		f	5	1	1	4	2023-12-19	\N	\N	I_38_EN_USUBJID_2592
868	VISDAT	Date of Visit	DD-MMM-YYYY	f	9	1	1	4	2023-12-11	\N	\N	I_S38_T_VISDAT
1456	XDDURNA	Duration # of weeks		f	6	1	1	4	2023-12-19	\N	\N	I_38_EN_XDDURNA_8864
1457	ZCDAT	Date enrollment form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_EN_ZCDAT_3310
1458	XDDSTXTA	Dose (mg)		f	7	1	1	4	2023-12-19	\N	\N	I_38_EN_XDDSTXTA_4381
1739	BESTATA	Pre-ref dose (t=1) Time point		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATA
1740	BETIMAA	Pre-ref dose (t=1) Actual blood collection time	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BETIMAA
1741	BETIMAB	Pre-ref dose (t=1) Time blood placed in centrifuge	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BETIMAB
1742	BETIMAC	Pre-ref dose (t=1) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BETIMAC
1743	BEOCCURA	Pre-ref dose (t=1) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEOCCURA
1744	BESTATB	Right before ref. dose (t=0) Time point		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATB
917	CABEREFID	TBTC Label Number at 3 hrs (post ref. dose) 1	#### 3 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CABEREFID
919	CCBEREFID	TBTC Label Number at 3 hrs (post ref. dose) 3	#### 3 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CCBEREFID
955	BEREFIDCCD	IPK 1C 3 hrs post ref. dose TBTC Label Number 4	####3#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDCCD
956	BEREFIDDAA	TSPK 1A Pre ref. dose TBTC Label Number 1	####-1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDAA
957	BEREFIDDAB	TSPK 1A Pre ref. dose TBTC Label Number 2	####-1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDAB
958	BEREFIDDAC	TSPK 1A Pre ref. dose TBTC Label Number 3	####-1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDAC
959	BEREFIDDAD	TSPK 1A Pre ref. dose TBTC Label Number 4	####-1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDAD
960	BEREFIDDBA	TSPK 1B 1hr post ref. dose TBTC Label Number 1	####1#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDBA
897	BBETIMA	Right before ref. dose (t=0) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBETIMA
898	BBETIMB	Right before ref. dose (t=0) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BBETIMB
973	BEREFIDDEB	TSPK 1E 6hrs post ref. dose TBTC Label Number 2	####6#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDEB
974	BEREFIDDEC	TSPK 1E 6hrs post ref. dose TBTC Label Number 3	####6#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDEC
975	BEREFIDDED	TSPK 1E 6hrs post ref. dose TBTC Label Number 4	####6#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDED
976	BEREFIDDFA	TSPK 1F 8-12 hrs post ref. dose TBTC Label Number 1	####12#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDFA
977	BEREFIDDFB	TSPK 1F 8-12 hrs post ref. dose TBTC Label Number 2	####12#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDFB
978	BEREFIDDFC	TSPK 1F 8-12 hrs post ref. dose TBTC Label Number 3	####12#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDFC
979	BEREFIDDFD	TSPK 1F 8-12 hrs post ref. dose TBTC Label Number 4	####12#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDFD
980	BEREFIDDGA	TSPK 1G 24 hrs post ref. dose TBTC Label Number 1	####24#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDGA
981	BEREFIDDGB	TSPK 1G 24 hrs post ref. dose TBTC Label Number 2	####24#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDGB
982	BEREFIDDGC	TSPK 1G 24 hrs post ref. dose TBTC Label Number 3	####24#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDGC
983	BEREFIDDGD	TSPK 1G 24 hrs post ref. dose TBTC Label Number 4	####24#	f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEREFIDDGD
984	BEOCCURFR	Specimens Frozen Prior To Shipping		f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEOCCURFR
985	BEOCCURTH	Specimens Thawed Before Shipping		f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEOCCURTH
986	BEDURC	Amount of time thawed Unknown		f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEDURC
987	BEDURN	Amount of time thawed Amount		f	6	1	1	4	2023-12-12	\N	\N	I_S38_P_BEDURN
988	BEDURU	Amount of time thawed Unit		f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEDURU
989	BEORRESC	Extent thawed		f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_BEORRESC
990	COVAL	Comments		f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_COVAL
991	ZCNAME	Form Completion		f	5	1	1	4	2023-12-12	\N	\N	I_S38_P_ZCNAME
992	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-12	\N	\N	I_S38_P_ZCDAT
1459	USUBJID	Participant ID		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_USUBJID
1460	AENO	Sequence ID		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_AENO
1461	VISDAT	Date of AE status evaluated	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_AE_VISDAT
1462	ZFTERM	Details of AE from its corresponding AE Form		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFTERM
1463	ZFDIFFDX	Is the FINAL reportable adverse event different from the initial event reported on the AE Form?		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFDIFFDX
1464	ZITERMB	If yes, specify		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZITERMB
1465	ZFSER	Did the initial reportable event become a serious adverse event (SAE)?		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFSER
1466	ZFSDTH	If yes, indicate type of SAE		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFSDTH
1467	SAESTDAT	Date event became an SAE:	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_AE_SAESTDAT
1468	SAEDAT	Site awareness date:	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_AE_SAEDAT
1469	ZFOUT	Status of the AE (check only one and provide date if indicated)		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFOUT
1470	ZFENDAT	Resolution Date/Death Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFENDAT
1471	ZFREL	In the opinion of the investigator, what is the final attribution to study treatment in causing this AE?		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFREL
1472	XATRT	select the study drug(s) to which the AE is attributed		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_XATRT
1473	ZFANTC	In the opinion of the investigator, is this an anticipated or unanticipated AE?		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFANTC
1474	ZFTOXGR	Indicate the maximum toxicity grade during the course of the AE		f	6	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFTOXGR
1475	ZNTERLB	Were any additional assessment, evaluations or tests done in response to this AE:		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZNTERLB
1476	ZNTERCE	Clinical evaluations		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZNTERCE
1477	ZNTERMSS	Signs and symptoms assessment		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZNTERMSS
1478	ZNTERMMB	Sputum or other specimen collected for TB diagnostic workup		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZNTERMMB
1479	ZTXTHELD	Was all or any part of study treatment held for any period of time?		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZTXTHELD
1480	ZRECH	Was the participant re-challenged with the intention of restarting study treatment?		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZRECH
1481	TXTDIS	Was study treatment permanently discontinued as a result of this AE?		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_TXTDIS
1482	AFSUM	Summary of current AE status		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_AFSUM
1483	AFRESLV	If applicable, specify how long after the onset date did the AE resolved (hours, days, weeks):		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_AFRESLV
1484	AFDC	If applicable, specify whether the participant permanently discontinued study treatment because of medical advice or participant decision to discontinue		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_AFDC
1485	RPTEST	Pregnancy outcome		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_RPTEST
1486	RPTESTCD	were any congenital anomalies present?		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_RPTESTCD
1487	RPORRESC	What was the gestational age at pregnancy outcome?		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_RPORRESC
1488	RPDAT	Date of pregnancy outcome	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_AE_RPDAT
1489	ZCEVAL	Name of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZCEVAL
1490	ZCNAME	Name of person completing form		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZCNAME
1491	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-19	\N	\N	I_38_AE_ZCDAT
1492	ZFLLTCD	Final MedDRA Lower Level Term Code		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFLLTCD
1493	ZFLLT	Final MedDRA Lower Level Term Description		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZFLLT
1494	ZISONAME	Safety officer providing MedDRA code		f	5	1	1	4	2023-12-19	\N	\N	I_38_AE_ZISONAME
1745	BETIMBA	Right before ref. dose (t=0) Actual blood collection time	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BETIMBA
1746	BETIMBB	Right before ref. dose (t=0) Time blood placed in centrifuge	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BETIMBB
871	AEXTMCOND	Reference Dose & Vomiting Pre-reference dose A Estimated		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_AEXTMCOND
901	CBESTAT	3 hrs (post ref. dose) Time point		f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBESTAT
902	CBETIMA	3 hrs (post ref. dose) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_CBETIMA
915	BDBEREFID	TBTC Label Number at ref. dose (t=0) 4	#### 0 #	f	5	1	1	4	2023-12-11	\N	\N	I_S38_T_BDBEREFID
1052	BEREFIDAD	TBTC Label Number at Pre-ref dose (t=1) 4	#### -1 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDAD_9354
1053	BEREFIDAC	TBTC Label Number at Pre-ref dose (t=1) 3	#### -1 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDAC_1594
1101	VISSTAT	Visit Missed		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_VISSTAT
1102	ZNVISIT	Week of evaluation		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNVISIT
1103	ZNVISDAT	Date of visit	DD-MMM-YYYY	f	9	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNVISDAT
1104	EOTTV	Early on-treatment termination visit		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_EOTTV
1105	ZNDTERMDR	Did participant take any TB medications?		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNDTERMDR
1106	ZNDTERMCM	Did participant report any changes in antiretroviral or non-TB medications?		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNDTERMCM
1107	ZNDTERMCE	Clinical evaluations		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNDTERMCE
1108	ZNTERMLB	Were new lab tests ordered		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMLB
1109	ZNTERMSS	Symptoms assessed		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMSS
1110	ZNTERMMB	Sputum Collection Attempted		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMMB
1111	ZNORRESN	If yes, how many specimens were collected		f	6	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNORRESN
1112	ZNTERMRS	Was sputum collected for RS ratio essay?		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMRS
1113	ZNTERMPG	Was a specimen for pharmacogenomics testing collected?		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMPG
1114	ZNTERMBR	Biomarker analysis collected		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMBR
1115	ZNTERMTSPK	Were TB drug sparse PK specimen collected?		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMTSPK
1116	ZNTERMIPK	Were tb drug intensive PK specimens collected		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMIPK
1117	ZNTERMPR	Participant is diagnosed as pregnant		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMPR
1118	ZNTERMTM	Were any modifications to the assigned study TB treatment		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZNTERMTM
1119	TXSTAT	Study Treatment		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_TXSTAT
1120	COVAL	Comments		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_COVAL
1121	ZCNAME	Form Completion		f	5	1	1	8	2023-12-17	\N	\N	I_38_TX_ZCNAME
1122	ZCDAT	Date Treatment Evaluation Form Completed	DD-MMM-YYYY	f	9	1	1	8	2023-12-17	\N	\N	I_38_TX_ZCDAT
1123	USUBJID	Participant's ID	38-##-####	f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_USUBJID_6356
1124	TRECHRRT	Visit for reporting treatment change		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHRRT_5940
1125	TRECHUNSC	Date of Unscheduled visits if any	DD-MMM-YYYY	f	9	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHUNSC_5608
1126	SEQIDADEV	Squence ID of Adverse event, if any		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_SEQIDADEV_3174
1127	SEQUIDPTR	Squence ID of Possible Poor Treatment Response, if any		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_SEQUIDPTR_4381
1128	TRECHADEV	Were there any additional events associated with this treatment change?		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHADEV_9780
1129	SEQUIDEVI	Sequence ID of additional adverse event 1, if any		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_SEQUIDEVI_2995
1130	SEQUIDEVII	Sequence ID of additional adverse event 2, if any		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_SEQUIDEVII_1819
1131	SEQUIDPTRI	Sequence ID of additional Possible Poor Treatment Response, if any.		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_SEQUIDPTRI_3824
1132	TRECHREC	Did the Site Investigator recommend a change in TB treatment?		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHREC_456
1133	TRECHTYP	Which change to TB treatment was recommended by the Site Investigator?		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHTYP_872
1134	TRECHOTR	Other change(s) to TB treatment recommended by the Site Investigator		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHOTR_9472
1135	TRECHRES	Reasons for recommending TB treatment change		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHRES_123
1136	TRECHROTH	Other reasons for recommending TB treatment change		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHROTH_4137
1137	TRECHINIT	Was a change in TB treatment actually initiated?		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHINIT_27
1138	TRECHALT	If TB treatment wasn't initiated or it is unknown, was an alternative diagnosis established?		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHALT_192
1139	TRECHXNIT	If Site Investigator recommended a change in TB treatment, and it was not initiated, what was the reason for not changing treatment?		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHXNIT_6429
1140	TRECHMED	Medications included in initial non-study regimen or extension of treatment if TB treatment was changed		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_TRECHMED_6178
1141	NREGSTRT	Knowledge of Start date of non-study regimen		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_NREGSTRT_8553
1142	NREGSDTE	Actual or estimated non-study regimen start date		f	9	1	1	4	2023-12-18	\N	\N	I_S38_T_NREGSDTE_2623
1143	COMMNTS	Comments		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_COMMNTS_1808
1144	PRINPIC	PRINT name of Principal Investigator or Co-PI:		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_PRINPIC_6419
1145	SIGNPIC	Signature of Principal Investigator or Co-PI:		f	11	1	1	4	2023-12-18	\N	\N	I_S38_T_SIGNPIC_7653
1146	PRINPCF	PRINT name of person completing form:		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_PRINPCF_1713
1147	SGNPCF	Signature of person completing form:		f	11	1	1	4	2023-12-18	\N	\N	I_S38_T_SGNPCF_106
1148	DATEFRCP	Date Form completed:		f	9	1	1	4	2023-12-18	\N	\N	I_S38_T_DATEFRCP_1262
1149	BEDATA	Storage withdrawal date		f	9	1	1	4	2023-12-18	\N	\N	I_S38_T_BEDATA
1150	BEDATB	Storage withdrawal date		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_BEDATB
1054	BEREFIDAB	TBTC Label Number at Pre-ref dose (t=1) 2	#### -1 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDAB_5838
1055	BEREFIDAA	TBTC Label Number at Pre-ref dose (t=1) 1	#### -1 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDAA_1709
1056	BESTATAA	2a Time point Pre ref. dose (t=-1)		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BESTATAA_48
1057	BETIMBC	Right before ref. dose (t=0) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BETIMBC_2870
1058	BETIMBB	Right before ref. dose (t=0) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BETIMBB_5449
1059	BETIMBA	Right before ref. dose (t=0) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BETIMBA_8977
1060	MLSTDAT	Day Last Meal	DD-MMM-YYYY	f	9	1	1	4	2023-12-14	\N	\N	I_S38_T_MLSTDAT_7830
1061	EXSTTIMB	Reference Dose & Vomiting (Pre-reference dose B) Time	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_EXSTTIMB_2782
1062	EXSTTIMC	Reference Dose & Vomiting (Reference dose) Time	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_EXSTTIMC_2835
1063	BEREFIDBD	TBTC Label Number at ref. dose (t=0) 4	#### 0 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDBD_4462
1064	EXSTTIMA	Reference Dose & Vomiting (Pre-reference dose A) Time	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_EXSTTIMA_8123
1065	BEREFIDBC	TBTC Label Number at ref. dose (t=0) 3	#### 0 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDBC_5320
1066	BEREFIDBB	TBTC Label Number at ref. dose (t=0) 2	#### 0 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDBB_1489
1067	BEREFIDBA	TBTC Label Number at ref. dose (t=0) 1	#### 0 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDBA_6686
1068	BETIMCA	3 hrs (post ref. dose) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BETIMCA_6608
1069	BETIMCC	3 hrs (post ref. dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BETIMCC_8259
1070	BETIMCB	3 hrs (post ref. dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BETIMCB_6407
1071	MLTMCONDA	Estimated Time within ± 1 Hour of Dose		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_MLTMCONDA_9943
1072	EXSTDATC	Reference Dose & Vomiting (Reference dose) Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-14	\N	\N	I_S38_T_EXSTDATC_8354
1073	USUBJID	Participant's ID	38 - ## - #####	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_USUBJID_6904
1074	MLTMCONDB	Estimated Time Last Meal		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_MLTMCONDB_2448
1075	BEOCCURC	3 hrs (post ref. dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEOCCURC_5633
1076	BEOCCURA	Pre-ref dose (t=1) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEOCCURA_3671
1077	BEOCCURB	Right before ref. dose (t=0) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEOCCURB_3250
1078	BEREFIDCD	TBTC Label Number at 3 hrs (post ref. dose) 4	#### 3 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDCD_5724
1079	BEREFIDCC	TBTC Label Number at 3 hrs (post ref. dose) 3	#### 3 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDCC_4216
1080	BEREFIDCB	TBTC Label Number at 3 hrs (post ref. dose) 2	#### 3 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDCB_5158
1081	BEREFIDCA	TBTC Label Number at 3 hrs (post ref. dose) 1	#### 3 #	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BEREFIDCA_4816
1082	EXSTDATB	Reference Dose & Vomiting (Pre-reference dose B) Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-14	\N	\N	I_S38_T_EXSTDATB_7960
1083	EXSTDATA	Reference Dose & Vomiting (Pre-reference dose A) Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-14	\N	\N	I_S38_T_EXSTDATA_5114
1084	BESTATCC	3 hrs (post ref. dose)		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BESTATCC_6533
1085	SUTRT	Did participant abstain from alcohol for at least 48 hours prior to PK sampling?		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_SUTRT_7063
1086	CETERMVMC	Reference Dose & Vomiting (Reference dose) Vomiting		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_CETERMVMC_7979
1087	CETERMVMB	Reference Dose & Vomiting (Pre-reference dose B) Vomiting		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_CETERMVMB
1088	CETERMVMA	Reference Dose & Vomiting (Pre-reference dose A) Vomiting		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_CETERMVMA_9870
1089	BESTATA	Pre-ref dose (t=1) Time point		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BESTATA_6443
1090	BESTATB	Right before ref. dose (t=0) Time point		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BESTATB_6539
1091	BESTATC	3 hrs (post ref. dose) Time point		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BESTATC_661
1092	EXTMCONDC	Reference Dose & Vomiting (Reference dose) Estimated		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_EXTMCONDC_7120
1093	EXTMCONDB	Reference Dose & Vomiting (Pre-reference dose B) Estimated		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_EXTMCONDB_6121
1094	BESTATBB	Right before ref. dose (t=0)		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BESTATBB_6610
1095	EXTMCONDA	Reference Dose & Vomiting (Pre-reference dose A) Estimated		f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_EXTMCONDA_7808
1096	BETIMAC	Pre-ref dose (t=1) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BETIMAC_8896
1097	BETIMAB	Pre-ref dose (t=1) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BETIMAB_7084
1098	BETIMAA	Pre-ref dose (t=1) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_BETIMAA_1909
1099	MLSTTIMA	Time within ± 1 Hour of Dose	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_MLSTTIMA_114
1100	MLSTTIMB	Time Last Meal	HH:MM	f	5	1	1	4	2023-12-14	\N	\N	I_S38_T_MLSTTIMB_481
1747	BETIMBC	Right before ref. dose (t=0) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BETIMBC
1748	BEOCCURB	Right before ref. dose (t=0) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEOCCURB
1749	BESTATC	3 hrs (post ref. dose) Time point		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATC
1750	BETIMCA	3 hrs (post ref. dose) Actual blood collection time	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BETIMCA
1751	BETIMCB	3 hrs (post ref. dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BETIMCB
1752	BETIMCC	3 hrs (post ref. dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BETIMCC
1753	BEOCCURC	3 hrs (post ref. dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEOCCURC
1151	BECATB	Storage of blood specimens for future research		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_BECATB
1152	DSSTDAT	Date reason checked in question 2 occurred		f	9	1	1	4	2023-12-18	\N	\N	I_S38_T_DSSTDAT
1153	BECATA	Participant decision for storage of blood specimens for pharmacogenomic testing		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_BECATA
1154	NCDAT	Date Non-enrollment Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-18	\N	\N	I_S38_T_NCDAT_869
1155	DSTERMA	Specify Reason		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_DSTERMA
1156	NCNAME	Form Completion		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_NCNAME_7707
1157	COREF	Comments		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_COREF_7674
1158	DSDECODA	Did participant complete study treatment?		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_DSDECODA
1159	FTWDREAS	Reason for withdrawal of specimen storage		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_FTWDREAS_5148
1160	DSTERM	Reason for Not Completing Study Treatment		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_DSTERM_8093
1161	USUBJID	Participant's ID		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_USUBJID_6689
1162	PGWDREAS	Reason for withdrawal of specimen storage		f	5	1	1	4	2023-12-18	\N	\N	I_S38_T_PGWDREAS_9073
1754	BESTATAA	2a Time point Pre ref. dose (t=-1)		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATAA
1755	BEREFIDAA	TBTC Label Number at Pre-ref dose (t=1) 1	#### -1 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDAA
1756	BEREFIDAB	TBTC Label Number at Pre-ref dose (t=1) 2	#### -1 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDAB
1757	BEREFIDAC	TBTC Label Number at Pre-ref dose (t=1) 3	#### -1 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDAC
1758	BEREFIDAD	TBTC Label Number at Pre-ref dose (t=1) 4	#### -1 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDAD
1759	BESTATBB	1 hr (post ref. dose)		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATBB
1760	BEREFIDBA	TBTC Label Number at ref. dose (t=1) 1	#### 1 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDBA
1761	BEREFIDBB	TBTC Label Number at ref. dose (t=1) 2	#### 1 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDBB
1762	BEREFIDBC	TBTC Label Number at ref. dose (t=1) 3	#### 1 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDBC
1763	BEREFIDBD	TBTC Label Number at ref. dose (t=1) 4	#### 1 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDBD
1764	BESTATCC	2 hrs (post ref. dose)		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATCC
1765	BEREFIDCA	TBTC Label Number at 2 hrs (post ref. dose) 1	#### 2 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDCA
1766	BEREFIDCB	TBTC Label Number at 2 hrs (post ref. dose) 2	#### 2 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDCB
1767	BEREFIDCC	TBTC Label Number at 2 hrs (post ref. dose) 3	#### 2 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDCC
1768	BEREFIDCD	TBTC Label Number at 2 hrs (post ref. dose) 4	#### 2 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDCD
1769	BESTATDD	4 hrs (post ref. dose)		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATDD
1770	BEREFIDDA	TBTC Label Number at 4 hrs (post ref. dose) 1	#### 4 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDDA
1771	BEREFIDDB	TBTC Label Number at 4 hrs (post ref. dose) 2	#### 4 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDDB
1772	BEREFIDDC	TBTC Label Number at 4 hrs (post ref. dose) 3	#### 4 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDDC
1773	BEREFIDDD	TBTC Label Number at 4 hrs (post ref. dose) 4	#### 4 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIDDD
1774	BESTATEE	6 hrs (post ref. dose)		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATEE
1775	BEREFIEEA	TBTC Label Number at 6 hrs (post ref. dose) 1	#### 6 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIEEA
1776	BEREFIEEB	TBTC Label Number at 6 hrs (post ref. dose) 2	#### 6 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIEEB
1777	BEREFIEEC	TBTC Label Number at 6 hrs (post ref. dose) 3	#### 6 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIEEC
1778	BEREFIEED	TBTC Label Number at 6 hrs (post ref. dose) 4	#### 6 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIEED
1779	BESTATFF	12 hrs (post ref. dose)		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATFF
1780	BEREFIFFA	TBTC Label Number at 12 hrs (post ref. dose) 1	#### 12 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIFFA
1781	BEREFIFFB	TBTC Label Number at 12 hrs (post ref. dose) 2	#### 12 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIFFB
1782	BEREFIFFC	TBTC Label Number at 12 hrs (post ref. dose) 3	#### 12 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIFFC
1783	BEREFIFFD	TBTC Label Number at 12 hrs (post ref. dose) 4	#### 12 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIFFD
1784	BESTATGG	24 hrs (post ref. dose)		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BESTATGG
1785	BEREFIGGA	TBTC Label Number at 24 hrs (post ref. dose) 1	#### 12 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIGGA
1786	BEREFIGGB	TBTC Label Number at 24 hrs (post ref. dose) 2	#### 12 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIGGB
1787	BEREFIGGC	TBTC Label Number at 24 hrs (post ref. dose) 3	#### 12 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIGGC
1788	BEREFIGGD	TBTC Label Number at 24 hrs (post ref. dose) 4	#### 12 #	f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_BEREFIGGD
1789	COVAL	Comments		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_COVAL
1790	ZCNAME	PRINT name of person completing form		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_ZCNAME
1791	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	8	2023-12-20	\N	\N	I_38_IP_ZCDAT
1792	COREF	Name of site POC for specimens		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_COREF
1793	COREFPH	Phone number of site POC for specimens		f	5	1	1	8	2023-12-20	\N	\N	I_38_IP_COREFPH
2083	ZFSER	Did the initial reportable event become a serious adverse event (SAE)?		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFSER
2084	ZITERMB	If yes, specify		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZITERMB
2085	ZFANTC	In the opinion of the investigator, is this an anticipated or unanticipated AE?		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFANTC
2086	ZFDIFFDX	Is the FINAL reportable adverse event different from the initial event reported on the AE Form?		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFDIFFDX
2087	ZNTERLB	Were any additional assessment, evaluations or tests done in response to this AE: Laboratory evaluations.		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZNTERLB
2088	TXTDIS	Was study treatment permanently discontinued as a result of this AE?		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_TXTDIS
1355	BEDAT	Date aliquots shipped to analysis laboratory or central storage facility	DD-MMM-YYYY	f	9	1	1	4	2023-12-18	\N	\N	I_38_PK_BEDAT_8233
1356	VISDAT	Date of blood specimen collection	DD-MMM-YYYY	f	9	1	1	4	2023-12-18	\N	\N	I_38_PK_VISDAT_5843
1380	BESCAT	2. Aliquots collected for which type of sampling		f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BESCAT_7589
1394	VISIT	Visit		f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_VISIT_2421
2089	AFRESLV	If applicable, specify how long after the onset date did the AE resolved (hours, days, weeks):		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_AFRESLV
2090	ZTXTHELD	Was all or any part of study treatment held for any period of time?		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZTXTHELD
2091	ZFTERM	Details of AE from its corresponding AE Form		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFTERM
2092	RPDAT	Date of pregnancy outcome	DD-MMM-YYYY	f	9	1	1	4	2023-12-20	\N	\N	I_38_AF_RPDAT
2093	ZFOUTB	Status of the AE (check only one and provide date if indicated)		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFOUTB
2094	AFSUM	Summary of current AE status		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_AFSUM
2095	ZFTOXGR	Indicate the maximum toxicity grade during the course of the AE		f	6	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFTOXGR
2096	ZFENDAT	Resolution Date/Death Date	DD-MMM-YYYY	f	9	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFENDAT
2097	ZFREL	In the opinion of the investigator, what is the final attribution to study treatment in causing this AE?		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFREL
2098	ZNTERMSS	Were any additional assessment, evaluations or tests done in response to this AE: Signs and symptoms assessment		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZNTERMSS
2099	VISDAT	Date of AE status evaluated	DD-MMM-YYYY	f	9	1	1	4	2023-12-20	\N	\N	I_38_AF_VISDAT
2100	ZCNAME	Name of person completing form		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZCNAME
2101	ZCEVAL	Name of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZCEVAL
2102	ZCNAMEB	Name of person entering form		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZCNAMEB
2103	ZCNAMEA	Name of person completing QA/QC		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZCNAMEA
2104	ZFSDTH	If yes, indicate type of SAE		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFSDTH
2105	ZNTERCE	Were any additional assessment, evaluations or tests done in response to this AE: Clinical evaluations		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZNTERCE
2106	RPORRESN	What was the gestational age at pregnancy outcome?	Weeks	f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_RPORRESN_7883
2107	ZISONAME	Safety officer providing MedDRA code		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZISONAME
2108	ZRECH	Was the participant re-challenged with the intention of restarting study treatment?		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZRECH
2109	RPTEST	Pregnancy outcome		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_RPTEST
2110	ZNTERMMB	Were any additional assessment, evaluations or tests done in response to this AE: Sputum or other specimen collected for TB diagnostic workup		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZNTERMMB
2111	RPTESTCD	were any congenital anomalies present?		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_RPTESTCD
2112	RPORRESC	Gestational age at pregnancy outcome is unknown		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_RPORRESC
2113	ZCDATB	Date Form entered	DD-MMM-YYYY	f	9	1	1	4	2023-12-20	\N	\N	I_38_AF_ZCDATB
2114	SAESTDAT	Date event became an SAE:	DD-MMM-YYYY	f	9	1	1	4	2023-12-20	\N	\N	I_38_AF_SAESTDAT
2115	SAEDAT	Site awareness date:	DD-MMM-YYYY	f	9	1	1	4	2023-12-20	\N	\N	I_38_AF_SAEDAT
2116	ZCDATA	Date Form  QA/QC completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-20	\N	\N	I_38_AF_ZCDATA
2117	USUBJID	Participant ID		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_USUBJID
2118	AFDC	If applicable, specify whether the participant permanently discontinued study treatment because of medical advice or participant decision to discontinue		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_AFDC
2119	AENO	Sequence ID		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_AENO
2120	XATRT	select the study drug(s) to which the AE is attributed		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_XATRT
2121	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-20	\N	\N	I_38_AF_ZCDAT
2122	ZFLLT	Final MedDRA Lower Level Term Description		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFLLT
2123	ZFLLTCD	Final MedDRA Lower Level Term Code		f	5	1	1	4	2023-12-20	\N	\N	I_38_AF_ZFLLTCD
1401	BEREFIDCAA	Sparse PK 1A Pre ref. dose TBTC Label Number 1	#### -1 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCAA_3194
1402	BEREFIDDCB	Intensive PK 1C 2hrs post ref. dose TBTC Label Number 2	####2#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDCB_966
1350	BEREFIDDFD	Intensive PK 1F 8-12 hrs post ref. dose TBTC Label Number 4	####12#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDFD_7240
1351	BEREFIDDFC	Intensive PK 1F 8-12 hrs post ref. dose TBTC Label Number 3	####12#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDFC_4589
1352	BEREFIDDFB	Intensive PK 1F 8-12 hrs post ref. dose TBTC Label Number 2	####12#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDFB_4708
1353	BEREFIDDFA	Intensive PK 1F 8-12 hrs post ref. dose TBTC Label Number 1	####12#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDFA_9113
1354	BEOCCURTH	Specimens Thawed Before Shipping		f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEOCCURTH_5280
1357	BEREFIDDBD	Intensive PK 1B 1hr post ref. dose TBTC Label Number 4	####1#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDBD_1383
1358	BEREFIDDBC	Intensive PK 1B 1hr post ref. dose TBTC Label Number 3	####1#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDBC_5684
1359	BEREFIDDBB	Intensive PK 1B 1hr post ref. dose TBTC Label Number 2	####1#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDBB_8686
1360	BEREFIDDBA	Intensive PK 1B 1hr post ref. dose TBTC Label Number 1	####1#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDBA_65
1361	BEREFIDCCB	Sparse PK 1C 3 hrs post ref. dose TBTC Label Number 2	#### 3 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCCB_2547
1362	BEREFIDDEC	Intensive PK 1E 6hrs post ref. dose TBTC Label Number 3	####6#	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDDEC_6764
1363	BEREFIDCCA	Sparse PK 1C 3 hrs post ref. dose TBTC Label Number 1	#### 3 #	f	5	1	1	4	2023-12-18	\N	\N	I_38_PK_BEREFIDCCA_1179
2874	BEREFIDAD	TBTC Label Number (Pre-ref. dose [-1]) 4	####-1#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDAD_9408
2875	BEREFIDAC	TBTC Label Number (Pre-ref. dose [-1]) 3	####-1#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDAC_7356
2876	BEREFIDAB	TBTC Label Number (Pre-ref. dose [-1]) 2	####-1#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDAB_8044
2877	BEREFIDAA	TBTC Label Number (Pre-ref. dose [-1]) 1	####-1#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDAA_6369
2878	BEREFIGGD	TBTC Label Number (24 hrs post ref. dose) 4	####24#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIGGD_9688
2879	BEREFIGGC	TBTC Label Number (24 hrs post ref. dose) 3	####24#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIGGC_3040
2880	BEREFIGGB	TBTC Label Number (24 hrs post ref. dose) 2	####24#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIGGB_4734
2881	BEREFIGGA	TBTC Label Number (24 hrs post ref. dose) 1	####24#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIGGA_7439
2882	BETIMBC	PK sampling (1 hr post ref. dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMBC_2862
2883	BETIMBB	PK sampling (1 hr post ref. dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMBB_3480
2884	BETIMBA	PK sampling (1 hr post ref. dose) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMBA_9834
2885	BETIMCDA	PK sampling (4 hr post ref. dose) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCDA_3647
2886	BETIMCDC	PK sampling (4 hr post ref. dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCDC_1136
2887	BETIMCDB	PK sampling (4 hr post ref. dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCDB_4663
2888	CEOCCURAA	Did participant vomit between PK reference dose administration and last PK specimen collection?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_CEOCCURAA_6478
2889	MLDOSTXT	Quantity of food consumed within ± 1 Hour of Dose		f	7	1	1	4	2023-12-22	\N	\N	I_38_IP_MLDOSTXT_7126
2890	VISDAT	Date of Visit	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_IP_VISDAT_7212
2891	MLSTDAT	Day of Last Meal	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_IP_MLSTDAT_1801
2892	EXSTTIMB	Time of dose (Pre-reference dose B)	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_EXSTTIMB_7750
2893	ESTTIMDA	Time participant started vomiting between PK reference dose administration and last PK specimen collection	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_ESTTIMDA_9689
2894	EXSTTIMC	Time of dose (Reference dose)	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_EXSTTIMC_3843
2895	BEREFIDBD	TBTC Label Number (1 hr post ref. dose) 4	####1#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDBD_5881
2896	EXSTTIMA	Time of dose (Pre-reference dose A)	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_EXSTTIMA_7502
2897	BEREFIDBC	TBTC Label Number (1 hr post ref. dose) 3	####1#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDBC_1013
2898	BEREFIDBB	TBTC Label Number (1 hr post ref. dose) 2	####1#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDBB_9968
2899	BEREFIFFD	TBTC Label Number (8 -12 hrs post ref. dose) 4	####12#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIFFD_3820
2900	BEREFIDBA	TBTC Label Number (1 hr post ref. dose) 1	####1#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDBA_2806
2901	BEREFIFFC	TBTC Label Number (8 -12 hrs post ref. dose) 3	####12#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIFFC_8137
2902	BEREFIFFB	TBTC Label Number (8 -12 hrs post ref. dose) 2	####12#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIFFB_4143
2903	BEREFIFFA	TBTC Label Number (8 -12 hrs post ref. dose) 1	####12#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIFFA_9385
2904	BETIMCA	PK sampling (2 hr post ref. dose) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCA_1129
2905	BETIMCC	PK sampling (2 hr post ref. dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCC_8173
2906	BETIMCB	PK sampling (2 hr post ref. dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCB_6558
2907	BETIMCEB	PK sampling (6 hr post ref. dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCEB_3327
2908	BETIMCEA	PK sampling (6 hr post ref. dose) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCEA_4923
2909	MLTMCONDA	Is the stated time of food consumption within ± 1 Hour of Dose ESTIMATED?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_MLTMCONDA_2356
2910	EXSTDATC	Date of dose (Reference dose)	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_IP_EXSTDATC_3368
2911	BETIMCEC	PK sampling (6 hr post ref. dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCEC_5172
2912	USUBJID	Participant's ID		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_USUBJID_6844
2913	MLTMCONDB	Is the stated time of last meal consumption ESTIMATED?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_MLTMCONDB_4246
2914	ZCDAT	Date Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_IP_ZCDAT_8197
2915	BEOCCURC	PK sampling (2 hr post ref. dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEOCCURC_6264
2916	COVAL	Comments		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_COVAL_2015
2917	BEOCCURD	PK sampling (4 hr post ref. dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEOCCURD_1853
2918	BEOCCURA	PK sampling (Pre-ref dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEOCCURA_2694
2919	BESTATG	PK sampling (24 hrs post ref. dose). Not done?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BESTATG_7653
2920	BEOCCURB	PK sampling (1 hr post ref. dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEOCCURB_7782
2921	BEREFIDCD	TBTC Label Number (2 hrs post ref. dose) 4	####2#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDCD_4812
2922	BEOCCURG	PK sampling (24 hrs post ref. dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEOCCURG_6040
2923	BEREFIDCC	TBTC Label Number (2 hrs post ref. dose) 3	####2#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDCC_5717
2924	BEREFIEED	TBTC Label Number (6 hrs post ref. dose) 4	####6#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIEED_9459
2925	ESTTIMD	Date participant started vomiting between PK reference dose administration and last PK specimen collection	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_IP_ESTTIMD_4734
2926	BEREFIDCB	TBTC Label Number (2 hrs post ref. dose) 2	####2#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDCB_4121
2927	BEREFIEEC	TBTC Label Number (6 hrs post ref. dose) 3	####6#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIEEC_3764
2928	BEOCCURE	PK sampling (6 hr post ref. dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEOCCURE_2291
2929	BEREFIDCA	TBTC Label Number (2 hrs post ref. dose) 1	####2#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDCA_9574
2930	BEREFIEEB	TBTC Label Number (6 hrs post ref. dose) 2	####6#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIEEB_6325
2931	BEOCCURF	PK sampling (8 -12 hrs post ref. dose) Blood collection to -70°C freezer time > 2 hrs		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEOCCURF_3983
2932	BEREFIEEA	TBTC Label Number (6 hrs post ref. dose) 1	####6#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIEEA_5689
2933	EXSTDATB	Date of dose (Pre-reference dose B)	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_IP_EXSTDATB_5191
2934	EXSTDATA	Date of dose (Pre-reference dose A)	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_IP_EXSTDATA_4320
2935	SUTRT	Did participant abstain from alcohol for at least 48 hours prior to PK sampling?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_SUTRT_4516
2936	BETIMCFC	PK sampling (8 -12 hrs post ref. dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCFC_7426
2937	BETIMCFB	PK sampling (8 -12 hrs post ref. dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCFB_1252
2938	BETIMCFA	PK sampling (8 -12 hrs post ref. dose) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCFA_3989
2939	CETERMVMC	There was vomiting within 2 hours after dose (Reference dose)		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_CETERMVMC_193
2940	CETERMVMB	There was vomiting within 2 hours after dose (Pre-reference dose B)		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_CETERMVMB_7659
2941	CETERMVMA	There was vomiting within 2 hours after dose (Pre-reference dose A)		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_CETERMVMA_2286
2942	MLCAT	Was food consumed ± 1 hour the administration of the reference dose?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_MLCAT_6952
2943	BESTATA	PK sampling (Pre-ref. dose). Not done?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BESTATA_9921
2944	BESTATB	PK sampling (1 hr post ref. dose). Not done?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BESTATB_4343
2945	BESTATE	PK sampling (6 hr post ref. dose). Not done?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BESTATE_2238
2946	ZCNAME	Name of person completing form		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_ZCNAME_1550
2947	BESTATF	PK sampling (8 -12 hrs post ref. dose). Not done?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BESTATF_2514
2948	BESTATC	PK sampling (2 hr post ref. dose). Not done?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BESTATC_2061
2949	BESTATD	PK sampling (4 hr post ref. dose). Not done?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BESTATD_7354
2950	BEREFIDDD	TBTC Label Number (4 hrs post ref. dose) 4	####4#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDDD_3702
2951	BEREFIDDC	TBTC Label Number (4 hrs post ref. dose) 3	####4#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDDC_8436
2952	BEREFIDDB	TBTC Label Number (4 hrs post ref. dose) 2	####4#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDDB_7699
2953	BEREFIDDA	TBTC Label Number (4 hrs post ref. dose) 1	####4#	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BEREFIDDA_9963
2954	EXTMCONDC	Time of dose is estimated (Reference dose)		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_EXTMCONDC_6765
2955	EXTMCONDB	Time of dose is estimated (Pre-reference dose B)		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_EXTMCONDB_7861
2956	EXTMCONDA	Time of dose is estimated (Pre-reference dose A)		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_EXTMCONDA_894
2957	BETIMAC	PK sampling (Pre-ref dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMAC_1014
2958	BETIMAB	PK sampling (Pre-ref dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMAB_4227
2959	BETIMAA	PK sampling (Pre-ref dose) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMAA_3593
2960	BETIMCGC	PK sampling (24 hrs post ref. dose) Time plasma placed in -70°C freezer or below	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCGC_983
2961	BETIMCGB	PK sampling (24 hrs post ref. dose) Time blood placed in centrifuge	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCGB_6084
2962	BETIMCGA	PK sampling (24 hrs post ref. dose) Actual blood collection time	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_BETIMCGA_2345
2963	MLSTTIMA	Time food was consumed within ± 1 Hour of Dose	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_MLSTTIMA_4492
2964	VISIT	Visit or date of blood specimen collection		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_VISIT_4603
2965	MLTRT	Food was consumed within ± 1 Hour of Dose		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_MLTRT_5324
2966	MLSTTIMB	Time of Last Meal	HH:MM	f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_MLSTTIMB_6841
2967	MLDOSU	Unit of quantity of food consumed within ± 1 Hour of Dose		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_MLDOSU_4633
2968	CMDOSFRQ	In general, how often does the participant take non-study medications within three (3) hours of study drug administration (1 hour before up to 2 hours after)?		f	5	1	1	4	2023-12-22	\N	\N	I_38_IP_CMDOSFRQ_1150
3693	SUCDURUD	Unit of amount of time since participant quit smoking		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SUCDURUD
3694	PERINEUR	Peripheral neuropathy		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_PERINEUR
3695	MHTERM	If participant has family member with mental illness, please specify the past mental health diagnoses		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTERM
3696	BRTHCTRY	Participant's Place of birth		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_BRTHCTRY
3697	MHBODSYS	If participant currently have extrapulmonary TB, specify the system organ class for each extrapulmonary site		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHBODSYS
3698	MHTERMART	Has the participant ever been prescribed and taken antiretroviral therapy (ART)?		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTERMART
3699	TBPRIORTX	Was the participant ever treated for active TB prior to this episode		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_TBPRIORTX
3700	MHSTSTYRCOND	The year of ART initiation that was given above is an ESTIMATION		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHSTSTYRCOND
3701	CANCER	Cancer		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_CANCER
3702	HEPB	Hepatitis B		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_HEPB
3703	HEPC	Hepatitis C		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_HEPC
3704	MHSTYRCOND	If participant was participant ever treated for active TB prior to this episode, what were the most recent month and year.	MMM-YYYY	f	10	1	1	4	2023-12-24	\N	\N	I_38_HX_MHSTYRCOND
3705	ZNTERMCM	Was the participant taking non-TB medications, including over-the-counter drugs, in the 14 days prior to study treatment start date		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_ZNTERMCM
3706	VISDAT	Visit date	DD-MMM-YYYY	f	9	1	1	4	2023-12-24	\N	\N	I_38_HX_VISDAT
3707	ZNOCCUR	Was the participant taking any antiretroviral therapy in the 14 days prior to study treatment start date		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_ZNOCCUR
3708	MHSCAT	Mental health history: Past personal mental illness		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHSCAT
3709	RCORRFACP	Risk factors within the past year: Resident of correctional facility		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_RCORRFACP
3710	MHTERMCARDIAC	Specify cardiac condition		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTERMCARDIAC
3711	EXTRATB	Does participant currently have extrapulmonary TB		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_EXTRATB
3712	SUCDURC	Total duration of tobacco use		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SUCDURC
3713	MHREASND	Year of Diabetes diagnosis is unknown		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHREASND
3714	MHSTYRHIVA	What year was the participant first documented as HIV-positive		f	6	1	1	4	2023-12-24	\N	\N	I_38_HX_MHSTYRHIVA
3715	DIABETES	Diabetes		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_DIABETES
3716	MHTERMTRAUMA	If participant has past personal experience of traumatic event(s ) please specify the event(s)		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTERMTRAUMA
3717	SUDSTXT	Number of cigarettes currently or formerly smoked per day		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SUDSTXT
3718	MHREASNDA	Not Applicable. Participant is HIV-negative		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHREASNDA
3719	RIDU	Risk factors within the past year: Injecting drug use		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_RIDU
3720	MHREASNDB	The year of participant's first documentation as HIV-positive is UNKNOWN		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHREASNDB
3721	SUCDURN	Amount of total duration of tobacco use		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SUCDURN
3722	SUCDURCD	Time since participant quit smoking		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SUCDURCD
3723	HEPUNK	Hepatitis (Type unknown)		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_HEPUNK
3724	SUCDURU	Unit of amount of total duration of tobacco use		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SUCDURU
3725	OTHERCA	Other concomitant diagnoses, including any current/active mental illness or problems		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_OTHERCA
2989	COVAL	Microscopic and histologic details if Q9a above is Yes		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_COVAL_9115
2990	ZCNAMEC	Name of person entering form		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_ZCNAMEC_156
2991	PMPEXAFB	If "yes", was the specimen positive for TB?		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_PMPEXAFB_328
2992	ZCEVAL	Name of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_ZCEVAL_3301
2993	ZCNAMEB	Name of person completing QA/QC		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_ZCNAMEB_1138
2994	AUTOPIND	Was an autopsy performed?		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_AUTOPIND_700
2995	PMPEX	Was a post-mortem specimen collected for pathological examination?		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_PMPEX_6082
2996	VIOACIND	Was the manner of death violent or accidental?		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_VIOACIND_2709
2997	PRCDTH	Was (were) the cause(s) of death known?		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_PRCDTH_5175
2998	ZCDATC	Date Form entered	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_DE_ZCDATC_1481
2999	ANTCDTH	In the opinion of the investigator, was this an anticipated or unanticipated death?		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_ANTCDTH_1226
3000	TBDTH	In the clinician's opinion, TB was:		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_TBDTH_3176
3001	USUBJID	Participant ID		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_USUBJID_2891
3002	DDORRE	If yes, list the primary cause(s) of death. (Indicate up to four causes or contributing factors, one per line, matching the death certificate, if available):		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_DDORRE_5948
3003	AENO	Sequence ID		f	6	1	1	4	2023-12-22	\N	\N	I_38_DE_AENO_1704
3004	DDSTDAT	Date of death	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_DE_DDSTDAT_9193
3005	ZCNAME	Signature of Principal Investigator or Co-PI		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_ZCNAME_6473
3006	ZCDAT	Date Form QA/QC completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-22	\N	\N	I_38_DE_ZCDAT_4690
3007	TXTDTH	What is the likelihood that study treatment was a factor in the participant's death?		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_TXTDTH_1923
3008	PMSPEC	Was a post-mortem specimen collected for microbiological or histological workup?		f	5	1	1	4	2023-12-22	\N	\N	I_38_DE_PMSPEC_3276
3726	LIVER	Liver disease		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_LIVER
3727	ZNTERMDR	Was the participant taking pre-study TB treatment in the 6 months prior to study start date and/or drugs with anti-TB activity given for purposes other than treatment of TB in the 30 days prior to study treatment start date.		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_ZNTERMDR
3728	USUBJID	Participant ID		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_USUBJID
3729	SUTRTA	Has participant ever smoked tobacco		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SUTRTA_8040
3730	SCORRESN	Karnofsky score		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SCORRESN
3731	ZCDAT	Date History Form completed	DD-MMM-YYYY	f	9	1	1	4	2023-12-24	\N	\N	I_38_HX_ZCDAT
3732	MHTERMCDLS	Has the participant ever had a CD4 cell count below 200 cells/mm^3?		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTERMCDLS
3733	ZNTERMART	In what year was ART initiated	YYYY	f	10	1	1	4	2023-12-24	\N	\N	I_38_HX_ZNTERMART
3734	COVAL	Comments		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_COVAL
3735	RALCOHOL	Risk factors within the past year: Alcohol use led to problems in relationships		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_RALCOHOL
3736	SEX	Participant's Sex		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SEX
3737	MHSTMOWHO	Month		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHSTMOWHO
3738	MHTERMSELF	If participant has past personal mental illness, please specify the past mental health diagnoses		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTERMSELF
3739	CARDIAC	Cardiac conditions		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_CARDIAC
3740	ETHNIC	Participant's Ethnicity		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_ETHNIC
3741	MHTRAUMA	Mental health history: Past personal experience of traumatic event(s)		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTRAUMA
3742	MHSTYR	Specify diabetes type		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHSTYR
3743	MHSTYRWHO	Year	YYYY	f	6	1	1	4	2023-12-24	\N	\N	I_38_HX_MHSTYRWHO
3744	ZCNAME	name of person completing form		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_ZCNAME
3745	MHTERMCHANGE	If participant has unintended mental status changes induced by specific medications or substances please specify medication and mental status change		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTERMCHANGE
3746	MHCAT	Mental health history: Family member with mental illness (primary relationship-biologic mother, biologic father, full sibling, or biologic child) with mental illness		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHCAT
3747	RACEOTH	Specify other Participant's race		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_RACEOTH
3748	RHOMELESS	Risk factors within the past year: Homeless		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_RHOMELESS
3749	HEPALC	Hepatitis due to alcohol use		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_HEPALC
3750	ZNCATAT	Was the participant taking any antidiabetic medications in the 14 days prior to study treatment start date?		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_ZNCATAT
3751	MHTERMWHO	WHO Clinical Stage 4 Condition		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTERMWHO
3752	CPLTPRTX	Did participant complete prescribed TB treatment?		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_CPLTPRTX
3753	MHCHANGE	Mental health history: Unintended mental status changes induced by specific medications or substances		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHCHANGE
3754	MHRECA	Is medical records confirming diabetes diagnosis available		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHRECA
3755	OTHER	Other		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_OTHER
3756	RACENR	Race was not reported		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_RACENR
3757	ESTIMATEA	Stated year of diabetes diagnosis is an estimation		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_ESTIMATEA
3758	RNIDU	Risk factors within the past year: Non-injecting drug use		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_RNIDU
3759	RACE	Participant's Race		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_RACE_4820
3760	SUCDURND	Amount of time since participant quit smoking		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_SUCDURND
3761	MHSTYRCONDA	The year of participant's first documentation as HIV-positive above that was is an ESTIMATION		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHSTYRCONDA
3762	MHDIAG	What year was Diabetes diagnosed?		f	6	1	1	4	2023-12-24	\N	\N	I_38_HX_MHDIAG
3763	ESTIMATE	The most recent month and year of diagnosis that was given above is an estimation		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_ESTIMATE_6591
3764	MHTERMCANCER	Specify cancer		f	5	1	1	4	2023-12-24	\N	\N	I_38_HX_MHTERMCANCER
\.


--
-- Data for Name: item_data; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.item_data (item_data_id, item_id, event_crf_id, status_id, value, date_created, date_updated, owner_id, update_id, ordinal, old_status_id, deleted) FROM stdin;
\.


--
-- Data for Name: item_data_flag; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.item_data_flag (id, path, tag_id, flag_workflow_id, owner_id, update_id, date_created, date_updated) FROM stdin;
\.


--
-- Data for Name: item_data_flag_workflow; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.item_data_flag_workflow (id, workflow_id, workflow_status, owner_id, update_id, date_created, date_updated) FROM stdin;
\.


--
-- Data for Name: item_data_type; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.item_data_type (item_data_type_id, code, name, definition, reference) FROM stdin;
1	BL	Boolean	\N	\N
2	BN	BooleanNonNull	\N	\N
3	ED	Encapsulated Data	\N	\N
4	TEL	A telecommunication address	\N	\N
5	ST	Character String	\N	\N
6	INT	Integer	\N	\N
7	REAL	Floating	\N	\N
8	SET	\N	a value that contains other distinct values	\N
9	DATE	date	date	\N
10	PDATE	partial date	year only or year with month or date	\N
11	FILE	File	File name, extension and path	\N
\.


--
-- Data for Name: item_form_metadata; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.item_form_metadata (item_form_metadata_id, item_id, crf_version_id, header, subheader, parent_id, parent_label, column_number, page_number_label, question_number_label, left_item_text, right_item_text, section_id, decision_condition_id, response_set_id, regexp, regexp_error_msg, ordinal, required, default_value, response_layout, width_decimal, show_item) FROM stdin;
1151	867	63	A. Visit Information		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Visit or date of blood specimen collection  <strong>(check one)</strong>:</span></p></tr><tr><p style=text-indent:40px; margin-bottom: 0px;><span>Study Evaluations</strong>:</span></p></tr>	155	\N	498			1	f				t
1152	868	63			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Date of Visit</strong>:</span></p></tr>	155	\N	499			2	f				f
1153	869	63	B. Reference Doses & Vomiting	PK reference dose must be preceded by two (2) directly observed study drug doses given approximately 24 and 48 hours prior to the reference dose.	0		1			<strong>1</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose A<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>	<div class="I_EXSD"><tr><br /><div style="text-indent:65px"><b>Date of Dose</b></tr>	155	\N	499			3	f				t
1154	870	63			0		2				<div class="I_EXS"><tr><br /><div style="text-indent:65px"><b>Time of Dose</b></tr>	155	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	4	f				t
1155	871	63			0		3				<tr><br /><div style="text-indent:50px"><b>Estimated Time</b></tr>	155	\N	500			5	f		Vertical		t
1156	872	63			0		4				<tr><br /><div style="text-indent:50px"><b>Vomiting</b></tr>	155	\N	501			6	f		Vertical		t
1157	873	63			0		1			<strong>2</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose B<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>	<div class="I_EXSD">	155	\N	499			7	f				t
1158	874	63			0		2				<div class="I_EXS">	155	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	8	f				t
1159	875	63			0		3					155	\N	502			9	f		Vertical		t
1160	876	63			0		4					155	\N	503			10	f		Vertical		t
1161	877	63			0		1			<strong>3</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose C<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>	<div class="I_EXSD">	155	\N	499			11	f				t
1162	878	63			0		2				<div class="I_EXS"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_EXS").parent().parent().find("input").css({\n        'width': '60px'\n    });    $(".I_EXSD").parent().parent().find("input").css({\n        'width': '85px'\n    });\n});  </script>	155	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	12	f				t
1163	879	63			0		3					155	\N	504			13	f		Vertical		t
1164	880	63			0		4					155	\N	505			14	f		Vertical		t
1165	881	63	C. Food & Alcohol Ingested		0		0				<tr><p><span>Participants enrolled in a bedaquiline-containing treatment arm should eat food within 1 hour before the administration of the reference dose.</span><br/>\n<span>Report the time and food eaten within 1 hour before to 1 hour after the administration of the reference dose.</span><br/>\n<span>If no food was eaten 1 hour before to 1 hour after the administration of the reference dose, report the date and time of the last meal ingested.</span></tr><tr><p><span><strong>Reference dose </strong></span></p></tr><tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>Food Consumed</strong></span></p></tr>	155	\N	505			15	f		Horizontal		t
1166	882	63	Food		0		0					155	\N	499			16	f				t
1167	883	63	Quantity		0		0					155	\N	499			17	f		Vertical		t
1168	884	63	Unit		0		0					155	\N	506			18	f		Vertical		t
1169	885	63	Time		0		0					155	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	19	f		Vertical		t
1170	886	63	Est. Time		0		0					155	\N	507			20	f		Vertical		t
1171	887	63			0		1				<div class="I_EXSD"><tr><br /><b>Last Meal</b></tr><tr><br /><div style="text-indent:65px"><b>Day</b></tr>	155	\N	499			21	f				t
1172	888	63			0		2				<div class="I_EXS"><tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Time</b></tr>	155	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	22	f				t
1173	889	63			0		3				<tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Est. Time</b></tr>	155	\N	508			23	f		Horizontal		t
1174	890	63			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Did participant abstain from alcohol for at least 48 hours prior to PK sampling?</span></p></tr>	155	\N	509			24	f		Horizontal		t
1175	891	63	1. PK sampling for participants assigned to receive Rifapentine (P)	Record sampling information 24+1 hour after most recent DOT study drug ingestion (reference dose #1), \n25 – 40 minutes post reference dose #2, and 5-8 hours post reference dose #2.	0		1			<strong>1a</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre ref. dose (t=-1)<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>	<tr><p style="text-align: center; width : 125px; height:30px; "><span><strong>Time Point</strong></span></p>	156	\N	510			25	f		Horizontal		t
294	309	10	A. Patient Information		0		0			Sex:		34	\N	148			1	t		Horizontal		t
1176	892	63			0		2				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Actual blood collection time</strong></p></tr>	156	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	26	f		Horizontal		t
1177	893	63			0		3				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time blood placed in centrifuge</strong></p></tr>	156	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	27	f		Horizontal		t
1178	894	63			0		4				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time plasma placed in -70°C freezer or below</strong></p></tr>	156	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	28	f		Horizontal		t
1179	895	63			0		5				<tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Blood collection to -70°C freezer time > 2 hrs</strong></p></tr>	156	\N	511			29	f		Horizontal		t
1180	896	63			0		1			<strong>1b</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Right before ref. dose (t=0) <br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		156	\N	512			30	f				t
1181	897	63			0		2				<div class="I_TIME">	156	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	31	f		Horizontal		t
1182	898	63			0		3				<div class="I_TIME">	156	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	32	f		Horizontal		t
1183	899	63			0		4				<div class="I_TIME">	156	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	33	f		Horizontal		t
1184	900	63			0		5					156	\N	513			34	f		Horizontal		t
1185	901	63			0		1			<strong>2c</strong><a href='javascript:void(0)' onmouseover='Tip("<br />3 hrs post ref. dose <br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		156	\N	512			35	f		Horizontal		t
1186	902	63			0		2				<div class="I_TIME">	156	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	36	f		Horizontal		t
1187	903	63			0		3				<div class="I_TIME">	156	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	37	f		Horizontal		t
1188	904	63			0		4				<div class="I_TIME"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_TIME").parent().parent().find("input").css({\n        'width': '60px'\n        \n    }); $(".I_TBTC").parent().parent().find("input").css({\n        'width': '70px'\n        \n    });\n});  </script>	156	\N	499	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	38	f		Horizontal		t
1189	905	63			0		5					156	\N	514			39	f		Horizontal		t
1190	906	63	D. PK sampling (Continued)	2. Cryovial Label Numbers<br/><div style="text-indent:20px"><span>Report the TBTC Label Number exactly as written on the labels affixed to the aliquot cryovials.</span></div>	0		1			<strong>2a</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre ref. dose (t=-1)<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		156	\N	515			40	f				t
1191	907	63			0		2				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	41	f				t
1192	908	63			0		3				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	42	f				t
1193	909	63			0		4				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	43	f				t
1194	910	63			0		5				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	44	f				t
1195	911	63			0		1			<strong>2b</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Right before ref. dose (t=0) <br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		156	\N	516			45	f				t
1196	912	63			0		2				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	46	f				t
1197	913	63			0		3				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	47	f				t
1198	914	63			0		4				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	48	f				t
1199	915	63			0		5				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	49	f				t
295	310	10			0		0			Year of birth		34	\N	149			2	t				t
296	311	10			0		0			Place of birth:		34	\N	150			3	t				t
297	312	10			0		0			Ethnicity:		34	\N	151			4	t		Vertical		t
298	313	10			0		0			Race:		34	\N	152			5	t		Vertical		t
299	314	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Other Specify</span></p></tr>	34	\N	153			6	t				f
300	315	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>6. Site Screening Number</span></p></tr>	34	\N	153			7	t				t
301	316	10	B. 7. Reason for Non-Enrollment		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span></span></p></tr>	34	\N	154			8	f		Vertical		t
302	317	10	C. Main reason(s) patient does not meet eligibility criteria (Check all that apply)		0		0					34	\N	155			9	f				t
303	318	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>For participants with HIV</strong></span></p></tr>	34	\N	156			10	f				t
304	319	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Specify Other medical conditions</span></p></tr>	34	\N	153			11	f				f
305	320	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>Laboratory parameters done at or within 14 days prior to screenin</strong></span></p></tr>	34	\N	157			12	f				t
306	321	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>1. Experimental Components</strong></span></p></tr>	35	\N	158			13	f				t
307	322	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>2. Study Procedures NESCAT</strong></span></p></tr>	35	\N	159			14	f				t
1200	916	63			0		1			<strong>2c</strong><a href='javascript:void(0)' onmouseover='Tip("<br />3 hrs post ref. dose <br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		156	\N	516			50	f				t
1201	917	63			0		2				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	51	f				t
1202	918	63			0		3				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	52	f				t
1203	919	63			0		4				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	53	f				t
1204	920	63			0		5				<div class="I_TBTC"></div>	156	\N	499	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	54	f				t
1205	921	63	E. Comments		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Comments</span></p></tr>	156	\N	517			55	f				t
1206	922	63	F. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>name of person completing form:</span></p></tr>	156	\N	499			56	f				t
308	323	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>3. Difficulties or Costs Associated with Study Participation</strong></span></p></tr>	35	\N	160			15	f				t
309	324	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>4. Opinion or Response of Others / Stigma</strong></span></p></tr>	35	\N	161			16	f				t
310	325	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>5. Miscellaneous STUDY PROCEDURES</strong></span></p></tr>	35	\N	162			17	f				t
311	326	10	E. Site decides not to enroll patient (Check all that apply)		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>E. Site decides not to enroll patient (Check all that apply)</strong></span></p></tr>	35	\N	163			18	f				t
312	327	10	F. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>name of person completing form:</span></p></tr>	35	\N	149			19	t				t
313	328	10			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Non-enrollment Form completed </span></p></tr>	35	\N	149			20	t				t
5587	3728	148			0		0			Participant ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	492	\N	2074			1	f				t
5588	3706	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Visit date</span></p></tr>	492	\N	2074			2	t				t
5589	3736	148	A. Participant History		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Sex:</span></p></tr>	492	\N	2075			3	t		Horizontal		t
5590	3696	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Place of birth:</span></p></tr>	492	\N	2076			4	t				t
5591	3740	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Ethnicity:</span></p></tr>	492	\N	2077			5	t		Vertical		t
326	341	12			0		0			Participant ID: 38-		37	\N	170	regexp: /[0-9]{2}-[0-9]{5}/	Format must be 2 digits followed by a dash followed by 5 digits	1	t			8	t
327	342	12			0		0					37	\N	170			2	t				t
328	343	12	A. Eligibility Criteria for TB Drug Sparse PK Sampling		0		0		1	Has the participant received a minimum of 14 doses of study drugs?	(If "No", ineligible)	37	\N	171			3	t		Horizontal		t
329	344	12			0		0		2	Did the participant receive two consecutive, daily study doses via DOT before the reference dose?	(If "No", ineligible)	37	\N	171			4	t		Horizontal		t
330	345	12			0		0		3	Is the participant willing to provide three blood samples over approximately a 4-hour period (approximately 30 mL or 6 teaspoons total)?	(If "No", ineligible)	37	\N	171			5	t		Horizontal		t
331	346	12	B. Form Completion		0		0			PRINT name of person completing form:		37	\N	170			6	t				t
332	347	12			0		0			Date Sparse PK Screening Form completed:		37	\N	170			7	t				t
333	341	13			0		0			Participant ID: 38-		38	\N	172	regexp: /[0-9]{2}-[0-9]{5}/	Format must be 2 digits followed by a dash followed by 5 digits	1	t			8	t
334	342	13			0		0					38	\N	172			2	t				t
3605	1711	117			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Participant's ID</strong>:</span></p></tr>	298	\N	1287			1	f				t
3606	1712	117	A. Visit Information		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Visit or date of blood specimen collection  <strong>(check one)</strong>:</span></p></tr><tr><p style=text-indent:40px; margin-bottom: 0px;><span>Study Evaluations</strong>:</span></p></tr>	298	\N	1288			2	f		Horizontal		t
3607	1713	117			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Date of Visit</strong>:</span></p></tr>	298	\N	1287			3	f				f
3608	1714	117	B. Reference Doses & Vomiting	PK reference dose <strong>must</strong> be preceded by two (2) directly observed study drug doses given approximately 1) 24 and 2) 48 hours prior to the reference dose.	0		1			<strong>1</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose A<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_EXSD"><tr><br /><div style="text-indent:65px"><b>Date of Dose</b></tr>	298	\N	1287			4	f				t
3609	1715	117			0		2				<div class="I_EXS"><tr><br /><div style="text-indent:65px"><b>Time of Dose</b></tr>	298	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	5	f				t
3610	1716	117			0		3				<tr><br /><div style="text-indent:50px"><b>Estimated Time</b></tr>	298	\N	1289			6	f		Vertical		t
3611	1717	117			0		4				<tr><br /><div style="text-indent:50px"><b>Vomiting<a href='javascript:void(0)' onmouseover='Tip("<br />Vomiting within 2 hours <br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a></b></tr>	298	\N	1290			7	f		Vertical		t
3612	1718	117			0		1			<strong>2</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose B<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_EXSD">	298	\N	1287			8	f				t
3613	1719	117			0		2				<div class="I_EXS">	298	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	9	f				t
335	343	13	A. Eligibility Criteria for TB Drug Sparse PK Sampling		0		0		1	Has the participant received a minimum of 14 doses of study drugs?	(If "No", ineligible)	38	\N	173			3	t		Horizontal		t
78	94	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of AE status evaluated:</span></p></tr>	14	\N	23			1	t				t
79	86	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Details of AE from its corresponding AE Form:</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Reportable AE:</span></p></tr>	14	\N	23			2	t				t
80	81	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Is the FINAL reportable adverse event different from the initial event reported on the AE Form?</span></p></tr>	14	\N	24			3	f		Horizontal		t
81	79	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If yes, specify:</span></p></tr>	14	\N	25	func:  gt(200)	maximum number of characters 200	4	f				f
82	78	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Did the initial reportable event become a serious adverse event (SAE)?</span></p></tr>	14	\N	26			5	f		Horizontal		t
83	97	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If 'yes', indicate type of SAE <span style="font-weight: bold">(select all that apply):</span> </span></p></tr>	14	\N	27			6	f		Vertical		f
84	105	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Date event became an SAE:</span></p></tr>	14	\N	23			7	f				t
85	106	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Site awareness date:</span></p></tr>	14	\N	23			8	f				t
86	91	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Status of the AE (check only one and provide date if indicated):</span></p></tr>	14	\N	28			9	f		Vertical		t
87	90	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>Resolution Date/Death Date</span></p></tr>	14	\N	23			10	f				t
88	92	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. In the opinion of the investigator, what is the final attribution to study treatment in causing this AE?</span></p></tr>	14	\N	29			11	f		Horizontal		t
89	108	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. select the study drug(s) to which the AE is attributed:</span></p></tr>	14	\N	30			12	f				f
90	80	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. In the opinion of the investigator, is this an anticipated or unanticipated AE?</span></p></tr>	14	\N	31			13	f		Horizontal		t
91	89	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Indicate the maximum toxicity grade during the course of the AE</span></p></tr>	14	\N	32			14	f		Horizontal		t
92	82	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Were any additional assessment, evaluations or tests done in response to this AE:</span></p></tr><tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Laboratory evaluations</span></p></tr>	15	\N	24			15	f		Horizontal		t
93	98	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Clinical evaluations</span></p></tr>	15	\N	24			16	f		Horizontal		t
94	93	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Signs and symptoms assessment</span></p></tr>	15	\N	24			17	f		Horizontal		t
95	102	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Sputum or other specimen collected for TB diagnostic workup</span></p></tr>	15	\N	24			18	f		Horizontal		t
96	85	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Was all or any part of study treatment held for any period of time? </span></p></tr>	15	\N	24			19	f		Horizontal		t
97	100	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Was the participant re-challenged with the intention of restarting study treatment?</span></p></tr>	15	\N	24			20	f		Horizontal		t
98	83	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Was study treatment permanently discontinued as a result of this AE?</span></p></tr>	15	\N	24			21	f		Horizontal		t
99	88	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Summary of current AE status</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Use the SOAP (Subjective, Objective, Analysis, and Plan) format for a brief clinical description</span></p></tr>	16	\N	25	func:  gt(3500)	maximum number of characters 3500	22	f				t
100	84	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. If applicable, specify how long after the onset date did the AE resolved (hours, days, weeks):</span></p></tr>	16	\N	25	func:  gt(500)	maximum number of characters 500	23	f				t
101	107	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Did the participant present with signs and symptoms similar to those reported in this AE report, but of lower toxicity grade, prior to this AE?</span></p></tr>	16	\N	25	func:  gt(500)	maximum number of characters 500	24	f				t
102	101	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Pregnancy outcome</span></p></tr>	17	\N	33			25	f		Vertical		t
103	103	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. were any congenital anomalies present?</span></p></tr>	17	\N	24			26	f		Horizontal		f
104	104	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. What was the gestational age at pregnancy outcome?</span></p></tr>	17	\N	23			27	f				t
105	87	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Date of pregnancy outcome:</span></p></tr>	17	\N	23			28	f				t
106	96	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of Principal Investigator or Co-PI:</span></p></tr>	18	\N	23			29	f				t
107	95	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	18	\N	23			30	f				t
108	109	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form completed:</span></p></tr>	18	\N	23			31	f				t
109	111	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Final MedDRA Lower Level Term Code:&nbsp;&nbsp;<a href="#" class="btn primary" onClick="openNewWindow('includes/meddra/meddra-browser-api.jsp','dnote_win','directories=no,location=no,menubar=no,scrollbars=yes,toolbar=no,status=no,resizable=yes','dnote'); return false;">medDra Access</a></span></p></tr><div id="I_ZFLLTCD"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     window.addEventListener('message', function(event) {\n      const rowData = event.data;\n      var medCode = $("#I_ZFLLTCD").parent().parent().find("input"); \n\t  var medName =$("#I_ZFLLT").parent().parent().find("input");\n\t  medCode.val(rowData.code);\n\t  medCode.change();\n\t  medName.val(rowData.name);\n\t  medName.change();\n      console.log("Valor seleccionado: " + rowData.code + " " + rowData.name);\n     \n    });\n  </script>\n  <style>\n     .btn {\n      border: none; \n      cursor: pointer;  font-size: 11px;\n      text-decoration: none;\n    }\n  </style>\n</head>\n<body>	19	\N	23			32	f				t
110	110	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Final MedDRA Lower Level Term Description:</span></p></tr><div id="I_ZFLLT"></div>	19	\N	23			33	f				t
111	99	3			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Safety officer providing MedDRA code:</span></p></tr>	19	\N	23			34	f				t
112	112	4	A. Visit		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Week/Month of evaluation:</span></p></tr>	20	\N	34			1	t		Horizontal		t
113	113	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date of AE onset:</span></p></tr>	20	\N	35			2	t				t
114	114	4	B. Evaluation		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Did participant report any changes in antiretroviral or non-TB/non-antiretroviral medications, including over-the-counter drugs?<script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>\n<div id="CMMessage" style="display:none;">&nbsp;(Complete or Update Concomitant Medication Form)</div>\n<script>\njQuery(document).ready(function() {\nenableRadioMessage("#CMMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#DRMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#CEMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#LBMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#SSMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#MBMessage", "Y");\n});\nfunction enableRadioMessage(containerId, value) {\n\tvar msgContainer = jQuery(containerId);\n\tvar radiosToCheck = msgContainer.parent().parent().find("input");\n\tradiosToCheck.change(function(){setMessage(radiosToCheck, msgContainer, value);});\n\tsetMessage(radiosToCheck, msgContainer, value);\n}\n\nfunction setMessage(radiosToCheck, msgContainer, value) {\n\tfor (var i = 0; i < radiosToCheck.length; i++) {\n\t\tif (radiosToCheck[i].checked) {\n\t\t\tvar valueToCheck = radiosToCheck[i].value;\n\t\t\tbreak;\n\t\t}\n\t}\n\tif (valueToCheck && (valueToCheck == value)){\n\t\tmsgContainer.show();\n\t}\n\telse {\n\t\tmsgContainer.hide();\n\t}\n}\n\n</script></span></p></tr>	20	\N	36			3	t		Horizontal		t
115	115	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Did participant take any drugs with anti-TB activity?\n<div id="DRMessage" style="display:none;">&nbsp;(Update TB Drug Dose Record Form)</div>\n </span></p></tr>	20	\N	37			4	t		Horizontal		t
116	116	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Were any clinical evaluations (e.g., chest X-ray, CT scan, MRI, ECG) performed?<div id="CEMessage" style="display:none;">&nbsp;(Complete Clinical Evaluation Form)</div></span></p></tr>	20	\N	38			5	t		Horizontal		t
117	117	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Are new laboratory test results available?<div id="LBMessage" style="display:none;">&nbsp;(Complete Laboratory Evaluation Form)</div></span></p></tr>	20	\N	39			6	t		Horizontal		t
118	118	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Were signs and symptoms assessed? <div id="SSMessage" style="display:none;">&nbsp;(Complete Signs and Symptoms Form)</div></span></p></tr>	20	\N	40			7	t		Horizontal		t
119	119	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Was sputum collection attempted or other specimen collected for AFB work-up?<div id="MBMessage" style="display:none;">&nbsp;(Complete Mycobacteriology Form)</div></span></p></tr>	20	\N	41			8	t		Horizontal		t
120	120	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Was sputum collected for RS ratio assay?</span></p></tr>	20	\N	42			9	t		Horizontal		t
121	121	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was a specimen for pharmacogenomics testing collected?</span></p></tr>	20	\N	43			10	f		Horizontal		t
122	122	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. Was a specimen for biomarker analysis collected (i.e., blood)?</span></p></tr>	20	\N	43			11	f		Horizontal		t
336	344	13			0		0		2	Did the participant receive two consecutive, daily study doses via DOT before the reference dose?	(If "No", ineligible)	38	\N	173			4	t		Horizontal		t
2763	1086	93			0		4					212	\N	1057			15	f		Vertical		t
123	123	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>10. Were any modifications made to the assigned study TB treatment (<strong>e.g., retreatment with any TB therapy after the participant completed assigned study treatment, extension of TB treatment beyond that of the participant’s assigned regimen</strong>)? </span></p></tr>	20	\N	44			12	t		Horizontal		t
124	124	4	C. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span> Comments </span></p></tr>	20	\N	45			13	f				t
125	125	4	D. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	20	\N	35			14	t				t
126	126	4			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Follow-up Evaluation Form completed:</span></p></tr>	20	\N	35			15	t				t
337	345	13			0		0		3	Is the participant willing to provide three blood samples over approximately a 4-hour period (approximately 30 mL or 6 teaspoons total)?	(If "No", ineligible)	38	\N	173			5	t		Horizontal		t
338	346	13	B. Form Completion		0		0			PRINT name of person completing form:		38	\N	172			6	t				t
339	347	13			0		0			Date Sparse PK Screening Form completed:		38	\N	172			7	t				t
130	145	6	A. Study Entry Enrollment		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of birth:</span></p></tr>	22	\N	49			1	t				t
131	146	6			145	BRTHDAT	0			Estimated		22	\N	50			2	f		Horizontal		t
132	147	6			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date participant or legal guardian signed informed consent</span> </span></p></tr>	22	\N	49			3	t		Horizontal		t
133	148	6			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Date participant assent:</span> </span></p></tr>	22	\N	49			4	t		Horizontal		t
134	149	6			148	DSSTDATB	0			NA (e.g., Participant > 18)		22	\N	51		This is a required field	5	t		Horizontal		t
135	150	6			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Height:</span> </span></p></tr>	22	\N	49		This is a required field	6	t		Horizontal		t
136	151	6			150	HEIGHT	0					22	\N	52		This is a required field	7	t		Horizontal		t
137	152	6			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Weight:</span> </span></p></tr>	22	\N	49		This is a required field	8	t		Horizontal		t
138	153	6			152	WEIGHT	0					22	\N	53			9	t		Horizontal		t
139	154	6			152	WEIGHT	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Date of weight: <b>(Cannot be more than 7 days prior to enrollment)</b></span></p></tr>	22	\N	49		This is a required field	10	t		Horizontal		t
140	155	6			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Date of chest X-ray: </p><br><p style="text-indent:40px; font-weight: bold">(Alternative imaging techniques (e.g. CT or MRI) may NOT be used in place of a plain chest X-ray)</span> </span></p></tr>	22	\N	49		This is a required field	11	t		Horizontal		t
141	156	6			155	MODAT	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px;margin-bottom:0px;"> a. Any cavitation on chest X-ray: </span></p></tr>	22	\N	54		This is a required field	12	t		Horizontal		t
142	157	6			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">7. Scheduled study treatment start date:</span></p></tr>	22	\N	49		This is a required field	13	t		Horizontal		t
143	158	6	B. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Comments</span></p></tr>	22	\N	55			14	t		Horizontal		t
144	159	6	C. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">PRINT name of person completing form:</span></p></tr>	22	\N	49			15	t		Horizontal		t
145	160	6			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Date Enrollment Form completed: </span></p></tr>	22	\N	49		This is a required field	16	t		Horizontal		t
146	161	6	Treatment Assigment upon Successful Enrollment Submission	REMINDER: Vitamin B6 (pyridoxine), 25 or 50mg, must be obtained locally and be administered daliy by mouth with isoniazid	0		0			Assigned treatment arm (study kit medications)		22	\N	56			17	f		Vertical		t
147	162	6			0		1			Medication		22	\N	49			18	f		Vertical		t
148	163	6			0		2			Dose (mg)		22	\N	49		This is a required field	19	t		Horizontal		t
149	164	6			0		3			Duration # of weeks		22	\N	49		This is a required field	20	t		Horizontal		t
150	165	7	A. Information Concerning Death		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of death:</span></p></tr>	23	\N	57			1	t				t
151	166	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Was (were) the cause(s) of death known??</span></p></tr>	23	\N	58			2	t		Horizontal		t
152	167	7			166	PRCDTH	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>a. If 'yes', indicate the primary cause(s) of death <br><b>(Indicate up to four causes or contributing factors, one per line, matching the death certificate, if available):</span> </span></p></tr>	23	\N	59	func:  gt(200)	maximum number of characters 200	3	f				f
153	168	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. In the clinician's opinion, <b>TB</b> was (check one):</span> </span></p></tr>	23	\N	60			4	t		Vertical		t
340	348	14			0		0			Participant ID:		39	\N	174	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
341	342	14			0		0			Sparse PK screening date:		39	\N	174			2	t				t
154	169	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. What is the likelihood that <b>study treatment </b>was a factor in the participant's death (check one)?</p><p style="text-indent:40px;margin-bottom:0px;"> <b>Refer to attribution scale at the bottom of the form, check only one </b> </span> </span></p></tr>	23	\N	61		This is a required field	5	t				t
155	170	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. In the opinion of the investigator, was this an anticipated or unanticipated death? </span> </span></p></tr>	23	\N	62		This is a required field	6	t		Horizontal		t
156	171	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Was the manner of death violent or accidental? </span> </span></p></tr>	23	\N	63		This is a required field	7	t		Horizontal		t
157	172	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Was an autopsy performed?</span></p></tr>	23	\N	63		This is a required field	8	t		Horizontal		t
158	173	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was a post-mortem specimen collected for microbiological or histological workup?</p><p style="text-indent:40px;margin-bottom:0px;"> <b>(If "yes", complete MB form)</b> </span></p></tr>	23	\N	63			9	f		Horizontal		t
159	174	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. Was a post-mortem specimen collected for pathological examination?</p><p style="text-indent:40px;margin-bottom:0px;"> <b>(If "No" or "Unknown", skip to Section B)</b> </span></p></tr>	23	\N	63			10	t		Horizontal		t
160	175	7			174	PMPEX	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If "yes", was the specimen positive for TB?</p><p style="text-indent:40px;margin-bottom:0px;"> <b>(If "Yes", provide microscopic and histologic details in Section B)</b> </span></p></tr>	23	\N	63			11	f		Horizontal		f
161	176	7	B. Narrative regarding the circumstances of the death and any relationship to study treatment		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;"> <b>Record Microscopic and histologic details here if Q9a above = "Yes"</b> </span></p></tr>	23	\N	59	func:  gt(3500)	This is a required field	12	f				t
162	177	7	C. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;"> PRINT name of Principal Investigator or Co-PI </span></p></tr>	23	\N	57			13	t				t
163	178	7			177	ZCEVAL	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;"> Signature of Principal Investigator or Co-PI: </span></p></tr>	23	\N	57			14	t		Horizontal		t
164	179	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Name of person completing QA/QC </span></p></tr>	23	\N	57			15	t		Horizontal		t
165	180	7			179	ZCNAMEB	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Date Form QA/QC completed: </span></p></tr>	23	\N	57			16	t		Horizontal		t
166	181	7			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Name of person entering form: </span></p></tr>	23	\N	57			17	t		Horizontal		t
167	182	7			181	ZCNAMEC	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Date form entered: </span></p></tr>	23	\N	57			18	t		Horizontal		t
342	343	14	A. Eligibility Criteria for TB Drug Sparse PK Sampling		0		0		1.	Has the participant received a minimum of 14 doses of study drugs?	(If "No", ineligible)	39	\N	175			3	t		Horizontal		t
343	344	14			0		0		2.	Did the participant receive two consecutive, daily study doses via DOT before the reference dose?	(If "No", ineligible)	39	\N	175			4	t		Horizontal		t
344	345	14			0		0		3.	Is the participant willing to provide three blood samples over approximately a 4-hour period (approximately 30 mL or 6 teaspoons total)?	(If "No", ineligible)	39	\N	175			5	t		Horizontal		t
345	346	14	B. Form Completion		0		0			PRINT name of person completing form:		39	\N	174			6	t			50	t
346	347	14			0		0			Date Sparse PK Screening Form completed:		39	\N	174			7	t				t
347	349	15			0		0			Participant ID:		40	\N	176	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
348	350	15			0		0			Screening date:		40	\N	176			2	t				t
349	351	15	A. Eligibility Criteria for TB Drug Intensive PK Sampling		0		0		1.	Has the participant received a minimum of 14 doses of study drugs?	(If "No", ineligible)	40	\N	177			3	t		Horizontal		t
350	352	15			0		0		2.	Did the participant receive two consecutive, daily study doses via DOT before the reference dose?	(If "No", ineligible)	40	\N	177			4	t		Horizontal		t
351	353	15			0		0		3.	Is the participant willing to provide 7 blood samples over a 24-hour period (approximately 70 mL or 14 teaspoons total)?	(If "No", ineligible)	40	\N	177			5	t		Horizontal		t
352	354	15			0		0		4.	Is the participant willing to be admitted to an out-patient clinic, clinical research center, or hospital (approximately 24 hours in duration) for the PK visit?	(If "No", ineligible)	40	\N	177			6	t		Horizontal		t
353	355	15			0		0		5.	Is the participant’s most recent (measured within 3 weeks before PK study sampling) hemoglobin ≥ 8 g/dL?	(If "No", ineligible)	40	\N	177			7	t		Horizontal		t
354	356	15	B. Form Completion		0		0			PRINT name of person completing form:		40	\N	176			8	t			50	t
355	357	15			0		0			Date Sparse PK Screening Form completed:		40	\N	176			9	t				t
407	409	19	C. Form Completion		0		0			PRINT name of person completing form:		45	\N	186			15	t			50	t
408	410	19			0		0			Date Concomitant Medication Form completed:	DD-MMM-YYYY<br><div style="page-break-before: always;"></div> <div><b>INSERT TWO TABLES OF MEDICATION HERE FROM ORIGINAL CDC FORM</b></div>	45	\N	186			16	t				t
458	1	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of site awareness:</span></p></tr>	52	\N	200			1	t				t
356	358	16			0		0			Participant ID:	<br>\n<b>Consent Review</b> This form should ONLY be completed for participants providing informed consent to collection of blood for pharmocogenomic testing.<br><br>\n\n<ul>\n    <li>Complete this form if a blood specimen is collected for pharmacogenomic analyses.</li>\n    <li>Record all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>).</li>\n    <li>Record all times in 24 hour format (e.g., <b>7 AM is recorded as 0700 and 10 PM is recorded as 2200</b>).</li>\n</ul>	41	\N	178	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
357	359	16	A. Visit Information		0		0		1.	Visit or date of pharmacogenomic blood sample collection <b>(check one)</b>:<br><br>\n\n<i>Study Evaluations</i>		41	\N	179			2	t		Vertical		t
358	360	16			0		0				Sequence ID	41	\N	178	regexp: /[0-9A-Z]{4}/	Format must be exactly 4 characters or digits in length	3	f			4	f
359	361	16			0		0			Date of visit:		41	\N	178			4	f				f
360	362	16	B. Pharmacogenomic Specimen Collection<br><br>\n<div style="font-weight: normal; display: flex;">\n    <span>Note:&nbsp;</span>\n    <span>Blood collected for the pharmacogenomic sample should be kept in the ACD tube in a tube rack at room temperature until separated into (whole blood) aliquots and then frozen at -70⁰ C. Do <b><u>NOT</u></b> place in ice/water or -20 o C freezer prior to freezing at -70 o C.</span>\n</div>		0		0		1.	Pharmacogenomic sampling<br>\nDate/time of specimen collection:<br>\n<b>Date:</b>		41	\N	178			5	t				t
361	363	16			0		0			<b>Time:</b>		41	\N	178	regexp: /[0-9]{2}:[0-9]{2}/	Format must be exactly 2 digits followed by a colon (':') followed by 2 digits	6	t			5	t
362	364	16			0		0		2.	Total volume collected:	mL	41	\N	178			7	t			4(1)	t
363	365	16			0		0		3.	Were any aliquots made?		41	\N	180			8	t		Horizontal		t
364	366	16			0		0		a.	Provide the following:<br>\nVolume in mL<br>\nAliquot #1		41	\N	178			9	f			4(1)	f
365	367	16			0		0			Aliquot #2		41	\N	178			10	f			4(1)	f
366	368	16			0		0		4.	Cryovial Label Numbers<br>\nReport the Label Number <u>exactly</u> as written on the labels affixed to the aliquot cryovials.<br>\nCUID Label Number<br>    \nAliquot #1		41	\N	178	regexp: /[0-9]{8}/	Format must be exactly 8 digits	11	t			8	t
367	369	16			0		0			Aliquot #2		41	\N	178	regexp: /[0-9]{8}/	Format must be exactly 8 digits	12	t			8	t
368	370	16			0		0		5.	Date/time aliquots stored locally in -70°C freezer:<br>\n<b>Date:</b>		41	\N	178			13	t				t
369	371	16			0		0			<b>Time:</b>		41	\N	178	regexp: /[0-9]{2}:[0-9]{2}/	Format must be exactly 2 digits followed by a colon (':') followed by 2 digits	14	t			5	t
370	372	16	C. Comments		0		0					41	\N	181			15	t				t
371	373	16	D. Form Completion		0		0			PRINT name of person completing form:		41	\N	178			16	t			50	t
372	374	16			0		0			Date Pharmacogenomics Form completed:		41	\N	178			17	t				t
409	411	20			0		0			Participant ID:	(38-##-#####) <br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at every study visit in which doses of drugs with anti-TB activity (listed on last page) are reported.<br>\n<div style="margin-left: 20px;">\n    This includes:\n    <ul>\n        <li>Pre-study doses <b>(TB treatment in the 6 months prior to study start date and/or drugs with anti-TB activity given for purposes other than treatment of TB in the 30 days prior to study start date)</b></li>\n        <li>Study doses <b>(including all changes in TB treatment)</b></li>\n        <li>Non-study doses of drugs with anti-TB activity given for treatment of incidental illnesses during study <b>(e.g., a fluoroquinolone given for a urinary tract infection)</b> after study start date.</li>\n        <li>Re-challenge doses of TB medications following an adverse event.</li>\n    </ul>\n</div>\nRecord all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>). </div>	46	\N	188	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
410	412	20	A. TB Drug Dose Record		0		0			Dose Type*		47	\N	188	regexp: /[PICNRpicnr]/	Must be P, I, C, N, or R	2	t			1	t
411	413	20			0		0			Food**		47	\N	188	regexp: /[BWNUbwnu]/	Must be B, W, N, or U	3	t			1	t
412	414	20			0		0			Vomiting within 1 hour of dose***		47	\N	188	regexp: /[YNUynu]/	Must be Y, N, or U	4	t			1	t
413	415	20			0		0			Dose Date		47	\N	188			5	t				t
414	416	20			0		0			___mg		47	\N	188	regexp: /[0-9]{5}/	Must be exactly 4 digits	6	t			4	t
415	417	20			0		0			___mg		47	\N	188	regexp: /[0-9]{5}/	Must be exactly 4 digits	7	t			4	t
416	418	20			0		0			___mg		47	\N	188	regexp: /[0-9]{5}/	Must be exactly 4 digits	8	t			4	t
417	419	20			0		0			___mg		47	\N	188	regexp: /[0-9]{5}/	Must be exactly 4 digits	9	t			4	t
418	420	20			0		0			___mg		47	\N	188	regexp: /[0-9]{5}/	Must be exactly 4 digits	10	t			4	t
419	421	20			0		0			___mg		47	\N	188	regexp: /[0-9]{5}/	Must be exactly 4 digits	11	t			4	t
420	422	20			0		0			Adm†		47	\N	188	regexp: /[DVSUdvsu]/	Must be D, V, S, or U	12	t			1	t
421	423	20			0		0			Tolerated re-challenge‡		47	\N	188	regexp: /[YNyn]/	Must be Y or N	13	t			1	t
422	424	20	"<br> <div>\n* Dose type: P=Pre-study dose; I=Intensive phase study dose; C=Continuation phase study dose; N=Non-study dose; R=Re-challenge dose<br>\n**Food intake: B=<1 hour before dose; W=with dose; N=no food consumed < 1 hour before or with dose; U=Unknown<br>\n***Vomiting within 1 hour of dose: Y=Yes; N=No; U=Unknown<br>\n† Administration: D=In-person DOT; V=Video-DOT; S=SAT; U=Unknown<br>\n‡ Tolerated re-challenge: Y=Yes; N=No<br> </div>"<br><br><b>B. Comments</b>		0		0					47	\N	189			14	t				t
423	425	20	C. Form Completion		0		0			PRINT name of person completing form:		47	\N	188			15	t			50	t
424	426	20			0		0			Date Concomitant Medication Form completed:		47	\N	188			16	t				t
441	443	22	A. Visit Information		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Participant's ID:</span></p></tr>	50	\N	192	regexp: /38-[0-9]{2}-[0-9]{5}/	The format should be '38', followed by a dash, two digits, another dash, and then five digits.	1	t	38  - -   - - - - -			t
3614	1720	117			0		3					298	\N	1291			10	f		Vertical		t
373	375	17			0		0			Participant ID:	(38-##-#####) <br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at each study visit if the participant reports taking any concomitant medications with no anti-TB activity, either in the 14 days prior to study treatment start date or while on study treatment, including analgesics and antipyretics. If there is no change in concomitant medications, do not update this form.</br></br>\nFor ongoing medications started more than 30 days before study start date, report medication start date as 30 days prior to study start date. If participant is still taking a medication, leave “End Date” blank. Record all dates in the following format: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>.</br></br>\nDo NOT report medications with anti-TB activity <b>(see page 3 of this form)</b> on this form. Report all medications with TB activity on the TB Drug Dose Record form. <b>(see TB Drug Dose Record Form)</b>. Antiretroviral Medications table is on the last page of this form.</div>	42	\N	182	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
374	376	17	A. Non-TB and Non-antiretroviral Medication		0		0			Name		42	\N	182			2	t				t
375	377	17			0		0			Start Date		42	\N	182			3	t				t
376	378	17			0		0			End Date		42	\N	182			4	t				t
377	379	17	B. Antiretroviral Medication		0		0			Name		42	\N	182			5	t				t
378	380	17			0		0			Start Date		42	\N	182			6	t				t
379	381	17			0		0			End Date		42	\N	182			7	t				t
380	382	17	C. Comments		0		0					42	\N	183			8	t				t
381	383	17	D. Form Completion		0		0			PRINT name of person completing form:		42	\N	182			9	t			50	t
382	384	17			0		0			Date Concomitant Medication Form completed:	DD-MMM-YYYY<br><div style="page-break-before: always;"></div> <div><b>INSERT TWO TABLES OF MEDICATION HERE FROM ORIGINAL CDC FORM</b></div>	42	\N	182			10	t				t
383	385	18			0		0			Participant ID:	(38-##-#####) <br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at each study visit if the participant reports taking any concomitant medications with no anti-TB activity, either in the 14 days prior to study treatment start date or while on study treatment, including analgesics and antipyretics. If there is no change in concomitant medications, do not update this form.</br></br>\nFor ongoing medications started more than 30 days before study start date, report medication start date as 30 days prior to study start date. If participant is still taking a medication, leave “End Date” blank. Record all dates in the following format: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>.</br></br>\nDo NOT report medications with anti-TB activity <b>(see page 3 of this form)</b> on this form. Report all medications with TB activity on the TB Drug Dose Record form. <b>(see TB Drug Dose Record Form)</b>. Antiretroviral Medications table is on the last page of this form.</div>	43	\N	184	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
384	386	18	A. Non-TB and Non-antiretroviral Medication		0		0			Name		43	\N	184			2	t				t
385	387	18			0		0			Start Date		43	\N	184			3	t				t
386	388	18			0		0			End Date		43	\N	184			4	t				t
387	389	18	B. Antiretroviral Medication		0		0			Name		43	\N	184			5	t				t
231	258	9			0		0			Visit date		29	\N	106			1	t				t
232	283	9	A. Participant History		0		0			Sex:		29	\N	107			2	t		Horizontal		t
233	249	9			0		0			Place of birth:		29	\N	108			3	t				t
234	288	9			0		0			Ethnicity:		29	\N	109			4	t		Vertical		t
235	304	9			0		0			Race:		29	\N	110			5	t		Vertical		t
236	295	9			0		0			Specify:		29	\N	111			6	t				f
237	296	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Risk factors within the past year</span></p></tr><tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Homeless:</span></p></tr>	29	\N	112			7	t		Horizontal		t
238	269	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Injecting drug use:</span></p></tr>	29	\N	113			8	t		Horizontal		t
239	305	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Non-injecting drug use:</span></p></tr>	29	\N	114			9	t		Horizontal		t
240	261	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Resident of correctional facility:</span></p></tr>	29	\N	115			10	t		Horizontal		t
241	282	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>e. Alcohol use led to problems in relationships, health, employment/work performance or finances:</span></p></tr>	29	\N	116			11	f		Horizontal		t
242	294	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Mental health history:</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>a. Family member (primary relationship-biologic mother, biologic father, full sibling, or biologic child) with mental illness:</span></p></tr>	29	\N	117			12	t		Horizontal		t
243	248	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>If yes, please specify the past mental health diagnoses:</span></p></tr>	29	\N	111			13	t				f
244	260	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>b. Past personal mental illness:</span></p></tr>	29	\N	118			14	t		Horizontal		t
245	285	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>If yes, please specify the past mental health diagnoses:</span></p></tr>	29	\N	111			15	t				f
246	289	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>c. Past personal experience of traumatic event(s):</span></p></tr>	29	\N	118			16	t		Horizontal		t
247	266	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>If yes, please specify the event(s):</span></p></tr>	29	\N	111			17	t				f
388	390	18			0		0			Start Date		43	\N	184			6	t				t
248	301	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>d. Unintended mental status changes induced by specific medications or substances</span></p></tr>	29	\N	118			18	t		Horizontal		t
249	293	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>If yes, please specify medication and mental status change:</span></p></tr>	29	\N	111			19	t				f
250	287	9	A. Participant History (continued)		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Cigarette use</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>a. Has participant ever smoked tobacco? </span></p></tr>	29	\N	119			20	t		Horizontal		t
251	264	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>b. Total duration of tobacco use: </span></p></tr>	29	\N	120			21	t		Horizontal		t
252	273	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>Unit: </span></p></tr>	29	\N	121			22	f		Horizontal		t
253	270	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>Amount: </span></p></tr>	29	\N	106			23	t				t
254	267	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>c. Number of cigarettes currently or formerly smoked per day: </span></p></tr>	29	\N	122			24	t		Horizontal		t
255	271	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>d. Time since participant quit smoking: </span></p></tr>	29	\N	123			25	f		Horizontal		t
256	246	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>Unit: </span></p></tr>	29	\N	121			26	f		Horizontal		t
257	306	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>Amount: </span></p></tr>	29	\N	106			27	t				t
258	276	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Karnofsky score: </span></p></tr>	29	\N	124			28	t		Horizontal		t
259	252	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Was the participant ever treated for active TB prior to this episode?</span></p></tr>	30	\N	125			29	t		Horizontal		t
260	256	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>a. If 'yes', what were the most recent month and year (e.g., JAN-2021) of diagnosis?</span></p></tr>	30	\N	106			30	t				f
261	300	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>b. Did participant complete prescribed TB treatment?   </span></p></tr>	30	\N	126			31	f		Horizontal		t
262	263	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Does participant currently have extrapulmonary TB?</span></p></tr>	30	\N	127			32	f		Horizontal		t
263	250	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>If 'yes', specify the system organ class for each extrapulmonary site :</span></p></tr>	30	\N	128			33	t				f
264	274	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Liver disease:</span></p></tr>	31	\N	129			34	t		Horizontal		t
265	254	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Hepatitis B:</span></p></tr>	31	\N	130			35	t		Horizontal		t
266	255	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Hepatitis C:</span></p></tr>	31	\N	131			36	t		Horizontal		t
267	272	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Hepatitis (Type unknown):</span></p></tr>	31	\N	132			37	t		Horizontal		t
268	297	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>e. Hepatitis due to alcohol use:</span></p></tr>	31	\N	133			38	t		Horizontal		t
269	302	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>f. Other:</span></p></tr>	31	\N	134			39	t		Horizontal		t
270	265	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Diabetes:</span></p></tr>	31	\N	135			40	t		Horizontal		t
271	290	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Specify diabetes type:</span></p></tr>	31	\N	136			41	t		Horizontal		f
272	307	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. In what year diabetes was diagnosed? :</span></p></tr>	31	\N	106			42	t				f
273	268	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Medical records confirming diabetes diagnosis available?</span></p></tr>	31	\N	137			43	t		Horizontal		f
274	298	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Was the participant taking any antidiabetic medications in the 14 days prior to study treatment start date?  </span></p></tr>	31	\N	137			44	t		Horizontal		f
275	247	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Peripheral neuropathy:</span></p></tr>	31	\N	138			45	t		Horizontal		t
276	253	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Cancer:</span></p></tr>	31	\N	139			46	t		Horizontal		t
277	308	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Specify:</span></p></tr>	31	\N	111			47	t				f
278	286	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Cardiac conditions:</span></p></tr>	31	\N	140			48	t		Horizontal		t
279	262	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Specify:</span></p></tr>	31	\N	111			49	t				f
280	281	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Other concomitant diagnoses, including any current/active mental illness or problems:</span></p></tr>	31	\N	111			50	f				t
281	303	9	D. HIV Infection History		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. What year was the participant first documented as HIV-positive?</span></p></tr>	32	\N	106			51	t				t
282	278	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Has the participant ever had a CD4 cell count below 200 cells/mm3?</span></p></tr>	32	\N	141			52	t		Horizontal		t
283	251	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Has the participant ever been prescribed and taken antiretroviral therapy (ART)?</span></p></tr>	32	\N	142			53	t		Horizontal		t
284	279	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. In what year was ART initiated?</span></p></tr>	32	\N	106			54	t				f
285	259	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Was the participant taking any antiretroviral therapy in the 14 days prior to study treatment start date?</span></p></tr>	32	\N	143			55	t		Horizontal		f
286	299	9	Clinical Stage		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>List WHO Clinical Stage 4 Conditions and provide month and year </span></p></tr>	32	\N	144			56	t				t
287	284	9			0		0			Month		32	\N	145			57	t				t
288	291	9			0		0			Year		32	\N	106			58	t				t
289	275	9	E. Additional Information		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span> 1. Was the participant taking pre-study TB treatment in the 6 months prior to study start date and/or drugs with anti-TB activity given for purposes other than treatment of TB in the 30 days prior to study treatment start date?</span></p></tr>	33	\N	146			59	t		Horizontal		t
290	257	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span> 2. Was the participant taking non-TB medications, including over-the-counter drugs, in the 14 days prior to study treatment start date? </span></p></tr>	33	\N	147			60	t		Horizontal		t
291	280	9	Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span> Comments </span></p></tr>	33	\N	111			61	f				t
292	292	9	F. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	33	\N	106			62	t				t
293	277	9			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date History Form completed:</span></p></tr>	33	\N	106			63	t				t
389	391	18			0		0			End Date		43	\N	184			7	t				t
390	392	18	C. Comments		0		0					43	\N	185			8	t				t
391	393	18	D. Form Completion		0		0			PRINT name of person completing form:		43	\N	184			9	t			50	t
392	394	18			0		0			Date Concomitant Medication Form completed:	DD-MMM-YYYY<br><div style="page-break-before: always;"></div> <div><b>INSERT TWO TABLES OF MEDICATION HERE FROM ORIGINAL CDC FORM</b></div>	43	\N	184			10	t				t
393	395	19			0		0			Participant ID:	(38-##-#####) <br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at every study visit in which doses of drugs with anti-TB activity (listed on last page) are reported.<br>\n<div style="margin-left: 20px;">\n    This includes:\n    <ul>\n        <li>Pre-study doses <b>(TB treatment in the 6 months prior to study start date and/or drugs with anti-TB activity given for purposes other than treatment of TB in the 30 days prior to study start date)</b></li>\n        <li>Study doses <b>(including all changes in TB treatment)</b></li>\n        <li>Non-study doses of drugs with anti-TB activity given for treatment of incidental illnesses during study <b>(e.g., a fluoroquinolone given for a urinary tract infection)</b> after study start date.</li>\n        <li>Re-challenge doses of TB medications following an adverse event.</li>\n    </ul>\n</div>\nRecord all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>). </div>	44	\N	186	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
394	396	19			0		0			Dose Type*		45	\N	186	regexp: /[PICNRpicnr]/	Must be P, I, C, N, or R	2	t			1	t
395	397	19			0		0			Food**		45	\N	186	regexp: /[BWNUbwnu]/	Must be B, W, N, or U	3	t			1	t
396	398	19			0		0			Vomiting within 1 hour of dose***		45	\N	186	regexp: /[YNUynu]/	Must be Y, N, or U	4	t			1	t
397	399	19			0		0			Dose Date		45	\N	186			5	t				t
398	400	19			0		0			___mg		45	\N	186	regexp: /[0-9]{5}/	Must be exactly 4 digits	6	t			4	t
399	401	19			0		0			___mg		45	\N	186	regexp: /[0-9]{5}/	Must be exactly 4 digits	7	t			4	t
400	402	19			0		0			___mg		45	\N	186	regexp: /[0-9]{5}/	Must be exactly 4 digits	8	t			4	t
401	403	19			0		0			___mg		45	\N	186	regexp: /[0-9]{5}/	Must be exactly 4 digits	9	t			4	t
402	404	19			0		0			___mg		45	\N	186	regexp: /[0-9]{5}/	Must be exactly 4 digits	10	t			4	t
403	405	19			0		0			___mg		45	\N	186	regexp: /[0-9]{5}/	Must be exactly 4 digits	11	t			4	t
404	406	19			0		0			Adm†		45	\N	186	regexp: /[DVSUdvsu]/	Must be D, V, S, or U	12	t			1	t
405	407	19			0		0			Tolerated re-challenge‡	<br> <div>\n* Dose type: P=Pre-study dose; I=Intensive phase study dose; C=Continuation phase study dose; N=Non-study dose; R=Re-challenge dose<br>\n**Food intake: B=<1 hour before dose; W=with dose; N=no food consumed < 1 hour before or with dose; U=Unknown<br>\n***Vomiting within 1 hour of dose: Y=Yes; N=No; U=Unknown<br>\n† Administration: D=In-person DOT; V=Video-DOT; S=SAT; U=Unknown<br>\n‡ Tolerated re-challenge: Y=Yes; N=No<br> </div>	45	\N	186	regexp: /[YNyn]/	Must be Y or N	13	t			1	t
406	408	19	B. Comments		0		0					45	\N	187			14	t				t
425	427	21			0		0			Participant ID:	(38-##-#####) <br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at every study visit in which doses of drugs with anti-TB activity (listed on last page) are reported.<br>\n<div style="margin-left: 20px;">\n    This includes:\n    <ul>\n        <li>Pre-study doses <b>(TB treatment in the 6 months prior to study start date and/or drugs with anti-TB activity given for purposes other than treatment of TB in the 30 days prior to study start date)</b></li>\n        <li>Study doses <b>(including all changes in TB treatment)</b></li>\n        <li>Non-study doses of drugs with anti-TB activity given for treatment of incidental illnesses during study <b>(e.g., a fluoroquinolone given for a urinary tract infection)</b> after study start date.</li>\n        <li>Re-challenge doses of TB medications following an adverse event.</li>\n    </ul>\n</div>\nRecord all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>). </div>	48	\N	190	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
426	428	21	A. TB Drug Dose Record		0		0			Dose Type*		49	\N	190	regexp: /[PICNRpicnr]/	Must be P, I, C, N, or R	2	t			1	t
427	429	21			0		0			Food**		49	\N	190	regexp: /[BWNUbwnu]/	Must be B, W, N, or U	3	t			1	t
428	430	21			0		0			Vomiting within 1 hour of dose***		49	\N	190	regexp: /[YNUynu]/	Must be Y, N, or U	4	t			1	t
429	431	21			0		0			Dose Date		49	\N	190			5	t				t
430	432	21			0		0			___mg		49	\N	190	regexp: /[0-9]{5}/	Must be exactly 4 digits	6	t			4	t
431	433	21			0		0			___mg		49	\N	190	regexp: /[0-9]{5}/	Must be exactly 4 digits	7	t			4	t
432	434	21			0		0			___mg		49	\N	190	regexp: /[0-9]{5}/	Must be exactly 4 digits	8	t			4	t
433	435	21			0		0			___mg		49	\N	190	regexp: /[0-9]{5}/	Must be exactly 4 digits	9	t			4	t
434	436	21			0		0			___mg		49	\N	190	regexp: /[0-9]{5}/	Must be exactly 4 digits	10	t			4	t
435	437	21			0		0			___mg		49	\N	190	regexp: /[0-9]{5}/	Must be exactly 4 digits	11	t			4	t
436	438	21			0		0			Adm†		49	\N	190	regexp: /[DVSUdvsu]/	Must be D, V, S, or U	12	t			1	t
437	439	21			0		0			Tolerated re-challenge‡		49	\N	190	regexp: /[YNyn]/	Must be Y or N	13	t			1	t
438	440	21	<br> <div>\n* Dose type: P=Pre-study dose; I=Intensive phase study dose; C=Continuation phase study dose; N=Non-study dose; R=Re-challenge dose<br>\n**Food intake: B=<1 hour before dose; W=with dose; N=no food consumed < 1 hour before or with dose; U=Unknown<br>\n***Vomiting within 1 hour of dose: Y=Yes; N=No; U=Unknown<br>\n† Administration: D=In-person DOT; V=Video-DOT; S=SAT; U=Unknown<br>\n‡ Tolerated re-challenge: Y=Yes; N=No<br> </div> <br><br><b>B. Comments</b>		0		0					49	\N	191			14	t				t
439	441	21	C. Form Completion		0		0			PRINT name of person completing form:		49	\N	190			15	t			50	t
440	442	21			0		0			Date Concomitant Medication Form completed:		49	\N	190			16	t				t
1207	923	63			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Form completed: </span></p></tr>	156	\N	499			57	f				t
2807	1101	94	A. Visit		0		0				&nbsp;&nbsp;\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Visit Missed <strong>(Indicate which scheduled visit was missed in A1, complete B1 then skip to Section D.)</strong></span></p></tr>	214	\N	1070			1	f		Horizontal		t
2808	1102	94			0		0				&nbsp;&nbsp;\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Week of evaluation <strong>(Check one)</strong></span></p></tr>	214	\N	1071			2	f		Horizontal		t
2809	1103	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date of visit:</span> </span></p></tr>	214	\N	1072			3	t		Horizontal		t
2810	1104	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3.Visit status </span> </span></p></tr>	214	\N	1073			4	t		Vertical		t
2811	1105	94	B. Evaluation (Since last study visit or during current visit and not previously reported)		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">1. Did participant take any TB medications?</span></p> <strong> (If "Yes", complete or update TB Drug Dose Record Form)</strong></tr>	214	\N	1074		This is a required field	5	t		Horizontal		t
2812	1106	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">2. Did participant report any changes in antiretroviral or non-TB/non-antiretroviral medications, including over-the-counter drugs?</span></p> <strong> (If "Yes", complete or update Concomitant Medication Form)</strong></tr>	214	\N	1074		This is a required field	6	t		Horizontal		t
2813	1107	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">3. Were any clinical evaluations <strong>(e.g., Chest X-ray, CT scan, MRI)</strong> performed?</span></p> <strong> (If "Yes", complete Clinical Evaluation Form)</strong></tr>	214	\N	1074		This is a required field	7	t		Horizontal		t
2814	1108	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">4. Were new laboratory tests ordered or are results available?</span></p> <strong> (If "Yes", complete Laboratory Evaluation Form)</strong></tr>	214	\N	1074		This is a required field	8	t		Horizontal		t
2815	1109	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">5. Were signs and symptoms assessed?</span></p> <strong> (If "Yes", complete Signs and Symptoms Form)</strong></tr>	214	\N	1074		This is a required field	9	t		Horizontal		t
2816	1110	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">6. Was sputum collection attempted or other specimen collected for AFB work-up?</span></p> <strong> (If "Yes", complete Mycobacteriology Form)</strong></tr>	214	\N	1074		This is a required field	10	t		Horizontal		t
2817	1111	94			1110	ZNTERMMB	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px;margin-bottom:0px;">If "Yes", how many specimens were collected?</span></p></tr>	214	\N	1072	func:  gt(0)	This is a required field	11	t		Horizontal		t
2818	1112	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">7. Was sputum collected for RS ratio essay?</span></p> <strong> (If "Yes", complete Mycobacteriology Form)</strong></tr>	214	\N	1074		This is a required field	12	t		Horizontal		t
442	444	22			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Visit or date of blood sample collection.:</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Study evaluations:</span></p></tr>	50	\N	193			2	t		Vertical		t
443	445	22			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Possible Poor TB Treatment Response:</span></p></tr>\nVisit or date of blood sample collection.	50	\N	194			3	f				t
444	446	22			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Sequence ID</span></p></tr>	50	\N	192	func:  gt(4)	You can only enter a maximum of 4 characters	4	t				t
445	447	22			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. If unscheduled, enter the visit date.</span></p></tr>	50	\N	192			5	t				f
446	448	22	B. Transport / Shipping		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Enter the date that the sample was shipped to Central Storage Facility.</span></p></tr>	50	\N	192			6	t				t
447	449	22			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Enter the label number of the shipped sample.</span></p></tr>	50	\N	192	func:  gt(8)	You can only enter a maximum of 8 characters	7	t	CUID Label Number			t
448	450	22	C. Specimen Shipping Conditions		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was the specimen frozen prior to shipping?</span></p></tr>	50	\N	195			8	t		Horizontal		t
449	451	22			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If yes, did the specimen thaw before shipping?</span></p></tr>	50	\N	195			9	f		Horizontal		t
450	452	22		<strong>If specimen thawed before shipping, provide the following:</strong>	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>i. Amount of time thawed</span></p></tr>	50	\N	196			10	f		Horizontal		t
451	453	22			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>ii. Specific number of hours or days thawed, if any</span></p></tr>	50	\N	192			11	f				t
452	454	22			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>iii. Extent Thawed</span></p></tr>	50	\N	197			12	f		Horizontal		t
453	455	22	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. Comments</span></p></tr>	50	\N	198			13	t				t
454	456	22	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>10. PRINT name of person completing form:</span></p></tr>	50	\N	192			14	t				t
455	457	22			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>11. Date Future Research Blood Form completed</span></p></tr>	50	\N	192			15	t				t
456	458	22	F. <strong>FOR CENTRAL STORAGE USE ONLY</strong>		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>12. Condition of Specimens</span></p></tr>	51	\N	199			16	t		Horizontal		t
457	459	22	G. <strong>FOR ANALYSIS LABORATORY USE ONLY</strong>		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>13. Condition of Specimens</span></p></tr>	51	\N	199			17	t		Horizontal		t
1208	560	64	A. Visit	Respond to the preliminary questions below.	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Visit</span></p></tr>	157	\N	518			1	f		Vertical		t
1209	112	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Week/Month of evaluation:</span></p></tr>	157	\N	519			2	t		Horizontal		t
1210	113	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date of AE onset:</span></p></tr>	157	\N	520			3	t				t
1211	114	64	B. Evaluation (Since last study visit or during current visit and not previously reported)		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<div id="CMMessage" style="display:none;">&nbsp;(Complete or Update Concomitant Medication Form)</div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Did participant report any changes in antiretroviral or non-TB/non-antiretroviral medications, including over-the-counter drugs?<script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>\n<script>\njQuery(document).ready(function() {\nenableRadioMessage("#CMMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#DRMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#CEMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#LBMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#SSMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#MBMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#RSMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#TMMessage", "Y");\n});\nfunction enableRadioMessage(containerId, value) {\n\tvar msgContainer = jQuery(containerId);\n\tvar radiosToCheck = msgContainer.parent().parent().find("input");\n\tradiosToCheck.change(function(){setMessage(radiosToCheck, msgContainer, value);});\n\tsetMessage(radiosToCheck, msgContainer, value);\n}\n\nfunction setMessage(radiosToCheck, msgContainer, value) {\n\tfor (var i = 0; i < radiosToCheck.length; i++) {\n\t\tif (radiosToCheck[i].checked) {\n\t\t\tvar valueToCheck = radiosToCheck[i].value;\n\t\t\tbreak;\n\t\t}\n\t}\n\tif (valueToCheck && (valueToCheck == value)){\n\t\tmsgContainer.show();\n\t}\n\telse {\n\t\tmsgContainer.hide();\n\t}\n}\n\n</script></span></p></tr>	157	\N	521			4	t		Horizontal		t
1212	115	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<div id="DRMessage" style="display:none;">&nbsp;(Update TB Drug Dose Record Form)</div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Did participant take any drugs with anti-TB activity?\n </span></p></tr>	157	\N	522			5	t		Horizontal		t
1213	116	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<div id="CEMessage" style="display:none;">&nbsp;(Complete Clinical Evaluation Form)</div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Were any clinical evaluations (e.g., chest X-ray, CT scan, MRI, ECG) performed?</span></p></tr>	157	\N	523			6	t		Horizontal		t
3615	1721	117			0		4					298	\N	1292			11	f		Vertical		t
459	2	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date of AE onset:</span></p></tr>	52	\N	200			2	t				t
460	3	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Was a diagnosis assigned?</span></p></tr>	52	\N	201			3	t		Horizontal		t
461	4	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. What is the reportable adverse event? <a href='javascript:void(0)' onmouseover='Tip("<br />Report a diagnosis, if assigned; if no diagnosis was assigned, report an individual sign or symptom<br />&nbsp;")' onmouseout='UnTip()'> (?)</a>  </span></p></tr>	52	\N	202	func:  gt(200)	maximum number of characters 200	4	t				t
462	5	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Was this a serious adverse event (SAE)?  <a href='javascript:void(0)' onmouseover='Tip("<br />An SAE requires that this form be submitted to CDC within 48 hours of site’s awareness of SAE, and to local ethics committees as per local guidelines<br />&nbsp;")' onmouseout='UnTip()'> (?)</a></span></p></tr>	52	\N	201			5	t		Horizontal		t
463	6	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a.\tIf 'yes', indicate type of SAE <span style="font-weight: bold">(select all that apply):</span> </span></p></tr>	52	\N	203			6	f		Vertical		f
464	7	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. In the opinion of the investigator, what is the attribution to study treatment in causing this AE?</span></p></tr>	52	\N	204			7	t		Horizontal		t
465	8	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. In the opinion of the investigator, is this an anticipated or unanticipated AE?</span></p></tr>	52	\N	205			8	t		Horizontal		t
466	9	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Indicate the maximum toxicity grade of event by the time of this report<a href='javascript:void(0)' onmouseover='Tip("<br />Refer to CTCAE in the Manual of Procedures.<br />&nbsp;")' onmouseout='UnTip()'> (?)</a></span></p></tr>	53	\N	206			9	t		Horizontal		t
467	10	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. Was this event a worsening to grade 3 or higher of sign(s), symptoms or medical condition that was present at screening/baseline?</span></p></tr>	53	\N	201			10	t		Horizontal		t
468	11	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Were any non-study medications taken within 7 days of initial presentation of sign(s) or symptoms(s)?</span></p></tr>	54	\N	207			11	t		Horizontal		t
469	12	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Are results for any of the following evaluations or procedures available for this AE?<a href='javascript:void(0)' onmouseover='Tip("<br />If &ldquo;Yes&rdquo; to any of the following, either report new results on the specified form, or link this AE to an existing form for results already reported.<br />&nbsp;")' onmouseout='UnTip()'> (?)</a></span></p></tr><tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Laboratory evaluations</span></p></tr>	54	\N	201			12	t		Horizontal		t
470	13	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Clinical evaluations</span></p></tr>	54	\N	201			13	t		Horizontal		t
471	14	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Signs and symptoms assessment</span></p></tr>	54	\N	201			14	t		Horizontal		t
472	15	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Sputum or other specimen collected for TB diagnostic workup</span></p></tr>	54	\N	201			15	t		Horizontal		t
473	16	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. How many post-enrollment study drug doses were administered prior to the participant initially presenting with sign(s) or symptom(s)?</span></p></tr>	54	\N	200			16	t				t
474	17	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Clinician action taken with regard to study treatment</span></p></tr>	54	\N	208			17	t		Horizontal		t
475	18	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Summary of AE:<a href='javascript:void(0)' onmouseover='Tip("<br />Use the SOAP (Subjective, Objective, Analysis, and Plan) format for a brief clinical description. Include  the context for clinician action taken in regard to changes in study medication, if applicable. If more than one AE occurred on the same day, note here and report event on a separate AE form.<br />&nbsp;")' onmouseout='UnTip()'> (?)</a></span></p></tr>	55	\N	202	func:  gt(3500)	maximum number of characters 3500	18	t				t
476	19	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. How long, in hours, after the dose immediately before the AE did the signs and symptoms start?:</span></p></tr>	55	\N	202	func:  gt(500)	maximum number of characters 500	19	t				t
477	20	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Did the participant present with signs and symptoms similar to those reported in this AE report, but of lower toxicity grade, prior to this AE?</span></p></tr>	55	\N	202	func:  gt(500)	maximum number of characters 500	20	t				t
478	21	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Was participant seen by an MD, urgent care or ER staff?<a href='javascript:void(0)' onmouseover='Tip("<br />including study staff<br />&nbsp;")' onmouseout='UnTip()'> (?)</a></span></p></tr>	55	\N	202	func:  gt(500)	maximum number of characters 500	21	t				t
479	22	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. If applicable, list the medications that were prescribed to treat the AE, including doses and frequency:</span></p></tr>	55	\N	202	func:  gt(500)	maximum number of characters 500	22	f				t
480	23	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of first day of last menstrual period:</span></p></tr>	56	\N	200			23	f				t
481	24	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Estimated date of delivery:</span></p></tr>	56	\N	200			24	f				t
482	25	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. What method was used to estimate date of delivery?</span></p></tr>	56	\N	209			25	t		Horizontal		t
483	26	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Was an ultrasound done?</span></p></tr>	56	\N	207			26	t		Horizontal		t
484	27	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:25px; margin-bottom: 0px;"><span>a.\tDate of ultrasound: </span></p></tr>	56	\N	200			27	f				f
485	28	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:25px; margin-bottom: 0px;"><span>b. Estimated gestational age (in weeks): </span></p></tr>	56	\N	200			28	f				f
486	29	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	57	\N	200			29	f				t
487	30	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Signature of Principal Investigator or Co-PI:</span></p></tr>	57	\N	200			30	t				t
488	31	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	57	\N	200			31	t				t
489	32	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form completed:</span></p></tr>	57	\N	200			32	t				t
490	33	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing QA/QC:</span></p></tr>	57	\N	200			33	f				t
491	34	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form QA/QC completed:</span></p></tr>	57	\N	200			34	f				t
492	35	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person entering form:</span></p></tr>	57	\N	200			35	f				t
493	36	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form entered:</span></p></tr>	57	\N	200			36	f				t
494	37	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Is this a reportable event?</span></p></tr>	58	\N	201			37	t		Horizontal		t
495	38	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Safety Officer determining reportability</span></p></tr>	58	\N	200			38	f				t
496	39	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Initial MedDRA Lower Level Term Code:&nbsp;&nbsp;<a href="#" class="btn primary" onClick="openNewWindow('includes/meddra/meddra-browser-api.jsp','dnote_win','directories=no,location=no,menubar=no,scrollbars=yes,toolbar=no,status=no,resizable=yes','dnote'); return false;">medDra Access</a></span></p></tr><div id="I_ZILLTCD"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     window.addEventListener('message', function(event) {\n      const rowData = event.data;\n      var medCode = $("#I_ZILLTCD").parent().parent().find("input"); \n\t  var medName =$("#I_ZILLT").parent().parent().find("input");\n\t  medCode.val(rowData.code);\n\t  medCode.change();\n\t  medName.val(rowData.name);\n\t  medName.change();\n      console.log("Valor seleccionado: " + rowData.code + " " + rowData.name);\n     \n    });\n  </script>\n  <style>\n     .btn {\n      border: none; \n      cursor: pointer;  font-size: 11px;\n      text-decoration: none;\n    }\n  </style>\n</head>\n<body>	58	\N	200			39	f				t
497	40	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Initial MedDRA Lower Level Term Description:</span></p></tr><div id="I_ZILLT"></div>	58	\N	200			40	f				t
498	41	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Safety officer providing MedDRA code:</span></p></tr>	58	\N	200			41	f				t
499	42	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. In the opinion of the CDC Safety Officer, what is the attribution to study treatment in causing this AE?</span></p></tr>	58	\N	210			42	f				t
500	43	23			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Safety officer determining attribution:</span></p></tr>	58	\N	202	func:  gt(100)	maximum number of characters 100	43	f				t
501	443	24	A. Visit Information		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Participant's ID:</span></p></tr>	59	\N	211	regexp: /38-[0-9]{2}-[0-9]{5}/	The format should be '38', followed by a dash, two digits, another dash, and then five digits.	1	t	38  - -   - - - - -			t
502	444	24			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Visit or date of blood sample collection.:</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Study evaluations:</span></p></tr>	59	\N	212			2	t		Vertical		t
503	445	24			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Possible Poor TB Treatment Response:</span></p></tr>	59	\N	213			3	f				t
504	446	24			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Sequence ID</span></p></tr>	59	\N	211	func:  gt(4)	You can only enter a maximum of 4 characters	4	t				t
505	447	24			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. If unscheduled, enter the visit date.</span></p></tr>	59	\N	211			5	t				f
506	448	24	B. Transport / Shipping		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Enter the date that the sample was shipped to Central Storage Facility.</span></p></tr>	59	\N	211			6	t				t
507	449	24			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Enter the label number of the shipped sample.</span></p></tr>	59	\N	211	func:  gt(8)	You can only enter a maximum of 8 characters	7	t	CUID Label Number			t
508	450	24	C. Specimen Shipping Conditions		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was the specimen frozen prior to shipping?</span></p></tr>	59	\N	214			8	t		Horizontal		t
509	451	24			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If yes, did the specimen thaw before shipping?</span></p></tr>	59	\N	214			9	f		Horizontal		t
510	452	24		<strong>If specimen thawed before shipping, provide the following:</strong>	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>i. Amount of time thawed:</span></p></tr>	59	\N	215			10	f		Horizontal		t
511	453	24			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>ii. Specific number of hours or days thawed, if any:</span></p></tr>	59	\N	211			11	f				t
512	454	24			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>iii. Extent Thawed:</span></p></tr>	59	\N	216			12	f		Horizontal		t
513	455	24	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. Comments:</span></p></tr>	59	\N	217			13	t				t
514	456	24	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>10. PRINT name of person completing form:</span></p></tr>	59	\N	211			14	t				t
515	457	24			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>11. Date Future Research Blood Form completed:</span></p></tr>	59	\N	211			15	t				t
516	458	24	F. <strong>FOR CENTRAL STORAGE USE ONLY</strong>		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>12. Condition of Specimens:</span></p></tr>	60	\N	218			16	t		Horizontal		t
517	459	24	G. <strong>FOR ANALYSIS LABORATORY USE ONLY</strong>		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>13. Condition of Specimens:</span></p></tr>	60	\N	218			17	t		Horizontal		t
518	460	25	A. Visit Information		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Participant's ID</span></p></tr>ant's ID	61	\N	219	regexp: /38-[0-9]{2}-[0-9]{5}/	The format should be '38', followed by a dash, two digits, another dash, and then five digits.	1	t	38 - ### - #####			t
519	461	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Visit for reporting treatment change <strong>(check one):<strong><p><i>Study Evaluations</i></p></span></p></tr>	61	\N	220			2	t		Vertical		t
520	462	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. If unscheduled, enter the visit date.</span></p></tr>	61	\N	219			3	f				t
521	463	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Squence ID of Adverse event, if any:</span></p></tr>	61	\N	219			4	f				t
522	464	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Squence ID of Possible Poor Treatment Response, if any:</span></p></tr>	61	\N	219			5	f				t
523	465	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Were there any additional events associated with this treatment change?</span></p></tr>	61	\N	221			6	t				t
524	466	25		If there were any additional events associated with this treatment change, indicate them below.	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Sequence ID of additional adverse event 1, if any.</span></p></tr>	61	\N	219			7	f				t
525	467	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Sequence ID of additional adverse event 2, if any.</span></p></tr>	61	\N	219			8	f				t
526	468	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Sequence ID of additional Possible Poor Treatment Response, if any.</span></p></tr>	61	\N	219			9	f				t
527	469	25	B. Site Investigator TB Treatment Change Recommendation		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Did the Site Investigator recommend a change in TB treatment?</span></p></tr>	62	\N	222			10	t		Vertical		t
528	470	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4.Which change to TB treatment was recommended by the Site Investigator?</span></p></tr>	62	\N	223			11	t		Vertical		t
529	471	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other change(s) to TB treatment recommended by the Site Investigator, if any.</span></p></tr>	62	\N	224			12	f				t
530	472	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Describe reasons for recommending TB treatment change (check all that apply)<strong></span></p></tr>	62	\N	225			13	t		Vertical		t
531	473	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other reasons for recommending TB treatment change, if any. <strong>(check all that apply)<strong></span></p></tr>	62	\N	224			14	f				t
532	474	25	C. Actual TB Treatment Change		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Was a change in TB treatment actually initiated?</span></p></tr>	62	\N	226			15	t		Vertical		t
533	475	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If <strong>NO</strong> or <strong>UNKNOWN</strong>, was an alternative diagnosis established?</span></p></tr>	62	\N	227			16	f		Horizontal		t
534	476	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. If Site Investigator recommended a change in TB treatment, <strong>and it was not initiated</strong>, what was the reason for not changing treatment?</span></p></tr>	62	\N	224			17	f				t
535	477	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. If TB treatment was changed, which medications were included in initial non-study regimen (or extension of treatment)?  <strong></span></p></tr>	62	\N	228			18	f		Vertical		t
536	478	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Start date of non-study regimen</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Knowledge of non-study regimen strart date</span></p></tr>	62	\N	229			19	f		Horizontal		t
537	479	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Enter the actual or estimated non-study regimen start date (ensure to indicate above if the entered start date is estimated)</span></p></tr>	62	\N	219			20	f				t
538	480	25	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Comments</span></p></tr>	63	\N	224			21	t				t
539	481	25	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	63	\N	219			22	t				t
540	482	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	63	\N	230			23	t				t
541	483	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	63	\N	219			24	t				t
542	484	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	63	\N	230			25	t				t
543	485	25			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	63	\N	219			26	t				t
544	1	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of site awareness:</span></p></tr>	64	\N	231			1	t				t
545	2	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date of AE onset:</span></p></tr>	64	\N	231			2	t				t
546	3	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Was a diagnosis assigned?</span></p></tr>	64	\N	232			3	t		Horizontal		t
547	4	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. What is the reportable adverse event? <a href='javascript:void(0)' onmouseover='Tip("<br />Report a diagnosis, if assigned; if no diagnosis was assigned, report an individual sign or symptom<br />&nbsp;")' onmouseout='UnTip()'> (?)</a>  </span></p></tr>	64	\N	233	func:  gt(200)	maximum number of characters 200	4	t				t
548	5	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Was this a serious adverse event (SAE)?  <a href='javascript:void(0)' onmouseover='Tip("<br />An SAE requires that this form be submitted to CDC within 48 hours of site’s awareness of SAE) and to local ethics committees as per local guidelines<br />&nbsp;")' onmouseout='UnTip()'> (?)</a></span></p></tr>	64	\N	232			5	t		Horizontal		t
549	6	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a.\tIf 'yes', indicate type of SAE <span style="font-weight: bold">(select all that apply):</span> </span></p></tr>	64	\N	234			6	f		Vertical		f
550	7	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. In the opinion of the investigator, what is the attribution to study treatment in causing this AE?</span></p></tr>	64	\N	235			7	t		Horizontal		t
551	8	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. In the opinion of the investigator, is this an anticipated or unanticipated AE?&nbsp;&nbsp;<a href='javascript:void(0)' onmouseover='Tip("<br/> <strong>Anticipated and Unanticipated Adverse Events (AE)</strong> <br><strong>Anticipated</strong> AE which meets any one (or both) of the following: <ol> <li>Consistent with listing in the current study protocol narrative and/or consent form and/or pharmaceutical package insert for the study treatment(s), in terms of the nature, intensity, and frequency.</li> <li>Based on clinical judgment by the principal investigator/primary treating physician, the adverse event was expected to occur based on the study participant’s underlying medical condition and/or concomitant disorder, disease process, or non-study treatment.</li> </ol><br/><strong>Unanticipated</strong>  AE which meets BOTH of the following: <ol> <li>NOT consistent with listing in the current study protocol narrative and/or consent form and/or pharmaceutical package insert for the study treatment(s), in terms of the nature, intensity, and frequency. <br>AND</li> <li>Based on clinical judgment by the principal investigator/primary treating physician, the adverse event was NOT expected to occur based on the study participant’s underlying medical condition and/or concomitant disorder, disease process, or non-study treatment.</li> </ol>");' onmouseout='UnTip()'> (?)</a></span></p></tr>	64	\N	236			8	t		Horizontal		t
552	9	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Indicate the maximum toxicity grade of event by the time of this report</span></p></tr>	65	\N	237			9	t		Horizontal		t
553	10	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. Was this event a worsening to grade 3 or higher of sign(s), symptoms or medical condition that was present at screening/baseline?</span></p></tr>	65	\N	232			10	t		Horizontal		t
554	11	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Were any non-study medications taken within 7 days of initial presentation of sign(s) or symptoms(s)?</span></p></tr>	66	\N	238			11	t		Horizontal		t
555	12	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Are results for any of the following evaluations or procedures available for this AE?</span></p></tr><tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Laboratory evaluations</span></p></tr>	66	\N	232			12	t		Horizontal		t
556	13	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Clinical evaluations</span></p></tr>	66	\N	232			13	t		Horizontal		t
557	14	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Signs and symptoms assessment</span></p></tr>	66	\N	232			14	t		Horizontal		t
558	15	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Sputum or other specimen collected for TB diagnostic workup</span></p></tr>	66	\N	232			15	t		Horizontal		t
559	16	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. How many post-enrollment study drug doses were administered prior to the participant initially presenting with sign(s) or symptom(s)?</span></p></tr>	66	\N	231			16	t				t
560	17	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Clinician action taken with regard to study treatment</span></p></tr>	66	\N	239			17	t		Horizontal		t
561	18	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Summary of AE:</span></p></tr>	67	\N	233	func:  gt(3500)	maximum number of characters 3500	18	t				t
562	19	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. How long, in hours, after the dose immediately before the AE did the signs and symptoms start?:</span></p></tr>	67	\N	233	func:  gt(500)	maximum number of characters 500	19	t				t
563	20	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Did the participant present with signs and symptoms similar to those reported in this AE report, but of lower toxicity grade, prior to this AE?</span></p></tr>	67	\N	233	func:  gt(500)	maximum number of characters 500	20	t				t
564	21	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Was participant seen by an MD, urgent care or ER staff?</span></p></tr>	67	\N	233	func:  gt(500)	maximum number of characters 500	21	t				t
565	22	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. If applicable, list the medications that were prescribed to treat the AE, including doses and frequency:</span></p></tr>	67	\N	233	func:  gt(500)	maximum number of characters 500	22	f				t
566	23	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of first day of last menstrual period:</span></p></tr>	68	\N	231			23	t				t
567	24	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Estimated date of delivery:</span></p></tr>	68	\N	231			24	f				t
568	25	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. What method was used to estimate date of delivery?</span></p></tr>	68	\N	240			25	t		Horizontal		t
569	486	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Specify Other:</span></p></tr>	68	\N	233			26	f				f
570	26	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Was an ultrasound done?</span></p></tr>	68	\N	238			27	t		Horizontal		t
571	27	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:25px; margin-bottom: 0px;"><span>a.\tDate of ultrasound: </span></p></tr>	68	\N	231			28	f				f
572	28	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:25px; margin-bottom: 0px;"><span>b. Estimated gestational age: </span></p></tr>	68	\N	231			29	f				f
573	29	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	69	\N	231			30	f				t
574	30	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Signature of Principal Investigator or Co-PI:</span></p></tr>	69	\N	231			31	t				t
575	31	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	69	\N	231			32	t				t
576	32	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form completed:</span></p></tr>	69	\N	231			33	t				t
577	33	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing QA/QC:</span></p></tr>	69	\N	231			34	f				t
578	34	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form QA/QC completed:</span></p></tr>	69	\N	231			35	f				t
579	35	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person entering form:</span></p></tr>	69	\N	231			36	f				t
580	36	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form entered:</span></p></tr>	69	\N	231			37	f				t
581	37	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Is this a reportable event?</span></p></tr>	70	\N	232			38	t		Horizontal		t
582	38	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Safety Officer determining reportability</span></p></tr>	70	\N	231			39	f				t
653	496	32			0		0			CUID Label Number:	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>2. Report the Label Number exactly as written on the label affixed to the tube </span></p></tr>	102	\N	258			7	t				t
583	39	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Initial MedDRA Lower Level Term Code:&nbsp;&nbsp;<a href="#" class="btn primary" onClick="openNewWindow('includes/meddra/meddra-browser-api.jsp','dnote_win','directories=no,location=no,menubar=no,scrollbars=yes,toolbar=no,status=no,resizable=yes','dnote'); return false;">medDra Access</a></span></p></tr><div id="I_ZILLTCD"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     window.addEventListener('message', function(event) {\n      const rowData = event.data;\n      var medCode = $("#I_ZILLTCD").parent().parent().find("input"); \n\t  var medName =$("#I_ZILLT").parent().parent().find("input");\n\t  medCode.val(rowData.code);\n\t  medCode.change();\n\t  medName.val(rowData.name);\n\t  medName.change();\n      console.log("Valor seleccionado: " + rowData.code + " " + rowData.name);\n     \n    });\n  </script>\n  <style>\n     .btn {\n      border: none; \n      cursor: pointer;  font-size: 11px;\n      text-decoration: none;\n    }\n  </style>\n</head>\n<body>	70	\N	231			40	f				t
584	40	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Initial MedDRA Lower Level Term Description:</span></p></tr><div id="I_ZILLT"></div>	70	\N	231			41	f				t
585	41	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Safety officer providing MedDRA code:</span></p></tr>	70	\N	231			42	f				t
586	42	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style=""text-indent:20px; margin-bottom: 0px;""><span>6. In the opinion of the CDC Safety Officer, what is the attribution to study treatment in causing this AE? &nbsp;<a href='javascript:void(0)' onmouseover='Tip("<br/><strong>Scale for Attribution of Adverse Events</strong><br/><br><strong>Definite</strong> Events occurring within a timely manner after administration of the study drug(s), that are known sequelae to the administration of the study drug(s), and follow a previously documented pattern of reaction but for which no other explanation is known.<br/><br><strong>Probable</strong> Any event occurring in a timely manner after administration of the study drug(s), that follows a known pattern of reaction to the study drug(s), and for which no other explanation is known.<br/><br><strong>Possible</strong> Any event occurring in a timely manner after administration of the study drug(s) that does not follow a known pattern of reaction and for which no other explanation is known.<br/><br><strong>Unlikely</strong> In general, this category can be considered applicable to those AEs that, after careful medical consideration at the time they are evaluated, are considered to be unrelated to administration of the study drug(s).<br/><br><strong>Not related</strong> Any AE for which there is evidence that an alternative etiology exists or for which no timely relationship exists to the administration of the study drug(s) and the AE does not follow any previously documented pattern.  This category applies to those AEs that, after careful medical consideration, are clearly and incontrovertibly due to causes other than the study drug(s).<br/><br><strong>Unclassifiable</strong> There is insufficient information about the AE to allow for an assessment of causality.<br/>");' onmouseout='UnTip()'> (?)</a></span></p></tr>	70	\N	241			43	f				t
587	43	26			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Safety officer determining attribution:</span></p></tr>	70	\N	233	func:  gt(100)	maximum number of characters 100	44	f				t
588	385	27			0		0			Participant ID:	(38-##-#####) <tr style="white-space: nowrap"><td><br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at each study visit if the participant reports taking any concomitant medications with no anti-TB activity, either in the 14 days prior to study treatment start date or while on study treatment, including analgesics and antipyretics. If there is no change in concomitant medications, do not update this form.</br></br>\nFor ongoing medications started more than 30 days before study start date, report medication start date as 30 days prior to study start date. If participant is still taking a medication, leave “End Date” blank. Record all dates in the following format: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>.</br></br>\nDo NOT report medications with anti-TB activity <b>(see page 3 of this form)</b> on this form. Report all medications with TB activity on the TB Drug Dose Record form. <b>(see TB Drug Dose Record Form)</b>. Antiretroviral Medications table is on the last page of this form.</div>	71	\N	242	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
589	386	27			0		0			Name		72	\N	242			2	f				t
590	387	27			0		0			Start Date		72	\N	242			3	f				t
591	388	27			0		0			End Date		72	\N	242			4	f				t
592	389	27			0		0			Name		73	\N	242			5	f				t
593	390	27			0		0			Start Date		73	\N	242			6	f				t
594	391	27			0		0			End Date		73	\N	242			7	f				t
595	392	27			0		0					74	\N	243			8	f				t
596	393	27			0		0			PRINT name of person completing form:		75	\N	242			9	t			50	t
597	394	27			0		0			Date Concomitant Medication Form completed:	DD-MMM-YYYY	75	\N	242			10	t				t
598	487	27			0		0				<tr style="white-space: nowrap"><td>\n<head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications<br /><i>(continued)</i></b></h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Fosamprenavir</td>\n  <td>FPV</td>\n</tr>\n<tr>\n  <td>Indinavir</td>\n  <td>IDV</td>\n</tr>\n<tr>\n  <td>Lamivudine</td>\n  <td>3TC</td>\n</tr>\n<tr>\n  <td>Lopinavir/Ritonavir</td>\n  <td>LPV</td>\n</tr>\n<tr>\n  <td>Maraviroc</td>\n  <td>MVC</td>\n</tr>\n<tr>\n  <td>Nelfinavir</td>\n  <td>NFV</td>\n</tr>\n<tr>\n  <td>Nevirapine</td>\n  <td>NVP</td>\n</tr>\n<tr>\n  <td>Other</td>\n  <td>OAR</td>\n</tr>\n<tr>\n  <td>Raltegravir</td>\n  <td>RAL</td>\n</tr>\n<tr>\n  <td>Rilpivirine</td>\n  <td>RPV</td>\n</tr>\n<tr>\n  <td>Rilpivirine/Tenofovir/Emtricitabine</td>\n  <td>CPA</td>\n</tr>\n<tr>\n  <td>Ritonavir</td>\n  <td>RTV</td>\n</tr>\n<tr>\n  <td>Saquinavir</td>\n  <td>SQV</td>\n</tr>\n<tr>\n  <td>Stavudine</td>\n  <td>D4T</td>\n</tr>\n<tr>\n  <td>Stavudine/Lamivudine/Nevirapine</td>\n  <td>SLN</td>\n</tr>\n<tr>\n  <td>Tenofovir alafenamide</td>\n  <td>TAF</td>\n</tr>\n<tr>\n  <td>Tenofovir disoproxil fumarate</td>\n  <td>TDF</td>\n</tr>\n<tr>\n  <td>Tenofovir/Emtricitabine</td>\n  <td>TRU</td>\n</tr>\n<tr>\n  <td>Tenofovir/Lamivudine/Dolutegravir</td>\n  <td>TLD</td>\n</tr>\n<tr>\n  <td>Tipranavir</td>\n  <td>TPV</td>\n</tr>\n<tr>\n  <td>Zidovudine</td>\n  <td>ZDV</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine</td>\n  <td>CMB</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine/Abacavir</td>\n  <td>TZV</td>\n</tr>\n</table>\n</body>	76	\N	244			11	f				t
599	385	28			0		0			Participant ID:	(38-##-#####) <tr style="white-space: nowrap"><td><br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at each study visit if the participant reports taking any concomitant medications with no anti-TB activity, either in the 14 days prior to study treatment start date or while on study treatment, including analgesics and antipyretics. If there is no change in concomitant medications, do not update this form.</br></br>\nFor ongoing medications started more than 30 days before study start date, report medication start date as 30 days prior to study start date. If participant is still taking a medication, leave “End Date” blank. Record all dates in the following format: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>.</br></br>\nDo NOT report medications with anti-TB activity <b>(see page 3 of this form)</b> on this form. Report all medications with TB activity on the TB Drug Dose Record form. <b>(see TB Drug Dose Record Form)</b>. Antiretroviral Medications table is on the last page of this form.</div>	77	\N	245	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
600	386	28			0		0			Name		78	\N	245			2	f				t
601	387	28			0		0			Start Date		78	\N	245			3	f				t
602	388	28			0		0			End Date		78	\N	245			4	f				t
603	389	28			0		0			Name		79	\N	245			5	f				t
604	390	28			0		0			Start Date		79	\N	245			6	f				t
605	391	28			0		0			End Date		79	\N	245			7	f				t
606	392	28			0		0					80	\N	246			8	f				t
607	393	28			0		0			PRINT name of person completing form:		81	\N	245			9	t			50	t
608	394	28			0		0			Date Concomitant Medication Form completed:	DD-MMM-YYYY	81	\N	245			10	t				t
609	487	28			0		0			<br /><br />\n<head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n <tr>\n  <td>Abacavir</td>\n  <td>ABC</td>\n</tr>\n<tr>\n  <td>Abacavir/Lamivudine</td>\n  <td>EPZ</td>\n</tr>\n<tr>\n  <td>Atazanavir</td>\n  <td>ATV</td>\n</tr>\n<tr>\n  <td>Atazanavir/Cobicistat</td>\n  <td>ATC</td>\n</tr>\n<tr>\n  <td>Atazanavir/Ritonavir</td>\n  <td>AZR</td>\n</tr>\n<tr>\n  <td>Cobicistat</td>\n  <td>COB</td>\n</tr>\n<tr>\n  <td>Darunavir</td>\n  <td>DRV</td>\n</tr>\n<tr>\n  <td>Darunavir/Cobicistat</td>\n  <td>DRC</td>\n</tr>\n<tr>\n  <td>Delavirdine</td>\n  <td>DLV</td>\n</tr>\n<tr>\n  <td>Didanosine</td>\n  <td>DDI</td>\n</tr>\n<tr>\n  <td>Dolutegravir</td>\n  <td>DTG</td>\n</tr>\n<tr>\n  <td>Dolutegravir/Abacavir/Lamivudine</td>\n  <td>TMQ</td>\n</tr>\n<tr>\n  <td>Efavirenz</td>\n  <td>EFV</td>\n</tr>\n<tr>\n  <td>Efavirenz/Lamivudine/Tenofovir</td>\n  <td>ELT</td>\n</tr>\n<tr>\n  <td>Efavirenz/Tenofovir/Emtricitabine</td>\n  <td>ATR</td>\n</tr>\n<tr>\n  <td>Elvitegravir/Cobicistat/Tenofovir/Emtricitabine</td>\n  <td>STB</td>\n</tr>\n<tr>\n  <td>Emtricitabine</td>\n  <td>FTC</td>\n</tr>\n<tr>\n  <td>Enfuvirtide</td>\n  <td>T20</td>\n</tr>\n<tr>\n  <td>Etravirine</td>\n  <td>ETV</td>\n</tr>\n</table>\n</body>	<tr style="white-space: nowrap"><td>\n<head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications<br /><i>(continued)</i></b></h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Fosamprenavir</td>\n  <td>FPV</td>\n</tr>\n<tr>\n  <td>Indinavir</td>\n  <td>IDV</td>\n</tr>\n<tr>\n  <td>Lamivudine</td>\n  <td>3TC</td>\n</tr>\n<tr>\n  <td>Lopinavir/Ritonavir</td>\n  <td>LPV</td>\n</tr>\n<tr>\n  <td>Maraviroc</td>\n  <td>MVC</td>\n</tr>\n<tr>\n  <td>Nelfinavir</td>\n  <td>NFV</td>\n</tr>\n<tr>\n  <td>Nevirapine</td>\n  <td>NVP</td>\n</tr>\n<tr>\n  <td>Other</td>\n  <td>OAR</td>\n</tr>\n<tr>\n  <td>Raltegravir</td>\n  <td>RAL</td>\n</tr>\n<tr>\n  <td>Rilpivirine</td>\n  <td>RPV</td>\n</tr>\n<tr>\n  <td>Rilpivirine/Tenofovir/Emtricitabine</td>\n  <td>CPA</td>\n</tr>\n<tr>\n  <td>Ritonavir</td>\n  <td>RTV</td>\n</tr>\n<tr>\n  <td>Saquinavir</td>\n  <td>SQV</td>\n</tr>\n<tr>\n  <td>Stavudine</td>\n  <td>D4T</td>\n</tr>\n<tr>\n  <td>Stavudine/Lamivudine/Nevirapine</td>\n  <td>SLN</td>\n</tr>\n<tr>\n  <td>Tenofovir alafenamide</td>\n  <td>TAF</td>\n</tr>\n<tr>\n  <td>Tenofovir disoproxil fumarate</td>\n  <td>TDF</td>\n</tr>\n<tr>\n  <td>Tenofovir/Emtricitabine</td>\n  <td>TRU</td>\n</tr>\n<tr>\n  <td>Tenofovir/Lamivudine/Dolutegravir</td>\n  <td>TLD</td>\n</tr>\n<tr>\n  <td>Tipranavir</td>\n  <td>TPV</td>\n</tr>\n<tr>\n  <td>Zidovudine</td>\n  <td>ZDV</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine</td>\n  <td>CMB</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine/Abacavir</td>\n  <td>TZV</td>\n</tr>\n</table>\n</body>	82	\N	247			11	f				t
610	385	29			0		0			Participant ID:	(38-##-#####) <tr style="white-space: nowrap"><td><br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at each study visit if the participant reports taking any concomitant medications with no anti-TB activity, either in the 14 days prior to study treatment start date or while on study treatment, including analgesics and antipyretics. If there is no change in concomitant medications, do not update this form.</br></br>\nFor ongoing medications started more than 30 days before study start date, report medication start date as 30 days prior to study start date. If participant is still taking a medication, leave “End Date” blank. Record all dates in the following format: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>.</br></br>\nDo NOT report medications with anti-TB activity <b>(see page 3 of this form)</b> on this form. Report all medications with TB activity on the TB Drug Dose Record form. <b>(see TB Drug Dose Record Form)</b>. Antiretroviral Medications table is on the last page of this form.</div>	83	\N	248	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
611	386	29			0		0			Name		84	\N	248			2	f				t
612	387	29			0		0			Start Date		84	\N	248			3	f				t
613	388	29			0		0			End Date		84	\N	248			4	f				t
614	389	29			0		0			Name		85	\N	248			5	f				t
615	390	29			0		0			Start Date		85	\N	248			6	f				t
616	391	29			0		0			End Date		85	\N	248			7	f				t
617	392	29			0		0					86	\N	249			8	f				t
618	393	29			0		0			PRINT name of person completing form:		87	\N	248			9	t			50	t
619	394	29			0		0			Date Concomitant Medication Form completed:	DD-MMM-YYYY	87	\N	248			10	t				t
620	487	29			0		0			<br /><br /><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Anti-tuberculosis Medications<br />(*exception)</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Gemifloxacin</td>\n  <td>GEM</td>\n</tr>\n<tr>\n  <td>Imipenem</td>\n  <td>IPM</td>\n</tr>\n<tr>\n  <td>Isoniazid</td>\n  <td>H</td>\n</tr>\n<tr>\n  <td>Kanamycin</td>\n  <td>KM</td>\n</tr>\n<tr>\n  <td>Levofloxacin</td>\n  <td>LFX</td>\n</tr>\n<tr>\n  <td>Linezolid</td>\n  <td>LZD</td>\n</tr>\n<tr>\n  <td>Meropenem</td>\n  <td>MPN</td>\n</tr>\n<tr>\n  <td>Moxifloxacin</td>\n  <td>M</td>\n</tr>\n<tr>\n  <td>Ofloxacin</td>\n  <td>OFX</td>\n</tr>\n<tr>\n  <td>P-aminosalicylic acid</td>\n  <td>PAS</td>\n</tr>\n<tr>\n  <td>Pretomanid</td>\n  <td>Pa</td>\n</tr>\n<tr>\n  <td>Protionamide</td>\n  <td>PTO</td>\n</tr>\n<tr>\n  <td>Pyrazinamide</td>\n  <td>Z</td>\n</tr>\n<tr>\n  <td>Rifabutin</td>\n  <td>RBT</td>\n</tr>\n<tr>\n  <td>Rifampicin</td>\n  <td>R</td>\n</tr>\n<tr>\n  <td>Rifapentine</td>\n  <td>P</td>\n</tr>\n<tr>\n  <td>Sparfloxacin</td>\n  <td>SPR</td>\n</tr>\n<tr>\n  <td>Streptomycin</td>\n  <td>S</td>\n</tr>\n<tr>\n  <td>Sutezolid</td>\n  <td>SUT</td>\n</tr>\n<tr>\n  <td>Thioacetazone</td>\n  <td>THZ</td>\n</tr>\n<tr>\n  <td>Terizidone</td>\n  <td>TRD</td>\n</tr>\n<tr>\n  <td>Viomycin</td>\n  <td>VM</td>\n</tr>\n<tr>\n  <td>Pyridoxine*</td>\n  <td>B6</td>\n</tr>\n</table>\n\n<h2>Antiretroviral Medications</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n <tr>\n  <td>Abacavir</td>\n  <td>ABC</td>\n</tr>\n<tr>\n  <td>Abacavir/Lamivudine</td>\n  <td>EPZ</td>\n</tr>\n<tr>\n  <td>Atazanavir</td>\n  <td>ATV</td>\n</tr>\n<tr>\n  <td>Atazanavir/Cobicistat</td>\n  <td>ATC</td>\n</tr>\n<tr>\n  <td>Atazanavir/Ritonavir</td>\n  <td>AZR</td>\n</tr>\n<tr>\n  <td>Cobicistat</td>\n  <td>COB</td>\n</tr>\n<tr>\n  <td>Darunavir</td>\n  <td>DRV</td>\n</tr>\n<tr>\n  <td>Darunavir/Cobicistat</td>\n  <td>DRC</td>\n</tr>\n<tr>\n  <td>Delavirdine</td>\n  <td>DLV</td>\n</tr>\n<tr>\n  <td>Didanosine</td>\n  <td>DDI</td>\n</tr>\n<tr>\n  <td>Dolutegravir</td>\n  <td>DTG</td>\n</tr>\n<tr>\n  <td>Dolutegravir/Abacavir/Lamivudine</td>\n  <td>TMQ</td>\n</tr>\n<tr>\n  <td>Efavirenz</td>\n  <td>EFV</td>\n</tr>\n<tr>\n  <td>Efavirenz/Lamivudine/Tenofovir</td>\n  <td>ELT</td>\n</tr>\n<tr>\n  <td>Efavirenz/Tenofovir/Emtricitabine</td>\n  <td>ATR</td>\n</tr>\n<tr>\n  <td>Elvitegravir/Cobicistat/Tenofovir/Emtricitabine</td>\n  <td>STB</td>\n</tr>\n<tr>\n  <td>Emtricitabine</td>\n  <td>FTC</td>\n</tr>\n<tr>\n  <td>Enfuvirtide</td>\n  <td>T20</td>\n</tr>\n<tr>\n  <td>Etravirine</td>\n  <td>ETV</td>\n</tr>\n</table>\n</body>	<tr style="white-space: nowrap"><td>\n<head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications<br /><i>(continued)</i></b></h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Fosamprenavir</td>\n  <td>FPV</td>\n</tr>\n<tr>\n  <td>Indinavir</td>\n  <td>IDV</td>\n</tr>\n<tr>\n  <td>Lamivudine</td>\n  <td>3TC</td>\n</tr>\n<tr>\n  <td>Lopinavir/Ritonavir</td>\n  <td>LPV</td>\n</tr>\n<tr>\n  <td>Maraviroc</td>\n  <td>MVC</td>\n</tr>\n<tr>\n  <td>Nelfinavir</td>\n  <td>NFV</td>\n</tr>\n<tr>\n  <td>Nevirapine</td>\n  <td>NVP</td>\n</tr>\n<tr>\n  <td>Other</td>\n  <td>OAR</td>\n</tr>\n<tr>\n  <td>Raltegravir</td>\n  <td>RAL</td>\n</tr>\n<tr>\n  <td>Rilpivirine</td>\n  <td>RPV</td>\n</tr>\n<tr>\n  <td>Rilpivirine/Tenofovir/Emtricitabine</td>\n  <td>CPA</td>\n</tr>\n<tr>\n  <td>Ritonavir</td>\n  <td>RTV</td>\n</tr>\n<tr>\n  <td>Saquinavir</td>\n  <td>SQV</td>\n</tr>\n<tr>\n  <td>Stavudine</td>\n  <td>D4T</td>\n</tr>\n<tr>\n  <td>Stavudine/Lamivudine/Nevirapine</td>\n  <td>SLN</td>\n</tr>\n<tr>\n  <td>Tenofovir alafenamide</td>\n  <td>TAF</td>\n</tr>\n<tr>\n  <td>Tenofovir disoproxil fumarate</td>\n  <td>TDF</td>\n</tr>\n<tr>\n  <td>Tenofovir/Emtricitabine</td>\n  <td>TRU</td>\n</tr>\n<tr>\n  <td>Tenofovir/Lamivudine/Dolutegravir</td>\n  <td>TLD</td>\n</tr>\n<tr>\n  <td>Tipranavir</td>\n  <td>TPV</td>\n</tr>\n<tr>\n  <td>Zidovudine</td>\n  <td>ZDV</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine</td>\n  <td>CMB</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine/Abacavir</td>\n  <td>TZV</td>\n</tr>\n</table>\n</body>	88	\N	250			11	f				t
654	497	32			0		1			<b>Date/Time	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>3. Date/time PAXGene tube transferred to -20°C freezer: </span></p></tr>	102	\N	258			8	f				t
655	498	32			0		2			<tr>	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	102	\N	258			9	f				t
621	385	30			0		0			Participant ID:	(38-##-#####) <tr style="white-space: nowrap"><td><br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at each study visit if the participant reports taking any concomitant medications with no anti-TB activity, either in the 14 days prior to study treatment start date or while on study treatment, including analgesics and antipyretics. If there is no change in concomitant medications, do not update this form.</br></br>\nFor ongoing medications started more than 30 days before study start date, report medication start date as 30 days prior to study start date. If participant is still taking a medication, leave “End Date” blank. Record all dates in the following format: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>.</br></br>\nDo NOT report medications with anti-TB activity <b>(see page 3 of this form)</b> on this form. Report all medications with TB activity on the TB Drug Dose Record form. <b>(see TB Drug Dose Record Form)</b>. Antiretroviral Medications table is on the last page of this form.</div>	89	\N	251	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
622	386	30			0		0			Name		90	\N	251			2	f				t
623	387	30			0		0			Start Date		90	\N	251			3	f				t
624	388	30			0		0			End Date		90	\N	251			4	f				t
625	389	30			0		0			Name		91	\N	251			5	f				t
626	390	30			0		0			Start Date		91	\N	251			6	f				t
627	391	30			0		0			End Date		91	\N	251			7	f				t
628	392	30			0		0					92	\N	252			8	f				t
629	393	30			0		0			PRINT name of person completing form:		93	\N	251			9	t			50	t
630	394	30			0		0			Date Concomitant Medication Form completed:	DD-MMM-YYYY	93	\N	251			10	t				t
631	487	30			0		0				<tr style="white-space: nowrap"><td><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Anti-tuberculosis Medications<br />(*exception)<br /><i>(continued)</i></h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Gemifloxacin</td>\n  <td>GEM</td>\n</tr>\n<tr>\n  <td>Imipenem</td>\n  <td>IPM</td>\n</tr>\n<tr>\n  <td>Isoniazid</td>\n  <td>H</td>\n</tr>\n<tr>\n  <td>Kanamycin</td>\n  <td>KM</td>\n</tr>\n<tr>\n  <td>Levofloxacin</td>\n  <td>LFX</td>\n</tr>\n<tr>\n  <td>Linezolid</td>\n  <td>LZD</td>\n</tr>\n<tr>\n  <td>Meropenem</td>\n  <td>MPN</td>\n</tr>\n<tr>\n  <td>Moxifloxacin</td>\n  <td>M</td>\n</tr>\n<tr>\n  <td>Ofloxacin</td>\n  <td>OFX</td>\n</tr>\n<tr>\n  <td>P-aminosalicylic acid</td>\n  <td>PAS</td>\n</tr>\n<tr>\n  <td>Pretomanid</td>\n  <td>Pa</td>\n</tr>\n<tr>\n  <td>Protionamide</td>\n  <td>PTO</td>\n</tr>\n<tr>\n  <td>Pyrazinamide</td>\n  <td>Z</td>\n</tr>\n<tr>\n  <td>Rifabutin</td>\n  <td>RBT</td>\n</tr>\n<tr>\n  <td>Rifampicin</td>\n  <td>R</td>\n</tr>\n<tr>\n  <td>Rifapentine</td>\n  <td>P</td>\n</tr>\n<tr>\n  <td>Sparfloxacin</td>\n  <td>SPR</td>\n</tr>\n<tr>\n  <td>Streptomycin</td>\n  <td>S</td>\n</tr>\n<tr>\n  <td>Sutezolid</td>\n  <td>SUT</td>\n</tr>\n<tr>\n  <td>Thioacetazone</td>\n  <td>THZ</td>\n</tr>\n<tr>\n  <td>Terizidone</td>\n  <td>TRD</td>\n</tr>\n<tr>\n  <td>Viomycin</td>\n  <td>VM</td>\n</tr>\n<tr>\n  <td>Pyridoxine*</td>\n  <td>B6</td>\n</tr>\n</table>\n</body>	94	\N	253			11	f				t
632	488	30			0		0				<tr style="white-space: nowrap"><td><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n <tr>\n  <td>Abacavir</td>\n  <td>ABC</td>\n</tr>\n<tr>\n  <td>Abacavir/Lamivudine</td>\n  <td>EPZ</td>\n</tr>\n<tr>\n  <td>Atazanavir</td>\n  <td>ATV</td>\n</tr>\n<tr>\n  <td>Atazanavir/Cobicistat</td>\n  <td>ATC</td>\n</tr>\n<tr>\n  <td>Atazanavir/Ritonavir</td>\n  <td>AZR</td>\n</tr>\n<tr>\n  <td>Cobicistat</td>\n  <td>COB</td>\n</tr>\n<tr>\n  <td>Darunavir</td>\n  <td>DRV</td>\n</tr>\n<tr>\n  <td>Darunavir/Cobicistat</td>\n  <td>DRC</td>\n</tr>\n<tr>\n  <td>Delavirdine</td>\n  <td>DLV</td>\n</tr>\n<tr>\n  <td>Didanosine</td>\n  <td>DDI</td>\n</tr>\n<tr>\n  <td>Dolutegravir</td>\n  <td>DTG</td>\n</tr>\n<tr>\n  <td>Dolutegravir/Abacavir/Lamivudine</td>\n  <td>TMQ</td>\n</tr>\n<tr>\n  <td>Efavirenz</td>\n  <td>EFV</td>\n</tr>\n<tr>\n  <td>Efavirenz/Lamivudine/Tenofovir</td>\n  <td>ELT</td>\n</tr>\n<tr>\n  <td>Efavirenz/Tenofovir/Emtricitabine</td>\n  <td>ATR</td>\n</tr>\n<tr>\n  <td>Elvitegravir/Cobicistat/Tenofovir/Emtricitabine</td>\n  <td>STB</td>\n</tr>\n<tr>\n  <td>Emtricitabine</td>\n  <td>FTC</td>\n</tr>\n<tr>\n  <td>Enfuvirtide</td>\n  <td>T20</td>\n</tr>\n<tr>\n  <td>Etravirine</td>\n  <td>ETV</td>\n</tr>\n</table>\n</body>	94	\N	253			12	f				t
633	489	30			0		0				<tr style="white-space: nowrap"><td>\n<head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications<br /><i>(continued)</i></b></h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Fosamprenavir</td>\n  <td>FPV</td>\n</tr>\n<tr>\n  <td>Indinavir</td>\n  <td>IDV</td>\n</tr>\n<tr>\n  <td>Lamivudine</td>\n  <td>3TC</td>\n</tr>\n<tr>\n  <td>Lopinavir/Ritonavir</td>\n  <td>LPV</td>\n</tr>\n<tr>\n  <td>Maraviroc</td>\n  <td>MVC</td>\n</tr>\n<tr>\n  <td>Nelfinavir</td>\n  <td>NFV</td>\n</tr>\n<tr>\n  <td>Nevirapine</td>\n  <td>NVP</td>\n</tr>\n<tr>\n  <td>Other</td>\n  <td>OAR</td>\n</tr>\n<tr>\n  <td>Raltegravir</td>\n  <td>RAL</td>\n</tr>\n<tr>\n  <td>Rilpivirine</td>\n  <td>RPV</td>\n</tr>\n<tr>\n  <td>Rilpivirine/Tenofovir/Emtricitabine</td>\n  <td>CPA</td>\n</tr>\n<tr>\n  <td>Ritonavir</td>\n  <td>RTV</td>\n</tr>\n<tr>\n  <td>Saquinavir</td>\n  <td>SQV</td>\n</tr>\n<tr>\n  <td>Stavudine</td>\n  <td>D4T</td>\n</tr>\n<tr>\n  <td>Stavudine/Lamivudine/Nevirapine</td>\n  <td>SLN</td>\n</tr>\n<tr>\n  <td>Tenofovir alafenamide</td>\n  <td>TAF</td>\n</tr>\n<tr>\n  <td>Tenofovir disoproxil fumarate</td>\n  <td>TDF</td>\n</tr>\n<tr>\n  <td>Tenofovir/Emtricitabine</td>\n  <td>TRU</td>\n</tr>\n<tr>\n  <td>Tenofovir/Lamivudine/Dolutegravir</td>\n  <td>TLD</td>\n</tr>\n<tr>\n  <td>Tipranavir</td>\n  <td>TPV</td>\n</tr>\n<tr>\n  <td>Zidovudine</td>\n  <td>ZDV</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine</td>\n  <td>CMB</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine/Abacavir</td>\n  <td>TZV</td>\n</tr>\n</table>\n</body>	94	\N	253			13	f				t
656	499	32			0		1			<b>Date/Time	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>4. Date/time PAXGene tube transferred to -70°C freezer or below for long term storage: </span></p></tr>	102	\N	258			10	f				t
657	500	32			0		2			<tr>	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	102	\N	258			11	f				t
658	501	32	C. Comments		0		0					102	\N	259			12	f				t
659	502	32	F. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>name of person completing form:</span></p></tr>	102	\N	258			13	t				t
634	385	31			0		0			Participant ID:	(38-##-#####) <tr style="white-space: nowrap"><td><br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at each study visit if the participant reports taking any concomitant medications with no anti-TB activity, either in the 14 days prior to study treatment start date or while on study treatment, including analgesics and antipyretics. If there is no change in concomitant medications, do not update this form.</br></br>\nFor ongoing medications started more than 30 days before study start date, report medication start date as 30 days prior to study start date. If participant is still taking a medication, leave “End Date” blank. Record all dates in the following format: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>.</br></br>\nDo NOT report medications with anti-TB activity <b>(see page 3 of this form)</b> on this form. Report all medications with TB activity on the TB Drug Dose Record form. <b>(see TB Drug Dose Record Form)</b>. Antiretroviral Medications table is on the last page of this form.</div>	95	\N	254	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
635	386	31			0		0			Name		96	\N	254			2	f				t
636	387	31			0		0			Start Date		96	\N	254			3	f				t
637	388	31			0		0			End Date		96	\N	254			4	f				t
638	389	31			0		0			Name		97	\N	254			5	f				t
639	390	31			0		0			Start Date		97	\N	254			6	f				t
640	391	31			0		0			End Date		97	\N	254			7	f				t
641	392	31			0		0					98	\N	255			8	f				t
642	393	31			0		0			PRINT name of person completing form:		99	\N	254			9	t			50	t
643	394	31			0		0			Date Concomitant Medication Form completed:	DD-MMM-YYYY	99	\N	254			10	t				t
644	487	31			0		0				<tr style="white-space: nowrap"><td><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Anti-tuberculosis Medications<br />(*exception)<br /><i>(continued)</i></h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Meropenem</td>\n  <td>MPN</td>\n</tr>\n<tr>\n  <td>Moxifloxacin</td>\n  <td>M</td>\n</tr>\n<tr>\n  <td>Ofloxacin</td>\n  <td>OFX</td>\n</tr>\n<tr>\n  <td>P-aminosalicylic acid</td>\n  <td>PAS</td>\n</tr>\n<tr>\n  <td>Pretomanid</td>\n  <td>Pa</td>\n</tr>\n<tr>\n  <td>Protionamide</td>\n  <td>PTO</td>\n</tr>\n<tr>\n  <td>Pyrazinamide</td>\n  <td>Z</td>\n</tr>\n<tr>\n  <td>Rifabutin</td>\n  <td>RBT</td>\n</tr>\n<tr>\n  <td>Rifampicin</td>\n  <td>R</td>\n</tr>\n<tr>\n  <td>Rifapentine</td>\n  <td>P</td>\n</tr>\n<tr>\n  <td>Sparfloxacin</td>\n  <td>SPR</td>\n</tr>\n<tr>\n  <td>Streptomycin</td>\n  <td>S</td>\n</tr>\n<tr>\n  <td>Sutezolid</td>\n  <td>SUT</td>\n</tr>\n<tr>\n  <td>Thioacetazone</td>\n  <td>THZ</td>\n</tr>\n<tr>\n  <td>Terizidone</td>\n  <td>TRD</td>\n</tr>\n<tr>\n  <td>Viomycin</td>\n  <td>VM</td>\n</tr>\n<tr>\n  <td>Pyridoxine*</td>\n  <td>B6</td>\n</tr>\n</table>\n</body>	100	\N	256			11	f				t
645	488	31			0		0				<tr style="white-space: nowrap"><td><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n <tr>\n  <td>Abacavir</td>\n  <td>ABC</td>\n</tr>\n<tr>\n  <td>Abacavir/Lamivudine</td>\n  <td>EPZ</td>\n</tr>\n<tr>\n  <td>Atazanavir</td>\n  <td>ATV</td>\n</tr>\n<tr>\n  <td>Atazanavir/Cobicistat</td>\n  <td>ATC</td>\n</tr>\n<tr>\n  <td>Atazanavir/Ritonavir</td>\n  <td>AZR</td>\n</tr>\n<tr>\n  <td>Cobicistat</td>\n  <td>COB</td>\n</tr>\n<tr>\n  <td>Darunavir</td>\n  <td>DRV</td>\n</tr>\n<tr>\n  <td>Darunavir/Cobicistat</td>\n  <td>DRC</td>\n</tr>\n<tr>\n  <td>Delavirdine</td>\n  <td>DLV</td>\n</tr>\n<tr>\n  <td>Didanosine</td>\n  <td>DDI</td>\n</tr>\n<tr>\n  <td>Dolutegravir</td>\n  <td>DTG</td>\n</tr>\n<tr>\n  <td>Dolutegravir/Abacavir/Lamivudine</td>\n  <td>TMQ</td>\n</tr>\n<tr>\n  <td>Efavirenz</td>\n  <td>EFV</td>\n</tr>\n<tr>\n  <td>Efavirenz/Lamivudine/Tenofovir</td>\n  <td>ELT</td>\n</tr>\n<tr>\n  <td>Efavirenz/Tenofovir/Emtricitabine</td>\n  <td>ATR</td>\n</tr>\n<tr>\n  <td>Elvitegravir/Cobicistat/Tenofovir/Emtricitabine</td>\n  <td>STB</td>\n</tr>\n<tr>\n  <td>Emtricitabine</td>\n  <td>FTC</td>\n</tr>\n<tr>\n  <td>Enfuvirtide</td>\n  <td>T20</td>\n</tr>\n<tr>\n  <td>Etravirine</td>\n  <td>ETV</td>\n</tr><tr>\n  <td>Fosamprenavir</td>\n  <td>FPV</td>\n</tr>\n<tr>\n  <td>Indinavir</td>\n  <td>IDV</td>\n</tr>\n</table>\n</body>	100	\N	256			12	f				t
646	489	31			0		0				<tr style="white-space: nowrap"><td>\n<head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications<br /><i>(continued)</i></b></h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Lamivudine</td>\n  <td>3TC</td>\n</tr>\n<tr>\n  <td>Lopinavir/Ritonavir</td>\n  <td>LPV</td>\n</tr>\n<tr>\n  <td>Maraviroc</td>\n  <td>MVC</td>\n</tr>\n<tr>\n  <td>Nelfinavir</td>\n  <td>NFV</td>\n</tr>\n<tr>\n  <td>Nevirapine</td>\n  <td>NVP</td>\n</tr>\n<tr>\n  <td>Other</td>\n  <td>OAR</td>\n</tr>\n<tr>\n  <td>Raltegravir</td>\n  <td>RAL</td>\n</tr>\n<tr>\n  <td>Rilpivirine</td>\n  <td>RPV</td>\n</tr>\n<tr>\n  <td>Rilpivirine/Tenofovir/Emtricitabine</td>\n  <td>CPA</td>\n</tr>\n<tr>\n  <td>Ritonavir</td>\n  <td>RTV</td>\n</tr>\n<tr>\n  <td>Saquinavir</td>\n  <td>SQV</td>\n</tr>\n<tr>\n  <td>Stavudine</td>\n  <td>D4T</td>\n</tr>\n<tr>\n  <td>Stavudine/Lamivudine/Nevirapine</td>\n  <td>SLN</td>\n</tr>\n<tr>\n  <td>Tenofovir alafenamide</td>\n  <td>TAF</td>\n</tr>\n<tr>\n  <td>Tenofovir disoproxil fumarate</td>\n  <td>TDF</td>\n</tr>\n<tr>\n  <td>Tenofovir/Emtricitabine</td>\n  <td>TRU</td>\n</tr>\n<tr>\n  <td>Tenofovir/Lamivudine/Dolutegravir</td>\n  <td>TLD</td>\n</tr>\n<tr>\n  <td>Tipranavir</td>\n  <td>TPV</td>\n</tr>\n<tr>\n  <td>Zidovudine</td>\n  <td>ZDV</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine</td>\n  <td>CMB</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine/Abacavir</td>\n  <td>TZV</td>\n</tr>\n</table>\n</body>	100	\N	256			13	f				t
647	490	32	A. Visit Information		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Visit or date of blood sample collection  </span></p></tr>	101	\N	257			1	t				t
648	491	32			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Sequence ID </span></p></tr>	101	\N	258			2	t				f
649	492	32			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Date of Visit: </span></p></tr>	101	\N	258			3	t				f
650	493	32	Blood collection date		0		0					102	\N	258			4	t				t
651	494	32	Actual blood collection time		0		0					102	\N	258			5	t				t
652	495	32	Total volume collected		0		0					102	\N	258			6	t			1	t
660	503	32			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Non-enrollment Form completed </span></p></tr>	102	\N	258			14	t				t
661	460	33	A. Visit Information		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Participant's ID</span></p></tr>	103	\N	260	regexp: /38-[0-9]{2}-[0-9]{5}/	The format should be '38', followed by a dash, two digits, another dash, and then five digits.	1	t	38 - ### - #####			t
662	461	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Visit for reporting treatment change <strong>(check one):</strong><p><i>Study Evaluations</i></p></span></p></tr>	103	\N	261			2	t		Vertical		t
663	462	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If unscheduled, enter the visit date.</span></p></tr>	103	\N	260			3	f				t
664	463	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Squence ID of Adverse event, if any:</span></p></tr>	103	\N	260			4	f				t
665	464	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Squence ID of Possible Poor Treatment Response, if any:</span></p></tr>	103	\N	260			5	f				t
666	465	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Were there any additional events associated with this treatment change?</span></p></tr>	103	\N	262			6	t				t
667	466	33		If there were any additional events associated with this treatment change, indicate them below.	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Sequence ID of additional adverse event 1, if any.</span></p></tr>	103	\N	260			7	f				t
668	467	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Sequence ID of additional adverse event 2, if any.</span></p></tr>	103	\N	260			8	f				t
669	468	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Sequence ID of additional Possible Poor Treatment Response, if any.</span></p></tr>	103	\N	260			9	f				t
670	469	33	B. Site Investigator TB Treatment Change Recommendation		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Did the Site Investigator recommend a change in TB treatment?</span></p></tr>	104	\N	263			10	t		Vertical		t
671	470	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Which change to TB treatment was recommended by the Site Investigator?</span></p></tr>	104	\N	264			11	t		Vertical		t
672	471	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other change(s) to TB treatment recommended by the Site Investigator, if any.</span></p></tr>	104	\N	265			12	f				t
673	472	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Describe reasons for recommending TB treatment change <strong>(check all that apply)</strong></span></p></tr>	104	\N	266			13	t		Vertical		t
674	473	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other reasons for recommending TB treatment change, if any.</span></p></tr>	104	\N	265			14	f				t
675	504	33	C. Actual TB Treatment Change		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was a change in TB treatment actually initiated?</span></p></tr>	104	\N	267			15	t		Vertical		t
676	505	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If <strong>NO</strong> or <strong>UNKNOWN</strong>, was an alternative diagnosis established?</span></p></tr>	104	\N	268			16	f		Horizontal		t
677	476	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. If Site Investigator recommended a change in TB treatment, <strong>and it was not initiated</strong>, what was the reason for not changing treatment?</span></p></tr>	104	\N	265			17	f				t
678	477	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. If TB treatment was changed, which medications were included in initial non-study regimen (or extension of treatment)?  <strong></span></p></tr>	104	\N	269			18	f		Vertical		t
679	478	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>10. Start date of non-study regimen</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Knowledge of non-study regimen strart date</span></p></tr>	104	\N	270			19	f		Horizontal		t
680	479	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Enter the actual or estimated non-study regimen start date (ensure to indicate above if the entered start date is estimated)</span></p></tr>	104	\N	260			20	f				t
681	480	33	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Comments</span></p></tr>	105	\N	265			21	t				t
682	481	33	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	105	\N	260			22	t				t
683	482	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	105	\N	271			23	t				t
684	483	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	105	\N	260			24	t				t
685	484	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	105	\N	271			25	t				t
686	485	33			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	105	\N	260			26	t				t
687	460	34	A. Visit Information		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Participant's ID</span></p></tr>	106	\N	272	regexp: /38-[0-9]{2}-[0-9]{5}/	The format should be '38', followed by a dash, two digits, another dash, and then five digits.	1	t	38 - ## - #####			t
688	506	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Visit for reporting treatment change <strong>(check one):</strong><p><i>Study Evaluations</i></p></span></p></tr>	106	\N	273			2	t		Vertical		t
689	462	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If unscheduled, enter the visit date.</span></p></tr>	106	\N	272			3	f				t
690	463	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Squence ID of Adverse event, if any:</span></p></tr>	106	\N	272			4	f				t
691	464	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Squence ID of Possible Poor Treatment Response, if any:</span></p></tr>	106	\N	272			5	f				t
692	465	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Were there any additional events associated with this treatment change?</span></p></tr>	106	\N	274			6	t				t
693	466	34		If there were any additional events associated with this treatment change, indicate them below.	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Sequence ID of additional adverse event 1, if any.</span></p></tr>	106	\N	272			7	f				t
694	467	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Sequence ID of additional adverse event 2, if any.</span></p></tr>	106	\N	272			8	f				t
695	468	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Sequence ID of additional Possible Poor Treatment Response, if any.</span></p></tr>	106	\N	272			9	f				t
696	469	34	B. Site Investigator TB Treatment Change Recommendation		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Did the Site Investigator recommend a change in TB treatment?</span></p></tr>	107	\N	275			10	t		Vertical		t
697	470	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Which change to TB treatment was recommended by the Site Investigator?</span></p></tr>	107	\N	276			11	t		Vertical		t
698	471	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other change(s) to TB treatment recommended by the Site Investigator, if any.</span></p></tr>	107	\N	277			12	f				t
699	472	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Describe reasons for recommending TB treatment change <strong>(check all that apply)</strong></span></p></tr>	107	\N	278			13	t		Vertical		t
700	473	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other reasons for recommending TB treatment change, if any.</span></p></tr>	107	\N	277			14	f				t
701	504	34	C. Actual TB Treatment Change		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was a change in TB treatment actually initiated?</span></p></tr>	107	\N	279			15	t		Vertical		t
702	505	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If <strong>NO</strong> or <strong>UNKNOWN</strong>, was an alternative diagnosis established?</span></p></tr>	107	\N	280			16	f		Horizontal		t
703	476	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. If Site Investigator recommended a change in TB treatment, <strong>and it was not initiated</strong>, what was the reason for not changing treatment?</span></p></tr>	107	\N	277			17	f				t
704	477	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. If TB treatment was changed, which medications were included in initial non-study regimen (or extension of treatment)?  <strong></span></p></tr>	107	\N	281			18	f		Vertical		t
705	478	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>10. Start date of non-study regimen</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Knowledge of non-study regimen strart date</span></p></tr>	107	\N	282			19	f		Horizontal		t
706	479	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Enter the actual or estimated non-study regimen start date (ensure to indicate above if the entered start date is estimated)</span></p></tr>	107	\N	272			20	f				t
707	480	34	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Comments</span></p></tr>	108	\N	277			21	t				t
708	481	34	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	108	\N	272			22	t				t
709	482	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	108	\N	283			23	t				t
710	483	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	108	\N	272			24	t				t
711	484	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	108	\N	283			25	t				t
712	485	34			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	108	\N	272			26	t				t
739	533	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>19.  PRINT name of person completing form:</span></p></tr>	110	\N	284			27	t				t
713	507	35	Identification Values		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Participant's ID:</span></p></tr>	109	\N	284	regexp: /38-[0-9]{2}-[0-9]{5}/	The format should be '38', followed by a dash, two digits, another dash, and then five digits.	1	t	38 - ## - #####			t
714	508	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Sequence ID:</span></p></tr>	109	\N	284			2	t				t
715	509	35	A. Initial Assessment		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1.  What has prompted assessment for possible poor treatment response? <strong>(check all that apply)</strong></span></p></tr>	109	\N	285			3	t		Vertical		t
716	510	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If there are other thnngs that prompted the assessment for possible poor treatment response, specify here:</span></p></tr>	109	\N	286			4	f	Enter prompts here			t
717	511	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2.  Was the Central Study Clinician contacted at the time a possible poor treatment response was suspected?</span></p></tr>	109	\N	287			5	t				t
718	512	35	B. Evaluation (Since last study visit or during current visit and not previously reported)		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3.  Date of Report</span></p></tr>	109	\N	284			6	t				t
719	513	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4.  Did participant report any changes in antiretroviral or non-TB/non-antiretroviral medications, including over-the-counter drugs since the last study visit?</span></p></tr>	109	\N	288			7	t				t
720	514	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5.  Did participant take any drugs with anti-TB activity since the last study visit? </span></p></tr>	109	\N	289			8	t				t
721	515	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6.  Was a chest X-ray obtained?</span></p></tr>	109	\N	290			9	t				t
722	516	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7.  Are new laboratory test results available?</span></p></tr>	109	\N	291			10	t				t
723	517	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8.  Were signs and symptoms assessed and/or weight measured?</span></p></tr>	109	\N	292			11	t				t
724	518	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9.  Was sputum collection attempted (expectorated or induced)?</span></p></tr>	109	\N	293			12	t				t
725	519	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a.  How many specimens were collected?</span></p></tr>	109	\N	284			13	f				t
726	520	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>10.  Was a specimen for biomarker analysis collected (i.e., blood)?</span></p></tr>	109	\N	294			14	t				t
727	521	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>11.  Did the participant die?\t</span></p></tr>	109	\N	295			15	t				t
728	522	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>12.  Were any modifications made to the assigned study TB treatment?</span></p></tr>	109	\N	296			16	t				t
729	523	35	C. Event Description		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>12.  Based on information <strong>available at the time of initial PR form completion</strong>, in the site investigator’s judgment, this possible poor treatment response is most likely indicative of which of the following? <strong>(Select one)</strong></span></p></tr>	109	\N	297			17	t		Vertical		t
730	524	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a.  Other? Specify: </strong></span></p></tr>	109	\N	286			18	f				t
731	525	35	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>13  What is occurring with the participant to prompt a possible poor treatment response evaluation:</span></p></tr>	110	\N	286			19	f				t
732	526	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>14  Specify any concurrent illnesses or conditions present at the time of this visit which might explain the participant’s symptoms and diagnostic findings:</span></p></tr>	110	\N	286			20	f				t
733	527	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>15  Document considered or actual changes to TB treatment, TB treatment extension or re-initiation of TB treatment:</span></p></tr>	110	\N	286			21	f				t
734	528	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>16  If extrapulmonary TB is suspected, identify the anatomic site(s) (e.g., lymph node, meninges, kidney) and describe the clinical findings:</span></p></tr>	110	\N	286			22	f				t
735	529	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>16  If applicable, report the pathologic findings from specimens obtained from extrapulmonary sites and provide a copy of the report with the participant’s personal identifiers blacked out to TBTCcrush@cdc.gov:</span></p></tr>	110	\N	286			23	f				t
736	530	35	Additional Comments, if any		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Additional Comments</span></p></tr>	110	\N	286			24	f				t
737	531	35	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>17. PRINT name of Principal Investigator or Co-PI:</span></p></tr>	110	\N	284			25	t				t
738	532	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>18.  Signature of Principal Investigator</span></p></tr>	110	\N	298			26	t				t
740	534	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>20.  Signature of person completing form:</span></p></tr>	110	\N	298			28	t				t
741	535	35			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>21.  Date Possible Poor Treatment Response Form completed</span></p></tr>	110	\N	284			29	t				t
742	536	36	A. Visit Information		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Participant's ID</span></p></tr>	111	\N	299	regexp: /38-[0-9]{2}-[0-9]{5}/	The format should be '38', followed by a dash, two digits, another dash, and then five digits.	1	t	38 - ## - #####			t
743	506	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Visit for reporting treatment change <strong>(check one):</strong><p><i>Study Evaluations</i></p></span></p></tr>	111	\N	300			2	t		Vertical		t
744	462	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If unscheduled, enter the visit date.</span></p></tr>	111	\N	299			3	f				t
745	463	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Squence ID of Adverse event, if any:</span></p></tr>	111	\N	299			4	f				t
746	464	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Squence ID of Possible Poor Treatment Response, if any:</span></p></tr>	111	\N	299			5	f				t
747	465	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Were there any additional events associated with this treatment change?</span></p></tr>	111	\N	301			6	t				t
748	466	36		If there were any additional events associated with this treatment change, indicate them below.	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Sequence ID of additional adverse event 1, if any.</span></p></tr>	111	\N	299			7	f				t
749	467	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Sequence ID of additional adverse event 2, if any.</span></p></tr>	111	\N	299			8	f				t
750	468	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Sequence ID of additional Possible Poor Treatment Response, if any.</span></p></tr>	111	\N	299			9	f				t
751	469	36	B. Site Investigator TB Treatment Change Recommendation		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Did the Site Investigator recommend a change in TB treatment?</span></p></tr>	112	\N	302			10	t		Vertical		t
752	470	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Which change to TB treatment was recommended by the Site Investigator?</span></p></tr>	112	\N	303			11	t		Vertical		t
753	471	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other change(s) to TB treatment recommended by the Site Investigator, if any.</span></p></tr>	112	\N	304			12	f				t
754	472	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Describe reasons for recommending TB treatment change <strong>(check all that apply)</strong></span></p></tr>	112	\N	305			13	t		Vertical		t
755	473	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other reasons for recommending TB treatment change, if any.</span></p></tr>	112	\N	304			14	f				t
756	504	36	C. Actual TB Treatment Change		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was a change in TB treatment actually initiated?</span></p></tr>	112	\N	306			15	t		Vertical		t
757	505	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If <strong>NO</strong> or <strong>UNKNOWN</strong>, was an alternative diagnosis established?</span></p></tr>	112	\N	307			16	f		Horizontal		t
758	476	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. If Site Investigator recommended a change in TB treatment, <strong>and it was not initiated</strong>, what was the reason for not changing treatment?</span></p></tr>	112	\N	304			17	f				t
759	477	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. If TB treatment was changed, which medications were included in initial non-study regimen (or extension of treatment)?  <strong></span></p></tr>	112	\N	308			18	f		Vertical		t
760	478	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>10. Start date of non-study regimen</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Knowledge of non-study regimen strart date</span></p></tr>	112	\N	309			19	f		Horizontal		t
761	479	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Enter the actual or estimated non-study regimen start date (ensure to indicate above if the entered start date is estimated)</span></p></tr>	112	\N	299			20	f				t
762	480	36	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Comments</span></p></tr>	113	\N	304			21	t				t
763	481	36	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	113	\N	299			22	t				t
764	482	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Signature of Principal Investigator or Co-PI:</span></p></tr>	113	\N	310			23	t				t
765	483	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of person completing form:</span></p></tr>	113	\N	299			24	t				t
766	484	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Signature of person completing form:</span></p></tr>	113	\N	310			25	t				t
767	485	36			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Possible Poor Treatment Response Form completed</span></p></tr>	113	\N	299			26	t				t
768	537	37	A. Study Follow-up Completion		0		0		1	Did participant complete study follow-up?		114	\N	311			1	t		Horizontal		t
769	538	37	B. Reason for not completing study follow-up		0		0		1	Select the <b><u>primary</u></b> reason why participant did not complete study follow-up  <strong>(Select ONE reason only)</strong>		114	\N	312			2	f		Vertical		t
770	539	37			0		0					114	\N	313			3	f		Vertical		t
771	540	37			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:70px; margin-bottom: 0px;"><span>Specify reason:</span></p></tr>	114	\N	314			4	t				f
772	541	37			0		0					114	\N	315			5	f		Vertical		t
773	542	37			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:70px; margin-bottom: 0px;"><span>Specify reason:</span></p></tr>	114	\N	314			6	t				f
774	543	37			0		0					114	\N	316			7	f		Vertical		t
775	544	37			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:70px; margin-bottom: 0px;"><span>Specify reason:</span></p></tr>	114	\N	314			8	t				f
776	545	37			0		0					114	\N	317			9	f		Vertical		t
777	546	37			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:70px; margin-bottom: 0px;"><span>Specify reason:</span></p></tr>	114	\N	314			10	t				f
778	547	37			0		0		2	Date study follow-up ended		114	\N	318			11	t		Vertical		t
779	548	37	C. Storage of blood specimens for pharmacogenomic testing		0		0		1	Participant decision for storage of blood specimens for pharmacogenomic testing		114	\N	319			12	t		Vertical		t
780	549	37			0		0		2	Storage withdrawal date:		114	\N	318			13	t				t
781	550	37			0		0		3	Reason for withdrawal of specimen storage:		114	\N	314			14	f				t
782	551	37	D. Storage of blood specimens for future research		0		0		1	Participant decision for storage of blood specimens for future research		114	\N	320			15	t		Vertical		t
783	552	37			0		0		2	Storage withdrawal date:		114	\N	318			16	t				t
784	553	37	E. Comments		0		0					114	\N	314			17	t				t
785	554	37	F. Form Completion		0		0			PRINT name of person completing form:		114	\N	318			18	t		Horizontal		t
786	555	37			0		0			Date Follow-up Completion Form completed		114	\N	318			19	t				t
1214	117	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<div id="LBMessage" style="display:none;">&nbsp;(Complete Laboratory Evaluation Form)</div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Are new laboratory test results available?</span></p></tr>	157	\N	524			7	t		Horizontal		t
1215	118	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n <div id="SSMessage" style="display:none;">&nbsp;(Complete Signs and Symptoms Form)</div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Were signs and symptoms assessed?</span></p></tr>	157	\N	525			8	t		Horizontal		t
1216	119	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<div id="MBMessage" style="display:none;">&nbsp;(Complete Mycobacteriology Form)</div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Was sputum collection attempted or other specimen collected for AFB work-up?</span></p></tr>	157	\N	526			9	t		Horizontal		t
1217	561	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If yes, how many specimens were collected?</span></p></tr>	157	\N	520			10	t				f
1218	120	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<div id="RSMessage" style="display:none;">&nbsp;(Complete Mycobacteriology Form)</div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Was sputum collected for RS ratio assay?</span></p></tr>	157	\N	527			11	t		Horizontal		t
1219	121	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was a specimen for pharmacogenomics testing collected?</span></p></tr>	157	\N	528			12	f		Horizontal		t
1220	122	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. Was a specimen for biomarker analysis collected (i.e., blood)?</span></p></tr>	157	\N	529			13	f		Horizontal		t
1221	123	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<div id="TMMessage" style="display:none;">&nbsp;(Complete the Treatment Change Form)</div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>10. Were any modifications made to the assigned study TB treatment (e.g., retreatment with any TB therapy after the participant completed assigned study treatment, extension of TB treatment beyond that of the participant’s assigned regimen)?</span></p></tr>	157	\N	530			14	t		Horizontal		t
1222	124	64	C. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span> Comments </span></p></tr>	157	\N	531			15	f				t
1223	125	64	D. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	157	\N	520			16	t				t
1224	126	64			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Follow-up Evaluation Form completed:</span></p></tr>	157	\N	520			17	t				t
1225	145	65	A. Study Entry Enrollment		0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of birth:</span> </span></p></tr>	158	\N	532			1	t				t
1226	146	65			0		2				<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>&nbsp;</span> </span></p></tr>	158	\N	533			2	f		Horizontal		t
1227	147	65			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date participant or legal guardian signed informed consent</span> </span></p></tr>	158	\N	532			3	t		Horizontal		t
1228	148	65			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Date participant assent:</span> </span></p></tr>	158	\N	532			4	t		Horizontal		t
1229	149	65			0		2				<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>&nbsp;</span> </span></p></tr>	158	\N	534		This is a required field	5	t		Horizontal		t
1230	150	65			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Height:</span> </span></p></tr>	158	\N	532		This is a required field	6	t		Horizontal		t
1231	924	65			0		2				<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>&nbsp;</span> </span></p></tr>	158	\N	535		This is a required field	7	t		Horizontal		t
1232	152	65			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Weight:</span> </span></p></tr>	158	\N	532		This is a required field	8	t		Horizontal		t
1233	153	65			0		2				<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>&nbsp;</span> </span></p></tr>	158	\N	536			9	t		Horizontal		t
1234	154	65			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Date of weight: <b>(Cannot be more than 7 days prior to enrollment)</b></span></p></tr>	158	\N	532		This is a required field	10	t		Horizontal		t
852	576	42	A. TB Drug Dose Record		0		0			Dose Type*		125	\N	366	regexp: /[PICNRpicnr]/	Must be P, I, C, N, or R	2	t			1	t
853	577	42			0		0			Food**		125	\N	366	regexp: /[BWNUbwnu]/	Must be B, W, N, or U	3	t			1	t
854	578	42			0		0			Vomiting within 1 hour of dose***		125	\N	366	regexp: /[YNUynu]/	Must be Y, N, or U	4	t			1	t
855	579	42			0		0			Dose Date		125	\N	366			5	t				t
856	580	42			0		0			___mg		125	\N	366	regexp: /[0-9]{5}/	Must be exactly 4 digits	6	t			4	t
857	581	42			0		0			___mg		125	\N	366	regexp: /[0-9]{5}/	Must be exactly 4 digits	7	t			4	t
858	582	42			0		0			___mg		125	\N	366	regexp: /[0-9]{5}/	Must be exactly 4 digits	8	t			4	t
859	583	42			0		0			___mg		125	\N	366	regexp: /[0-9]{5}/	Must be exactly 4 digits	9	t			4	t
860	584	42			0		0			___mg		125	\N	366	regexp: /[0-9]{5}/	Must be exactly 4 digits	10	t			4	t
861	585	42			0		0			___mg		125	\N	366	regexp: /[0-9]{5}/	Must be exactly 4 digits	11	t			4	t
862	586	42			0		0			Adm†		125	\N	366	regexp: /[DVSUdvsu]/	Must be D, V, S, or U	12	t			1	t
863	587	42			0		0			Tolerated re-challenge‡		125	\N	366	regexp: /[YNyn]/	Must be Y or N	13	t			1	t
864	588	42	<br> <div>\n* Dose type: P=Pre-study dose; I=Intensive phase study dose; C=Continuation phase study dose; N=Non-study dose; R=Re-challenge dose<br>\n**Food intake: B=<1 hour before dose; W=with dose; N=no food consumed < 1 hour before or with dose; U=Unknown<br>\n***Vomiting within 1 hour of dose: Y=Yes; N=No; U=Unknown<br>\n† Administration: D=In-person DOT; V=Video-DOT; S=SAT; U=Unknown<br>\n‡ Tolerated re-challenge: Y=Yes; N=No<br> </div> <br><br><b>B. Comments</b>		0		0					125	\N	367			14	t				t
865	589	42	C. Form Completion		0		0			PRINT name of person completing form:		125	\N	366			15	t			50	t
866	590	42			0		0			Date Concomitant Medication Form completed:		125	\N	366			16	t				t
867	591	43			0		0			Participant ID:	<br>\n<b>Consent Review</b> This form should ONLY be completed for participants providing informed consent to collection of blood for pharmocogenomic testing.<br><br>\n\n<ul>\n    <li>Complete this form if a blood specimen is collected for pharmacogenomic analyses.</li>\n    <li>Record all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>).</li>\n    <li>Record all times in 24 hour format (e.g., <b>7 AM is recorded as 0700 and 10 PM is recorded as 2200</b>).</li>\n</ul>	126	\N	368	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
868	592	43	A. Visit Information		0		0		1.	Visit or date of pharmacogenomic blood sample collection <b>(check one)</b>:<br><br>\n\n<i>Study Evaluations</i>		126	\N	369			2	t		Vertical		t
869	593	43			0		0				Sequence ID	126	\N	368	regexp: /[0-9A-Z]{4}/	Format must be exactly 4 characters or digits in length	3	f			4	f
870	594	43			0		0			Date of visit:		126	\N	368			4	f				f
871	595	43	B. Pharmacogenomic Specimen Collection<br><br>\n<div style="font-weight: normal; display: flex;">\n    <span>Note:&nbsp;</span>\n    <span>Blood collected for the pharmacogenomic sample should be kept in the ACD tube in a tube rack at room temperature until separated into (whole blood) aliquots and then frozen at -70⁰ C. Do <b><u>NOT</u></b> place in ice/water or -20 o C freezer prior to freezing at -70 o C.</span>\n</div>		0		0		1.	Pharmacogenomic sampling<br>\nDate/time of specimen collection:<br>\n<b>Date:</b>		126	\N	368			5	t				t
872	596	43			0		0			<b>Time:</b>		126	\N	368	regexp: /[0-9]{2}:[0-9]{2}/	Format must be exactly 2 digits followed by a colon (':') followed by 2 digits	6	t			5	t
873	597	43			0		0		2.	Total volume collected:	mL	126	\N	368			7	t			4(1)	t
874	598	43			0		0		3.	Were any aliquots made?		126	\N	370			8	t		Horizontal		t
875	599	43			0		0		a.	Provide the following:<br>\nVolume in mL<br>\nAliquot #1		126	\N	368			9	f			4(1)	f
876	600	43			0		0			Aliquot #2		126	\N	368			10	f			4(1)	f
877	601	43			0		0		4.	Cryovial Label Numbers<br>\nReport the Label Number <u>exactly</u> as written on the labels affixed to the aliquot cryovials.<br>\nCUID Label Number<br>    \nAliquot #1		126	\N	368	regexp: /[0-9]{8}/	Format must be exactly 8 digits	11	t			8	t
878	602	43			0		0			Aliquot #2		126	\N	368	regexp: /[0-9]{8}/	Format must be exactly 8 digits	12	t			8	t
879	603	43			0		0		5.	Date/time aliquots stored locally in -70°C freezer:<br>\n<b>Date:</b>		126	\N	368			13	t				t
880	604	43			0		0			<b>Time:</b>		126	\N	368	regexp: /[0-9]{2}:[0-9]{2}/	Format must be exactly 2 digits followed by a colon (':') followed by 2 digits	14	t			5	t
881	605	43	C. Comments		0		0					126	\N	371			15	t				t
882	606	43	D. Form Completion		0		0			PRINT name of person completing form:		126	\N	368			16	t			50	t
883	607	43			0		0			Date Pharmacogenomics Form completed:		126	\N	368			17	t				t
1235	155	65			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Date of chest X-ray: </p><br><p style="text-indent:40px; font-weight: bold">(Alternative imaging techniques (e.g. CT or MRI) may NOT be used in place of a plain chest X-ray)</span> </span></p></tr>	158	\N	532		This is a required field	11	t		Horizontal		t
1236	156	65			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px;margin-bottom:0px;"> a. Any cavitation on chest X-ray: </span></p></tr>	158	\N	537		This is a required field	12	t		Horizontal		t
1237	157	65			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">7. Scheduled study treatment start date:</span></p></tr>	158	\N	532		This is a required field	13	t		Horizontal		t
821	560	40	A. Visit	Respond to the preliminary questions below.	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Visit</span></p></tr>	117	\N	349			1	f		Vertical		t
822	112	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Week/Month of evaluation:</span></p></tr>	117	\N	350			2	t		Horizontal		t
823	113	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date of AE onset:</span></p></tr>	117	\N	351			3	t				t
824	114	40	B. Evaluation		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Did participant report any changes in antiretroviral or non-TB/non-antiretroviral medications, including over-the-counter drugs?<script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>\n<div id="CMMessage" style="display:none;">&nbsp;(Complete or Update Concomitant Medication Form)</div>\n<script>\njQuery(document).ready(function() {\nenableRadioMessage("#CMMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#DRMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#CEMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#LBMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#SSMessage", "Y");\n});jQuery(document).ready(function() {\nenableRadioMessage("#MBMessage", "Y");\n});\nfunction enableRadioMessage(containerId, value) {\n\tvar msgContainer = jQuery(containerId);\n\tvar radiosToCheck = msgContainer.parent().parent().find("input");\n\tradiosToCheck.change(function(){setMessage(radiosToCheck, msgContainer, value);});\n\tsetMessage(radiosToCheck, msgContainer, value);\n}\n\nfunction setMessage(radiosToCheck, msgContainer, value) {\n\tfor (var i = 0; i < radiosToCheck.length; i++) {\n\t\tif (radiosToCheck[i].checked) {\n\t\t\tvar valueToCheck = radiosToCheck[i].value;\n\t\t\tbreak;\n\t\t}\n\t}\n\tif (valueToCheck && (valueToCheck == value)){\n\t\tmsgContainer.show();\n\t}\n\telse {\n\t\tmsgContainer.hide();\n\t}\n}\n\n</script></span></p></tr>	117	\N	352			4	t		Horizontal		t
825	115	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Did participant take any drugs with anti-TB activity?\n<div id="DRMessage" style="display:none;">&nbsp;(Update TB Drug Dose Record Form)</div>\n </span></p></tr>	117	\N	353			5	t		Horizontal		t
826	116	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Were any clinical evaluations (e.g., chest X-ray, CT scan, MRI, ECG) performed?<div id="CEMessage" style="display:none;">&nbsp;(Complete Clinical Evaluation Form)</div></span></p></tr>	117	\N	354			6	t		Horizontal		t
827	117	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Are new laboratory test results available?<div id="LBMessage" style="display:none;">&nbsp;(Complete Laboratory Evaluation Form)</div></span></p></tr>	117	\N	355			7	t		Horizontal		t
828	118	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Were signs and symptoms assessed? <div id="SSMessage" style="display:none;">&nbsp;(Complete Signs and Symptoms Form)</div></span></p></tr>	117	\N	356			8	t		Horizontal		t
829	119	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Was sputum collection attempted or other specimen collected for AFB work-up?<div id="MBMessage" style="display:none;">&nbsp;(Complete Mycobacteriology Form)</div></span></p></tr>	117	\N	357			9	t		Horizontal		t
830	561	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. How many specimens were collected?</span></p></tr>	117	\N	351			10	t				f
831	120	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Was sputum collected for RS ratio assay</span></p></tr>	117	\N	358			11	t		Horizontal		t
832	121	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Was a specimen for pharmacogenomics testing collected</span></p></tr>	117	\N	359			12	f		Horizontal		t
833	122	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was a specimen for biomarker analysis collected</span></p></tr>	117	\N	360			13	f		Horizontal		t
834	123	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. Were any modifications made to the assigned study TB treatment</span></p></tr>	117	\N	361			14	t		Horizontal		t
835	124	40	C. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span> Comments </span></p></tr>	117	\N	362			15	f				t
836	125	40	D. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	117	\N	351			16	t				t
837	126	40			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Follow-up Evaluation Form completed:</span></p></tr>	117	\N	351			17	t				t
1238	158	65	B. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Comments</span></p></tr>	158	\N	538			14	t		Horizontal		t
1239	159	65	C. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">PRINT name of person completing form:</span></p></tr>	158	\N	532			15	t		Horizontal		t
1240	160	65			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Date Enrollment Form completed: </span></p></tr>	158	\N	532		This is a required field	16	t		Horizontal		t
838	562	41			0		0			Participant ID:	(38-##-#####) <tr style="white-space: nowrap"><td><br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at each study visit if the participant reports taking any concomitant medications with no anti-TB activity, either in the 14 days prior to study treatment start date or while on study treatment, including analgesics and antipyretics. If there is no change in concomitant medications, do not update this form.</br></br>\nFor ongoing medications started more than 30 days before study start date, report medication start date as 30 days prior to study start date. If participant is still taking a medication, leave “End Date” blank. Record all dates in the following format: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>.</br></br>\nDo NOT report medications with anti-TB activity <b>(see page 3 of this form)</b> on this form. Report all medications with TB activity on the TB Drug Dose Record form. <b>(see TB Drug Dose Record Form)</b>. Antiretroviral Medications table is on the last page of this form.</div>	118	\N	363	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
839	563	41			0		0			Name		119	\N	363			2	f				t
840	564	41			0		0			Start Date		119	\N	363			3	f				t
841	565	41			0		0			End Date		119	\N	363			4	f				t
842	566	41			0		0			Name		120	\N	363			5	f				t
843	567	41			0		0			Start Date		120	\N	363			6	f				t
844	568	41			0		0			End Date		120	\N	363			7	f				t
845	569	41			0		0					121	\N	364			8	f				t
846	570	41			0		0			PRINT name of person completing form:		122	\N	363			9	t			50	t
847	571	41			0		0			Date Concomitant Medication Form completed:	DD-MMM-YYYY	122	\N	363			10	t				t
848	572	41			0		0				<tr style="white-space: nowrap"><td><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Anti-tuberculosis Medications<br />(*exception)<br /><i>(continued)</i></h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Meropenem</td>\n  <td>MPN</td>\n</tr>\n<tr>\n  <td>Moxifloxacin</td>\n  <td>M</td>\n</tr>\n<tr>\n  <td>Ofloxacin</td>\n  <td>OFX</td>\n</tr>\n<tr>\n  <td>P-aminosalicylic acid</td>\n  <td>PAS</td>\n</tr>\n<tr>\n  <td>Pretomanid</td>\n  <td>Pa</td>\n</tr>\n<tr>\n  <td>Protionamide</td>\n  <td>PTO</td>\n</tr>\n<tr>\n  <td>Pyrazinamide</td>\n  <td>Z</td>\n</tr>\n<tr>\n  <td>Rifabutin</td>\n  <td>RBT</td>\n</tr>\n<tr>\n  <td>Rifampicin</td>\n  <td>R</td>\n</tr>\n<tr>\n  <td>Rifapentine</td>\n  <td>P</td>\n</tr>\n<tr>\n  <td>Sparfloxacin</td>\n  <td>SPR</td>\n</tr>\n<tr>\n  <td>Streptomycin</td>\n  <td>S</td>\n</tr>\n<tr>\n  <td>Sutezolid</td>\n  <td>SUT</td>\n</tr>\n<tr>\n  <td>Thioacetazone</td>\n  <td>THZ</td>\n</tr>\n<tr>\n  <td>Terizidone</td>\n  <td>TRD</td>\n</tr>\n<tr>\n  <td>Viomycin</td>\n  <td>VM</td>\n</tr>\n<tr>\n  <td>Pyridoxine*</td>\n  <td>B6</td>\n</tr>\n</table>\n</body>	123	\N	365			11	f				t
849	573	41			0		0				<tr style="white-space: nowrap"><td><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n <tr>\n  <td>Abacavir</td>\n  <td>ABC</td>\n</tr>\n<tr>\n  <td>Abacavir/Lamivudine</td>\n  <td>EPZ</td>\n</tr>\n<tr>\n  <td>Atazanavir</td>\n  <td>ATV</td>\n</tr>\n<tr>\n  <td>Atazanavir/Cobicistat</td>\n  <td>ATC</td>\n</tr>\n<tr>\n  <td>Atazanavir/Ritonavir</td>\n  <td>AZR</td>\n</tr>\n<tr>\n  <td>Cobicistat</td>\n  <td>COB</td>\n</tr>\n<tr>\n  <td>Darunavir</td>\n  <td>DRV</td>\n</tr>\n<tr>\n  <td>Darunavir/Cobicistat</td>\n  <td>DRC</td>\n</tr>\n<tr>\n  <td>Delavirdine</td>\n  <td>DLV</td>\n</tr>\n<tr>\n  <td>Didanosine</td>\n  <td>DDI</td>\n</tr>\n<tr>\n  <td>Dolutegravir</td>\n  <td>DTG</td>\n</tr>\n<tr>\n  <td>Dolutegravir/Abacavir/Lamivudine</td>\n  <td>TMQ</td>\n</tr>\n<tr>\n  <td>Efavirenz</td>\n  <td>EFV</td>\n</tr>\n<tr>\n  <td>Efavirenz/Lamivudine/Tenofovir</td>\n  <td>ELT</td>\n</tr>\n<tr>\n  <td>Efavirenz/Tenofovir/Emtricitabine</td>\n  <td>ATR</td>\n</tr>\n<tr>\n  <td>Elvitegravir/Cobicistat/Tenofovir/Emtricitabine</td>\n  <td>STB</td>\n</tr>\n<tr>\n  <td>Emtricitabine</td>\n  <td>FTC</td>\n</tr>\n<tr>\n  <td>Enfuvirtide</td>\n  <td>T20</td>\n</tr>\n<tr>\n  <td>Etravirine</td>\n  <td>ETV</td>\n</tr><tr>\n  <td>Fosamprenavir</td>\n  <td>FPV</td>\n</tr>\n<tr>\n  <td>Indinavir</td>\n  <td>IDV</td>\n</tr>\n</table>\n</body>	123	\N	365			12	f				t
850	574	41			0		0				<tr style="white-space: nowrap"><td>\n<head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications<br /><i>(continued)</i></b></h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n<tr>\n  <td>Lamivudine</td>\n  <td>3TC</td>\n</tr>\n<tr>\n  <td>Lopinavir/Ritonavir</td>\n  <td>LPV</td>\n</tr>\n<tr>\n  <td>Maraviroc</td>\n  <td>MVC</td>\n</tr>\n<tr>\n  <td>Nelfinavir</td>\n  <td>NFV</td>\n</tr>\n<tr>\n  <td>Nevirapine</td>\n  <td>NVP</td>\n</tr>\n<tr>\n  <td>Other</td>\n  <td>OAR</td>\n</tr>\n<tr>\n  <td>Raltegravir</td>\n  <td>RAL</td>\n</tr>\n<tr>\n  <td>Rilpivirine</td>\n  <td>RPV</td>\n</tr>\n<tr>\n  <td>Rilpivirine/Tenofovir/Emtricitabine</td>\n  <td>CPA</td>\n</tr>\n<tr>\n  <td>Ritonavir</td>\n  <td>RTV</td>\n</tr>\n<tr>\n  <td>Saquinavir</td>\n  <td>SQV</td>\n</tr>\n<tr>\n  <td>Stavudine</td>\n  <td>D4T</td>\n</tr>\n<tr>\n  <td>Stavudine/Lamivudine/Nevirapine</td>\n  <td>SLN</td>\n</tr>\n<tr>\n  <td>Tenofovir alafenamide</td>\n  <td>TAF</td>\n</tr>\n<tr>\n  <td>Tenofovir disoproxil fumarate</td>\n  <td>TDF</td>\n</tr>\n<tr>\n  <td>Tenofovir/Emtricitabine</td>\n  <td>TRU</td>\n</tr>\n<tr>\n  <td>Tenofovir/Lamivudine/Dolutegravir</td>\n  <td>TLD</td>\n</tr>\n<tr>\n  <td>Tipranavir</td>\n  <td>TPV</td>\n</tr>\n<tr>\n  <td>Zidovudine</td>\n  <td>ZDV</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine</td>\n  <td>CMB</td>\n</tr>\n<tr>\n  <td>Zidovudine/Lamivudine/Abacavir</td>\n  <td>TZV</td>\n</tr>\n</table>\n</body>	123	\N	365			13	f				t
851	575	42			0		0			Participant ID:	(38-##-#####) <br> <br> <br> <div> <b>Instructions:</b> Complete or update this form at every study visit in which doses of drugs with anti-TB activity (listed on last page) are reported.<br>\n<div style="margin-left: 20px;">\n    This includes:\n    <ul>\n        <li>Pre-study doses <b>(TB treatment in the 6 months prior to study start date and/or drugs with anti-TB activity given for purposes other than treatment of TB in the 30 days prior to study start date)</b></li>\n        <li>Study doses <b>(including all changes in TB treatment)</b></li>\n        <li>Non-study doses of drugs with anti-TB activity given for treatment of incidental illnesses during study <b>(e.g., a fluoroquinolone given for a urinary tract infection)</b> after study start date.</li>\n        <li>Re-challenge doses of TB medications following an adverse event.</li>\n    </ul>\n</div>\nRecord all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>). </div>	124	\N	366	regexp: /38-[0-9]{2}-[0-9]{5}/	Format must be '38' followed by a dash followed by 2 digits followed by a dash followed by 5 digits	1	t	38-		8	t
1241	161	65	Treatment Assigment upon Successful Enrollment Submission	REMINDER: Vitamin B6 (pyridoxine), 25 or 50mg, <u>must be obtained locally</u> and be administered daliy by mouth with isoniazid	0		0			Assigned treatment arm (study kit medications)		158	\N	539			17	f		Vertical		t
1242	162	65			0		1			Medication		158	\N	532			18	f		Vertical		t
1243	163	65			0		2			Dose (mg)		158	\N	532		This is a required field	19	t		Horizontal		t
1244	164	65			0		3			Duration # of weeks		158	\N	532		This is a required field	20	t		Horizontal		t
2819	1113	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">8. Was a specimen for pharmacogenomics testing collected?</span></p> <strong> (If "Yes", complete Pharmacogenomic Blood Sample Form)</strong></tr>	214	\N	1075		This is a required field	13	t		Horizontal		t
2820	1114	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">9. Was a specimen for biomarker analysis collected? <strong> (e.g., blood)</strong></span></p></tr>	214	\N	1075		This is a required field	14	t		Horizontal		t
2821	1115	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">10. Were TB drug sparse PK specimens collected?<strong> (If "Yes", complete TB Drug Sparse PK Form)</strong></span></p></tr>	214	\N	1075		This is a required field	15	t		Horizontal		t
2822	1116	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">11. Were TB drug intensive pK specimens collected?<strong> (If "Yes", complete TB Drug Intensive PK Form)</strong></span></p></tr>	214	\N	1075		This is a required field	16	t		Horizontal		t
2823	1117	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">12. Has the participant been newly diagnosed as being pregnant?<strong> (If "Yes", report pregnancy test result on Laboratory Evaluation Form and complete Adverse Event Form)</strong></span></p></tr>	214	\N	1075		This is a required field	17	t		Horizontal		t
2824	1118	94			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">13. Were any modifications made to the assigned study TB treatment?<strong> (If "Yes", complete Treatment Change Form)</strong></span></p></tr>	214	\N	1074		This is a required field	18	t		Horizontal		t
2825	1119	94	C. Study Treatment Status		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">1. What is the participant's current study treatment status <strong>(check one)</strong>?</span></p></tr>	214	\N	1076		This is a required field	19	t		Horizontal		t
2826	1120	94	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">D. Comments</span></p></tr>	214	\N	1077			20	f		Horizontal		t
2827	1121	94	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Print name of person completing form:</span></p></tr>	214	\N	1072			21	f		Horizontal		t
2828	1122	94			0		0			Date Treatment Evaluation Form completed		214	\N	1072			22	f		Horizontal		t
2829	1123	95	A. Visit Information		0		0				<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	215	\N	1078	regexp: /38-[0-9]{2}-[0-9]{5}/	The format should be '38', followed by a dash, two digits, another dash, and then five digits.	1	t	38 - ## - #####			t
2830	1124	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Visit for reporting treatment change <strong>(check one):</strong><p><i>Study Evaluations</i></p></span></p></tr>	215	\N	1079			2	t		Vertical		t
2831	1125	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If unscheduled, enter the visit date.</span></p></tr>	215	\N	1078			3	f				t
2832	1126	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Squence ID of Adverse event, if any:</span></p></tr>	215	\N	1078			4	f				t
2833	1127	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Squence ID of Possible Poor Treatment Response, if any:</span></p></tr>	215	\N	1078			5	f				t
2834	1128	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Were there any additional events associated with this treatment change?</span></p></tr>	215	\N	1080			6	t				t
2835	1129	95		If there were any additional events associated with this treatment change, indicate them below.	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Sequence ID of additional adverse event 1, if any.</span></p></tr>	215	\N	1078			7	f				t
2836	1130	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Sequence ID of additional adverse event 2, if any.</span></p></tr>	215	\N	1078			8	f				t
2837	1131	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Sequence ID of additional Possible Poor Treatment Response, if any.</span></p></tr>	215	\N	1078			9	f				t
2838	1132	95	B. Site Investigator TB Treatment Change Recommendation		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Did the Site Investigator recommend a change in TB treatment?</span></p></tr>	216	\N	1081			10	t		Vertical		t
2839	1133	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Which change to TB treatment was recommended by the Site Investigator?</span></p></tr>	216	\N	1082			11	t		Vertical		t
2840	1134	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other change(s) to TB treatment recommended by the Site Investigator, if any.</span></p></tr>	216	\N	1083			12	f				t
2841	1135	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Describe reasons for recommending TB treatment change <strong>(check all that apply)</strong></span></p></tr>	216	\N	1084			13	t		Vertical		t
2842	1136	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:45px; margin-bottom: 0px;"><span>a. Specify other reasons for recommending TB treatment change, if any.</span></p></tr>	216	\N	1083			14	f				t
2843	1137	95	C. Actual TB Treatment Change		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was a change in TB treatment actually initiated?</span></p></tr>	216	\N	1085			15	t		Vertical		t
2844	1138	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If <strong>NO</strong> or <strong>UNKNOWN</strong>, was an alternative diagnosis established?</span></p></tr>	216	\N	1086			16	f		Horizontal		t
2845	1139	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. If Site Investigator recommended a change in TB treatment, <strong>and it was not initiated</strong>, what was the reason for not changing treatment?</span></p></tr>	216	\N	1083			17	f				t
2846	1140	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. If TB treatment was changed, which medications were included in initial non-study regimen (or extension of treatment)?  <strong></span></p></tr>	216	\N	1087			18	f		Vertical		t
2847	1141	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>10. Start date of non-study regimen</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Knowledge of non-study regimen strart date</span></p></tr>	216	\N	1088			19	f		Horizontal		t
2848	1142	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Enter the actual or estimated non-study regimen start date (ensure to indicate above if the entered start date is estimated)</span></p></tr>	216	\N	1078			20	f				t
2849	1143	95	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Comments</span></p></tr>	217	\N	1083			21	t				t
2850	1144	95	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of Principal Investigator or Co-PI:</span></p></tr>	217	\N	1078			22	t				t
5592	3759	148			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Race:</span></p></tr>	492	\N	2078			6	t		Vertical		t
5593	3756	148			0		2					492	\N	2079			7	f				t
2851	1145	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Signature of Principal Investigator or Co-PI:</span></p></tr>	217	\N	1089			23	t				t
2852	1146	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of person completing form:</span></p></tr>	217	\N	1078			24	t				t
2853	1147	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Signature of person completing form:</span></p></tr>	217	\N	1089			25	t				t
2854	1148	95			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Possible Poor Treatment Response Form completed</span></p></tr>	217	\N	1078			26	t				t
5594	3747	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>Specify:</span></p></tr>	492	\N	2080			8	t				f
5595	3748	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Risk factors within the past year</span></p></tr><tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Homeless:</span></p></tr>	492	\N	2081			9	t		Horizontal		t
5596	3719	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Injecting drug use:</span></p></tr>	492	\N	2082			10	t		Horizontal		t
5597	3758	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Non-injecting drug use:</span></p></tr>	492	\N	2083			11	t		Horizontal		t
5598	3709	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Resident of correctional facility:</span></p></tr>	492	\N	2084			12	t		Horizontal		t
5599	3735	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>e. Alcohol use led to problems in relationships, health, employment/work performance or finances:</span></p></tr>	492	\N	2085			13	f		Horizontal		t
5600	3746	148	A. Participant History (continued)		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">6. Mental health history</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(Past mental illness refers to issues for which the participant is NOT currently receiving medications and/or seeing clinician at present)</strong></span>\n  </p><p style="text-indent:40px; margin-bottom: 0px;">a. Family member with mental illness <b><small>(primary relationship-biologic mother, biologic father, full sibling, or biologic child)</small></b> with mental illness*</p>\n</tr>	493	\N	2086			14	t		Horizontal		t
5601	3695	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:50px; margin-bottom: 0px;"><span>If yes, please specify the past mental health diagnoses:</span></p></tr>	493	\N	2080			15	t	1. \n2. \n3. \n4. \n5.			t
5602	3708	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Past personal mental illness:</span></p></tr>	493	\N	2087			16	t		Horizontal		t
5603	3738	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:50px; margin-bottom: 0px;"><span>If yes, please specify the past mental health diagnoses:</span></p></tr>	493	\N	2080			17	t	1. \n2. \n3. \n4. \n5.			t
1061	790	60			0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Participant's ID</span></p></tr>	149	\N	462			1	t				t
1062	777	60	A. Study Follow-up Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1.   Did participant complete study follow-up?</span></p></tr>	149	\N	463			2	t		Horizontal		t
1063	793	60	B. Reason for not completing study follow-up		0		0				<tr><p style=text-indent:20px; margin-bottom: 0px;><span>2.   Select the primary reason why participant did not complete study follow-up (select ONE reason only)</span></p></tr>	149	\N	464			3	t		Vertical		t
1064	783	60			0		1			<tr>	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	149	\N	465			4	f		Vertical		t
1065	782	60			0		2			<tr>Specify reason	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	149	\N	462			5	f				f
1066	795	60			0		1			<tr>	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	149	\N	466			6	f		Vertical		t
1067	780	60			0		2			<tr>Specify reason	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	149	\N	462			7	f				f
1068	784	60			0		1			<tr>	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	149	\N	467			8	f		Vertical		t
1069	796	60			0		2			<tr>Specify reason	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	149	\N	462			9	f				f
1070	794	60			0		1			<tr>	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	149	\N	468			10	f		Vertical		t
1071	778	60			0		2			<tr>Specify reason	<tr><p style=text-indent:20px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	149	\N	462			11	f				f
1072	788	60			0		0		2	Date study follow-up ended		150	\N	462			12	t		Vertical		t
1073	781	60	C. Storage of blood specimens for pharmacogenomic testing		0		0		1	Participant decision for storage of blood specimens for pharmacogenomic testing		150	\N	469			13	t		Vertical		t
1074	789	60			0		0		2	Storage withdrawal date:		150	\N	462			14	t				t
1075	786	60			0		0		3	Reason for withdrawal of specimen storage:		150	\N	470			15	f				t
1076	785	60	D. Storage of blood specimens for future research		0		0		1	Participant decision for storage of blood specimens for future research		150	\N	471			16	t		Vertical		t
1077	787	60			0		0		2	Storage withdrawal date:		150	\N	462			17	t				t
1078	779	60	E. Comments		0		0					150	\N	470			18	t				t
1079	791	60	F. Form Completion		0		0			PRINT name of person completing form:		150	\N	462			19	t		Horizontal		t
1080	792	60			0		0			Date Follow-up Completion Form completed		150	\N	462			20	t				t
1081	797	61			0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Participant's ID</span></p></tr>	151	\N	472			1	t				t
1082	798	61	A. Study Follow-up Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1.   Did participant complete study follow-up?</span></p></tr>	151	\N	473			2	t		Horizontal		t
1083	799	61	B. Reason for not completing study follow-up		0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2.\t  Select the primary reason why participant did not complete study follow-</span></p></tr>	151	\N	474			3	t		Vertical		t
1084	800	61			0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a.   Specify the reason for your response above, if any.<strong>(only specify a reason here if requested in the response you chose)</strong></span></p></tr>	151	\N	475			4	f				t
1085	801	61			0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3.   Date study follow-up ended <strong>(refer to page 3 for guidance in choosing the appropriate date)</strong>:</span></p></tr>	151	\N	472			5	t				t
1086	802	61	C. Storage of blood specimens for pharmacogenomic testing		0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4.   Participant decision for storage of blood specimens for pharmacogenomic testing:</span></p></tr>	152	\N	476			6	t		Vertical		t
1087	803	61			0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5.  Storage withdrawal date:</span></p></tr>	152	\N	472			7	f				t
1088	804	61			0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6.   Reason for withdrawal of specimen storage:</span></p></tr>	152	\N	475			8	f				t
1089	805	61	D. Storage of blood specimens for future research		0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7.  Participant decision for storage of blood specimens for future research:</span></p></tr>	152	\N	477			9	t		Vertical		t
1090	806	61			0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8.  Storage withdrawal date:</span></p></tr>	152	\N	472			10	f				t
1091	807	61	E. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Comments:</span></p></tr>	152	\N	475			11	t				t
1092	808	61	F. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>PRINT name of person completing form::</span></p></tr>	152	\N	472			12	t				t
1093	809	61			0		0				&nbsp;&nbsp;<div name="undoradio"></div><tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Comments:</span></p></tr>	152	\N	472			13	t				t
1125	831	62			0		3				<div class="I_TIME">	154	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	32	f		Horizontal		t
1094	861	62	A. Visit Information		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Visit or date of blood specimen collection  <strong>(check one)</strong>:</span></p></tr><tr><p style=text-indent:40px; margin-bottom: 0px;><span>Study Evaluations</strong>:</span></p></tr>	153	\N	478			1	f				t
1095	823	62			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Date of Visit</strong>:</span></p></tr>	153	\N	479			2	f				f
1096	855	62	B. Reference Doses & Vomiting	PK reference dose must be preceded by two (2) directly observed study drug doses given approximately 24 and 48 hours prior to the reference dose.	0		1			<strong>1</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose A<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>	<div class="I_EXSD"><tr><br /><div style="text-indent:65px"><b>Date of Dose</b></tr>	153	\N	479			3	f				t
1097	854	62			0		2				<div class="I_EXS"><tr><br /><div style="text-indent:65px"><b>Time of Dose</b></tr>	153	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	4	f				t
1098	833	62			0		3				<tr><br /><div style="text-indent:50px"><b>Estimated Time</b></tr>	153	\N	480			5	f		Vertical		t
1099	860	62			0		4				<tr><br /><div style="text-indent:50px"><b>Vomiting</b></tr>	153	\N	481			6	f		Vertical		t
1100	856	62			0		1			<strong>2</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose B<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>	<div class="I_EXSD">	153	\N	479			7	f				t
1101	853	62			0		2				<div class="I_EXS">	153	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	8	f				t
1102	866	62			0		3					153	\N	482			9	f		Vertical		t
1103	835	62			0		4					153	\N	483			10	f		Vertical		t
1104	857	62			0		1			<strong>3</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose C<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>	<div class="I_EXSD">	153	\N	479			11	f				t
1105	859	62			0		2				<div class="I_EXS"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_EXS").parent().parent().find("input").css({\n        'width': '60px'\n    });    $(".I_EXSD").parent().parent().find("input").css({\n        'width': '85px'\n    });\n});  </script>	153	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	12	f				t
1106	832	62			0		3					153	\N	484			13	f		Vertical		t
1107	858	62			0		4					153	\N	485			14	f		Vertical		t
1108	848	62	C. Food & Alcohol Ingested		0		0				<tr><p><span>Participants enrolled in a bedaquiline-containing treatment arm should eat food within 1 hour before the administration of the reference dose.</span><br/>\n<span>Report the time and food eaten within 1 hour before to 1 hour after the administration of the reference dose.</span><br/>\n<span>If no food was eaten 1 hour before to 1 hour after the administration of the reference dose, report the date and time of the last meal ingested.</span></tr><tr><p><span><strong>Reference dose </strong></span></p></tr><tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>Food Consumed</strong></span></p></tr>	153	\N	485			15	f		Horizontal		t
1109	862	62	Food		0		0					153	\N	479			16	f				t
1110	822	62	Quantity		0		0					153	\N	479			17	f		Vertical		t
1111	863	62	Unit		0		0					153	\N	486			18	f		Vertical		t
1112	819	62	Time		0		0					153	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	19	f		Vertical		t
1113	838	62	Est. Time		0		0					153	\N	487			20	f		Vertical		t
1114	813	62			0		1				<div class="I_EXSD"><tr><br /><b>Last Meal</b></tr><tr><br /><div style="text-indent:65px"><b>Day</b></tr>	153	\N	479			21	f				t
1115	812	62			0		2				<div class="I_EXS"><tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Time</b></tr>	153	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	22	f				t
1116	820	62			0		3				<tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Est. Time</b></tr>	153	\N	488			23	f		Horizontal		t
1117	814	62			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Did participant abstain from alcohol for at least 48 hours prior to PK sampling?</span></p></tr>	153	\N	489			24	f		Horizontal		t
1118	816	62	1. PK sampling for participants assigned to receive Rifapentine (P)	Record sampling information 24+1 hour after most recent DOT study drug ingestion (reference dose #1), \n25 – 40 minutes post reference dose #2, and 5-8 hours post reference dose #2.	0		1			<strong>1a</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre ref. dose (t=-1)<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>	<tr><p style="text-align: center; width : 125px; height:30px; "><span><strong>Time Point</strong></span></p>	154	\N	490			25	f		Horizontal		t
1119	829	62			0		2				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Actual blood collection time</strong></p></tr>	154	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	26	f		Horizontal		t
1120	826	62			0		3				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time blood placed in centrifuge</strong></p></tr>	154	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	27	f		Horizontal		t
1121	825	62			0		4				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time plasma placed in -70°C freezer or below</strong></p></tr>	154	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	28	f		Horizontal		t
1122	865	62			0		5				<tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Blood collection to -70°C freezer time > 2 hrs</strong></p></tr>	154	\N	491			29	f		Horizontal		t
1123	837	62			0		1			<strong>1b</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Right before ref. dose (t=0) <br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		154	\N	492			30	f				t
1124	830	62			0		2				<div class="I_TIME">	154	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	31	f		Horizontal		t
1126	840	62			0		4				<div class="I_TIME">	154	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	33	f		Horizontal		t
1127	864	62			0		5					154	\N	493			34	f		Horizontal		t
1128	847	62			0		1			<strong>2c</strong><a href='javascript:void(0)' onmouseover='Tip("<br />3 hrs post ref. dose <br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		154	\N	492			35	f		Horizontal		t
1129	850	62			0		2				<div class="I_TIME">	154	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	36	f		Horizontal		t
1130	843	62			0		3				<div class="I_TIME">	154	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	37	f		Horizontal		t
1131	845	62			0		4				<div class="I_TIME"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_TIME").parent().parent().find("input").css({\n        'width': '60px'\n        \n    }); $(".I_TBTC").parent().parent().find("input").css({\n        'width': '70px'\n        \n    });\n});  </script>	154	\N	479	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	Error: Invalid Time Format HH:MM	38	f		Horizontal		t
1132	846	62			0		5					154	\N	494			39	f		Horizontal		t
1133	815	62	D. PK sampling (Continued)	2. Cryovial Label Numbers<br/><div style="text-indent:20px"><span>Report the TBTC Label Number exactly as written on the labels affixed to the aliquot cryovials.</span></div>	0		1			<strong>2a</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre ref. dose (t=-1)<br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		154	\N	495			40	f				t
1134	810	62			0		2				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	41	f				t
1135	811	62			0		3				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	42	f				t
1136	817	62			0		4				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	43	f				t
1137	818	62			0		5				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	44	f				t
1138	834	62			0		1			<strong>2b</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Right before ref. dose (t=0) <br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		154	\N	496			45	f				t
1139	842	62			0		2				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	46	f				t
1140	844	62			0		3				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	47	f				t
1141	849	62			0		4				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	48	f				t
1142	851	62			0		5				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	49	f				t
1143	836	62			0		1			<strong>2c</strong><a href='javascript:void(0)' onmouseover='Tip("<br />3 hrs post ref. dose <br />&nbsp;")' onmouseout='UnTip()'>&nbsp; (!)</a>		154	\N	496			50	f				t
1144	827	62			0		2				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	51	f				t
1145	821	62			0		3				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	52	f				t
1146	828	62			0		4				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	53	f				t
1147	824	62			0		5				<div class="I_TBTC"></div>	154	\N	479	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	54	f				t
1148	841	62	E. Comments		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Comments</span></p></tr>	154	\N	497			55	f				t
1149	852	62	F. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>name of person completing form:</span></p></tr>	154	\N	479			56	f				t
1150	839	62			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Form completed: </span></p></tr>	154	\N	479			57	f				t
2855	1161	96			0		0			Participant's ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	218	\N	1090			1	f				t
2856	1158	96	A. Study Treatment Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>1.   Did participant complete study treatment?</span></p></tr>	218	\N	1091			2	t		Vertical		t
3326	1446	109			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Site ID</span> </span></p></tr>	253	\N	1202			1	t				t
3327	1438	109			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Enrollment date</span> </span></p></tr>	253	\N	1202			2	t				t
3328	1454	109	A. Study Entry Enrollment		0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of birth:</span> </span></p></tr>	253	\N	1202			3	t				t
3329	1442	109			0		2				<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>&nbsp;</span> </span></p></tr>	253	\N	1203			4	f		Horizontal		t
3330	1433	109			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date participant or legal guardian signed informed consent</span> </span></p></tr>	253	\N	1202			5	t		Horizontal		t
2857	1160	96	B. Reason for Not Completing Study Treatment (Select ONE reason only)		0		0				<script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>\n<script>\njQuery(document).ready(function() {\nenableRadioMessage("#DEATHMessage", "DEATH");\n});jQuery(document).ready(function() {\nenableRadioMessage("#MYCOMessage", "SCREEN FAILURE");\n});jQuery(document).ready(function() {\nenableRadioMessage("#ADVERMessage", "ADVERSE EVENT");\n});\nfunction enableRadioMessage(containerId, value) {\n\tvar msgContainer = jQuery(containerId);\n\tvar radiosToCheck = msgContainer.parent().parent().find("input");\n\tradiosToCheck.change(function(){setMessage(radiosToCheck, msgContainer, value);});\n\tsetMessage(radiosToCheck, msgContainer, value);\n}\n\nfunction setMessage(radiosToCheck, msgContainer, value) {\n\tfor (var i = 0; i < radiosToCheck.length; i++) {\n\t\tif (radiosToCheck[i].checked) {\n\t\t\tvar valueToCheck = radiosToCheck[i].value;\n\t\t\tbreak;\n\t\t}\n\t}\n\tif (valueToCheck && (valueToCheck == value)){\n\t\tmsgContainer.show();\n\t}\n\telse {\n\t\tmsgContainer.hide();\n\t}\n}\n\n</script>\n<tr style="width:200px;white-space: nowrap">2 &nbsp;&nbsp;&nbsp; Select the <b><u>primary</u></b> reason why participant did not complete study treatment. Continue to follow participant, unless reason for not completing study treatment is followed by an asterisk (*)</tr><tr><p style=text-indent:140px; margin-bottom: 0px;>&nbsp;\n     <strong>\n       <div  id="DEATHMessage" style="display:none;">* (Complete Notification of Death Form)</div>\n\t   <div  id="MYCOMessage" style="display:none;">* (Complete Mycobacteriology Form)</div>\n\t   <div  id="ADVERMessage" style="display:none;">* (Complete Adverse Event Form)</div>\n\t</strong></p></tr>	218	\N	1092			3	t				t
2858	1155	96			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Specify Reason</span></p></tr>	218	\N	1093			4	t				f
2859	1152	96			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>3.   Date reason checked in Question 2 occurred: <strong><small>(refer to page 3 for guidance in choosing the appropriate date):</strong></small></span></p></tr>	218	\N	1090			5	t				t
2860	1153	96	C. Storage of blood specimens for pharmacogenomic testing		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1.   Participant decision for storage of blood specimens for pharmacogenomic testing:</span></p></tr>	219	\N	1094			6	t				t
2861	1149	96			0		0			DD-MMM-YYYY	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span><strong>2.   Storage withdrawal date:</strong></span></p></tr>	219	\N	1093			7	t				t
2862	1162	96			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>3.   Reason for withdrawal of specimen storage:</span></p></tr>	219	\N	1090			8	t				t
2863	1151	96	D. Storage of blood specimens for future research		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1.   Participant decision for storage of blood specimens for future research:</span></p></tr>	219	\N	1095			9	t				t
2864	1150	96			0		0			DD-MMM-YYYY	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>2.   Storage withdrawal date:</span></p></tr>	219	\N	1090			10	t				t
2865	1159	96			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>3.   Reason for withdrawal of specimen storage:</span></p></tr>	219	\N	1093			11	t				t
2866	1157	96	E. Comments		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span></span></p></tr>	220	\N	1093			12	t				t
2867	1156	96	F. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>PRINT name of person completing form:</span></p></tr>	220	\N	1090			13	t				t
2868	1154	96			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Treatment Completion Form completed:</span></p></tr>	220	\N	1090			14	t				t
3331	1436	109			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Date participant assent:</span> </span></p></tr>	253	\N	1202			6	t		Horizontal		t
3332	1443	109			0		2				<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>&nbsp;</span> </span></p></tr>	253	\N	1204		This is a required field	7	t		Horizontal		t
3333	1447	109			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Height:</span> </span></p></tr>	253	\N	1202		This is a required field	8	t		Horizontal		t
3334	1450	109			0		2				<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>&nbsp;</span> </span></p></tr>	253	\N	1205		This is a required field	9	t		Horizontal		t
3335	1439	109			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Weight:</span> </span></p></tr>	253	\N	1202		This is a required field	10	t		Horizontal		t
3336	1441	109			0		2				<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>&nbsp;</span> </span></p></tr>	253	\N	1206			11	t		Horizontal		t
3337	1453	109			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Date of weight: <b>(Cannot be more than 7 days prior to enrollment)</b></span></p></tr>	253	\N	1202		This is a required field	12	t		Horizontal		t
3338	1452	109			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Date of chest X-ray: </p><br><p style="text-indent:40px; font-weight: bold">(Alternative imaging techniques (e.g. CT or MRI) may NOT be used in place of a plain chest X-ray)</span> </span></p></tr>	253	\N	1202		This is a required field	13	t		Horizontal		t
3339	1449	109			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px;margin-bottom:0px;"> a. Any cavitation on chest X-ray: </span></p></tr>	253	\N	1207		This is a required field	14	t		Horizontal		t
3340	1448	109			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">7. Scheduled study treatment start date:</span></p></tr>	253	\N	1202		This is a required field	15	t		Horizontal		t
3341	1432	109	B. Comments		0		0					254	\N	1208			16	t		Horizontal		t
3342	1440	109	C. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">PRINT name of person completing form:</span></p></tr>	254	\N	1202			17	t		Horizontal		t
3343	1457	109			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Date Enrollment Form completed: </span></p></tr>	254	\N	1202		This is a required field	18	t		Horizontal		t
3344	1434	109	Treatment Assigment upon Successful Enrollment Submission		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Was there a successful enrollment submission? </span></p></tr>	255	\N	1207			19	t				t
3345	1455	109			0		0			Participant ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	255	\N	1202			20	t				f
3346	1445	109			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Assigned treatment arm (study kit medications)</span></p></tr>	255	\N	1209			21	t		Vertical		f
3347	1437	109		<strong>REMINDER</strong>: Vitamin B6 (pyridoxine), 25 or 50mg, <u>must be obtained locally</u> and be administered daliy by mouth with isoniazid	0		1			Medication		255	\N	1202			22	t		Vertical		f
3348	1444	109			0		2			Dose (mg)		255	\N	1202		This is a required field	23	t		Horizontal		f
3349	1451	109			0		3			Duration # of weeks		255	\N	1202		This is a required field	24	t		Horizontal		f
3350	1435	109			0		1			Medication		255	\N	1202			25	t		Vertical		f
3351	1458	109			0		2			Dose (mg)		255	\N	1202		This is a required field	26	t		Horizontal		f
3352	1456	109			0		3			Duration # of weeks		255	\N	1202		This is a required field	27	t		Horizontal		f
3353	1459	110			0		0			Participant ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	256	\N	1210			1	f				t
3354	1460	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Sequence ID</span></p></tr>	256	\N	1210			2	t				t
3355	1461	110	A. Adverse Event Description		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of AE status evaluated:</span></p></tr>	256	\N	1210			3	t				t
3356	1462	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Details of AE from its corresponding AE Form:</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Reportable AE:</span></p></tr>	256	\N	1210			4	t				t
3357	1463	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 6px">3. Is the <strong>FINAL</strong> reportable adverse event different from the initial event reported on the AE Form?</span>\n    <span style="margin-left: 25px; font-size: 12px;"><strong>(If a symptom was reported on the AE form but a diagnosis has now been assigned, select YES and report the diagnosis)</strong></span>\n  </p>\n</tr>	256	\N	1211			5	f		Horizontal		t
3358	1464	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If yes, specify:</span></p></tr>	256	\N	1212	func:  gt(200)	maximum number of characters 200	6	f				f
3359	1465	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 6px">4. Did the initial reportable event become a serious adverse event (SAE)?</span>\n    <span style="margin-left: 25px; font-size: 12px;"><strong>(an SAE requires that this form be submitted to CDC within 48 hours of site’s awareness of SAE and to local ethics committees as per local guidelines)</strong></span>\n  </p>\n</tr>	256	\N	1213			7	f		Horizontal		t
3360	1466	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Indicate type of SAE <span style="font-weight: bold">(select all that apply):</span> </span></p></tr>	256	\N	1214			8	f		Vertical		f
3361	1467	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 6px">b. Date event became an SAE:</span>\n    <span style="margin-left: 25px; font-size: 12px;"><strong>(Provide the date when the event worsened in seriousness to be an SAE)</strong></span>\n  </p>\n</tr>	256	\N	1210			9	f				f
3362	1468	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 6px">c.\tSite awareness date:</span>\n    <span style="margin-left: 25px; font-size: 12px;"><strong>(Provide the date when site staff were made aware that the event worsened)</strong></span>\n  </p>\n</tr>	256	\N	1210			10	f				f
3363	1469	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Status of the AE (check only one and provide date if indicated):</span></p></tr>	256	\N	1215			11	f		Vertical		t
3364	1470	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>Resolution Date/Death Date</span></p></tr>	256	\N	1210			12	f				t
3365	1471	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. In the opinion of the investigator, what is the final attribution to study treatment in causing this AE?</span></p></tr>	256	\N	1216			13	f		Horizontal		t
2913	1164	99			0		0			Participant's ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	227	\N	1111			1	f				t
2914	1165	99	A. Visit		0		0				&nbsp;&nbsp;\n<tr><p style="text-indent:17px; margin-bottom: 0px;"><span>Visit Missed <strong><small>(Indicate which scheduled visit was missed in A1, complete B1 then skip to Section D.)</small></strong></span></p></tr>	227	\N	1112			2	f		Horizontal		t
2915	1166	99			0		0				&nbsp;&nbsp;\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Week of evaluation <strong><small>(check one)</small></strong></span></p></tr>	227	\N	1113			3	f		Vertical		t
2916	1167	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date of visit:</span> </span></p></tr>	227	\N	1111			4	t		Horizontal		t
2917	1168	99	B. Evaluation (Since last study visit or during current visit and not previously reported)		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">1. Did participant take any TB medications?</span></p> <strong> (If "Yes", complete or update TB Drug Dose Record Form)</strong></tr>	228	\N	1114		This is a required field	5	t		Horizontal		t
2918	1169	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">2. Did participant report any changes in antiretroviral or non-TB/non-antiretroviral medications, including over-the-counter drugs?</span></p> <strong> (If "Yes", complete or update Concomitant Medication Form)</strong></tr>	228	\N	1114		This is a required field	6	t		Horizontal		t
2919	1170	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">3. Were any clinical evaluations <strong>(e.g., Chest X-ray, CT scan, MRI)</strong> performed?</span></p> <strong> (If "Yes", complete Clinical Evaluation Form)</strong></tr>	228	\N	1114		This is a required field	7	t		Horizontal		t
2920	1171	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">4. Were new laboratory tests ordered or are results available?</span></p> <strong> (If "Yes", complete Laboratory Evaluation Form)</strong></tr>	228	\N	1114		This is a required field	8	t		Horizontal		t
2921	1172	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">5. Were signs and symptoms assessed?</span></p> <strong> (If "Yes", complete Signs and Symptoms Form)</strong></tr>	228	\N	1114		This is a required field	9	t		Horizontal		t
2922	1173	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">6. Was sputum collection attempted or other specimen collected for AFB work-up?</span></p> <strong> (If "Yes", complete Mycobacteriology Form)</strong></tr>	228	\N	1114		This is a required field	10	t		Horizontal		t
2923	1174	99			119	ZNTERMMB	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px;margin-bottom:0px;">If "Yes", how many specimens were collected?</span></p></tr>	228	\N	1111	func:  gt(0)	This is a required field	11	t		Horizontal		t
2924	1175	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">7. Was sputum collected for RS ratio essay?</span></p> <strong> (If "Yes", complete Mycobacteriology Form)</strong></tr>	228	\N	1114		This is a required field	12	t		Horizontal		t
2925	1176	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">8. Was a specimen for pharmacogenomics testing collected?</span></p> <strong> (If "Yes", complete Pharmacogenomic Blood Sample Form)</strong></tr>	228	\N	1115		This is a required field	13	t		Horizontal		t
2926	1177	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">9. Was a specimen for biomarker analysis collected? <strong> (i.e., blood)</strong></span></p></tr>	228	\N	1115		This is a required field	14	t		Horizontal		t
2927	1178	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">10. Were TB drug sparse PK specimens collected?<strong> (If "Yes", complete TB Drug Sparse PK Form)</strong></span></p></tr>	228	\N	1116		This is a required field	15	t		Horizontal		t
2928	1179	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">11. Were TB drug intensive pK specimens collected?<strong> (If "Yes", complete TB Drug Intensive PK Form)</strong></span></p></tr>	228	\N	1116		This is a required field	16	t		Horizontal		t
2929	1180	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">12. Has the participant been newly diagnosed as being pregnant?<strong> (If "Yes", report pregnancy test result on Laboratory Evaluation Form and complete Adverse Event Form)</strong></span></p></tr>	228	\N	1117		This is a required field	17	t		Horizontal		t
2930	1181	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">13. Were any modifications made to the assigned study TB treatment?<strong> (If "Yes", complete Treatment Change Form)</strong></span></p></tr>	228	\N	1114		This is a required field	18	t		Horizontal		t
2931	1182	99	C. Study Treatment Status		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">1. What is the participant's current study treatment status <strong><small>(check one)</small></strong>?</span></p></tr>	229	\N	1118		This is a required field	19	t		Vertical		t
2932	1183	99	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;"> </span></p></tr>	229	\N	1119			20	f		Horizontal		t
2933	1184	99	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">PRINT name of person completing form:</span></p></tr>	229	\N	1111			21	f		Horizontal		t
2934	1185	99			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Date Treatment Evaluation Form completed:</span></p></tr>	229	\N	1111			22	f		Horizontal		t
3366	1472	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. select the study drug(s) to which the AE is attributed:</span></p></tr>	256	\N	1217			14	f				f
3367	1473	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. In the opinion of the investigator, is this an anticipated or unanticipated AE?</span></p></tr>	256	\N	1218			15	f		Horizontal		t
3368	1474	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Indicate the maximum toxicity grade during the course of the AE</span></p></tr>	256	\N	1219			16	f		Horizontal		t
3369	1475	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Were any additional assessment, evaluations or tests done in response to this AE:</span></p></tr><tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Laboratory evaluations</span></p></tr>	257	\N	1211			17	f		Horizontal		t
3370	1476	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Clinical evaluations</span></p></tr>	257	\N	1211			18	f		Horizontal		t
3371	1477	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Signs and symptoms assessment</span></p></tr>	257	\N	1211			19	f		Horizontal		t
3372	1478	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Sputum or other specimen collected for TB diagnostic workup</span></p></tr>	257	\N	1211			20	f		Horizontal		t
3373	1479	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Was all or any part of study treatment held for any period of time? </span></p></tr>	257	\N	1211			21	f		Horizontal		t
3374	1480	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Was the participant re-challenged with the intention of restarting study treatment?</span></p></tr>	257	\N	1211			22	f		Horizontal		t
3375	1481	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Was study treatment permanently discontinued as a result of this AE?</span></p></tr>	257	\N	1211			23	f		Horizontal		t
3376	1482	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Summary of current AE status</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Use the SOAP (Subjective, Objective, Analysis, and Plan) format for a brief clinical description</span></p></tr>	258	\N	1212	func:  gt(3500)	maximum number of characters 3500	24	f				t
3377	1483	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. If applicable, specify how long after the onset date did the AE resolved (hours, days, weeks):</span></p></tr>	258	\N	1212	func:  gt(500)	maximum number of characters 500	25	f				t
3378	1484	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Did the participant present with signs and symptoms similar to those reported in this AE report, but of lower toxicity grade, prior to this AE?</span></p></tr>	258	\N	1212	func:  gt(500)	maximum number of characters 500	26	f				t
3379	1485	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Pregnancy outcome</span></p></tr>	259	\N	1220			27	f		Vertical		t
3380	1486	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. were any congenital anomalies present?</span></p></tr>	259	\N	1211			28	f		Horizontal		f
3381	1487	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. What was the gestational age at pregnancy outcome?</span></p></tr>	259	\N	1210			29	f				t
3382	1488	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Date of pregnancy outcome:</span></p></tr>	259	\N	1210			30	f				t
3383	1489	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of Principal Investigator or Co-PI:</span></p></tr>	260	\N	1210			31	f				t
3384	1490	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	260	\N	1210			32	f				t
3385	1491	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form completed:</span></p></tr>	260	\N	1210			33	f				t
3386	1492	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Final MedDRA Lower Level Term Code:&nbsp;&nbsp;<a href="#" class="btn primary" onClick="openNewWindow('includes/meddra/meddra-browser-api.jsp','dnote_win','directories=no,location=no,menubar=no,scrollbars=yes,toolbar=no,status=no,resizable=yes','dnote'); return false;">medDra Access</a></span></p></tr><div id="I_ZFLLTCD"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     window.addEventListener('message', function(event) {\n      const rowData = event.data;\n      var medCode = $("#I_ZFLLTCD").parent().parent().find("input"); \n\t  var medName =$("#I_ZFLLT").parent().parent().find("input");\n\t  medCode.val(rowData.code);\n\t  medCode.change();\n\t  medName.val(rowData.name);\n\t  medName.change();\n      console.log("Valor seleccionado: " + rowData.code + " " + rowData.name);\n     \n    });\n  </script>\n  <style>\n     .btn {\n      border: none; \n      cursor: pointer;  font-size: 11px;\n      text-decoration: none;\n    }\n  </style>\n</head>\n<body>	261	\N	1210			34	f				t
3387	1493	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Final MedDRA Lower Level Term Description:</span></p></tr><div id="I_ZFLLT"></div>	261	\N	1210			35	f				t
3388	1494	110			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Safety officer providing MedDRA code:</span></p></tr>	261	\N	1210			36	f				t
5604	3741	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Past personal experience of traumatic event(s):</span></p></tr>	493	\N	2087			18	t		Horizontal		t
2058	940	81	A. Visit Information		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Visit or date of blood specimen collection  <strong>(check one)</strong>:</span></p></tr><tr><p style=text-indent:40px; margin-bottom: 0px;><span>Study Evaluations</strong>:</span></p></tr>	189	\N	821			1	t				t
2059	941	81			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Date of Visit</strong>:</span></p></tr>	189	\N	822			2	t				f
2060	942	81	B. Transport/Shipping		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Date aliquots shipped to analysis laboratory or central storage facility:</span></p></tr>	189	\N	822			3	t				t
2061	943	81			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>2. Aliquots collected for which type of sampling</span></p></tr><tr><p style=text-indent:40px; margin-bottom: 0px;><strong>Select only one; if aliquots are being shipped from several collection activities (e.g., separate sparse samplings, intensive sampling and sparse sampling) a separate shipping form is required for each collection and must be associated with the appropriate PK sampling form.</strong></p></tr>	189	\N	823			4	t				t
2062	944	81	C. Study 38 TB Drug Sparse PK Cryovial Label Numbers	Report the TBTC Label Numbers exactly as written on the labels affixed to the aliquot cryovials.\nIf sampling was not conducted at a given time point, select Not Done for that time point.\nWhen this section is complete, skip to Section E.	0		1			<div class="I_TBTCLBL"></div><strong>1a</strong> Pre ref. dose	<div class="I_TBTC"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script> <script>\n     $(document).ready(function() {\n          $(".I_TBTC").parent().parent().find("input").css({ 'width': '70px'}); $(".I_TBTCLBL").parent().css({ 'width': '130px'});$(".I_TBTCLBLS").parent().css({ 'width': '40px'});$(".I_TBTCLBLSM").parent().css({ 'width': '35px'});\n});  </script>	189	\N	822	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	5	f				t
2063	945	81			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	6	f				t
2064	946	81			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	7	f				t
2065	947	81			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	8	f				t
2066	948	81			0		1			<div class="I_TBTCLBL"></div><strong>1b</strong> Right before ref. dose	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	9	f				t
2067	949	81			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	10	f				t
2068	950	81			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	11	f				t
2069	951	81			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	12	f				t
2070	952	81			0		1			<div class="I_TBTCLBL"></div><strong>1c</strong> 3 hrs post ref. dose	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	13	f				t
2071	953	81			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	14	f				t
2072	954	81			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	15	f				t
2073	955	81			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	16	f				t
2074	956	81	D. Study 38 PK/PD TB Drug Intensive PK Cryovial Label Numbers	Report the TBTC Label Numbers exactly as written on the labels affixed to the aliquot cryovials.\nIf sampling was not conducted at a given time point, select ‘Not Done’ for that time point.\nWhen this section is complete, skip to Section E.	0		1			<div class="I_TBTCLBL"></div><strong>1a</strong> Pre ref. dose	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	17	f				t
2075	957	81			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	18	f				t
2076	958	81			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	19	f				t
2077	959	81			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	20	f				t
2078	960	81			0		1			<div class="I_TBTCLBL"></div><strong>1b</strong> 1hr post ref. dose	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}1[0-9]{1}/	Error: Invalid TBTC Label Number ####1#	21	f				t
2079	961	81			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}1[0-9]{1}/	Error: Invalid TBTC Label Number ####1#	22	f				t
2080	962	81			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}1[0-9]{1}/	Error: Invalid TBTC Label Number ####1#	23	f				t
2081	963	81			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}1[0-9]{1}/	Error: Invalid TBTC Label Number ####1#	24	f				t
2082	964	81			0		1			<div class="I_TBTCLBL"></div><strong>1c</strong> 2hrs post ref. dose	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}2[0-9]{1}/	Error: Invalid TBTC Label Number ####2#	25	f				t
2083	965	81			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}2[0-9]{1}/	Error: Invalid TBTC Label Number ####2#	26	f				t
2084	966	81			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}2[0-9]{1}/	Error: Invalid TBTC Label Number ####2#	27	f				t
2085	967	81			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}2[0-9]{1}/	Error: Invalid TBTC Label Number ####2#	28	f				t
2086	968	81			0		1			<div class="I_TBTCLBL"></div><strong>1d</strong> 4hrs post ref. dose	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}4[0-9]{1}/	Error: Invalid TBTC Label Number ####4#	29	f				t
2957	1164	101			0		0			Participant's ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	233	\N	1129			1	f				t
2958	1165	101	A. Visit		0		0				&nbsp;&nbsp;\n<tr><p style="text-indent:17px; margin-bottom: 0px;"><span>Visit Missed <strong><small>(Indicate which scheduled visit was missed in A1, complete B1 then skip to Section D.)</small></strong></span></p></tr>	233	\N	1130			2	f		Horizontal		t
2959	1166	101			0		0				&nbsp;&nbsp;\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Week of evaluation <strong><small>(check one)</small></strong></span></p></tr>	233	\N	1131			3	f		Vertical		t
2960	1167	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Date of visit:</span> </span></p></tr>	233	\N	1129			4	t		Horizontal		t
2961	1168	101	B. Evaluation (Since last study visit or during current visit and not previously reported)		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">1. Did participant take any TB medications?</span></p> <strong> (If "Yes", complete or update TB Drug Dose Record Form)</strong></tr>	234	\N	1132		This is a required field	5	t		Horizontal		t
2087	969	81			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}4[0-9]{1}/	Error: Invalid TBTC Label Number ####4#	30	f				t
2088	970	81			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}4[0-9]{1}/	Error: Invalid TBTC Label Number ####4#	31	f				t
2089	971	81			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}4[0-9]{1}/	Error: Invalid TBTC Label Number ####4#	32	f				t
2090	972	81			0		1			<div class="I_TBTCLBL"></div><strong>1e</strong> 6hrs post ref. dose	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}6[0-9]{1}/	Error: Invalid TBTC Label Number ####6#	33	f				t
2091	973	81			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}6[0-9]{1}/	Error: Invalid TBTC Label Number ####6#	34	f				t
2092	974	81			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}6[0-9]{1}/	Error: Invalid TBTC Label Number ####6#	35	f				t
2093	975	81			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}6[0-9]{1}/	Error: Invalid TBTC Label Number ####6#	36	f				t
2094	976	81			0		1			<div class="I_TBTCLBL"></div><strong>1f</strong> 8-12hrs post ref. dose	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}12[0-9]{1}/	Error: Invalid TBTC Label Number ####12#	37	f				t
2095	977	81			0		2			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}12[0-9]{1}/	Error: Invalid TBTC Label Number ####12#	38	f				t
2096	978	81			0		3			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}12[0-9]{1}/	Error: Invalid TBTC Label Number ####12#	39	f				t
2097	979	81			0		4			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}12[0-9]{1}/	Error: Invalid TBTC Label Number ####12#	40	f				t
2098	980	81			0		1			<div class="I_TBTCLBL"></div><strong>1g</strong> 24hrs post ref. dose	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}24[0-9]{1}/	Error: Invalid TBTC Label Number ####24#	41	f				t
2099	981	81			0		2			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}24[0-9]{1}/	Error: Invalid TBTC Label Number ####24#	42	f				t
2100	982	81			0		3			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}24[0-9]{1}/	Error: Invalid TBTC Label Number ####24#	43	f				t
2101	983	81			0		4			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	189	\N	822	regexp: /[0-9]{4}24[0-9]{1}/	Error: Invalid TBTC Label Number ####24#	44	f				t
2102	984	81	E. Specimen Shipping Conditions		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Were specimens frozen prior to shipping?</span></p></tr>	189	\N	824			45	t		Horizontal		t
2103	985	81			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:35px; margin-bottom: 0px;><span>a. If “yes”, did the specimens thaw before shipping? </span></p></tr>	189	\N	825			46	t		Horizontal		f
2104	986	81			0		1				<tr><p style=text-indent:45px; margin-bottom: 0px;><span>If “yes”, provide the following</span></p></tr><tr><p style=text-indent:45px; margin-bottom: 0px;><span>1. Amount of time thawed</span></p></tr>	189	\N	826			47	f				f
2105	987	81			0		2				<div class="I_TBTC"></div><tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr><tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	189	\N	822			48	f				f
2106	988	81			0		3				<tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr><tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	189	\N	827			49	f		Horizontal		f
2107	989	81			0		0				<tr><p style=text-indent:45px; margin-bottom: 0px;><span>2. Extent thawed:</span></p></tr>	189	\N	828			50	f		Horizontal		f
2108	990	81	E. Comments		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Comments</span></p></tr>	189	\N	829			51	f				t
2109	991	81	F. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>name of person completing form:</span></p></tr>	189	\N	822			52	f				t
2110	992	81			0		0			<style type="text/css">.aka_text_block{width:20px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Form completed: </span></p></tr>	189	\N	822			53	f				t
2962	1169	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">2. Did participant report any changes in antiretroviral or non-TB/non-antiretroviral medications, including over-the-counter drugs?</span></p> <strong> (If "Yes", complete or update Concomitant Medication Form)</strong></tr>	234	\N	1132		This is a required field	6	t		Horizontal		t
2963	1170	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">3. Were any clinical evaluations <strong>(e.g., Chest X-ray, CT scan, MRI)</strong> performed?</span></p> <strong> (If "Yes", complete Clinical Evaluation Form)</strong></tr>	234	\N	1132		This is a required field	7	t		Horizontal		t
2964	1171	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">4. Were new laboratory tests ordered or are results available?</span></p> <strong> (If "Yes", complete Laboratory Evaluation Form)</strong></tr>	234	\N	1132		This is a required field	8	t		Horizontal		t
2965	1172	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">5. Were signs and symptoms assessed?</span></p> <strong> (If "Yes", complete Signs and Symptoms Form)</strong></tr>	234	\N	1132		This is a required field	9	t		Horizontal		t
2966	1173	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">6. Was sputum collection attempted or other specimen collected for AFB work-up?</span></p> <strong> (If "Yes", complete Mycobacteriology Form)</strong></tr>	234	\N	1132		This is a required field	10	t		Horizontal		t
2967	1174	101			119	ZNTERMMB	0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px;margin-bottom:0px;">If "Yes", how many specimens were collected?</span></p></tr>	234	\N	1129	func:  gt(0)	This is a required field	11	t		Horizontal		t
2968	1190	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">7. Was sputum collected for RS ratio essay?</span></p> <strong> (If "Yes", complete Mycobacteriology Form)</strong></tr>	234	\N	1132		This is a required field	12	t		Horizontal		t
2969	1189	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">8. Was a specimen for pharmacogenomics testing collected?</span></p> <strong> (If "Yes", complete Pharmacogenomic Blood Sample Form)</strong></tr>	234	\N	1133		This is a required field	13	t		Horizontal		t
2970	1187	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">9. Was a specimen for biomarker analysis collected? <strong> (i.e., blood)</strong></span></p></tr>	234	\N	1134		This is a required field	14	t		Horizontal		t
2971	1178	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">10. Were TB drug sparse PK specimens collected?<strong> (If "Yes", complete TB Drug Sparse PK Form)</strong></span></p></tr>	234	\N	1135		This is a required field	15	t		Horizontal		t
2972	1188	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">11. Were TB drug intensive pK specimens collected?<strong> (If "Yes", complete TB Drug Intensive PK Form)</strong></span></p></tr>	234	\N	1136		This is a required field	16	t		Horizontal		t
2973	1186	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">12. Has the participant been newly diagnosed as being pregnant?<strong> (If "Yes", report pregnancy test result on Laboratory Evaluation Form and complete Adverse Event Form)</strong></span></p></tr>	234	\N	1137		This is a required field	17	t		Horizontal		t
2974	1181	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">13. Were any modifications made to the assigned study TB treatment?<strong> (If "Yes", complete Treatment Change Form)</strong></span></p></tr>	234	\N	1132		This is a required field	18	t		Horizontal		t
2975	1182	101	C. Study Treatment Status		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">1. What is the participant's current study treatment status <strong><small>(check one)</small></strong>?</span></p></tr>	235	\N	1138		This is a required field	19	t		Vertical		t
2976	1183	101	D. Comments		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;"> </span></p></tr>	235	\N	1139			20	f		Horizontal		t
2977	1184	101	E. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">PRINT name of person completing form:</span></p></tr>	235	\N	1129			21	f		Horizontal		t
2978	1185	101			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Date Treatment Evaluation Form completed:</span></p></tr>	235	\N	1129			22	f		Horizontal		t
3171	1364	105			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}6[0-9]{1}/	Error: Invalid TBTC Label Number ####6#	34	f				t
3172	1362	105			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}6[0-9]{1}/	Error: Invalid TBTC Label Number ####6#	35	f				t
3173	1374	105			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}6[0-9]{1}/	Error: Invalid TBTC Label Number ####6#	36	f				t
3174	1353	105			0		1			<div class="I_TBTCLBL"></div><strong>1f</strong> 8-12hrs post ref. dose	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}12[0-9]{1}/	Error: Invalid TBTC Label Number ####12#	37	f				t
3175	1352	105			0		2			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}12[0-9]{1}/	Error: Invalid TBTC Label Number ####12#	38	f				t
3176	1351	105			0		3			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}12[0-9]{1}/	Error: Invalid TBTC Label Number ####12#	39	f				t
3177	1350	105			0		4			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}12[0-9]{1}/	Error: Invalid TBTC Label Number ####12#	40	f				t
3178	1393	105			0		1			<div class="I_TBTCLBL"></div><strong>1g</strong> 24hrs post ref. dose	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}24[0-9]{1}/	Error: Invalid TBTC Label Number ####24#	41	f				t
3179	1392	105			0		2			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}24[0-9]{1}/	Error: Invalid TBTC Label Number ####24#	42	f				t
3180	1391	105			0		3			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}24[0-9]{1}/	Error: Invalid TBTC Label Number ####24#	43	f				t
5605	3716	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:50px; margin-bottom: 0px;"><span>If yes, please specify the event(s):</span></p></tr>	493	\N	2080			19	t	1. \n2. \n3. \n4. \n5.			f
5606	3753	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Unintended mental status changes induced by specific medications or substances</span></p></tr>	493	\N	2087			20	t		Horizontal		t
5607	3745	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 50px; margin-bottom: 11px">If yes, please specify medication and mental status change</span>\n     </br><span style="margin-left: 53px; font-size: 9px;"><strong>(If participant is currently taking medication, complete Concomitant Medication Form):</strong></span>\n  </p>\n</tr>	493	\N	2080			21	t	1. \n2. \n3. \n4. \n5.			f
5608	3729	148	A. Participant History (continued)		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Cigarette use</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>a. Has participant ever smoked tobacco? </span></p></tr>	494	\N	2088			22	t		Vertical		t
5609	3712	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>b. Total duration of tobacco use: </span></p></tr>	494	\N	2089			23	t		Horizontal		t
5610	3724	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:50px; margin-bottom: 0px;"><span>Unit: </span></p></tr>	494	\N	2090			24	f		Horizontal		t
5611	3721	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:50px; margin-bottom: 0px;"><span>Amount: </span></p></tr>	494	\N	2074			25	t				t
5612	3717	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>c. Number of cigarettes currently or formerly smoked per day: </span></p></tr>	494	\N	2091			26	t		Horizontal		t
5613	3722	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>d. Time since participant quit smoking: </span></p></tr>	494	\N	2092			27	f		Horizontal		t
5614	3693	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:50px; margin-bottom: 0px;"><span>Unit: </span></p></tr>	494	\N	2090			28	f		Horizontal		t
5615	3760	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:50px; margin-bottom: 0px;"><span>Amount: </span></p></tr>	494	\N	2074			29	t				t
5616	3730	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Karnofsky score: </span></p></tr>	494	\N	2074			30	t		Horizontal		t
5617	3699	148	B. Tuberculosis (TB) History and Treatment		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">1. Was the participant ever treated for active TB prior to this episode?</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “No” or “Unknown”, skip to B2)</strong></span>\n  </p>\n</tr>	495	\N	2093			31	t		Horizontal		t
2749	1073	93			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Participant's ID</strong>:</span></p></tr>	212	\N	1050			1	f				t
2750	867	93	A. Visit Information		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Visit or date of blood specimen collection  <strong>(check one)</strong>:</span></p></tr><tr><p style=text-indent:40px; margin-bottom: 0px;><span>Study Evaluations</strong>:</span></p></tr>	212	\N	1051			2	f				t
2751	868	93			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Date of Visit</strong>:</span></p></tr>	212	\N	1050			3	f				f
2752	1083	93	B. Reference Doses & Vomiting	PK reference dose <strong>must</strong> be preceded by two (2) directly observed study drug doses given approximately 24 and 48 hours prior to the reference dose.	0		1			<strong>1</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose A<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_EXSD"><tr><br /><div style="text-indent:65px"><b>Date of Dose</b></tr>	212	\N	1050			4	f				t
2753	1064	93			0		2				<div class="I_EXS"><tr><br /><div style="text-indent:65px"><b>Time of Dose</b></tr>	212	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	5	f				t
2754	1095	93			0		3				<tr><br /><div style="text-indent:50px"><b>Estimated Time</b></tr>	212	\N	1052			6	f		Vertical		t
2755	1088	93			0		4				<tr><br /><div style="text-indent:50px"><b>Vomiting<a href='javascript:void(0)' onmouseover='Tip("<br />Vomiting within 2 hours <br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a></b></tr>	212	\N	1053			7	f		Vertical		t
2756	1082	93			0		1			<strong>2</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose B<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_EXSD">	212	\N	1050			8	f				t
2757	1061	93			0		2				<div class="I_EXS">	212	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	9	f				t
2758	1093	93			0		3					212	\N	1054			10	f		Vertical		t
2759	1087	93			0		4					212	\N	1055			11	f		Vertical		t
2760	1072	93			0		1			<strong>3</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Reference dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_EXSD">	212	\N	1050			12	f				t
2761	1062	93			0		2				<div class="I_EXS"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_EXS").parent().parent().find("input").css({\n        'width': '60px'\n    });    $(".I_EXSD").parent().parent().find("input").css({\n        'width': '85px'\n    });\n});  </script>	212	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	13	f				t
2762	1092	93			0		3					212	\N	1056			14	f		Vertical		t
2764	881	93	C. Food & Alcohol Ingested		0		0				<tr>\n  <p style="margin-bottom: 0px;">\n    <span style="display: block; text-indent: 7px;">Participants enrolled in a bedaquiline-containing treatment arm should eat food within 1 hour before the administration of the reference dose.</span>\n    <span style="display: block; text-indent: 7px;">Report the time and food eaten within 1 hour before to 1 hour after the administration of the reference dose.</span>\n    <span style="display: block; text-indent: 7px;">If no food was eaten 1 hour before to 1 hour after the administration of the reference dose, report the date and time of the last meal ingested.</span>\n  </p>\n</tr></span></tr><tr><p style=text-indent:7px; margin-bottom: 0px;><span><strong><u>Reference dose</u></strong></span></p></tr><tr><p style=text-indent:0px; margin-bottom: 0px;><span style="display: block; text-indent: 35px;"><strong>Food Consumed</strong></span><span style="display: block; text-indent: 35px; color: #0047AB;"><small>If No or Unknown, skip to “Last Meal”</small></span></p></tr>	212	\N	1057			16	f		Horizontal		t
2765	882	93	Food		0		0					212	\N	1050			17	f				t
2766	883	93	Quantity		0		0					212	\N	1050			18	f		Vertical		t
2767	884	93	Unit		0		0					212	\N	1058			19	f		Vertical		t
2768	1099	93	Time		0		0					212	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	20	f		Vertical		t
2769	1071	93	Est. Time		0		0					212	\N	1059			21	f		Vertical		t
2770	1060	93			0		1				<div class="I_EXSD"><tr><br /><b>Last Meal</b></tr><tr><br /><div style="text-indent:65px"><b>Day</b></tr>	212	\N	1050			22	f				t
2771	1100	93			0		2				<div class="I_EXS"><tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Time</b></tr>	212	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	23	f				t
2772	1074	93			0		3				<tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Est. Time</b></tr>	212	\N	1060			24	f		Horizontal		t
2773	1085	93			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Did participant abstain from alcohol for at least 48 hours prior to PK sampling?</span></p></tr>	212	\N	1061			25	f		Horizontal		t
2774	1089	93	1. PK sampling for participants assigned to receive Rifapentine (P)	Record sampling information 24+1 hour after most recent DOT study drug ingestion (reference dose #1), \n25 – 40 minutes post reference dose #2, and 5-8 hours post reference dose #2.	0		1			<strong>1a</strong>\n<a href='javascript:void(0)' onmouseover='Tip("<br />Pre ref. dose (t=-1)<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<tr><p style="text-align: center; width : 125px; height:30px; "><span><strong>Time Point</strong></span></p>	213	\N	1062			26	f		Horizontal		t
2775	1098	93			0		2				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Actual blood collection time</strong></p></tr>	213	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	27	f		Horizontal		t
2776	1097	93			0		3				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time blood placed in centrifuge</strong></p></tr>	213	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	28	f		Horizontal		t
2777	1096	93			0		4				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time plasma placed in -70°C freezer or below</strong></p></tr>	213	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	29	f		Horizontal		t
2778	1076	93			0		5				<tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Blood collection to -70°C freezer time > 2 hrs</strong><a href='javascript:void(0)' onmouseover='Tip("<br />if Yes, provide Comment in Section E<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a></p></tr>	213	\N	1063			30	f		Horizontal		t
2779	1090	93			0		1			<strong>1b</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Right before ref. dose (t=0)<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		213	\N	1064			31	f				t
2780	1059	93			0		2				<div class="I_TIME">	213	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	32	f		Horizontal		t
2781	1058	93			0		3				<div class="I_TIME">	213	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	33	f		Horizontal		t
2782	1057	93			0		4				<div class="I_TIME">	213	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	34	f		Horizontal		t
2783	1077	93			0		5					213	\N	1065			35	f		Horizontal		t
2784	1091	93			0		1			<strong>1c</strong><a href='javascript:void(0)' onmouseover='Tip("<br />3 hrs (post ref. dose) <br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		213	\N	1064			36	f		Horizontal		t
2785	1068	93			0		2				<div class="I_TIME">	213	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	37	f		Horizontal		t
2786	1070	93			0		3				<div class="I_TIME">	213	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	38	f		Horizontal		t
2787	1069	93			0		4				<div class="I_TIME"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_TIME").parent().parent().find("input").css({\n        'width': '60px'\n        \n    }); $(".I_TBTC").parent().parent().find("input").css({\n        'width': '70px'\n        \n    });\n});  </script>	213	\N	1050	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	39	f		Horizontal		t
2788	1075	93			0		5					213	\N	1066			40	f		Horizontal		t
2789	1056	93	2. Cryovial Label Numbers	Report the TBTC Label Number <strong>exactly</strong> as written on the labels affixed to the aliquot cryovials.	0		1			<strong>2a</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre ref. dose (t=-1)<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		213	\N	1067			41	f				t
2790	1055	93			0		2				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	42	f				t
2791	1054	93			0		3				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	43	f				t
2792	1053	93			0		4				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	44	f				t
2793	1052	93			0		5				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	45	f				t
2794	1094	93			0		1			<strong>2b</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Right before ref. dose (t=0)<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		213	\N	1068			46	f				t
2795	1067	93			0		2				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	47	f				t
2796	1066	93			0		3				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	48	f				t
2797	1065	93			0		4				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	49	f				t
2798	1063	93			0		5				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	50	f				t
2799	1084	93			0		1			<strong>2c</strong><a href='javascript:void(0)' onmouseover='Tip("<br />3 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		213	\N	1068			51	f				t
2800	1081	93			0		2				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 3 #.	52	f				t
2801	1080	93			0		3				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 3 #.	53	f				t
2802	1079	93			0		4				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 3 #.	54	f				t
2803	1078	93			0		5				<div class="I_TBTC"></div>	213	\N	1050	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 3 #.	55	f				t
2804	921	93	E. Comments		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Comments</span></p></tr>	213	\N	1069			56	f				t
2805	922	93	F. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>PRINT name of person completing form:</span></p></tr>	213	\N	1050			57	f				t
2806	923	93			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Form completed: </span></p></tr>	213	\N	1050			58	f				t
5618	3704	148			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>a. If 'yes', what were the most recent month and year <b>(e.g., JAN-2021)<b> of diagnosis?</span></p></tr>	495	\N	2074			32	t				f
5619	3763	148			0		2				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span> </span></p></tr>	495	\N	2094			33	f				t
5620	3752	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>b. Did participant complete prescribed TB treatment?   </span></p></tr>	495	\N	2095			34	f		Horizontal		t
5621	3711	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Does participant currently have extrapulmonary TB?</span></p></tr>	495	\N	2096			35	f		Horizontal		t
5622	3697	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:30px; margin-bottom: 0px;"><span>If 'yes', specify the system organ class for each extrapulmonary site :</span></p></tr>	495	\N	2097			36	t				f
5623	3726	148	C. Concomitant Diagnoses at the Time of TB Diagnosis		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">1. Liver disease</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “No” or “Unknown”, skip to C2)</strong></span>\n  </p>\n</tr>	496	\N	2098			37	t		Horizontal		t
5624	3702	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Hepatitis B:</span></p></tr>	496	\N	2099			38	t		Horizontal		t
5625	3703	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Hepatitis C:</span></p></tr>	496	\N	2100			39	t		Horizontal		t
5626	3723	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Hepatitis (Type unknown):</span></p></tr>	496	\N	2101			40	t		Horizontal		t
5627	3749	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>e. Hepatitis due to alcohol use:</span></p></tr>	496	\N	2102			41	t		Horizontal		t
5628	3755	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 40px; margin-bottom: 11px">Other: </span>\n     </br><span style="margin-left: 53px; font-size: 9px;"><strong>(Specify in C6, as applicable) </strong></span>\n  </p>\n</tr>	496	\N	2103			42	t		Horizontal		t
5629	3715	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">2. Diabetes</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “No” or “Unknown”, skip to C3)</strong></span>\n  </p>\n</tr></strong></span>\n  </p>\n</tr>	496	\N	2104			43	t		Horizontal		t
5630	3742	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Specify diabetes type:</span></p></tr>	496	\N	2105			44	t		Horizontal		t
5631	3762	148			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. What year was diabetes diagnosed?</span></p></tr>	496	\N	2074			45	f				t
5632	3757	148			0		2					496	\N	2106			46	f				t
5633	3713	148			0		3					496	\N	2107			47	f				t
5634	3754	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Medical records confirming diabetes diagnosis available?</span></p></tr>	496	\N	2108			48	t		Horizontal		t
5635	3750	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 40px; margin-bottom: 11px">d. Was the participant taking any antidiabetic medications in the 14 days prior to study treatment start date?</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “yes,” list on Concomitant Medications form)</strong></span>\n  </p>\n</tr>	496	\N	2109			49	t		Horizontal		t
5636	3694	148	C. Concomitant Diagnoses at the Time of TB Diagnosis (continued)		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Peripheral neuropathy:</span></p></tr>	497	\N	2110			50	t		Horizontal		t
5637	3701	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">4. Cancer</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “No” or “Unknown”, skip to C5)</strong></span>\n  </p>\n</tr>	497	\N	2111			51	t		Horizontal		t
5638	3764	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If “yes”, specify: </span></p></tr>	497	\N	2080			52	t				f
5639	3739	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">5. Cardiac conditions</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “No” or “Unknown”, skip to C6)</strong></span>\n  </p>\n</tr></strong></span>\n  </p>\n</tr>	497	\N	2112			53	t		Horizontal		t
5640	3710	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If “yes”, specify: </span></p></tr>	497	\N	2080			54	t				f
5641	3725	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Other concomitant diagnoses, including any current/active mental illness or problems:</span></p></tr>	497	\N	2080			55	f	a.\nb.\nc.\nd.\ne.			t
5642	3718	148	D. HIV Infection History		0		0					498	\N	2113			56	f				t
5643	3714	148			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. What year was the participant first documented as HIV-positive?</span></p></tr>	498	\N	2074			57	t				t
5644	3761	148			0		2					498	\N	2114			58	f				t
5645	3720	148			0		3					498	\N	2115			59	f				t
5646	3732	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Has the participant ever had a CD4 cell count below 200 cells/mm<sup>3</sup>?</span></p></tr>	498	\N	2116			60	t		Horizontal		t
5647	3698	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">3. Has the participant ever been prescribed and taken antiretroviral therapy (ART)? </span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “No” or “Unknown”, Skip to D4)</strong></span>\n  </p>\n</tr>	498	\N	2117			61	t		Horizontal		t
5648	3733	148			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. In what year was ART initiated?</span></p></tr>	498	\N	2074			62	t				f
5649	3700	148			0		2					498	\N	2118			63	f				t
5650	3707	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 40px; margin-bottom: 11px">b. Was the participant taking any antiretroviral therapy in the 14 days prior to study treatment start date? </span>\n     </br><span style="margin-left: 53px; font-size: 9px;"><strong>(If “yes,” complete Concomitant Medications form and skip to D4):</strong></span>\n  </p>\n</tr>	498	\N	2119			64	t		Horizontal		f
5651	3751	148	WHO Clinical Stage 4 Condition		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>List WHO Clinical Stage 4 Conditions and provide month and year </span></p></tr>	498	\N	2120			65	t				t
5652	3737	148			0		0			Month		498	\N	2121			66	t				t
5653	3743	148			0		0			Year		498	\N	2074			67	t				t
5654	3727	148	E. Additional Information		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">1. Was the participant taking pre-study TB treatment in the 6 months prior to study start date and/or drugs with anti-TB activity given </span>\n     </br><span style="margin-left: 30px;">for purposes other than treatment of TB in the 30 days prior to study treatment start date?</span></br><span style="margin-left: 38px; font-size: 9px;"><strong>(If “Yes”, complete TB Drug Dose Record Form)</strong></span>\n  </p>\n</tr>	499	\N	2122			68	t		Horizontal		t
5655	3705	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">2. Was the participant taking non-TB medications, including over-the-counter drugs, in the 14 days prior to study treatment start date?</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “Yes”, complete Concomitant Medication Form)</strong></span>\n  </p>\n</tr>	499	\N	2123			69	t		Horizontal		t
5656	3734	148	Comments		0		0					499	\N	2080			70	f				t
5657	3744	148	F. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	499	\N	2074			71	t				t
5658	3731	148			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date History Form completed:</span></p></tr>	499	\N	2074			72	t				t
3138	1394	105	A. Visit Information		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Visit or date of blood specimen collection  <strong>(check one)</strong>:</span></p></tr><tr><p style=text-indent:40px; margin-bottom: 0px;><span>Study Evaluations</strong>:</span></p></tr>	239	\N	1167			1	t				t
3139	1356	105			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Date of Visit</strong>:</span></p></tr>	239	\N	1168			2	t				f
3140	1355	105	B. Transport/Shipping		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Date aliquots shipped to analysis laboratory or central storage facility:</span></p></tr>	239	\N	1168			3	t				t
3170	1365	105			0		1			<div class="I_TBTCLBL"></div><strong>1e</strong> 6hrs post ref. dose	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}6[0-9]{1}/	Error: Invalid TBTC Label Number ####6#	33	f				t
3141	1380	105			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n    <p style="text-indent:0px; margin-bottom: 0px;">\n        <span style="display: block; margin-left: 20px; margin-bottom: 12px">2.   Aliquots collected for which type of sampling </span>\n        <span style="display: block; margin-left: 40px;"><small><strong>Select only one; if aliquots are being shipped from several collection activities (e.g., separate sparse samplings, intensive sampling and sparse sampling) a separate shipping form is required for each collection and must be associated with the appropriate PK sampling form.</small></strong></span>\n    </p>\n</tr>	239	\N	1169			4	t				t
3142	1401	105	C. Study 38 TB Drug Sparse PK Cryovial Label Numbers	Report the TBTC Label Numbers exactly as written on the labels affixed to the aliquot cryovials.\nIf sampling was not conducted at a given time point, select Not Done for that time point.\nWhen this section is complete, skip to Section E.	0		1			<div class="I_TBTCLBL"></div><strong>1a</strong> Pre ref. dose	<div class="I_TBTC"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script> <script>\n     $(document).ready(function() {\n          $(".I_TBTC").parent().parent().find("input").css({ 'width': '70px'}); $(".I_TBTCLBL").parent().css({ 'width': '130px'});$(".I_TBTCLBLS").parent().css({ 'width': '40px'});$(".I_TBTCLBLSM").parent().css({ 'width': '35px'});\n});  </script>	239	\N	1168	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	5	f				t
3143	1399	105			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	6	f				t
3144	1397	105			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	7	f				t
3145	1396	105			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	8	f				t
3146	1377	105			0		1			<div class="I_TBTCLBL"></div><strong>1b</strong> Right before ref. dose	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	9	f				t
3147	1387	105			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	10	f				t
3148	1385	105			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	11	f				t
3149	1384	105			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}0[0-9]{1}/	Error: Invalid TBTC Label Number ####0#	12	f				t
3150	1363	105			0		1			<div class="I_TBTCLBL"></div><strong>1c</strong> 3 hrs post ref. dose	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	13	f				t
3151	1361	105			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	14	f				t
3152	1373	105			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	15	f				t
3153	1371	105			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}3[0-9]{1}/	Error: Invalid TBTC Label Number ####3#	16	f				t
3154	1372	105	D. Study 38 PK/PD TB Drug Intensive PK Cryovial Label Numbers	Report the TBTC Label Numbers exactly as written on the labels affixed to the aliquot cryovials.\nIf sampling was not conducted at a given time point, select ‘Not Done’ for that time point.\nWhen this section is complete, skip to Section E.	0		1			<div class="I_TBTCLBL"></div><strong>1a</strong> Pre ref. dose	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	17	f				t
3155	1368	105			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	18	f				t
3156	1367	105			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	19	f				t
3157	1366	105			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}-1[0-9]{1}/	Error: Invalid TBTC Label Number ####-1#	20	f				t
3158	1360	105			0		1			<div class="I_TBTCLBL"></div><strong>1b</strong> 1hr post ref. dose	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}1[0-9]{1}/	Error: Invalid TBTC Label Number ####1#	21	f				t
3159	1359	105			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}1[0-9]{1}/	Error: Invalid TBTC Label Number ####1#	22	f				t
3160	1358	105			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}1[0-9]{1}/	Error: Invalid TBTC Label Number ####1#	23	f				t
3161	1357	105			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}1[0-9]{1}/	Error: Invalid TBTC Label Number ####1#	24	f				t
3162	1389	105			0		1			<div class="I_TBTCLBL"></div><strong>1c</strong> 2hrs post ref. dose	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}2[0-9]{1}/	Error: Invalid TBTC Label Number ####2#	25	f				t
3163	1402	105			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}2[0-9]{1}/	Error: Invalid TBTC Label Number ####2#	26	f				t
3164	1400	105			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}2[0-9]{1}/	Error: Invalid TBTC Label Number ####2#	27	f				t
3165	1398	105			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}2[0-9]{1}/	Error: Invalid TBTC Label Number ####2#	28	f				t
3166	1379	105			0		1			<div class="I_TBTCLBL"></div><strong>1d</strong> 4hrs post ref. dose	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}4[0-9]{1}/	Error: Invalid TBTC Label Number ####4#	29	f				t
3167	1378	105			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}4[0-9]{1}/	Error: Invalid TBTC Label Number ####4#	30	f				t
3168	1388	105			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}4[0-9]{1}/	Error: Invalid TBTC Label Number ####4#	31	f				t
3169	1386	105			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}4[0-9]{1}/	Error: Invalid TBTC Label Number ####4#	32	f				t
3181	1390	105			0		4			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	239	\N	1168	regexp: /[0-9]{4}24[0-9]{1}/	Error: Invalid TBTC Label Number ####24#	44	f				t
3182	1395	105	E. Specimen Shipping Conditions		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Were specimens frozen prior to shipping?</span></p></tr>	239	\N	1170			45	t		Horizontal		t
3183	1354	105			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:35px; margin-bottom: 0px;><span>a. If “yes”, did the specimens thaw before shipping? </span></p></tr>	239	\N	1171			46	t		Horizontal		f
3184	1376	105			0		1				<tr><p style=text-indent:45px; margin-bottom: 0px;><span>If “yes”, provide the following</span></p></tr><tr><p style=text-indent:45px; margin-bottom: 0px;><span>1. Amount of time thawed</span></p></tr>	239	\N	1172			47	f				f
3185	1382	105			0		2				<div class="I_TBTC"></div><tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr><tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	239	\N	1168			48	f				f
3186	1381	105			0		3				<tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr><tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	239	\N	1173			49	f		Horizontal		f
3187	1369	105			0		0				<tr><p style=text-indent:45px; margin-bottom: 0px;><span>2. Extent thawed:</span></p></tr>	239	\N	1174			50	f		Horizontal		f
3188	1375	105	E. Comments		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Comments</span></p></tr>	239	\N	1175			51	f				t
3189	1383	105	F. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>name of person completing form:</span></p></tr>	239	\N	1168			52	f				t
3190	1370	105			0		0			<style type="text/css">.aka_text_block{width:20px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Form completed: </span></p></tr>	239	\N	1168			53	f				t
3245	1404	107			0		0			Participant's ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	245	\N	1185			1	f				t
3246	1394	107	A. Visit Information		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Visit or date of blood specimen collection  <strong>(check one)</strong>:</span></p></tr><tr><p style=text-indent:40px; margin-bottom: 0px;><span>Study Evaluations</strong>:</span></p></tr>	245	\N	1186			2	t				t
3247	1356	107			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Date of Visit</strong>:</span></p></tr>	245	\N	1185			3	t				f
3248	1355	107	B. Transport/Shipping		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Date aliquots shipped to analysis laboratory or central storage facility:</span></p></tr>	245	\N	1185			4	t				t
3249	1380	107			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n    <p style="text-indent:0px; margin-bottom: 0px;">\n        <span style="display: block; margin-left: 20px; margin-bottom: 9px">2.   Aliquots collected for which type of sampling </span>\n        <span style="display: block; margin-left: 40px;"><small><strong>If aliquots are being shipped from several collection activities (e.g., separate sparse samplings, intensive sampling and sparse sampling) a separate shipping form is required for each collection and must be associated with the appropriate PK sampling form.</small></strong></span>\n    </p>\n</tr>	245	\N	1187			5	t				t
3250	1401	107	C. Study 38 TB Drug Sparse PK Cryovial Label Numbers		0		1			<div class="I_TBTCLBL"></div><strong>1a</strong> Pre ref. dose	<div class="I_TBTC"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script> <script>\n     $(document).ready(function() {\n          $(".I_TBTC").parent().parent().find("input").css({ 'width': '70px'}); $(".I_TBTCLBL").parent().css({ 'width': '130px'});$(".I_TBTCLBLS").parent().css({ 'width': '40px'});$(".I_TBTCLBLSM").parent().css({ 'width': '35px'});\n});  </script>	246	\N	1185	regexp: /[0-9]{4}-1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### -1 #	6	f				t
3251	1399	107			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}-1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### -1 #	7	f				t
3252	1397	107			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}-1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### -1 #	8	f				t
3253	1396	107			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}-1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### -1 #	9	f				t
3254	1377	107			0		1			<div class="I_TBTCLBL"></div><strong>1b</strong> Right before ref. dose	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}0[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 0 #	10	f				t
3255	1387	107			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}0[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 0 #	11	f				t
3256	1385	107			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}0[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 0 #	12	f				t
3257	1384	107			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}0[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 0 #	13	f				t
3258	1363	107			0		1			<div class="I_TBTCLBL"></div><strong>1c</strong> 3 hrs post ref. dose	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}3[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 3 #	14	f				t
3259	1361	107			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}3[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 3 #	15	f				t
3260	1373	107			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}3[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 3 #	16	f				t
3261	1371	107			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	246	\N	1185	regexp: /[0-9]{4}3[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 3 #	17	f				t
3262	1372	107	D. Study 38 PK/PD TB Drug Intensive PK Cryovial Label Numbers		0		1			<div class="I_TBTCLBL"></div><strong>1a</strong> Pre ref. dose	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}-1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### -1 #	18	f				t
3263	1368	107			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}-1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### -1 #	19	f				t
3264	1367	107			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}-1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### -1 #	20	f				t
3265	1366	107			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}-1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### -1 #	21	f				t
3266	1360	107			0		1			<div class="I_TBTCLBL"></div><strong>1b</strong> 1hr post ref. dose	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 1 #	22	f				t
3267	1359	107			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 1 #	23	f				t
3268	1358	107			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 1 #	24	f				t
3269	1357	107			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}1[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 1 #	25	f				t
3270	1389	107			0		1			<div class="I_TBTCLBL"></div><strong>1c</strong> 2hrs post ref. dose	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}2[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 2 #	26	f				t
3271	1402	107			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}2[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 2 #	27	f				t
3272	1400	107			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}2[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 2 #	28	f				t
3273	1398	107			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}2[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 2 #	29	f				t
3274	1379	107			0		1			<div class="I_TBTCLBL"></div><strong>1d</strong> 4hrs post ref. dose	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}4[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 4 #	30	f				t
3275	1378	107			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}4[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 4 #	31	f				t
3276	1388	107			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}4[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 4 #	32	f				t
3277	1386	107			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}4[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 4 #	33	f				t
3278	1365	107			0		1			<div class="I_TBTCLBL"></div><strong>1e</strong> 6hrs post ref. dose	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}6[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 6 #	34	f				t
3279	1364	107			0		2			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}6[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 6 #	35	f				t
3280	1362	107			0		3			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}6[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 6 #	36	f				t
3281	1374	107			0		4			<div class="I_TBTCLBLS"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}6[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 6 #	37	f				t
3282	1353	107			0		1			<div class="I_TBTCLBL"></div><strong>1f</strong> 8-12hrs post ref. dose	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}12[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 12 #	38	f				t
3283	1352	107			0		2			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}12[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 12 #	39	f				t
3284	1351	107			0		3			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}12[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 12 #	40	f				t
3285	1350	107			0		4			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}12[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 12 #	41	f				t
3286	1393	107			0		1			<div class="I_TBTCLBL"></div><strong>1g</strong> 24hrs post ref. dose	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}24[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 24 #	42	f				t
3287	1392	107			0		2			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}24[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 24 #	43	f				t
3288	1391	107			0		3			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}24[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 24 #	44	f				t
3289	1390	107			0		4			<div class="I_TBTCLBLSM"></div>	<div class="I_TBTC"></div>	247	\N	1185	regexp: /[0-9]{4}24[0-9]{1}/	[Error] Invalid TBTC Label Number. Correct format is  #### 24 #	45	f				t
3290	1395	107	E. Specimen Shipping Conditions		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Were specimens frozen prior to shipping?</span></p></tr>	248	\N	1188			46	t		Horizontal		t
3291	1354	107			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:35px; margin-bottom: 0px;><span>a. If “yes”, did the specimens thaw before shipping? </span></p></tr>	248	\N	1189			47	t		Horizontal		f
3292	1376	107			0		1				<tr><p style=text-indent:45px; margin-bottom: 0px;><span>If “yes”, provide the following</span></p></tr><tr><p style=text-indent:45px; margin-bottom: 0px;><span>1. Amount of time thawed</span></p></tr>	248	\N	1190			48	f				f
3293	1382	107			0		2				<div class="I_TBTC"></div><tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr><tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	248	\N	1185			49	f	AMT Time Thawed			f
3294	1381	107			0		3				<tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr><tr><p style=text-indent:45px; margin-bottom: 0px;><span>&nbsp;</span></p></tr>	248	\N	1191			50	f		Horizontal		f
3295	1369	107			0		0				<tr><p style=text-indent:45px; margin-bottom: 0px;><span>2. Extent thawed:</span></p></tr>	248	\N	1192			51	f		Horizontal		f
3296	1375	107	E. Comments		0		0					249	\N	1193			52	f				t
3297	1383	107	F. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>PRINT name of person completing form:</span></p></tr>	249	\N	1185			53	f				t
3298	1370	107			0		0			<style type="text/css">.aka_text_block{width:20px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Form completed: </span></p></tr>	249	\N	1185			54	f				t
4768	2912	135			0		0			Participant ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	402	\N	1577			1	f				t
4769	2964	135	A. Visit Information		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. Visit or date of blood specimen collection  <strong>(check one)</strong>:</span></p></tr><tr><p style=text-indent:40px; margin-bottom: 0px;><span>Study Evaluations</strong>:</span></p></tr>	402	\N	1578			2	f		Horizontal		t
4770	2890	135			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Date of Visit</strong>:</span></p></tr>	402	\N	1577			3	f				f
4771	2934	135	B. Reference Doses & Vomiting	PK reference dose <strong>must</strong> be preceded by two (2) directly observed study drug doses given approximately 1] 24 and 2] 48 hours prior to the reference dose.	0		1			<strong>1</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose A<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_EXSD"><tr><br /><div style="text-indent:80px"><b>Date of Dose</b></tr>	403	\N	1577			4	f				t
4772	2896	135			0		2				<div class="I_EXS"><tr><br /><div style="text-indent:65px"><b>Time of Dose</b></tr>	403	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	5	f				t
4773	2956	135			0		3				<tr><br /><div style="text-indent:50px"><b>Estimated Time</b></tr>	403	\N	1579			6	f		Vertical		t
4774	2941	135			0		4				<tr><br /><div style="text-indent:50px"><b>Vomiting<a href='javascript:void(0)' onmouseover='Tip("<br />Vomiting within 2 hours <br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a></b></tr>	403	\N	1580			7	f		Vertical		t
4775	2933	135			0		1			<strong>2</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-reference dose B<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_EXSD">	403	\N	1577			8	f				t
4776	2892	135			0		2				<div class="I_EXS">	403	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	9	f				t
4777	2955	135			0		3					403	\N	1581			10	f		Vertical		t
4778	2940	135			0		4					403	\N	1582			11	f		Vertical		t
4779	2910	135			0		1			<strong>3</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Reference dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_EXSD">	403	\N	1577			12	f				t
4780	2894	135			0		2				<div class="I_EXS"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_EXS").parent().parent().find("input").css({\n        'width': '60px'\n    });    $(".I_EXSD").parent().parent().find("input").css({\n        'width': '85px'\n    });\n});  </script>	403	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	13	f				t
4781	2954	135			0		3					403	\N	1583			14	f		Vertical		t
4782	2939	135			0		4					403	\N	1584			15	f		Vertical		t
4783	2888	135	C. Vomiting after the PK Reference Dose		0		0				<tr>\n  <p style="margin-bottom: 0px;">\n    <span style="display: block; text-indent: 7px;">1. Did participant vomit between PK reference dose administration and last PK specimen collection <strong>(total of 24 hours)</strong>?</span>\n  </p>\n</tr>	403	\N	1585			16	f		Horizontal		t
4784	2925	135			0		1			<strong>Day</strong>	<div class="I_EXSD"><tr><br />2. If "Yes", provide the date/time when vomiting started: </tr><tr><br /><div style="text-indent:65px"></tr>	403	\N	1577			17	f		Horizontal		t
4785	2893	135			0		2				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:40px; margin-bottom: 0px;><span>Time</strong>:</span></p></tr>	403	\N	1577			18	f				t
4786	2942	135	D. Food & Alcohol Ingested		0		0				<tr>\n  <p>\n    <span style="display: block; text-indent: 7px;">Participants enrolled in a bedaquiline-containing treatment arm should eat food within 1 hour before the administration of the reference dose.</span>\n    <span style="display: block; text-indent: 7px;">Report the time and food eaten within 1 hour before to 1 hour after the administration of the reference dose.</span>\n    <span style="display: block; text-indent: 7px;">If no food was eaten 1 hour before to 1 hour after the administration of the reference dose, report the date and time of the last meal ingested.</span>\n  </p>\n</tr></span></tr><tr><p style=text-indent:7px; margin-bottom: 0px;><span><strong> </span></p></tr><tr><p style=text-indent:0px; margin-bottom: 0px;><span style="display: block; text-indent: 35px;"><strong>Food Consumed</strong></span><span style="display: block; text-indent: 35px; color: #0047AB;"><small>If No or Unknown, skip to “Last Meal”</small></span></p></tr>	404	\N	1584			19	f		Horizontal		t
4787	2965	135	Food		0		0					404	\N	1577			20	f				t
4788	2889	135	Quantity		0		0					404	\N	1577			21	f		Vertical		t
4789	2967	135	Unit		0		0					404	\N	1586			22	f		Vertical		t
4790	2963	135	Time		0		0					404	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	23	f		Vertical		t
4791	2909	135	Est. Time		0		0					404	\N	1587			24	f		Vertical		t
4792	2891	135			0		1				<div class="I_EXSD"><tr><br /><b>Last Meal</b></tr><tr><br /><div style="text-indent:65px"><b>Day</b></tr>	404	\N	1577			25	f				t
4793	2966	135			0		2				<div class="I_EXS"><tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Time</b></tr>	404	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	26	f				t
4794	2913	135			0		3				<tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Est. Time</b></tr>	404	\N	1588			27	f		Horizontal		t
4795	2935	135			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>2. Did participant abstain from alcohol for at least 48 hours prior to PK sampling?</span></p></tr>	404	\N	1589			28	f		Horizontal		t
4796	2968	135	E. Non-Study Medications		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>1. In general, how often does the participant take non-study medications within three (3) hours of study drug administration (1 hour before up to 2 hours after)?</span></p></tr>	404	\N	1590			29	f		Horizontal		t
4797	2943	135	F. PK sampling		0		1			<strong>1a</strong>\n<a href='javascript:void(0)' onmouseover='Tip("<br />Pre-ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<tr><p style="text-align: center; width : 125px; height:30px; "><span><strong>Time Point</strong></span></p>	405	\N	1591			30	f		Horizontal		t
4798	2959	135			0		2				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Actual blood collection time</strong></p></tr>	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	31	f		Horizontal		t
4799	2958	135			0		3				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time blood placed in centrifuge</strong></p></tr>	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	32	f		Horizontal		t
4800	2957	135			0		4				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time plasma placed in -70°C freezer or below</strong></p></tr>	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	33	f		Horizontal		t
4801	2918	135			0		5				<tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Blood collection to -70°C freezer time > 2 hrs</strong><a href='javascript:void(0)' onmouseover='Tip("<br />if Yes, provide Comment in Section G<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a></p></tr>	405	\N	1592			34	f		Horizontal		t
4802	2944	135			0		1			<strong>1b</strong>\n<a href='javascript:void(0)' onmouseover='Tip("<br />1 hr\npost ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		405	\N	1593			35	f				t
4803	2884	135			0		2				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	36	f		Horizontal		t
4804	2883	135			0		3				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	37	f		Horizontal		t
4805	2882	135			0		4				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	38	f		Horizontal		t
4806	2920	135			0		5					405	\N	1594			39	f		Horizontal		t
4807	2948	135			0		1			<strong>1c</strong>\n<a href='javascript:void(0)' onmouseover='Tip("<br />2 hrs\npost ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		405	\N	1593			40	f		Horizontal		t
4808	2904	135			0		2				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	41	f		Horizontal		t
4809	2906	135			0		3				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	42	f		Horizontal		t
4810	2905	135			0		4				<div class="I_TIME"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_TIME").parent().parent().find("input").css({\n        'width': '60px'\n        \n    }); $(".I_TBTC").parent().parent().find("input").css({\n        'width': '70px'\n        \n    });\n});  </script>	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	43	f		Horizontal		t
4811	2915	135			0		5					405	\N	1595			44	f		Horizontal		t
4812	2949	135			0		1			<strong>1d</strong>\n<a href='javascript:void(0)' onmouseover='Tip("<br />4 hrs\npost ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		405	\N	1593			45	f		Horizontal		t
3977	2117	126			0		0			Participant ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	348	\N	1397			1	f				t
3978	2119	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Sequence ID</span></p></tr>	348	\N	1397			2	t				t
3979	2099	126	A. Adverse Event Description		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of AE status evaluated:</span></p></tr>	348	\N	1397			3	t				t
4813	2885	135			0		2				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	46	f		Horizontal		t
4814	2887	135			0		3				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	47	f		Horizontal		t
4815	2886	135			0		4				<div class="I_TIME"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_TIME").parent().parent().find("input").css({\n        'width': '60px'\n        \n    }); $(".I_TBTC").parent().parent().find("input").css({\n        'width': '70px'\n        \n    });\n});  </script>	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	48	f		Horizontal		t
4816	2917	135			0		5					405	\N	1595			49	f		Horizontal		t
3980	2091	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Details of AE from its corresponding AE Form:</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Reportable AE:</span></p></tr>	348	\N	1397			4	t				t
3981	2086	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">3. Is the <strong>FINAL</strong> reportable adverse event different from the initial event reported on the AE Form?</span>\n    </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If a symptom was reported on the AE form but a diagnosis has now been assigned, select YES and report the diagnosis)</strong></span>\n  </p>\n</tr>	348	\N	1398			5	f		Horizontal		t
3982	2084	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If yes, specify:</span></p></tr>	348	\N	1399	func:  gt(200)	maximum number of characters 200	6	f				f
3983	2083	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">4. Did the initial reportable event become a serious adverse event (SAE)?</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(an SAE requires that this form be submitted to CDC within 48 hours of site’s awareness of SAE and to local ethics committees as per local guidelines)</strong></span>\n  </p>\n</tr>	348	\N	1400			7	f		Horizontal		t
3984	2104	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. Indicate type of SAE <span style="font-weight: bold">(select all that apply):</span> </span></p></tr>	348	\N	1401			8	f		Vertical		f
3985	2114	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">b. Date event became an SAE:</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(Provide the date when the event worsened in seriousness to be an SAE)</strong></span>\n  </p>\n</tr>	348	\N	1397			9	f				f
3986	2115	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">c. Site awareness date:</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(Provide the date when site staff were made aware that the event worsened)</strong></span>\n  </p>\n</tr>	348	\N	1397			10	f				f
3987	2093	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">Status of the AE:</span>\n    </br><span style="margin-left: 33px; font-size: 9px;"><strong>(provide date if indicated)</strong></span>\n  </p>\n</tr>	348	\N	1402			11	f		Vertical		t
3988	2096	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>Resolution Date/Death Date</span></p></tr>	348	\N	1397			12	f				t
3989	2097	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. In the opinion of the investigator, what is the final attribution to study treatment in causing this AE?</span></p></tr>	348	\N	1403			13	f		Horizontal		t
3990	2120	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If “Definite”, “Probable” or “Possible”, select the study drug(s) to which the AE is attributed</span></p></tr>	348	\N	1404			14	f				f
3991	2085	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. In the opinion of the investigator, is this an anticipated or unanticipated AE?</span></p></tr>	348	\N	1405			15	f		Horizontal		t
3992	2095	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">8. Indicate the maximum toxicity grade during the course of the AE </span>\n    </br><span style="margin-left: 33px; font-size: 9px;"><strong>(Refer to the CTCAE, in the Manual of Procedures) </strong></span>\n  </p>\n</tr>	348	\N	1406			16	f		Horizontal		t
3993	2087	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">1. Were any additional assessment, evaluations or tests done in response to this AE?</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “Yes” to any of the following, either report new results on the specified form, or link this AE to an existing form for results already reported.)</strong></span></p><p><span style="margin-left: 40px;"> a. Laboratory evaluations  <strong><small>(LB Form)</small></strong></span></p>\n</tr>	349	\N	1398			17	f		Horizontal		t
3994	2105	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. Clinical evaluations  <strong><small>(e.g., chest x-ray) (CE Form)</small></strong></span></p></tr>	349	\N	1398			18	f		Horizontal		t
3995	2098	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>c. Signs and symptoms assessment  <strong><small>(SS Form)</small></strong></span></p></tr>	349	\N	1398			19	f		Horizontal		t
3996	2110	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>d. Sputum or other specimen collected for TB microbiology workup <strong><small>(MB Form)</small></strong></span></p></tr>	349	\N	1398			20	f		Horizontal		t
3997	2090	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 20px; margin-bottom: 11px">3. Was the participant re-challenged with the intention of restarting study treatment?</span>\n     </br><span style="margin-left: 33px; font-size: 9px;"><strong>(Re-starting treatment with a full per-protocol study drug dose is not considered a re-challenge)</strong></span></br><span style="margin-left: 33px; font-size: 9px;"><strong>(If “Yes”, complete or update TB Drug Dose Record Form.)</strong></span>\n  </p>\n</tr>	349	\N	1398			21	f		Horizontal		t
3998	2108	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Was the participant re-challenged with the intention of restarting study treatment?</span></p></tr>	349	\N	1398			22	f		Horizontal		t
3999	2088	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. Was study treatment permanently discontinued as a result of this AE?</span></p></tr>	349	\N	1398			23	f		Horizontal		t
3616	1722	117			0		1			<strong>3</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Reference dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_EXSD">	298	\N	1287			12	f				t
3617	1723	117			0		2				<div class="I_EXS"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_EXS").parent().parent().find("input").css({\n        'width': '60px'\n    });    $(".I_EXSD").parent().parent().find("input").css({\n        'width': '85px'\n    });\n});  </script>	298	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	13	f				t
3618	1724	117			0		3					298	\N	1293			14	f		Vertical		t
3619	1725	117			0		4					298	\N	1294			15	f		Vertical		t
3620	1726	117	C. Vomiting after the PK Reference Dose		0		0				<tr>\n  <p style="margin-bottom: 0px;">\n    <span style="display: block; text-indent: 7px;">1. Did participant vomit between PK reference dose administration and last PK specimen collection <strong>(total of 24 hours)</strong>?</span>\n   <span style="display:blocl;text-indent: 7px;"><strong>If "No", Skip to Section D</strong></span>\n  </p>\n</tr>	298	\N	1295			16	f		Horizontal		t
3621	1727	117			0		1				<div class="I_EXSD"><tr><br />2. If "Yes", provide the date/time when vomiting started: </tr><tr><br /><div style="text-indent:65px"><b>Day</b></tr>	298	\N	1287			17	f		Horizontal		t
3622	1728	117			0		2				<div class="I_EXS"><tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Time</b></tr>	298	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	18	f		Horizontal		t
3623	1729	117	D. Food & Alcohol Ingested		0		0				<tr>\n  <p>\n    <span style="display: block; text-indent: 7px;">Participants enrolled in a bedaquiline-containing treatment arm should eat food within 1 hour before the administration of the reference dose.</span>\n    <span style="display: block; text-indent: 7px;">Report the time and food eaten within 1 hour before to 1 hour after the administration of the reference dose.</span>\n    <span style="display: block; text-indent: 7px;">If no food was eaten 1 hour before to 1 hour after the administration of the reference dose, report the date and time of the last meal ingested.</span>\n  </p>\n</tr></span></tr><tr><p style=text-indent:7px; margin-bottom: 0px;><span><strong><u>Reference dose</u></strong></span></p></tr><tr><p style=text-indent:0px; margin-bottom: 0px;><span style="display: block; text-indent: 35px;"><strong>Food Consumed</strong></span><span style="display: block; text-indent: 35px; color: #0047AB;"><small>If No or Unknown, skip to “Last Meal”</small></span></p></tr>	298	\N	1294			19	f		Horizontal		t
3624	1730	117	Food		0		0					298	\N	1287			20	f				t
3625	1731	117	Quantity		0		0					298	\N	1287			21	f		Vertical		t
3626	1732	117	Unit		0		0					298	\N	1296			22	f		Vertical		t
3627	1733	117	Time		0		0					298	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	23	f		Vertical		t
3628	1734	117	Est. Time		0		0					298	\N	1297			24	f		Vertical		t
3629	1735	117			0		1				<div class="I_EXSD"><tr><br /><b>Last Meal</b></tr><tr><br /><div style="text-indent:65px"><b>Day</b></tr>	298	\N	1287			25	f				t
3630	1736	117			0		2				<div class="I_EXS"><tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Time</b></tr>	298	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	26	f				t
3631	1737	117			0		3				<tr><br /><b>&nbsp;</b></tr><tr><br /><div style="text-indent:65px"><b>Est. Time</b></tr>	298	\N	1298			27	f		Horizontal		t
3632	1738	117			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>2. Did participant abstain from alcohol for at least 48 hours prior to PK sampling?</span></p></tr>	298	\N	1299			28	f		Horizontal		t
3633	1739	117	1. PK sampling		0		1			<strong>1a</strong>\n<a href='javascript:void(0)' onmouseover='Tip("<br />Pre ref. dose (t=-1)<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<tr><p style="text-align: center; width : 125px; height:30px; "><span><strong>Time Point</strong></span></p>	299	\N	1300			29	f		Horizontal		t
3634	1740	117			0		2				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Actual blood collection time</strong></p></tr>	299	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	30	f		Horizontal		t
3635	1741	117			0		3				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time blood placed in centrifuge</strong></p></tr>	299	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	31	f		Horizontal		t
3636	1742	117			0		4				<div class="I_TIME"></div><tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Time plasma placed in -70°C freezer or below</strong></p></tr>	299	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	32	f		Horizontal		t
3637	1743	117			0		5				<tr><p  style="text-align: center; width : 125px; height:30px; "><strong>Blood collection to -70°C freezer time > 2 hrs</strong><a href='javascript:void(0)' onmouseover='Tip("<br />if Yes, provide Comment in Section E<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a></p></tr>	299	\N	1301			33	f		Horizontal		t
3638	1744	117			0		1			<strong>1b</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Right before ref. dose (t=0)<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		299	\N	1302			34	f				t
3639	1745	117			0		2				<div class="I_TIME">	299	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	35	f		Horizontal		t
3640	1746	117			0		3				<div class="I_TIME">	299	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	36	f		Horizontal		t
3641	1747	117			0		4				<div class="I_TIME">	299	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	37	f		Horizontal		t
3642	1748	117			0		5					299	\N	1303			38	f		Horizontal		t
3676	1782	117			0		4				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 12 #.	72	f				t
3643	1749	117			0		1			<strong>1c</strong><a href='javascript:void(0)' onmouseover='Tip("<br />3 hrs (post ref. dose) <br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		299	\N	1302			39	f		Horizontal		t
3644	1750	117			0		2				<div class="I_TIME">	299	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	40	f		Horizontal		t
3645	1751	117			0		3				<div class="I_TIME">	299	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	41	f		Horizontal		t
3646	1752	117			0		4				<div class="I_TIME"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_TIME").parent().parent().find("input").css({\n        'width': '60px'\n        \n    }); $(".I_TBTC").parent().parent().find("input").css({\n        'width': '70px'\n        \n    });\n});  </script>	299	\N	1287	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	42	f		Horizontal		t
3647	1753	117			0		5					299	\N	1304			43	f		Horizontal		t
3648	1754	117	2. Cryovial Label Numbers	Report the TBTC Label Number <strong>exactly</strong> as written on the labels affixed to the aliquot cryovials.	0		1			<strong>2a</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre ref. dose (t=-1)<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		299	\N	1305			44	f				t
3649	1755	117			0		2				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	45	f				t
3650	1756	117			0		3				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	46	f				t
3651	1757	117			0		4				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	47	f				t
3652	1758	117			0		5				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	48	f				t
3653	1759	117			0		1			<strong>2b</strong><a href='javascript:void(0)' onmouseover='Tip("<br />post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		299	\N	1306			49	f				t
3654	1760	117			0		2				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	50	f				t
3655	1761	117			0		3				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	51	f				t
3656	1762	117			0		4				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	52	f				t
3657	1763	117			0		5				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	53	f				t
3658	1764	117			0		1			<strong>2c</strong><a href='javascript:void(0)' onmouseover='Tip("<br />3 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		299	\N	1306			54	f				t
3659	1765	117			0		2				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 1 #.	55	f				t
3660	1766	117			0		3				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 1 #.	56	f				t
3661	1767	117			0		4				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 1 #.	57	f				t
3662	1768	117			0		5				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 1 #.	58	f				t
3663	1769	117			0		1			<strong>2d</strong><a href='javascript:void(0)' onmouseover='Tip("<br />4 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		299	\N	1306			59	f				t
3664	1770	117			0		2				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 4 #.	60	f				t
3665	1771	117			0		3				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 4 #.	61	f				t
3666	1772	117			0		4				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 4 #.	62	f				t
3667	1773	117			0		5				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 4 #.	63	f				t
3668	1774	117			0		1			<strong>2e</strong><a href='javascript:void(0)' onmouseover='Tip("<br />6 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		299	\N	1306			64	f				t
3669	1775	117			0		2				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 6 #.	65	f				t
3670	1776	117			0		3				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 6 #.	66	f				t
3671	1777	117			0		4				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 6 #.	67	f				t
3672	1778	117			0		5				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 6 #.	68	f				t
3673	1779	117			0		1			<strong>2f</strong><a href='javascript:void(0)' onmouseover='Tip("<br />8 - 12 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		299	\N	1306			69	f				t
3674	1780	117			0		2				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 12 #.	70	f				t
3675	1781	117			0		3				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 12 #.	71	f				t
3677	1783	117			0		5				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 12 #.	73	f				t
3678	1784	117			0		1			<strong>2g</strong><a href='javascript:void(0)' onmouseover='Tip("<br />24 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		299	\N	1306			74	f				t
3679	1785	117			0		2				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 24 #.	75	f				t
3680	1786	117			0		3				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 24 #.	76	f				t
3681	1787	117			0		4				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 24 #.	77	f				t
3682	1788	117			0		5				<div class="I_TBTC"></div>	299	\N	1287	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 24 #.	78	f				t
3683	1789	117	Comments		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Comments</span></p></tr>	299	\N	1307			79	f				t
3684	1790	117	Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>PRINT name of person completing form:</span></p></tr>	299	\N	1287			80	f				t
3685	1791	117			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Form completed: </span></p></tr>	299	\N	1287			81	f				t
3686	1792	117			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Name of site POC for specimens: </span></p></tr>	299	\N	1287			82	f				t
3687	1793	117			0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Phone number of site POC for specimens: </span></p></tr>	299	\N	1287			83	f				t
4000	2094	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Summary of current AE status</span></p></tr><tr><p style="text-indent:30px; margin-bottom: 0px;"><span>Use the SOAP <small><strong>(Subjective, Objective, Analysis, and Plan)</strong></small> format for a brief clinical description</span></p></tr>	350	\N	1399	func:  gt(3500)	maximum number of characters 3500	24	f				t
4001	2089	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. If applicable, specify how long after the onset date did the AE resolved <small><strong>(hours, days, weeks):</strong></small></span></p></tr>	350	\N	1399	func:  gt(500)	maximum number of characters 500	25	f				t
4002	2118	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. If applicable, specify whether the participant permanently discontinued study treatment because of medical advice or participant decision to discontinue:</span></p></tr>	350	\N	1399	func:  gt(500)	maximum number of characters 500	26	f				t
4003	2109	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Pregnancy outcome</span></p></tr>	351	\N	1407			27	f		Vertical		t
4004	2111	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>b. were any congenital anomalies present?</span></p></tr>	351	\N	1398			28	f		Horizontal		f
4005	2106	126			0		1				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. What was the gestational age at pregnancy outcome?</span></p></tr>	351	\N	1397			29	f				t
4006	2112	126			0		2				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span> </span></p></tr>	351	\N	1408			30	f				t
4007	2092	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. Date of pregnancy outcome:</span></p></tr>	351	\N	1397			31	f				t
4008	2101	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of Principal Investigator or Co-PI:</span></p></tr>	352	\N	1397			32	f				t
4009	2100	126		Required only for grade 3 AE and SAEs	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing form:</span></p></tr>	352	\N	1397			33	f				t
4010	2121	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form completed:</span></p></tr>	352	\N	1397			34	f				t
4011	2103	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person completing QA/QC:</span></p></tr>	352	\N	1397			35	f				t
4012	2116	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form  QA/QC completed</span></p></tr>	352	\N	1397			36	f				t
4013	2102	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Name of person entering form:</span></p></tr>	352	\N	1397			37	f				t
4014	2113	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Date Form entered:</span></p></tr>	352	\N	1397			38	f				t
4015	2123	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Final MedDRA Lower Level Term Code:&nbsp;&nbsp;<a href="#" class="btn primary" onClick="openNewWindow('includes/meddra/meddra-browser-api.jsp','dnote_win','directories=no,location=no,menubar=no,scrollbars=yes,toolbar=no,status=no,resizable=yes','dnote'); return false;">medDra Access</a></span></p></tr><div id="I_ZFLLTCD"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     window.addEventListener('message', function(event) {\n      const rowData = event.data;\n      var medCode = $("#I_ZFLLTCD").parent().parent().find("input"); \n\t  var medName =$("#I_ZFLLT").parent().parent().find("input");\n\t  medCode.val(rowData.code);\n\t  medCode.change();\n\t  medName.val(rowData.name);\n\t  medName.change();\n      console.log("Valor seleccionado: " + rowData.code + " " + rowData.name);\n     \n    });\n  </script>\n  <style>\n     .btn {\n      border: none; \n      cursor: pointer;  font-size: 11px;\n      text-decoration: none;\n    }\n  </style>\n</head>\n<body>	353	\N	1397			39	f				t
4016	2122	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Final MedDRA Lower Level Term Description:</span></p></tr><div id="I_ZFLLT"></div>	353	\N	1397			40	f				t
4017	2107	126			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. Safety officer providing MedDRA code:</span></p></tr>	353	\N	1397			41	f				t
4817	2945	135			0		1			<strong>1e</strong>\n<a href='javascript:void(0)' onmouseover='Tip("<br />6 hrs\npost ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		405	\N	1593			50	f		Horizontal		t
4818	2908	135			0		2				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	51	f		Horizontal		t
4819	2907	135			0		3				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	52	f		Horizontal		t
4820	2911	135			0		4				<div class="I_TIME"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_TIME").parent().parent().find("input").css({\n        'width': '60px'\n        \n    }); $(".I_TBTC").parent().parent().find("input").css({\n        'width': '70px'\n        \n    });\n});  </script>	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	53	f		Horizontal		t
4821	2928	135			0		5					405	\N	1595			54	f		Horizontal		t
4822	2947	135			0		1			<strong>1f</strong>\n<a href='javascript:void(0)' onmouseover='Tip("<br />8-12 hrs\npost ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		405	\N	1593			55	f		Horizontal		t
4823	2938	135			0		2				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	56	f		Horizontal		t
4824	2937	135			0		3				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	57	f		Horizontal		t
4825	2936	135			0		4				<div class="I_TIME"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_TIME").parent().parent().find("input").css({\n        'width': '60px'\n        \n    }); $(".I_TBTC").parent().parent().find("input").css({\n        'width': '70px'\n        \n    });\n});  </script>	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	58	f		Horizontal		t
4826	2931	135			0		5					405	\N	1595			59	f		Horizontal		t
4827	2919	135			0		1			<strong>1g</strong>\n<a href='javascript:void(0)' onmouseover='Tip("<br />24 hrs\npost ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>		405	\N	1593			60	f		Horizontal		t
4828	2962	135			0		2				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	61	f		Horizontal		t
4829	2961	135			0		3				<div class="I_TIME">	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	62	f		Horizontal		t
4830	2960	135			0		4				<div class="I_TIME"><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n     $(document).ready(function() {\n    $(".I_TIME").parent().parent().find("input").css({\n        'width': '60px'\n        \n    }); $(".I_TBTC").parent().parent().find("input").css({\n        'width': '70px'\n        \n    });\n});  </script>	405	\N	1577	regexp: /^([01]?[0-9]|2[0-3]):[0-5][0-9]$/	[Error]: Invalid Time Format. Correct Format Is HH:MM.	63	f		Horizontal		t
4831	2922	135			0		5					405	\N	1595			64	f		Horizontal		t
4832	2877	135	2. Cryovial Label Numbers	Report the TBTC Label Number <strong>exactly</strong> as written on the labels affixed to the aliquot cryovials.	0		1			<strong>2a</strong><a href='javascript:void(0)' onmouseover='Tip("<br />Pre-ref. dose (-1)<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	65	f				t
4833	2876	135			0		2				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	66	f				t
4834	2875	135			0		3				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	67	f				t
4835	2874	135			0		4				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}-1[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is  #### -1 #.	68	f				t
4836	2900	135			0		1			<strong>2b</strong><a href='javascript:void(0)' onmouseover='Tip("<br />1 hr post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	69	f				t
4837	2898	135			0		2				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	70	f				t
4838	2897	135			0		3				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	71	f				t
4839	2895	135			0		4				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 0 #.	72	f				t
4840	2929	135			0		1			<strong>2c</strong><a href='javascript:void(0)' onmouseover='Tip("<br />2 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 1 #.	73	f				t
4841	2926	135			0		2				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 1 #.	74	f				t
4842	2923	135			0		3				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 1 #.	75	f				t
4843	2921	135			0		4				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}0[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 1 #.	76	f				t
4844	2953	135			0		1			<strong>2d</strong><a href='javascript:void(0)' onmouseover='Tip("<br />4 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 4 #.	77	f				t
4845	2952	135			0		2				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 4 #.	78	f				t
4846	2951	135			0		3				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 4 #.	79	f				t
4847	2950	135			0		4				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 4 #.	80	f				t
4848	2932	135			0		1			<strong>2e</strong><a href='javascript:void(0)' onmouseover='Tip("<br />6 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 6 #.	81	f				t
4849	2930	135			0		2				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 6 #.	82	f				t
4850	2927	135			0		3				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 6 #.	83	f				t
4851	2924	135			0		4				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 6 #.	84	f				t
4852	2903	135			0		1			<strong>2f</strong><a href='javascript:void(0)' onmouseover='Tip("<br />8 - 12 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 12 #.	85	f				t
4853	2902	135			0		2				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 12 #.	86	f				t
4854	2901	135			0		3				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 12 #.	87	f				t
4855	2899	135			0		4				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 12 #.	88	f				t
4856	2881	135			0		1			<strong>2g</strong><a href='javascript:void(0)' onmouseover='Tip("<br />24 hrs post ref. dose<br />&nbsp;")' onmouseout='UnTip()'>\n    &nbsp;<span style='color: #e31010; font-weight: bold;'>&#9432;</span>\n</a>	<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 24 #.	89	f				t
4857	2880	135			0		2				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 24 #.	90	f				t
4858	2879	135			0		3				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 24 #.	91	f				t
4859	2878	135			0		4				<div class="I_TBTC"></div>	406	\N	1577	regexp: /[0-9]{4}3[0-9]{1}/	[Error]: Invalid TBTC Label Number. Correct Format is #### 24 #.	92	f				t
4860	2916	135	G. Comments		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Comments</span></p></tr>	407	\N	1596			93	f				t
4861	2946	135	H. Form Completion		0		0				&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Name of person completing form:</span></p></tr>	407	\N	1577			94	f				t
4862	2914	135			0		0			<style type="text/css">.aka_text_block{width:15px;text-align:left;}</style>	&nbsp;&nbsp;<div name=undoradio></div>\n<tr><p style=text-indent:20px; margin-bottom: 0px;><span>Date Form completed: </span></p></tr>	407	\N	1577			95	f				t
4883	3001	137			0		0			Participant ID	<div id="I_ParticipantID"></div><script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>  <script>\n       $(document).ready(function() {\n                 const participantOID = $("#I_ParticipantOID").parent().parent().find("input");  \n\t   const participantID = $("#I_ParticipantID").parent().parent().find("input"); \n\t   \n\t   const  participantOIDval = '${studySubjectOID}';\n\t   const  participantIDval = '${studySubject}';\n\t   participantOID.attr('readonly',true);\n                  participantOID.css("background-color", "#E6E6E6");\n\t   participantID.attr('readonly',true);\n                  participantID.css("background-color", "#E6E6E6");\n\t   participantOID.val(participantOIDval);\n\t   participantOID.change();   \t   \n\t   participantID.val(participantIDval);\n\t   participantID.change();\n\t     });\n  </script>	410	\N	1604			1	f				t
4884	3003	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>Sequence ID</span></p></tr>	410	\N	1604			2	t				t
4885	3004	137	A. Information Concerning Death		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>1. Date of death:</span></p></tr>	410	\N	1604			3	t				t
4886	2997	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>2. Was (were) the cause(s) of death known??</span></p></tr>	410	\N	1605			4	t		Horizontal		t
4887	3002	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr>\n  <p style="text-indent:0px; margin-bottom: 0px;">\n    <span style="margin-left: 40px; margin-bottom: 11px">a. If yes, <b>list</b> the primary cause(s) of death</span>\n     </br><span style="margin-left: 53px; font-size: 9px;"><strong>(Indicate up to four causes or contributing factors, one per line, matching the death certificate, if available):</strong></span>\n  </p>\n</tr>	410	\N	1606	func:  gt(200)	maximum number of characters 200	5	f				f
4888	3000	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>3. In the clinician's opinion, <b>TB</b> was:</span> </span></p></tr>	410	\N	1607			6	t		Vertical		t
4889	3007	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>4. What is the likelihood that <b>study treatment </b>was a factor in the participant's death?</span> </span></p></tr>	410	\N	1608		This is a required field	7	t				t
4890	2999	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>5. In the opinion of the investigator, was this an anticipated or unanticipated death? </span> </span></p></tr>	410	\N	1609		This is a required field	8	t		Horizontal		t
4891	2996	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>6. Was the manner of death violent or accidental? </span> </span></p></tr>	410	\N	1610		This is a required field	9	t		Horizontal		t
4892	2994	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>7. Was an autopsy performed?</span></p></tr>	410	\N	1610		This is a required field	10	t		Horizontal		t
4893	3008	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>8. Was a post-mortem specimen collected for microbiological or histological workup?</p><p style="text-indent:40px;margin-bottom:0px;"> <b>(If "yes", complete MB form)</b> </span></p></tr>	410	\N	1610			11	f		Horizontal		t
4894	2995	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px; margin-bottom: 0px;"><span>9. Was a post-mortem specimen collected for pathological examination?</p><p style="text-indent:40px;margin-bottom:0px;"> <b>(If "No" or "Unknown", skip to Section B)</b> </span></p></tr>	410	\N	1610			12	t		Horizontal		t
4895	2991	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:40px; margin-bottom: 0px;"><span>a. If "yes", was the specimen positive for TB?</p><p style="text-indent:40px;margin-bottom:0px;"> <b>(If "Yes", provide microscopic and histologic details in Section B)</b> </span></p></tr>	410	\N	1610			13	f		Horizontal		f
4896	2989	137	B. Narrative regarding the circumstances of the death and any relationship to study treatment	(Record microscopic and histologic details here if Q9a above = “Yes”)	0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;"> </p></tr>	411	\N	1606	func:  gt(3500)	This is a required field	14	f				t
4897	2992	137	C. Form Completion		0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;"> Name of Principal Investigator or Co-PI:</span></p></tr>	411	\N	1604			15	t				t
4898	3005	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;"> Signature of Principal Investigator or Co-PI: </span></p></tr>	411	\N	1604			16	t		Horizontal		t
4899	2993	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Name of person completing QA/QC:</span></p></tr>	411	\N	1604			17	t		Horizontal		t
4900	3006	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Date Form QA/QC completed: </span></p></tr>	411	\N	1604			18	t		Horizontal		t
4901	2990	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Name of person entering form: </span></p></tr>	411	\N	1604			19	t		Horizontal		t
4902	2998	137			0		0				&nbsp;&nbsp;<div name="undoradio"></div>\n<tr><p style="text-indent:20px;margin-bottom:0px;">Date form entered: </span></p></tr>	411	\N	1604			20	t		Horizontal		t
\.


--
-- Data for Name: item_group; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.item_group (item_group_id, name, crf_id, status_id, date_created, date_updated, owner_id, update_id, oc_oid) FROM stdin;
1	Ungrouped	1	1	2023-12-03	\N	4	\N	IG_S38_A_UNGROUPED
2	A	1	1	2023-12-03	\N	4	\N	IG_S38_A_A
3	Ungrouped	2	1	2023-12-03	\N	4	\N	IG_S38_A_UNGROUPED_8147
4	A	2	1	2023-12-03	\N	4	\N	IG_S38_A_A_4290
5	Ungrouped	3	1	2023-12-03	\N	4	\N	IG_S38_F_UNGROUPED
6	A	3	1	2023-12-03	\N	4	\N	IG_S38_F_A
7	B	3	1	2023-12-03	\N	4	\N	IG_S38_F_B
8	C	3	1	2023-12-03	\N	4	\N	IG_S38_F_C
9	D	3	1	2023-12-03	\N	4	\N	IG_S38_F_D
15	Ungrouped	5	1	2023-12-04	\N	4	\N	IG_S38_E_UNGROUPED
16	A	5	1	2023-12-04	\N	4	\N	IG_S38_E_A
17	B	5	1	2023-12-04	\N	4	\N	IG_S38_E_B
18	C	5	1	2023-12-04	\N	4	\N	IG_S38_E_C
19	CA	5	1	2023-12-04	\N	4	\N	IG_S38_E_CA
20	CB	5	1	2023-12-04	\N	4	\N	IG_S38_E_CB
21	Ungrouped	6	1	2023-12-04	\N	4	\N	IG_S38_D_UNGROUPED
22	A	6	1	2023-12-04	\N	4	\N	IG_S38_D_A
23	B	6	1	2023-12-04	\N	4	\N	IG_S38_D_B
24	C	6	1	2023-12-04	\N	4	\N	IG_S38_D_C
25	D	6	1	2023-12-04	\N	4	\N	IG_S38_D_D
26	Ungrouped	7	1	2023-12-04	\N	4	\N	IG_S38_H_UNGROUPED
27	A	7	1	2023-12-04	\N	4	\N	IG_S38_H_A
28	who	7	1	2023-12-04	\N	4	\N	IG_S38_H_WHO
29	Ungrouped	8	1	2023-12-05	\N	4	\N	IG_S38_N_UNGROUPED
30	A	8	1	2023-12-05	\N	4	\N	IG_S38_N_A
31	Ungrouped	9	1	2023-12-05	\N	4	\N	IG_S38_T_UNGROUPED
32	A	9	1	2023-12-05	\N	4	\N	IG_S38_T_A
33	Ungrouped	12	1	2023-12-05	\N	4	\N	IG_S38_T_UNGROUPED_1601
34	CDISC1	12	1	2023-12-05	\N	4	\N	IG_S38_T_CDISC1
35	Ungrouped	13	1	2023-12-05	\N	4	\N	IG_S38_I_UNGROUPED
36	CDISC1	13	1	2023-12-05	\N	4	\N	IG_S38_I_CDISC1
37	Ungrouped	25	1	2023-12-05	\N	4	\N	IG_S38_P_UNGROUPED
38	CDISC1	25	1	2023-12-05	\N	4	\N	IG_S38_P_CDISC1
39	Ungrouped	28	1	2023-12-05	\N	4	\N	IG_S38_C_UNGROUPED
40	CDISC1	28	1	2023-12-05	\N	4	\N	IG_S38_C_CDISC1
41	CDISC2	28	1	2023-12-05	\N	4	\N	IG_S38_C_CDISC2
42	Ungrouped	30	1	2023-12-05	\N	4	\N	IG_S38_C_UNGROUPED_3232
43	CDISC1	30	1	2023-12-05	\N	4	\N	IG_S38_C_CDISC1_5498
44	CDISC2	30	1	2023-12-05	\N	4	\N	IG_S38_C_CDISC2_9108
45	CDISC3	30	1	2023-12-05	\N	4	\N	IG_S38_C_CDISC3
46	Ungrouped	32	1	2023-12-05	\N	4	\N	IG_S38_D_UNGROUPED_9646
47	CDISC1	32	1	2023-12-05	\N	4	\N	IG_S38_D_CDISC1
48	CDISC2	32	1	2023-12-05	\N	4	\N	IG_S38_D_CDISC2
49	CDISC3	32	1	2023-12-05	\N	4	\N	IG_S38_D_CDISC3
50	Ungrouped	33	1	2023-12-05	\N	4	\N	IG_S38_D_UNGROUPED_4793
51	CDISC1	33	1	2023-12-05	\N	4	\N	IG_S38_D_CDISC1_4543
52	CDISC2	33	1	2023-12-05	\N	4	\N	IG_S38_D_CDISC2_7644
53	CDISC3	33	1	2023-12-05	\N	4	\N	IG_S38_D_CDISC3_3311
54	Ungrouped	35	1	2023-12-05	\N	4	\N	IG_S38_D_UNGROUPED_4863
55	CDISC1	35	1	2023-12-05	\N	4	\N	IG_S38_D_CDISC1_5848
56	CDISC2	35	1	2023-12-05	\N	4	\N	IG_S38_D_CDISC2_3422
57	CDISC3	35	1	2023-12-05	\N	4	\N	IG_S38_D_CDISC3_1324
58	Ungrouped	44	1	2023-12-06	\N	4	\N	IG_S38_B_UNGROUPED
59	A	44	1	2023-12-06	\N	4	\N	IG_S38_B_A
60	Ungrouped	58	1	2023-12-06	\N	4	\N	IG_S38_T_UNGROUPED_5170
61	A	58	1	2023-12-06	\N	4	\N	IG_S38_T_A_7298
62	Ungrouped	59	1	2023-12-07	\N	4	\N	IG_S38_F_UNGROUPED_3251
63	A	59	1	2023-12-07	\N	4	\N	IG_S38_F_A_5858
64	Research	59	1	2023-12-07	\N	4	\N	IG_S38_F_RESEARCH
65	Ungrouped	63	1	2023-12-07	\N	4	\N	IG_S38_P_UNGROUPED_4299
66	A	63	1	2023-12-07	\N	4	\N	IG_S38_P_A
67	Ungrouped	65	1	2023-12-08	\N	4	\N	IG_S38_F_UNGROUPED_6411
68	A	65	1	2023-12-08	\N	4	\N	IG_S38_F_A_5893
69	B	65	1	2023-12-08	\N	4	\N	IG_S38_F_B_3883
70	C	65	1	2023-12-08	\N	4	\N	IG_S38_F_C_2926
71	D	65	1	2023-12-08	\N	4	\N	IG_S38_F_D_9804
72	E	65	1	2023-12-08	\N	4	\N	IG_S38_F_E
73	F	65	1	2023-12-08	\N	4	\N	IG_S38_F_F
74	Ungrouped	66	1	2023-12-09	\N	4	\N	IG_S38_C_UNGROUPED_628
75	CDISC1	66	1	2023-12-09	\N	4	\N	IG_S38_C_CDISC1_5425
76	CDISC2	66	1	2023-12-09	\N	4	\N	IG_S38_C_CDISC2_4275
77	CDISC3	66	1	2023-12-09	\N	4	\N	IG_S38_C_CDISC3_4476
78	Ungrouped	69	1	2023-12-09	\N	4	\N	IG_S38_D_UNGROUPED_6447
79	CDISC1	69	1	2023-12-09	\N	4	\N	IG_S38_D_CDISC1_5116
80	CDISC2	69	1	2023-12-09	\N	4	\N	IG_S38_D_CDISC2_3174
81	CDISC3	69	1	2023-12-09	\N	4	\N	IG_S38_D_CDISC3_9364
82	Ungrouped	70	1	2023-12-09	\N	4	\N	IG_S38_P_UNGROUPED_2417
83	CDISC1	70	1	2023-12-09	\N	4	\N	IG_S38_P_CDISC1_9056
84	Ungrouped	71	1	2023-12-10	\N	4	\N	IG_S38_T_UNGROUPED_3786
85	A	71	1	2023-12-10	\N	4	\N	IG_S38_T_A_2303
86	Food	71	1	2023-12-10	\N	4	\N	IG_S38_T_FOOD
87	Ungrouped	73	1	2023-12-10	\N	4	\N	IG_T1_TF_UNGROUPED
88	A	73	1	2023-12-10	\N	4	\N	IG_T1_TF_A
89	B	73	1	2023-12-10	\N	4	\N	IG_T1_TF_B
90	Ungrouped	76	1	2023-12-10	\N	4	\N	IG_S38_F_UNGROUPED_8732
91	A	76	1	2023-12-10	\N	4	\N	IG_S38_F_A_4545
92	B	76	1	2023-12-10	\N	4	\N	IG_S38_F_B_8366
93	C	76	1	2023-12-10	\N	4	\N	IG_S38_F_C_5364
94	Ungrouped	79	1	2023-12-10	\N	4	\N	IG_S38_F_UNGROUPED_1795
95	A	79	1	2023-12-10	\N	4	\N	IG_S38_F_A_592
96	Ungrouped	80	1	2023-12-11	\N	4	\N	IG_S38_T_UNGROUPED_5580
97	A	80	1	2023-12-11	\N	4	\N	IG_S38_T_A_3557
98	Food	80	1	2023-12-11	\N	4	\N	IG_S38_T_FOOD_5272
99	Ungrouped	82	1	2023-12-12	\N	4	\N	IG_S38_P_UNGROUPED_1506
100	A	82	1	2023-12-12	\N	4	\N	IG_S38_P_A_9748
101	Ungrouped	84	1	2023-12-17	\N	8	\N	IG_38_TX_UNGROUPED
102	A	84	1	2023-12-17	\N	8	\N	IG_38_TX_A
103	B	84	1	2023-12-17	\N	8	\N	IG_38_TX_B
104	C	84	1	2023-12-17	\N	8	\N	IG_38_TX_C
105	CA	84	1	2023-12-17	\N	8	\N	IG_38_TX_CA
106	CB	84	1	2023-12-17	\N	8	\N	IG_38_TX_CB
107	D	84	1	2023-12-17	\N	8	\N	IG_38_TX_D
108	E	84	1	2023-12-17	\N	8	\N	IG_38_TX_E
109	Ungrouped	85	1	2023-12-18	\N	4	\N	IG_S38_T_UNGROUPED_778
110	A	85	1	2023-12-18	\N	4	\N	IG_S38_T_A_6759
111	Ungrouped	87	1	2023-12-18	\N	4	\N	IG_38_TX_UNGROUPED_4450
112	A	87	1	2023-12-18	\N	4	\N	IG_38_TX_A_2922
113	Ungrouped	88	1	2023-12-18	\N	4	\N	IG_38_PK_UNGROUPED
114	A	88	1	2023-12-18	\N	4	\N	IG_38_PK_A
115	Ungrouped	90	1	2023-12-19	\N	4	\N	IG_38_EN_UNGROUPED
116	A	90	1	2023-12-19	\N	4	\N	IG_38_EN_A
117	B	90	1	2023-12-19	\N	4	\N	IG_38_EN_B
118	C	90	1	2023-12-19	\N	4	\N	IG_38_EN_C
119	CA	90	1	2023-12-19	\N	4	\N	IG_38_EN_CA
120	CB	90	1	2023-12-19	\N	4	\N	IG_38_EN_CB
121	CC	90	1	2023-12-19	\N	4	\N	IG_38_EN_CC
122	Ungrouped	92	1	2023-12-19	\N	4	\N	IG_38_AE_UNGROUPED
123	A	92	1	2023-12-19	\N	4	\N	IG_38_AE_A
124	Ungrouped	93	1	2023-12-19	\N	4	\N	IG_38_AF_UNGROUPED
125	A	93	1	2023-12-19	\N	4	\N	IG_38_AF_A
126	Ungrouped	94	1	2023-12-20	\N	8	\N	IG_38_IP_UNGROUPED
127	A	94	1	2023-12-20	\N	8	\N	IG_38_IP_A
128	FoodHeader	94	1	2023-12-20	\N	8	\N	IG_38_IP_FOODHEADER
129	Food	94	1	2023-12-20	\N	8	\N	IG_38_IP_FOOD
130	Ungrouped	96	1	2023-12-21	\N	4	\N	IG_38_IP_UNGROUPED_5222
131	A	96	1	2023-12-21	\N	4	\N	IG_38_IP_A_5635
132	FoodHeader	96	1	2023-12-21	\N	4	\N	IG_38_IP_FOODHEADER_1424
133	Food	96	1	2023-12-21	\N	4	\N	IG_38_IP_FOOD_8741
134	Ungrouped	98	1	2023-12-22	\N	4	\N	IG_38_DE_UNGROUPED
135	A	98	1	2023-12-22	\N	4	\N	IG_38_DE_A
136	Ungrouped	99	1	2023-12-22	\N	4	\N	IG_38_HX_UNGROUPED
137	A	99	1	2023-12-22	\N	4	\N	IG_38_HX_A
138	who	99	1	2023-12-22	\N	4	\N	IG_38_HX_WHO
\.


--
-- Data for Name: item_group_metadata; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.item_group_metadata (item_group_metadata_id, item_group_id, header, subheader, layout, repeat_number, repeat_max, repeat_array, row_start_number, crf_version_id, item_id, ordinal, borders, show_group, repeating_group) FROM stdin;
1151	97	Visit Information			1	1		0	63	867	1	\N	t	f
1152	97	Visit Information			1	1		0	63	868	2	\N	t	f
1153	97	Visit Information			1	1		0	63	869	3	\N	t	f
1154	97	Visit Information			1	1		0	63	870	4	\N	t	f
1155	97	Visit Information			1	1		0	63	871	5	\N	t	f
1156	97	Visit Information			1	1		0	63	872	6	\N	t	f
1157	97	Visit Information			1	1		0	63	873	7	\N	t	f
1158	97	Visit Information			1	1		0	63	874	8	\N	t	f
1159	97	Visit Information			1	1		0	63	875	9	\N	t	f
1160	97	Visit Information			1	1		0	63	876	10	\N	t	f
1161	97	Visit Information			1	1		0	63	877	11	\N	t	f
1162	97	Visit Information			1	1		0	63	878	12	\N	t	f
1163	97	Visit Information			1	1		0	63	879	13	\N	t	f
1164	97	Visit Information			1	1		0	63	880	14	\N	t	f
1165	97	Visit Information			1	1		0	63	881	15	\N	t	f
1166	98	Food within + 1 Hour of Dose			1	40		0	63	882	16	\N	t	t
1167	98	Food within + 1 Hour of Dose			1	40		0	63	883	17	\N	t	t
1168	98	Food within + 1 Hour of Dose			1	40		0	63	884	18	\N	t	t
1169	98	Food within + 1 Hour of Dose			1	40		0	63	885	19	\N	t	t
1170	98	Food within + 1 Hour of Dose			1	40		0	63	886	20	\N	t	t
1171	97	Visit Information			1	1		0	63	887	21	\N	t	f
1172	97	Visit Information			1	1		0	63	888	22	\N	t	f
1173	97	Visit Information			1	1		0	63	889	23	\N	t	f
1174	97	Visit Information			1	1		0	63	890	24	\N	t	f
1175	97	Visit Information			1	1		0	63	891	25	\N	t	f
1176	97	Visit Information			1	1		0	63	892	26	\N	t	f
1177	97	Visit Information			1	1		0	63	893	27	\N	t	f
1178	97	Visit Information			1	1		0	63	894	28	\N	t	f
1179	97	Visit Information			1	1		0	63	895	29	\N	t	f
1180	97	Visit Information			1	1		0	63	896	30	\N	t	f
1181	97	Visit Information			1	1		0	63	897	31	\N	t	f
1182	97	Visit Information			1	1		0	63	898	32	\N	t	f
1183	97	Visit Information			1	1		0	63	899	33	\N	t	f
1184	97	Visit Information			1	1		0	63	900	34	\N	t	f
1185	97	Visit Information			1	1		0	63	901	35	\N	t	f
1186	97	Visit Information			1	1		0	63	902	36	\N	t	f
5586	137	Participant History			1	1		0	148	3728	1	\N	t	f
5587	137	Participant History			1	1		0	148	3706	2	\N	t	f
5588	137	Participant History			1	1		0	148	3736	3	\N	t	f
5589	137	Participant History			1	1		0	148	3696	4	\N	t	f
5590	137	Participant History			1	1		0	148	3740	5	\N	t	f
5591	137	Participant History			1	1		0	148	3759	6	\N	t	f
5592	137	Participant History			1	1		0	148	3756	7	\N	t	f
294	30	Patient Information			1	1		0	10	309	1	\N	t	f
295	29				1	1		1	10	310	2	\N	t	f
296	29				1	1		1	10	311	3	\N	t	f
297	29				1	1		1	10	312	4	\N	t	f
298	29				1	1		1	10	313	5	\N	t	f
299	29				1	1		1	10	314	6	\N	t	f
300	29				1	1		1	10	315	7	\N	t	f
301	30	Patient Information			1	1		0	10	316	8	\N	t	f
302	30	Patient Information			1	1		0	10	317	9	\N	t	f
303	29				1	1		1	10	318	10	\N	t	f
304	29				1	1		1	10	319	11	\N	t	f
305	29				1	1		1	10	320	12	\N	t	f
306	29				1	1		1	10	321	13	\N	t	f
307	29				1	1		1	10	322	14	\N	t	f
308	29				1	1		1	10	323	15	\N	t	f
309	29				1	1		1	10	324	16	\N	t	f
310	29				1	1		1	10	325	17	\N	t	f
311	30	Patient Information			1	1		0	10	326	18	\N	t	f
312	30	Patient Information			1	1		0	10	327	19	\N	t	f
313	30	Patient Information			1	1		0	10	328	20	\N	t	f
5593	137	Participant History			1	1		0	148	3747	8	\N	t	f
5594	137	Participant History			1	1		0	148	3748	9	\N	t	f
5595	137	Participant History			1	1		0	148	3719	10	\N	t	f
78	3				1	1		1	3	94	1	\N	t	f
79	3				1	1		1	3	86	2	\N	t	f
80	3				1	1		1	3	81	3	\N	t	f
81	3				1	1		1	3	79	4	\N	t	f
82	3				1	1		1	3	78	5	\N	t	f
83	3				1	1		1	3	97	6	\N	t	f
84	3				1	1		1	3	105	7	\N	t	f
85	3				1	1		1	3	106	8	\N	t	f
86	3				1	1		1	3	91	9	\N	t	f
87	3				1	1		1	3	90	10	\N	t	f
88	3				1	1		1	3	92	11	\N	t	f
89	3				1	1		1	3	108	12	\N	t	f
90	3				1	1		1	3	80	13	\N	t	f
91	3				1	1		1	3	89	14	\N	t	f
92	3				1	1		1	3	82	15	\N	t	f
93	3				1	1		1	3	98	16	\N	t	f
94	3				1	1		1	3	93	17	\N	t	f
95	3				1	1		1	3	102	18	\N	t	f
96	3				1	1		1	3	85	19	\N	t	f
97	3				1	1		1	3	100	20	\N	t	f
98	3				1	1		1	3	83	21	\N	t	f
99	3				1	1		1	3	88	22	\N	t	f
100	3				1	1		1	3	84	23	\N	t	f
101	3				1	1		1	3	107	24	\N	t	f
102	3				1	1		1	3	101	25	\N	t	f
103	3				1	1		1	3	103	26	\N	t	f
104	3				1	1		1	3	104	27	\N	t	f
105	3				1	1		1	3	87	28	\N	t	f
106	3				1	1		1	3	96	29	\N	t	f
107	3				1	1		1	3	95	30	\N	t	f
108	3				1	1		1	3	109	31	\N	t	f
109	3				1	1		1	3	111	32	\N	t	f
110	3				1	1		1	3	110	33	\N	t	f
111	3				1	1		1	3	99	34	\N	t	f
112	6	Visit			1	1		0	4	112	1	\N	t	f
113	6	Visit			1	1		0	4	113	2	\N	t	f
114	7	Evaluation			1	1		0	4	114	3	\N	t	f
115	7	Evaluation			1	1		0	4	115	4	\N	t	f
116	7	Evaluation			1	1		0	4	116	5	\N	t	f
117	7	Evaluation			1	1		0	4	117	6	\N	t	f
118	7	Evaluation			1	1		0	4	118	7	\N	t	f
119	7	Evaluation			1	1		0	4	119	8	\N	t	f
120	7	Evaluation			1	1		0	4	120	9	\N	t	f
121	7	Evaluation			1	1		0	4	121	10	\N	t	f
122	7	Evaluation			1	1		0	4	122	11	\N	t	f
123	7	Evaluation			1	1		0	4	123	12	\N	t	f
124	8	Comments			1	1		0	4	124	13	\N	t	f
125	9	Form Completion			1	1		0	4	125	14	\N	t	f
126	9	Form Completion			1	1		0	4	126	15	\N	t	f
5596	137	Participant History			1	1		0	148	3758	11	\N	t	f
326	33				1	1		1	12	341	1	\N	t	f
327	33				1	1		1	12	342	2	\N	t	f
130	16	Study Entry Enrollment			1	1		0	6	145	1	\N	t	f
131	16	Study Entry Enrollment			1	1		0	6	146	2	\N	t	f
132	16	Study Entry Enrollment			1	1		0	6	147	3	\N	t	f
133	16	Study Entry Enrollment			1	1		0	6	148	4	\N	t	f
134	16	Study Entry Enrollment			1	1		0	6	149	5	\N	t	f
135	16	Study Entry Enrollment			1	1		0	6	150	6	\N	t	f
136	16	Study Entry Enrollment			1	1		0	6	151	7	\N	t	f
137	16	Study Entry Enrollment			1	1		0	6	152	8	\N	t	f
138	16	Study Entry Enrollment			1	1		0	6	153	9	\N	t	f
139	16	Study Entry Enrollment			1	1		0	6	154	10	\N	t	f
140	16	Study Entry Enrollment			1	1		0	6	155	11	\N	t	f
141	16	Study Entry Enrollment			1	1		0	6	156	12	\N	t	f
142	16	Study Entry Enrollment			1	1		0	6	157	13	\N	t	f
143	17	Comments			1	1		0	6	158	14	\N	t	f
144	18	Form Completion			1	1		0	6	159	15	\N	t	f
145	18	Form Completion			1	1		0	6	160	16	\N	t	f
146	19	Treatment Assigment upon Successful Enrollment Submission			1	1		0	6	161	17	\N	t	f
147	20	Intensive Phase Study Therapy			1	40		0	6	162	18	\N	t	t
148	20	Intensive Phase Study Therapy			1	40		0	6	163	19	\N	t	t
149	20	Intensive Phase Study Therapy			1	40		0	6	164	20	\N	t	t
150	22	Information Concerning Death			1	1		0	7	165	1	\N	t	f
151	22	Information Concerning Death			1	1		0	7	166	2	\N	t	f
152	22	Information Concerning Death			1	1		0	7	167	3	\N	t	f
153	22	Information Concerning Death			1	1		0	7	168	4	\N	t	f
154	22	Information Concerning Death			1	1		0	7	169	5	\N	t	f
155	22	Information Concerning Death			1	1		0	7	170	6	\N	t	f
156	22	Information Concerning Death			1	1		0	7	171	7	\N	t	f
157	22	Information Concerning Death			1	1		0	7	172	8	\N	t	f
158	22	Information Concerning Death			1	1		0	7	173	9	\N	t	f
159	22	Information Concerning Death			1	1		0	7	174	10	\N	t	f
160	22	Information Concerning Death			1	1		0	7	175	11	\N	t	f
161	23	Narrative regarding the circumstances of the death and any relationship to study treatment			1	1		0	7	176	12	\N	t	f
162	24	Form Completion			1	1		0	7	177	13	\N	t	f
163	24	Form Completion			1	1		0	7	178	14	\N	t	f
164	24	Form Completion			1	1		0	7	179	15	\N	t	f
165	24	Form Completion			1	1		0	7	180	16	\N	t	f
166	24	Form Completion			1	1		0	7	181	17	\N	t	f
167	24	Form Completion			1	1		0	7	182	18	\N	t	f
328	33				1	1		1	12	343	3	\N	t	f
329	33				1	1		1	12	344	4	\N	t	f
330	33				1	1		1	12	345	5	\N	t	f
331	33				1	1		1	12	346	6	\N	t	f
332	33				1	1		1	12	347	7	\N	t	f
333	33				1	1		1	13	341	1	\N	t	f
334	33				1	1		1	13	342	2	\N	t	f
335	33				1	1		1	13	343	3	\N	t	f
336	33				1	1		1	13	344	4	\N	t	f
337	33				1	1		1	13	345	5	\N	t	f
338	33				1	1		1	13	346	6	\N	t	f
339	33				1	1		1	13	347	7	\N	t	f
340	33				1	1		1	14	348	1	\N	t	f
341	33				1	1		1	14	342	2	\N	t	f
342	33				1	1		1	14	343	3	\N	t	f
343	33				1	1		1	14	344	4	\N	t	f
344	33				1	1		1	14	345	5	\N	t	f
345	33				1	1		1	14	346	6	\N	t	f
346	33				1	1		1	14	347	7	\N	t	f
347	35				1	1		1	15	349	1	\N	t	f
348	35				1	1		1	15	350	2	\N	t	f
349	35				1	1		1	15	351	3	\N	t	f
350	35				1	1		1	15	352	4	\N	t	f
351	35				1	1		1	15	353	5	\N	t	f
352	35				1	1		1	15	354	6	\N	t	f
353	35				1	1		1	15	355	7	\N	t	f
354	35				1	1		1	15	356	8	\N	t	f
355	35				1	1		1	15	357	9	\N	t	f
373	39				1	1		1	17	375	1	\N	t	f
374	41				1	40		0	17	376	2	\N	t	t
375	41				1	40		0	17	377	3	\N	t	t
376	41				1	40		0	17	378	4	\N	t	t
377	41				1	40		0	17	379	5	\N	t	t
378	41				1	40		0	17	380	6	\N	t	t
379	41				1	40		0	17	381	7	\N	t	t
380	39				1	1		1	17	382	8	\N	t	f
381	39				1	1		1	17	383	9	\N	t	f
382	39				1	1		1	17	384	10	\N	t	f
383	42				1	1		1	18	385	1	\N	t	f
384	44				1	40		0	18	386	2	\N	t	t
385	44				1	40		0	18	387	3	\N	t	t
386	44				1	40		0	18	388	4	\N	t	t
387	45				1	40		0	18	389	5	\N	t	t
388	45				1	40		0	18	390	6	\N	t	t
389	45				1	40		0	18	391	7	\N	t	t
390	42				1	1		1	18	392	8	\N	t	f
391	42				1	1		1	18	393	9	\N	t	f
392	42				1	1		1	18	394	10	\N	t	f
393	47				1	1		0	19	395	1	\N	t	f
394	48				1	40		0	19	396	2	\N	t	t
395	48				1	40		0	19	397	3	\N	t	t
396	48				1	40		0	19	398	4	\N	t	t
397	48				1	40		0	19	399	5	\N	t	t
398	48				1	40		0	19	400	6	\N	t	t
399	48				1	40		0	19	401	7	\N	t	t
400	48				1	40		0	19	402	8	\N	t	t
401	48				1	40		0	19	403	9	\N	t	t
402	48				1	40		0	19	404	10	\N	t	t
403	48				1	40		0	19	405	11	\N	t	t
404	48				1	40		0	19	406	12	\N	t	t
405	48				1	40		0	19	407	13	\N	t	t
406	49				1	1		0	19	408	14	\N	t	f
407	49				1	1		0	19	409	15	\N	t	f
408	49				1	1		0	19	410	16	\N	t	f
409	51				1	1		0	20	411	1	\N	t	f
410	52				1	40		0	20	412	2	\N	t	t
231	26				1	1		1	9	258	1	\N	t	f
232	27	Participant History			1	1		0	9	283	2	\N	t	f
233	27	Participant History			1	1		0	9	249	3	\N	t	f
234	27	Participant History			1	1		0	9	288	4	\N	t	f
235	27	Participant History			1	1		0	9	304	5	\N	t	f
236	27	Participant History			1	1		0	9	295	6	\N	t	f
237	27	Participant History			1	1		0	9	296	7	\N	t	f
238	27	Participant History			1	1		0	9	269	8	\N	t	f
239	27	Participant History			1	1		0	9	305	9	\N	t	f
240	27	Participant History			1	1		0	9	261	10	\N	t	f
241	27	Participant History			1	1		0	9	282	11	\N	t	f
242	27	Participant History			1	1		0	9	294	12	\N	t	f
243	27	Participant History			1	1		0	9	248	13	\N	t	f
244	27	Participant History			1	1		0	9	260	14	\N	t	f
245	27	Participant History			1	1		0	9	285	15	\N	t	f
246	27	Participant History			1	1		0	9	289	16	\N	t	f
247	27	Participant History			1	1		0	9	266	17	\N	t	f
248	27	Participant History			1	1		0	9	301	18	\N	t	f
249	27	Participant History			1	1		0	9	293	19	\N	t	f
250	27	Participant History			1	1		0	9	287	20	\N	t	f
251	27	Participant History			1	1		0	9	264	21	\N	t	f
252	27	Participant History			1	1		0	9	273	22	\N	t	f
253	27	Participant History			1	1		0	9	270	23	\N	t	f
254	27	Participant History			1	1		0	9	267	24	\N	t	f
255	27	Participant History			1	1		0	9	271	25	\N	t	f
256	27	Participant History			1	1		0	9	246	26	\N	t	f
257	27	Participant History			1	1		0	9	306	27	\N	t	f
258	27	Participant History			1	1		0	9	276	28	\N	t	f
259	26				1	1		1	9	252	29	\N	t	f
260	26				1	1		1	9	256	30	\N	t	f
261	26				1	1		1	9	300	31	\N	t	f
262	26				1	1		1	9	263	32	\N	t	f
263	26				1	1		1	9	250	33	\N	t	f
411	52				1	40		0	20	413	3	\N	t	t
412	52				1	40		0	20	414	4	\N	t	t
413	52				1	40		0	20	415	5	\N	t	t
414	52				1	40		0	20	416	6	\N	t	t
415	52				1	40		0	20	417	7	\N	t	t
416	52				1	40		0	20	418	8	\N	t	t
417	52				1	40		0	20	419	9	\N	t	t
264	26				1	1		1	9	274	34	\N	t	f
265	26				1	1		1	9	254	35	\N	t	f
266	26				1	1		1	9	255	36	\N	t	f
267	26				1	1		1	9	272	37	\N	t	f
268	26				1	1		1	9	297	38	\N	t	f
269	26				1	1		1	9	302	39	\N	t	f
270	26				1	1		1	9	265	40	\N	t	f
271	26				1	1		1	9	290	41	\N	t	f
272	26				1	1		1	9	307	42	\N	t	f
273	26				1	1		1	9	268	43	\N	t	f
274	26				1	1		1	9	298	44	\N	t	f
275	26				1	1		1	9	247	45	\N	t	f
276	26				1	1		1	9	253	46	\N	t	f
277	26				1	1		1	9	308	47	\N	t	f
278	26				1	1		1	9	286	48	\N	t	f
279	26				1	1		1	9	262	49	\N	t	f
280	26				1	1		1	9	281	50	\N	t	f
281	27	Participant History			1	1		0	9	303	51	\N	t	f
282	26				1	1		1	9	278	52	\N	t	f
283	26				1	1		1	9	251	53	\N	t	f
284	26				1	1		1	9	279	54	\N	t	f
285	26				1	1		1	9	259	55	\N	t	f
286	28	List WHO Clinical Stage 4 Conditions and provide month and year			1	40		0	9	299	56	\N	t	t
287	28	List WHO Clinical Stage 4 Conditions and provide month and year			1	40		0	9	284	57	\N	t	t
288	28	List WHO Clinical Stage 4 Conditions and provide month and year			1	40		0	9	291	58	\N	t	t
289	27	Participant History			1	1		0	9	275	59	\N	t	f
290	27	Participant History			1	1		0	9	257	60	\N	t	f
291	27	Participant History			1	1		0	9	280	61	\N	t	f
292	27	Participant History			1	1		0	9	292	62	\N	t	f
293	27	Participant History			1	1		0	9	277	63	\N	t	f
356	37				1	1		1	16	358	1	\N	t	f
357	37				1	1		1	16	359	2	\N	t	f
358	37				1	1		1	16	360	3	\N	t	f
359	37				1	1		1	16	361	4	\N	t	f
360	37				1	1		1	16	362	5	\N	t	f
361	37				1	1		1	16	363	6	\N	t	f
362	37				1	1		1	16	364	7	\N	t	f
363	37				1	1		1	16	365	8	\N	t	f
364	37				1	1		1	16	366	9	\N	t	f
365	37				1	1		1	16	367	10	\N	t	f
366	37				1	1		1	16	368	11	\N	t	f
367	37				1	1		1	16	369	12	\N	t	f
368	37				1	1		1	16	370	13	\N	t	f
369	37				1	1		1	16	371	14	\N	t	f
370	37				1	1		1	16	372	15	\N	t	f
371	37				1	1		1	16	373	16	\N	t	f
372	37				1	1		1	16	374	17	\N	t	f
418	52				1	40		0	20	420	10	\N	t	t
419	52				1	40		0	20	421	11	\N	t	t
420	52				1	40		0	20	422	12	\N	t	t
421	52				1	40		0	20	423	13	\N	t	t
422	53				1	1		0	20	424	14	\N	t	f
423	53				1	1		0	20	425	15	\N	t	f
424	53				1	1		0	20	426	16	\N	t	f
425	55				1	1		0	21	427	1	\N	t	f
426	56				1	40		0	21	428	2	\N	t	t
427	56				1	40		0	21	429	3	\N	t	t
428	56				1	40		0	21	430	4	\N	t	t
429	56				1	40		0	21	431	5	\N	t	t
430	56				1	40		0	21	432	6	\N	t	t
431	56				1	40		0	21	433	7	\N	t	t
432	56				1	40		0	21	434	8	\N	t	t
433	56				1	40		0	21	435	9	\N	t	t
434	56				1	40		0	21	436	10	\N	t	t
435	56				1	40		0	21	437	11	\N	t	t
436	56				1	40		0	21	438	12	\N	t	t
437	56				1	40		0	21	439	13	\N	t	t
438	57				1	1		0	21	440	14	\N	t	f
439	57				1	1		0	21	441	15	\N	t	f
440	57				1	1		0	21	442	16	\N	t	f
441	59	Blood Collection and Shipping			1	1		0	22	443	1	\N	t	f
442	58				1	1		1	22	444	2	\N	t	f
443	58				1	1		1	22	445	3	\N	t	f
444	58				1	1		1	22	446	4	\N	t	f
445	58				1	1		1	22	447	5	\N	t	f
446	59	Blood Collection and Shipping			1	1		0	22	448	6	\N	t	f
447	58				1	1		1	22	449	7	\N	t	f
448	59	Blood Collection and Shipping			1	1		0	22	450	8	\N	t	f
449	58				1	1		1	22	451	9	\N	t	f
450	58				1	1		1	22	452	10	\N	t	f
451	58				1	1		1	22	453	11	\N	t	f
452	58				1	1		1	22	454	12	\N	t	f
453	59	Blood Collection and Shipping			1	1		0	22	455	13	\N	t	f
454	59	Blood Collection and Shipping			1	1		0	22	456	14	\N	t	f
455	58				1	1		1	22	457	15	\N	t	f
456	59	Blood Collection and Shipping			1	1		0	22	458	16	\N	t	f
457	59	Blood Collection and Shipping			1	1		0	22	459	17	\N	t	f
458	1				1	1		1	23	1	1	\N	t	f
459	1				1	1		1	23	2	2	\N	t	f
460	1				1	1		1	23	3	3	\N	t	f
461	1				1	1		1	23	4	4	\N	t	f
462	1				1	1		1	23	5	5	\N	t	f
463	1				1	1		1	23	6	6	\N	t	f
464	1				1	1		1	23	7	7	\N	t	f
465	1				1	1		1	23	8	8	\N	t	f
466	1				1	1		1	23	9	9	\N	t	f
467	1				1	1		1	23	10	10	\N	t	f
468	1				1	1		1	23	11	11	\N	t	f
469	1				1	1		1	23	12	12	\N	t	f
470	1				1	1		1	23	13	13	\N	t	f
471	1				1	1		1	23	14	14	\N	t	f
472	1				1	1		1	23	15	15	\N	t	f
473	1				1	1		1	23	16	16	\N	t	f
474	1				1	1		1	23	17	17	\N	t	f
475	1				1	1		1	23	18	18	\N	t	f
476	1				1	1		1	23	19	19	\N	t	f
477	1				1	1		1	23	20	20	\N	t	f
478	1				1	1		1	23	21	21	\N	t	f
479	1				1	1		1	23	22	22	\N	t	f
480	1				1	1		1	23	23	23	\N	t	f
481	1				1	1		1	23	24	24	\N	t	f
482	1				1	1		1	23	25	25	\N	t	f
483	1				1	1		1	23	26	26	\N	t	f
484	1				1	1		1	23	27	27	\N	t	f
485	1				1	1		1	23	28	28	\N	t	f
486	1				1	1		1	23	29	29	\N	t	f
487	1				1	1		1	23	30	30	\N	t	f
488	1				1	1		1	23	31	31	\N	t	f
489	1				1	1		1	23	32	32	\N	t	f
490	1				1	1		1	23	33	33	\N	t	f
491	1				1	1		1	23	34	34	\N	t	f
492	1				1	1		1	23	35	35	\N	t	f
493	1				1	1		1	23	36	36	\N	t	f
494	1				1	1		1	23	37	37	\N	t	f
495	1				1	1		1	23	38	38	\N	t	f
496	1				1	1		1	23	39	39	\N	t	f
497	1				1	1		1	23	40	40	\N	t	f
498	1				1	1		1	23	41	41	\N	t	f
499	1				1	1		1	23	42	42	\N	t	f
500	1				1	1		1	23	43	43	\N	t	f
501	59	Blood Collection and Shipping			1	1		0	24	443	1	\N	t	f
502	58				1	1		1	24	444	2	\N	t	f
503	58				1	1		1	24	445	3	\N	t	f
504	58				1	1		1	24	446	4	\N	t	f
505	58				1	1		1	24	447	5	\N	t	f
506	59	Blood Collection and Shipping			1	1		0	24	448	6	\N	t	f
507	58				1	1		1	24	449	7	\N	t	f
508	59	Blood Collection and Shipping			1	1		0	24	450	8	\N	t	f
509	58				1	1		1	24	451	9	\N	t	f
510	58				1	1		1	24	452	10	\N	t	f
511	58				1	1		1	24	453	11	\N	t	f
512	58				1	1		1	24	454	12	\N	t	f
513	59	Blood Collection and Shipping			1	1		0	24	455	13	\N	t	f
514	59	Blood Collection and Shipping			1	1		0	24	456	14	\N	t	f
515	58				1	1		1	24	457	15	\N	t	f
516	59	Blood Collection and Shipping			1	1		0	24	458	16	\N	t	f
517	59	Blood Collection and Shipping			1	1		0	24	459	17	\N	t	f
518	61				1	1		0	25	460	1	\N	t	f
519	60				1	1		1	25	461	2	\N	t	f
520	60				1	1		1	25	462	3	\N	t	f
521	60				1	1		1	25	463	4	\N	t	f
522	60				1	1		1	25	464	5	\N	t	f
523	60				1	1		1	25	465	6	\N	t	f
524	60				1	1		1	25	466	7	\N	t	f
525	60				1	1		1	25	467	8	\N	t	f
526	60				1	1		1	25	468	9	\N	t	f
527	61				1	1		0	25	469	10	\N	t	f
528	60				1	1		1	25	470	11	\N	t	f
529	60				1	1		1	25	471	12	\N	t	f
530	60				1	1		1	25	472	13	\N	t	f
531	60				1	1		1	25	473	14	\N	t	f
532	61				1	1		0	25	474	15	\N	t	f
533	60				1	1		1	25	475	16	\N	t	f
534	60				1	1		1	25	476	17	\N	t	f
535	60				1	1		1	25	477	18	\N	t	f
536	60				1	1		1	25	478	19	\N	t	f
537	60				1	1		1	25	479	20	\N	t	f
538	61				1	1		0	25	480	21	\N	t	f
539	61				1	1		0	25	481	22	\N	t	f
540	60				1	1		1	25	482	23	\N	t	f
541	60				1	1		1	25	483	24	\N	t	f
542	60				1	1		1	25	484	25	\N	t	f
543	60				1	1		1	25	485	26	\N	t	f
544	1				1	1		1	26	1	1	\N	t	f
545	1				1	1		1	26	2	2	\N	t	f
546	1				1	1		1	26	3	3	\N	t	f
547	1				1	1		1	26	4	4	\N	t	f
548	1				1	1		1	26	5	5	\N	t	f
549	1				1	1		1	26	6	6	\N	t	f
550	1				1	1		1	26	7	7	\N	t	f
551	1				1	1		1	26	8	8	\N	t	f
552	1				1	1		1	26	9	9	\N	t	f
553	1				1	1		1	26	10	10	\N	t	f
554	1				1	1		1	26	11	11	\N	t	f
555	1				1	1		1	26	12	12	\N	t	f
556	1				1	1		1	26	13	13	\N	t	f
557	1				1	1		1	26	14	14	\N	t	f
558	1				1	1		1	26	15	15	\N	t	f
559	1				1	1		1	26	16	16	\N	t	f
560	1				1	1		1	26	17	17	\N	t	f
561	1				1	1		1	26	18	18	\N	t	f
562	1				1	1		1	26	19	19	\N	t	f
563	1				1	1		1	26	20	20	\N	t	f
564	1				1	1		1	26	21	21	\N	t	f
565	1				1	1		1	26	22	22	\N	t	f
566	1				1	1		1	26	23	23	\N	t	f
567	1				1	1		1	26	24	24	\N	t	f
568	1				1	1		1	26	25	25	\N	t	f
569	1				1	1		1	26	486	26	\N	t	f
570	1				1	1		1	26	26	27	\N	t	f
571	1				1	1		1	26	27	28	\N	t	f
572	1				1	1		1	26	28	29	\N	t	f
573	1				1	1		1	26	29	30	\N	t	f
574	1				1	1		1	26	30	31	\N	t	f
575	1				1	1		1	26	31	32	\N	t	f
576	1				1	1		1	26	32	33	\N	t	f
577	1				1	1		1	26	33	34	\N	t	f
578	1				1	1		1	26	34	35	\N	t	f
579	1				1	1		1	26	35	36	\N	t	f
580	1				1	1		1	26	36	37	\N	t	f
581	1				1	1		1	26	37	38	\N	t	f
582	1				1	1		1	26	38	39	\N	t	f
583	1				1	1		1	26	39	40	\N	t	f
584	1				1	1		1	26	40	41	\N	t	f
585	1				1	1		1	26	41	42	\N	t	f
586	1				1	1		1	26	42	43	\N	t	f
587	1				1	1		1	26	43	44	\N	t	f
588	42				1	1		1	27	385	1	\N	t	f
589	44				1	40		0	27	386	2	\N	t	t
590	44				1	40		0	27	387	3	\N	t	t
591	44				1	40		0	27	388	4	\N	t	t
592	45				1	40		0	27	389	5	\N	t	t
593	45				1	40		0	27	390	6	\N	t	t
594	45				1	40		0	27	391	7	\N	t	t
595	42				1	1		1	27	392	8	\N	t	f
596	42				1	1		1	27	393	9	\N	t	f
597	42				1	1		1	27	394	10	\N	t	f
598	42				1	1		1	27	487	11	\N	t	f
599	42				1	1		1	28	385	1	\N	t	f
600	44				1	40		0	28	386	2	\N	t	t
601	44				1	40		0	28	387	3	\N	t	t
602	44				1	40		0	28	388	4	\N	t	t
603	45				1	40		0	28	389	5	\N	t	t
604	45				1	40		0	28	390	6	\N	t	t
605	45				1	40		0	28	391	7	\N	t	t
606	42				1	1		1	28	392	8	\N	t	f
607	42				1	1		1	28	393	9	\N	t	f
608	42				1	1		1	28	394	10	\N	t	f
609	42				1	1		1	28	487	11	\N	t	f
610	42				1	1		1	29	385	1	\N	t	f
611	44				1	40		0	29	386	2	\N	t	t
612	44				1	40		0	29	387	3	\N	t	t
613	44				1	40		0	29	388	4	\N	t	t
614	45				1	40		0	29	389	5	\N	t	t
615	45				1	40		0	29	390	6	\N	t	t
616	45				1	40		0	29	391	7	\N	t	t
617	42				1	1		1	29	392	8	\N	t	f
618	42				1	1		1	29	393	9	\N	t	f
619	42				1	1		1	29	394	10	\N	t	f
620	42				1	1		1	29	487	11	\N	t	f
621	42				1	1		1	30	385	1	\N	t	f
622	44				1	40		0	30	386	2	\N	t	t
623	44				1	40		0	30	387	3	\N	t	t
624	44				1	40		0	30	388	4	\N	t	t
625	45				1	40		0	30	389	5	\N	t	t
626	45				1	40		0	30	390	6	\N	t	t
627	45				1	40		0	30	391	7	\N	t	t
628	42				1	1		1	30	392	8	\N	t	f
629	42				1	1		1	30	393	9	\N	t	f
630	42				1	1		1	30	394	10	\N	t	f
631	42				1	1		1	30	487	11	\N	t	f
632	42				1	1		1	30	488	12	\N	t	f
633	42				1	1		1	30	489	13	\N	t	f
634	42				1	1		1	31	385	1	\N	t	f
635	44				1	40		0	31	386	2	\N	t	t
636	44				1	40		0	31	387	3	\N	t	t
637	44				1	40		0	31	388	4	\N	t	t
638	45				1	40		0	31	389	5	\N	t	t
639	45				1	40		0	31	390	6	\N	t	t
640	45				1	40		0	31	391	7	\N	t	t
641	42				1	1		1	31	392	8	\N	t	f
642	42				1	1		1	31	393	9	\N	t	f
643	42				1	1		1	31	394	10	\N	t	f
644	42				1	1		1	31	487	11	\N	t	f
645	42				1	1		1	31	488	12	\N	t	f
646	42				1	1		1	31	489	13	\N	t	f
647	63	Visit Information			1	1		0	32	490	1	\N	t	f
648	62				1	1		1	32	491	2	\N	t	f
649	63	Visit Information			1	1		0	32	492	3	\N	t	f
650	64				1	40		0	32	493	4	\N	t	t
651	64				1	40		0	32	494	5	\N	t	t
652	64				1	40		0	32	495	6	\N	t	t
653	62				1	1		1	32	496	7	\N	t	f
654	62				1	1		1	32	497	8	\N	t	f
655	62				1	1		1	32	498	9	\N	t	f
656	62				1	1		1	32	499	10	\N	t	f
657	62				1	1		1	32	500	11	\N	t	f
658	62				1	1		1	32	501	12	\N	t	f
659	63	Visit Information			1	1		0	32	502	13	\N	t	f
660	63	Visit Information			1	1		0	32	503	14	\N	t	f
661	61				1	1		0	33	460	1	\N	t	f
662	60				1	1		1	33	461	2	\N	t	f
663	60				1	1		1	33	462	3	\N	t	f
664	60				1	1		1	33	463	4	\N	t	f
665	60				1	1		1	33	464	5	\N	t	f
666	60				1	1		1	33	465	6	\N	t	f
667	60				1	1		1	33	466	7	\N	t	f
668	60				1	1		1	33	467	8	\N	t	f
669	60				1	1		1	33	468	9	\N	t	f
670	61				1	1		0	33	469	10	\N	t	f
671	60				1	1		1	33	470	11	\N	t	f
672	60				1	1		1	33	471	12	\N	t	f
673	60				1	1		1	33	472	13	\N	t	f
674	60				1	1		1	33	473	14	\N	t	f
675	61				1	1		0	33	504	15	\N	t	f
676	60				1	1		1	33	505	16	\N	t	f
677	60				1	1		1	33	476	17	\N	t	f
678	60				1	1		1	33	477	18	\N	t	f
679	60				1	1		1	33	478	19	\N	t	f
680	60				1	1		1	33	479	20	\N	t	f
681	61				1	1		0	33	480	21	\N	t	f
682	61				1	1		0	33	481	22	\N	t	f
683	60				1	1		1	33	482	23	\N	t	f
684	60				1	1		1	33	483	24	\N	t	f
685	60				1	1		1	33	484	25	\N	t	f
686	60				1	1		1	33	485	26	\N	t	f
687	61				1	1		0	34	460	1	\N	t	f
688	60				1	1		1	34	506	2	\N	t	f
689	60				1	1		1	34	462	3	\N	t	f
690	60				1	1		1	34	463	4	\N	t	f
691	60				1	1		1	34	464	5	\N	t	f
692	60				1	1		1	34	465	6	\N	t	f
693	60				1	1		1	34	466	7	\N	t	f
694	60				1	1		1	34	467	8	\N	t	f
695	60				1	1		1	34	468	9	\N	t	f
696	61				1	1		0	34	469	10	\N	t	f
697	60				1	1		1	34	470	11	\N	t	f
698	60				1	1		1	34	471	12	\N	t	f
699	60				1	1		1	34	472	13	\N	t	f
700	60				1	1		1	34	473	14	\N	t	f
701	61				1	1		0	34	504	15	\N	t	f
702	60				1	1		1	34	505	16	\N	t	f
703	60				1	1		1	34	476	17	\N	t	f
704	60				1	1		1	34	477	18	\N	t	f
705	60				1	1		1	34	478	19	\N	t	f
706	60				1	1		1	34	479	20	\N	t	f
707	61				1	1		0	34	480	21	\N	t	f
708	61				1	1		0	34	481	22	\N	t	f
709	60				1	1		1	34	482	23	\N	t	f
710	60				1	1		1	34	483	24	\N	t	f
711	60				1	1		1	34	484	25	\N	t	f
712	60				1	1		1	34	485	26	\N	t	f
713	66				1	1		0	35	507	1	\N	t	f
714	65				1	1		1	35	508	2	\N	t	f
715	66				1	1		0	35	509	3	\N	t	f
716	65				1	1		1	35	510	4	\N	t	f
717	65				1	1		1	35	511	5	\N	t	f
718	66				1	1		0	35	512	6	\N	t	f
719	65				1	1		1	35	513	7	\N	t	f
720	65				1	1		1	35	514	8	\N	t	f
721	65				1	1		1	35	515	9	\N	t	f
722	65				1	1		1	35	516	10	\N	t	f
723	65				1	1		1	35	517	11	\N	t	f
724	65				1	1		1	35	518	12	\N	t	f
725	65				1	1		1	35	519	13	\N	t	f
726	65				1	1		1	35	520	14	\N	t	f
727	65				1	1		1	35	521	15	\N	t	f
728	65				1	1		1	35	522	16	\N	t	f
729	66				1	1		0	35	523	17	\N	t	f
730	65				1	1		1	35	524	18	\N	t	f
731	66				1	1		0	35	525	19	\N	t	f
732	65				1	1		1	35	526	20	\N	t	f
733	65				1	1		1	35	527	21	\N	t	f
734	65				1	1		1	35	528	22	\N	t	f
735	65				1	1		1	35	529	23	\N	t	f
736	66				1	1		0	35	530	24	\N	t	f
737	66				1	1		0	35	531	25	\N	t	f
738	65				1	1		1	35	532	26	\N	t	f
739	65				1	1		1	35	533	27	\N	t	f
740	65				1	1		1	35	534	28	\N	t	f
741	65				1	1		1	35	535	29	\N	t	f
742	61				1	1		0	36	536	1	\N	t	f
743	60				1	1		1	36	506	2	\N	t	f
744	60				1	1		1	36	462	3	\N	t	f
745	60				1	1		1	36	463	4	\N	t	f
746	60				1	1		1	36	464	5	\N	t	f
747	60				1	1		1	36	465	6	\N	t	f
748	60				1	1		1	36	466	7	\N	t	f
749	60				1	1		1	36	467	8	\N	t	f
750	60				1	1		1	36	468	9	\N	t	f
751	61				1	1		0	36	469	10	\N	t	f
752	60				1	1		1	36	470	11	\N	t	f
753	60				1	1		1	36	471	12	\N	t	f
754	60				1	1		1	36	472	13	\N	t	f
755	60				1	1		1	36	473	14	\N	t	f
756	61				1	1		0	36	504	15	\N	t	f
757	60				1	1		1	36	505	16	\N	t	f
758	60				1	1		1	36	476	17	\N	t	f
759	60				1	1		1	36	477	18	\N	t	f
760	60				1	1		1	36	478	19	\N	t	f
761	60				1	1		1	36	479	20	\N	t	f
762	61				1	1		0	36	480	21	\N	t	f
763	61				1	1		0	36	481	22	\N	t	f
764	60				1	1		1	36	482	23	\N	t	f
765	60				1	1		1	36	483	24	\N	t	f
766	60				1	1		1	36	484	25	\N	t	f
767	60				1	1		1	36	485	26	\N	t	f
768	68				1	1		0	37	537	1	\N	t	f
769	69				1	1		0	37	538	2	\N	t	f
770	69				1	1		0	37	539	3	\N	t	f
771	69				1	1		0	37	540	4	\N	t	f
772	69				1	1		0	37	541	5	\N	t	f
773	69				1	1		0	37	542	6	\N	t	f
774	69				1	1		0	37	543	7	\N	t	f
775	69				1	1		0	37	544	8	\N	t	f
776	69				1	1		0	37	545	9	\N	t	f
777	69				1	1		0	37	546	10	\N	t	f
778	69				1	1		0	37	547	11	\N	t	f
779	70				1	1		0	37	548	12	\N	t	f
780	70				1	1		0	37	549	13	\N	t	f
781	70				1	1		0	37	550	14	\N	t	f
782	71				1	1		0	37	551	15	\N	t	f
783	71				1	1		0	37	552	16	\N	t	f
784	72				1	1		0	37	553	17	\N	t	f
785	73				1	1		0	37	554	18	\N	t	f
786	73				1	1		0	37	555	19	\N	t	f
821	6	Visit			1	1		0	40	560	1	\N	t	f
822	6	Visit			1	1		0	40	112	2	\N	t	f
823	6	Visit			1	1		0	40	113	3	\N	t	f
824	7	Evaluation			1	1		0	40	114	4	\N	t	f
825	7	Evaluation			1	1		0	40	115	5	\N	t	f
826	7	Evaluation			1	1		0	40	116	6	\N	t	f
827	7	Evaluation			1	1		0	40	117	7	\N	t	f
828	7	Evaluation			1	1		0	40	118	8	\N	t	f
829	7	Evaluation			1	1		0	40	119	9	\N	t	f
830	7	Evaluation			1	1		0	40	561	10	\N	t	f
831	7	Evaluation			1	1		0	40	120	11	\N	t	f
832	7	Evaluation			1	1		0	40	121	12	\N	t	f
833	7	Evaluation			1	1		0	40	122	13	\N	t	f
834	7	Evaluation			1	1		0	40	123	14	\N	t	f
835	8	Comments			1	1		0	40	124	15	\N	t	f
836	9	Form Completion			1	1		0	40	125	16	\N	t	f
837	9	Form Completion			1	1		0	40	126	17	\N	t	f
838	74				1	1		1	41	562	1	\N	t	f
839	76				1	40		0	41	563	2	\N	t	t
840	76				1	40		0	41	564	3	\N	t	t
841	76				1	40		0	41	565	4	\N	t	t
842	77				1	40		0	41	566	5	\N	t	t
843	77				1	40		0	41	567	6	\N	t	t
844	77				1	40		0	41	568	7	\N	t	t
845	74				1	1		1	41	569	8	\N	t	f
846	74				1	1		1	41	570	9	\N	t	f
847	74				1	1		1	41	571	10	\N	t	f
848	74				1	1		1	41	572	11	\N	t	f
849	74				1	1		1	41	573	12	\N	t	f
850	74				1	1		1	41	574	13	\N	t	f
851	79				1	1		0	42	575	1	\N	t	f
852	80				1	40		0	42	576	2	\N	t	t
853	80				1	40		0	42	577	3	\N	t	t
854	80				1	40		0	42	578	4	\N	t	t
855	80				1	40		0	42	579	5	\N	t	t
856	80				1	40		0	42	580	6	\N	t	t
857	80				1	40		0	42	581	7	\N	t	t
858	80				1	40		0	42	582	8	\N	t	t
859	80				1	40		0	42	583	9	\N	t	t
860	80				1	40		0	42	584	10	\N	t	t
861	80				1	40		0	42	585	11	\N	t	t
862	80				1	40		0	42	586	12	\N	t	t
863	80				1	40		0	42	587	13	\N	t	t
864	81				1	1		0	42	588	14	\N	t	f
865	81				1	1		0	42	589	15	\N	t	f
866	81				1	1		0	42	590	16	\N	t	f
867	82				1	1		1	43	591	1	\N	t	f
868	82				1	1		1	43	592	2	\N	t	f
869	82				1	1		1	43	593	3	\N	t	f
870	82				1	1		1	43	594	4	\N	t	f
871	82				1	1		1	43	595	5	\N	t	f
872	82				1	1		1	43	596	6	\N	t	f
873	82				1	1		1	43	597	7	\N	t	f
874	82				1	1		1	43	598	8	\N	t	f
875	82				1	1		1	43	599	9	\N	t	f
876	82				1	1		1	43	600	10	\N	t	f
877	82				1	1		1	43	601	11	\N	t	f
878	82				1	1		1	43	602	12	\N	t	f
879	82				1	1		1	43	603	13	\N	t	f
880	82				1	1		1	43	604	14	\N	t	f
881	82				1	1		1	43	605	15	\N	t	f
882	82				1	1		1	43	606	16	\N	t	f
883	82				1	1		1	43	607	17	\N	t	f
1187	97	Visit Information			1	1		0	63	903	37	\N	t	f
1188	97	Visit Information			1	1		0	63	904	38	\N	t	f
1189	97	Visit Information			1	1		0	63	905	39	\N	t	f
1190	97	Visit Information			1	1		0	63	906	40	\N	t	f
1191	97	Visit Information			1	1		0	63	907	41	\N	t	f
1192	97	Visit Information			1	1		0	63	908	42	\N	t	f
1193	97	Visit Information			1	1		0	63	909	43	\N	t	f
1194	97	Visit Information			1	1		0	63	910	44	\N	t	f
1195	97	Visit Information			1	1		0	63	911	45	\N	t	f
1196	97	Visit Information			1	1		0	63	912	46	\N	t	f
1197	97	Visit Information			1	1		0	63	913	47	\N	t	f
1198	97	Visit Information			1	1		0	63	914	48	\N	t	f
1199	97	Visit Information			1	1		0	63	915	49	\N	t	f
1200	97	Visit Information			1	1		0	63	916	50	\N	t	f
1201	97	Visit Information			1	1		0	63	917	51	\N	t	f
1202	97	Visit Information			1	1		0	63	918	52	\N	t	f
1203	97	Visit Information			1	1		0	63	919	53	\N	t	f
1204	97	Visit Information			1	1		0	63	920	54	\N	t	f
1205	97	Visit Information			1	1		0	63	921	55	\N	t	f
1206	97	Visit Information			1	1		0	63	922	56	\N	t	f
1207	97	Visit Information			1	1		0	63	923	57	\N	t	f
2806	102	Visit			1	1		0	94	1101	1	\N	t	f
2807	102	Visit			1	1		0	94	1102	2	\N	t	f
2808	102	Visit			1	1		0	94	1103	3	\N	t	f
2809	102	Visit			1	1		0	94	1104	4	\N	t	f
2810	103	Evaluation			1	1		0	94	1105	5	\N	t	f
2811	103	Evaluation			1	1		0	94	1106	6	\N	t	f
2812	103	Evaluation			1	1		0	94	1107	7	\N	t	f
2813	103	Evaluation			1	1		0	94	1108	8	\N	t	f
2814	103	Evaluation			1	1		0	94	1109	9	\N	t	f
2815	103	Evaluation			1	1		0	94	1110	10	\N	t	f
2816	103	Evaluation			1	1		0	94	1111	11	\N	t	f
2817	103	Evaluation			1	1		0	94	1112	12	\N	t	f
2818	103	Evaluation			1	1		0	94	1113	13	\N	t	f
2819	103	Evaluation			1	1		0	94	1114	14	\N	t	f
2820	103	Evaluation			1	1		0	94	1115	15	\N	t	f
2821	103	Evaluation			1	1		0	94	1116	16	\N	t	f
2822	103	Evaluation			1	1		0	94	1117	17	\N	t	f
2823	103	Evaluation			1	1		0	94	1118	18	\N	t	f
2824	104	Study Treatment Status			1	1		0	94	1119	19	\N	t	f
2825	107	Comments			1	1		0	94	1120	20	\N	t	f
2826	108	Form Completion			1	1		0	94	1121	21	\N	t	f
2827	108	Form Completion			1	1		0	94	1122	22	\N	t	f
2828	110				1	1		0	95	1123	1	\N	t	f
2829	109				1	1		1	95	1124	2	\N	t	f
2830	109				1	1		1	95	1125	3	\N	t	f
2831	109				1	1		1	95	1126	4	\N	t	f
2832	109				1	1		1	95	1127	5	\N	t	f
2833	109				1	1		1	95	1128	6	\N	t	f
2834	109				1	1		1	95	1129	7	\N	t	f
2835	109				1	1		1	95	1130	8	\N	t	f
2836	109				1	1		1	95	1131	9	\N	t	f
2837	110				1	1		0	95	1132	10	\N	t	f
2838	109				1	1		1	95	1133	11	\N	t	f
2839	109				1	1		1	95	1134	12	\N	t	f
2840	109				1	1		1	95	1135	13	\N	t	f
2841	109				1	1		1	95	1136	14	\N	t	f
2842	110				1	1		0	95	1137	15	\N	t	f
2843	109				1	1		1	95	1138	16	\N	t	f
5597	137	Participant History			1	1		0	148	3709	12	\N	t	f
5598	137	Participant History			1	1		0	148	3735	13	\N	t	f
2844	109				1	1		1	95	1139	17	\N	t	f
2845	109				1	1		1	95	1140	18	\N	t	f
2846	109				1	1		1	95	1141	19	\N	t	f
2847	109				1	1		1	95	1142	20	\N	t	f
2848	110				1	1		0	95	1143	21	\N	t	f
2849	110				1	1		0	95	1144	22	\N	t	f
2850	109				1	1		1	95	1145	23	\N	t	f
2851	109				1	1		1	95	1146	24	\N	t	f
2852	109				1	1		1	95	1147	25	\N	t	f
2853	109				1	1		1	95	1148	26	\N	t	f
5599	137	Participant History			1	1		0	148	3746	14	\N	t	f
5600	137	Participant History			1	1		0	148	3695	15	\N	t	f
5601	137	Participant History			1	1		0	148	3708	16	\N	t	f
5602	137	Participant History			1	1		0	148	3738	17	\N	t	f
5603	137	Participant History			1	1		0	148	3741	18	\N	t	f
5604	137	Participant History			1	1		0	148	3716	19	\N	t	f
5605	137	Participant History			1	1		0	148	3753	20	\N	t	f
5606	137	Participant History			1	1		0	148	3745	21	\N	t	f
5607	137	Participant History			1	1		0	148	3729	22	\N	t	f
5608	137	Participant History			1	1		0	148	3712	23	\N	t	f
1208	6	Visit			1	1		0	64	560	1	\N	t	f
1209	6	Visit			1	1		0	64	112	2	\N	t	f
1210	6	Visit			1	1		0	64	113	3	\N	t	f
1211	7	Evaluation			1	1		0	64	114	4	\N	t	f
1212	7	Evaluation			1	1		0	64	115	5	\N	t	f
1213	7	Evaluation			1	1		0	64	116	6	\N	t	f
1214	7	Evaluation			1	1		0	64	117	7	\N	t	f
1215	7	Evaluation			1	1		0	64	118	8	\N	t	f
1216	7	Evaluation			1	1		0	64	119	9	\N	t	f
1217	7	Evaluation			1	1		0	64	561	10	\N	t	f
1218	7	Evaluation			1	1		0	64	120	11	\N	t	f
1219	7	Evaluation			1	1		0	64	121	12	\N	t	f
1220	7	Evaluation			1	1		0	64	122	13	\N	t	f
1221	7	Evaluation			1	1		0	64	123	14	\N	t	f
1222	8	Comments			1	1		0	64	124	15	\N	t	f
1223	9	Form Completion			1	1		0	64	125	16	\N	t	f
1224	9	Form Completion			1	1		0	64	126	17	\N	t	f
1225	16	Study Entry Enrollment			1	1		0	65	145	1	\N	t	f
1061	91				1	1		0	60	790	1	\N	t	f
1062	91				1	1		0	60	777	2	\N	t	f
1063	92				1	1		0	60	793	3	\N	t	f
1064	92				1	1		0	60	783	4	\N	t	f
1065	92				1	1		0	60	782	5	\N	t	f
1066	92				1	1		0	60	795	6	\N	t	f
1067	92				1	1		0	60	780	7	\N	t	f
1068	92				1	1		0	60	784	8	\N	t	f
1069	92				1	1		0	60	796	9	\N	t	f
1070	92				1	1		0	60	794	10	\N	t	f
1071	92				1	1		0	60	778	11	\N	t	f
1072	93				1	1		0	60	788	12	\N	t	f
1073	93				1	1		0	60	781	13	\N	t	f
1074	93				1	1		0	60	789	14	\N	t	f
1075	93				1	1		0	60	786	15	\N	t	f
1076	93				1	1		0	60	785	16	\N	t	f
1077	93				1	1		0	60	787	17	\N	t	f
1078	93				1	1		0	60	779	18	\N	t	f
1079	93				1	1		0	60	791	19	\N	t	f
1080	93				1	1		0	60	792	20	\N	t	f
1081	95				1	1		0	61	797	1	\N	t	f
1082	95				1	1		0	61	798	2	\N	t	f
1083	95				1	1		0	61	799	3	\N	t	f
1084	94				1	1		1	61	800	4	\N	t	f
1085	94				1	1		1	61	801	5	\N	t	f
1086	95				1	1		0	61	802	6	\N	t	f
1087	94				1	1		1	61	803	7	\N	t	f
1088	94				1	1		1	61	804	8	\N	t	f
1089	95				1	1		0	61	805	9	\N	t	f
1090	94				1	1		1	61	806	10	\N	t	f
1091	95				1	1		0	61	807	11	\N	t	f
1092	95				1	1		0	61	808	12	\N	t	f
1093	94				1	1		1	61	809	13	\N	t	f
1094	85	Visit Information			1	1		0	62	861	1	\N	t	f
1095	85	Visit Information			1	1		0	62	823	2	\N	t	f
1096	85	Visit Information			1	1		0	62	855	3	\N	t	f
1097	85	Visit Information			1	1		0	62	854	4	\N	t	f
1098	85	Visit Information			1	1		0	62	833	5	\N	t	f
1099	85	Visit Information			1	1		0	62	860	6	\N	t	f
1100	85	Visit Information			1	1		0	62	856	7	\N	t	f
1101	85	Visit Information			1	1		0	62	853	8	\N	t	f
1102	85	Visit Information			1	1		0	62	866	9	\N	t	f
1103	85	Visit Information			1	1		0	62	835	10	\N	t	f
1104	85	Visit Information			1	1		0	62	857	11	\N	t	f
1105	85	Visit Information			1	1		0	62	859	12	\N	t	f
1106	85	Visit Information			1	1		0	62	832	13	\N	t	f
1107	85	Visit Information			1	1		0	62	858	14	\N	t	f
1108	85	Visit Information			1	1		0	62	848	15	\N	t	f
1109	86	Food within + 1 Hour of Dose			1	40		0	62	862	16	\N	t	t
1110	86	Food within + 1 Hour of Dose			1	40		0	62	822	17	\N	t	t
1111	86	Food within + 1 Hour of Dose			1	40		0	62	863	18	\N	t	t
1112	86	Food within + 1 Hour of Dose			1	40		0	62	819	19	\N	t	t
1113	86	Food within + 1 Hour of Dose			1	40		0	62	838	20	\N	t	t
1114	85	Visit Information			1	1		0	62	813	21	\N	t	f
1115	85	Visit Information			1	1		0	62	812	22	\N	t	f
1116	85	Visit Information			1	1		0	62	820	23	\N	t	f
1117	85	Visit Information			1	1		0	62	814	24	\N	t	f
1118	85	Visit Information			1	1		0	62	816	25	\N	t	f
1119	85	Visit Information			1	1		0	62	829	26	\N	t	f
1120	85	Visit Information			1	1		0	62	826	27	\N	t	f
1121	85	Visit Information			1	1		0	62	825	28	\N	t	f
1122	85	Visit Information			1	1		0	62	865	29	\N	t	f
1123	85	Visit Information			1	1		0	62	837	30	\N	t	f
1124	85	Visit Information			1	1		0	62	830	31	\N	t	f
1125	85	Visit Information			1	1		0	62	831	32	\N	t	f
1126	85	Visit Information			1	1		0	62	840	33	\N	t	f
1127	85	Visit Information			1	1		0	62	864	34	\N	t	f
1128	85	Visit Information			1	1		0	62	847	35	\N	t	f
1129	85	Visit Information			1	1		0	62	850	36	\N	t	f
1130	85	Visit Information			1	1		0	62	843	37	\N	t	f
1131	85	Visit Information			1	1		0	62	845	38	\N	t	f
1132	85	Visit Information			1	1		0	62	846	39	\N	t	f
1133	85	Visit Information			1	1		0	62	815	40	\N	t	f
1134	85	Visit Information			1	1		0	62	810	41	\N	t	f
1135	85	Visit Information			1	1		0	62	811	42	\N	t	f
1136	85	Visit Information			1	1		0	62	817	43	\N	t	f
1137	85	Visit Information			1	1		0	62	818	44	\N	t	f
1138	85	Visit Information			1	1		0	62	834	45	\N	t	f
1139	85	Visit Information			1	1		0	62	842	46	\N	t	f
1140	85	Visit Information			1	1		0	62	844	47	\N	t	f
1141	85	Visit Information			1	1		0	62	849	48	\N	t	f
1142	85	Visit Information			1	1		0	62	851	49	\N	t	f
1143	85	Visit Information			1	1		0	62	836	50	\N	t	f
1144	85	Visit Information			1	1		0	62	827	51	\N	t	f
1145	85	Visit Information			1	1		0	62	821	52	\N	t	f
1146	85	Visit Information			1	1		0	62	828	53	\N	t	f
1147	85	Visit Information			1	1		0	62	824	54	\N	t	f
1148	85	Visit Information			1	1		0	62	841	55	\N	t	f
1149	85	Visit Information			1	1		0	62	852	56	\N	t	f
1150	85	Visit Information			1	1		0	62	839	57	\N	t	f
1226	16	Study Entry Enrollment			1	1		0	65	146	2	\N	t	f
1227	16	Study Entry Enrollment			1	1		0	65	147	3	\N	t	f
1228	16	Study Entry Enrollment			1	1		0	65	148	4	\N	t	f
1229	16	Study Entry Enrollment			1	1		0	65	149	5	\N	t	f
1230	16	Study Entry Enrollment			1	1		0	65	150	6	\N	t	f
1231	16	Study Entry Enrollment			1	1		0	65	924	7	\N	t	f
1232	16	Study Entry Enrollment			1	1		0	65	152	8	\N	t	f
1233	16	Study Entry Enrollment			1	1		0	65	153	9	\N	t	f
1234	16	Study Entry Enrollment			1	1		0	65	154	10	\N	t	f
1235	16	Study Entry Enrollment			1	1		0	65	155	11	\N	t	f
1236	16	Study Entry Enrollment			1	1		0	65	156	12	\N	t	f
1237	16	Study Entry Enrollment			1	1		0	65	157	13	\N	t	f
1238	17	Comments			1	1		0	65	158	14	\N	t	f
1239	18	Form Completion			1	1		0	65	159	15	\N	t	f
1240	18	Form Completion			1	1		0	65	160	16	\N	t	f
1241	19	Treatment Assigment upon Successful Enrollment Submission			1	1		0	65	161	17	\N	t	f
1242	20	Intensive Phase Study Therapy			1	40		0	65	162	18	\N	t	t
1243	20	Intensive Phase Study Therapy			1	40		0	65	163	19	\N	t	t
1244	20	Intensive Phase Study Therapy			1	40		0	65	164	20	\N	t	t
2854	32	Patient Information			1	1		0	96	1161	1	\N	t	f
2855	32	Patient Information			1	1		0	96	1158	2	\N	t	f
2856	32	Patient Information			1	1		0	96	1160	3	\N	t	f
2857	32	Patient Information			1	1		0	96	1155	4	\N	t	f
2858	32	Patient Information			1	1		0	96	1152	5	\N	t	f
2859	32	Patient Information			1	1		0	96	1153	6	\N	t	f
2860	31				1	1		1	96	1149	7	\N	t	f
2861	31				1	1		1	96	1162	8	\N	t	f
2862	32	Patient Information			1	1		0	96	1151	9	\N	t	f
2863	31				1	1		1	96	1150	10	\N	t	f
2864	31				1	1		1	96	1159	11	\N	t	f
2865	32	Patient Information			1	1		0	96	1157	12	\N	t	f
2866	32	Patient Information			1	1		0	96	1156	13	\N	t	f
2867	32	Patient Information			1	1		0	96	1154	14	\N	t	f
5609	137	Participant History			1	1		0	148	3724	24	\N	t	f
5610	137	Participant History			1	1		0	148	3721	25	\N	t	f
5611	137	Participant History			1	1		0	148	3717	26	\N	t	f
5612	137	Participant History			1	1		0	148	3722	27	\N	t	f
5613	137	Participant History			1	1		0	148	3693	28	\N	t	f
5614	137	Participant History			1	1		0	148	3760	29	\N	t	f
5615	137	Participant History			1	1		0	148	3730	30	\N	t	f
5616	136				1	1		1	148	3699	31	\N	t	f
5617	136				1	1		1	148	3704	32	\N	t	f
5618	136				1	1		1	148	3763	33	\N	t	f
5619	136				1	1		1	148	3752	34	\N	t	f
5620	136				1	1		1	148	3711	35	\N	t	f
5621	136				1	1		1	148	3697	36	\N	t	f
5622	136				1	1		1	148	3726	37	\N	t	f
5623	136				1	1		1	148	3702	38	\N	t	f
5624	136				1	1		1	148	3703	39	\N	t	f
5625	136				1	1		1	148	3723	40	\N	t	f
5626	136				1	1		1	148	3749	41	\N	t	f
5627	136				1	1		1	148	3755	42	\N	t	f
5628	136				1	1		1	148	3715	43	\N	t	f
5629	136				1	1		1	148	3742	44	\N	t	f
5630	136				1	1		1	148	3762	45	\N	t	f
5631	136				1	1		1	148	3757	46	\N	t	f
5632	136				1	1		1	148	3713	47	\N	t	f
5633	136				1	1		1	148	3754	48	\N	t	f
5634	136				1	1		1	148	3750	49	\N	t	f
5635	136				1	1		1	148	3694	50	\N	t	f
5636	136				1	1		1	148	3701	51	\N	t	f
3325	116	Study Entry Enrollment			1	1		0	109	1446	1	\N	t	f
3326	116	Study Entry Enrollment			1	1		0	109	1438	2	\N	t	f
3327	116	Study Entry Enrollment			1	1		0	109	1454	3	\N	t	f
3328	116	Study Entry Enrollment			1	1		0	109	1442	4	\N	t	f
3329	116	Study Entry Enrollment			1	1		0	109	1433	5	\N	t	f
3330	116	Study Entry Enrollment			1	1		0	109	1436	6	\N	t	f
3331	116	Study Entry Enrollment			1	1		0	109	1443	7	\N	t	f
3332	116	Study Entry Enrollment			1	1		0	109	1447	8	\N	t	f
3333	116	Study Entry Enrollment			1	1		0	109	1450	9	\N	t	f
3334	116	Study Entry Enrollment			1	1		0	109	1439	10	\N	t	f
3335	116	Study Entry Enrollment			1	1		0	109	1441	11	\N	t	f
3336	116	Study Entry Enrollment			1	1		0	109	1453	12	\N	t	f
3337	116	Study Entry Enrollment			1	1		0	109	1452	13	\N	t	f
3338	116	Study Entry Enrollment			1	1		0	109	1449	14	\N	t	f
3339	116	Study Entry Enrollment			1	1		0	109	1448	15	\N	t	f
3340	117	Comments			1	1		0	109	1432	16	\N	t	f
3341	118	Form Completion			1	1		0	109	1440	17	\N	t	f
2912	112	Visit			1	1		0	99	1164	1	\N	t	f
2913	112	Visit			1	1		0	99	1165	2	\N	t	f
2914	112	Visit			1	1		0	99	1166	3	\N	t	f
2915	112	Visit			1	1		0	99	1167	4	\N	t	f
2916	112	Visit			1	1		0	99	1168	5	\N	t	f
2917	112	Visit			1	1		0	99	1169	6	\N	t	f
2918	112	Visit			1	1		0	99	1170	7	\N	t	f
2919	112	Visit			1	1		0	99	1171	8	\N	t	f
2920	112	Visit			1	1		0	99	1172	9	\N	t	f
2921	112	Visit			1	1		0	99	1173	10	\N	t	f
2922	112	Visit			1	1		0	99	1174	11	\N	t	f
2923	112	Visit			1	1		0	99	1175	12	\N	t	f
2924	112	Visit			1	1		0	99	1176	13	\N	t	f
2925	112	Visit			1	1		0	99	1177	14	\N	t	f
2926	112	Visit			1	1		0	99	1178	15	\N	t	f
2770	97	Visit Information			1	1		0	93	1100	23	\N	t	f
2771	97	Visit Information			1	1		0	93	1074	24	\N	t	f
2772	97	Visit Information			1	1		0	93	1085	25	\N	t	f
2773	97	Visit Information			1	1		0	93	1089	26	\N	t	f
2774	97	Visit Information			1	1		0	93	1098	27	\N	t	f
2775	97	Visit Information			1	1		0	93	1097	28	\N	t	f
2776	97	Visit Information			1	1		0	93	1096	29	\N	t	f
2777	97	Visit Information			1	1		0	93	1076	30	\N	t	f
2778	97	Visit Information			1	1		0	93	1090	31	\N	t	f
2779	97	Visit Information			1	1		0	93	1059	32	\N	t	f
2780	97	Visit Information			1	1		0	93	1058	33	\N	t	f
2781	97	Visit Information			1	1		0	93	1057	34	\N	t	f
2782	97	Visit Information			1	1		0	93	1077	35	\N	t	f
2783	97	Visit Information			1	1		0	93	1091	36	\N	t	f
2784	97	Visit Information			1	1		0	93	1068	37	\N	t	f
2785	97	Visit Information			1	1		0	93	1070	38	\N	t	f
2786	97	Visit Information			1	1		0	93	1069	39	\N	t	f
2787	97	Visit Information			1	1		0	93	1075	40	\N	t	f
2788	97	Visit Information			1	1		0	93	1056	41	\N	t	f
2789	97	Visit Information			1	1		0	93	1055	42	\N	t	f
2790	97	Visit Information			1	1		0	93	1054	43	\N	t	f
2791	97	Visit Information			1	1		0	93	1053	44	\N	t	f
2792	97	Visit Information			1	1		0	93	1052	45	\N	t	f
2793	97	Visit Information			1	1		0	93	1094	46	\N	t	f
2794	97	Visit Information			1	1		0	93	1067	47	\N	t	f
2795	97	Visit Information			1	1		0	93	1066	48	\N	t	f
2796	97	Visit Information			1	1		0	93	1065	49	\N	t	f
2797	97	Visit Information			1	1		0	93	1063	50	\N	t	f
2798	97	Visit Information			1	1		0	93	1084	51	\N	t	f
2799	97	Visit Information			1	1		0	93	1081	52	\N	t	f
2800	97	Visit Information			1	1		0	93	1080	53	\N	t	f
2801	97	Visit Information			1	1		0	93	1079	54	\N	t	f
2802	97	Visit Information			1	1		0	93	1078	55	\N	t	f
2803	97	Visit Information			1	1		0	93	921	56	\N	t	f
2804	97	Visit Information			1	1		0	93	922	57	\N	t	f
2805	97	Visit Information			1	1		0	93	923	58	\N	t	f
2927	112	Visit			1	1		0	99	1179	16	\N	t	f
2928	112	Visit			1	1		0	99	1180	17	\N	t	f
2929	112	Visit			1	1		0	99	1181	18	\N	t	f
2930	112	Visit			1	1		0	99	1182	19	\N	t	f
2931	112	Visit			1	1		0	99	1183	20	\N	t	f
2932	112	Visit			1	1		0	99	1184	21	\N	t	f
2933	112	Visit			1	1		0	99	1185	22	\N	t	f
3342	118	Form Completion			1	1		0	109	1457	18	\N	t	f
3343	115				1	1		1	109	1434	19	\N	t	f
3344	115				1	1		1	109	1455	20	\N	t	f
3345	119	Treatment Assigment upon Successful Enrollment Submission			1	1		0	109	1445	21	\N	t	f
3346	120	Intensive Phase Study Therapy			1	40		0	109	1437	22	\N	t	t
3347	120	Intensive Phase Study Therapy			1	40		0	109	1444	23	\N	t	t
3348	120	Intensive Phase Study Therapy			1	40		0	109	1451	24	\N	t	t
3349	121	Continuation Phase Study Therapy			1	40		0	109	1435	25	\N	t	t
3350	121	Continuation Phase Study Therapy			1	40		0	109	1458	26	\N	t	t
3351	121	Continuation Phase Study Therapy			1	40		0	109	1456	27	\N	t	t
3352	123	Adverse Event Description			1	1		0	110	1459	1	\N	t	f
3353	123	Adverse Event Description			1	1		0	110	1460	2	\N	t	f
3354	123	Adverse Event Description			1	1		0	110	1461	3	\N	t	f
3355	123	Adverse Event Description			1	1		0	110	1462	4	\N	t	f
3356	123	Adverse Event Description			1	1		0	110	1463	5	\N	t	f
3357	123	Adverse Event Description			1	1		0	110	1464	6	\N	t	f
3358	123	Adverse Event Description			1	1		0	110	1465	7	\N	t	f
3359	123	Adverse Event Description			1	1		0	110	1466	8	\N	t	f
3360	123	Adverse Event Description			1	1		0	110	1467	9	\N	t	f
3361	123	Adverse Event Description			1	1		0	110	1468	10	\N	t	f
3362	123	Adverse Event Description			1	1		0	110	1469	11	\N	t	f
3363	123	Adverse Event Description			1	1		0	110	1470	12	\N	t	f
3364	123	Adverse Event Description			1	1		0	110	1471	13	\N	t	f
3365	123	Adverse Event Description			1	1		0	110	1472	14	\N	t	f
3366	123	Adverse Event Description			1	1		0	110	1473	15	\N	t	f
3367	123	Adverse Event Description			1	1		0	110	1474	16	\N	t	f
3368	123	Adverse Event Description			1	1		0	110	1475	17	\N	t	f
3369	123	Adverse Event Description			1	1		0	110	1476	18	\N	t	f
3370	123	Adverse Event Description			1	1		0	110	1477	19	\N	t	f
3371	123	Adverse Event Description			1	1		0	110	1478	20	\N	t	f
3372	123	Adverse Event Description			1	1		0	110	1479	21	\N	t	f
3373	123	Adverse Event Description			1	1		0	110	1480	22	\N	t	f
3374	123	Adverse Event Description			1	1		0	110	1481	23	\N	t	f
3375	123	Adverse Event Description			1	1		0	110	1482	24	\N	t	f
3376	123	Adverse Event Description			1	1		0	110	1483	25	\N	t	f
3377	123	Adverse Event Description			1	1		0	110	1484	26	\N	t	f
3378	123	Adverse Event Description			1	1		0	110	1485	27	\N	t	f
3379	123	Adverse Event Description			1	1		0	110	1486	28	\N	t	f
3380	123	Adverse Event Description			1	1		0	110	1487	29	\N	t	f
3381	123	Adverse Event Description			1	1		0	110	1488	30	\N	t	f
3382	123	Adverse Event Description			1	1		0	110	1489	31	\N	t	f
3383	123	Adverse Event Description			1	1		0	110	1490	32	\N	t	f
3384	123	Adverse Event Description			1	1		0	110	1491	33	\N	t	f
3385	123	Adverse Event Description			1	1		0	110	1492	34	\N	t	f
3386	123	Adverse Event Description			1	1		0	110	1493	35	\N	t	f
3387	123	Adverse Event Description			1	1		0	110	1494	36	\N	t	f
5637	136				1	1		1	148	3764	52	\N	t	f
5638	136				1	1		1	148	3739	53	\N	t	f
5639	136				1	1		1	148	3710	54	\N	t	f
5640	136				1	1		1	148	3725	55	\N	t	f
5641	137	Participant History			1	1		0	148	3718	56	\N	t	f
5642	136				1	1		1	148	3714	57	\N	t	f
5643	136				1	1		1	148	3761	58	\N	t	f
5644	136				1	1		1	148	3720	59	\N	t	f
5645	136				1	1		1	148	3732	60	\N	t	f
5646	136				1	1		1	148	3698	61	\N	t	f
5647	136				1	1		1	148	3733	62	\N	t	f
5648	136				1	1		1	148	3700	63	\N	t	f
5649	136				1	1		1	148	3707	64	\N	t	f
5650	138	4. List WHO Clinical Stage 4 Conditions and provide month and year			1	40		0	148	3751	65	\N	t	t
5651	138	4. List WHO Clinical Stage 4 Conditions and provide month and year			1	40		0	148	3737	66	\N	t	t
5652	138	4. List WHO Clinical Stage 4 Conditions and provide month and year			1	40		0	148	3743	67	\N	t	t
5653	137	Participant History			1	1		0	148	3727	68	\N	t	f
5654	137	Participant History			1	1		0	148	3705	69	\N	t	f
2748	97	Visit Information			1	1		0	93	1073	1	\N	t	f
2749	97	Visit Information			1	1		0	93	867	2	\N	t	f
2750	97	Visit Information			1	1		0	93	868	3	\N	t	f
2751	97	Visit Information			1	1		0	93	1083	4	\N	t	f
2752	97	Visit Information			1	1		0	93	1064	5	\N	t	f
2753	97	Visit Information			1	1		0	93	1095	6	\N	t	f
2754	97	Visit Information			1	1		0	93	1088	7	\N	t	f
2755	97	Visit Information			1	1		0	93	1082	8	\N	t	f
2756	97	Visit Information			1	1		0	93	1061	9	\N	t	f
2757	97	Visit Information			1	1		0	93	1093	10	\N	t	f
2758	97	Visit Information			1	1		0	93	1087	11	\N	t	f
2759	97	Visit Information			1	1		0	93	1072	12	\N	t	f
2760	97	Visit Information			1	1		0	93	1062	13	\N	t	f
2761	97	Visit Information			1	1		0	93	1092	14	\N	t	f
2762	97	Visit Information			1	1		0	93	1086	15	\N	t	f
2763	97	Visit Information			1	1		0	93	881	16	\N	t	f
2764	98	Food within ± 1 Hour of Dose			1	40		0	93	882	17	\N	t	t
2765	98	Food within ± 1 Hour of Dose			1	40		0	93	883	18	\N	t	t
2766	98	Food within ± 1 Hour of Dose			1	40		0	93	884	19	\N	t	t
2767	98	Food within ± 1 Hour of Dose			1	40		0	93	1099	20	\N	t	t
2768	98	Food within ± 1 Hour of Dose			1	40		0	93	1071	21	\N	t	t
2769	97	Visit Information			1	1		0	93	1060	22	\N	t	f
2057	100	Information			1	1		0	81	940	1	\N	t	f
2058	100	Information			1	1		0	81	941	2	\N	t	f
2059	100	Information			1	1		0	81	942	3	\N	t	f
2060	100	Information			1	1		0	81	943	4	\N	t	f
2061	100	Information			1	1		0	81	944	5	\N	t	f
2062	100	Information			1	1		0	81	945	6	\N	t	f
2063	100	Information			1	1		0	81	946	7	\N	t	f
2064	100	Information			1	1		0	81	947	8	\N	t	f
2065	100	Information			1	1		0	81	948	9	\N	t	f
2066	100	Information			1	1		0	81	949	10	\N	t	f
2067	100	Information			1	1		0	81	950	11	\N	t	f
2068	100	Information			1	1		0	81	951	12	\N	t	f
2069	100	Information			1	1		0	81	952	13	\N	t	f
2070	100	Information			1	1		0	81	953	14	\N	t	f
2071	100	Information			1	1		0	81	954	15	\N	t	f
2072	100	Information			1	1		0	81	955	16	\N	t	f
2073	100	Information			1	1		0	81	956	17	\N	t	f
2074	100	Information			1	1		0	81	957	18	\N	t	f
2075	100	Information			1	1		0	81	958	19	\N	t	f
2076	100	Information			1	1		0	81	959	20	\N	t	f
2077	100	Information			1	1		0	81	960	21	\N	t	f
2078	100	Information			1	1		0	81	961	22	\N	t	f
2079	100	Information			1	1		0	81	962	23	\N	t	f
2080	100	Information			1	1		0	81	963	24	\N	t	f
2081	100	Information			1	1		0	81	964	25	\N	t	f
2082	100	Information			1	1		0	81	965	26	\N	t	f
2083	100	Information			1	1		0	81	966	27	\N	t	f
2084	100	Information			1	1		0	81	967	28	\N	t	f
2085	100	Information			1	1		0	81	968	29	\N	t	f
2086	100	Information			1	1		0	81	969	30	\N	t	f
2087	100	Information			1	1		0	81	970	31	\N	t	f
2088	100	Information			1	1		0	81	971	32	\N	t	f
2089	100	Information			1	1		0	81	972	33	\N	t	f
2090	100	Information			1	1		0	81	973	34	\N	t	f
2091	100	Information			1	1		0	81	974	35	\N	t	f
2092	100	Information			1	1		0	81	975	36	\N	t	f
2093	100	Information			1	1		0	81	976	37	\N	t	f
2094	100	Information			1	1		0	81	977	38	\N	t	f
2095	100	Information			1	1		0	81	978	39	\N	t	f
2096	100	Information			1	1		0	81	979	40	\N	t	f
2097	100	Information			1	1		0	81	980	41	\N	t	f
2098	100	Information			1	1		0	81	981	42	\N	t	f
2099	100	Information			1	1		0	81	982	43	\N	t	f
2100	100	Information			1	1		0	81	983	44	\N	t	f
2101	100	Information			1	1		0	81	984	45	\N	t	f
2102	100	Information			1	1		0	81	985	46	\N	t	f
2103	100	Information			1	1		0	81	986	47	\N	t	f
2104	100	Information			1	1		0	81	987	48	\N	t	f
2105	100	Information			1	1		0	81	988	49	\N	t	f
2106	100	Information			1	1		0	81	989	50	\N	t	f
2107	100	Information			1	1		0	81	990	51	\N	t	f
2108	100	Information			1	1		0	81	991	52	\N	t	f
2109	100	Information			1	1		0	81	992	53	\N	t	f
2956	112	Visit			1	1		0	101	1164	1	\N	t	f
2957	112	Visit			1	1		0	101	1165	2	\N	t	f
2958	112	Visit			1	1		0	101	1166	3	\N	t	f
2959	112	Visit			1	1		0	101	1167	4	\N	t	f
2960	112	Visit			1	1		0	101	1168	5	\N	t	f
2961	112	Visit			1	1		0	101	1169	6	\N	t	f
2962	112	Visit			1	1		0	101	1170	7	\N	t	f
2963	112	Visit			1	1		0	101	1171	8	\N	t	f
2964	112	Visit			1	1		0	101	1172	9	\N	t	f
2965	112	Visit			1	1		0	101	1173	10	\N	t	f
2966	112	Visit			1	1		0	101	1174	11	\N	t	f
2967	112	Visit			1	1		0	101	1190	12	\N	t	f
2968	112	Visit			1	1		0	101	1189	13	\N	t	f
2969	112	Visit			1	1		0	101	1187	14	\N	t	f
2970	112	Visit			1	1		0	101	1178	15	\N	t	f
2971	112	Visit			1	1		0	101	1188	16	\N	t	f
2972	112	Visit			1	1		0	101	1186	17	\N	t	f
2973	112	Visit			1	1		0	101	1181	18	\N	t	f
2974	112	Visit			1	1		0	101	1182	19	\N	t	f
2975	112	Visit			1	1		0	101	1183	20	\N	t	f
2976	112	Visit			1	1		0	101	1184	21	\N	t	f
2977	112	Visit			1	1		0	101	1185	22	\N	t	f
5655	137	Participant History			1	1		0	148	3734	70	\N	t	f
5656	137	Participant History			1	1		0	148	3744	71	\N	t	f
5657	137	Participant History			1	1		0	148	3731	72	\N	t	f
3137	114	Information			1	1		0	105	1394	1	\N	t	f
3138	114	Information			1	1		0	105	1356	2	\N	t	f
3139	114	Information			1	1		0	105	1355	3	\N	t	f
3140	114	Information			1	1		0	105	1380	4	\N	t	f
3141	114	Information			1	1		0	105	1401	5	\N	t	f
3142	114	Information			1	1		0	105	1399	6	\N	t	f
3143	114	Information			1	1		0	105	1397	7	\N	t	f
3144	114	Information			1	1		0	105	1396	8	\N	t	f
3145	114	Information			1	1		0	105	1377	9	\N	t	f
3146	114	Information			1	1		0	105	1387	10	\N	t	f
3604	127	Visit Information			1	1		0	117	1711	1	\N	t	f
3605	127	Visit Information			1	1		0	117	1712	2	\N	t	f
3606	127	Visit Information			1	1		0	117	1713	3	\N	t	f
3607	127	Visit Information			1	1		0	117	1714	4	\N	t	f
3608	127	Visit Information			1	1		0	117	1715	5	\N	t	f
3609	127	Visit Information			1	1		0	117	1716	6	\N	t	f
3610	127	Visit Information			1	1		0	117	1717	7	\N	t	f
3611	127	Visit Information			1	1		0	117	1718	8	\N	t	f
3612	127	Visit Information			1	1		0	117	1719	9	\N	t	f
3613	127	Visit Information			1	1		0	117	1720	10	\N	t	f
3614	127	Visit Information			1	1		0	117	1721	11	\N	t	f
3615	127	Visit Information			1	1		0	117	1722	12	\N	t	f
3616	127	Visit Information			1	1		0	117	1723	13	\N	t	f
3617	127	Visit Information			1	1		0	117	1724	14	\N	t	f
3618	127	Visit Information			1	1		0	117	1725	15	\N	t	f
3619	127	Visit Information			1	1		0	117	1726	16	\N	t	f
3620	127	Visit Information			1	1		0	117	1727	17	\N	t	f
3621	127	Visit Information			1	1		0	117	1728	18	\N	t	f
3622	127	Visit Information			1	1		0	117	1729	19	\N	t	f
3623	129				1	40		0	117	1730	20	\N	t	t
3624	129				1	40		0	117	1731	21	\N	t	t
3625	129				1	40		0	117	1732	22	\N	t	t
3626	129				1	40		0	117	1733	23	\N	t	t
3627	129				1	40		0	117	1734	24	\N	t	t
3628	127	Visit Information			1	1		0	117	1735	25	\N	t	f
3629	127	Visit Information			1	1		0	117	1736	26	\N	t	f
3630	127	Visit Information			1	1		0	117	1737	27	\N	t	f
3631	127	Visit Information			1	1		0	117	1738	28	\N	t	f
3632	127	Visit Information			1	1		0	117	1739	29	\N	t	f
3633	127	Visit Information			1	1		0	117	1740	30	\N	t	f
3634	127	Visit Information			1	1		0	117	1741	31	\N	t	f
3147	114	Information			1	1		0	105	1385	11	\N	t	f
3148	114	Information			1	1		0	105	1384	12	\N	t	f
3149	114	Information			1	1		0	105	1363	13	\N	t	f
3150	114	Information			1	1		0	105	1361	14	\N	t	f
3151	114	Information			1	1		0	105	1373	15	\N	t	f
3152	114	Information			1	1		0	105	1371	16	\N	t	f
3153	114	Information			1	1		0	105	1372	17	\N	t	f
3154	114	Information			1	1		0	105	1368	18	\N	t	f
3155	114	Information			1	1		0	105	1367	19	\N	t	f
3156	114	Information			1	1		0	105	1366	20	\N	t	f
3157	114	Information			1	1		0	105	1360	21	\N	t	f
3158	114	Information			1	1		0	105	1359	22	\N	t	f
3159	114	Information			1	1		0	105	1358	23	\N	t	f
3160	114	Information			1	1		0	105	1357	24	\N	t	f
3161	114	Information			1	1		0	105	1389	25	\N	t	f
3162	114	Information			1	1		0	105	1402	26	\N	t	f
3163	114	Information			1	1		0	105	1400	27	\N	t	f
3164	114	Information			1	1		0	105	1398	28	\N	t	f
3165	114	Information			1	1		0	105	1379	29	\N	t	f
3166	114	Information			1	1		0	105	1378	30	\N	t	f
3167	114	Information			1	1		0	105	1388	31	\N	t	f
3168	114	Information			1	1		0	105	1386	32	\N	t	f
3169	114	Information			1	1		0	105	1365	33	\N	t	f
3170	114	Information			1	1		0	105	1364	34	\N	t	f
3171	114	Information			1	1		0	105	1362	35	\N	t	f
3172	114	Information			1	1		0	105	1374	36	\N	t	f
3173	114	Information			1	1		0	105	1353	37	\N	t	f
3174	114	Information			1	1		0	105	1352	38	\N	t	f
3175	114	Information			1	1		0	105	1351	39	\N	t	f
3176	114	Information			1	1		0	105	1350	40	\N	t	f
3177	114	Information			1	1		0	105	1393	41	\N	t	f
3178	114	Information			1	1		0	105	1392	42	\N	t	f
3179	114	Information			1	1		0	105	1391	43	\N	t	f
3180	114	Information			1	1		0	105	1390	44	\N	t	f
3181	114	Information			1	1		0	105	1395	45	\N	t	f
3182	114	Information			1	1		0	105	1354	46	\N	t	f
3183	114	Information			1	1		0	105	1376	47	\N	t	f
3184	114	Information			1	1		0	105	1382	48	\N	t	f
3185	114	Information			1	1		0	105	1381	49	\N	t	f
3186	114	Information			1	1		0	105	1369	50	\N	t	f
3187	114	Information			1	1		0	105	1375	51	\N	t	f
3188	114	Information			1	1		0	105	1383	52	\N	t	f
3189	114	Information			1	1		0	105	1370	53	\N	t	f
4767	131	Visit Information			1	1		0	135	2912	1	\N	t	f
4768	131	Visit Information			1	1		0	135	2964	2	\N	t	f
4769	131	Visit Information			1	1		0	135	2890	3	\N	t	f
4770	131	Visit Information			1	1		0	135	2934	4	\N	t	f
4771	131	Visit Information			1	1		0	135	2896	5	\N	t	f
4772	131	Visit Information			1	1		0	135	2956	6	\N	t	f
4773	131	Visit Information			1	1		0	135	2941	7	\N	t	f
4774	131	Visit Information			1	1		0	135	2933	8	\N	t	f
4775	131	Visit Information			1	1		0	135	2892	9	\N	t	f
4776	131	Visit Information			1	1		0	135	2955	10	\N	t	f
4777	131	Visit Information			1	1		0	135	2940	11	\N	t	f
4778	131	Visit Information			1	1		0	135	2910	12	\N	t	f
4779	131	Visit Information			1	1		0	135	2894	13	\N	t	f
4780	131	Visit Information			1	1		0	135	2954	14	\N	t	f
4781	131	Visit Information			1	1		0	135	2939	15	\N	t	f
4782	131	Visit Information			1	1		0	135	2888	16	\N	t	f
4783	131	Visit Information			1	1		0	135	2925	17	\N	t	f
4784	131	Visit Information			1	1		0	135	2893	18	\N	t	f
4785	131	Visit Information			1	1		0	135	2942	19	\N	t	f
4786	133				1	40		0	135	2965	20	\N	t	t
4787	133				1	40		0	135	2889	21	\N	t	t
4788	133				1	40		0	135	2967	22	\N	t	t
4789	133				1	40		0	135	2963	23	\N	t	t
4790	133				1	40		0	135	2909	24	\N	t	t
4791	131	Visit Information			1	1		0	135	2891	25	\N	t	f
4792	131	Visit Information			1	1		0	135	2966	26	\N	t	f
4793	131	Visit Information			1	1		0	135	2913	27	\N	t	f
4794	131	Visit Information			1	1		0	135	2935	28	\N	t	f
4795	131	Visit Information			1	1		0	135	2968	29	\N	t	f
4796	131	Visit Information			1	1		0	135	2943	30	\N	t	f
4797	131	Visit Information			1	1		0	135	2959	31	\N	t	f
4798	131	Visit Information			1	1		0	135	2958	32	\N	t	f
4799	131	Visit Information			1	1		0	135	2957	33	\N	t	f
4800	131	Visit Information			1	1		0	135	2918	34	\N	t	f
4801	131	Visit Information			1	1		0	135	2944	35	\N	t	f
4802	131	Visit Information			1	1		0	135	2884	36	\N	t	f
4803	131	Visit Information			1	1		0	135	2883	37	\N	t	f
3976	125	Adverse Event Description			1	1		0	126	2117	1	\N	t	f
3977	125	Adverse Event Description			1	1		0	126	2119	2	\N	t	f
4804	131	Visit Information			1	1		0	135	2882	38	\N	t	f
4805	131	Visit Information			1	1		0	135	2920	39	\N	t	f
4806	131	Visit Information			1	1		0	135	2948	40	\N	t	f
3978	125	Adverse Event Description			1	1		0	126	2099	3	\N	t	f
3979	125	Adverse Event Description			1	1		0	126	2091	4	\N	t	f
3980	125	Adverse Event Description			1	1		0	126	2086	5	\N	t	f
3981	125	Adverse Event Description			1	1		0	126	2084	6	\N	t	f
3982	125	Adverse Event Description			1	1		0	126	2083	7	\N	t	f
3983	125	Adverse Event Description			1	1		0	126	2104	8	\N	t	f
3984	125	Adverse Event Description			1	1		0	126	2114	9	\N	t	f
3985	125	Adverse Event Description			1	1		0	126	2115	10	\N	t	f
3986	125	Adverse Event Description			1	1		0	126	2093	11	\N	t	f
3244	114	Information			1	1		0	107	1404	1	\N	t	f
3245	114	Information			1	1		0	107	1394	2	\N	t	f
3246	114	Information			1	1		0	107	1356	3	\N	t	f
3247	114	Information			1	1		0	107	1355	4	\N	t	f
3248	114	Information			1	1		0	107	1380	5	\N	t	f
3249	114	Information			1	1		0	107	1401	6	\N	t	f
3250	114	Information			1	1		0	107	1399	7	\N	t	f
3251	114	Information			1	1		0	107	1397	8	\N	t	f
3252	114	Information			1	1		0	107	1396	9	\N	t	f
3253	114	Information			1	1		0	107	1377	10	\N	t	f
3254	114	Information			1	1		0	107	1387	11	\N	t	f
3255	114	Information			1	1		0	107	1385	12	\N	t	f
3256	114	Information			1	1		0	107	1384	13	\N	t	f
3257	114	Information			1	1		0	107	1363	14	\N	t	f
3258	114	Information			1	1		0	107	1361	15	\N	t	f
3259	114	Information			1	1		0	107	1373	16	\N	t	f
3260	114	Information			1	1		0	107	1371	17	\N	t	f
3261	114	Information			1	1		0	107	1372	18	\N	t	f
3262	114	Information			1	1		0	107	1368	19	\N	t	f
3263	114	Information			1	1		0	107	1367	20	\N	t	f
3264	114	Information			1	1		0	107	1366	21	\N	t	f
3265	114	Information			1	1		0	107	1360	22	\N	t	f
3266	114	Information			1	1		0	107	1359	23	\N	t	f
3267	114	Information			1	1		0	107	1358	24	\N	t	f
3268	114	Information			1	1		0	107	1357	25	\N	t	f
3269	114	Information			1	1		0	107	1389	26	\N	t	f
3270	114	Information			1	1		0	107	1402	27	\N	t	f
3271	114	Information			1	1		0	107	1400	28	\N	t	f
3272	114	Information			1	1		0	107	1398	29	\N	t	f
3273	114	Information			1	1		0	107	1379	30	\N	t	f
3274	114	Information			1	1		0	107	1378	31	\N	t	f
3275	114	Information			1	1		0	107	1388	32	\N	t	f
3276	114	Information			1	1		0	107	1386	33	\N	t	f
3277	114	Information			1	1		0	107	1365	34	\N	t	f
3278	114	Information			1	1		0	107	1364	35	\N	t	f
3279	114	Information			1	1		0	107	1362	36	\N	t	f
3280	114	Information			1	1		0	107	1374	37	\N	t	f
3281	114	Information			1	1		0	107	1353	38	\N	t	f
3282	114	Information			1	1		0	107	1352	39	\N	t	f
3283	114	Information			1	1		0	107	1351	40	\N	t	f
3284	114	Information			1	1		0	107	1350	41	\N	t	f
3285	114	Information			1	1		0	107	1393	42	\N	t	f
3286	114	Information			1	1		0	107	1392	43	\N	t	f
3287	114	Information			1	1		0	107	1391	44	\N	t	f
3288	114	Information			1	1		0	107	1390	45	\N	t	f
3289	114	Information			1	1		0	107	1395	46	\N	t	f
3290	114	Information			1	1		0	107	1354	47	\N	t	f
3291	114	Information			1	1		0	107	1376	48	\N	t	f
3292	114	Information			1	1		0	107	1382	49	\N	t	f
3293	114	Information			1	1		0	107	1381	50	\N	t	f
3294	114	Information			1	1		0	107	1369	51	\N	t	f
3295	114	Information			1	1		0	107	1375	52	\N	t	f
3296	114	Information			1	1		0	107	1383	53	\N	t	f
3297	114	Information			1	1		0	107	1370	54	\N	t	f
3987	125	Adverse Event Description			1	1		0	126	2096	12	\N	t	f
3988	125	Adverse Event Description			1	1		0	126	2097	13	\N	t	f
3989	125	Adverse Event Description			1	1		0	126	2120	14	\N	t	f
3990	125	Adverse Event Description			1	1		0	126	2085	15	\N	t	f
3991	125	Adverse Event Description			1	1		0	126	2095	16	\N	t	f
3992	125	Adverse Event Description			1	1		0	126	2087	17	\N	t	f
3993	125	Adverse Event Description			1	1		0	126	2105	18	\N	t	f
3994	125	Adverse Event Description			1	1		0	126	2098	19	\N	t	f
3995	125	Adverse Event Description			1	1		0	126	2110	20	\N	t	f
3996	125	Adverse Event Description			1	1		0	126	2090	21	\N	t	f
3997	125	Adverse Event Description			1	1		0	126	2108	22	\N	t	f
3998	125	Adverse Event Description			1	1		0	126	2088	23	\N	t	f
3999	125	Adverse Event Description			1	1		0	126	2094	24	\N	t	f
4000	125	Adverse Event Description			1	1		0	126	2089	25	\N	t	f
4001	125	Adverse Event Description			1	1		0	126	2118	26	\N	t	f
4002	125	Adverse Event Description			1	1		0	126	2109	27	\N	t	f
4003	125	Adverse Event Description			1	1		0	126	2111	28	\N	t	f
4004	125	Adverse Event Description			1	1		0	126	2106	29	\N	t	f
4005	125	Adverse Event Description			1	1		0	126	2112	30	\N	t	f
4006	125	Adverse Event Description			1	1		0	126	2092	31	\N	t	f
3635	127	Visit Information			1	1		0	117	1742	32	\N	t	f
3636	127	Visit Information			1	1		0	117	1743	33	\N	t	f
3637	127	Visit Information			1	1		0	117	1744	34	\N	t	f
3638	127	Visit Information			1	1		0	117	1745	35	\N	t	f
3639	127	Visit Information			1	1		0	117	1746	36	\N	t	f
3640	127	Visit Information			1	1		0	117	1747	37	\N	t	f
3641	127	Visit Information			1	1		0	117	1748	38	\N	t	f
3642	127	Visit Information			1	1		0	117	1749	39	\N	t	f
3643	127	Visit Information			1	1		0	117	1750	40	\N	t	f
3644	127	Visit Information			1	1		0	117	1751	41	\N	t	f
3645	127	Visit Information			1	1		0	117	1752	42	\N	t	f
3646	127	Visit Information			1	1		0	117	1753	43	\N	t	f
3647	127	Visit Information			1	1		0	117	1754	44	\N	t	f
3648	127	Visit Information			1	1		0	117	1755	45	\N	t	f
3649	127	Visit Information			1	1		0	117	1756	46	\N	t	f
3650	127	Visit Information			1	1		0	117	1757	47	\N	t	f
3651	127	Visit Information			1	1		0	117	1758	48	\N	t	f
3652	127	Visit Information			1	1		0	117	1759	49	\N	t	f
3653	127	Visit Information			1	1		0	117	1760	50	\N	t	f
3654	127	Visit Information			1	1		0	117	1761	51	\N	t	f
3655	127	Visit Information			1	1		0	117	1762	52	\N	t	f
3656	127	Visit Information			1	1		0	117	1763	53	\N	t	f
3657	127	Visit Information			1	1		0	117	1764	54	\N	t	f
3658	127	Visit Information			1	1		0	117	1765	55	\N	t	f
3659	127	Visit Information			1	1		0	117	1766	56	\N	t	f
3660	127	Visit Information			1	1		0	117	1767	57	\N	t	f
3661	127	Visit Information			1	1		0	117	1768	58	\N	t	f
3662	127	Visit Information			1	1		0	117	1769	59	\N	t	f
3663	127	Visit Information			1	1		0	117	1770	60	\N	t	f
3664	127	Visit Information			1	1		0	117	1771	61	\N	t	f
3665	127	Visit Information			1	1		0	117	1772	62	\N	t	f
3666	127	Visit Information			1	1		0	117	1773	63	\N	t	f
3667	127	Visit Information			1	1		0	117	1774	64	\N	t	f
3668	127	Visit Information			1	1		0	117	1775	65	\N	t	f
3669	127	Visit Information			1	1		0	117	1776	66	\N	t	f
3670	127	Visit Information			1	1		0	117	1777	67	\N	t	f
3671	127	Visit Information			1	1		0	117	1778	68	\N	t	f
3672	127	Visit Information			1	1		0	117	1779	69	\N	t	f
3673	127	Visit Information			1	1		0	117	1780	70	\N	t	f
3674	127	Visit Information			1	1		0	117	1781	71	\N	t	f
3675	127	Visit Information			1	1		0	117	1782	72	\N	t	f
3676	127	Visit Information			1	1		0	117	1783	73	\N	t	f
3677	127	Visit Information			1	1		0	117	1784	74	\N	t	f
3678	127	Visit Information			1	1		0	117	1785	75	\N	t	f
3679	127	Visit Information			1	1		0	117	1786	76	\N	t	f
3680	127	Visit Information			1	1		0	117	1787	77	\N	t	f
3681	127	Visit Information			1	1		0	117	1788	78	\N	t	f
3682	127	Visit Information			1	1		0	117	1789	79	\N	t	f
3683	127	Visit Information			1	1		0	117	1790	80	\N	t	f
3684	127	Visit Information			1	1		0	117	1791	81	\N	t	f
3685	127	Visit Information			1	1		0	117	1792	82	\N	t	f
3686	127	Visit Information			1	1		0	117	1793	83	\N	t	f
4007	125	Adverse Event Description			1	1		0	126	2101	32	\N	t	f
4008	125	Adverse Event Description			1	1		0	126	2100	33	\N	t	f
4009	125	Adverse Event Description			1	1		0	126	2121	34	\N	t	f
4010	125	Adverse Event Description			1	1		0	126	2103	35	\N	t	f
4011	125	Adverse Event Description			1	1		0	126	2116	36	\N	t	f
4012	125	Adverse Event Description			1	1		0	126	2102	37	\N	t	f
4013	125	Adverse Event Description			1	1		0	126	2113	38	\N	t	f
4014	125	Adverse Event Description			1	1		0	126	2123	39	\N	t	f
4015	125	Adverse Event Description			1	1		0	126	2122	40	\N	t	f
4016	125	Adverse Event Description			1	1		0	126	2107	41	\N	t	f
4807	131	Visit Information			1	1		0	135	2904	41	\N	t	f
4808	131	Visit Information			1	1		0	135	2906	42	\N	t	f
4809	131	Visit Information			1	1		0	135	2905	43	\N	t	f
4810	131	Visit Information			1	1		0	135	2915	44	\N	t	f
4811	131	Visit Information			1	1		0	135	2949	45	\N	t	f
4812	131	Visit Information			1	1		0	135	2885	46	\N	t	f
4813	131	Visit Information			1	1		0	135	2887	47	\N	t	f
4814	131	Visit Information			1	1		0	135	2886	48	\N	t	f
4815	131	Visit Information			1	1		0	135	2917	49	\N	t	f
4816	131	Visit Information			1	1		0	135	2945	50	\N	t	f
4817	131	Visit Information			1	1		0	135	2908	51	\N	t	f
4818	131	Visit Information			1	1		0	135	2907	52	\N	t	f
4819	131	Visit Information			1	1		0	135	2911	53	\N	t	f
4820	131	Visit Information			1	1		0	135	2928	54	\N	t	f
4821	131	Visit Information			1	1		0	135	2947	55	\N	t	f
4822	131	Visit Information			1	1		0	135	2938	56	\N	t	f
4823	131	Visit Information			1	1		0	135	2937	57	\N	t	f
4824	131	Visit Information			1	1		0	135	2936	58	\N	t	f
4825	131	Visit Information			1	1		0	135	2931	59	\N	t	f
4826	131	Visit Information			1	1		0	135	2919	60	\N	t	f
4827	131	Visit Information			1	1		0	135	2962	61	\N	t	f
4828	131	Visit Information			1	1		0	135	2961	62	\N	t	f
4829	131	Visit Information			1	1		0	135	2960	63	\N	t	f
4830	131	Visit Information			1	1		0	135	2922	64	\N	t	f
4831	131	Visit Information			1	1		0	135	2877	65	\N	t	f
4832	131	Visit Information			1	1		0	135	2876	66	\N	t	f
4833	131	Visit Information			1	1		0	135	2875	67	\N	t	f
4834	131	Visit Information			1	1		0	135	2874	68	\N	t	f
4835	131	Visit Information			1	1		0	135	2900	69	\N	t	f
4836	131	Visit Information			1	1		0	135	2898	70	\N	t	f
4837	131	Visit Information			1	1		0	135	2897	71	\N	t	f
4838	131	Visit Information			1	1		0	135	2895	72	\N	t	f
4839	131	Visit Information			1	1		0	135	2929	73	\N	t	f
4840	131	Visit Information			1	1		0	135	2926	74	\N	t	f
4841	131	Visit Information			1	1		0	135	2923	75	\N	t	f
4842	131	Visit Information			1	1		0	135	2921	76	\N	t	f
4843	131	Visit Information			1	1		0	135	2953	77	\N	t	f
4844	131	Visit Information			1	1		0	135	2952	78	\N	t	f
4845	131	Visit Information			1	1		0	135	2951	79	\N	t	f
4846	131	Visit Information			1	1		0	135	2950	80	\N	t	f
4847	131	Visit Information			1	1		0	135	2932	81	\N	t	f
4848	131	Visit Information			1	1		0	135	2930	82	\N	t	f
4849	131	Visit Information			1	1		0	135	2927	83	\N	t	f
4850	131	Visit Information			1	1		0	135	2924	84	\N	t	f
4851	131	Visit Information			1	1		0	135	2903	85	\N	t	f
4852	131	Visit Information			1	1		0	135	2902	86	\N	t	f
4853	131	Visit Information			1	1		0	135	2901	87	\N	t	f
4854	131	Visit Information			1	1		0	135	2899	88	\N	t	f
4855	131	Visit Information			1	1		0	135	2881	89	\N	t	f
4856	131	Visit Information			1	1		0	135	2880	90	\N	t	f
4857	131	Visit Information			1	1		0	135	2879	91	\N	t	f
4858	131	Visit Information			1	1		0	135	2878	92	\N	t	f
4859	131	Visit Information			1	1		0	135	2916	93	\N	t	f
4860	131	Visit Information			1	1		0	135	2946	94	\N	t	f
4861	131	Visit Information			1	1		0	135	2914	95	\N	t	f
4882	135	Information Concerning Death			1	1		0	137	3001	1	\N	t	f
4883	135	Information Concerning Death			1	1		0	137	3003	2	\N	t	f
4884	135	Information Concerning Death			1	1		0	137	3004	3	\N	t	f
4885	135	Information Concerning Death			1	1		0	137	2997	4	\N	t	f
4886	135	Information Concerning Death			1	1		0	137	3002	5	\N	t	f
4887	135	Information Concerning Death			1	1		0	137	3000	6	\N	t	f
4888	135	Information Concerning Death			1	1		0	137	3007	7	\N	t	f
4889	135	Information Concerning Death			1	1		0	137	2999	8	\N	t	f
4890	135	Information Concerning Death			1	1		0	137	2996	9	\N	t	f
4891	135	Information Concerning Death			1	1		0	137	2994	10	\N	t	f
4892	135	Information Concerning Death			1	1		0	137	3008	11	\N	t	f
4893	135	Information Concerning Death			1	1		0	137	2995	12	\N	t	f
4894	135	Information Concerning Death			1	1		0	137	2991	13	\N	t	f
4895	135	Information Concerning Death			1	1		0	137	2989	14	\N	t	f
4896	135	Information Concerning Death			1	1		0	137	2992	15	\N	t	f
4897	135	Information Concerning Death			1	1		0	137	3005	16	\N	t	f
4898	135	Information Concerning Death			1	1		0	137	2993	17	\N	t	f
4899	135	Information Concerning Death			1	1		0	137	3006	18	\N	t	f
4900	135	Information Concerning Death			1	1		0	137	2990	19	\N	t	f
4901	135	Information Concerning Death			1	1		0	137	2998	20	\N	t	f
\.


--
-- Data for Name: item_reference_type; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.item_reference_type (item_reference_type_id, name, description) FROM stdin;
1	literal	\N
\.


--
-- Data for Name: measurement_unit; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.measurement_unit (id, oc_oid, name, description, version) FROM stdin;
1	MU_DDMMMYYYY	DD-MMM-YYYY	\N	\N
2	MU_YYYY	YYYY	\N	\N
3	MU_9583	##-#####	\N	\N
4	MU_38	38-##-#####	\N	\N
5	MU_3123	####	\N	\N
6	MU_HHMM	HH:MM	\N	\N
7	MU_ML	mL	\N	\N
8	MU_3448	########	\N	\N
9	MU_ML_2936	ml	\N	\N
10	MU_38_9354	38-##-####	\N	\N
11	MU_1	####-1#	\N	\N
12	MU_0	####0#	\N	\N
13	MU_3	####3#	\N	\N
14	MU_8440	##-##-#####	\N	\N
15	MU_38_1519	38 - ## - #####	\N	\N
16	MU_1_2701	####1#	\N	\N
17	MU_2	####2#	\N	\N
18	MU_4	####4#	\N	\N
19	MU_6	####6#	\N	\N
20	MU_12	####12#	\N	\N
21	MU_24	####24#	\N	\N
22	MU_1_6077	#### -1 #	\N	\N
23	MU_0_1508	#### 0 #	\N	\N
24	MU_3_7044	#### 3 #	\N	\N
25	MU_1_1784	#### 1 #	\N	\N
26	MU_2_9243	#### 2 #	\N	\N
27	MU_4_4245	#### 4 #	\N	\N
28	MU_6_1015	#### 6 #	\N	\N
29	MU_12_3668	#### 12 #	\N	\N
30	MU_24_304	#### 24 #	\N	\N
31	MU_WEEKS	Weeks	\N	\N
32	MU_MMMYYYY	MMM-YYYY	\N	\N
\.


--
-- Data for Name: null_value_type; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.null_value_type (null_value_type_id, code, name, definition, reference) FROM stdin;
1	NI	NoInformation	\N	\N
2	NA	not applicable	\N	\N
3	UNK	unknown	\N	\N
4	NASK	not asked	\N	\N
5	ASKU	asked but unknown	\N	\N
6	NAV	temporarily unavailable	\N	\N
7	OTH	other	\N	\N
8	PINF	positive infinity	\N	\N
9	NINF	negative infinity	\N	\N
10	MSK	masked	\N	\N
11	NP	not present	\N	\N
12	NPE	not performed	\N	\N
\.


--
-- Data for Name: oc_qrtz_blob_triggers; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_blob_triggers (trigger_name, trigger_group, blob_data) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_calendars; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_calendars (calendar_name, sched_name, calendar) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_cron_triggers; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_cron_triggers (trigger_name, trigger_group, cron_expression, time_zone_id, sched_name) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_fired_triggers; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_fired_triggers (entry_id, trigger_name, trigger_group, instance_name, fired_time, priority, state, job_name, job_group, is_stateful, requests_recovery, sched_name, is_nonconcurrent, is_update_data, sched_time) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_job_details; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_job_details (job_name, job_group, description, job_class_name, is_durable, requests_recovery, sched_name, is_nonconcurrent, is_update_data, job_data) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_job_listeners; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_job_listeners (job_name, job_group, job_listener) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_locks; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_locks (lock_name, sched_name) FROM stdin;
TRIGGER_ACCESS	TestScheduler
JOB_ACCESS	TestScheduler
CALENDAR_ACCESS	TestScheduler
STATE_ACCESS	TestScheduler
MISFIRE_ACCESS	TestScheduler
TRIGGER_ACCESS	public
\.


--
-- Data for Name: oc_qrtz_paused_trigger_grps; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_paused_trigger_grps (trigger_group, sched_name) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_scheduler_state; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_scheduler_state (instance_name, last_checkin_time, checkin_interval, sched_name) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_simple_triggers; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_simple_triggers (trigger_name, trigger_group, repeat_count, repeat_interval, times_triggered, sched_name) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_trigger_listeners; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_trigger_listeners (trigger_name, trigger_group, trigger_listener) FROM stdin;
\.


--
-- Data for Name: oc_qrtz_triggers; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.oc_qrtz_triggers (trigger_name, trigger_group, job_name, job_group, description, next_fire_time, prev_fire_time, priority, trigger_state, trigger_type, start_time, end_time, calendar_name, misfire_instr, sched_name, job_data) FROM stdin;
\.


--
-- Data for Name: openclinica_version; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.openclinica_version (id, name, build_number, version, update_timestamp) FROM stdin;
1		\N	0	2023-12-02 09:30:26.339
\.


--
-- Data for Name: privilege; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.privilege (priv_id, priv_name, priv_desc) FROM stdin;
\.


--
-- Data for Name: resolution_status; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.resolution_status (resolution_status_id, name, description) FROM stdin;
1	New	
2	Updated	
3	Resolution Proposed	
4	Closed	
5	Not Applicable	
\.


--
-- Data for Name: response_set; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.response_set (response_set_id, response_type_id, label, options_text, options_values, version_id) FROM stdin;
23	1	text	text	text	3
24	5	Yes,No	Yes,No	Y,N	3
25	2	textarea	text	text	3
26	5	Yes,No,Not applicable	Yes,No,Not applicable	Y,N,NA	3
27	3	SAE	Death,Any life-threatening experience,Any inpatient hospitalization,Persistently or significantly disabling event,Congenital anomaly or birth defect,Other medically important event	Death,Any life-threatening experience,Any inpatient hospitalization,Persistently or significantly disabling event,Congenital anomaly or birth defect,Other medically important event	3
28	5	STATUS	Recovered/Resolved,Recovered/Resolved With Sequelae,Fatal,Recovering/Resolving,Not Recovered/Not Resolved,Unknown	RECOVERED/RESOLVED,RECOVERED/RESOLVED WITH SEQUELAE,FATAL,RECOVERING/RESOLVING,NOT RECOVERED/NOT RESOLVED,UNKNOWN	3
29	5	Drugs	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	DEFINITE,PROBABLE,POSSIBLE,UNLIKELY,NOT RELATED,UNCLASSIFIABLE	3
30	3	AESTUDY	Bedaquiline,Moxifloxacin,Pyrazinamide,Rifampin,Delamanid,Rifabutin,Ethambutol,Isoniazid	BDQ,M,PZA,RIF,DLM,RBT,ETH,INH	3
31	5	Anticipated,Unanticipated	Anticipated,Unanticipated	ANTICIPATED,UNANTICIPATED	3
32	5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	1,2,3,4,5	3
33	5	outcome	Spontaneous abortion,Elective abortion,Live birth,Fetal death,Unknown	Spontaneous Abortion,Elective Abortion,Live Birth,Fetal Death,Unknown Pregnancy Outcome	3
34	5	Evaluation	Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early Off Treatment Termination,Unscheduled	W22,W26,W39,W52,W65,W78,EOFFTT,UNS	4
35	1	text	text	text	4
36	5	CM	Yes,No	Y,N	4
37	5	DR	Yes,No	Y,N	4
38	5	CE	Yes,No	Y,N	4
39	5	LB	Yes,No	Y,N	4
40	5	SS	Yes,No	Y,N	4
41	5	MB	Yes,No	Y,N	4
42	5	RS	Yes,No	Y,N	4
43	5	BR	Yes,No	Y,N	4
44	5	TM	Yes,No	Y,N	4
45	2	textarea	text	text	4
49	1	text	text	text	6
50	3	Estimated	Estimated	ESTIMATE	6
51	3	NA	NA	NA	6
52	5	cm, in	cm, in	cm,in	6
53	5	kg,lbs	kg,lbs	kg,lbs	6
54	5	Yes,No	Yes,No	Y,N	6
55	2	textarea	text	text	6
56	5	Regimen 1 (BMZRb), Regimen 2 (BMZD), Regimen 3 (HRZE)	Regimen 1 (BMZRb), Regimen 2 (BMZD), Regimen 3 (HRZE)	BMZRb,BMZD,HRZE	6
57	1	text	text	text	7
58	5	Yes,No	Yes,No	Y,N	7
59	2	textarea	text	text	7
60	5	Immediate,Contributing cause of death,Not a cause of death,Uncertain	An immediate cause of death,A contributing cause of death,Not a cause of death,Uncertain as a contributor to the cause of death	AN IMMEDIATE CAUSE OF DEATH,A CONTRIBUTING CAUSE OF DEATH,NOT A CAUSE OF DEATH,UNCERTAIN AS A CONTRIBUTOR TO THE CAUSE OF DEATH	7
61	5	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	DEFINITE,PROBABLE,POSSIBLE,UNLIKELY,NOT RELATED,UNCLASSIFIABLE	7
62	5	Anticipated,Unanticipated	Anticipated,Unanticipated	ANTICIPATED,UNANTICIPATED	7
63	5	Yes,No,Unknown	Yes,No,Unknown	Y,N,U	7
462	1	text	text	text	60
463	5	CF	Yes (Skip to section C),No	Y,N	60
464	5	NS	Participant died (Complete Notification of Death Form),Participant’s screening and baseline study visit sputum cultures all failed to grow M. tuberculosis   (Complete Mycobacteriology Form),Participant’s screening or baseline isolate is resistant to any one or more of isoniazid\\, rifampin\\, fluoroquinolones\\, pyrazinamide\\, ethambutol\\, delamanid\\, or bedaquiline (Complete Mycobacteriology Form)	DEATH,SCREEN FAILURE (FAILED TO GROW M. TUBERCULOSIS),SCREEN FAILURE (SCREENING OR BASELINE ISOLATE IS RESISTANT)	60
465	5	WS	Participant withdrew consent	WITHDRAWAL BY SUBJECT	60
466	5	PV	Participant determined ineligible after enrollment for reasons other than mycobacteriology	PROTOCOL VIOLATION	60
467	5	LF	Participant is lost to follow-up	LOST TO FOLLOW-UP	60
468	5	MO	Other\\, specify	OTHER	60
469	3	Storage of blood	Retain blood specimens and use for future pharmacogenomic testing (skip to Section D), Participant withdraws consent for blood specimen use for future pharmacogenomic testing and has requested specimens be destroyed. (complete C.2 & C.3)	PGKEEP, PGDESTROY	60
470	2	textarea	text	text	60
471	3	Storage of blood specimens	Retain blood specimens and use for future research(Skip to section E), Participant withdraws consent for blood specimen use for future research and has requested specimens be destroyed. (complete D.2 & D.3)	FTRKEEP, FTRKEEP	60
472	1	text	text	text	61
473	5	CF	Yes (Skip to section C),No	Y,N	61
474	5	NS	Participant died (Complete Notification of Death Form),Participant’s screening and baseline study visit sputum cultures all failed to grow M. tuberculosis   (Complete Mycobacteriology Form),Participant’s screening or baseline isolate is resistant to any one or more of isoniazid\\, rifampin\\, fluoroquinolones\\, pyrazinamide\\, ethambutol\\, delamanid\\, or bedaquiline (Complete Mycobacteriology Form),Participant withdrew consent   (specify reason below),Participant determined ineligible after enrollment for reasons other than mycobacteriology (PROTOCOL VIOLATION)   (specify reason below),Participant is lost to follow-up   (specify reason below),Other   (specify below)	DEATH,SCREEN FAILURE (FAILED TO GROW M. TUBERCULOSIS),SCREEN FAILURE (SCREENING OR BASELINE ISOLATE IS RESISTANT),WITHDRAWAL BY SUBJECT,PROTOCOL VIOLATION,LOST TO FOLLOWUP,OTHER	61
475	2	textarea	text	text	61
476	5	BCATP	Retain blood specimens and use for future pharmacogenomic testing (skip to Section D),Participant withdraws consent for blood specimen use for future pharmacogenomic testing and has requested specimens be destroyed. (complete 5 & 6)	PGKEEP, PGDESTROY	61
477	5	BCATF	Retain blood specimens and use for future research (skip to Section E),Participant withdraws consent for blood specimen use for future research and has requested specimens be destroyed (complete question 8)	FTRKEEP, FTRDESTROY	61
478	5	VisitLbl	Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Unscheduled	W02,W03,W04,W06,W08,W10,W12,UNS	62
479	1	text	text	text	62
480	5	aextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	62
481	5	aceoccurlbl	Yes,No,Unknown	Y,N,U	62
482	5	bextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	62
106	1	text	text	text	9
107	5	Sex	Male,Female	M,F	9
108	6	Place	ARUBA,AFGHANISTAN,ANGOLA,ANGUILLA,ALAND ISLANDS,ALBANIA,ANDORRA,NETHERLANDS ANTILLES,UNITED ARAB EMIRATES,ARGENTINA,ARMENIA,AMERICAN SAMOA,ANTARCTICA,FRENCH SOUTHERN TERRITORIES,ANTIGUA AND BARBUDA,AUSTRALIA,AUSTRIA,AZERBAIJAN,BURUNDI,BELGIUM,BENIN REPUBLIC,BURKINA FASO,BANGLADESH,BULGARIA,BAHRAIN,BAHAMAS,BOSNIA-HERZEGOVINA,SAINT BARTHELEMY,BELARUS,BELIZE,BERMUDA,BOLIVIA,BRAZIL,BARBADOS,BRUNEI,BHUTAN,BOUVET ISLAND,BOTSWANA,CENTRAL AFRICAN REPUBLIC,CANADA,COCOS (KEELING) ISLANDS,SWITZERLAND,CHILE,CHINA,COTE D'IVOIRE,CAMEROON,DEMOCRATIC REPUBLIC OF THE CONGO,CONGO,COOK ISLANDS,COLOMBIA,COMOROS,CAPE VERDE,COSTA RICA,CUBA,CHRISTMAS ISLAND,CAYMAN ISLANDS,CYPRUS,CZECH REPUBLIC,GERMANY,DJIBOUTI,DOMINICA,DENMARK,DOMINICAN REPUBLIC,ALGERIA,ECUADOR,EGYPT,ERITREA,WESTERN SAHARA,SPAIN,ESTONIA,ETHIOPIA,FINLAND,FIJI,FALKLAND ISLANDS,FRANCE,FAROE ISLANDS,MICRONESIA FEDERATED STATES OF,GABON,UNITED KINGDOM,GEORGIA,GUERNSEY,GHANA,GIBRALTAR,GUINEA,GUADELOUPE,GAMBIA,GUINEA-BISSAU,EQUATORIAL GUINEA,GREECE,GRENADA,GREENLAND,GUATEMALA,FRENCH GUIANA,GUAM,GUYANA,HONG KONG,HEARD ISLAND AND MCDONALD ISLANDS,HONDURAS,CROATIA,HAITI,HUNGARY,INDONESIA,INDIA,ISLE OF MAN,BRITISH INDIAN OCEAN TERRITORY,IRELAND,IRAN,IRAQ,ICELAND,ISRAEL,ITALY,JAMAICA,JORDAN,JAPAN,JERSEY,KAZAKHSTAN,KENYA,KYRGYZSTAN,CAMBODIA,KIRIBATI,SAINT KITTS AND NEVIS,SOUTH KOREA,KUWAIT,LAO PEOPLES DEMOCRATIC REPUBLIC,LEBANON,LIBERIA,LIBYAN ARAB JAMAHIRIYA,SAINT LUCIA,LIECHTENSTEIN,SRI LANKA,LESOTHO,LITHUANIA,LUXEMBOURG,LATVIA,MACAO,SAINT MARTIN FRENCH,MOROCCO,MONACO,MOLDOVA REPUBLIC OF,MADAGASCAR,MALDIVES,MEXICO,MARSHALL ISLANDS,REPUBLIC OF MACEDONIA,MALI,MALTA,MYANMAR,MONTENEGRO,MONGOLIA,NORTHERN MARIANA ISLANDS,MOZAMBIQUE,MAURITANIA,MONTSERRAT,MARTINIQUE,MAURITIUS,MALAWI,MALAYSIA,MAYOTTE,NAMIBIA,NEW CALEDONIA,NIGER,NORFOLK ISLAND,NIGERIA,NICARAGUA,NIUE,NETHERLANDS,NORWAY,NEPAL,NAURU,NEW ZEALAND,OMAN,PAKISTAN,PANAMA,PITCAIRN,PERU,PHILIPPINES,PALAU,PAPUA NEW GUINEA,POLAND,PUERTO RICO,NORTH KOREA,PORTUGAL,PARAGUAY,PALESTINIAN TERRITORY OCCUPIED,FRENCH POLYNESIA,QATAR,REUNION,ROMANIA,RUSSIAN FEDERATION,RWANDA,SAUDI ARABIA,SERBIA,SUDAN,SENEGAL,SINGAPORE,SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS,SAINT HELENA,SVALBARD AND JAN MAYEN,SOLOMON ISLANDS,SIERRA LEONE,EL SALVADOR,SAN MARINO,SOMALIA,SAINT PIERRE AND MIQUELON,SAO TOME AND PRINCIPE,SURINAME,SLOVAKIA,SLOVENIA,SWEDEN,SWAZILAND,SEYCHELLES,SYRIAN ARAB REPUBLIC,TURKS AND CAICOS ISLANDS,CHAD,TOGO,THAILAND,TAJIKISTAN,TOKELAU,TURKMENISTAN,TIMOR-LESTE,TONGA,TRINIDAD AND TOBAGO,TUNISIA,TURKEY,TUVALU,TAIWAN,TANZANIA UNITED REPUBLIC OF,UGANDA,UKRAINE,UNITED STATES MINOR OUTLYING ISLANDS,URUGUAY,UNITED STATES,UZBEKISTAN,VATICAN CITY STATE,SAINT VINCENT AND THE GRENADINES,VENEZUELA,VIRGIN ISLANDS BRITISH,VIRGIN ISLANDS U.S.,VIETNAM,VANUATU,WALLIS AND FUTUNA,SAMOA,YEMEN,SOUTH AFRICA,ZAMBIA,ZIMBABWE	ABW,AFG,AGO,AIA,ALA,ALB,AND,ANT,ARE,ARG,ARM,ASM,ATA,ATF,ATG,AUS,AUT,AZE,BDI,BEL,BEN,BFA,BGD,BGR,BHR,BHS,BIH,BLM,BLR,BLZ,BMU,BOL,BRA,BRB,BRN,BTN,BVT,BWA,CAF,CAN,CCK,CHE,CHL,CHN,CIV,CMR,COD,COG,COK,COL,COM,CPV,CRI,CUB,CXR,CYM,CYP,CZE,DEU,DJI,DMA,DNK,DOM,DZA,ECU,EGY,ERI,ESH,ESP,EST,ETH,FIN,FJI,FLK,FRA,FRO,FSM,GAB,GBR,GEO,GGY,GHA,GIB,GIN,GLP,GMB,GNB,GNQ,GRC,GRD,GRL,GTM,GUF,GUM,GUY,HKG,HMD,HND,HRV,HTI,HUN,IDN,IND,IMN,IOT,IRL,IRN,IRQ,ISL,ISR,ITA,JAM,JOR,JPN,JEY,KAZ,KEN,KGZ,KHM,KIR,KNA,KOR,KWT,LAO,LBN,LBR,LBY,LCA,LIE,LKA,LSO,LTU,LUX,LVA,MAC,MAF,MAR,MCO,MDA,MDG,MDV,MEX,MHL,MKD,MLI,MLT,MMR,MNE,MNG,MNP,MOZ,MRT,MSR,MTQ,MUS,MWI,MYS,MYT,NAM,NCL,NER,NFK,NGA,NIC,NIU,NLD,NOR,NPL,NRU,NZL,OMN,PAK,PAN,PCN,PER,PHL,PLW,PNG,POL,PRI,PRK,PRT,PRY,PSE,PYF,QAT,REU,ROU,RUS,RWA,SAU,SRB,SDN,SEN,SGP,SGS,SHN,SJM,SLB,SLE,SLV,SMR,SOM,SPM,STP,SUR,SVK,SVN,SWE,SWZ,SYC,SYR,TCA,TCD,TGO,THA,TJK,TKL,TKM,TLS,TON,TTO,TUN,TUR,TUV,TWN,TZA,UGA,UKR,UMI,URY,USA,UZB,VAT,VCT,VEN,VGB,VIR,VNM,VUT,WLF,WSM,YEM,ZAF,ZMB,ZWE	9
109	5	Ethnicity	Hispanic or Latino,Not Hispanic or Latino,Not Reported	HISPANIC OR LATINO,NOT HISPANIC OR LATINO,NOT REPORTED	9
110	3	race	Not Reported,American Indian or Alaska Native,Black or African American,White,Asian,Native Hawaiian or Other…,Other	NOT REPORTED,AMERICAN INDIAN OR ALASKA NATIVE,BLACK OR AFRICAN AMERICAN,WHITE,ASIAN,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,OTHER	9
111	2	textarea	text	text	9
112	5	homeless	Yes,No,Unknown	Y,N,U	9
113	5	idu	Yes,No,Unknown	Y,N,U	9
114	5	nidu	Yes,No,Unknown	Y,N,U	9
115	5	corrfa	Yes,No,Unknown	Y,N,U	9
116	5	alcohol	Yes,No,Unknown	Y,N,U	9
117	5	mental	Yes,No,Unknown	Y,N,U	9
118	5	past	Yes,No,Unknown	Y,N,U	9
119	5	tabacco	Never,Current,Former	NEVER,CURRENT,FORMER	9
120	3	duration	Duration Unknown	U	9
121	5	Unit	Days,Weeks,Months,Years	DAYS,WEEKS,MONTHS,YEARS	9
122	5	Number	Less than 10 cigarettes,10-20 cigarettes,More than 20 cigarettes,Don't know	LESS THAN 10 CIGARETTES,10-20 CIGARETTES,MORE THAN 20 CIGARETTES,DON'T KNOW	9
123	3	smoking	Duration Unknown	U	9
124	5	score	60,70,80,90,100	60,70,80,90,100	9
125	5	treated	Yes,No,Unknown	Y,N,U	9
126	5	prescribed	Yes,No,Unknown	Y,N,U	9
127	5	extrapulmonary	Yes,No,Unknown	Y,N,U	9
177	5	radioYN	Yes,No	Y,N	15
190	1	text	text	text	21
191	2	textarea	text	text	21
194	3	poortbresp	Possible Poor TB Treatment Response	POSSIBLE POOR TB TREATMENT RESPONSE	22
195	5	radioynu	Yes,No,Unknown	Y,N,UNK	22
196	5	radiotime	Unknown,Days,Hours	UNKNOWN,DAYS,HOURS	22
197	5	radioext	Partial,Complete	PARTIAL,COMPLETE	22
198	2	textarea	text	text	22
199	5	radiospecond	Frozen,Thawed,Not Recieved	FROZEN,THAWED,NOT RECEIVED	22
200	1	text	text	text	23
201	5	Yes,No	Yes,No	Y,N	23
202	2	textarea	text	text	23
203	3	SAE	Death,Any life-threatening experience,Any inpatient hospitalization,Persistently or significantly disabling event,Congenital anomaly or birth defect,Other medically important event	Death,Any life-threatening experience,Any inpatient hospitalization,Persistently or significantly disabling event,Congenital anomaly or birth defect,Other medically important event	23
204	5	attribution	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	DEFINITE,PROBABLE,POSSIBLE,UNLIKELY,NOT RELATED,UNCLASSIFIABLE	23
205	5	Anticipated,Unanticipated	Anticipated,Unanticipated	ANTICIPATED,UNANTICIPATED	23
206	5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	1,2,3,4,5	23
207	5	Yes,No,Unknown	Yes,No,Unknown	Y,N,U	23
208	5	Clinician action	Dose not changed,Dose reduced,Drug interrupted,Drug withdrawn,Not applicable	DOSE NOT CHANGED,DOSE REDUCED,DRUG INTERRUPTED,DRUG WITHDRAWN,NOT APPLICABLE	23
209	5	method	Ultrasound,First day of last menstrual period,Obstetric examination,Other	ULTRASOUND,FIRST DAY OF LAST MENSTRUAL PERIOD,OBSTETRIC EXAMINATION,OTHER	23
210	5	Opinion	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	DEFINITE,PROBABLE,POSSIBLE,UNLIKELY,NOT RELATED,UNCLASSIFIABLE	23
212	5	datevisit	Baseline,Week 2,Week 4,Week 8,Week 17,Week 26	BASELINE,WEEK 2,WEEK 4,WEEK 8,WEEK 17,WEEK 26	24
213	3	poortbresp	Possible Poor TB Treatment Response	POSSIBLE POOR TB TREATMENT RESPONSE	24
214	5	radioynu	Yes,No,Unknown	Y,N,UNK	24
215	5	radiotime	Unknown,Days,Hours	UNKNOWN,DAYS,HOURS	24
216	5	radioext	Partial,Complete	PARTIAL,COMPLETE	24
217	2	textarea	text	text	24
218	5	radiospecond	Frozen,Thawed,Not Recieved	FROZEN,THAWED,NOT RECEIVED	24
219	1	text	text	text	25
220	5	visitradio	Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early On-Treatment Termination Visit (approximately 14 days after early treatment discontinuation),Early Off-Treatment Termination Visit	WEEK 1,WEEK 2,WEEK 3,WEEK 4,WEEK 6,WEEK 8,WEEK 10,WEEK 12,WEEK 14,WEEK 17,WEEK 22,WEEK 26,WEEK 39,WEEK 52,WEEK 65,WEEK 78,EARLY ON-TREATMENT TERMINATION VISIT (APPROXIMATELY 14 DAYS AFTER EARLY TREATMENT DISCONTINUATION),EARLY OFF-TREATMENT TERMINATION VISIT	25
221	5	radioyn	Yes,No	YES,NO	25
222	5	radiorec	YES the Site Investigator recommended a change in TB treatment (Complete 5 and 6 and then go to Section C),NO the Site Investigator did not recommend a change in TB treatment (Skip to Section C),TB treatment change recommendation is PENDING (Skip to Section C)	YES,NO,TB TREATMENT CHANGE RECOMMENDATION IS PENDING	25
223	5	radiochg	Retreatment after completion of TB treatment,Extension of TB treatment,Modifications to assigned treatment <strong>(i.e. addition\\, subtraction\\, replacement of TB medications for any reason except changes in treatment for pregnancy\\, temporary drug challenge\\, or toxicity)</strong>	RETREATMENT AFTER COMPLETION OF TB TREATMENT,EXTENSION OF TB TREATMENT,MODIFICATIONS TO ASSIGNED TREATMENT	25
224	2	textarea	text	text	25
128	7	organ	Blood and Lymphatic System Disorders,Cardiac Disorders,Endocrine Disorders,Gastrointestinal Disorders,Hepatobiliary Disorders,Musculoskeletal and Connective Tissue Disorders,Nervous System Disorders,Renal and Urinary Disorders,Reproductive System and Breast Disorders,Respiratory Thoracic and Mediastinal Disorders,Skin and Subcutaneous Tissue Disorders	BLOOD AND LYMPHATIC SYSTEM DISORDERS,CARDIAC DISORDERS,ENDOCRINE DISORDERS,GASTROINTESTINAL DISORDERS,HEPATOBILIARY DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NERVOUS SYSTEM DISORDERS,RENAL AND URINARY DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,RESPIRATORY THORACIC AND MEDIASTINAL DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS	9
129	5	liver disease	Yes,No,Unknown	Y,N,U	9
130	5	hepatitisa	Yes,No,Unknown	Y,N,U	9
131	5	hepatitisb	Yes,No,Unknown	Y,N,U	9
132	5	hepatitisT	Yes,No,Unknown	Y,N,U	9
133	5	hepatitisD	Yes,No,Unknown	Y,N,U	9
134	5	other	Yes,No,Unknown	Y,N,U	9
135	5	diabetes	Yes,No,Unknown	Y,N,U	9
136	5	type	Type I,Type II,Unknown	DIABI,DIABII,DIABUNK	9
137	5	radio	Yes,No,Unknown	Y,N,U	9
138	5	peripheral	Yes,No,Unknown	Y,N,U	9
139	5	cancer	Yes,No,Unknown	Y,N,U	9
140	5	cardiac	Yes,No,Unknown	Y,N,U	9
141	5	CD4	Yes,No,Unknown	Y,N,U	9
142	5	antiretroviral	Yes,No,Unknown	Y,N,U	9
143	5	startdate	Yes,No,Unknown	Y,N,U	9
144	6	whoterm	American Trypanososmiasis Reactivation (Meningoencephalitis Or Myocarditis),Atypical Disseminated Leishmaniasis,Candidiasis Of Bronchi Trachea Or Lungs,Candidiasis Esophageal,Cardiomyopathy Symptomatic HIV-Associated,Cervical Cancer Invasive,Cryptococcosis Extrapulmonary. Including Meningitis,Cryptosporidiosis Chronic Intestinal With Diarrhea (>1 Months Duration),Cytomegalovirus Infection (Retinitis Or Infection Of Other Organs),Cytomegalovirus Retinitis (With Loss Of Vision),Encephalopathy HIV-Related,Herpes Simplex Infection Chronic (Orolabial Genital Or Anorectal Site For > 1 Month Or Visceral Herpes At Any Site,HIV Wasting Syndrome,Isosporiasis Chronic Intestinal (>1 Months Duration),Kaposi’S Sarcoma,Lymphoma Primary Of Brain,Lymphoma (Cerebral Or B-Cell Non-Hodgkin Including Burkitt’S And Immunoblastic),Mycobacterium Avium Complex Or M. Kansasii Disseminated Or Extrapulmonary,Mycobacterium Other Species Or Unidentified Species Disseminated Or Extrapulmonary,Mycobacterium Tuberculosis Extrapulmonary,Mycosis Disseminated ,Nephropathy Symptomatic HIV-Associated,Pneumocystis Pneumonia,Pneumonia Bacterial Recurrent Severe,Progressive Multifocal Leukoencephalopathy,Salmonella Bacteremia Recurrent Nontyphoidal,Toxoplasmosis Of Brain Or CNS	AMERICAN TRYPANOSOSMIASIS REACTIVATION (MENINGOENCEPHALITIS OR MYOCARDITIS),ATYPICAL DISSEMINATED LEISHMANIASIS,CANDIDIASIS OF BRONCHI TRACHEA OR LUNGS,CANDIDIASIS ESOPHAGEAL,CARDIOMYOPATHY SYMPTOMATIC HIV-ASSOCIATED,CERVICAL CANCER INVASIVE,CRYPTOCOCCOSIS EXTRAPULMONARY. INCLUDING MENINGITIS,CRYPTOSPORIDIOSIS CHRONIC INTESTINAL WITH DIARRHEA (>1 MONTHS DURATION),CYTOMEGALOVIRUS INFECTION (RETINITIS OR INFECTION OF OTHER ORGANS),CYTOMEGALOVIRUS RETINITIS (WITH LOSS OF VISION),ENCEPHALOPATHY HIV-RELATED,HERPES SIMPLEX INFECTION CHRONIC (OROLABIAL GENITAL OR ANORECTAL SITE FOR > 1 MONTH OR VISCERAL HERPES AT ANY SITE,HIV WASTING SYNDROME,ISOSPORIASIS CHRONIC INTESTINAL (>1 MONTHS DURATION),KAPOSI’S SARCOMA,LYMPHOMA PRIMARY OF BRAIN,LYMPHOMA (CEREBRAL OR B-CELL NON-HODGKIN INCLUDING BURKITT’S AND IMMUNOBLASTIC),MYCOBACTERIUM AVIUM COMPLEX OR M. KANSASII DISSEMINATED OR EXTRAPULMONARY,MYCOBACTERIUM OTHER SPECIES OR UNIDENTIFIED SPECIES DISSEMINATED OR EXTRAPULMONARY,MYCOBACTERIUM TUBERCULOSIS EXTRAPULMONARY,MYCOSIS DISSEMINATED ,NEPHROPATHY SYMPTOMATIC HIV-ASSOCIATED,PNEUMOCYSTIS PNEUMONIA,PNEUMONIA BACTERIAL RECURRENT SEVERE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,SALMONELLA BACTEREMIA RECURRENT NONTYPHOIDAL,TOXOPLASMOSIS OF BRAIN OR CNS	9
145	6	monthwho	JAN,FEB,MAR,APR,MAY,JUN,JUL,AUG,SEP,OCT,NOV,DEC	JAN,FEB,MAR,APR,MAY,JUN,JUL,AUG,SEP,OCT,NOV,DEC	9
146	5	additionala	Yes,No	Y,N	9
147	5	additionalb	Yes,No	Y,N	9
148	5	Sex	Male,Female	M,F	10
149	1	text	text	text	10
150	6	Place	ARUBA,AFGHANISTAN,ANGOLA,ANGUILLA,ALAND ISLANDS,ALBANIA,ANDORRA,NETHERLANDS ANTILLES,UNITED ARAB EMIRATES,ARGENTINA,ARMENIA,AMERICAN SAMOA,ANTARCTICA,FRENCH SOUTHERN TERRITORIES,ANTIGUA AND BARBUDA,AUSTRALIA,AUSTRIA,AZERBAIJAN,BURUNDI,BELGIUM,BENIN REPUBLIC,BURKINA FASO,BANGLADESH,BULGARIA,BAHRAIN,BAHAMAS,BOSNIA-HERZEGOVINA,SAINT BARTHELEMY,BELARUS,BELIZE,BERMUDA,BOLIVIA,BRAZIL,BARBADOS,BRUNEI,BHUTAN,BOUVET ISLAND,BOTSWANA,CENTRAL AFRICAN REPUBLIC,CANADA,COCOS (KEELING) ISLANDS,SWITZERLAND,CHILE,CHINA,COTE D'IVOIRE,CAMEROON,DEMOCRATIC REPUBLIC OF THE CONGO,CONGO,COOK ISLANDS,COLOMBIA,COMOROS,CAPE VERDE,COSTA RICA,CUBA,CHRISTMAS ISLAND,CAYMAN ISLANDS,CYPRUS,CZECH REPUBLIC,GERMANY,DJIBOUTI,DOMINICA,DENMARK,DOMINICAN REPUBLIC,ALGERIA,ECUADOR,EGYPT,ERITREA,WESTERN SAHARA,SPAIN,ESTONIA,ETHIOPIA,FINLAND,FIJI,FALKLAND ISLANDS,FRANCE,FAROE ISLANDS,MICRONESIA FEDERATED STATES OF,GABON,UNITED KINGDOM,GEORGIA,GUERNSEY,GHANA,GIBRALTAR,GUINEA,GUADELOUPE,GAMBIA,GUINEA-BISSAU,EQUATORIAL GUINEA,GREECE,GRENADA,GREENLAND,GUATEMALA,FRENCH GUIANA,GUAM,GUYANA,HONG KONG,HEARD ISLAND AND MCDONALD ISLANDS,HONDURAS,CROATIA,HAITI,HUNGARY,INDONESIA,INDIA,ISLE OF MAN,BRITISH INDIAN OCEAN TERRITORY,IRELAND,IRAN,IRAQ,ICELAND,ISRAEL,ITALY,JAMAICA,JORDAN,JAPAN,JERSEY,KAZAKHSTAN,KENYA,KYRGYZSTAN,CAMBODIA,KIRIBATI,SAINT KITTS AND NEVIS,SOUTH KOREA,KUWAIT,LAO PEOPLES DEMOCRATIC REPUBLIC,LEBANON,LIBERIA,LIBYAN ARAB JAMAHIRIYA,SAINT LUCIA,LIECHTENSTEIN,SRI LANKA,LESOTHO,LITHUANIA,LUXEMBOURG,LATVIA,MACAO,SAINT MARTIN FRENCH,MOROCCO,MONACO,MOLDOVA REPUBLIC OF,MADAGASCAR,MALDIVES,MEXICO,MARSHALL ISLANDS,REPUBLIC OF MACEDONIA,MALI,MALTA,MYANMAR,MONTENEGRO,MONGOLIA,NORTHERN MARIANA ISLANDS,MOZAMBIQUE,MAURITANIA,MONTSERRAT,MARTINIQUE,MAURITIUS,MALAWI,MALAYSIA,MAYOTTE,NAMIBIA,NEW CALEDONIA,NIGER,NORFOLK ISLAND,NIGERIA,NICARAGUA,NIUE,NETHERLANDS,NORWAY,NEPAL,NAURU,NEW ZEALAND,OMAN,PAKISTAN,PANAMA,PITCAIRN,PERU,PHILIPPINES,PALAU,PAPUA NEW GUINEA,POLAND,PUERTO RICO,NORTH KOREA,PORTUGAL,PARAGUAY,PALESTINIAN TERRITORY OCCUPIED,FRENCH POLYNESIA,QATAR,REUNION,ROMANIA,RUSSIAN FEDERATION,RWANDA,SAUDI ARABIA,SERBIA,SUDAN,SENEGAL,SINGAPORE,SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS,SAINT HELENA,SVALBARD AND JAN MAYEN,SOLOMON ISLANDS,SIERRA LEONE,EL SALVADOR,SAN MARINO,SOMALIA,SAINT PIERRE AND MIQUELON,SAO TOME AND PRINCIPE,SURINAME,SLOVAKIA,SLOVENIA,SWEDEN,SWAZILAND,SEYCHELLES,SYRIAN ARAB REPUBLIC,TURKS AND CAICOS ISLANDS,CHAD,TOGO,THAILAND,TAJIKISTAN,TOKELAU,TURKMENISTAN,TIMOR-LESTE,TONGA,TRINIDAD AND TOBAGO,TUNISIA,TURKEY,TUVALU,TAIWAN,TANZANIA UNITED REPUBLIC OF,UGANDA,UKRAINE,UNITED STATES MINOR OUTLYING ISLANDS,URUGUAY,UNITED STATES,UZBEKISTAN,VATICAN CITY STATE,SAINT VINCENT AND THE GRENADINES,VENEZUELA,VIRGIN ISLANDS BRITISH,VIRGIN ISLANDS U.S.,VIETNAM,VANUATU,WALLIS AND FUTUNA,SAMOA,YEMEN,SOUTH AFRICA,ZAMBIA,ZIMBABWE	ABW,AFG,AGO,AIA,ALA,ALB,AND,ANT,ARE,ARG,ARM,ASM,ATA,ATF,ATG,AUS,AUT,AZE,BDI,BEL,BEN,BFA,BGD,BGR,BHR,BHS,BIH,BLM,BLR,BLZ,BMU,BOL,BRA,BRB,BRN,BTN,BVT,BWA,CAF,CAN,CCK,CHE,CHL,CHN,CIV,CMR,COD,COG,COK,COL,COM,CPV,CRI,CUB,CXR,CYM,CYP,CZE,DEU,DJI,DMA,DNK,DOM,DZA,ECU,EGY,ERI,ESH,ESP,EST,ETH,FIN,FJI,FLK,FRA,FRO,FSM,GAB,GBR,GEO,GGY,GHA,GIB,GIN,GLP,GMB,GNB,GNQ,GRC,GRD,GRL,GTM,GUF,GUM,GUY,HKG,HMD,HND,HRV,HTI,HUN,IDN,IND,IMN,IOT,IRL,IRN,IRQ,ISL,ISR,ITA,JAM,JOR,JPN,JEY,KAZ,KEN,KGZ,KHM,KIR,KNA,KOR,KWT,LAO,LBN,LBR,LBY,LCA,LIE,LKA,LSO,LTU,LUX,LVA,MAC,MAF,MAR,MCO,MDA,MDG,MDV,MEX,MHL,MKD,MLI,MLT,MMR,MNE,MNG,MNP,MOZ,MRT,MSR,MTQ,MUS,MWI,MYS,MYT,NAM,NCL,NER,NFK,NGA,NIC,NIU,NLD,NOR,NPL,NRU,NZL,OMN,PAK,PAN,PCN,PER,PHL,PLW,PNG,POL,PRI,PRK,PRT,PRY,PSE,PYF,QAT,REU,ROU,RUS,RWA,SAU,SRB,SDN,SEN,SGP,SGS,SHN,SJM,SLB,SLE,SLV,SMR,SOM,SPM,STP,SUR,SVK,SVN,SWE,SWZ,SYC,SYR,TCA,TCD,TGO,THA,TJK,TKL,TKM,TLS,TON,TTO,TUN,TUR,TUV,TWN,TZA,UGA,UKR,UMI,URY,USA,UZB,VAT,VCT,VEN,VGB,VIR,VNM,VUT,WLF,WSM,YEM,ZAF,ZMB,ZWE	10
151	5	Ethnicity	Hispanic or Latino,Not Hispanic or Latino,Not Reported	HISPANIC OR LATINO,NOT HISPANIC OR LATINO,NOT REPORTED	10
152	3	race	Not Reported,American Indian or Alaska Native,Black or African American,White,Asian,Native Hawaiian or Other…,Other	NOT REPORTED,AMERICAN INDIAN OR ALASKA NATIVE,BLACK OR AFRICAN AMERICAN,WHITE,ASIAN,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,OTHER	10
153	2	textarea	text	text	10
154	5	reason	Patient does not meet eligibility criteria,Patient declines to participate,Site decides not to enroll patient	PATIENT DOES NOT MEET ELIGIBILITY CRITERIA,PATIENT DECLINES TO PARTICIPATE,SITE DECIDES NOT TO ENROLL PATIENT	10
155	3	reasona	No evidence of pulmonary tuberculosis with or without suspected or proven concomitant extrapulmonary tuberculosis outside the central nervous system or bones,No acid-fast bacilli (AFB) seen in an expectorated sputum specimen at least 1+ (WHO/IUATLD criteria) AND no positive GeneXpert (or GeneXpert Ultra) for M, Age <12 years,No documentation of negative HIV status within the past 3 months prior to enrollment nor documentation confirming HIV infection	NOPULMTB,NOAFB,UNDERAGE,HIVDOC	10
178	1	text	text	text	16
179	5	radioSTDYEVAL	Baseline,Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early On-Treatment Termination Visit (approximately 14 days after early treatment discontinuation),Early Off-Treatment Termination Visit (approximately 14 days after stopping study participation),Possible Poor TB Treatment Response,Unscheduled	BASELINE,WK1,WK2,WK3,WK4,WK6,WK8,WK10,WK12,WK14,WK17,WK22,WK26,WK39,WK52,WK65,WK78,EARLY_ON_TREATMENT_TERMINATION_VISIT,EARLY_OFF_TREATMENT_TERMINATION_VISIT,POSSIBLE_POOR_TB_TREATMENT_RESPONSE,UNSCHEDULED	16
180	5	radioYN	Yes,No	Y,N	16
181	2	textarea	text	text	16
182	1	text	text	text	17
183	2	textarea	text	text	17
184	1	text	text	text	18
185	2	textarea	text	text	18
186	1	text	text	text	19
187	2	textarea	text	text	19
188	1	text	text	text	20
189	2	textarea	text	text	20
192	1	text	text	text	22
193	5	datevisit	Baseline,Week 2,Week 4,Week 8,Week 17,Week 26	BASELINE,WEEK 2,WEEK 4,WEEK 8,WEEK 17,WEEK 26	22
211	1	text	text	text	24
156	3	reasonhiv	No current use of dolutegravir-based ART\\, or inability or non-willingness to start or transition to a dolutegravir-based antiretroviral therapy regimen, CD4 T cell count <100 cells/mm3 based on testing performed at or within 30 days prior to study enrollment,No written informed consent/assent,Karnofsky score < 60,No verifiable address or residence location that is readily accessible for visiting\\, and/or no willingness to inform the study team of any change of address during the treatment and follow-up period,Person of childbearing potential who does not agree to practice a reliable method of contraception (barrier method or non-hormonal intrauterine device) or abstain from sexual activity that could lead to pregnancy while receiving study drug treatment and for 30 days after stopping study treatment,Pregnant or breast-feeding,More than 5 days of tuberculosis treatment in the previous 6 months, Unable to take oral medications, Hypersensitivity or previous intolerance to any of the study drugs , Current or planned use of medications that have unacceptable drug-drug interactions with any of the study drugs during study treatment , Suspected or proven central nervous system tuberculosis, Suspected or proven bone tuberculosis, Screening ECG with QTcF >450 for men or >470 for women, Clinically significant ECG abnormality in the opinion of the site investigator\\, including but not limited to second or third degree atrioventricular (AV) block\\, prolongation of the QRS complex over 120 ms (in both male and female participants)\\, or clinically important arrhythmia, Current clinically relevant cardiovascular disorder in the opinion of the site investigator\\, including but not limited to heart failure\\, coronary heart disease\\, arrhythmia\\, or Tachyarrhythmia, Known family history of Long QT Syndrome in a first-degree relative (i.e.\\, parent\\, offspring\\, or sibling) , History of aortic aneurysm or dissection, Hepatic cirrhosis or other serious liver disease , Other medical conditions\\, that\\, in the investigator’s judgment\\, make study participation not in the individual’s best interest	DOLUTEGRAVIR,LOWCD4,NOCONSENT,LOWKPS,NOADDRESS,CONTRACEPTION,PREG,PREVTREAT,ORALMED,HYPER,INTERACT,CNSTB,BONETB,QTCF,ABNECG,CARDIODIS,HISQT,AORTIC,LIVERDIS,OTHERCOND	10
157	3	reasoncat	Serum or plasma alanine aminotransferase >3 times the upper limit of normal, Serum or plasma total bilirubin >2.5 times the upper limit of normal , Serum creatinine >2 times the upper limit of normal, Platelet count <75\\,000 cells/mm3, Absolute neutrophil count <1\\,000 cells/mm3, Serum or plasma potassium <3.5 meq/L, Weight <40.0 kg , Known or suspected resistance to isoniazid or rifamycins (by phenotypic or molecular test), Previous treatment with any drug or combination of drugs known to have activity against M. tuberculosis (e.g. isoniazid\\, rifamycins\\, pyrazinamide\\, ethambutol\\, fluoroquinolones\\, etc.) for more than five days in the thirty days prior to enrollment , Previously enrolled in this study or currently enrolled in another therapeutic clinical trial that\\, in the investigator’s judgment\\, would compromise study integrity or participant safety, Current or planned incarceration or other involuntary detention	AMINOTRANS,BILIRUBIN,CREATININE,PLATELET,NEUTROPHIL,POTASSIUM,UNDERWEIGHT,RESISTANCE,PREVTREAT,PREVENROL,INCARCERATION	10
158	3	components	a. Distrust or fear of research,b. Undergoing randomization	DISTMED,RAND	10
159	3	componentstu	Effectiveness of study medication, Side effects of study medication, Interaction of study medication with other prescribed medications (including contraceptives) or effect on other medical problems , Desire to take approved medications / alternate regimen , Duration of treatment / Frequency of dosing / Number of pills per dose , Recommendation to avoid alcohol or recreational drugs while on study medication , Undergoing additional diagnostic tests for study purposes, The number and/or location of study visits is not convenient , The number and/or location of DOT visits is not convenient In Clinic DOT, Outreach DOT,	EFF,MEDSIDE,MEDINT,ALTTRX,DUR,DISPALC,BLOOD,NUMVIS,DOTCLN,DOTOUT	10
160	3	componentsdif	a. Study will interfere with work\\, school\\, family\\, or other life commitments  , b. Too busy or stressed to participate in a study , c. Study participation will result in a loss of income , d. Inconvenience / costs associated with transportation\\, travel\\, or parking , e. Plans to move or travel (for work or pleasure) , f. Study will negatively impact immigration status	INTFLIFE,BUSY,INCO,TRANS,MOVTRAV,IMG	10
161	3	componentstopi	a. Family member\\, spouse/partner\\, friend discourages tudy enrollment , b. Boss / teacher not likely to support missed work / school due to study commitments , c. Personal physician has concerns related to patient’s participation in study , d. Stigmatization related to TB diagnosis or taking TB medication	FAMILY,CONRESP,MDCON,STIGMA	10
162	3	componentsmis	a. Length and/or complexity of informed cinsent form, b. Patient cited other health problems/ feels too ill to participate in a study , c. Patient expressed a TB-specific misperception or belief that contributed to the decision to decline study enrollment	CONSENT,TOOILL,BELIEF	10
163	3	decidescomp	Patient's work\\, school\\, family or life commitments may hinder study participation , Psychiatric\\, cognitive (e.g.\\, reasoning\\, thought processes)\\, or behavioral (e.g.\\, substance abuse\\, belligerence) factors are likely to affect ability to provide consent and/or adherence to the study protocol , Patient’s immigration status may affect adherence to the study protocol, Inconclusive diagnostic test results and/orclinical presentation of TB, Communications/language barriers:  Staff do not speak patient's language/Patient is unable to understand available interpreter., Communications/language barriers: Written materials/informed consent form not available in patient's language., Communications/language barriers: Although the language employed during the informed consent process is understod\\, the patient does not understand study.	LIFCOM,PSYCOG,SIT,INCLAB,LANGBAR,MATLANG,UNDSTDY	10
1287	1	text	text	text	117
1288	5	VisitLbl	Week 4, Week 6, Unscheduled	W04,W06,UNS	117
1289	5	aextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	117
1290	5	aceoccurlbl	Yes,No,Unknown	Y,N,U	117
1291	5	bextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	117
1292	5	bceoccurlbl	Yes,No,Unknown	Y,N,U	117
170	1	text	text	text	12
171	5	radioYN	Yes,No	Y,N	12
172	1	text	text	text	13
173	5	radioYN	Yes,No	Y,N	13
174	1	text	text	text	14
175	5	radioYN	Yes,No	Y,N	14
176	1	text	text	text	15
1293	5	cextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	117
1294	5	cceoccurlbl	Yes,No,Unknown	Y,N,U	117
1295	5	cceoccurlbla	Yes,No	Y,N	117
1296	6	mldosulbl	Bag, Bar, Bottle, Bowl, Box, Can, Container, Cup, Fluid Ounce US, Gram, Half, Jar, Kilogram, Liter, Milliliter, Ounce, Quarter, Slice, Tablespoon, Teaspoon, whole	BAG, BAR, BOTTLE, BOWL, BOX, CAN, CONTAINER, CUP, foz_us, g, HALF, JAR, kg, L, mL, oz, QUARTER, SLICE, Tbsp, tsp, WHOLE	117
1297	5	mltmcondlbl	Yes,No,Unknown	Y,N,U	117
1298	5	amltmcondlbl	Yes,No,Unknown	Y,N,U	117
1299	5	suoccurlbl	Yes,No,Unknown	Y,N,U	117
1300	3	bestatlbl	Not Done	NOT DONE	117
1301	5	beoccurlbl	Yes,No	Y,N	117
1302	3	bbestatlbl	Not Done	NOT DONE	117
1303	5	bbeoccurlbl	Yes,No	Y,N	117
1304	5	cbeoccurlbl	Yes,No	Y,N	117
1305	3	aabestatlbl	Not Done	NOT DONE	117
225	3	textres	Sputum smear positive for acid fast bacilli at or after week 17,Sputum culture positive for Mycobacterium tuberculosis at or after week 17,Worsening signs and/or symptoms consistent with TB at or after week 17,Radiographic worsening consistent with TB at or after week 17,Adverse event,Early study treatment discontinuation	SPUTUM SMEAR POSITIVE FOR ACID FAST BACILLI AT OR AFTER WEEK 17,SPUTUM CULTURE POSITIVE FOR MYCOBACTERIUM TUBERCULOSIS AT OR AFTER WEEK 17,WORSENING SIGNS AND/OR SYMPTOMS CONSISTENT WITH TB AT OR AFTER WEEK 17,RADIOGRAPHIC WORSENING CONSISTENT WITH TB AT OR AFTER WEEK 17,ADVERSE EVENT,EARLY STUDY TREATMENT DISCONTINUATION	25
226	5	radionit	YES: Change to TB treatment was initiated (Skip to C2),NO: Change to TB treatment was not initiated,It is UNKNOWN whether change to TB treatment was or was not initiated	YES,NO,UNKNOWN	25
227	5	radioalt	Yes <strong>(if this is a reportable adverse event submit AE form)</strong>,No	Y,N	25
228	3	tremed	Unknown,Ethambutol,Pyrazinamide,Isoniazid,Rifampin	UNKNOWN,ETHAMBUTOL,PYRAZINAMIDE,ISONIAZID,RIFAMPIN	25
229	5	radiostrtdt	Start date is unknown,Only estimated start date is known	START DATE IS UNKNOWN,ONLY ESTIMATED START DATE IS KNOWN	25
230	4	file	file	file	25
231	1	text	text	text	26
232	5	Yes,No	Yes,No	Y,N	26
233	2	textarea	text	text	26
234	3	SAE	Death,Any life-threatening experience,Any inpatient hospitalization,Persistently or significantly disabling event,Congenital anomaly or birth defect,Other medically important event	Death,Any life-threatening experience,Any inpatient hospitalization,Persistently or significantly disabling event,Congenital anomaly or birth defect,Other medically important event	26
235	5	attribution	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	DEFINITE,PROBABLE,POSSIBLE,UNLIKELY,NOT RELATED,UNCLASSIFIABLE	26
236	5	Anticipated,Unanticipated	Anticipated,Unanticipated	ANTICIPATED,UNANTICIPATED	26
237	5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	1,2,3,4,5	26
238	5	Yes,No,Unknown	Yes,No,Unknown	Y,N,U	26
239	5	Clinician action	Dose not changed,Dose reduced,Drug interrupted,Drug withdrawn,Not applicable	DOSE NOT CHANGED,DOSE REDUCED,DRUG INTERRUPTED,DRUG WITHDRAWN,NOT APPLICABLE	26
240	5	method	Ultrasound,First day of last menstrual period,Obstetric examination,Other	ULTRASOUND,FIRST DAY OF LAST MENSTRUAL PERIOD,OBSTETRIC EXAMINATION,OTHER	26
241	5	Opinion	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	DEFINITE,PROBABLE,POSSIBLE,UNLIKELY,NOT RELATED,UNCLASSIFIABLE	26
242	1	text	text	text	27
243	2	textarea	text	text	27
244	3	checkboxJUNK	_	DONE	27
245	1	text	text	text	28
246	2	textarea	text	text	28
247	3	checkboxJUNK	_	DONE	28
248	1	text	text	text	29
249	2	textarea	text	text	29
250	3	checkboxJUNK	_	DONE	29
251	1	text	text	text	30
252	2	textarea	text	text	30
253	3	checkboxJUNK	_	DONE	30
254	1	text	text	text	31
255	2	textarea	text	text	31
256	3	checkboxJUNK	_	DONE	31
257	5	visitlbl	Baseline,Week 2,Week 4,Week 8,Week 17,Week 26,Possible Poor TB Treatment Response,Unscheduled	BL,W02,W04,W08,W17,W26,PPTR,UNS	32
258	1	text	text	text	32
259	2	textarea	text	text	32
260	1	text	text	text	33
261	5	visitradio	Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early On-Treatment Termination Visit (approximately 14 days after early treatment discontinuation),Early Off-Treatment Termination Visit	WEEK 1,WEEK 2,WEEK 3,WEEK 4,WEEK 6,WEEK 8,WEEK 10,WEEK 12,WEEK 14,WEEK 17,WEEK 22,WEEK 26,WEEK 39,WEEK 52,WEEK 65,WEEK 78,EARLY ON-TREATMENT TERMINATION VISIT (APPROXIMATELY 14 DAYS AFTER EARLY TREATMENT DISCONTINUATION),EARLY OFF-TREATMENT TERMINATION VISIT	33
262	5	radioyn	Yes,No	YES,NO	33
263	5	radiorec	YES the Site Investigator recommended a change in TB treatment (Complete 5 and 6 and then go to Section C),NO the Site Investigator did not recommend a change in TB treatment (Skip to Section C),TB treatment change recommendation is PENDING (Skip to Section C)	YES,NO,TB TREATMENT CHANGE RECOMMENDATION IS PENDING	33
264	5	radiochg	Retreatment after completion of TB treatment,Extension of TB treatment,Modifications to assigned treatment <strong>(i.e. addition\\, subtraction\\, replacement of TB medications for any reason except changes in treatment for pregnancy\\, temporary drug challenge\\, or toxicity)</strong>	RETREATMENT AFTER COMPLETION OF TB TREATMENT,EXTENSION OF TB TREATMENT,MODIFICATIONS TO ASSIGNED TREATMENT	33
265	2	textarea	text	text	33
266	3	textres	Sputum smear positive for acid fast bacilli at or after week 17,Sputum culture positive for Mycobacterium tuberculosis at or after week 17,Worsening signs and/or symptoms consistent with TB at or after week 17,Radiographic worsening consistent with TB at or after week 17,Adverse event,Early study treatment discontinuation	SPUTUM SMEAR POSITIVE FOR ACID FAST BACILLI AT OR AFTER WEEK 17,SPUTUM CULTURE POSITIVE FOR MYCOBACTERIUM TUBERCULOSIS AT OR AFTER WEEK 17,WORSENING SIGNS AND/OR SYMPTOMS CONSISTENT WITH TB AT OR AFTER WEEK 17,RADIOGRAPHIC WORSENING CONSISTENT WITH TB AT OR AFTER WEEK 17,ADVERSE EVENT,EARLY STUDY TREATMENT DISCONTINUATION	33
267	5	radionit	YES: Change to TB treatment was initiated (Skip to 9),NO: Change to TB treatment was not initiated,It is UNKNOWN whether change to TB treatment was or was not initiated	YES,NO,UNKNOWN	33
268	5	radioalt	Yes (if this is a reportable adverse event submit AE form,No	Y,N	33
269	3	tremed	Unknown,Ethambutol,Pyrazinamide,Isoniazid,Rifampin	UNKNOWN,ETHAMBUTOL,PYRAZINAMIDE,ISONIAZID,RIFAMPIN	33
270	5	radiostrtdt	Start date is unknown,Only estimated start date is known	START DATE IS UNKNOWN,ONLY ESTIMATED START DATE IS KNOWN	33
271	4	file	file	file	33
272	1	text	text	text	34
273	5	visitradio	Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early On-Treatment Termination Visit (approximately 14 days after early treatment discontinuation),Early Off-Treatment Termination Visit	W01,W02,W03,W04,W06,W08,W10,W12,W14,W17,W22,W26,W39,W52,W65,W78,EONTT,EOFFTT	34
274	5	radioyn	Yes,No	YES,NO	34
483	5	bceoccurlbl	Yes,No,Unknown	Y,N,U	62
484	5	cextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	62
275	5	radiorec	YES the Site Investigator recommended a change in TB treatment (Complete 5 and 6 and then go to Section C),NO the Site Investigator did not recommend a change in TB treatment (Skip to Section C),TB treatment change recommendation is PENDING (Skip to Section C)	YES,NO,TB TREATMENT CHANGE RECOMMENDATION IS PENDING	34
276	5	radiochg	Retreatment after completion of TB treatment,Extension of TB treatment,Modifications to assigned treatment <strong>(i.e. addition\\, subtraction\\, replacement of TB medications for any reason except changes in treatment for pregnancy\\, temporary drug challenge\\, or toxicity)</strong>	RETREATMENT AFTER COMPLETION OF TB TREATMENT,EXTENSION OF TB TREATMENT,MODIFICATIONS TO ASSIGNED TREATMENT	34
277	2	textarea	text	text	34
278	3	textres	Sputum smear positive for acid fast bacilli at or after week 17,Sputum culture positive for Mycobacterium tuberculosis at or after week 17,Worsening signs and/or symptoms consistent with TB at or after week 17,Radiographic worsening consistent with TB at or after week 17,Adverse event,Early study treatment discontinuation	SPUTUM SMEAR POSITIVE FOR ACID FAST BACILLI AT OR AFTER WEEK 17,SPUTUM CULTURE POSITIVE FOR MYCOBACTERIUM TUBERCULOSIS AT OR AFTER WEEK 17,WORSENING SIGNS AND/OR SYMPTOMS CONSISTENT WITH TB AT OR AFTER WEEK 17,RADIOGRAPHIC WORSENING CONSISTENT WITH TB AT OR AFTER WEEK 17,ADVERSE EVENT,EARLY STUDY TREATMENT DISCONTINUATION	34
279	5	radionit	YES: Change to TB treatment was initiated (Skip to 9),NO: Change to TB treatment was not initiated,It is UNKNOWN whether change to TB treatment was or was not initiated	YES,NO,UNKNOWN	34
280	5	radioalt	Yes (if this is a reportable adverse event submit AE form,No	Y,N	34
281	3	tremed	Unknown,Ethambutol,Pyrazinamide,Isoniazid,Rifampin	UNKNOWN,ETHAMBUTOL,PYRAZINAMIDE,ISONIAZID,RIFAMPIN	34
282	5	radiostrtdt	Start date is unknown,Only estimated start date is known	START DATE IS UNKNOWN,ONLY ESTIMATED START DATE IS KNOWN	34
283	4	file	file	file	34
284	1	text	text	text	35
285	3	boxasm	Sputum smear positive for acid fast bacilli at or after week 17,Sputum culture positive for Mycobacterium tuberculosis at or after week 17,Worsening signs and/or symptoms consistent with TB at or after week 17,Radiographic worsening consistent with TB at or after week 17,Consideration of extension of TB treatment beyond that of the assigned treatment regimen (Comment is required in Section D),Consideration of retreatment with any TB therapy after the participant has completed assigned study treatment (Comment is required in Section D),Consideration of a permanent change in treatment\\, except for pregnancy\\, temporary drug challenge or toxicity (for a participant currently on assigned study treatment) (Comment is required in Section D)	SPUTUM SMEAR POSITIVE FOR ACID FAST BACILLI AT OR AFTER WEEK 17,SPUTUM CULTURE POSITIVE FOR MYCOBACTERIUM TUBERCULOSIS AT OR AFTER WEEK 17,WORSENING SIGNS AND/OR SYMPTOMS CONSISTENT WITH TB AT OR AFTER WEEK 17,RADIOGRAPHIC WORSENING CONSISTENT WITH TB AT OR AFTER WEEK 17,CONSIDERATION OF EXTENSION OF TB TREATMENT BEYOND THAT OF THE ASSIGNED TREATMENT REGIMEN,CONSIDERATION OF RETREATMENT WITH ANY TB THERAPY AFTER THE PARTICIPANT HAS COMPLETED ASSIGNED STUDY TREATMENT,CONSIDERATION OF A PERMANENT CHANGE IN TREATMENT\\, EXCEPT FOR PREGNANCY\\, TEMPORARY DRUG CHALLENGE OR TOXICITY	35
286	2	textarea	text	text	35
287	5	radyn	Yes,No	Y,N	35
288	5	radrpt	Yes (If Yes\\, complete or update Concomitant Medication Form),No	Y,N	35
289	5	radant	Yes (If Yes\\, update TB Drug Dose Record Form),No	Y,N	35
290	5	radxry	Yes (If Yes\\, complete Clinical Evaluation Form),No	Y,N	35
291	5	radlab	Yes (If Yes\\, complete Laboratory Evaluation Form\\, refer to MOOP for required tests),No	Y,N	35
292	5	radsywe	Yes (If Yes\\, complete Signs and Symptoms Form documenting signs and symptoms that \n       occurred in the 14 days prior to this visit),No	Y,N	35
293	5	radspuc	Yes (If Yes\\, complete Mycobacteriology Form),No	Y,N	35
294	5	radbio	Yes,No,Not applicable (e.g.\\, did not consent to collection)	Y,N,NOT APPLICABLE	35
295	5	radpdie	Yes (If Yes\\, complete Adverse Event Form and Notification of Death Form),No	Y,N	35
296	5	radmods	Yes (If Yes\\, complete the Treatment Change Form),No	Y,N	35
297	5	radindc	Sputum smear positive for acid fast bacilli at or after week 17,Sputum culture positive for Mycobacterium tuberculosis at or after week 17,Worsening signs and/or symptoms consistent with TB at or after week 17,Radiographic worsening consistent with TB at or after week 17,Consideration of extension of TB treatment beyond that of the assigned treatment regimen,Consideration of retreatment with any TB therapy after the participant has completed assigned study treatment,Consideration of a permanent change in treatment\\, except for pregnancy\\, temporary drug challenge or toxicity	SPUTUM SMEAR POSITIVE FOR ACID FAST BACILLI AT OR AFTER WEEK 17,SPUTUM CULTURE POSITIVE FOR MYCOBACTERIUM TUBERCULOSIS AT OR AFTER WEEK 17,WORSENING SIGNS AND/OR SYMPTOMS CONSISTENT WITH TB AT OR AFTER WEEK 17,RADIOGRAPHIC WORSENING CONSISTENT WITH TB AT OR AFTER WEEK 17,CONSIDERATION OF EXTENSION OF TB TREATMENT BEYOND THAT OF THE ASSIGNED TREATMENT REGIMEN,CONSIDERATION OF RETREATMENT WITH ANY TB THERAPY AFTER THE PARTICIPANT HAS COMPLETED ASSIGNED STUDY TREATMENT,CONSIDERATION OF A PERMANENT CHANGE IN TREATMENT\\, EXCEPT FOR PREGNANCY\\, TEMPORARY DRUG CHALLENGE OR TOXICITY	35
298	4	file	file	file	35
299	1	text	text	text	36
300	5	visitradio	Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early On-Treatment Termination Visit (approximately 14 days after early treatment discontinuation),Early Off-Treatment Termination Visit	W01,W02,W03,W04,W06,W08,W10,W12,W14,W17,W22,W26,W39,W52,W65,W78,EONTT,EOFFTT	36
301	5	radioyn	Yes,No	YES,NO	36
302	5	radiorec	YES the Site Investigator recommended a change in TB treatment (Complete 5 and 6 and then go to Section C),NO the Site Investigator did not recommend a change in TB treatment (Skip to Section C),TB treatment change recommendation is PENDING (Skip to Section C)	YES,NO,TB TREATMENT CHANGE RECOMMENDATION IS PENDING	36
303	5	radiochg	Retreatment after completion of TB treatment,Extension of TB treatment,Modifications to assigned treatment <strong>(i.e. addition\\, subtraction\\, replacement of TB medications for any reason except changes in treatment for pregnancy\\, temporary drug challenge\\, or toxicity)</strong>	RETREATMENT AFTER COMPLETION OF TB TREATMENT,EXTENSION OF TB TREATMENT,MODIFICATIONS TO ASSIGNED TREATMENT	36
304	2	textarea	text	text	36
485	5	cceoccurlbl	Yes,No,Unknown	Y,N,U	62
486	6	mldosulbl	Bag, Bar, Bottle, Bowl, Box, Can, Container, Cup, Fluid Ounce US, Gram, Half, Jar, Kilogram, Liter, Milliliter, Ounce, Quarter, Slice, Tablespoon, Teaspoon, whole	BAG, BAR, BOTTLE, BOWL, BOX, CAN, CONTAINER, CUP, foz_us, g, HALF, JAR, kg, L, mL, oz, QUARTER, SLICE, Tbsp, tsp, WHOLE	62
305	3	textres	Sputum smear positive for acid fast bacilli at or after week 17,Sputum culture positive for Mycobacterium tuberculosis at or after week 17,Worsening signs and/or symptoms consistent with TB at or after week 17,Radiographic worsening consistent with TB at or after week 17,Adverse event,Early study treatment discontinuation	SPUTUM SMEAR POSITIVE FOR ACID FAST BACILLI AT OR AFTER WEEK 17,SPUTUM CULTURE POSITIVE FOR MYCOBACTERIUM TUBERCULOSIS AT OR AFTER WEEK 17,WORSENING SIGNS AND/OR SYMPTOMS CONSISTENT WITH TB AT OR AFTER WEEK 17,RADIOGRAPHIC WORSENING CONSISTENT WITH TB AT OR AFTER WEEK 17,ADVERSE EVENT,EARLY STUDY TREATMENT DISCONTINUATION	36
306	5	radionit	YES: Change to TB treatment was initiated (Skip to 9),NO: Change to TB treatment was not initiated,It is UNKNOWN whether change to TB treatment was or was not initiated	YES,NO,UNKNOWN	36
307	5	radioalt	Yes (if this is a reportable adverse event submit AE form,No	Y,N	36
308	3	tremed	Unknown,Ethambutol,Pyrazinamide,Isoniazid,Rifampin	UNKNOWN,ETHAMBUTOL,PYRAZINAMIDE,ISONIAZID,RIFAMPIN	36
309	5	radiostrtdt	Start date is unknown,Only estimated start date is known	START DATE IS UNKNOWN,ONLY ESTIMATED START DATE IS KNOWN	36
310	4	file	file	file	36
311	3	Completion	Yes (Skip to section C),No	COMPLETED,DISPOSITION EVENT	37
312	3	DEATH	Participant died, Participant’s screening and baseline study visit sputum cultures all failed to grow M. tuberculosis, Participant’s screening or baseline isolate is resistant to any one or more of isoniazid\\, rifampin\\, fluoroquinolones\\, pyrazinamide\\, ethambutol\\, delamanid\\, or bedaquiline	DEATH, SCREEN FAILURE, SCREEN FAILURE	37
313	3	Participant withdrew consent	Participant withdrew consent	WITHDRAWAL BY SUBJECT	37
314	2	textarea	text	text	37
315	3	Participant determined ineligible	Participant determined ineligible after enrollment for reasons other than mycobacteriology	PROTOCOL VIOLATION	37
316	3	Participant is lost to follow-up	Participant is lost to follow-up	LOST TO FOLLOW-UP	37
317	3	Other	Other\\, specify	OTHER	37
318	1	text	text	text	37
319	3	Storage of blood	Retain blood specimens and use for future pharmacogenomic testing (skip to Section D), Participant withdraws consent for blood specimen use for future pharmacogenomic testing and has requested specimens be destroyed. (complete C.2 & C.3)	PGKEEP, PGDESTROY	37
320	3	Storage of blood specimens	Retain blood specimens and use for future research(Skip to section E), Participant withdraws consent for blood specimen use for future research and has requested specimens be destroyed. (complete D.2 & D.3)	FTRKEEP, FTRKEEP	37
487	5	mltmcondlbl	Yes,No,Unknown	Y,N,U	62
488	5	amltmcondlbl	Yes,No,Unknown	Y,N,U	62
489	5	suoccurlbl	Yes,No,Unknown	Y,N,U	62
490	3	bestatlbl	Not Done	NOT DONE	62
1306	3	bbbestatlbl	Not Done	NOT DONE	117
1307	2	textarea	text	text	117
2074	1	text	text	text	148
2075	5	Sex	Male,Female	M,F	148
2076	6	Place	ARUBA,AFGHANISTAN,ANGOLA,ANGUILLA,ALAND ISLANDS,ALBANIA,ANDORRA,NETHERLANDS ANTILLES,UNITED ARAB EMIRATES,ARGENTINA,ARMENIA,AMERICAN SAMOA,ANTARCTICA,FRENCH SOUTHERN TERRITORIES,ANTIGUA AND BARBUDA,AUSTRALIA,AUSTRIA,AZERBAIJAN,BURUNDI,BELGIUM,BENIN REPUBLIC,BURKINA FASO,BANGLADESH,BULGARIA,BAHRAIN,BAHAMAS,BOSNIA-HERZEGOVINA,SAINT BARTHELEMY,BELARUS,BELIZE,BERMUDA,BOLIVIA,BRAZIL,BARBADOS,BRUNEI,BHUTAN,BOUVET ISLAND,BOTSWANA,CENTRAL AFRICAN REPUBLIC,CANADA,COCOS (KEELING) ISLANDS,SWITZERLAND,CHILE,CHINA,COTE D'IVOIRE,CAMEROON,DEMOCRATIC REPUBLIC OF THE CONGO,CONGO,COOK ISLANDS,COLOMBIA,COMOROS,CAPE VERDE,COSTA RICA,CUBA,CHRISTMAS ISLAND,CAYMAN ISLANDS,CYPRUS,CZECH REPUBLIC,GERMANY,DJIBOUTI,DOMINICA,DENMARK,DOMINICAN REPUBLIC,ALGERIA,ECUADOR,EGYPT,ERITREA,WESTERN SAHARA,SPAIN,ESTONIA,ETHIOPIA,FINLAND,FIJI,FALKLAND ISLANDS,FRANCE,FAROE ISLANDS,MICRONESIA FEDERATED STATES OF,GABON,UNITED KINGDOM,GEORGIA,GUERNSEY,GHANA,GIBRALTAR,GUINEA,GUADELOUPE,GAMBIA,GUINEA-BISSAU,EQUATORIAL GUINEA,GREECE,GRENADA,GREENLAND,GUATEMALA,FRENCH GUIANA,GUAM,GUYANA,HONG KONG,HEARD ISLAND AND MCDONALD ISLANDS,HONDURAS,CROATIA,HAITI,HUNGARY,INDONESIA,INDIA,ISLE OF MAN,BRITISH INDIAN OCEAN TERRITORY,IRELAND,IRAN,IRAQ,ICELAND,ISRAEL,ITALY,JAMAICA,JORDAN,JAPAN,JERSEY,KAZAKHSTAN,KENYA,KYRGYZSTAN,CAMBODIA,KIRIBATI,SAINT KITTS AND NEVIS,SOUTH KOREA,KUWAIT,LAO PEOPLES DEMOCRATIC REPUBLIC,LEBANON,LIBERIA,LIBYAN ARAB JAMAHIRIYA,SAINT LUCIA,LIECHTENSTEIN,SRI LANKA,LESOTHO,LITHUANIA,LUXEMBOURG,LATVIA,MACAO,SAINT MARTIN FRENCH,MOROCCO,MONACO,MOLDOVA REPUBLIC OF,MADAGASCAR,MALDIVES,MEXICO,MARSHALL ISLANDS,REPUBLIC OF MACEDONIA,MALI,MALTA,MYANMAR,MONTENEGRO,MONGOLIA,NORTHERN MARIANA ISLANDS,MOZAMBIQUE,MAURITANIA,MONTSERRAT,MARTINIQUE,MAURITIUS,MALAWI,MALAYSIA,MAYOTTE,NAMIBIA,NEW CALEDONIA,NIGER,NORFOLK ISLAND,NIGERIA,NICARAGUA,NIUE,NETHERLANDS,NORWAY,NEPAL,NAURU,NEW ZEALAND,OMAN,PAKISTAN,PANAMA,PITCAIRN,PERU,PHILIPPINES,PALAU,PAPUA NEW GUINEA,POLAND,PUERTO RICO,NORTH KOREA,PORTUGAL,PARAGUAY,PALESTINIAN TERRITORY OCCUPIED,FRENCH POLYNESIA,QATAR,REUNION,ROMANIA,RUSSIAN FEDERATION,RWANDA,SAUDI ARABIA,SERBIA,SUDAN,SENEGAL,SINGAPORE,SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS,SAINT HELENA,SVALBARD AND JAN MAYEN,SOLOMON ISLANDS,SIERRA LEONE,EL SALVADOR,SAN MARINO,SOMALIA,SAINT PIERRE AND MIQUELON,SAO TOME AND PRINCIPE,SURINAME,SLOVAKIA,SLOVENIA,SWEDEN,SWAZILAND,SEYCHELLES,SYRIAN ARAB REPUBLIC,TURKS AND CAICOS ISLANDS,CHAD,TOGO,THAILAND,TAJIKISTAN,TOKELAU,TURKMENISTAN,TIMOR-LESTE,TONGA,TRINIDAD AND TOBAGO,TUNISIA,TURKEY,TUVALU,TAIWAN,TANZANIA UNITED REPUBLIC OF,UGANDA,UKRAINE,UNITED STATES MINOR OUTLYING ISLANDS,URUGUAY,UNITED STATES,UZBEKISTAN,VATICAN CITY STATE,SAINT VINCENT AND THE GRENADINES,VENEZUELA,VIRGIN ISLANDS BRITISH,VIRGIN ISLANDS U.S.,VIETNAM,VANUATU,WALLIS AND FUTUNA,SAMOA,YEMEN,SOUTH AFRICA,ZAMBIA,ZIMBABWE	ABW,AFG,AGO,AIA,ALA,ALB,AND,ANT,ARE,ARG,ARM,ASM,ATA,ATF,ATG,AUS,AUT,AZE,BDI,BEL,BEN,BFA,BGD,BGR,BHR,BHS,BIH,BLM,BLR,BLZ,BMU,BOL,BRA,BRB,BRN,BTN,BVT,BWA,CAF,CAN,CCK,CHE,CHL,CHN,CIV,CMR,COD,COG,COK,COL,COM,CPV,CRI,CUB,CXR,CYM,CYP,CZE,DEU,DJI,DMA,DNK,DOM,DZA,ECU,EGY,ERI,ESH,ESP,EST,ETH,FIN,FJI,FLK,FRA,FRO,FSM,GAB,GBR,GEO,GGY,GHA,GIB,GIN,GLP,GMB,GNB,GNQ,GRC,GRD,GRL,GTM,GUF,GUM,GUY,HKG,HMD,HND,HRV,HTI,HUN,IDN,IND,IMN,IOT,IRL,IRN,IRQ,ISL,ISR,ITA,JAM,JOR,JPN,JEY,KAZ,KEN,KGZ,KHM,KIR,KNA,KOR,KWT,LAO,LBN,LBR,LBY,LCA,LIE,LKA,LSO,LTU,LUX,LVA,MAC,MAF,MAR,MCO,MDA,MDG,MDV,MEX,MHL,MKD,MLI,MLT,MMR,MNE,MNG,MNP,MOZ,MRT,MSR,MTQ,MUS,MWI,MYS,MYT,NAM,NCL,NER,NFK,NGA,NIC,NIU,NLD,NOR,NPL,NRU,NZL,OMN,PAK,PAN,PCN,PER,PHL,PLW,PNG,POL,PRI,PRK,PRT,PRY,PSE,PYF,QAT,REU,ROU,RUS,RWA,SAU,SRB,SDN,SEN,SGP,SGS,SHN,SJM,SLB,SLE,SLV,SMR,SOM,SPM,STP,SUR,SVK,SVN,SWE,SWZ,SYC,SYR,TCA,TCD,TGO,THA,TJK,TKL,TKM,TLS,TON,TTO,TUN,TUR,TUV,TWN,TZA,UGA,UKR,UMI,URY,USA,UZB,VAT,VCT,VEN,VGB,VIR,VNM,VUT,WLF,WSM,YEM,ZAF,ZMB,ZWE	148
2077	5	Ethnicity	Hispanic or Latino,Not Hispanic or Latino,Not Reported	HISPANIC OR LATINO,NOT HISPANIC OR LATINO,NOT REPORTED	148
2078	3	race	American Indian or Alaska Native,Black or African American,White,Asian,Native Hawaiian or Other…,Other	AMERICAN INDIAN OR ALASKA NATIVE,BLACK OR AFRICAN AMERICAN,WHITE,ASIAN,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,OTHER	148
2079	5	racenr	Not reported	NOT REPORTED	148
2080	2	textarea	text	text	148
2081	5	homeless	Yes,No,Unknown	Y,N,U	148
2082	5	idu	Yes,No,Unknown	Y,N,U	148
2083	5	nidu	Yes,No,Unknown	Y,N,U	148
2084	5	corrfa	Yes,No,Unknown	Y,N,U	148
349	5	VM	Visit missed (Indicate which scheduled visit was missed in A1\\, then skip to Section C),Not applicable/participant still on TB treatment (Indicate at which scheduled visit \nparticipant was still on TB treatment in A1\\, then skip to Section C and complete a Treatment Evaluation form.)	VISIT MISSED,NOT APPLICABLE	40
350	5	Evaluation	Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early Off Treatment Termination,Unscheduled	W22,W26,W39,W52,W65,W78,EOFFTT,UNS	40
351	1	text	text	text	40
352	5	CM	Yes,No	Y,N	40
353	5	DR	Yes,No	Y,N	40
354	5	CE	Yes,No	Y,N	40
355	5	LB	Yes,No	Y,N	40
356	5	SS	Yes,No	Y,N	40
357	5	MB	Yes,No	Y,N	40
358	5	RS	Yes,No	Y,N	40
359	5	PG	Yes,No	Y,N	40
360	5	BR	Yes,No	Y,N	40
361	5	TM	Yes,No	Y,N	40
362	2	textarea	text	text	40
363	1	text	text	text	41
364	2	textarea	text	text	41
365	3	checkboxJUNK	_	DONE	41
366	1	text	text	text	42
367	2	textarea	text	text	42
368	1	text	text	text	43
369	5	radioSTDYEVAL	Baseline,Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early On-Treatment Termination Visit (approximately 14 days after early treatment discontinuation),Early Off-Treatment Termination Visit (approximately 14 days after stopping study participation),Possible Poor TB Treatment Response,Unscheduled	BASELINE,WK1,WK2,WK3,WK4,WK6,WK8,WK10,WK12,WK14,WK17,WK22,WK26,WK39,WK52,WK65,WK78,EARLY_ON_TREATMENT_TERMINATION_VISIT,EARLY_OFF_TREATMENT_TERMINATION_VISIT,POSSIBLE_POOR_TB_TREATMENT_RESPONSE,UNSCHEDULED	43
370	5	radioYN	Yes,No	Y,N	43
371	2	textarea	text	text	43
491	5	beoccurlbl	Yes,No	Y,N	62
492	3	bbestatlbl	Not Done	NOT DONE	62
493	5	bbeoccurlbl	Yes,No	Y,N	62
494	5	cbeoccurlbl	Yes,No	Y,N	62
495	3	aabestatlbl	Not Done	NOT DONE	62
496	3	bbbestatlbl	Not Done	NOT DONE	62
497	2	textarea	text	text	62
498	5	VisitLbl	Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Unscheduled	W02,W03,W04,W06,W08,W10,W12,UNS	63
499	1	text	text	text	63
500	5	aextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	63
501	5	aceoccurlbl	Yes,No,Unknown	Y,N,U	63
502	5	bextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	63
503	5	bceoccurlbl	Yes,No,Unknown	Y,N,U	63
504	5	cextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	63
505	5	cceoccurlbl	Yes,No,Unknown	Y,N,U	63
506	6	mldosulbl	Bag, Bar, Bottle, Bowl, Box, Can, Container, Cup, Fluid Ounce US, Gram, Half, Jar, Kilogram, Liter, Milliliter, Ounce, Quarter, Slice, Tablespoon, Teaspoon, whole	BAG, BAR, BOTTLE, BOWL, BOX, CAN, CONTAINER, CUP, foz_us, g, HALF, JAR, kg, L, mL, oz, QUARTER, SLICE, Tbsp, tsp, WHOLE	63
507	5	mltmcondlbl	Yes,No,Unknown	Y,N,U	63
508	5	amltmcondlbl	Yes,No,Unknown	Y,N,U	63
509	5	suoccurlbl	Yes,No,Unknown	Y,N,U	63
510	3	bestatlbl	Not Done	NOT DONE	63
511	5	beoccurlbl	Yes,No	Y,N	63
512	3	bbestatlbl	Not Done	NOT DONE	63
513	5	bbeoccurlbl	Yes,No	Y,N	63
514	5	cbeoccurlbl	Yes,No	Y,N	63
515	3	aabestatlbl	Not Done	NOT DONE	63
516	3	bbbestatlbl	Not Done	NOT DONE	63
517	2	textarea	text	text	63
518	5	VM	Visit missed (Indicate which scheduled visit was missed in A1\\, then skip to Section C),Not applicable/participant still on TB treatment (Indicate at which scheduled visit \nparticipant was still on TB treatment in A1\\, then skip to Section C and complete a Treatment Evaluation form.)	VISIT MISSED,NOT APPLICABLE	64
519	5	Evaluation	Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early Off Treatment Termination,Unscheduled	W22,W26,W39,W52,W65,W78,EOFFTT,UNS	64
520	1	text	text	text	64
521	5	CM	Yes,No	Y,N	64
522	5	DR	Yes,No	Y,N	64
523	5	CE	Yes,No	Y,N	64
524	5	LB	Yes,No	Y,N	64
525	5	SS	Yes,No	Y,N	64
526	5	MB	Yes,No	Y,N	64
527	5	RS	Yes,No	Y,N	64
528	5	PG	Yes,No,Not aplicable (e.g. did not consent to collection)	Y,N,NA	64
529	5	BR	Yes,No,Not applicable	Y,N,NA	64
530	5	TM	Yes,No	Y,N	64
531	2	textarea	text	text	64
532	1	text	text	text	65
533	3	Estimated	Estimated	ESTIMATE	65
534	3	NA	NA	NA	65
535	5	cm, in	cm, in	cm,in	65
536	5	kg,lbs	kg,lbs	kg,lbs	65
537	5	Yes,No	Yes,No	Y,N	65
538	2	textarea	text	text	65
539	5	Regimen 1 (BMZRb), Regimen 2 (BMZD), Regimen 3 (HRZE)	Regimen 1 (BMZRb), Regimen 2 (BMZD), Regimen 3 (HRZE)	BMZRb,BMZD,HRZE	65
1050	1	text	text	text	93
1051	5	VisitLbl	Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Unscheduled	W02,W03,W04,W06,W08,W10,W12,UNS	93
1052	5	aextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	93
1053	5	aceoccurlbl	Yes,No,Unknown	Y,N,U	93
1054	5	bextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	93
1055	5	bceoccurlbl	Yes,No,Unknown	Y,N,U	93
1056	5	cextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	93
1057	5	cceoccurlbl	Yes,No,Unknown	Y,N,U	93
1058	6	mldosulbl	Bag, Bar, Bottle, Bowl, Box, Can, Container, Cup, Fluid Ounce US, Gram, Half, Jar, Kilogram, Liter, Milliliter, Ounce, Quarter, Slice, Tablespoon, Teaspoon, whole	BAG, BAR, BOTTLE, BOWL, BOX, CAN, CONTAINER, CUP, foz_us, g, HALF, JAR, kg, L, mL, oz, QUARTER, SLICE, Tbsp, tsp, WHOLE	93
1059	5	mltmcondlbl	Yes,No,Unknown	Y,N,U	93
1060	5	amltmcondlbl	Yes,No,Unknown	Y,N,U	93
1061	5	suoccurlbl	Yes,No,Unknown	Y,N,U	93
1062	3	bestatlbl	Not Done	NOT DONE	93
1063	5	beoccurlbl	Yes,No	Y,N	93
1064	3	bbestatlbl	Not Done	NOT DONE	93
1065	5	bbeoccurlbl	Yes,No	Y,N	93
1066	5	cbeoccurlbl	Yes,No	Y,N	93
1067	3	aabestatlbl	Not Done	NOT DONE	93
1068	3	bbbestatlbl	Not Done	NOT DONE	93
1069	2	textarea	text	text	93
1111	1	text	text	text	99
1112	3	VisitMissed	Visit Missed	VISIT_MISSED	99
1113	5	WeekOfEvaluation	Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26,Early On-treatmnet Termination Visit (Approximately 14 days after early treatment discontinuation),Unscheduled	W01,W02,W03,W04,W06,W08,W10,W12,W14,W17,W22,W26,EONTT,UNS	99
1114	5	Yes,No	Yes,No	Y,N	99
1115	5	Yes,No,Not Applicable  (e.g.\\\\, did not consent to collection)	Yes,No,Not Applicable	Y,N,NA	99
1116	5	Yes,No,Not Applicable	Yes,No,Not Applicable	Y,N,NA	99
1117	5	Yes,No,Not Applicable (not of childbearing potential)	Yes,No,Not Applicable	Y,N,NA	99
1118	5	Continued,DiscontinuedPerm,Completed,Held	Participant will continue study treatmnet,Participant permanently discontinued study treatment (Complete Treatment Completion Form if not previously completed), Participant completed study treatment (Complete Treatment Completion Form),Study treatment temporarily held (e.g.\\, for toxicity)	CONTINUED,DISCONTINUED,COMPLETED,TEMPHELD	99
1119	2	textarea	text	text	99
2085	5	alcohol	Yes,No,Unknown	Y,N,U	148
2086	5	mental	No,Unknown	N,U	148
2087	5	past	No,Unknown	N,U	148
2088	5	tabacco	Never (Skip to A7),Current (Complete A6b-A6c\\, then skip to A7),Former (complete A6b-A6d\\, then skip to A7)	NEVER,CURRENT,FORMER	148
2089	3	duration	Duration Unknown	U	148
2090	5	Unit	Days,Weeks,Months,Years	DAYS,WEEKS,MONTHS,YEARS	148
821	5	VisitLbl	Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Unscheduled	W02,W03,W04,W06,W08,W10,W12,UNS	81
822	1	text	text	text	81
823	5	bescatlbl	Study 38 – TB Drug Sparse PK  (skip to C),Study 38 – TB Drug Intensive PK (skip to D)	IPK,TSPK	81
824	5	beoccurfrlbl	Yes,No,Unknown (If No or Unknown\\, skip to Section F)	Y,N,U	81
825	5	beoccurthlbl	Yes,No,Unknown	Y,N,U	81
826	3	bedurclbl	Unknown (Skip to 1a2)	UNKNOWN	81
827	5	bedurulbl	Days  OR, Hours	DAYS,HOURS	81
828	5	beorresclbl	Partial, Complete	PARTIAL,COMPLETE	81
829	2	textarea	text	text	81
1070	3	VisitMissed	Visit Missed	VISIT_MISSED	94
1071	5	WeekOfEvaluation	Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26	Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26	94
1072	1	text	text	text	94
1073	5	Treatment	Early On-treatmnet Termination Visit (Approximately 14 days after early treatment discontinuation),Unscheduled	Early,Unscheduled	94
1074	5	Yes,No	Yes,No	Y,N	94
1075	5	Yes,No,Not Applicable	Yes,No,Not Applicable	Y,N,NA	94
1076	5	Continued,DiscontinuedPerm,Completed,Held	Participant will continue study treatmnet,Participant permanently discontinued study treatment (Complete Treatment Completion Form if not previously completed), Participant completed study treatment (Complete Treatment Completion Form),Study treatment temporarily held	CONTINUED,DISCONTINUED,COMPLETED,TEMPHELD	94
1077	2	textarea	text	text	94
1078	1	text	text	text	95
1079	5	visitradio	Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26,Week 39,Week 52,Week 65,Week 78,Early On-Treatment Termination Visit (approximately 14 days after early treatment discontinuation),Early Off-Treatment Termination Visit	W01,W02,W03,W04,W06,W08,W10,W12,W14,W17,W22,W26,W39,W52,W65,W78,EONTT,EOFFTT	95
1080	5	radioyn	Yes,No	YES,NO	95
1081	5	radiorec	YES the Site Investigator recommended a change in TB treatment (Complete 5 and 6 and then go to Section C),NO the Site Investigator did not recommend a change in TB treatment (Skip to Section C),TB treatment change recommendation is PENDING (Skip to Section C)	YES,NO,TB TREATMENT CHANGE RECOMMENDATION IS PENDING	95
1082	5	radiochg	Retreatment after completion of TB treatment,Extension of TB treatment,Modifications to assigned treatment <strong>(i.e. addition\\, subtraction\\, replacement of TB medications for any reason except changes in treatment for pregnancy\\, temporary drug challenge\\, or toxicity)</strong>	RETREATMENT AFTER COMPLETION OF TB TREATMENT,EXTENSION OF TB TREATMENT,MODIFICATIONS TO ASSIGNED TREATMENT	95
1083	2	textarea	text	text	95
1084	3	textres	Sputum smear positive for acid fast bacilli at or after week 17,Sputum culture positive for Mycobacterium tuberculosis at or after week 17,Worsening signs and/or symptoms consistent with TB at or after week 17,Radiographic worsening consistent with TB at or after week 17,Adverse event,Early study treatment discontinuation	SPUTUM SMEAR POSITIVE FOR ACID FAST BACILLI AT OR AFTER WEEK 17,SPUTUM CULTURE POSITIVE FOR MYCOBACTERIUM TUBERCULOSIS AT OR AFTER WEEK 17,WORSENING SIGNS AND/OR SYMPTOMS CONSISTENT WITH TB AT OR AFTER WEEK 17,RADIOGRAPHIC WORSENING CONSISTENT WITH TB AT OR AFTER WEEK 17,ADVERSE EVENT,EARLY STUDY TREATMENT DISCONTINUATION	95
1085	5	radionit	YES: Change to TB treatment was initiated (Skip to 9),NO: Change to TB treatment was not initiated,It is UNKNOWN whether change to TB treatment was or was not initiated	YES,NO,UNKNOWN	95
1086	5	radioalt	Yes (if this is a reportable adverse event submit AE form,No	Y,N	95
1087	3	tremed	Unknown,Ethambutol,Pyrazinamide,Isoniazid,Rifampin	UNKNOWN,ETHAMBUTOL,PYRAZINAMIDE,ISONIAZID,RIFAMPIN	95
1088	5	radiostrtdt	Start date is unknown,Only estimated start date is known	START DATE IS UNKNOWN,ONLY ESTIMATED START DATE IS KNOWN	95
1089	4	file	file	file	95
1090	1	text	text	text	96
1091	5	treatment	Yes (Skip to Section C),No	Y,N	96
1092	5	reason	Participant died*, Participant’s screening and baseline study visit sputum cultures all failed to grow M. tuberculosis.*, Participant’s screening or baseline isolate is resistant to any one or more of isoniazid\\, rifampin\\, fluoroquinolones\\, pyrazinamide\\, ethambutol\\, delamanid\\, or bedaquiline* , Participant withdrew consent*, Participant determined ineligible after enrollment\\, for reasons other than mycobacteriology*, Study treatment not started , Participant developed drug toxicities requiring permanent discontinuation of any study drug, Site investigator  judged it no longer advisable for participant to continue study treatment, Participant refused further study treatment, Participant became pregnant during study treatment , Participant is lost to follow-up, Other,	DEATH,SCREEN FAILURE,SCREEN FAILURE,WITHDRAWAL BY SUBJECT,PROTOCOL VIOLATION,STUDY TREATMENT NOT STARTED,ADVERSE EVENT,PHYSICIAN JUDGEMENT,PARTICIPANT REFUSED FURTHER STUDY TREATMENT,ADVERSE EVENT,LOST TO FOLLOW-UP,OTHER	96
1093	2	textarea	text	text	96
1094	5	decision	Retain blood specimens and use for future pharmacogenomic testing(skip to Section D) ,Participant withdraws consent for blood specimen use for future pharmacogenomic testing and has requested specimens be destroyed (complete C.2 & C.3)	PGKEEP,PGDESTROY	96
1095	5	storageb	Retain blood specimens and use for future research (skip to Section E),Participant withdraws consent for blood specimen use for future research and has requested specimens be destroyed (complete D.2 & D.3)	FTRKEEP,FTRDESTRY	96
1129	1	text	text	text	101
1130	3	VisitMissed	Visit Missed	VISIT_MISSED	101
1131	5	WeekOfEvaluation	Week 1,Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Week 14,Week 17,Week 22,Week 26,Early On-treatmnet Termination Visit (Approximately 14 days after early treatment discontinuation),Unscheduled	W01,W02,W03,W04,W06,W08,W10,W12,W14,W17,W22,W26,EONTT,UNS	101
1132	5	Yes,No	Yes,No	Y,N	101
1133	5	LblPG	Yes,No,Not Applicable (e.g.\\, did not consent to collection)	Y,N,NA	101
1134	5	LblSPK	Yes,No,Not Applicable (e.g.\\, did not consent to collection)	Y,N,NA	101
1135	5	LblIPK	Yes,No,Not Applicable	Y,N,NA	101
1136	5	LbMPR	Yes,No,Not Applicable	Y,N,NA	101
1137	5	LblMTM	Yes,No,Not Applicable (not of childbearing potential)	Y,N,NA	101
1138	5	Continued,DiscontinuedPerm,Completed,Held	Participant will continue study treatmnet,Participant permanently discontinued study treatment (Complete Treatment Completion Form if not previously completed), Participant completed study treatment (Complete Treatment Completion Form),Study treatment temporarily held (e.g.\\, for toxicity)	CONTINUED,DISCONTINUED,COMPLETED,TEMPHELD	101
1139	2	textarea	text	text	101
1167	5	VisitLbl	Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Unscheduled	W02,W03,W04,W06,W08,W10,W12,UNS	105
1168	1	text	text	text	105
1169	5	bescatlbl	Study 38 – TB Drug Sparse PK  (skip to C),Study 38 – TB Drug Intensive PK (skip to D)	IPK,TSPK	105
1170	5	beoccurfrlbl	Yes,No,Unknown (If No or Unknown\\, skip to Section F)	Y,N,U	105
1171	5	beoccurthlbl	Yes,No,Unknown	Y,N,U	105
1172	3	bedurclbl	Unknown (Skip to 1a2)	UNKNOWN	105
1173	5	bedurulbl	Days  OR, Hours	DAYS,HOURS	105
1174	5	beorresclbl	Partial, Complete	PARTIAL,COMPLETE	105
1175	2	textarea	text	text	105
1185	1	text	text	text	107
1186	5	VisitLbl	Week 2,Week 3,Week 4,Week 6,Week 8,Week 10,Week 12,Unscheduled	W02,W03,W04,W06,W08,W10,W12,UNS	107
1187	5	bescatlbl	Study 38 – TB Drug Sparse PK  (skip to C),Study 38 – TB Drug Intensive PK (skip to D)	IPK,TSPK	107
1188	5	beoccurfrlbl	Yes,No,Unknown (If No or Unknown\\, skip to Section F)	Y,N,U	107
1189	5	beoccurthlbl	Yes,No,Unknown	Y,N,U	107
1190	3	bedurclbl	Unknown (Skip to 1a2)	UNKNOWN	107
1191	5	bedurulbl	Days  OR, Hours	DAYS,HOURS	107
1192	5	beorresclbl	Partial, Complete	PARTIAL,COMPLETE	107
1193	2	textarea	text	text	107
1202	1	text	text	text	109
1203	3	Estimated	Estimated	ESTIMATE	109
1204	3	NA	NA (E.g.\\, participant > 18)	NA	109
1205	5	cm, in	cm, in	cm,in	109
1206	5	kg,lbs	kg,lbs	kg,lbs	109
1207	5	Yes,No	Yes,No	Y,N	109
1208	2	textarea	text	text	109
1209	5	Regimen 1 (BMZRb), Regimen 2 (BMZD), Regimen 3 (HRZE)	Regimen 1 (BMZRb), Regimen 2 (BMZD), Regimen 3 (HRZE)	BMZRb,BMZD,HRZE	109
1210	1	text	text	text	110
1211	5	Yes,No	Yes,No	Y,N	110
1212	2	textarea	text	text	110
1213	5	Yes,No,Not applicable	Yes,No,Not applicable	Y,N,NA	110
1214	3	SAE	Death,Any life-threatening experience,Any inpatient hospitalization (>24 hours) or prolongation of any hospitalization\\, except for non-complicated\\, planned medical procedures,Persistently or significantly disabling event (as determined by the principal investigator),Congenital anomaly or birth defect,Other medically important event (an event that could harm the participant's health or require medical intervention to prevent any of the other listed SAEs above)	Death,Any life-threatening experience,Any inpatient hospitalization,Persistently or significantly disabling event,Congenital anomaly or birth defect,Other medically important event	110
1215	5	STATUS	Recovered/Resolved,Recovered/Resolved With Sequelae,Fatal,Recovering/Resolving,Not Recovered/Not Resolved,Unknown	RECOVERED/RESOLVED,RECOVERED/RESOLVED WITH SEQUELAE,FATAL,RECOVERING/RESOLVING,NOT RECOVERED/NOT RESOLVED,UNKNOWN	110
1216	5	Drugs	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	DEFINITE,PROBABLE,POSSIBLE,UNLIKELY,NOT RELATED,UNCLASSIFIABLE	110
1217	3	AESTUDY	Bedaquiline,Moxifloxacin,Pyrazinamide,Rifampin,Delamanid,Rifabutin,Ethambutol,Isoniazid	BDQ,M,PZA,RIF,DLM,RBT,ETH,INH	110
1218	5	Anticipated,Unanticipated	Anticipated,Unanticipated	ANTICIPATED,UNANTICIPATED	110
1219	5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	1,2,3,4,5	110
1220	5	outcome	Spontaneous abortion,Elective abortion,Live birth,Fetal death,Unknown	Spontaneous Abortion,Elective Abortion,Live Birth,Fetal Death,Unknown Pregnancy Outcome	110
2091	5	Number	Less than 10 cigarettes,10-20 cigarettes,More than 20 cigarettes,Don't know	LESS THAN 10 CIGARETTES,10-20 CIGARETTES,MORE THAN 20 CIGARETTES,DON'T KNOW	148
2092	3	smoking	Duration Unknown	U	148
2093	5	treated	Yes,No,Unknown	Y,N,U	148
2094	3	Estimd	Estimated	ESTIMATED	148
2095	5	prescribed	Yes,No,Unknown	Y,N,U	148
2096	5	extrapulmonary	Yes,No,Unknown	Y,N,U	148
1577	1	text	text	text	135
1578	5	VisitLbl	Week 4, Week 6, Unscheduled	W04,W06,UNS	135
1579	5	aextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	135
1580	5	aceoccurlbl	Yes,No,Unknown	Y,N,U	135
1581	5	bextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	135
1582	5	bceoccurlbl	Yes,No,Unknown	Y,N,U	135
2097	7	organ	Blood and Lymphatic System Disorders,Cardiac Disorders,Endocrine Disorders,Gastrointestinal Disorders,Hepatobiliary Disorders,Musculoskeletal and Connective Tissue Disorders,Nervous System Disorders,Renal and Urinary Disorders,Reproductive System and Breast Disorders,Respiratory Thoracic and Mediastinal Disorders,Skin and Subcutaneous Tissue Disorders	BLOOD AND LYMPHATIC SYSTEM DISORDERS,CARDIAC DISORDERS,ENDOCRINE DISORDERS,GASTROINTESTINAL DISORDERS,HEPATOBILIARY DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NERVOUS SYSTEM DISORDERS,RENAL AND URINARY DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,RESPIRATORY THORACIC AND MEDIASTINAL DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS	148
2098	5	liver disease	Yes,No,Unknown	Y,N,U	148
2099	5	hepatitisa	Yes,No,Unknown	Y,N,U	148
2100	5	hepatitisb	Yes,No,Unknown	Y,N,U	148
2101	5	hepatitisT	Yes,No,Unknown	Y,N,U	148
2102	5	hepatitisD	Yes,No,Unknown	Y,N,U	148
2103	5	other	Yes,No,Unknown	Y,N,U	148
2104	5	diabetes	No,Unknown	N,U	148
1397	1	text	text	text	126
1398	5	Yes,No	Yes,No	Y,N	126
1399	2	textarea	text	text	126
1400	5	Yes,No,Not applicable	Yes,No,Not applicable	Y,N,NA	126
1401	3	SAE	Death,Any life-threatening experience,Any inpatient hospitalization (>24 hours) or prolongation of any hospitalization\\, except for non-complicated\\, planned medical procedures,Persistently or significantly disabling event (as determined by the principal investigator),Congenital anomaly or birth defect,Other medically important event (an event that could harm the participant's health or require medical intervention to prevent any of the other listed SAEs above)	Death,Any life-threatening experience,Any inpatient hospitalization,Persistently or significantly disabling event,Congenital anomaly or birth defect,Other medically important event	126
1402	5	STATUS	Recovered/Resolved (enter resolution date below),Recovered/Resolved With Sequelae (enter resolution date below),Fatal (enter death date below) (complete Notification of Death Form),Recovering/Resolving (i.e.\\, improving),Not Recovered/Not Resolved (i.e.\\, ongoing or worsening),Unknown	RECOVERED/RESOLVED,RECOVERED/RESOLVED WITH SEQUELAE,FATAL,RECOVERING/RESOLVING,NOT RECOVERED/NOT RESOLVED,UNKNOWN	126
1403	5	Drugs	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	DEFINITE,PROBABLE,POSSIBLE,UNLIKELY,NOT RELATED,UNCLASSIFIABLE	126
1404	3	AESTUDY	Bedaquiline,Moxifloxacin,Pyrazinamide,Rifampin,Delamanid,Rifabutin,Ethambutol,Isoniazid	BDQ,M,PZA,RIF,DLM,RBT,ETH,INH	126
1405	5	Anticipated,Unanticipated	Anticipated,Unanticipated	ANTICIPATED,UNANTICIPATED	126
1406	5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	Grade 1,Grade 2,Grade 3,Grade 4,Grade 5	1,2,3,4,5	126
2105	5	type	Type I,Type II,Unknown	DIABI,DIABII,DIABUNK	148
2106	3	diagyrest	Estimated	ESTIMATED	148
1407	5	outcome	Spontaneous abortion,Elective abortion,Live birth,Fetal death,Unknown	Spontaneous Abortion,Elective Abortion,Live Birth,Fetal Death,Unknown Pregnancy Outcome	126
1408	3	Unk	Unknown	UNKNOWN	126
1583	5	cextmcondlbl	Yes,No,Unknown	ESTIMATE,(BLANK),UNKNOWN	135
1584	5	cceoccurlbl	Yes,No,Unknown	Y,N,U	135
1585	5	cceoccurlbla	Yes,No (Skip to Section D)	Y,N	135
1586	6	mldosulbl	Bag, Bar, Bottle, Bowl, Box, Can, Container, Cup, Fluid Ounce US, Gram, Half, Jar, Kilogram, Liter, Milliliter, Ounce, Quarter, Slice, Tablespoon, Teaspoon, whole	BAG, BAR, BOTTLE, BOWL, BOX, CAN, CONTAINER, CUP, foz_us, g, HALF, JAR, kg, L, mL, oz, QUARTER, SLICE, Tbsp, tsp, WHOLE	135
1587	5	mltmcondlbl	Yes,No,Unknown	Y,N,U	135
1588	5	amltmcondlbl	Yes,No,Unknown	Y,N,U	135
1589	5	suoccurlbl	Yes,No,Unknown	Y,N,U	135
1590	5	frqlbl	Always,Usually,Sometimes,Rarely,Never\t,Unknown	ALWAYS,USUALLY,SOMETIMES,RARELY,NEVER,UNKNOWN	135
1591	3	bestatlbl	Not Done	NOT DONE	135
1592	5	beoccurlbl	Yes,No	Y,N	135
1593	3	bbestatlbl	Not Done	NOT DONE	135
1594	5	bbeoccurlbl	Yes,No	Y,N	135
1595	5	cbeoccurlbl	Yes,No	Y,N	135
1596	2	textarea	text	text	135
1604	1	text	text	text	137
1605	5	Yes,No (skip to A3)	Yes,No	Y,N	137
1606	2	textarea	text	text	137
1607	5	Immediate,Contributing cause of death,Not a cause of death,Uncertain	An immediate cause of death,A contributing cause of death,Not a cause of death,Uncertain as a contributor to the cause of death	AN IMMEDIATE CAUSE OF DEATH,A CONTRIBUTING CAUSE OF DEATH,NOT A CAUSE OF DEATH,UNCERTAIN AS A CONTRIBUTOR TO THE CAUSE OF DEATH	137
1608	5	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	Definite,Probable,Possible,Unlikely,Not related,Unclassifiable	DEFINITE,PROBABLE,POSSIBLE,UNLIKELY,NOT RELATED,UNCLASSIFIABLE	137
1609	5	Anticipated,Unanticipated	Anticipated,Unanticipated	ANTICIPATED,UNANTICIPATED	137
1610	5	Yes,No,Unknown	Yes,No,Unknown	Y,N,U	137
2107	3	diaunk	Unknown	U	148
2108	5	radioa	Yes,No (self-reported),Unknown	Y,N,U	148
2109	5	radio	Yes,No,Unknown	Y,N,U	148
2110	5	peripheral	Yes,No,Unknown	Y,N,U	148
2111	5	cancer	No,Unknown	N,U	148
2112	5	cardiac	No,Unknown	N,U	148
2113	3	mhna	Not Applicable (i.e. participant is HIV-negative; If NA\\, skip to Section E)	NA	148
2114	3	mhest	Estimated	ESTIMATED	148
2115	3	mhunk	Unknown	U	148
2116	5	CD4	Yes,No,Unknown	Y,N,U	148
2117	5	antiretroviral	Yes,No,Unknown	Y,N,U	148
2118	3	martest	Estimated	ESTIMATED	148
2119	5	startdate	Yes,No,Unknown	Y,N,U	148
2120	6	whoterm	American Trypanososmiasis Reactivation (Meningoencephalitis Or Myocarditis),Atypical Disseminated Leishmaniasis,Candidiasis Of Bronchi Trachea Or Lungs,Candidiasis Esophageal,Cardiomyopathy Symptomatic HIV-Associated,Cervical Cancer Invasive,Cryptococcosis Extrapulmonary. Including Meningitis,Cryptosporidiosis Chronic Intestinal With Diarrhea (>1 Months Duration),Cytomegalovirus Infection (Retinitis Or Infection Of Other Organs),Cytomegalovirus Retinitis (With Loss Of Vision),Encephalopathy HIV-Related,Herpes Simplex Infection Chronic (Orolabial Genital Or Anorectal Site For > 1 Month Or Visceral Herpes At Any Site,HIV Wasting Syndrome,Isosporiasis Chronic Intestinal (>1 Months Duration),Kaposi’S Sarcoma,Lymphoma Primary Of Brain,Lymphoma (Cerebral Or B-Cell Non-Hodgkin Including Burkitt’S And Immunoblastic),Mycobacterium Avium Complex Or M. Kansasii Disseminated Or Extrapulmonary,Mycobacterium Other Species Or Unidentified Species Disseminated Or Extrapulmonary,Mycobacterium Tuberculosis Extrapulmonary,Mycosis Disseminated ,Nephropathy Symptomatic HIV-Associated,Pneumocystis Pneumonia,Pneumonia Bacterial Recurrent Severe,Progressive Multifocal Leukoencephalopathy,Salmonella Bacteremia Recurrent Nontyphoidal,Toxoplasmosis Of Brain Or CNS	AMERICAN TRYPANOSOSMIASIS REACTIVATION (MENINGOENCEPHALITIS OR MYOCARDITIS),ATYPICAL DISSEMINATED LEISHMANIASIS,CANDIDIASIS OF BRONCHI TRACHEA OR LUNGS,CANDIDIASIS ESOPHAGEAL,CARDIOMYOPATHY SYMPTOMATIC HIV-ASSOCIATED,CERVICAL CANCER INVASIVE,CRYPTOCOCCOSIS EXTRAPULMONARY. INCLUDING MENINGITIS,CRYPTOSPORIDIOSIS CHRONIC INTESTINAL WITH DIARRHEA (>1 MONTHS DURATION),CYTOMEGALOVIRUS INFECTION (RETINITIS OR INFECTION OF OTHER ORGANS),CYTOMEGALOVIRUS RETINITIS (WITH LOSS OF VISION),ENCEPHALOPATHY HIV-RELATED,HERPES SIMPLEX INFECTION CHRONIC (OROLABIAL GENITAL OR ANORECTAL SITE FOR > 1 MONTH OR VISCERAL HERPES AT ANY SITE,HIV WASTING SYNDROME,ISOSPORIASIS CHRONIC INTESTINAL (>1 MONTHS DURATION),KAPOSI’S SARCOMA,LYMPHOMA PRIMARY OF BRAIN,LYMPHOMA (CEREBRAL OR B-CELL NON-HODGKIN INCLUDING BURKITT’S AND IMMUNOBLASTIC),MYCOBACTERIUM AVIUM COMPLEX OR M. KANSASII DISSEMINATED OR EXTRAPULMONARY,MYCOBACTERIUM OTHER SPECIES OR UNIDENTIFIED SPECIES DISSEMINATED OR EXTRAPULMONARY,MYCOBACTERIUM TUBERCULOSIS EXTRAPULMONARY,MYCOSIS DISSEMINATED ,NEPHROPATHY SYMPTOMATIC HIV-ASSOCIATED,PNEUMOCYSTIS PNEUMONIA,PNEUMONIA BACTERIAL RECURRENT SEVERE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,SALMONELLA BACTEREMIA RECURRENT NONTYPHOIDAL,TOXOPLASMOSIS OF BRAIN OR CNS	148
2121	6	monthwho	JAN,FEB,MAR,APR,MAY,JUN,JUL,AUG,SEP,OCT,NOV,DEC	JAN,FEB,MAR,APR,MAY,JUN,JUL,AUG,SEP,OCT,NOV,DEC	148
2122	5	additionala	Yes,No,Unknown	Y,N,U	148
2123	5	additionalb	Yes,No	Y,N	148
\.


--
-- Data for Name: response_type; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.response_type (response_type_id, name, description) FROM stdin;
1	text	free form text entry limited to one line
2	textarea	free form text area display
3	checkbox	selecting one from many options
4	file	for upload of files
5	radio	selecting one from many options
6	single-select	pick one from a list
7	multi-select	pick many from a list
8	calculation	value calculated automatically
9	group-calculation	value calculated automatically from an entire group of items
10	instant-calculation	for barcode
\.


--
-- Data for Name: role_privilege_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.role_privilege_map (role_id, priv_id, priv_value) FROM stdin;
\.


--
-- Data for Name: rule; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule (id, name, description, oc_oid, enabled, rule_expression_id, owner_id, date_created, date_updated, update_id, status_id, version, study_id) FROM stdin;
1	visit cannot be blank	Rule to check if visit is blank	ERROR_VISIT_ISBLANK	f	1	\N	2023-12-11	\N	\N	1	0	3
2	Unscheduled visit date cannot be blank	Rule to check if Unscheduled visit date is blank	ERROR_UNSCHEDULEVISDATE_ISBLANK	f	2	\N	2023-12-11	\N	\N	1	0	3
3	Unscheduled visit date cannot be a future date	Rule to check if Unscheduled visit date is a future date	ERROR_UNSCHEDULEVISDATE_DATEFUTURE	f	3	\N	2023-12-11	\N	\N	1	0	3
4	Date of dose A Cannot be blank	Rule to check if Date of dose A is blank	ERROR_DOSEA_DATE_ISBLANK	f	4	\N	2023-12-11	\N	\N	1	0	3
5	Date of dose A must be a future date	Rule to check if Date of dose A is a future date	ERROR_DOSEA_DATEFUTURE	f	5	\N	2023-12-11	\N	\N	1	0	3
6	time of dose A Cannot be blank	Rule to check if time of dose A is a future date	ERROR_DOSEA_TIME_ISBLANK	f	6	\N	2023-12-11	\N	\N	1	0	3
7	Estimated Time of dose A Cannot be blank	Rule to check if Estimated Time of dose A is a future date	ERROR_DOSEA_ESTIMATEDTIME_ISBLANK	f	7	\N	2023-12-11	\N	\N	1	0	3
8	Vomiting of dose A Cannot be blank	Rule to check if Vomiting of dose A is a future date	ERROR_DOSEA_VOMITING_ISBLANK	f	8	\N	2023-12-11	\N	\N	1	0	3
9	Date of dose B cannot be blank	Rule to check if Date of dose B is blank	ERROR_DOSEB_DATE_ISBLANK	f	9	\N	2023-12-11	\N	\N	1	0	3
10	Date of dose B must be a future date	Rule to check if Date of dose B is a future date	ERROR_DOSEB_DATEFUTURE	f	10	\N	2023-12-11	\N	\N	1	0	3
11	Must be pre-reference dose A + 1 day	Rule to check if pre-reference dose A + 1 day	ERROR_DOSEB_DATEDIF_DOSEA	f	11	\N	2023-12-11	\N	\N	1	0	3
12	time of dose B Cannot be blank	Rule to check if time of dose B is a future date	ERROR_DOSEB_TIME_ISBLANK	f	12	\N	2023-12-11	\N	\N	1	0	3
13	Estimated Time of dose B Cannot be blank	Rule to check if Estimated Time of dose B is a future date	ERROR_DOSEB_ESTIMATEDTIME_ISBLANK	f	13	\N	2023-12-11	\N	\N	1	0	3
14	Vomiting of dose B Cannot be blank	Rule to check if Vomiting of dose B is a future date	ERROR_DOSEB_VOMITING_ISBLANK	f	14	\N	2023-12-11	\N	\N	1	0	3
15	Date of dose C cannot be blank	Rule to check if Date of dose C is blank	ERROR_DOSEC_DATE_ISBLANK	f	15	\N	2023-12-11	\N	\N	1	0	3
16	Date of dose C must be a future date	Rule to check if Date of dose C is a future date	ERROR_DOSEC_DATEFUTURE	f	16	\N	2023-12-11	\N	\N	1	0	3
17	Must be pre-reference dose B + 1 day	Rule to check if pre-reference dose B + 1 day	ERROR_DOSEC_DATEDIF_DOSEB	f	17	\N	2023-12-11	\N	\N	1	0	3
18	time of dose C Cannot be blank	Rule to check if time of dose C is a future date	ERROR_DOSEC_TIME_ISBLANK	f	18	\N	2023-12-11	\N	\N	1	0	3
19	Estimated Time of dose C Cannot be blank	Rule to check if Estimated Time of dose C is a future date	ERROR_DOSEC_ESTIMATEDTIME_ISBLANK	f	19	\N	2023-12-11	\N	\N	1	0	3
20	Vomiting of dose C Cannot be blank	Rule to check if Vomiting of dose C is a future date	ERROR_DOSEC_VOMITING_ISBLANK	f	20	\N	2023-12-11	\N	\N	1	0	3
21	Food Consumed cannot be blank	Rule to check if food consumed is blank	ERROR_FOODCONSUMED_ISBLANK	f	21	\N	2023-12-11	\N	\N	1	0	3
22	Food Cannot be blank, if Food Consumed =yes	Rule to check if Food within + 1 Hour of Dose is blank when food consumed = yes	ERROR_FOOD_ISBLANK	f	22	\N	2023-12-11	\N	\N	1	0	3
23	Quantity Cannot be blank, if Food Consumed =yes	Rule to check if Quantity within + 1 Hour of Dose is blank when food consumed = yes	ERROR_QTY_ISBLANK	f	23	\N	2023-12-11	\N	\N	1	0	3
24	Unit Cannot be blank, if Food Consumed =yes	Rule to check if Unit within + 1 Hour of Dose is blank when food consumed = yes	ERROR_UNIT_ISBLANK	f	24	\N	2023-12-11	\N	\N	1	0	3
25	Time Cannot be blank, if Food Consumed =yes	Rule to check if Time within + 1 Hour of Dose is blank when food consumed = yes	ERROR_TIME_ISBLANK	f	25	\N	2023-12-11	\N	\N	1	0	3
26	Estimated time cannot be blank, if Food Consumed =yes	Rule to check if Estimated time within + 1 Hour of Dose is blank when food consumed = yes	ERROR_ESTIMATED_ISBLANK	f	26	\N	2023-12-11	\N	\N	1	0	3
27	Last Meal day Cannot be blank, if Food Consumed = No or Unknown	Rule to check if Last Meal day is blank when Food Consumed = No or Unknown	ERROR_LMDAY_ISBLANK	f	27	\N	2023-12-11	\N	\N	1	0	3
28	Last Meal time Cannot be blank, if Food Consumed = No or Unknown	Rule to check if Last Meal time is blank when Food Consumed = No or Unknown	ERROR_LMTIME_ISBLANK	f	28	\N	2023-12-11	\N	\N	1	0	3
29	Last Meal estimated time Cannot be blank, if Food Consumed = No or Unknown	Rule to check if Last Meal estimated time is blank when Food Consumed = No or Unknown	ERROR_LMESTIMATEDTIME_ISBLANK	f	29	\N	2023-12-11	\N	\N	1	0	3
30	Did participant abstain from alcohol for at least 48 hours prior to PK sampling?	Rule to check if participant abstain from alcohol for at least 48 hours prior to PK sampling	ERROR_DIDPARTICI_ABSFOR48HR_ISBLANK	f	30	\N	2023-12-11	\N	\N	1	0	3
31	 1A Actual blood collection time Cannot be blank, if Not done is not selected	Rule to check if 1A Actual blood collection time is blank when Not done is not selected	ERROR_1AACTBLOOD_COLLECTIONTIME_ISBLANK	f	31	\N	2023-12-11	\N	\N	1	0	3
32	1A Time blood placed in centrifuge Cannot be blank, if Not done is not selected	Rule to check if 1A Time blood placed in centrifuge is blank when Not done is not selected	ERROR_1ATIMEBLOODPLACED_CENTRIF_ISBLANK	f	32	\N	2023-12-11	\N	\N	1	0	3
33	1A Time plasma placed in -70 freezer Cannot be blank, if Not done is not selected	Rule to check if 1A Time plasma placed in -70 freezer is blank when Not done is not selected	ERROR_1ATIMEPLASMAPLACED_LESS70_ISBLANK	f	33	\N	2023-12-11	\N	\N	1	0	3
34	1A Blood collection to freezing time > 2 hrs Cannot be blank, if Not done is not selected	Rule to check if 1A Blood collection to freezing time gt 2 hrs is blank when Not done is not selected	ERROR_1ABLOODCOLLECT_FREEZUP2_ISBLANK	f	34	\N	2023-12-11	\N	\N	1	0	3
35	 1B Actual blood collection time Cannot be blank, if Not done is not selected	Rule to check if 1B Actual blood collection time is blank when Not done is not selected	ERROR_1BACTBLOOD_COLLECTIONTIME_ISBLANK	f	35	\N	2023-12-11	\N	\N	1	0	3
36	1B Time blood placed in centrifuge Cannot be blank, if Not done is not selected	Rule to check if 1B Time blood placed in centrifuge is blank when Not done is not selected	ERROR_1BTIMEBLOODPLACED_CENTRIF_ISBLANK	f	36	\N	2023-12-11	\N	\N	1	0	3
37	1B Time plasma placed in -70 freezer Cannot be blank, if Not done is not selected	Rule to check if 1B Time plasma placed in -70 freezer is blank when Not done is not selected	ERROR_1BTIMEPLASMAPLACED_LESS70_ISBLANK	f	37	\N	2023-12-11	\N	\N	1	0	3
38	1B Blood collection to freezing time > 2 hrs Cannot be blank, if Not done is not selected	Rule to check if 1B Blood collection to freezing time gt 2 hrs is blank when Not done is not selected	ERROR_1BBLOODCOLLECT_FREEZUP2_ISBLANK	f	38	\N	2023-12-11	\N	\N	1	0	3
39	 1C Actual blood collection time Cannot be blank, if Not done is not selected	Rule to check if 1C Actual blood collection time is blank when Not done is not selected	ERROR_1CACTBLOOD_COLLECTIONTIME_ISBLANK	f	39	\N	2023-12-11	\N	\N	1	0	3
40	1C Time blood placed in centrifuge Cannot be blank, if Not done is not selected	Rule to check if 1C Time blood placed in centrifuge is blank when Not done is not selected	ERROR_1CTIMEBLOODPLACED_CENTRIF_ISBLANK	f	40	\N	2023-12-11	\N	\N	1	0	3
41	1C Time plasma placed in -70 freezer Cannot be blank, if Not done is not selected	Rule to check if 1C Time plasma placed in -70 freezer is blank when Not done is not selected	ERROR_1CTIMEPLASMAPLACED_LESS70_ISBLANK	f	41	\N	2023-12-11	\N	\N	1	0	3
42	1C Blood collection to freezing time > 2 hrs Cannot be blank, if Not done is not selected	Rule to check if 1C Blood collection to freezing time gt 2 hrs is blank when Not done is not selected	ERROR_1CBLOODCOLLECT_FREEZUP2_ISBLANK	f	42	\N	2023-12-11	\N	\N	1	0	3
43	Comments is required when Blood collection to -70C freezer time GT 2 hrs*, D1a, b and c  = Yes.	Rule to check  If Blood collection to -70C freezer time GT 2 hrs*, D1a, b and c  = Yes.	ERROR_COMMENTS_ISBLANK	f	43	\N	2023-12-11	\N	\N	1	0	3
44	2a1 TBTC label numberc cannot be blank 	Rule to check if 2a1 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2A1TBTNUMBER_ISBLANK	f	44	\N	2023-12-11	\N	\N	1	0	3
45	2a2 TBTC label numberc cannot be blank 	Rule to check if 2a2 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2A2TBTNUMBER_ISBLANK	f	45	\N	2023-12-11	\N	\N	1	0	3
46	2a3 TBTC label numberc cannot be blank 	Rule to check if 2a3 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2A3TBTNUMBER_ISBLANK	f	46	\N	2023-12-11	\N	\N	1	0	3
47	2a4 TBTC label numberc cannot be blank 	Rule to check if 2a4 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2A4TBTNUMBER_ISBLANK	f	47	\N	2023-12-11	\N	\N	1	0	3
48	2b1 TBTC label numberc cannot be blank 	Rule to check if 2b1 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2B1TBTNUMBER_ISBLANK	f	48	\N	2023-12-11	\N	\N	1	0	3
49	2b2 TBTC label numberc cannot be blank 	Rule to check if 2b2 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2B2TBTNUMBER_ISBLANK	f	49	\N	2023-12-11	\N	\N	1	0	3
50	2b3 TBTC label numberc cannot be blank 	Rule to check if 2b3 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2B3TBTNUMBER_ISBLANK	f	50	\N	2023-12-11	\N	\N	1	0	3
51	2b4 TBTC label numberc cannot be blank 	Rule to check if 2b4 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2B4TBTNUMBER_ISBLANK	f	51	\N	2023-12-11	\N	\N	1	0	3
52	2c1 TBTC label numberc cannot be blank 	Rule to check if 2c1 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2C1TBTNUMBER_ISBLANK	f	52	\N	2023-12-11	\N	\N	1	0	3
53	2c2 TBTC label numberc cannot be blank 	Rule to check if 2c2 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2C2TBTNUMBER_ISBLANK	f	53	\N	2023-12-11	\N	\N	1	0	3
54	2c3 TBTC label numberc cannot be blank 	Rule to check if 2c3 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2C3TBTNUMBER_ISBLANK	f	54	\N	2023-12-11	\N	\N	1	0	3
55	2c4 TBTC label numberc cannot be blank 	Rule to check if 2c4 TBTC label numberc cannot be blank when Not done is not selected	ERROR_2C4TBTNUMBER_ISBLANK	f	55	\N	2023-12-11	\N	\N	1	0	3
56	name of Person completing the form cannot be blank	Rule to check if name of Person completing the form is blank	ERROR_PERSONCOMPLETING_ISBLANK	f	56	\N	2023-12-11	\N	\N	1	0	3
\.


--
-- Data for Name: rule_action; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_action (id, rule_set_rule_id, action_type, expression_evaluates_to, message, email_to, owner_id, date_created, date_updated, update_id, status_id, version, rule_action_run_id, oc_oid_reference, email_subject) FROM stdin;
1	1	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	1	\N	\N
2	2	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	2	\N	\N
3	3	1	t	[Error] Cannot be a future date	\N	\N	2023-12-11	\N	\N	1	0	3	\N	\N
4	4	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	4	\N	\N
5	5	1	t	[Error] Cannot be a future date	\N	\N	2023-12-11	\N	\N	1	0	5	\N	\N
6	6	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	6	\N	\N
7	7	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	7	\N	\N
8	8	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	8	\N	\N
9	9	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	9	\N	\N
10	10	1	t	[Error] Cannot be a future date	\N	\N	2023-12-11	\N	\N	1	0	10	\N	\N
11	11	1	t	[Error] Pre-reference dose B must be the day after Pre-reference dose A	\N	\N	2023-12-11	\N	\N	1	0	11	\N	\N
12	12	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	12	\N	\N
13	13	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	13	\N	\N
14	14	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	14	\N	\N
15	15	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	15	\N	\N
16	16	1	t	[Error] Cannot be a future date	\N	\N	2023-12-11	\N	\N	1	0	16	\N	\N
17	17	1	t	[Error] Pre-reference dose C must be the day after Pre-reference dose B	\N	\N	2023-12-11	\N	\N	1	0	17	\N	\N
18	18	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	18	\N	\N
19	19	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	19	\N	\N
20	20	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	20	\N	\N
21	21	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	21	\N	\N
22	22	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	22	\N	\N
23	23	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	23	\N	\N
24	24	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	24	\N	\N
25	25	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	25	\N	\N
26	26	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	26	\N	\N
27	27	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	27	\N	\N
28	28	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	28	\N	\N
29	29	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	29	\N	\N
30	30	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	30	\N	\N
31	31	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	31	\N	\N
32	32	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	32	\N	\N
33	33	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	33	\N	\N
34	34	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	34	\N	\N
35	35	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	35	\N	\N
36	36	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	36	\N	\N
37	37	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	37	\N	\N
38	38	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	38	\N	\N
39	39	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	39	\N	\N
40	40	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	40	\N	\N
41	41	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	41	\N	\N
42	42	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	42	\N	\N
43	43	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	43	\N	\N
44	44	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	44	\N	\N
45	45	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	45	\N	\N
46	46	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	46	\N	\N
47	47	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	47	\N	\N
48	48	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	48	\N	\N
49	49	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	49	\N	\N
50	50	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	50	\N	\N
51	51	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	51	\N	\N
52	52	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	52	\N	\N
53	53	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	53	\N	\N
54	54	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	54	\N	\N
55	55	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	55	\N	\N
56	56	1	t	[Error] This is a required field	\N	\N	2023-12-11	\N	\N	1	0	56	\N	\N
\.


--
-- Data for Name: rule_action_property; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_action_property (id, rule_action_id, oc_oid, value, version, rule_expression_id, property) FROM stdin;
\.


--
-- Data for Name: rule_action_run; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_action_run (id, administrative_data_entry, initial_data_entry, double_data_entry, import_data_entry, batch, version, not_started, scheduled, data_entry_started, complete, skipped, stopped) FROM stdin;
1	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
2	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
3	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
4	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
5	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
6	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
7	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
8	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
9	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
10	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
11	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
12	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
13	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
14	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
15	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
16	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
17	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
18	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
19	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
20	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
21	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
22	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
23	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
24	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
25	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
26	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
27	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
28	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
29	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
30	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
31	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
32	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
33	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
34	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
35	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
36	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
37	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
38	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
39	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
40	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
41	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
42	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
43	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
44	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
45	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
46	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
47	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
48	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
49	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
50	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
51	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
52	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
53	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
54	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
55	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
56	t	t	t	t	t	0	\N	\N	\N	\N	\N	\N
\.


--
-- Data for Name: rule_action_run_log; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_action_run_log (id, action_type, item_data_id, value, rule_oc_oid, version) FROM stdin;
\.


--
-- Data for Name: rule_action_stratification_factor; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_action_stratification_factor (id, rule_action_id, version, rule_expression_id) FROM stdin;
\.


--
-- Data for Name: rule_expression; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_expression (id, value, context, owner_id, date_created, date_updated, update_id, status_id, version) FROM stdin;
1	I_S38_T_VISIT eq ""	1	\N	2023-12-11	\N	\N	1	0
2	(I_S38_T_VISIT eq "UNS" ) and I_S38_T_VISDAT eq ""	1	\N	2023-12-11	\N	\N	1	0
3	I_S38_T_VISDAT gt _CURRENT_DATE	1	\N	2023-12-11	\N	\N	1	0
4	I_S38_T_AEXSTDAT eq ""	1	\N	2023-12-11	\N	\N	1	0
5	I_S38_T_AEXSTDAT gt _CURRENT_DATE	1	\N	2023-12-11	\N	\N	1	0
6	I_S38_T_AEXSTTIM eq ""	1	\N	2023-12-11	\N	\N	1	0
7	I_S38_T_AEXTMCOND eq ""	1	\N	2023-12-11	\N	\N	1	0
8	I_S38_T_ACEOCCUR eq ""	1	\N	2023-12-11	\N	\N	1	0
9	I_S38_T_BEXSTDAT eq ""	1	\N	2023-12-11	\N	\N	1	0
10	I_S38_T_BEXSTDAT gt _CURRENT_DATE	1	\N	2023-12-11	\N	\N	1	0
11	I_S38_T_BEXSTDAT ne I_S38_T_AEXSTDAT +1	1	\N	2023-12-11	\N	\N	1	0
12	I_S38_T_BEXSTTIM eq ""	1	\N	2023-12-11	\N	\N	1	0
13	I_S38_T_BEXTMCOND eq ""	1	\N	2023-12-11	\N	\N	1	0
14	I_S38_T_BCEOCCUR eq ""	1	\N	2023-12-11	\N	\N	1	0
15	I_S38_T_CEXSTDAT eq ""	1	\N	2023-12-11	\N	\N	1	0
16	I_S38_T_CEXSTDAT gt _CURRENT_DATE	1	\N	2023-12-11	\N	\N	1	0
17	I_S38_T_CEXSTDAT ne I_S38_T_BEXSTDAT +1	1	\N	2023-12-11	\N	\N	1	0
18	I_S38_T_CEXSTTIM eq ""	1	\N	2023-12-11	\N	\N	1	0
19	I_S38_T_CEXTMCOND eq ""	1	\N	2023-12-11	\N	\N	1	0
20	I_S38_T_CCEOCCUR eq ""	1	\N	2023-12-11	\N	\N	1	0
21	I_S38_T_MLCAT eq ""	1	\N	2023-12-11	\N	\N	1	0
22	(I_S38_T_MLCAT eq "Y" ) and (I_S38_T_MLTRT eq "")	1	\N	2023-12-11	\N	\N	1	0
23	(I_S38_T_MLCAT eq "Y" ) and (I_S38_T_MLDOSTXT eq "")	1	\N	2023-12-11	\N	\N	1	0
24	(I_S38_T_MLCAT eq "Y" ) and (I_S38_T_MLDOSU eq "")	1	\N	2023-12-11	\N	\N	1	0
25	(I_S38_T_MLCAT eq "Y" ) and (I_S38_T_MLSTTIM eq "")	1	\N	2023-12-11	\N	\N	1	0
26	(I_S38_T_MLCAT eq "Y" ) and (I_S38_T_MLTMCOND eq "")	1	\N	2023-12-11	\N	\N	1	0
27	((I_S38_T_MLCAT eq "N") or (I_S38_T_MLCAT eq "U")) and I_S38_T_AMLSTDAT eq ""	1	\N	2023-12-11	\N	\N	1	0
28	((I_S38_T_MLCAT eq "N") or (I_S38_T_MLCAT eq "U")) and I_S38_T_AMLSTTIM eq ""	1	\N	2023-12-11	\N	\N	1	0
29	((I_S38_T_MLCAT eq "N") or (I_S38_T_MLCAT eq "U")) and I_S38_T_AMLTMCOND eq ""	1	\N	2023-12-11	\N	\N	1	0
30	(I_S38_T_SUOCCUR eq "" )	1	\N	2023-12-11	\N	\N	1	0
31	(I_S38_T_BESTAT eq "" ) and (I_S38_T_BETIMA eq "")	1	\N	2023-12-11	\N	\N	1	0
32	(I_S38_T_BESTAT eq "" ) and (I_S38_T_BETIMB eq "")	1	\N	2023-12-11	\N	\N	1	0
33	(I_S38_T_BESTAT eq "" ) and (I_S38_T_BETIMC eq "")	1	\N	2023-12-11	\N	\N	1	0
34	(I_S38_T_BESTAT eq "" ) and (I_S38_T_BEOCCUR eq "")	1	\N	2023-12-11	\N	\N	1	0
35	(I_S38_T_BBESTAT eq "" ) and (I_S38_T_BBETIMA eq "")	1	\N	2023-12-11	\N	\N	1	0
36	(I_S38_T_BBESTAT eq "" ) and (I_S38_T_BBETIMB eq "")	1	\N	2023-12-11	\N	\N	1	0
37	(I_S38_T_BBESTAT eq "" ) and (I_S38_T_BBETIMC eq "")	1	\N	2023-12-11	\N	\N	1	0
38	(I_S38_T_BBESTAT eq "" ) and (I_S38_T_BBEOCCUR eq "")	1	\N	2023-12-11	\N	\N	1	0
39	(I_S38_T_CBESTAT eq "" ) and (I_S38_T_CBETIMA eq "")	1	\N	2023-12-11	\N	\N	1	0
40	(I_S38_T_CBESTAT eq "" ) and (I_S38_T_CBETIMB eq "")	1	\N	2023-12-11	\N	\N	1	0
41	(I_S38_T_CBESTAT eq "" ) and (I_S38_T_CBETIMC eq "")	1	\N	2023-12-11	\N	\N	1	0
42	(I_S38_T_CBESTAT eq "" ) and (I_S38_T_CBEOCCUR eq "")	1	\N	2023-12-11	\N	\N	1	0
43	((I_S38_T_BEOCCUR eq "Y" ) or (I_S38_T_BBEOCCUR eq "Y" ) or (I_S38_T_CBEOCCUR eq "Y" )) and I_S38_T_COVAL eq ""	1	\N	2023-12-11	\N	\N	1	0
44	(I_S38_T_AABESTAT eq "" ) and (I_S38_T_AABEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
45	(I_S38_T_AABESTAT eq "" ) and (I_S38_T_ABBEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
46	(I_S38_T_AABESTAT eq "" ) and (I_S38_T_ACBEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
47	(I_S38_T_AABESTAT eq "" ) and (I_S38_T_ADBEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
48	(I_S38_T_BBBESTAT eq "" ) and (I_S38_T_BABEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
49	(I_S38_T_BBBESTAT eq "" ) and (I_S38_T_BBBEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
50	(I_S38_T_BBBESTAT eq "" ) and (I_S38_T_BCBEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
51	(I_S38_T_BBBESTAT eq "" ) and (I_S38_T_BDBEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
52	(I_S38_T_CCBESTAT eq "" ) and (I_S38_T_CABEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
53	(I_S38_T_CCBESTAT eq "" ) and (I_S38_T_CBBEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
54	(I_S38_T_CCBESTAT eq "" ) and (I_S38_T_CCBEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
55	(I_S38_T_CCBESTAT eq "" ) and (I_S38_T_CDBEREFID eq "")	1	\N	2023-12-11	\N	\N	1	0
56	I_S38_T_ZCNAME eq ""	1	\N	2023-12-11	\N	\N	1	0
57	I_S38_T_VISIT	1	\N	2023-12-11	\N	\N	1	0
58	I_S38_T_VISDAT	1	\N	2023-12-11	\N	\N	1	0
59	I_S38_T_AEXSTDAT	1	\N	2023-12-11	\N	\N	1	0
60	I_S38_T_AEXSTTIM	1	\N	2023-12-11	\N	\N	1	0
61	I_S38_T_AEXTMCOND	1	\N	2023-12-11	\N	\N	1	0
62	I_S38_T_ACEOCCUR	1	\N	2023-12-11	\N	\N	1	0
63	I_S38_T_BEXSTDAT	1	\N	2023-12-11	\N	\N	1	0
64	I_S38_T_BEXSTTIM	1	\N	2023-12-11	\N	\N	1	0
65	I_S38_T_BEXTMCOND	1	\N	2023-12-11	\N	\N	1	0
66	I_S38_T_BCEOCCUR	1	\N	2023-12-11	\N	\N	1	0
67	I_S38_T_CEXSTDAT	1	\N	2023-12-11	\N	\N	1	0
68	I_S38_T_CEXSTTIM	1	\N	2023-12-11	\N	\N	1	0
69	I_S38_T_CEXTMCOND	1	\N	2023-12-11	\N	\N	1	0
70	I_S38_T_CCEOCCUR	1	\N	2023-12-11	\N	\N	1	0
71	I_S38_T_MLCAT	1	\N	2023-12-11	\N	\N	1	0
72	I_S38_T_MLTRT	1	\N	2023-12-11	\N	\N	1	0
73	I_S38_T_MLDOSTXT	1	\N	2023-12-11	\N	\N	1	0
74	I_S38_T_MLDOSU	1	\N	2023-12-11	\N	\N	1	0
75	I_S38_T_MLSTTIM	1	\N	2023-12-11	\N	\N	1	0
76	I_S38_T_MLTMCOND	1	\N	2023-12-11	\N	\N	1	0
77	I_S38_T_AMLSTDAT	1	\N	2023-12-11	\N	\N	1	0
78	I_S38_T_AMLSTTIM	1	\N	2023-12-11	\N	\N	1	0
79	I_S38_T_AMLTMCOND	1	\N	2023-12-11	\N	\N	1	0
80	I_S38_T_SUOCCUR	1	\N	2023-12-11	\N	\N	1	0
81	I_S38_T_BETIMA	1	\N	2023-12-11	\N	\N	1	0
82	I_S38_T_BETIMB	1	\N	2023-12-11	\N	\N	1	0
83	I_S38_T_BETIMC	1	\N	2023-12-11	\N	\N	1	0
84	I_S38_T_BEOCCUR	1	\N	2023-12-11	\N	\N	1	0
85	I_S38_T_BBETIMA	1	\N	2023-12-11	\N	\N	1	0
86	I_S38_T_BBETIMB	1	\N	2023-12-11	\N	\N	1	0
87	I_S38_T_BBETIMC	1	\N	2023-12-11	\N	\N	1	0
88	I_S38_T_BBEOCCUR	1	\N	2023-12-11	\N	\N	1	0
89	I_S38_T_CBETIMA	1	\N	2023-12-11	\N	\N	1	0
90	I_S38_T_CBETIMB	1	\N	2023-12-11	\N	\N	1	0
91	I_S38_T_CBETIMC	1	\N	2023-12-11	\N	\N	1	0
92	I_S38_T_CBEOCCUR	1	\N	2023-12-11	\N	\N	1	0
93	I_S38_T_AABEREFID	1	\N	2023-12-11	\N	\N	1	0
94	I_S38_T_ABBEREFID	1	\N	2023-12-11	\N	\N	1	0
95	I_S38_T_ACBEREFID	1	\N	2023-12-11	\N	\N	1	0
96	I_S38_T_ADBEREFID	1	\N	2023-12-11	\N	\N	1	0
97	I_S38_T_BABEREFID	1	\N	2023-12-11	\N	\N	1	0
98	I_S38_T_BBBEREFID	1	\N	2023-12-11	\N	\N	1	0
99	I_S38_T_BCBEREFID	1	\N	2023-12-11	\N	\N	1	0
100	I_S38_T_BDBEREFID	1	\N	2023-12-11	\N	\N	1	0
101	I_S38_T_CABEREFID	1	\N	2023-12-11	\N	\N	1	0
102	I_S38_T_CBBEREFID	1	\N	2023-12-11	\N	\N	1	0
103	I_S38_T_CCBEREFID	1	\N	2023-12-11	\N	\N	1	0
104	I_S38_T_CDBEREFID	1	\N	2023-12-11	\N	\N	1	0
105	I_S38_T_COVAL	1	\N	2023-12-11	\N	\N	1	0
106	I_S38_T_ZCNAME	1	\N	2023-12-11	\N	\N	1	0
\.


--
-- Data for Name: rule_set; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_set (id, rule_expression_id, study_event_definition_id, crf_id, crf_version_id, study_id, owner_id, date_created, date_updated, update_id, status_id, version, item_id, item_group_id, run_schedule, run_time) FROM stdin;
1	57	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	867	\N	f	\N
2	58	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	868	\N	f	\N
3	59	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	869	\N	f	\N
4	60	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	870	\N	f	\N
5	61	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	871	\N	f	\N
6	62	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	872	\N	f	\N
7	63	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	873	\N	f	\N
8	64	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	874	\N	f	\N
9	65	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	875	\N	f	\N
10	66	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	876	\N	f	\N
11	67	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	877	\N	f	\N
12	68	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	878	\N	f	\N
13	69	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	879	\N	f	\N
14	70	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	880	\N	f	\N
15	71	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	881	\N	f	\N
16	72	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	882	\N	f	\N
17	73	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	883	\N	f	\N
18	74	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	884	\N	f	\N
19	75	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	885	\N	f	\N
20	76	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	886	\N	f	\N
21	77	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	887	\N	f	\N
22	78	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	888	\N	f	\N
23	79	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	889	\N	f	\N
24	80	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	890	\N	f	\N
25	81	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	892	\N	f	\N
26	82	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	893	\N	f	\N
27	83	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	894	\N	f	\N
28	84	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	895	\N	f	\N
29	85	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	897	\N	f	\N
30	86	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	898	\N	f	\N
31	87	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	899	\N	f	\N
32	88	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	900	\N	f	\N
33	89	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	902	\N	f	\N
34	90	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	903	\N	f	\N
35	91	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	904	\N	f	\N
36	92	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	905	\N	f	\N
37	93	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	907	\N	f	\N
38	94	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	908	\N	f	\N
39	95	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	909	\N	f	\N
40	96	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	910	\N	f	\N
41	97	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	912	\N	f	\N
42	98	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	913	\N	f	\N
43	99	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	914	\N	f	\N
44	100	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	915	\N	f	\N
45	101	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	917	\N	f	\N
46	102	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	918	\N	f	\N
47	103	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	919	\N	f	\N
48	104	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	920	\N	f	\N
49	105	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	921	\N	f	\N
50	106	\N	\N	\N	3	\N	2023-12-11	\N	\N	1	0	922	\N	f	\N
\.


--
-- Data for Name: rule_set_audit; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_set_audit (id, rule_set_id, date_updated, updater_id, status_id, version) FROM stdin;
\.


--
-- Data for Name: rule_set_rule; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_set_rule (id, rule_set_id, rule_id, owner_id, date_created, date_updated, update_id, status_id, version) FROM stdin;
1	1	1	\N	2023-12-11	\N	\N	1	0
2	2	2	\N	2023-12-11	\N	\N	1	0
3	2	3	\N	2023-12-11	\N	\N	1	0
4	3	4	\N	2023-12-11	\N	\N	1	0
5	3	5	\N	2023-12-11	\N	\N	1	0
6	4	6	\N	2023-12-11	\N	\N	1	0
7	5	7	\N	2023-12-11	\N	\N	1	0
8	6	8	\N	2023-12-11	\N	\N	1	0
9	7	9	\N	2023-12-11	\N	\N	1	0
10	7	10	\N	2023-12-11	\N	\N	1	0
11	7	11	\N	2023-12-11	\N	\N	1	0
12	8	12	\N	2023-12-11	\N	\N	1	0
13	9	13	\N	2023-12-11	\N	\N	1	0
14	10	14	\N	2023-12-11	\N	\N	1	0
15	11	15	\N	2023-12-11	\N	\N	1	0
16	11	16	\N	2023-12-11	\N	\N	1	0
17	11	17	\N	2023-12-11	\N	\N	1	0
18	12	18	\N	2023-12-11	\N	\N	1	0
19	13	19	\N	2023-12-11	\N	\N	1	0
20	14	20	\N	2023-12-11	\N	\N	1	0
21	15	21	\N	2023-12-11	\N	\N	1	0
22	16	22	\N	2023-12-11	\N	\N	1	0
23	17	23	\N	2023-12-11	\N	\N	1	0
24	18	24	\N	2023-12-11	\N	\N	1	0
25	19	25	\N	2023-12-11	\N	\N	1	0
26	20	26	\N	2023-12-11	\N	\N	1	0
27	21	27	\N	2023-12-11	\N	\N	1	0
28	22	28	\N	2023-12-11	\N	\N	1	0
29	23	29	\N	2023-12-11	\N	\N	1	0
30	24	30	\N	2023-12-11	\N	\N	1	0
31	25	31	\N	2023-12-11	\N	\N	1	0
32	26	32	\N	2023-12-11	\N	\N	1	0
33	27	33	\N	2023-12-11	\N	\N	1	0
34	28	34	\N	2023-12-11	\N	\N	1	0
35	29	35	\N	2023-12-11	\N	\N	1	0
36	30	36	\N	2023-12-11	\N	\N	1	0
37	31	37	\N	2023-12-11	\N	\N	1	0
38	32	38	\N	2023-12-11	\N	\N	1	0
39	33	39	\N	2023-12-11	\N	\N	1	0
40	34	40	\N	2023-12-11	\N	\N	1	0
41	35	41	\N	2023-12-11	\N	\N	1	0
42	36	42	\N	2023-12-11	\N	\N	1	0
43	37	44	\N	2023-12-11	\N	\N	1	0
44	38	45	\N	2023-12-11	\N	\N	1	0
45	39	46	\N	2023-12-11	\N	\N	1	0
46	40	47	\N	2023-12-11	\N	\N	1	0
47	41	48	\N	2023-12-11	\N	\N	1	0
48	42	49	\N	2023-12-11	\N	\N	1	0
49	43	50	\N	2023-12-11	\N	\N	1	0
50	44	51	\N	2023-12-11	\N	\N	1	0
51	45	52	\N	2023-12-11	\N	\N	1	0
52	46	53	\N	2023-12-11	\N	\N	1	0
53	47	54	\N	2023-12-11	\N	\N	1	0
54	48	55	\N	2023-12-11	\N	\N	1	0
55	49	43	\N	2023-12-11	\N	\N	1	0
56	50	56	\N	2023-12-11	\N	\N	1	0
\.


--
-- Data for Name: rule_set_rule_audit; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.rule_set_rule_audit (id, rule_set_rule_id, date_updated, updater_id, status_id, version) FROM stdin;
\.


--
-- Data for Name: scd_item_metadata; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.scd_item_metadata (id, scd_item_form_metadata_id, control_item_form_metadata_id, control_item_name, option_value, message, version) FROM stdin;
7	81	80	ZFDIFFDX	Y	Indicate reportable adverse event.	\N
8	83	82	ZFSER	Y	Indicate type of SAE.	\N
9	89	88	ZFREL	DEFINITE	Indicate type of SAE.	\N
10	103	102	RPTEST	Live Birth	Indicate congenital anomalies.	\N
130	3139	3138	VISIT	UNS	Date of Visit	\N
12	152	151	PRCDTH	Y	List the primary cause(s) of death.	\N
13	160	159	PMPEX	Y	Provide microscopic and histologic details in Section B	\N
131	3183	3182	BEOCCURFR	Y	Specimens Thawed Before Shipping	\N
132	3184	3183	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
133	3185	3183	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
134	3186	3183	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
135	3187	3183	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
269	4770	4769	VISIT	UNS	Date of Visit	\N
142	3247	3246	VISIT	UNS	Date of Visit	\N
143	3291	3290	BEOCCURFR	Y	Specimens Thawed Before Shipping	\N
144	3292	3291	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
145	3293	3291	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
29	236	235	RACENR	OTHER	Specify	\N
30	243	242	MHCAT	Y	Specify Mental Health	\N
31	245	244	MHSCAT	Y	Specify Mental illness	\N
32	247	246	MHTRAUMA	Y	Specify Mental illness	\N
33	249	248	MHCHANGE	Y	Specify Mental illness	\N
34	260	259	TBPRIORTX	Y	the most recent month and year	\N
35	263	262	EXTRATB	Y	Specify the system organ class	\N
36	271	270	DIABETES	Y	Specify diabetes type	\N
37	272	270	DIABETES	Y	year diabetes was diagnosed	\N
38	273	270	DIABETES	Y	diabetes diagnosis available	\N
39	274	270	DIABETES	Y	taking any antidiabetic medications	\N
40	277	276	CANCER	Y	Specify Mental Health	\N
41	279	278	CARDIAC	Y	Specify Mental Health	\N
42	284	283	MHTERMART	Y	year was ART initiated	\N
43	285	283	MHTERMART	Y	the participant taking any antiretroviral	\N
44	299	298	RACENR	OTHER	Specify	\N
45	304	303	HIV	OTHERCOND	Specify	\N
146	3294	3291	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
47	358	357	STDYEVAL	POSSIBLE_POOR_TB_TREATMENT_RESPONSE	Only enter Sequence ID in the case of possible poor TB treatment response	\N
48	359	357	STDYEVAL	UNSCHEDULED	Only enter date in the case of unscheduled visit	\N
49	364	363	ALIQMADE	Y	Only enter data if there were aliquots made	\N
50	365	363	ALIQMADE	Y	Only enter data if there were aliquots made	\N
51	463	462	ZISER	Y	Indicate type of SAE.	\N
52	484	483	ZNCAT	Y	Indicate Ultrasound Detail.	\N
53	485	483	ZNCAT	Y	Indicate Ultrasound Detail.	\N
54	549	548	ZISER	Y	Indicate type of SAE.	\N
55	569	568	RPMETHOD	OTHER	Indicate Other.	\N
56	571	570	ZNCAT	Y	Indicate Ultrasound Detail.	\N
57	572	570	ZNCAT	Y	Indicate Ultrasound Detail.	\N
58	648	647	VISDAT	PPTR	Specify	\N
59	649	647	VISDAT	UNS	Specify	\N
60	771	770	DSPWCR	WITHDRAWAL BY SUBJECT	Specify reason	\N
147	3295	3291	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
63	830	829	ZNTERMMB	Y	Wrong value has been entered	\N
64	869	868	STDYEVAL	POSSIBLE_POOR_TB_TREATMENT_RESPONSE	Only enter Sequence ID in the case of possible poor TB treatment response	\N
65	870	868	STDYEVAL	UNSCHEDULED	Only enter date in the case of unscheduled visit	\N
66	875	874	ALIQMADE	Y	Only enter data if there were aliquots made	\N
67	876	874	ALIQMADE	Y	Only enter data if there were aliquots made	\N
272	4887	4886	PRCDTH	Y	List the primary cause(s) of death.	\N
273	4895	4894	PMPEX	Y	Provide microscopic and histologic details in Section B	\N
156	3345	3344	XDOCCUR	Y	No longer relevant	\N
76	1095	1094	VISIT	UNS	Date of Visit	\N
77	1152	1151	VISIT	UNS	Date of Visit	\N
78	1217	1216	ZNTERMMB	Y	Wrong value has been entered	\N
157	3346	3344	XDOCCUR	Y	No longer relevant	\N
158	3347	3344	XDOCCUR	Y	No longer relevant	\N
159	3348	3344	XDOCCUR	Y	No longer relevant	\N
160	3349	3344	XDOCCUR	Y	No longer relevant	\N
161	3350	3344	XDOCCUR	Y	No longer relevant	\N
162	3351	3344	XDOCCUR	Y	No longer relevant	\N
163	3352	3344	XDOCCUR	Y	No longer relevant	\N
164	3358	3357	ZFDIFFDX	Y	[Error]  Data is No longer relevant.	\N
165	3360	3359	ZFSER	Y	[Error]  Data is No longer relevant.	\N
166	3361	3359	ZFSER	Y	[Error]  Data is No longer relevant.	\N
167	3362	3359	ZFSER	Y	[Error]  Data is No longer relevant.	\N
168	3366	3365	ZFREL	DEFINITE	[Error]  Data is No longer relevant.	\N
169	3380	3379	RPTEST	Live Birth	Indicate congenital anomalies.	\N
93	2059	2058	VISIT	UNS	Date of Visit	\N
94	2103	2102	BEOCCURFR	Y	Specimens Thawed Before Shipping	\N
95	2104	2103	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
96	2105	2103	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
97	2106	2103	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
98	2107	2103	BEOCCURTH	Y	Specimens Thawed Before Shipping	\N
110	2751	2750	VISIT	UNS	Date of Visit	\N
111	2858	2857	DSTERM	OTHER	Specify	\N
206	3607	3606	VISIT	UNS	Date of Visit	\N
255	3982	3981	ZFDIFFDX	Y	[Error]  Data is No longer relevant.	\N
256	3984	3983	ZFSER	Y	[Error]  Data is No longer relevant.	\N
257	3985	3983	ZFSER	Y	[Error]  Data is No longer relevant.	\N
258	3986	3983	ZFSER	Y	[Error]  Data is No longer relevant.	\N
259	3990	3989	ZFREL	DEFINITE	[Error]  Data is No longer relevant.	\N
260	4004	4003	RPTEST	Live Birth	Indicate congenital anomalies.	\N
360	5594	5592	RACE	OTHER	Specify	\N
361	5618	5617	TBPRIORTX	Y	the most recent month and year	\N
362	5622	5621	EXTRATB	Y	Specify the system organ class	\N
363	5648	5647	MHTERMART	Y	year was ART initiated	\N
364	5650	5647	MHTERMART	Y	the participant taking any antiretroviral	\N
\.


--
-- Data for Name: section; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.section (section_id, crf_version_id, status_id, label, title, subtitle, instructions, page_number_label, ordinal, parent_id, date_created, date_updated, owner_id, update_id, borders) FROM stdin;
218	96	1	Completion	Study Treatment Completion		Complete this form when participant has completed or permanently discontinued TB treatment.  Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.		1	0	2023-12-18	\N	4	\N	0
219	96	1	Storage	Storage of Blood Specimens		Complete this form when participant has completed or permanently discontinued TB treatment.  Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.		2	0	2023-12-18	\N	4	\N	0
220	96	1	Comments	Comments and Form Completion		Complete this form when participant has completed or permanently discontinued TB treatment.  Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.		3	0	2023-12-18	\N	4	\N	0
235	101	1	Completion	Comments and Form completion		Complete this form at each study evaluation during TB treatment. Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2021) </b>. Verify participant locator information and document any changes on the site’s locator form.\n\n<ul>\n<li> Visits at Weeks 1,2,3,4,6,8,10,12,14,17 and 22 must be &pm; 3 days of scheduled visit </li>\n<li> Visit at Week 26 must be &pm;7 days of scheduled visit </li>\n<p><li> Visits at Weeks 22 and 26: \n  <ul>\n     <li>Complete the Treatment Evaluation (TX) form for participats taking regimen 3 (RHZE/RH) only</li>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD)</li>\n  </ul>\n</li></p>\n\n</ul>		3	0	2023-12-18	\N	4	\N	0
29	9	7	History	Participant History		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). Refer to the Study 38 MOOP (Section TBD) for detailed instructions for form completion.		1	0	2023-12-04	2023-12-22	4	4	0
30	9	7	Tuberculosis	Tuberculosis (TB) History and Treatment		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). Refer to the Study 38 MOOP (Section TBD) for detailed instructions for form completion.		2	0	2023-12-04	2023-12-22	4	4	0
31	9	7	Concomitant	Concomitant Diagnoses at the Time of TB Diagnosis		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). Refer to the Study 38 MOOP (Section TBD) for detailed instructions for form completion.		3	0	2023-12-04	2023-12-22	4	4	0
259	110	7	Pregnancy	Pregnancy-Specific Information		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		4	0	2023-12-19	2023-12-19	4	4	0
149	60	7	Completion	Completion of the study follow up		Complete this form when participant has completed study follow-up, discontinued study follow-up, or permanently departed from the study. Record all dates in the following format: \nDD-MMM-YYYY <strong>(e.g., 01-JAN-2022).</strong>		1	0	2023-12-10	2023-12-10	4	4	0
150	60	7	Storage	Storage of Blood Specimens		Complete this form when participant has completed study follow-up, discontinued study follow-up, or permanently departed from the study. Record all dates in the following format: \nDD-MMM-YYYY <strong>(e.g., 01-JAN-2022).</strong>		2	0	2023-12-10	2023-12-10	4	4	0
151	61	1	Completion	Completion of the study follow up		Complete this form when participant has completed study follow-up, discontinued study follow-up, or permanently departed from the study. Record all dates in the following format: \nDD-MMM-YYYY <strong>(e.g., 01-JAN-2022).</strong>		1	0	2023-12-10	\N	4	\N	0
152	61	1	Storage	Storage of Blood Specimens		Complete this form when participant has completed study follow-up, discontinued study follow-up, or permanently departed from the study. Record all dates in the following format: \nDD-MMM-YYYY <strong>(e.g., 01-JAN-2022).</strong>		2	0	2023-12-10	\N	4	\N	0
260	110	7	Completion	Form Completion		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		5	0	2023-12-19	2023-12-19	4	4	0
32	9	7	Infection	HIV Infection History		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). Refer to the Study 38 MOOP (Section TBD) for detailed instructions for form completion.		4	0	2023-12-04	2023-12-22	4	4	0
153	62	7	TBDrug	TB Drug Sparse PK Specimen Collection Form		<ul>\n<li>Complete this form if TB drug sparse PK specimens are collected.</li>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		1	0	2023-12-11	2023-12-11	4	4	0
154	62	7	Sampling	PK Sampling		Store 4 cryovials of plasma at each sampling point. Specimens must be frozen at -70oC or lower within 2 hours of collection.<br/>\nKeep cryovials with plasma in a slurry of ice and water prior to placement in freezer. <br/>\nIf samples cannot be placed in a -70oC or lower freezer within 2 hours of collection, freeze on dry ice for up to 12 hours. If stored on dry ice and not transferred to a -70°C freezer in ≤ 2 hours from collection, indicate “Yes” in “Blood collection to -70°C freezer time > 2 hrs” column and provide a comment in Section E		2	0	2023-12-11	2023-12-11	4	4	0
155	63	1	TBDrug	TB Drug Sparse PK Specimen Collection Form		<ul>\n<li>Complete this form if TB drug sparse PK specimens are collected.</li>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		1	0	2023-12-11	\N	4	\N	0
156	63	1	Sampling	PK Sampling		Store 4 cryovials of plasma at each sampling point. Specimens must be frozen at -70oC or lower within 2 hours of collection.<br/>\nKeep cryovials with plasma in a slurry of ice and water prior to placement in freezer. <br/>\nIf samples cannot be placed in a -70oC or lower freezer within 2 hours of collection, freeze on dry ice for up to 12 hours. If stored on dry ice and not transferred to a -70°C freezer in ≤ 2 hours from collection, indicate “Yes” in “Blood collection to -70°C freezer time > 2 hrs” column and provide a comment in Section E		2	0	2023-12-11	\N	4	\N	0
407	135	1	Completion	Form Completion		<ul>\n<li>Complete this form if TB drug intensive PK specimens are collected.</li>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		6	0	2023-12-22	\N	4	\N	0
23	7	7	Completion	Notification of Death Form		Complete this form in the event of a participant death at any time during the study. Send this form, along with copies of the death certificate and if available, an autopsy report, to the CDC. Completely obscure personal identifiers from the death certificate and autopsy report, and label the copy sent to CDC with the Participant ID.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021).</b>		1	0	2023-12-04	2023-12-22	4	4	0
14	3	1	Description	Adverse Event Description		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). For additional instructions, refer to the Study 38 Manual of Operating Procedures.		1	0	2023-12-03	\N	4	\N	0
15	3	1	Management	Management of AE		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). For additional instructions, refer to the Study 38 Manual of Operating Procedures.		2	0	2023-12-03	\N	4	\N	0
16	3	1	Comments	Comments		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). For additional instructions, refer to the Study 38 Manual of Operating Procedures.		3	0	2023-12-03	\N	4	\N	0
17	3	1	Pregnancy	Pregnancy-Specific Information		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). For additional instructions, refer to the Study 38 Manual of Operating Procedures.		4	0	2023-12-03	\N	4	\N	0
18	3	1	Completion	Form Completion		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). For additional instructions, refer to the Study 38 Manual of Operating Procedures.		5	0	2023-12-03	\N	4	\N	0
19	3	1	CDC	CDC Safety Officer Review		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). For additional instructions, refer to the Study 38 Manual of Operating Procedures.		6	0	2023-12-03	\N	4	\N	0
20	4	1	Description	Follow-up Evaluation Form		Complete this form at each follow-up evaluation visit when participant is no longer taking study treatment.  Record all dates in the following format: DD-MMM-YYYY (e.g., 01-JAN-2021).  Verify participant locator information and document any changes on the site’s locator form.\n<ul>\n     <li>Visit at Week 22 must be + 3 days of scheduled visit</li>\n     <li>Visit at Week 26 must be + 7 days of scheduled visit</li>\n     <li>Visits at weeks 39, 52, 65, 78 are for all participants and must be + 7 days of scheduled visit</li>\n     <li>Visits at Weeks 22 and 26:</li>\n     <ul>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD only.</li>\n     <li>Complete the Treatment Evaluation (TX) form for participants taking regimen 3 (RHZE/RH) only.</li>\n     <ul>\n</ul>		1	0	2023-12-03	\N	4	\N	0
239	105	7	Shipping	PK Shipping Form for TB Drug Sparse PK and Intensive PK specimens		<ul>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		1	0	2023-12-18	2023-12-19	4	4	0
22	6	7	Completion	Enrollment Form		Complete this form if participant has met all eligibility criteria and provided consent to the study.  Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2022) </b>.  A Participant ID will be generated after submission of this form.		1	0	2023-12-04	2023-12-19	4	4	0
34	10	1	Information	Patient Information		Complete this form for individuals who completed screening but not enrolled. Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.		1	0	2023-12-05	\N	4	\N	0
35	10	1	Declines	Patient declines to participate		Complete this form for individuals who completed screening but not enrolled. Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.		2	0	2023-12-05	\N	4	\N	0
33	9	7	Additional	Additional Information		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021). Refer to the Study 38 MOOP (Section TBD) for detailed instructions for form completion.		5	0	2023-12-04	2023-12-22	4	4	0
37	12	1	Section 1	TB Drug Sparse PK Screening/Eligibility Form		<b>Instructions:</b><br>\n<ul>\n    <li>Complete this form BEFORE each blood collection for sparse PK analysis.</li>\n    <li>Record all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>).</li>\n    <li>This form is to be completed and retained locally at the site. This form will not be submitted to the CDC/Clinical Research Branch via the TBTC2 Web Portal.</li>\n</ul>\n\nThis form is to screen participants for Sparse PK Screening/Eligibility. If a participant is also being screened for intensive PK sampling, complete the TB Drug Intensive PK Screening/Eligibility Form at the time of screening for Intensive PK.		1	0	2023-12-05	\N	4	\N	0
38	13	1	Section 1	TB Drug Sparse PK Screening/Eligibility Form	Study 38	<b>Instructions:</b><br>\n<ul>\n    <li>Complete this form BEFORE each blood collection for sparse PK analysis.</li>\n    <li>Record all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>).</li>\n    <li>This form is to be completed and retained locally at the site. This form will not be submitted to the CDC/Clinical Research Branch via the TBTC2 Web Portal.</li>\n</ul>\n\nThis form is to screen participants for Sparse PK Screening/Eligibility. If a participant is also being screened for intensive PK sampling, complete the TB Drug Intensive PK Screening/Eligibility Form at the time of screening for Intensive PK.		1	0	2023-12-05	\N	4	\N	0
39	14	1	Section 1	TB Drug Sparse PK Screening/Eligibility Form	Study 38	<br>\n<ul>\n    <li>Complete this form BEFORE each blood collection for sparse PK analysis.</li>\n    <li>Record all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>).</li>\n    <li>This form is to be completed and retained locally at the site. This form will not be submitted to the CDC/Clinical Research Branch via the TBTC2 Web Portal.</li>\n</ul>\n\nThis form is to screen participants for Sparse PK Screening/Eligibility. If a participant is also being screened for intensive PK sampling, complete the TB Drug Intensive PK Screening/Eligibility Form at the time of screening for Intensive PK.		1	0	2023-12-05	\N	4	\N	0
40	15	1	Section 1	TB Drug Intensive PK Screening/Eligibility Form	Study 38	<br>\n<ul>\n    <li>Complete this form BEFORE drawing any blood specimens for intensive PK analysis.</li>\n    <li>Record all dates in the following format: DD-MMM-YYYY (e.g., <b>01-JAN-2021</b>).</li>\n    <li>This form is to be completed and retained locally at the site. This form will not be submitted to the CDC/Clinical Research Branch via the TBTC2 Web Portal.</li>\n</ul>		1	0	2023-12-05	\N	4	\N	0
157	64	1	Description	Follow-up Evaluation Form		Complete this form at each follow-up evaluation visit when participant is no longer taking study treatment.  Record all dates in the following format: DD-MMM-YYYY (e.g., 01-JAN-2021).  Verify participant locator information and document any changes on the site’s locator form.\n<ul>\n     <li>Visit at Week 22 must be + 3 days of scheduled visit</li>\n     <li>Visit at Week 26 must be + 7 days of scheduled visit</li>\n     <li>Visits at weeks 39, 52, 65, 78 are for all participants and must be + 7 days of scheduled visit</li>\n     <li>Visits at Weeks 22 and 26:</li>\n     <ul>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD only.</li>\n     <li>Complete the Treatment Evaluation (TX) form for participants taking regimen 3 (RHZE/RH) only.</li>\n     <ul>\n</ul>		1	0	2023-12-11	\N	4	\N	0
42	17	7	Section 1	Concomitant Medication Form	Study 38			1	0	2023-12-05	2023-12-05	4	4	0
44	19	7	Section 1	TB Drug Dose Record Form	Study 38			1	0	2023-12-05	2023-12-05	4	4	0
45	19	7	Section 2	A. TB Drug Dose Record				2	0	2023-12-05	2023-12-05	4	4	0
158	65	7	Completion	Enrollment Form		Complete this form if participant has met all eligibility criteria and provided consent to the study.  Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2022) </b>.  A Participant ID will be generated after submission of this form.		1	0	2023-12-11	2023-12-19	5	4	0
46	20	7	Section 1	TB Drug Dose Record Form	Study 38			1	0	2023-12-05	2023-12-05	4	4	0
47	20	7	Section 2	Section 2: Dose Record				2	0	2023-12-05	2023-12-05	4	4	0
50	22	1	Shipping	Blood collection and shipping		Complete this form if a blood specimen collected for future biomarker research is shipped. <p>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</p> <p>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>. </p> <p>A separate form is required for each blood specimen collected for Future Biomarker Research being shipped.</p>		1	0	2023-12-06	\N	4	\N	0
51	22	1	Special	Special use fields		Complete this form if a blood specimen collected for future biomarker research is shipped. <p>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</p> <p>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>. </p> <p>A separate form is required for each blood specimen collected for Future Biomarker Research being shipped.</p>		2	0	2023-12-06	\N	4	\N	0
43	18	7	Section 1	Concomitant Medication Form	Study 38			1	0	2023-12-05	2023-12-09	4	4	0
93	30	7	Section D	D. Form Completion				5	0	2023-12-06	2023-12-09	4	4	0
48	21	7	Section 1	TB Drug Dose Record Form	Study 38			1	0	2023-12-05	2023-12-09	4	4	0
49	21	7	Section 2	Section 2: Dose Record				2	0	2023-12-05	2023-12-09	4	4	0
41	16	7	Section 1	Pharmacogenomic Blood Sample Form	Study 38			1	0	2023-12-05	2023-12-10	4	4	0
52	23	1	Description	Adverse Event Description		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		1	0	2023-12-06	\N	4	\N	0
53	23	1	DescriptionC	Adverse Event Description (continued)		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		2	0	2023-12-06	\N	4	\N	0
54	23	1	Management	Management of Adverse Event		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		3	0	2023-12-06	\N	4	\N	0
55	23	1	Comments	Comments		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		4	0	2023-12-06	\N	4	\N	0
56	23	1	Pregnancy	Pregnancy-Specific Information		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		5	0	2023-12-06	\N	4	\N	0
57	23	1	Completion	Form Completion		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		6	0	2023-12-06	\N	4	\N	0
58	23	1	CDC	CDC Safety Officer Review		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		7	0	2023-12-06	\N	4	\N	0
59	24	1	Shipping	Blood collection and shipping		Complete this form if a blood specimen collected for future biomarker research is shipped. Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>. A separate form is required for each blood specimen collected for Future Biomarker Research being shipped.		1	0	2023-12-06	\N	4	\N	0
60	24	1	Special	Special use fields		Complete this form if a blood specimen collected for future biomarker research is shipped. Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>. A separate form is required for each blood specimen collected for Future Biomarker Research being shipped.		2	0	2023-12-06	\N	4	\N	0
64	26	1	Description	Adverse Event Description		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		1	0	2023-12-06	\N	4	\N	0
65	26	1	DescriptionC	Adverse Event Description (continued)		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		2	0	2023-12-06	\N	4	\N	0
66	26	1	Management	Management of Adverse Event		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		3	0	2023-12-06	\N	4	\N	0
67	26	1	Comments	Comments		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		4	0	2023-12-06	\N	4	\N	0
68	26	1	Pregnancy	Pregnancy-Specific Information		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		5	0	2023-12-06	\N	4	\N	0
62	25	7	Change	Change Details and Recommendation		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		2	0	2023-12-06	2023-12-18	4	4	0
63	25	7	Completion	Comments and Form Completion				3	0	2023-12-06	2023-12-18	4	4	0
69	26	1	Completion	Form Completion		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		6	0	2023-12-06	\N	4	\N	0
70	26	1	CDC	CDC Safety Officer Review		This form must be completed when a participant has a reportable adverse event (AE) any time during the study treatment or follow-up. Only one (1) diagnosis, sign or symptom can be reported per AE Form.  Use the following format for dates: DD-MMM-YYYY (e.g., 01-JAN-2021)<p>In the event that the AE led to, or is a death, a Notification of Death Form must also be completed.  Whether the AE has resolved, an AE Follow-up Form (AF) must be completed within 45 days of the date of onset. If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal whenever there is a change in status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of a pregnancy, submit an AF Form when the outcome of pregnancy is known.  For additional instructions, refer to the Study 38 Manual of Operating Procedures.</p>		7	0	2023-12-06	\N	4	\N	0
72	27	7	Section A	A. Non-TB and Non-antiretroviral Medications				2	0	2023-12-06	2023-12-09	4	4	0
73	27	7	Section B	B. Antiretroviral Medications				3	0	2023-12-06	2023-12-09	4	4	0
74	27	7	Section C	C. Comments				4	0	2023-12-06	2023-12-09	4	4	0
75	27	7	Section D	D. Form Completion				5	0	2023-12-06	2023-12-09	4	4	0
77	28	7	Section Intro	Concomitant Medication Form	Study 38			1	0	2023-12-06	2023-12-09	4	4	0
78	28	7	Section A	A. Non-TB and Non-antiretroviral Medications				2	0	2023-12-06	2023-12-09	4	4	0
79	28	7	Section B	B. Antiretroviral Medications				3	0	2023-12-06	2023-12-09	4	4	0
80	28	7	Section C	C. Comments				4	0	2023-12-06	2023-12-09	4	4	0
81	28	7	Section D	D. Form Completion				5	0	2023-12-06	2023-12-09	4	4	0
82	28	7	Section End	List of Anti-tuberculosis and Antiretroviral Medications\n\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n\n\n\n\nAnti-tuberculosis Medications(*exception)\n\n  \n    Name\n    Abbreviation\n  \n  \n    Amikacin\n    AMK\n  \n  \n    Bedaquiline\n    BDQ\n  \n  \n    Ciprofloxacin\n    CFX\n  \n  \n    Clofazimine\n    CFZ\n  \n\n  Cilastatin\n  CLN\n\n\n  Capreomycin\n  CM\n\n\n  Cycloserine\n  CS\n\n\n  Delamanid\n  DLM\n\n\n  Ethambutol\n  E\n\n\n  Ethionamide\n  ETO\n\n\n  Gatifloxacin\n  GFX\n\n\n  Gemifloxacin\n  GEM\n\n\n  Imipenem\n  IPM\n\n\n  Isoniazid\n  H\n\n\n  Kanamycin\n  KM\n\n\n  Levofloxacin\n  LFX\n\n\n  Linezolid\n  LZD\n\n\n  Meropenem\n  MPN\n\n\n  Moxifloxacin\n  M\n\n\n  Ofloxacin\n  OFX\n\n\n  P-aminosalicylic acid\n  PAS\n\n\n  Pretomanid\n  Pa\n\n\n  Protionamide\n  PTO\n\n\n  Pyrazinamide\n  Z\n\n\n  Rifabutin\n  RBT\n\n\n  Rifampicin\n  R\n\n\n  Rifapentine\n  P\n\n\n  Sparfloxacin\n  SPR\n\n\n  Streptomycin\n  S\n\n\n  Sutezolid\n  SUT\n\n\n  Thioacetazone\n  THZ\n\n\n  Terizidone\n  TRD\n\n\n  Viomycin\n  VM\n\n\n  Pyridoxine*\n  B6\n\n\n				6	0	2023-12-06	2023-12-09	4	4	0
83	29	7	Section Intro	Concomitant Medication Form	Study 38			1	0	2023-12-06	2023-12-09	4	4	0
84	29	7	Section A	A. Non-TB and Non-antiretroviral Medications				2	0	2023-12-06	2023-12-09	4	4	0
85	29	7	Section B	B. Antiretroviral Medications				3	0	2023-12-06	2023-12-09	4	4	0
86	29	7	Section C	C. Comments				4	0	2023-12-06	2023-12-09	4	4	0
87	29	7	Section D	D. Form Completion				5	0	2023-12-06	2023-12-09	4	4	0
88	29	7	Section End	List of Anti-tuberculosis and Antiretroviral Medications	<br /><br /><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Anti-tuberculosis Medications<br />(*exception)</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n  <tr>\n    <td>Amikacin</td>\n    <td>AMK</td>\n  </tr>\n  <tr>\n    <td>Bedaquiline</td>\n    <td>BDQ</td>\n  </tr>\n  <tr>\n    <td>Ciprofloxacin</td>\n    <td>CFX</td>\n  </tr>\n  <tr>\n    <td>Clofazimine</td>\n    <td>CFZ</td>\n  </tr>\n<tr>\n  <td>Cilastatin</td>\n  <td>CLN</td>\n</tr>\n<tr>\n  <td>Capreomycin</td>\n  <td>CM</td>\n</tr>\n<tr>\n  <td>Cycloserine</td>\n  <td>CS</td>\n</tr>\n<tr>\n  <td>Delamanid</td>\n  <td>DLM</td>\n</tr>\n<tr>\n  <td>Ethambutol</td>\n  <td>E</td>\n</tr>\n<tr>\n  <td>Ethionamide</td>\n  <td>ETO</td>\n</tr>\n<tr>\n  <td>Gatifloxacin</td>\n  <td>GFX</td>\n</tr>\n</table>\n</body>			6	0	2023-12-06	2023-12-09	4	4	0
89	30	7	Section Intro	Concomitant Medication Form	Study 38			1	0	2023-12-06	2023-12-09	4	4	0
90	30	7	Section A	A. Non-TB and Non-antiretroviral Medications				2	0	2023-12-06	2023-12-09	4	4	0
91	30	7	Section B	B. Antiretroviral Medications				3	0	2023-12-06	2023-12-09	4	4	0
92	30	7	Section C	C. Comments				4	0	2023-12-06	2023-12-09	4	4	0
214	94	7	Completion	Treatment Evaluation Form		Complete this form at each study evaluation during TB treatment. Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2021) </b>. Verify participant locator information and document any changes on the site’s locator form.\n\n<ul>\n<li> Visits at Weeks 1,2,3,4,6,8,10,12,14,17 and 22 must be &pm; 3 days of scheduled visit </li>\n<li> Visit at Week 26 must be &pm;7 days of scheduled visit </li>\n<li> Visits at Weeks 22 and 26: \n  <ul>\n     <li>Complete the Treatment Evaluation (TX) form for participats taking regimen 3 (RHZE/RH) only</li>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD)</li>\n  </ul>\n</li>\n\n</ul>		1	0	2023-12-17	2023-12-18	8	4	0
189	81	7	Shipping	PK Shipping Form for TB Drug Sparse PK and Intensive PK specimens		<ul>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		1	0	2023-12-12	2023-12-18	4	4	0
245	107	1	Shipping	Visit Information and Shipping		<ul>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		1	0	2023-12-19	\N	4	\N	0
246	107	1	Cryovial A	TB Drug Sparse PK Cryovial Label Numbers		Report the TBTC Label Numbers exactly as written on the labels affixed to the aliquot cryovials. When this section is complete, skip to Section E.		2	0	2023-12-19	\N	4	\N	0
101	32	1	Visit	Future Research Blood Sample Form		<ul>\n<li>Complete this form if a blood specimen is collected for future research. </li>\n<li>Record all dates in the following format: DD-MMM-YYYY (e.g., 01-JAN-2021).</li>\n<li>Record all times in 24 hour format (e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200).</li>\n<ul>		1	0	2023-12-07	\N	4	\N	0
102	32	1	Research	Research Lab Evaluation Specimen Collection		<p style=text-indent:10px; margin-bottom: 0px;><span><strong>Note:&nbsp;</strong>Blood collected for the future research sample must be kept in the PAXgene tube upright at room temperature for minimum of 2 hours and a maximum of 72 hours before freezing. To freeze the PAXgene tube, place in an open tube rack (NOT foam/Styrofoam) at -20°C for a minimum of 24 hours then transfer to -70°C or below for long term storage</span></p></tr><tr><p style=text-indent:10px; margin-bottom: 0px;><span>1. Blood for future research sampling</span></p>		2	0	2023-12-07	\N	4	\N	0
247	107	1	Cryovial B	PK/PD TB Drug Intensive PK Cryovial Label Numbers		Report the TBTC Label Numbers exactly as written on the labels affixed to the aliquot cryovials.		3	0	2023-12-19	\N	4	\N	0
95	31	7	Section Intro	Concomitant Medication Form	Study 38			1	0	2023-12-06	2023-12-09	4	4	0
96	31	7	Section A	A. Non-TB and Non-antiretroviral Medications				2	0	2023-12-06	2023-12-09	4	4	0
97	31	7	Section B	B. Antiretroviral Medications				3	0	2023-12-06	2023-12-09	4	4	0
98	31	7	Section C	C. Comments				4	0	2023-12-06	2023-12-09	4	4	0
99	31	7	Section D	D. Form Completion				5	0	2023-12-06	2023-12-09	4	4	0
61	25	7	Details	Visit Details and Reasons		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		1	0	2023-12-06	2023-12-18	4	4	0
104	33	7	Change	Change Details and Recommendation		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		2	0	2023-12-07	2023-12-18	4	4	0
105	33	7	Completion	Comments and Form Completion		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		3	0	2023-12-07	2023-12-18	4	4	0
227	99	1	Visit	Visit		Complete this form at each study evaluation during TB treatment. Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2021) </b>. Verify participant locator information and document any changes on the site’s locator form.\n\n<ul>\n<li> Visits at Weeks 1,2,3,4,6,8,10,12,14,17 and 22 must be &pm; 3 days of scheduled visit </li>\n<li> Visit at Week 26 must be &pm;7 days of scheduled visit </li>\n<p><li> Visits at Weeks 22 and 26: \n  <ul>\n     <li>Complete the Treatment Evaluation (TX) form for participats taking regimen 3 (RHZE/RH) only</li>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD)</li>\n  </ul>\n</li></p>\n\n</ul>		1	0	2023-12-18	\N	4	\N	0
248	107	1	State	Specimen Shipping Conditions		<ul>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		4	0	2023-12-19	\N	4	\N	0
109	35	1	Evaluation	Analysis and Evaluation of PPTR		<strong>Instructions:  Submit this form as soon as possible poor treatment response evaluations are initiated, even if required evaluations are in-progress.</strong> Data reported on this form can be edited when all evaluations are complete.<p><strong>Email the Central Study Clinicians at TBTCcrush@cdc.gov as soon as a Possible Poor Treatment Response is suspected. Ideally, evaluation of the Possible Poor Treatment Response should be performed before a change or re-start of TB treatment.</strong></p>\n<p><strong>Protocol definitions of Possible Poor Treatment Response start at week 17 for all treatment arms.</strong></p><p>Record all dates in the following format:  DD-MMM-YYYY <strong>(e.g., 01-JAN-2021).</strong> Record all times in 24-hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong></p>		1	0	2023-12-07	\N	4	\N	0
110	35	1	Completion	Comments and Form Completion		<strong>Instructions:  Submit this form as soon as possible poor treatment response evaluations are initiated, even if required evaluations are in-progress.</strong> Data reported on this form can be edited when all evaluations are complete.<p><strong>Email the Central Study Clinicians at TBTCcrush@cdc.gov as soon as a Possible Poor Treatment Response is suspected. Ideally, evaluation of the Possible Poor Treatment Response should be performed before a change or re-start of TB treatment.</strong></p>\n<p><strong>Protocol definitions of Possible Poor Treatment Response start at week 17 for all treatment arms.</strong></p><p>Record all dates in the following format:  DD-MMM-YYYY <strong>(e.g., 01-JAN-2021).</strong> Record all times in 24-hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong></p>		2	0	2023-12-07	\N	4	\N	0
107	34	7	Change	Change Details and Recommendation		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		2	0	2023-12-07	2023-12-18	4	4	0
108	34	7	Completion	Comments and Form Completion		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		3	0	2023-12-07	2023-12-18	4	4	0
111	36	7	Details	Visit Details and Reasons		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		1	0	2023-12-07	2023-12-18	4	4	0
112	36	7	Change	Change Details and Recommendation		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		2	0	2023-12-07	2023-12-18	4	4	0
228	99	1	Evaluation	Evaluation and Study Treatment Status		Complete this form at each study evaluation during TB treatment. Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2021) </b>. Verify participant locator information and document any changes on the site’s locator form.\n\n<ul>\n<li> Visits at Weeks 1,2,3,4,6,8,10,12,14,17 and 22 must be &pm; 3 days of scheduled visit </li>\n<li> Visit at Week 26 must be &pm;7 days of scheduled visit </li>\n<p><li> Visits at Weeks 22 and 26: \n  <ul>\n     <li>Complete the Treatment Evaluation (TX) form for participats taking regimen 3 (RHZE/RH) only</li>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD)</li>\n  </ul>\n</li></p>\n\n</ul>		2	0	2023-12-18	\N	4	\N	0
229	99	1	Completion	Comments and Form completion		Complete this form at each study evaluation during TB treatment. Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2021) </b>. Verify participant locator information and document any changes on the site’s locator form.\n\n<ul>\n<li> Visits at Weeks 1,2,3,4,6,8,10,12,14,17 and 22 must be &pm; 3 days of scheduled visit </li>\n<li> Visit at Week 26 must be &pm;7 days of scheduled visit </li>\n<p><li> Visits at Weeks 22 and 26: \n  <ul>\n     <li>Complete the Treatment Evaluation (TX) form for participats taking regimen 3 (RHZE/RH) only</li>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD)</li>\n  </ul>\n</li></p>\n\n</ul>		3	0	2023-12-18	\N	4	\N	0
114	37	7	Follow-upCompletion	Follow-up Completion Form		Complete this form when participant has completed study follow-up, discontinued study follow-up, or permanently departed from the study. Record all dates in the following format: \nDD-MMM-YYYY <strong>(e.g., 01-JAN-2022).</strong>		1	0	2023-12-08	2023-12-11	4	4	0
249	107	1	Completion	Comments and Form Completion		<ul>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		5	0	2023-12-19	\N	4	\N	0
117	40	1	Description	Follow-up Evaluation Form		Complete this form at each follow-up evaluation visit when participant is no longer taking study treatment.  Record all dates in the following format: DD-MMM-YYYY (e.g., 01-JAN-2021).  Verify participant locator information and document any changes on the site’s locator form.\n<ul>\n     <li>Visit at Week 22 must be + 3 days of scheduled visit</li>\n     <li>Visit at Week 26 must be + 7 days of scheduled visit</li>\n     <li>Visits at weeks 39, 52, 65, 78 are for all participants and must be + 7 days of scheduled visit</li>\n     <li>Visits at Weeks 22 and 26:</li>\n     <ul>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD only.</li>\n     <li>Complete the Treatment Evaluation (TX) form for participants taking regimen 3 (RHZE/RH) only.</li>\n     <ul>\n</ul>		1	0	2023-12-09	\N	4	\N	0
118	41	1	Section Intro	Concomitant Medication Form	Study 38			1	0	2023-12-09	\N	4	\N	0
119	41	1	Section A	A. Non-TB and Non-antiretroviral Medications				2	0	2023-12-09	\N	4	\N	0
120	41	1	Section B	B. Antiretroviral Medications				3	0	2023-12-09	\N	4	\N	0
121	41	1	Section C	C. Comments				4	0	2023-12-09	\N	4	\N	0
122	41	1	Section D	D. Form Completion				5	0	2023-12-09	\N	4	\N	0
123	41	1	Section End	List of Anti-tuberculosis and Antiretroviral Medications	<br /><br /><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Anti-tuberculosis Medications<br />(*exception)</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n  <tr>\n    <td>Amikacin</td>\n    <td>AMK</td>\n  </tr>\n  <tr>\n    <td>Bedaquiline</td>\n    <td>BDQ</td>\n  </tr>\n  <tr>\n    <td>Ciprofloxacin</td>\n    <td>CFX</td>\n  </tr>\n  <tr>\n    <td>Clofazimine</td>\n    <td>CFZ</td>\n  </tr>\n<tr>\n  <td>Cilastatin</td>\n  <td>CLN</td>\n</tr>\n<tr>\n  <td>Capreomycin</td>\n  <td>CM</td>\n</tr>\n<tr>\n  <td>Cycloserine</td>\n  <td>CS</td>\n</tr>\n<tr>\n  <td>Delamanid</td>\n  <td>DLM</td>\n</tr>\n<tr>\n  <td>Ethambutol</td>\n  <td>E</td>\n</tr>\n<tr>\n  <td>Ethionamide</td>\n  <td>ETO</td>\n</tr>\n<tr>\n  <td>Gatifloxacin</td>\n  <td>GFX</td>\n</tr><tr>\n  <td>Gemifloxacin</td>\n  <td>GEM</td>\n</tr>\n<tr>\n  <td>Imipenem</td>\n  <td>IPM</td>\n</tr>\n<tr>\n  <td>Isoniazid</td>\n  <td>H</td>\n</tr>\n<tr>\n  <td>Kanamycin</td>\n  <td>KM</td>\n</tr>\n<tr>\n  <td>Levofloxacin</td>\n  <td>LFX</td>\n</tr>\n<tr>\n  <td>Linezolid</td>\n  <td>LZD</td>\n</tr>\n</table>\n</body>			6	0	2023-12-09	\N	4	\N	0
71	27	7	Section Intro	Concomitant Medication Form	Study 38			1	0	2023-12-06	2023-12-09	4	4	0
212	93	1	TBDrug	TB Drug Sparse PK Specimen Collection Form		<ul>\n<li>Complete this form if TB drug sparse PK specimens are collected.</li>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		1	0	2023-12-14	\N	4	\N	0
113	36	7	Completion	Comments and Form Completion		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		3	0	2023-12-07	2023-12-18	4	4	0
76	27	7	Section End	\n\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n\n\n\n\nAnti-tuberculosis Medications(*exception)\n\n  \n    Name\n    Abbreviation\n  \n  \n    Amikacin\n    AMK\n  \n  \n    Bedaquiline\n    BDQ\n  \n  \n    Ciprofloxacin\n    CFX\n  \n  \n    Clofazimine\n    CFZ\n  \n\n  Cilastatin\n  CLN\n\n\n  Capreomycin\n  CM\n\n\n  Cycloserine\n  CS\n\n\n  Delamanid\n  DLM\n\n\n  Ethambutol\n  E\n\n\n  Ethionamide\n  ETO\n\n\n  Gatifloxacin\n  GFX\n\n\n  Gemifloxacin\n  GEM\n\n\n  Imipenem\n  IPM\n\n\n  Isoniazid\n  H\n\n\n  Kanamycin\n  KM\n\n\n  Levofloxacin\n  LFX\n\n\n  Linezolid\n  LZD\n\n\n  Meropenem\n  MPN\n\n\n  Moxifloxacin\n  M\n\n\n  Ofloxacin\n  OFX\n\n\n  P-aminosalicylic acid\n  PAS\n\n\n  Pretomanid\n  Pa\n\n\n  Protionamide\n  PTO\n\n\n  Pyrazinamide\n  Z\n\n\n  Rifabutin\n  RBT\n\n\n  Rifampicin\n  R\n\n\n  Rifapentine\n  P\n\n\n  Sparfloxacin\n  SPR\n\n\n  Streptomycin\n  S\n\n\n  Sutezolid\n  SUT\n\n\n  Thioacetazone\n  THZ\n\n\n  Terizidone\n  TRD\n\n\n  Viomycin\n  VM\n\n\n  Pyridoxine*\n  B6\n\n\n	<br /><br />\n<head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Antiretroviral Medications</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n <tr>\n  <td>Abacavir</td>\n  <td>ABC</td>\n</tr>\n<tr>\n  <td>Abacavir/Lamivudine</td>\n  <td>EPZ</td>\n</tr>\n<tr>\n  <td>Atazanavir</td>\n  <td>ATV</td>\n</tr>\n<tr>\n  <td>Atazanavir/Cobicistat</td>\n  <td>ATC</td>\n</tr>\n<tr>\n  <td>Atazanavir/Ritonavir</td>\n  <td>AZR</td>\n</tr>\n<tr>\n  <td>Cobicistat</td>\n  <td>COB</td>\n</tr>\n<tr>\n  <td>Darunavir</td>\n  <td>DRV</td>\n</tr>\n<tr>\n  <td>Darunavir/Cobicistat</td>\n  <td>DRC</td>\n</tr>\n<tr>\n  <td>Delavirdine</td>\n  <td>DLV</td>\n</tr>\n<tr>\n  <td>Didanosine</td>\n  <td>DDI</td>\n</tr>\n<tr>\n  <td>Dolutegravir</td>\n  <td>DTG</td>\n</tr>\n<tr>\n  <td>Dolutegravir/Abacavir/Lamivudine</td>\n  <td>TMQ</td>\n</tr>\n<tr>\n  <td>Efavirenz</td>\n  <td>EFV</td>\n</tr>\n<tr>\n  <td>Efavirenz/Lamivudine/Tenofovir</td>\n  <td>ELT</td>\n</tr>\n<tr>\n  <td>Efavirenz/Tenofovir/Emtricitabine</td>\n  <td>ATR</td>\n</tr>\n<tr>\n  <td>Elvitegravir/Cobicistat/Tenofovir/Emtricitabine</td>\n  <td>STB</td>\n</tr>\n<tr>\n  <td>Emtricitabine</td>\n  <td>FTC</td>\n</tr>\n<tr>\n  <td>Enfuvirtide</td>\n  <td>T20</td>\n</tr>\n<tr>\n  <td>Etravirine</td>\n  <td>ETV</td>\n</tr>\n</table>\n</body>			6	0	2023-12-06	2023-12-09	4	4	0
94	30	7	Section End	List of Anti-tuberculosis and Antiretroviral Medications	<br /><br /><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Anti-tuberculosis Medications<br />(*exception)</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n  <tr>\n    <td>Amikacin</td>\n    <td>AMK</td>\n  </tr>\n  <tr>\n    <td>Bedaquiline</td>\n    <td>BDQ</td>\n  </tr>\n  <tr>\n    <td>Ciprofloxacin</td>\n    <td>CFX</td>\n  </tr>\n  <tr>\n    <td>Clofazimine</td>\n    <td>CFZ</td>\n  </tr>\n<tr>\n  <td>Cilastatin</td>\n  <td>CLN</td>\n</tr>\n<tr>\n  <td>Capreomycin</td>\n  <td>CM</td>\n</tr>\n<tr>\n  <td>Cycloserine</td>\n  <td>CS</td>\n</tr>\n<tr>\n  <td>Delamanid</td>\n  <td>DLM</td>\n</tr>\n<tr>\n  <td>Ethambutol</td>\n  <td>E</td>\n</tr>\n<tr>\n  <td>Ethionamide</td>\n  <td>ETO</td>\n</tr>\n<tr>\n  <td>Gatifloxacin</td>\n  <td>GFX</td>\n</tr>\n</table>\n</body>			6	0	2023-12-06	2023-12-09	4	4	0
100	31	7	Section End	List of Anti-tuberculosis and Antiretroviral Medications	<br /><br /><head>\n<style>\n  table {\n    border-collapse: collapse;\n    width: 100%;\n  }\n  table, th, td {\n    border: 1px solid black;\n  }\n  th, td {\n    padding: 8px;\n    text-align: left;\n  }\n  th {\n    font-weight: bold;\n  }\n</style>\n</head>\n\n<body>\n<h2>Anti-tuberculosis Medications<br />(*exception)</h2>\n<table>\n  <tr>\n    <th>Name</th>\n    <th>Abbreviation</th>\n  </tr>\n  <tr>\n    <td>Amikacin</td>\n    <td>AMK</td>\n  </tr>\n  <tr>\n    <td>Bedaquiline</td>\n    <td>BDQ</td>\n  </tr>\n  <tr>\n    <td>Ciprofloxacin</td>\n    <td>CFX</td>\n  </tr>\n  <tr>\n    <td>Clofazimine</td>\n    <td>CFZ</td>\n  </tr>\n<tr>\n  <td>Cilastatin</td>\n  <td>CLN</td>\n</tr>\n<tr>\n  <td>Capreomycin</td>\n  <td>CM</td>\n</tr>\n<tr>\n  <td>Cycloserine</td>\n  <td>CS</td>\n</tr>\n<tr>\n  <td>Delamanid</td>\n  <td>DLM</td>\n</tr>\n<tr>\n  <td>Ethambutol</td>\n  <td>E</td>\n</tr>\n<tr>\n  <td>Ethionamide</td>\n  <td>ETO</td>\n</tr>\n<tr>\n  <td>Gatifloxacin</td>\n  <td>GFX</td>\n</tr><tr>\n  <td>Gemifloxacin</td>\n  <td>GEM</td>\n</tr>\n<tr>\n  <td>Imipenem</td>\n  <td>IPM</td>\n</tr>\n<tr>\n  <td>Isoniazid</td>\n  <td>H</td>\n</tr>\n<tr>\n  <td>Kanamycin</td>\n  <td>KM</td>\n</tr>\n<tr>\n  <td>Levofloxacin</td>\n  <td>LFX</td>\n</tr>\n<tr>\n  <td>Linezolid</td>\n  <td>LZD</td>\n</tr>\n</table>\n</body>			6	0	2023-12-06	2023-12-09	4	4	0
124	42	1	Section 1	TB Drug Dose Record Form	Study 38			1	0	2023-12-09	\N	4	\N	0
125	42	1	Section 2	Section 2: Dose Record				2	0	2023-12-09	\N	4	\N	0
126	43	1	Section 1	Pharmacogenomic Blood Sample Form	Study 38			1	0	2023-12-09	\N	4	\N	0
213	93	1	Sampling	PK Sampling		Store 4 cryovials of plasma at each sampling point. Specimens must be frozen at -70oC or lower within 2 hours of collection.<br/>\nKeep cryovials with plasma in a slurry of ice and water prior to placement in freezer. <br/>\nIf samples cannot be placed in a -70oC or lower freezer within 2 hours of collection, freeze on dry ice for up to 12 hours. If stored on dry ice and not transferred to a -70°C freezer in ≤ 2 hours from collection, indicate “Yes” in “Blood collection to -70°C freezer time > 2 hrs” column and provide a comment in Section E		2	0	2023-12-14	\N	4	\N	0
103	33	7	Details	Visit Details and Reasons		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		1	0	2023-12-07	2023-12-18	4	4	0
106	34	7	Details	Visit Details and Reasons		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		1	0	2023-12-07	2023-12-18	4	4	0
215	95	1	Details	Visit Details and Reasons		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		1	0	2023-12-18	\N	4	\N	0
216	95	1	Change	Change Details and Recommendation		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		2	0	2023-12-18	\N	4	\N	0
217	95	1	Completion	Comments and Form Completion		For the purposes of this form, CHANGE IN TB TREATMENT means any permanent modification to the assigned Study 38 TB treatment, including:.<p><ol><li>Retreatment with any TB therapy after the participant has completed assigned study treatment within the period of follow-up;</li><li>Extension of TB treatment beyond that of the participant’s assigned regimen;</li><li>Modifications to assigned treatment (i.e. addition, subtraction, replacement of TB medications for any reason).</li></ol></p><p>Modifications to the assigned Study 38 TB treatment which are temporary should be added to the Dose Record [DR] form.</p><p>If the participant had a Possible Poor Treatment Response (PPTR) evaluation, submit this form within 90 days after initiating PPTR evaluation. If a decision to change TB treatment is ‘pending’ at that time, update this form when a decision is known, or at least every 90 days after PPTR evaluation. Data reported on this form can be edited when information is complete.</p><p>Record all dates in the following format:  DD-MMM-YYYY (e.g., 01-JAN-2021).</p>		3	0	2023-12-18	\N	4	\N	0
233	101	1	Visit	Visit		Complete this form at each study evaluation during TB treatment. Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2021) </b>. Verify participant locator information and document any changes on the site’s locator form.\n\n<ul>\n<li> Visits at Weeks 1,2,3,4,6,8,10,12,14,17 and 22 must be &pm; 3 days of scheduled visit </li>\n<li> Visit at Week 26 must be &pm;7 days of scheduled visit </li>\n<p><li> Visits at Weeks 22 and 26: \n  <ul>\n     <li>Complete the Treatment Evaluation (TX) form for participats taking regimen 3 (RHZE/RH) only</li>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD)</li>\n  </ul>\n</li></p>\n\n</ul>		1	0	2023-12-18	\N	4	\N	0
234	101	1	Evaluation	Evaluation and Study Treatment Status		Complete this form at each study evaluation during TB treatment. Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2021) </b>. Verify participant locator information and document any changes on the site’s locator form.\n\n<ul>\n<li> Visits at Weeks 1,2,3,4,6,8,10,12,14,17 and 22 must be &pm; 3 days of scheduled visit </li>\n<li> Visit at Week 26 must be &pm;7 days of scheduled visit </li>\n<p><li> Visits at Weeks 22 and 26: \n  <ul>\n     <li>Complete the Treatment Evaluation (TX) form for participats taking regimen 3 (RHZE/RH) only</li>\n     <li>Complete the Follow-up Evaluation (FU) form for participants taking regimens 1 and 2 (2BMZRb/2BMRb or 2BMZD/2BMD)</li>\n  </ul>\n</li></p>\n\n</ul>		2	0	2023-12-18	\N	4	\N	0
253	109	1	Enrollment	Study Entry Enrollment		Complete this form if participant has met all eligibility criteria and provided consent to the study.  Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2022) </b>.  <p>A Participant ID will be generated after submission of this form.</p>		1	0	2023-12-19	\N	4	\N	0
254	109	1	Completion	Comments and Form Completion		Complete this form if participant has met all eligibility criteria and provided consent to the study.  Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2022) </b>.  <p>A Participant ID will be generated after submission of this form.</p>		2	0	2023-12-19	\N	4	\N	0
255	109	1	Treatment	Treatment Assignment upon Successful Enrollment Submission		Complete this form if participant has met all eligibility criteria and provided consent to the study.  Record all dates in the following format: DD-MMM-YYYY <b> (e.g., 01-JAN-2022) </b>.  <p>A Participant ID will be generated after submission of this form.</p>		3	0	2023-12-19	\N	4	\N	0
257	110	7	Management	Management of AE		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		2	0	2023-12-19	2023-12-19	4	4	0
256	110	7	Description	Adverse Event Description		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		1	0	2023-12-19	2023-12-19	4	4	0
258	110	7	Comments	Comments		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		3	0	2023-12-19	2023-12-19	4	4	0
261	110	7	CDC	CDC Safety Officer Review		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		6	0	2023-12-19	2023-12-19	4	4	0
348	126	1	Description	Adverse Event Description		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		1	0	2023-12-20	\N	4	\N	0
349	126	1	Management	Management of AE		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		2	0	2023-12-20	\N	4	\N	0
350	126	1	Comments	Comments		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures. <strong><p>Provide a summary of the current status of the AE and answer the questions below.</p></strong>		3	0	2023-12-20	\N	4	\N	0
351	126	1	Pregnancy	Pregnancy-Specific Information		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		4	0	2023-12-20	\N	4	\N	0
352	126	1	Completion	Form Completion		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		5	0	2023-12-20	\N	4	\N	0
353	126	1	CDC	CDC Safety Officer Review		Submit an Adverse (AE) Event Follow-up (AF) Form within 45 days of the onset date of the AE, regardless of whether the AE has resolved.  If the AE has not resolved, continue to update the existing AF Form via the TBTC2 Web Portal, whenever there is a change in AE status, or every 45 days, until the AE has resolved, or the study has ended.  In the event of pregnancy, submit an AF Form when the outcome of pregnancy is known.  Use the following format for dates: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>. For additional instructions, refer to the Study 38 Manual of Operating Procedures.		6	0	2023-12-20	\N	4	\N	0
298	117	7	TBDrug	TB Drug Intensive PK Specimen Collection Form		<ul>\n<li>Complete this form if TB drug intensive PK specimens are collected.</li>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		1	0	2023-12-20	2023-12-21	8	4	0
299	117	7	Sampling	PK Sampling		Store 4 cryovials of plasma at each sampling point. <br/>\n<ul>\n  <li>Specimens must be frozen at -70oC or lower within 2 hours of collection.</li>\n <li>Keep cryovials with plasma in a slurry of ice and water prior to placement in freezer.</li>\n <li>If samples cannot be placed in a -70oC or lower freezer within 2 hours of collection, freeze on dry ice for up to 12 hours. If stored on dry ice and not transferred to a -70°C freezer in ≤ 2 hours from collection, indicate “Yes” in “Blood collection to -70°C freezer time > 2 hrs” column and provide a comment in Section G. </li>\n <li> Record sampling information pre-dose (t-1), and at\n    <ul>\n      <li> 1 hour, 2 hours, 4 hours, 6 hours, 8-12 hours, and 24 hours post reference dose.  </li>\n    </ul>\n  </li>\n</ul>		2	0	2023-12-20	2023-12-21	8	4	0
402	135	1	Visit	Visit Information		<ul>\n<li>Complete this form if TB drug intensive PK specimens are collected.</li>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		1	0	2023-12-22	\N	4	\N	0
403	135	1	Reference DV	Reference Doses and Vomitting		<ul>\n<li>Complete this form if TB drug intensive PK specimens are collected.</li>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		2	0	2023-12-22	\N	4	\N	0
404	135	1	Ingested	Food and Alcohol Ingested		<ul>\n<li>Complete this form if TB drug intensive PK specimens are collected.</li>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		3	0	2023-12-22	\N	4	\N	0
405	135	1	Sampling	PK Sampling		Store 4 cryovials of plasma at each sampling point. <br/>\n<ul>\n  <li>Specimens must be frozen at -70°C within 2 hours of collection.</li>\n <li>Keep cryovials with plasma in a slurry of ice and water prior to placement in freezer.</li>\n <li>If samples cannot be placed in a -70°C or lower freezer within 2 hours of collection, freeze on dry ice for up to 12 hours. If stored on dry ice and not transferred to a -70°C freezer in ≤ 2 hours from collection, indicate “Yes” in “Blood collection to -70°C freezer time > 2 hrs” column and provide a comment in Section G. </li>\n <li> Record sampling information pre-dose (t-1), and at\n    <ul>\n      <li> 1 hour, 2 hours, 4 hours, 6 hours, 8-12 hours, and 24 hours post reference dose.  </li>\n    </ul>\n  </li>\n</ul>		4	0	2023-12-22	\N	4	\N	0
406	135	1	Cryovial	Cryovial Label Numbers		<ul>\n<li>Complete this form if TB drug intensive PK specimens are collected.</li>\n<li>Record all dates in the following format: DD-MMM-YYYY <strong>(e.g., 01-JAN-2021)</strong>.</li>\n<li>Record all times in 24 hour format <strong>(e.g., 7 AM is recorded as 0700 and 10 PM is recorded as 2200)</strong>.</li>\n</ul>		5	0	2023-12-22	\N	4	\N	0
492	148	1	History A	Participant History A		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>. Refer to the Study 38 MOOP <em>(Section TBD)</em> for detailed instructions for form completion.		1	0	2023-12-24	\N	4	\N	0
493	148	1	History B	Participant History B		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>. Refer to the Study 38 MOOP <em>(Section TBD)</em> for detailed instructions for form completion.		2	0	2023-12-24	\N	4	\N	0
494	148	1	History C	Participant History C		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>. Refer to the Study 38 MOOP <em>(Section TBD)</em> for detailed instructions for form completion.		3	0	2023-12-24	\N	4	\N	0
495	148	1	Tuberculosis	Tuberculosis (TB) History and Treatment		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>. Refer to the Study 38 MOOP <em>(Section TBD)</em> for detailed instructions for form completion.		4	0	2023-12-24	\N	4	\N	0
496	148	1	Concomitant A	Concomitant Diagnoses at the Time of TB Diagnosis		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>. Refer to the Study 38 MOOP <em>(Section TBD)</em> for detailed instructions for form completion.		5	0	2023-12-24	\N	4	\N	0
497	148	1	Concomitant B	Concomitant Diagnoses at the Time of TB Diagnosis		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>. Refer to the Study 38 MOOP <em>(Section TBD)</em> for detailed instructions for form completion.		6	0	2023-12-24	\N	4	\N	0
498	148	1	Infection	HIV Infection History		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>. Refer to the Study 38 MOOP <em>(Section TBD)</em> for detailed instructions for form completion.		7	0	2023-12-24	\N	4	\N	0
499	148	1	Additional	Additional Information		Complete this form after participant has enrolled.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021)</b>. Refer to the Study 38 MOOP <em>(Section TBD)</em> for detailed instructions for form completion.		8	0	2023-12-24	\N	4	\N	0
410	137	1	Information	Information Concerning Death		Complete this form in the event of a participant death at any time during the study. Send this form, along with copies of the death certificate and if available, an autopsy report, to the CDC. Completely obscure personal identifiers from the death certificate and autopsy report, and label the copy sent to CDC with the Participant ID.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021).</b>		1	0	2023-12-22	\N	4	\N	0
411	137	1	Narrative	Narrative and Form Completion		Complete this form in the event of a participant death at any time during the study. Send this form, along with copies of the death certificate and if available, an autopsy report, to the CDC. Completely obscure personal identifiers from the death certificate and autopsy report, and label the copy sent to CDC with the Participant ID.  Use the following format for dates: DD-MMM-YYYY <b>(e.g., 01-JAN-2021).</b>		2	0	2023-12-22	\N	4	\N	0
\.


--
-- Data for Name: status; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.status (status_id, name, description) FROM stdin;
1	available	this is the active status
2	unavailable	this is the inactive status
3	private	\N
4	pending	\N
5	removed	this indicates that a record is specifically removed by user
6	locked	\N
7	auto-removed	this indicates that a record is removed due to the removal of its parent record
8	signed	this indicates all StudyEvents has been signed
10	souce_data_verification	indicates the element has undergone SDV
9	frozen	frozen
11	reset	deleting event crf resets status
\.


--
-- Data for Name: study; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study (study_id, parent_study_id, unique_identifier, secondary_identifier, name, summary, date_planned_start, date_planned_end, date_created, date_updated, owner_id, update_id, type_id, status_id, principal_investigator, facility_name, facility_city, facility_state, facility_zip, facility_country, facility_recruitment_status, facility_contact_name, facility_contact_degree, facility_contact_phone, facility_contact_email, protocol_type, protocol_description, protocol_date_verification, phase, expected_total_enrollment, sponsor, collaborators, medline_identifier, url, url_description, conditions, keywords, eligibility, gender, age_max, age_min, healthy_volunteer_accepted, purpose, allocation, masking, control, assignment, endpoint, interventions, duration, selection, timing, official_title, results_reference, oc_oid, old_status_id, mail_notification, contact_email) FROM stdin;
3	\N	Study38		Study 38	Study 38	\N	\N	2023-12-02	\N	1	\N	2	4	CDC											interventional		\N		0	n_a								both			f												f	S_STUDY38	1	DISABLED	\N
1	\N	default-study	default-study	Default Study		2006-10-23	2006-10-23	2006-10-23	2006-10-23	1	\N	1	1	default											observational		2006-10-23	default	0	default								both			f	Natural History							longitudinal	Convenience Sample	Retrospective		f	S_DEFAULTS1	1	DISABLED	\N
4	3	Site1		Site 1		\N	\N	2023-12-02	\N	1	\N	2	4	CDC													\N		10000	n_a								both			f												f	S_SITE1	1	DISABLED	\N
\.


--
-- Data for Name: study_event; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_event (study_event_id, study_event_definition_id, study_subject_id, location, sample_ordinal, date_start, date_end, owner_id, status_id, date_created, date_updated, update_id, subject_event_status_id, start_time_flag, end_time_flag) FROM stdin;
\.


--
-- Data for Name: study_event_definition; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_event_definition (study_event_definition_id, study_id, name, description, repeating, type, category, owner_id, status_id, date_created, date_updated, update_id, ordinal, oc_oid) FROM stdin;
1	3	visit		f	scheduled		1	1	2023-12-08	\N	\N	1	SE_VISIT
\.


--
-- Data for Name: study_group; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_group (study_group_id, name, description, study_group_class_id) FROM stdin;
\.


--
-- Data for Name: study_group_class; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_group_class (study_group_class_id, name, study_id, owner_id, date_created, group_class_type_id, status_id, date_updated, update_id, subject_assignment) FROM stdin;
\.


--
-- Data for Name: study_module_status; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_module_status (id, study_id, study, crf, event_definition, subject_group, rule, site, users, version, date_created, date_updated, owner_id, update_id, status_id) FROM stdin;
\.


--
-- Data for Name: study_parameter; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_parameter (study_parameter_id, handle, name, description, default_value, inheritable, overridable) FROM stdin;
13	personIdShownOnCRF			false	t	f
12	interviewDateEditable		In study creation, CRF Interview Name and Date can be set to editable or not editable	editable	t	f
11	interviewDateDefault		In study or site creation, CRF Interviewer Date can be set to default to blank or to be pre-populated with user's name and the date of the study event	eventDate	t	t
9	interviewerNameEditable		In study creation, CRF Interviewer Name can be set to editable or not editable	editable	t	f
10	interviewDateRequired		In study or site creation, CRF Interviewer Date can be set as optional or required fields	required	t	t
8	interviewerNameDefault		In study or site creation, CRF Interviewer Name can be set to default to blank or to be pre-populated with user's name and the date of the study event	blank	t	t
7	interviewerNameRequired		In study or site creation, CRF Interviewer Name can be set as optional or required fields	required	t	t
6	subjectIdPrefixSuffix		In study and/or site creation, if Study Subject ID is set to Auto-generate, user can optionally specify a prefix and suffix for the format of the ID, using the format [PRETEXT][AUTO#][POSTTEXT]	false	t	f
4	genderRequired		In study creation, Subject Gender can be set to required or not used	required	t	f
5	subjectIdGeneration		In study creation, Study Subject ID can be set to Manual Entry, Auto-generate (editable), Auto-generate (non-editable)	manual	t	f
3	subjectPersonIdRequired		In study creation, Person ID can be set to required, optional, or not used	required	t	f
2	discrepancyManagement			true	t	f
1	collectDob	collect subject's date of birth	In study creation, Subject Birthdate can be set to require collect full birthdate, year of birth, or not used	required	t	f
14	secondaryLabelViewable			not viewable	t	f
15	adminForcedReasonForChange	adminForcedResonForChange	In administrative editing, block changes if event CRF has already been finished.	true	t	f
16	eventLocationRequired	eventLocationRequired	Location Field Required	not_used	t	f
17	participantPortal	participantPortal	Participant Portal Enabled or Diabled option	disabled	t	f
18	randomization	randomization	Randomization Enabled or Diabled option	disabled	t	f
\.


--
-- Data for Name: study_parameter_value; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_parameter_value (study_parameter_value_id, study_id, value, parameter) FROM stdin;
1	1	1	collectDob
2	1	true	discrepancyManagement
3	1	true	genderRequired
4	1	required	subjectPersonIdRequired
6	1	blank	interviewerNameDefault
7	1	true	interviewerNameEditable
9	1	blank	interviewDateDefault
10	1	true	interviewDateEditable
11	1	manual	subjectIdGeneration
12	1		subjectIdPrefixSuffix
13	1	true	personIdShownOnCRF
14	1	false	secondaryLabelViewable
5	1	yes	interviewerNameRequired
8	1	yes	interviewDateRequired
1	4		collectDob
2	4		genderRequired
\.


--
-- Data for Name: study_subject; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_subject (study_subject_id, label, secondary_label, subject_id, study_id, status_id, enrollment_date, date_created, date_updated, owner_id, update_id, oc_oid, time_zone) FROM stdin;
1	001		1	1	1	2023-12-02	2023-12-02 17:21:32.996902+00	\N	1	\N	SS_001	
\.


--
-- Data for Name: study_type; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_type (study_type_id, name, description) FROM stdin;
1	genetic	\N
2	non-genetic	\N
\.


--
-- Data for Name: study_user_role; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.study_user_role (role_name, study_id, status_id, owner_id, date_created, date_updated, update_id, user_name) FROM stdin;
admin	1	1	1	2006-10-23	\N	\N	root
director	1	1	1	2006-10-23	\N	\N	root
coordinator	3	1	1	2023-12-02	\N	\N	root
director	1	7	1	2023-12-02	\N	\N	psinha
coordinator	3	7	1	2023-12-02	\N	\N	psinha
admin	\N	1	9	2023-12-20	2023-12-20	9	josue
admin	\N	1	5	2023-12-20	2023-12-20	5	claudia
coordinator	3	1	1	2023-12-06	\N	\N	cdctestuser
coordinator	3	1	1	2023-12-15	\N	\N	edenilson
admin	\N	1	4	2023-12-24	2023-12-24	4	admin
admin	\N	1	6	2023-12-08	2023-12-08	6	cdctestuser
admin	\N	1	1	2023-12-11	2023-12-11	1	admin2
coordinator	3	1	1	2023-12-11	\N	\N	admin2
coordinator	3	1	1	2023-12-05	2023-12-11	1	claudia
coordinator	3	1	1	2023-12-02	2023-12-11	1	admin
coordinator	3	1	1	2023-12-02	2023-12-11	1	psinha1
admin	\N	1	1	2023-12-11	2023-12-11	1	psinha1
coordinator	3	1	1	2023-12-21	\N	\N	otmar
coordinator	3	1	1	2023-12-19	\N	\N	josue
admin	\N	1	8	2023-12-20	2023-12-20	8	edenilson
\.


--
-- Data for Name: subject; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.subject (subject_id, father_id, mother_id, status_id, date_of_birth, gender, unique_identifier, date_created, owner_id, date_updated, update_id, dob_collected) FROM stdin;
1	\N	\N	1	1990-12-02	m	001	2023-12-02 17:21:32.984812+00	1	\N	\N	t
\.


--
-- Data for Name: subject_event_status; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.subject_event_status (subject_event_status_id, name, description) FROM stdin;
1	scheduled	
2	not scheduled	
3	data entry started	
4	completed	
5	stopped	
6	skipped	
7	locked	
8	signed	
\.


--
-- Data for Name: subject_group_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.subject_group_map (subject_group_map_id, study_group_class_id, study_subject_id, study_group_id, status_id, owner_id, date_created, date_updated, update_id, notes) FROM stdin;
\.


--
-- Data for Name: tag; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.tag (id, tag_name, workflow, owner_id, update_id, date_created, date_updated) FROM stdin;
1	SDV	Tagging	1	\N	2023-12-02 09:30:19.11972+00	\N
2	OffLine	Tagging	1	\N	2023-12-02 09:30:19.12481+00	\N
\.


--
-- Data for Name: usage_statistics_data; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.usage_statistics_data (id, param_key, param_value, update_timestamp, version) FROM stdin;
1	oc_start_time	2023-12-02 09:30:26.743	2023-12-02 09:30:26.743	0
\.


--
-- Data for Name: user_account; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.user_account (user_id, user_name, passwd, first_name, last_name, email, active_study, institutional_affiliation, status_id, owner_id, date_created, date_updated, date_lastvisit, passwd_timestamp, passwd_challenge_question, passwd_challenge_answer, phone, user_type_id, update_id, enabled, account_non_locked, lock_counter, run_webservices, access_code, time_zone, enable_api_key, api_key, authtype, authsecret) FROM stdin;
6	cdctestuser	{LUYTG62QSYL+mMQOAEVwZeiCcrUMJp+OjWNvgseJG0w=}0ea678e5470ca4ad3ff2482064b1573a9d9bc55c	CDC	Test 	cdctestuser@mailinator.com	3	CDC	1	1	2023-12-06	2023-12-08	2023-12-08 18:09:20.678	2023-12-08	Favorite Animal	dog		1	6	t	t	0	f	\N	\N	t	9b3d5ba4d1de4e69823975ffccf65aed	STANDARD	
2	psinha	{hp2I7gKPl/lwSArLjbDgSmLtCTFHjkh7Ort7cdAW4ug=}49226fc27b2ef1a79a2e7a7767c85d589b234161	Protyush	Sinha	protyush.sinha@alagant.com	1	CDC	5	1	2023-12-02	\N	\N	\N				2	1	f	t	0	f	null		t	a124eca1e8ae439f8996822218cf35f5	STANDARD	\N
1	root	{1JLU9mIdVVvonyK96DeTXz1mnT+4a+C+V9sTBlqv1sE=}17c2098b461d08bb3e6e42ba7be35e58c415bccf	Root	User	openclinica_admin@example.com	3	Akaza Research	1	1	\N	2023-12-21	2023-12-21 17:25:52.868	2023-12-02	Favorite Animal	Dog	617 621 8585	3	1	t	t	0	f	\N	\N	f	\N	STANDARD	
5	claudia	{bFBUVk0tySfJMTLH122Lf2nDMAjt5lxUQo9OzbbnS3Q=}c8b24b765a643d0e4c6c61f19d3796d136c1b361	Claudia	Trepte	c.trepte@reliatec.de	3	CDC	1	1	2023-12-05	2023-12-20	2023-12-20 17:28:14.292	2023-12-11	Favorite Color	blue		1	5	t	t	0	f	\N	\N	t	b0519f459fb44cdf9fb40295ab7d0134	STANDARD	
7	admin2	{8GXXLA7om8e5rIXHbLuGgXbAdfLuaQLFb89qDbLROeg=}7e2d3b9b8fde5451e60f8b51355028cf3ac44132	Admin	User	adminuser2@mailinator.com	3	CDC	1	1	2023-12-11	\N	\N	\N				1	\N	t	t	0	f	null		t	715f11e70ef743e1b7919dd4295b717c	STANDARD	\N
3	psinha1	{hc76bUCdKO3bAZNgRZ/1kQ6Fx+GZR39eAT+KQ4IkP2g=}74030d6b5370cb4f13c6eaf3d8093502755d19a9	Protyush	Sinha	protyush.sinha@alagant.com	3	CDC	1	1	2023-12-02	2023-12-11	\N	\N				1	1	t	t	0	f	\N	\N	t	be11cd3ff89346e9af960e944e366f24	STANDARD	
9	josue	{kpyZzc3CHH/Tvo6TkR2+EJabzWTiJXMvVBLNoHDTl9g=}ff598fae9ee6d305ec5b4fd6397c89a48b022c1c	Josue	Arias	jarias.sv@gmail.com	3	CDC	1	1	2023-12-19	2023-12-20	2023-12-20 16:57:53.096	2023-12-19	Favorite Animal	dog		1	9	t	t	0	f	\N	\N	t	3f97089b04fe4aec8daa9dd12d3c6edc	STANDARD	
8	edenilson	{Q1Bq2MAq3X8Bz6FF6X0a62AETPNYPJbmtLGek8VuwLg=}61b294c8ffafb9b262bbdb2dec6a8e42955a8f7b	Edenilson	Pineda	edenilsonpineda@outlook.com	3	CDC	1	1	2023-12-15	2023-12-20	2023-12-20 06:52:11.347	2023-12-17	City of Birth	san salvador		1	8	t	t	0	f	\N	\N	t	676127b89fed48c4bf77ae91f426eb99	STANDARD	
4	admin	{I1kK1DNavimOXrbXdGtdCaVlvjGiTzDFg2OQTX7jQLk=}9df4c328045fb01bdb75067cdd3c99f58e4102f6	Afeez	Study38	study38admin@mailinator.com	3	CDC	1	1	2023-12-02	2023-12-24	2023-12-24 00:49:03.96	2023-12-13	Favorite Animal	Dog	09012121212	1	4	t	t	0	f	\N	\N	t	1d271114b76e469c82875a35fb33ca32	STANDARD	
10	otmar	{mQLBujCY9xLYkA7tvLmlFoGmDGZkZDN9zq8gUVkhrOA=}515c6ecd83430786c8d7a4f3b0dabff53bf99efa	Otmar	B	o.bayer@reliatec.de	3	CDC	1	1	2023-12-21	2023-12-22	2023-12-22 05:25:40.217	\N				3	10	t	t	0	f	\N	\N	t	24ec0756186d4f828cda33a86c9cbf0a	STANDARD	
\.


--
-- Data for Name: user_role; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.user_role (role_id, role_name, parent_id, role_desc) FROM stdin;
1	admin	1	\N
2	coordinator	1	\N
3	director	1	\N
4	investigator	1	\N
5	ra	1	\N
6	monitor	1	\N
\.


--
-- Data for Name: user_type; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.user_type (user_type_id, user_type) FROM stdin;
1	admin
2	user
3	tech-admin
\.


--
-- Data for Name: versioning_map; Type: TABLE DATA; Schema: public; Owner: clinica
--

COPY public.versioning_map (crf_version_id, item_id) FROM stdin;
63	867
63	868
63	869
63	870
63	871
63	872
63	873
63	874
63	875
63	876
63	877
63	878
63	879
63	880
63	881
63	882
63	883
63	884
63	885
63	886
63	887
63	888
63	889
63	890
63	891
63	892
63	893
63	894
63	895
63	896
63	897
63	898
63	899
63	900
63	901
63	902
63	903
63	904
63	905
63	906
63	907
63	908
63	909
10	309
10	310
10	311
10	312
10	313
10	314
10	315
10	316
10	317
10	318
10	319
10	320
10	321
10	322
10	323
10	324
10	325
10	326
10	327
10	328
148	3728
148	3706
148	3736
148	3696
148	3740
148	3759
148	3756
148	3747
148	3748
148	3719
148	3758
148	3709
12	341
12	342
3	94
3	86
3	81
3	79
3	78
3	97
3	105
3	106
3	91
3	90
3	92
3	108
3	80
3	89
3	82
3	98
3	93
3	102
3	85
3	100
3	83
3	88
3	84
3	107
3	101
3	103
3	104
3	87
3	96
3	95
3	109
3	111
3	110
3	99
4	112
4	113
4	114
4	115
4	116
4	117
4	118
4	119
4	120
4	121
4	122
4	123
4	124
4	125
4	126
12	343
12	344
12	345
6	145
6	146
6	147
6	148
6	149
6	150
6	151
6	152
6	153
6	154
6	155
6	156
6	157
6	158
6	159
6	160
6	161
6	162
6	163
6	164
7	165
7	166
7	167
7	168
7	169
7	170
7	171
7	172
7	173
7	174
7	175
7	176
7	177
7	178
7	179
7	180
7	181
7	182
12	346
12	347
13	341
13	342
13	343
13	344
13	345
13	346
13	347
14	348
14	342
14	343
14	344
14	345
14	346
14	347
15	349
15	350
15	351
15	352
15	353
15	354
15	355
15	356
15	357
17	375
9	258
9	283
9	249
9	288
9	304
9	295
9	296
9	269
9	305
9	261
9	282
9	294
9	248
9	260
9	285
9	289
9	266
9	301
9	293
9	287
9	264
9	273
9	270
9	267
9	271
9	246
9	306
9	276
9	252
9	256
9	300
9	263
9	250
9	274
9	254
9	255
9	272
9	297
9	302
9	265
9	290
9	307
9	268
9	298
9	247
9	253
9	308
9	286
9	262
9	281
9	303
9	278
9	251
9	279
9	259
9	299
9	284
9	291
9	275
9	257
9	280
9	292
9	277
16	358
16	359
16	360
16	361
16	362
16	363
16	364
16	365
16	366
16	367
16	368
16	369
16	370
16	371
16	372
16	373
16	374
17	376
17	377
17	378
17	379
17	380
17	381
17	382
17	383
17	384
18	385
18	386
18	387
18	388
18	389
18	390
18	391
18	392
18	393
18	394
19	395
19	396
19	397
19	398
19	399
19	400
19	401
19	402
19	403
19	404
19	405
19	406
19	407
19	408
19	409
19	410
20	411
20	412
20	413
20	414
20	415
20	416
20	417
20	418
20	419
20	420
20	421
20	422
20	423
20	424
20	425
20	426
21	427
21	428
21	429
21	430
21	431
21	432
21	433
21	434
21	435
21	436
21	437
21	438
21	439
21	440
21	441
21	442
22	443
22	444
22	445
22	446
22	447
22	448
22	449
22	450
22	451
22	452
22	453
22	454
22	455
22	456
22	457
22	458
22	459
23	1
23	2
23	3
23	4
23	5
23	6
23	7
23	8
23	9
23	10
23	11
23	12
23	13
23	14
23	15
23	16
23	17
23	18
23	19
23	20
23	21
23	22
23	23
23	24
23	25
23	26
23	27
23	28
23	29
23	30
23	31
23	32
23	33
23	34
23	35
23	36
23	37
23	38
23	39
23	40
23	41
23	42
23	43
24	443
24	444
24	445
24	446
24	447
24	448
24	449
24	450
24	451
24	452
24	453
24	454
24	455
24	456
24	457
24	458
24	459
25	460
25	461
25	462
25	463
25	464
25	465
25	466
25	467
25	468
25	469
25	470
25	471
25	472
25	473
25	474
25	475
25	476
25	477
25	478
25	479
25	480
25	481
25	482
25	483
25	484
25	485
26	1
26	2
26	3
26	4
26	5
26	6
26	7
26	8
26	9
26	10
26	11
26	12
26	13
26	14
26	15
26	16
26	17
26	18
26	19
26	20
26	21
26	22
26	23
26	24
26	25
26	486
26	26
26	27
26	28
26	29
26	30
26	31
26	32
26	33
26	34
26	35
26	36
26	37
26	38
26	39
26	40
26	41
26	42
26	43
27	385
27	386
27	387
27	388
27	389
27	390
27	391
27	392
27	393
27	394
27	487
28	385
28	386
28	387
28	388
28	389
28	390
28	391
28	392
28	393
28	394
28	487
29	385
29	386
29	387
29	388
29	389
29	390
29	391
29	392
29	393
29	394
29	487
30	385
30	386
30	387
30	388
30	389
30	390
30	391
30	392
30	393
30	394
30	487
30	488
30	489
31	385
31	386
31	387
31	388
31	389
31	390
31	391
31	392
31	393
31	394
31	487
31	488
31	489
32	490
32	491
32	492
32	493
32	494
32	495
32	496
32	497
32	498
32	499
32	500
32	501
32	502
32	503
33	460
33	461
33	462
33	463
33	464
33	465
33	466
33	467
33	468
33	469
33	470
33	471
33	472
33	473
33	504
33	505
33	476
33	477
33	478
33	479
33	480
33	481
33	482
33	483
33	484
33	485
34	460
34	506
34	462
34	463
34	464
34	465
34	466
34	467
34	468
34	469
34	470
34	471
34	472
34	473
34	504
34	505
34	476
34	477
34	478
34	479
34	480
34	481
34	482
34	483
34	484
34	485
35	507
35	508
35	509
35	510
35	511
35	512
35	513
35	514
35	515
35	516
35	517
35	518
35	519
35	520
35	521
35	522
35	523
35	524
35	525
35	526
35	527
35	528
35	529
35	530
35	531
35	532
35	533
35	534
35	535
36	536
36	506
36	462
36	463
36	464
36	465
36	466
36	467
36	468
36	469
36	470
36	471
36	472
36	473
36	504
36	505
36	476
36	477
36	478
36	479
36	480
36	481
36	482
36	483
36	484
36	485
37	537
37	538
37	539
37	540
37	541
37	542
37	543
37	544
37	545
37	546
37	547
37	548
37	549
37	550
37	551
37	552
37	553
37	554
37	555
63	910
63	911
63	912
63	913
63	914
63	915
63	916
63	917
63	918
63	919
63	920
63	921
63	922
63	923
94	1101
94	1102
94	1103
94	1104
94	1105
94	1106
94	1107
94	1108
94	1109
94	1110
94	1111
94	1112
94	1113
94	1114
94	1115
94	1116
94	1117
94	1118
94	1119
94	1120
40	560
40	112
40	113
40	114
40	115
40	116
40	117
40	118
40	119
40	561
40	120
40	121
40	122
40	123
40	124
40	125
40	126
41	562
41	563
41	564
41	565
41	566
41	567
41	568
41	569
41	570
41	571
41	572
41	573
41	574
42	575
42	576
42	577
42	578
42	579
42	580
42	581
42	582
42	583
42	584
42	585
42	586
42	587
42	588
42	589
42	590
43	591
43	592
43	593
43	594
43	595
43	596
43	597
43	598
43	599
43	600
43	601
43	602
43	603
43	604
43	605
43	606
43	607
94	1121
94	1122
95	1123
95	1124
95	1125
95	1126
95	1127
95	1128
95	1129
95	1130
95	1131
95	1132
95	1133
95	1134
95	1135
95	1136
95	1137
95	1138
95	1139
95	1140
95	1141
95	1142
95	1143
95	1144
95	1145
95	1146
95	1147
95	1148
101	1164
101	1165
101	1166
101	1167
101	1168
101	1169
101	1170
101	1171
101	1172
101	1173
101	1174
101	1190
101	1189
101	1187
101	1178
101	1188
101	1186
101	1181
101	1182
101	1183
101	1184
101	1185
81	940
81	941
81	942
81	943
81	944
81	945
81	946
81	947
81	948
148	3735
81	949
81	950
81	951
81	952
81	953
81	954
81	955
81	956
81	957
81	958
81	959
81	960
81	961
81	962
81	963
81	964
81	965
81	966
81	967
81	968
81	969
81	970
81	971
81	972
81	973
81	974
81	975
81	976
81	977
81	978
81	979
81	980
81	981
81	982
81	983
81	984
81	985
81	986
81	987
81	988
81	989
81	990
81	991
81	992
60	790
60	777
60	793
60	783
60	782
60	795
60	780
60	784
60	796
60	794
60	778
60	788
60	781
60	789
60	786
60	785
60	787
60	779
60	791
60	792
61	797
61	798
61	799
61	800
61	801
61	802
61	803
61	804
61	805
61	806
61	807
61	808
61	809
62	861
62	823
62	855
62	854
62	833
62	860
62	856
62	853
62	866
62	835
62	857
62	859
62	832
62	858
62	848
62	862
62	822
62	863
62	819
62	838
62	813
62	812
62	820
62	814
62	816
62	829
62	826
62	825
62	865
62	837
62	830
62	831
62	840
62	864
62	847
62	850
62	843
62	845
62	846
62	815
62	810
62	811
62	817
62	818
62	834
62	842
62	844
62	849
62	851
62	836
62	827
62	821
62	828
62	824
62	841
62	852
62	839
64	560
64	112
64	113
64	114
64	115
64	116
64	117
64	118
64	119
64	561
64	120
64	121
64	122
64	123
64	124
64	125
64	126
65	145
65	146
65	147
65	148
65	149
65	150
65	924
65	152
65	153
65	154
65	155
65	156
65	157
65	158
65	159
65	160
65	161
65	162
65	163
65	164
96	1161
96	1158
96	1160
96	1155
96	1152
96	1153
96	1149
96	1162
96	1151
96	1150
96	1159
96	1157
96	1156
96	1154
148	3746
148	3695
148	3708
148	3738
148	3741
148	3716
148	3753
148	3745
148	3729
148	3712
148	3724
148	3721
148	3717
148	3722
148	3693
148	3760
148	3730
148	3699
148	3704
148	3763
148	3752
148	3711
148	3697
148	3726
148	3702
148	3703
148	3723
148	3749
148	3755
148	3715
148	3742
148	3762
148	3757
148	3713
148	3754
148	3750
148	3694
148	3701
148	3764
148	3739
148	3710
148	3725
148	3718
148	3714
99	1164
99	1165
99	1166
99	1167
99	1168
99	1169
99	1170
99	1171
99	1172
99	1173
99	1174
99	1175
99	1176
99	1177
99	1178
99	1179
99	1180
99	1181
99	1182
99	1183
99	1184
99	1185
148	3761
148	3720
148	3732
148	3698
148	3733
148	3700
148	3707
148	3751
148	3737
148	3743
148	3727
148	3705
148	3734
148	3744
148	3731
109	1446
109	1438
109	1454
109	1442
109	1433
109	1436
109	1443
109	1447
109	1450
109	1439
109	1441
109	1453
109	1452
109	1449
109	1448
109	1432
109	1440
109	1457
109	1434
109	1455
109	1445
109	1437
109	1444
109	1451
109	1435
109	1458
109	1456
110	1459
110	1460
110	1461
110	1462
110	1463
110	1464
110	1465
110	1466
110	1467
110	1468
110	1469
110	1470
110	1471
110	1472
110	1473
110	1474
110	1475
110	1476
110	1477
110	1478
110	1479
110	1480
110	1481
110	1482
110	1483
110	1484
110	1485
110	1486
110	1487
110	1488
110	1489
110	1490
110	1491
110	1492
110	1493
110	1494
93	1073
93	867
93	868
93	1083
93	1064
93	1095
93	1088
93	1082
93	1061
93	1093
93	1087
93	1072
93	1062
93	1092
93	1086
93	881
93	882
93	883
93	884
93	1099
93	1071
93	1060
93	1100
93	1074
93	1085
93	1089
93	1098
93	1097
93	1096
93	1076
93	1090
93	1059
93	1058
93	1057
93	1077
93	1091
93	1068
93	1070
93	1069
93	1075
93	1056
93	1055
93	1054
93	1053
93	1052
93	1094
93	1067
93	1066
93	1065
93	1063
93	1084
93	1081
93	1080
93	1079
93	1078
93	921
93	922
93	923
105	1394
105	1356
105	1355
105	1380
105	1401
105	1399
105	1397
105	1396
105	1377
105	1387
105	1385
105	1384
105	1363
105	1361
105	1373
105	1371
105	1372
105	1368
105	1367
105	1366
105	1360
105	1359
105	1358
105	1357
105	1389
105	1402
105	1400
105	1398
105	1379
105	1378
105	1388
105	1386
105	1365
105	1364
105	1362
105	1374
105	1353
105	1352
105	1351
105	1350
105	1393
105	1392
105	1391
105	1390
105	1395
105	1354
105	1376
105	1382
105	1381
105	1369
105	1375
105	1383
105	1370
135	2912
135	2964
135	2890
135	2934
135	2896
135	2956
135	2941
135	2933
135	2892
135	2955
135	2940
135	2910
135	2894
135	2954
135	2939
135	2888
135	2925
135	2893
135	2942
135	2965
135	2889
135	2967
135	2963
135	2909
135	2891
135	2966
135	2913
135	2935
135	2968
135	2943
107	1404
107	1394
107	1356
107	1355
107	1380
107	1401
107	1399
107	1397
107	1396
107	1377
107	1387
107	1385
107	1384
107	1363
107	1361
107	1373
107	1371
107	1372
107	1368
107	1367
107	1366
107	1360
107	1359
107	1358
107	1357
107	1389
107	1402
107	1400
107	1398
107	1379
107	1378
107	1388
107	1386
107	1365
107	1364
107	1362
107	1374
107	1353
107	1352
107	1351
107	1350
107	1393
107	1392
107	1391
107	1390
107	1395
107	1354
107	1376
107	1382
107	1381
107	1369
107	1375
107	1383
107	1370
135	2959
135	2958
135	2957
135	2918
135	2944
135	2884
135	2883
126	2117
126	2119
126	2099
126	2091
126	2086
126	2084
126	2083
126	2104
126	2114
126	2115
126	2093
126	2096
126	2097
126	2120
126	2085
126	2095
126	2087
126	2105
126	2098
126	2110
126	2090
126	2108
126	2088
126	2094
126	2089
126	2118
126	2109
126	2111
126	2106
126	2112
126	2092
126	2101
126	2100
126	2121
126	2103
126	2116
126	2102
126	2113
126	2123
126	2122
126	2107
135	2882
135	2920
135	2948
135	2904
135	2906
135	2905
135	2915
135	2949
135	2885
135	2887
135	2886
135	2917
135	2945
135	2908
135	2907
135	2911
135	2928
135	2947
135	2938
135	2937
135	2936
135	2931
135	2919
135	2962
117	1711
117	1712
117	1713
117	1714
117	1715
117	1716
117	1717
117	1718
117	1719
117	1720
117	1721
117	1722
117	1723
117	1724
117	1725
117	1726
117	1727
117	1728
117	1729
117	1730
117	1731
117	1732
117	1733
117	1734
117	1735
117	1736
117	1737
117	1738
117	1739
117	1740
117	1741
117	1742
117	1743
117	1744
117	1745
117	1746
117	1747
117	1748
117	1749
117	1750
117	1751
117	1752
117	1753
117	1754
117	1755
117	1756
117	1757
117	1758
117	1759
117	1760
117	1761
117	1762
117	1763
117	1764
117	1765
117	1766
117	1767
117	1768
117	1769
117	1770
117	1771
117	1772
117	1773
117	1774
117	1775
117	1776
117	1777
117	1778
117	1779
117	1780
117	1781
117	1782
117	1783
117	1784
117	1785
117	1786
117	1787
117	1788
117	1789
117	1790
117	1791
117	1792
117	1793
135	2961
135	2960
135	2922
135	2877
135	2876
135	2875
135	2874
135	2900
135	2898
135	2897
135	2895
135	2929
135	2926
135	2923
135	2921
135	2953
135	2952
135	2951
135	2950
135	2932
135	2930
135	2927
135	2924
135	2903
135	2902
135	2901
135	2899
135	2881
135	2880
135	2879
135	2878
135	2916
135	2946
135	2914
137	3001
137	3003
137	3004
137	2997
137	3002
137	3000
137	3007
137	2999
137	2996
137	2994
137	3008
137	2995
137	2991
137	2989
137	2992
137	3005
137	2993
137	3006
137	2990
137	2998
\.


--
-- Name: archived_dataset_file_archived_dataset_file_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.archived_dataset_file_archived_dataset_file_id_seq', 1, false);


--
-- Name: audit_event_audit_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.audit_event_audit_id_seq', 1, false);


--
-- Name: audit_log_event_audit_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.audit_log_event_audit_id_seq', 2, true);


--
-- Name: audit_log_event_type_audit_log_event_type_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.audit_log_event_type_audit_log_event_type_id_seq', 1, false);


--
-- Name: audit_user_login_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.audit_user_login_id_seq', 591, true);


--
-- Name: authorities_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.authorities_id_seq', 10, true);


--
-- Name: completion_status_completion_status_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.completion_status_completion_status_id_seq', 1, false);


--
-- Name: configuration_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.configuration_id_seq', 10, true);


--
-- Name: crf_crf_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.crf_crf_id_seq', 99, true);


--
-- Name: crf_version_crf_version_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.crf_version_crf_version_id_seq', 148, true);


--
-- Name: crf_version_media_crf_version_media_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.crf_version_media_crf_version_media_id_seq', 1, false);


--
-- Name: dataset_dataset_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dataset_dataset_id_seq', 1, false);


--
-- Name: dataset_item_status_dataset_item_status_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dataset_item_status_dataset_item_status_id_seq', 1, false);


--
-- Name: dc_computed_event_dc_summary_event_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dc_computed_event_dc_summary_event_id_seq', 1, false);


--
-- Name: dc_event_dc_event_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dc_event_dc_event_id_seq', 1, false);


--
-- Name: dc_primitive_dc_primitive_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dc_primitive_dc_primitive_id_seq', 1, false);


--
-- Name: dc_section_event_dc_event_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dc_section_event_dc_event_id_seq', 1, false);


--
-- Name: dc_send_email_event_dc_event_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dc_send_email_event_dc_event_id_seq', 1, false);


--
-- Name: dc_substitution_event_dc_event_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dc_substitution_event_dc_event_id_seq', 1, false);


--
-- Name: decision_condition_decision_condition_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.decision_condition_decision_condition_id_seq', 1, false);


--
-- Name: discrepancy_note_discrepancy_note_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.discrepancy_note_discrepancy_note_id_seq', 1, false);


--
-- Name: discrepancy_note_type_discrepancy_note_type_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.discrepancy_note_type_discrepancy_note_type_id_seq', 1, false);


--
-- Name: dyn_item_form_metadata_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dyn_item_form_metadata_id_seq', 1, false);


--
-- Name: dyn_item_group_metadata_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.dyn_item_group_metadata_id_seq', 1, false);


--
-- Name: event_crf_event_crf_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.event_crf_event_crf_id_seq', 1, false);


--
-- Name: event_crf_flag_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.event_crf_flag_id_seq', 1, false);


--
-- Name: event_crf_flag_workflow_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.event_crf_flag_workflow_id_seq', 1, false);


--
-- Name: event_definition_crf_event_definition_crf_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.event_definition_crf_event_definition_crf_id_seq', 3, true);


--
-- Name: event_definition_crf_item_tag_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.event_definition_crf_item_tag_id_seq', 1, false);


--
-- Name: event_definition_crf_tag_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.event_definition_crf_tag_id_seq', 1, false);


--
-- Name: export_format_export_format_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.export_format_export_format_id_seq', 1, false);


--
-- Name: filter_filter_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.filter_filter_id_seq', 1, false);


--
-- Name: group_class_types_group_class_type_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.group_class_types_group_class_type_id_seq', 1, false);


--
-- Name: item_data_flag_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.item_data_flag_id_seq', 1, false);


--
-- Name: item_data_flag_workflow_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.item_data_flag_workflow_id_seq', 1, false);


--
-- Name: item_data_item_data_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.item_data_item_data_id_seq', 1, false);


--
-- Name: item_data_type_item_data_type_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.item_data_type_item_data_type_id_seq', 1, false);


--
-- Name: item_form_metadata_item_form_metadata_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.item_form_metadata_item_form_metadata_id_seq', 5658, true);


--
-- Name: item_group_item_group_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.item_group_item_group_id_seq', 138, true);


--
-- Name: item_group_metadata_item_group_metadata_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.item_group_metadata_item_group_metadata_id_seq', 5657, true);


--
-- Name: item_item_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.item_item_id_seq', 3764, true);


--
-- Name: item_reference_type_item_reference_type_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.item_reference_type_item_reference_type_id_seq', 1, false);


--
-- Name: measurement_unit_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.measurement_unit_id_seq', 32, true);


--
-- Name: null_value_type_null_value_type_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.null_value_type_null_value_type_id_seq', 1, false);


--
-- Name: openclinica_version_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.openclinica_version_id_seq', 1, true);


--
-- Name: privilege_priv_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.privilege_priv_id_seq', 1, false);


--
-- Name: resolution_status_resolution_status_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.resolution_status_resolution_status_id_seq', 1, false);


--
-- Name: response_set_response_set_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.response_set_response_set_id_seq', 2123, true);


--
-- Name: response_type_response_type_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.response_type_response_type_id_seq', 1, false);


--
-- Name: rule_action_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_action_id_seq', 56, true);


--
-- Name: rule_action_property_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_action_property_id_seq', 1, false);


--
-- Name: rule_action_run_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_action_run_id_seq', 56, true);


--
-- Name: rule_action_run_log_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_action_run_log_id_seq', 1, false);


--
-- Name: rule_action_stratification_factor_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_action_stratification_factor_id_seq', 1, false);


--
-- Name: rule_expression_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_expression_id_seq', 106, true);


--
-- Name: rule_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_id_seq', 56, true);


--
-- Name: rule_set_audit_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_set_audit_id_seq', 1, false);


--
-- Name: rule_set_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_set_id_seq', 50, true);


--
-- Name: rule_set_rule_audit_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_set_rule_audit_id_seq', 1, false);


--
-- Name: rule_set_rule_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.rule_set_rule_id_seq', 56, true);


--
-- Name: scd_item_metadata_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.scd_item_metadata_id_seq', 364, true);


--
-- Name: section_section_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.section_section_id_seq', 499, true);


--
-- Name: status_status_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.status_status_id_seq', 1, false);


--
-- Name: study_event_definition_study_event_definition_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_event_definition_study_event_definition_id_seq', 1, true);


--
-- Name: study_event_study_event_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_event_study_event_id_seq', 1, false);


--
-- Name: study_group_class_study_group_class_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_group_class_study_group_class_id_seq', 1, false);


--
-- Name: study_group_study_group_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_group_study_group_id_seq', 1, false);


--
-- Name: study_module_status_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_module_status_id_seq', 1, false);


--
-- Name: study_parameter_study_parameter_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_parameter_study_parameter_id_seq', 1, false);


--
-- Name: study_parameter_value_study_parameter_value_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_parameter_value_study_parameter_value_id_seq', 2, true);


--
-- Name: study_study_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_study_id_seq', 4, true);


--
-- Name: study_subject_study_subject_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_subject_study_subject_id_seq', 1, true);


--
-- Name: study_type_study_type_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.study_type_study_type_id_seq', 1, false);


--
-- Name: subject_event_status_subject_event_status_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.subject_event_status_subject_event_status_id_seq', 1, false);


--
-- Name: subject_group_map_subject_group_map_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.subject_group_map_subject_group_map_id_seq', 1, false);


--
-- Name: subject_subject_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.subject_subject_id_seq', 1, true);


--
-- Name: tag_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.tag_id_seq', 1, false);


--
-- Name: usage_statistics_data_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.usage_statistics_data_id_seq', 1, true);


--
-- Name: user_account_user_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.user_account_user_id_seq', 10, true);


--
-- Name: user_role_role_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.user_role_role_id_seq', 1, false);


--
-- Name: user_type_user_type_id_seq; Type: SEQUENCE SET; Schema: public; Owner: clinica
--

SELECT pg_catalog.setval('public.user_type_user_type_id_seq', 1, false);


--
-- Name: archived_dataset_file archived_dataset_file_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.archived_dataset_file
    ADD CONSTRAINT archived_dataset_file_pkey PRIMARY KEY (archived_dataset_file_id);


--
-- Name: audit_event audit_event_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_event
    ADD CONSTRAINT audit_event_pkey PRIMARY KEY (audit_id);


--
-- Name: audit_log_event audit_log_event_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_log_event
    ADD CONSTRAINT audit_log_event_pkey PRIMARY KEY (audit_id);


--
-- Name: audit_log_event_type audit_log_event_type_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_log_event_type
    ADD CONSTRAINT audit_log_event_type_pkey PRIMARY KEY (audit_log_event_type_id);


--
-- Name: audit_user_login audit_user_login_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_user_login
    ADD CONSTRAINT audit_user_login_pkey PRIMARY KEY (id);


--
-- Name: completion_status completion_status_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.completion_status
    ADD CONSTRAINT completion_status_pkey PRIMARY KEY (completion_status_id);


--
-- Name: configuration configuration_key_key; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.configuration
    ADD CONSTRAINT configuration_key_key UNIQUE (key);


--
-- Name: configuration configuration_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.configuration
    ADD CONSTRAINT configuration_pkey PRIMARY KEY (id);


--
-- Name: crf crf_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf
    ADD CONSTRAINT crf_pkey PRIMARY KEY (crf_id);


--
-- Name: crf_version_media crf_version_media_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf_version_media
    ADD CONSTRAINT crf_version_media_pkey PRIMARY KEY (crf_version_media_id);


--
-- Name: crf_version crf_version_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf_version
    ADD CONSTRAINT crf_version_pkey PRIMARY KEY (crf_version_id);


--
-- Name: databasechangeloglock databasechangeloglock_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.databasechangeloglock
    ADD CONSTRAINT databasechangeloglock_pkey PRIMARY KEY (id);


--
-- Name: dataset_item_status dataset_item_status_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset_item_status
    ADD CONSTRAINT dataset_item_status_pkey PRIMARY KEY (dataset_item_status_id);


--
-- Name: dataset dataset_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset
    ADD CONSTRAINT dataset_pkey PRIMARY KEY (dataset_id);


--
-- Name: dc_computed_event dc_computed_event_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_computed_event
    ADD CONSTRAINT dc_computed_event_pkey PRIMARY KEY (dc_summary_event_id);


--
-- Name: dc_event dc_event_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_event
    ADD CONSTRAINT dc_event_pkey PRIMARY KEY (dc_event_id);


--
-- Name: dc_primitive dc_primitive_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_primitive
    ADD CONSTRAINT dc_primitive_pkey PRIMARY KEY (dc_primitive_id);


--
-- Name: dc_section_event dc_section_event_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_section_event
    ADD CONSTRAINT dc_section_event_pkey PRIMARY KEY (dc_event_id);


--
-- Name: dc_send_email_event dc_send_email_event_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_send_email_event
    ADD CONSTRAINT dc_send_email_event_pkey PRIMARY KEY (dc_event_id);


--
-- Name: dc_substitution_event dc_substitution_event_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_substitution_event
    ADD CONSTRAINT dc_substitution_event_pkey PRIMARY KEY (dc_event_id);


--
-- Name: decision_condition decision_condition_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.decision_condition
    ADD CONSTRAINT decision_condition_pkey PRIMARY KEY (decision_condition_id);


--
-- Name: discrepancy_note discrepancy_note_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.discrepancy_note
    ADD CONSTRAINT discrepancy_note_pkey PRIMARY KEY (discrepancy_note_id);


--
-- Name: discrepancy_note_type discrepancy_note_type_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.discrepancy_note_type
    ADD CONSTRAINT discrepancy_note_type_pkey PRIMARY KEY (discrepancy_note_type_id);


--
-- Name: event_definition_crf_tag duplicate_crfpath_tag_uniqueness_key; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf_tag
    ADD CONSTRAINT duplicate_crfpath_tag_uniqueness_key UNIQUE (path, tag_id);


--
-- Name: study_event duplicate_event_uniqueness_key; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event
    ADD CONSTRAINT duplicate_event_uniqueness_key UNIQUE (study_event_definition_id, study_subject_id, sample_ordinal);


--
-- Name: event_definition_crf_item_tag duplicate_itempath_tag_uniqueness_key; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf_item_tag
    ADD CONSTRAINT duplicate_itempath_tag_uniqueness_key UNIQUE (path, tag_id);


--
-- Name: dyn_item_form_metadata dyn_item_form_metadata_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dyn_item_form_metadata
    ADD CONSTRAINT dyn_item_form_metadata_pkey PRIMARY KEY (id);


--
-- Name: dyn_item_group_metadata dyn_item_group_metadata_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dyn_item_group_metadata
    ADD CONSTRAINT dyn_item_group_metadata_pkey PRIMARY KEY (id);


--
-- Name: event_crf event_crf_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf
    ADD CONSTRAINT event_crf_pkey PRIMARY KEY (event_crf_id);


--
-- Name: event_definition_crf event_definition_crf_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf
    ADD CONSTRAINT event_definition_crf_pkey PRIMARY KEY (event_definition_crf_id);


--
-- Name: export_format export_format_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.export_format
    ADD CONSTRAINT export_format_pkey PRIMARY KEY (export_format_id);


--
-- Name: filter filter_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.filter
    ADD CONSTRAINT filter_pkey PRIMARY KEY (filter_id);


--
-- Name: group_class_types group_class_types_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.group_class_types
    ADD CONSTRAINT group_class_types_pkey PRIMARY KEY (group_class_type_id);


--
-- Name: item_data item_data_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data
    ADD CONSTRAINT item_data_pkey PRIMARY KEY (item_data_id);


--
-- Name: item_data_type item_data_type_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data_type
    ADD CONSTRAINT item_data_type_pkey PRIMARY KEY (item_data_type_id);


--
-- Name: item_form_metadata item_form_metadata_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_form_metadata
    ADD CONSTRAINT item_form_metadata_pkey PRIMARY KEY (item_form_metadata_id);


--
-- Name: item_group_metadata item_group_metadata_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group_metadata
    ADD CONSTRAINT item_group_metadata_pkey PRIMARY KEY (item_group_metadata_id);


--
-- Name: item_group item_group_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group
    ADD CONSTRAINT item_group_pkey PRIMARY KEY (item_group_id);


--
-- Name: item item_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item
    ADD CONSTRAINT item_pkey PRIMARY KEY (item_id);


--
-- Name: item_reference_type item_reference_type_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_reference_type
    ADD CONSTRAINT item_reference_type_pkey PRIMARY KEY (item_reference_type_id);


--
-- Name: measurement_unit measurement_unit_name_key; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.measurement_unit
    ADD CONSTRAINT measurement_unit_name_key UNIQUE (name);


--
-- Name: measurement_unit measurement_unit_oc_oid_key; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.measurement_unit
    ADD CONSTRAINT measurement_unit_oc_oid_key UNIQUE (oc_oid);


--
-- Name: measurement_unit measurement_unit_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.measurement_unit
    ADD CONSTRAINT measurement_unit_pkey PRIMARY KEY (id);


--
-- Name: null_value_type null_value_type_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.null_value_type
    ADD CONSTRAINT null_value_type_pkey PRIMARY KEY (null_value_type_id);


--
-- Name: oc_qrtz_blob_triggers oc_qrtz_blob_triggers_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_blob_triggers
    ADD CONSTRAINT oc_qrtz_blob_triggers_pkey PRIMARY KEY (trigger_name, trigger_group);


--
-- Name: oc_qrtz_calendars oc_qrtz_calendars_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_calendars
    ADD CONSTRAINT oc_qrtz_calendars_pkey PRIMARY KEY (calendar_name);


--
-- Name: oc_qrtz_cron_triggers oc_qrtz_cron_triggers_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_cron_triggers
    ADD CONSTRAINT oc_qrtz_cron_triggers_pkey PRIMARY KEY (trigger_name, trigger_group);


--
-- Name: oc_qrtz_fired_triggers oc_qrtz_fired_triggers_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_fired_triggers
    ADD CONSTRAINT oc_qrtz_fired_triggers_pkey PRIMARY KEY (entry_id);


--
-- Name: oc_qrtz_job_details oc_qrtz_job_details_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_job_details
    ADD CONSTRAINT oc_qrtz_job_details_pkey PRIMARY KEY (job_name, job_group);


--
-- Name: oc_qrtz_job_listeners oc_qrtz_job_listeners_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_job_listeners
    ADD CONSTRAINT oc_qrtz_job_listeners_pkey PRIMARY KEY (job_name, job_group, job_listener);


--
-- Name: oc_qrtz_locks oc_qrtz_locks_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_locks
    ADD CONSTRAINT oc_qrtz_locks_pkey PRIMARY KEY (lock_name, sched_name);


--
-- Name: oc_qrtz_paused_trigger_grps oc_qrtz_paused_trigger_grps_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_paused_trigger_grps
    ADD CONSTRAINT oc_qrtz_paused_trigger_grps_pkey PRIMARY KEY (trigger_group);


--
-- Name: oc_qrtz_scheduler_state oc_qrtz_scheduler_state_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_scheduler_state
    ADD CONSTRAINT oc_qrtz_scheduler_state_pkey PRIMARY KEY (instance_name);


--
-- Name: oc_qrtz_simple_triggers oc_qrtz_simple_triggers_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_simple_triggers
    ADD CONSTRAINT oc_qrtz_simple_triggers_pkey PRIMARY KEY (trigger_name, trigger_group);


--
-- Name: oc_qrtz_trigger_listeners oc_qrtz_trigger_listeners_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_trigger_listeners
    ADD CONSTRAINT oc_qrtz_trigger_listeners_pkey PRIMARY KEY (trigger_name, trigger_group, trigger_listener);


--
-- Name: oc_qrtz_triggers oc_qrtz_triggers_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_triggers
    ADD CONSTRAINT oc_qrtz_triggers_pkey PRIMARY KEY (trigger_name, trigger_group);


--
-- Name: openclinica_version openclinica_version_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.openclinica_version
    ADD CONSTRAINT openclinica_version_pkey PRIMARY KEY (id);


--
-- Name: event_crf_flag pk_event_crf_flag; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf_flag
    ADD CONSTRAINT pk_event_crf_flag PRIMARY KEY (id);


--
-- Name: event_crf_flag_workflow pk_event_crf_flag_workflow; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf_flag_workflow
    ADD CONSTRAINT pk_event_crf_flag_workflow PRIMARY KEY (id);


--
-- Name: event_definition_crf_item_tag pk_event_definition_crf_item_tag; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf_item_tag
    ADD CONSTRAINT pk_event_definition_crf_item_tag PRIMARY KEY (id);


--
-- Name: event_definition_crf_tag pk_event_definition_crf_tag; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf_tag
    ADD CONSTRAINT pk_event_definition_crf_tag PRIMARY KEY (id);


--
-- Name: item_data_flag pk_item_data_flag; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data_flag
    ADD CONSTRAINT pk_item_data_flag PRIMARY KEY (id);


--
-- Name: item_data_flag_workflow pk_item_data_flag_workflow; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data_flag_workflow
    ADD CONSTRAINT pk_item_data_flag_workflow PRIMARY KEY (id);


--
-- Name: item_data pk_item_data_new; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data
    ADD CONSTRAINT pk_item_data_new UNIQUE (item_id, event_crf_id, ordinal);


--
-- Name: tag pk_tag; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.tag
    ADD CONSTRAINT pk_tag PRIMARY KEY (id);


--
-- Name: privilege privilege_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.privilege
    ADD CONSTRAINT privilege_pkey PRIMARY KEY (priv_id);


--
-- Name: resolution_status resolution_status_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.resolution_status
    ADD CONSTRAINT resolution_status_pkey PRIMARY KEY (resolution_status_id);


--
-- Name: response_set response_set_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.response_set
    ADD CONSTRAINT response_set_pkey PRIMARY KEY (response_set_id);


--
-- Name: response_type response_type_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.response_type
    ADD CONSTRAINT response_type_pkey PRIMARY KEY (response_type_id);


--
-- Name: rule_action rule_action_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action
    ADD CONSTRAINT rule_action_pkey PRIMARY KEY (id);


--
-- Name: rule_action_property rule_action_property_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action_property
    ADD CONSTRAINT rule_action_property_pkey PRIMARY KEY (id);


--
-- Name: rule_action_run_log rule_action_run_log_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action_run_log
    ADD CONSTRAINT rule_action_run_log_pkey PRIMARY KEY (id);


--
-- Name: rule_action_run rule_action_run_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action_run
    ADD CONSTRAINT rule_action_run_pkey PRIMARY KEY (id);


--
-- Name: rule_action_stratification_factor rule_action_stratification_factor_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_action_stratification_factor
    ADD CONSTRAINT rule_action_stratification_factor_pkey PRIMARY KEY (id);


--
-- Name: rule_expression rule_expression_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_expression
    ADD CONSTRAINT rule_expression_pkey PRIMARY KEY (id);


--
-- Name: rule rule_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule
    ADD CONSTRAINT rule_pkey PRIMARY KEY (id);


--
-- Name: rule_set_audit rule_set_audit_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_set_audit
    ADD CONSTRAINT rule_set_audit_pkey PRIMARY KEY (id);


--
-- Name: rule_set rule_set_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_set
    ADD CONSTRAINT rule_set_pkey PRIMARY KEY (id);


--
-- Name: rule_set_rule_audit rule_set_rule_audit_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_set_rule_audit
    ADD CONSTRAINT rule_set_rule_audit_pkey PRIMARY KEY (id);


--
-- Name: rule_set_rule rule_set_rule_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.rule_set_rule
    ADD CONSTRAINT rule_set_rule_pkey PRIMARY KEY (id);


--
-- Name: scd_item_metadata scd_item_metadata_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.scd_item_metadata
    ADD CONSTRAINT scd_item_metadata_pkey PRIMARY KEY (id);


--
-- Name: section section_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.section
    ADD CONSTRAINT section_pkey PRIMARY KEY (section_id);


--
-- Name: status status_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.status
    ADD CONSTRAINT status_pkey PRIMARY KEY (status_id);


--
-- Name: study_event_definition study_event_definition_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event_definition
    ADD CONSTRAINT study_event_definition_pkey PRIMARY KEY (study_event_definition_id);


--
-- Name: study_event study_event_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event
    ADD CONSTRAINT study_event_pkey PRIMARY KEY (study_event_id);


--
-- Name: study_group_class study_group_class_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_group_class
    ADD CONSTRAINT study_group_class_pkey PRIMARY KEY (study_group_class_id);


--
-- Name: study_group study_group_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_group
    ADD CONSTRAINT study_group_pkey PRIMARY KEY (study_group_id);


--
-- Name: study_module_status study_module_status_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_module_status
    ADD CONSTRAINT study_module_status_pkey PRIMARY KEY (id);


--
-- Name: study_parameter study_parameter_handle_key; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_parameter
    ADD CONSTRAINT study_parameter_handle_key UNIQUE (handle);


--
-- Name: study_parameter study_parameter_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_parameter
    ADD CONSTRAINT study_parameter_pkey PRIMARY KEY (study_parameter_id);


--
-- Name: study study_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study
    ADD CONSTRAINT study_pkey PRIMARY KEY (study_id);


--
-- Name: study_subject study_subject_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_subject
    ADD CONSTRAINT study_subject_pkey PRIMARY KEY (study_subject_id);


--
-- Name: study_type study_type_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_type
    ADD CONSTRAINT study_type_pkey PRIMARY KEY (study_type_id);


--
-- Name: subject_event_status subject_event_status_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject_event_status
    ADD CONSTRAINT subject_event_status_pkey PRIMARY KEY (subject_event_status_id);


--
-- Name: subject_group_map subject_group_map_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject_group_map
    ADD CONSTRAINT subject_group_map_pkey PRIMARY KEY (subject_group_map_id);


--
-- Name: subject subject_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject
    ADD CONSTRAINT subject_pkey PRIMARY KEY (subject_id);


--
-- Name: crf uniq_crf_oc_oid; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf
    ADD CONSTRAINT uniq_crf_oc_oid UNIQUE (oc_oid);


--
-- Name: crf_version uniq_crf_version_oc_oid; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf_version
    ADD CONSTRAINT uniq_crf_version_oc_oid UNIQUE (oc_oid);


--
-- Name: item_group uniq_item_group_oc_oid; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group
    ADD CONSTRAINT uniq_item_group_oc_oid UNIQUE (oc_oid);


--
-- Name: item uniq_item_oc_oid; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item
    ADD CONSTRAINT uniq_item_oc_oid UNIQUE (oc_oid);


--
-- Name: event_crf uniq_study_event_crf_version_study_subject; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf
    ADD CONSTRAINT uniq_study_event_crf_version_study_subject UNIQUE (study_event_id, crf_version_id, study_subject_id);


--
-- Name: study_event_definition uniq_study_event_def_oid; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event_definition
    ADD CONSTRAINT uniq_study_event_def_oid UNIQUE (oc_oid);


--
-- Name: event_definition_crf uniq_study_event_def_study_crf; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf
    ADD CONSTRAINT uniq_study_event_def_study_crf UNIQUE (study_event_definition_id, study_id, crf_id);


--
-- Name: study uniq_study_oid; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study
    ADD CONSTRAINT uniq_study_oid UNIQUE (oc_oid);


--
-- Name: study_subject uniq_study_subject_oid; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_subject
    ADD CONSTRAINT uniq_study_subject_oid UNIQUE (oc_oid);


--
-- Name: usage_statistics_data usage_statistics_data_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.usage_statistics_data
    ADD CONSTRAINT usage_statistics_data_pkey PRIMARY KEY (id);


--
-- Name: user_account user_account_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.user_account
    ADD CONSTRAINT user_account_pkey PRIMARY KEY (user_id);


--
-- Name: user_role user_role_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.user_role
    ADD CONSTRAINT user_role_pkey PRIMARY KEY (role_id);


--
-- Name: user_type user_type_pkey; Type: CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.user_type
    ADD CONSTRAINT user_type_pkey PRIMARY KEY (user_type_id);


--
-- Name: crf_version_idx_crf; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX crf_version_idx_crf ON public.crf_version USING btree (crf_id);


--
-- Name: discrepancy_note_idx_entity_type; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX discrepancy_note_idx_entity_type ON public.discrepancy_note USING btree (entity_type);


--
-- Name: discrepancy_note_idx_parent; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX discrepancy_note_idx_parent ON public.discrepancy_note USING btree (discrepancy_note_id) WHERE ((parent_dn_id IS NULL) OR (parent_dn_id = 0));


--
-- Name: event_definition_crf_idx_crf; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX event_definition_crf_idx_crf ON public.event_definition_crf USING btree (crf_id);


--
-- Name: event_definition_crf_idx_parent_null; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX event_definition_crf_idx_parent_null ON public.event_definition_crf USING btree (parent_id) WHERE (parent_id IS NULL);


--
-- Name: event_definition_crf_idx_parent_zero; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX event_definition_crf_idx_parent_zero ON public.event_definition_crf USING btree (parent_id) WHERE ((parent_id IS NOT NULL) OR (parent_id <> 0));


--
-- Name: event_definition_crf_idx_study_event_definition; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX event_definition_crf_idx_study_event_definition ON public.event_definition_crf USING btree (study_event_definition_id);


--
-- Name: i_audit_event_audit_table; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_event_audit_table ON public.audit_event USING btree (audit_table);


--
-- Name: i_audit_event_context_study_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_event_context_study_id ON public.audit_event_context USING btree (study_id);


--
-- Name: i_audit_event_entity_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_event_entity_id ON public.audit_event USING btree (entity_id);


--
-- Name: i_audit_event_user_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_event_user_id ON public.audit_event USING btree (user_id);


--
-- Name: i_audit_log_event_audit_log_event_type_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_log_event_audit_log_event_type_id ON public.audit_log_event USING btree (audit_log_event_type_id);


--
-- Name: i_audit_log_event_audit_table; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_log_event_audit_table ON public.audit_log_event USING btree (audit_table);


--
-- Name: i_audit_log_event_entity_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_log_event_entity_id ON public.audit_log_event USING btree (entity_id);


--
-- Name: i_audit_log_event_event_crf_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_log_event_event_crf_id ON public.audit_log_event USING btree (event_crf_id);


--
-- Name: i_audit_log_event_event_crf_version_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_log_event_event_crf_version_id ON public.audit_log_event USING btree (event_crf_version_id);


--
-- Name: i_audit_log_event_study_event_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_log_event_study_event_id ON public.audit_log_event USING btree (study_event_id);


--
-- Name: i_audit_log_event_user_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_audit_log_event_user_id ON public.audit_log_event USING btree (user_id);


--
-- Name: i_completion_status_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_completion_status_status_id ON public.completion_status USING btree (status_id);


--
-- Name: i_crf_name; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_crf_name ON public.crf USING btree (name);


--
-- Name: i_crf_oc_oid; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_crf_oc_oid ON public.crf USING btree (oc_oid);


--
-- Name: i_crf_owner_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_crf_owner_id ON public.crf USING btree (owner_id);


--
-- Name: i_crf_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_crf_status_id ON public.crf USING btree (status_id);


--
-- Name: i_crf_version_name; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_crf_version_name ON public.crf_version USING btree (name);


--
-- Name: i_crf_version_oc_oid; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_crf_version_oc_oid ON public.crf_version USING btree (oc_oid);


--
-- Name: i_crf_version_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_crf_version_status_id ON public.crf_version USING btree (status_id);


--
-- Name: i_dataset_crf_version_map_dataset_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dataset_crf_version_map_dataset_id ON public.dataset_crf_version_map USING btree (dataset_id);


--
-- Name: i_dataset_crf_version_map_event_definition_crf_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dataset_crf_version_map_event_definition_crf_id ON public.dataset_crf_version_map USING btree (event_definition_crf_id);


--
-- Name: i_dataset_filter_map_dataset_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dataset_filter_map_dataset_id ON public.dataset_filter_map USING btree (dataset_id);


--
-- Name: i_dataset_filter_map_filter_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dataset_filter_map_filter_id ON public.dataset_filter_map USING btree (filter_id);


--
-- Name: i_dataset_filter_map_ordinal; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dataset_filter_map_ordinal ON public.dataset_filter_map USING btree (ordinal);


--
-- Name: i_dataset_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dataset_status_id ON public.dataset USING btree (status_id);


--
-- Name: i_dataset_study_group_class_map_dataset_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dataset_study_group_class_map_dataset_id ON public.dataset_study_group_class_map USING btree (dataset_id);


--
-- Name: i_dataset_study_group_class_map_study_group_class_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dataset_study_group_class_map_study_group_class_id ON public.dataset_study_group_class_map USING btree (study_group_class_id);


--
-- Name: i_dc_computed_event_dc_event_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dc_computed_event_dc_event_id ON public.dc_computed_event USING btree (dc_event_id);


--
-- Name: i_dc_computed_event_item_target_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dc_computed_event_item_target_id ON public.dc_computed_event USING btree (item_target_id);


--
-- Name: i_dc_primitive_decision_condition_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dc_primitive_decision_condition_id ON public.dc_primitive USING btree (decision_condition_id);


--
-- Name: i_dc_primitive_dynamic_value_item_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dc_primitive_dynamic_value_item_id ON public.dc_primitive USING btree (dynamic_value_item_id);


--
-- Name: i_dc_primitive_item_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dc_primitive_item_id ON public.dc_primitive USING btree (item_id);


--
-- Name: i_dc_section_event_section_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dc_section_event_section_id ON public.dc_section_event USING btree (section_id);


--
-- Name: i_dc_substitution_event_item_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dc_substitution_event_item_id ON public.dc_substitution_event USING btree (item_id);


--
-- Name: i_dc_summary_item_map_item_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dc_summary_item_map_item_id ON public.dc_summary_item_map USING btree (item_id);


--
-- Name: i_decision_condition_crf_version_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_decision_condition_crf_version_id ON public.decision_condition USING btree (crf_version_id);


--
-- Name: i_decision_condition_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_decision_condition_status_id ON public.decision_condition USING btree (status_id);


--
-- Name: i_didm_column_name; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_didm_column_name ON public.dn_item_data_map USING btree (column_name);


--
-- Name: i_difm_event_crf_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_difm_event_crf_id ON public.dyn_item_form_metadata USING btree (event_crf_id);


--
-- Name: i_difm_item_data_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_difm_item_data_id ON public.dyn_item_form_metadata USING btree (item_data_id);


--
-- Name: i_difm_item_form_metadata_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_difm_item_form_metadata_id ON public.dyn_item_form_metadata USING btree (item_form_metadata_id);


--
-- Name: i_difm_item_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_difm_item_id ON public.dyn_item_form_metadata USING btree (item_id);


--
-- Name: i_difm_show_item; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_difm_show_item ON public.dyn_item_form_metadata USING btree (show_item);


--
-- Name: i_digm_event_crf_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_digm_event_crf_id ON public.dyn_item_group_metadata USING btree (event_crf_id);


--
-- Name: i_digm_item_group_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_digm_item_group_id ON public.dyn_item_group_metadata USING btree (item_group_id);


--
-- Name: i_digm_item_group_metadata_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_digm_item_group_metadata_id ON public.dyn_item_group_metadata USING btree (item_group_metadata_id);


--
-- Name: i_digm_show_group; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_digm_show_group ON public.dyn_item_group_metadata USING btree (show_group);


--
-- Name: i_discrepancy_note_discrepancy_note_type_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_discrepancy_note_discrepancy_note_type_id ON public.discrepancy_note USING btree (discrepancy_note_type_id);


--
-- Name: i_discrepancy_note_entity_type; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_discrepancy_note_entity_type ON public.discrepancy_note USING btree (entity_type);


--
-- Name: i_discrepancy_note_owner_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_discrepancy_note_owner_id ON public.discrepancy_note USING btree (owner_id);


--
-- Name: i_discrepancy_note_parent_dn_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_discrepancy_note_parent_dn_id ON public.discrepancy_note USING btree (parent_dn_id);


--
-- Name: i_discrepancy_note_resolution_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_discrepancy_note_resolution_status_id ON public.discrepancy_note USING btree (resolution_status_id);


--
-- Name: i_discrepancy_note_study_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_discrepancy_note_study_id ON public.discrepancy_note USING btree (study_id);


--
-- Name: i_dn_event_crf_map_discrepancy_note_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_event_crf_map_discrepancy_note_id ON public.dn_event_crf_map USING btree (discrepancy_note_id);


--
-- Name: i_dn_event_crf_map_event_crf_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_event_crf_map_event_crf_id ON public.dn_event_crf_map USING btree (event_crf_id);


--
-- Name: i_dn_item_data_map_discrepancy_note_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_item_data_map_discrepancy_note_id ON public.dn_item_data_map USING btree (discrepancy_note_id);


--
-- Name: i_dn_item_data_map_item_data_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_item_data_map_item_data_id ON public.dn_item_data_map USING btree (item_data_id);


--
-- Name: i_dn_study_event_map_discrepancy_note_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_study_event_map_discrepancy_note_id ON public.dn_study_event_map USING btree (discrepancy_note_id);


--
-- Name: i_dn_study_event_map_study_event_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_study_event_map_study_event_id ON public.dn_study_event_map USING btree (study_event_id);


--
-- Name: i_dn_study_subject_map_discrepancy_note_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_study_subject_map_discrepancy_note_id ON public.dn_study_subject_map USING btree (discrepancy_note_id);


--
-- Name: i_dn_study_subject_map_study_subject_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_study_subject_map_study_subject_id ON public.dn_study_subject_map USING btree (study_subject_id);


--
-- Name: i_dn_subject_map_discrepancy_note_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_subject_map_discrepancy_note_id ON public.dn_subject_map USING btree (discrepancy_note_id);


--
-- Name: i_dn_subject_map_subject_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_dn_subject_map_subject_id ON public.dn_subject_map USING btree (subject_id);


--
-- Name: i_event_crf_completion_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_crf_completion_status_id ON public.event_crf USING btree (completion_status_id);


--
-- Name: i_event_crf_date_interviewed; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_crf_date_interviewed ON public.event_crf USING btree (date_interviewed);


--
-- Name: i_event_crf_interviewer_name; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_crf_interviewer_name ON public.event_crf USING btree (interviewer_name);


--
-- Name: i_event_crf_owner_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_crf_owner_id ON public.event_crf USING btree (owner_id);


--
-- Name: i_event_crf_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_crf_status_id ON public.event_crf USING btree (status_id);


--
-- Name: i_event_crf_study_event_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_crf_study_event_id ON public.event_crf USING btree (study_event_id);


--
-- Name: i_event_crf_study_subject_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_crf_study_subject_id ON public.event_crf USING btree (study_subject_id);


--
-- Name: i_event_crf_validator_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_crf_validator_id ON public.event_crf USING btree (validator_id);


--
-- Name: i_event_definition_crf_crf_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_definition_crf_crf_id ON public.event_definition_crf USING btree (crf_id);


--
-- Name: i_event_definition_crf_default_version_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_definition_crf_default_version_id ON public.event_definition_crf USING btree (default_version_id);


--
-- Name: i_event_definition_crf_electronic_signature; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_definition_crf_electronic_signature ON public.event_definition_crf USING btree (electronic_signature);


--
-- Name: i_event_definition_crf_ordinal; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_definition_crf_ordinal ON public.event_definition_crf USING btree (ordinal);


--
-- Name: i_event_definition_crf_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_definition_crf_status_id ON public.event_definition_crf USING btree (status_id);


--
-- Name: i_event_definition_crf_study_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_event_definition_crf_study_id ON public.event_definition_crf USING btree (study_id);


--
-- Name: i_filter_crf_version_map_crf_version_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_filter_crf_version_map_crf_version_id ON public.filter_crf_version_map USING btree (crf_version_id);


--
-- Name: i_filter_crf_version_map_filter_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_filter_crf_version_map_filter_id ON public.filter_crf_version_map USING btree (filter_id);


--
-- Name: i_ifm_item_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_ifm_item_id ON public.item_form_metadata USING btree (item_id);


--
-- Name: i_ifm_response_set_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_ifm_response_set_id ON public.item_form_metadata USING btree (response_set_id);


--
-- Name: i_ifm_section_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_ifm_section_id ON public.item_form_metadata USING btree (section_id);


--
-- Name: i_item_data_event_crf_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_data_event_crf_id ON public.item_data USING btree (event_crf_id);


--
-- Name: i_item_data_item_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_data_item_id ON public.item_data USING btree (item_id);


--
-- Name: i_item_data_ordinal; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_data_ordinal ON public.item_data USING btree (ordinal);


--
-- Name: i_item_data_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_data_status_id ON public.item_data USING btree (status_id);


--
-- Name: i_item_form_metadata_decision_condition_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_form_metadata_decision_condition_id ON public.item_form_metadata USING btree (decision_condition_id);


--
-- Name: i_item_form_metadata_ordinal; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_form_metadata_ordinal ON public.item_form_metadata USING btree (ordinal);


--
-- Name: i_item_form_metadata_parent_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_form_metadata_parent_id ON public.item_form_metadata USING btree (parent_id);


--
-- Name: i_item_group_crf_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_group_crf_id ON public.item_group USING btree (crf_id);


--
-- Name: i_item_group_metadata_crf_version_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_group_metadata_crf_version_id ON public.item_group_metadata USING btree (crf_version_id);


--
-- Name: i_item_group_metadata_item_group_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_group_metadata_item_group_id ON public.item_group_metadata USING btree (item_group_id);


--
-- Name: i_item_group_metadata_item_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_group_metadata_item_id ON public.item_group_metadata USING btree (item_id);


--
-- Name: i_item_group_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_group_status_id ON public.item_group USING btree (status_id);


--
-- Name: i_item_item_data_type_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_item_data_type_id ON public.item USING btree (item_data_type_id);


--
-- Name: i_item_item_reference_type_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_item_reference_type_id ON public.item USING btree (item_reference_type_id);


--
-- Name: i_item_name; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_name ON public.item USING btree (name);


--
-- Name: i_item_oc_oid; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_oc_oid ON public.item USING btree (oc_oid);


--
-- Name: i_item_units; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_item_units ON public.item USING btree (units);


--
-- Name: i_itm_form_metadata_crf_ver_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_itm_form_metadata_crf_ver_id ON public.item_form_metadata USING btree (crf_version_id);


--
-- Name: i_key_index; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_key_index ON public.configuration USING btree (key);


--
-- Name: i_null_value_type_code; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_null_value_type_code ON public.null_value_type USING btree (code);


--
-- Name: i_rule_action_action_type; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_action_action_type ON public.rule_action USING btree (action_type);


--
-- Name: i_rule_action_rule_set_rule_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_action_rule_set_rule_id ON public.rule_action USING btree (rule_set_rule_id);


--
-- Name: i_rule_action_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_action_status_id ON public.rule_action USING btree (status_id);


--
-- Name: i_rule_expression_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_expression_status_id ON public.rule_expression USING btree (status_id);


--
-- Name: i_rule_oc_oid; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_oc_oid ON public.rule USING btree (oc_oid);


--
-- Name: i_rule_rule_expression_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_rule_expression_id ON public.rule USING btree (rule_expression_id);


--
-- Name: i_rule_set_audit_rule_set_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_audit_rule_set_id ON public.rule_set_audit USING btree (rule_set_id);


--
-- Name: i_rule_set_audit_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_audit_status_id ON public.rule_set_audit USING btree (status_id);


--
-- Name: i_rule_set_crf_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_crf_id ON public.rule_set USING btree (crf_id);


--
-- Name: i_rule_set_crf_version_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_crf_version_id ON public.rule_set USING btree (crf_version_id);


--
-- Name: i_rule_set_rule_audit_rule_set_rule_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_rule_audit_rule_set_rule_id ON public.rule_set_rule_audit USING btree (rule_set_rule_id);


--
-- Name: i_rule_set_rule_audit_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_rule_audit_status_id ON public.rule_set_rule_audit USING btree (status_id);


--
-- Name: i_rule_set_rule_expression_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_rule_expression_id ON public.rule_set USING btree (rule_expression_id);


--
-- Name: i_rule_set_rule_rule_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_rule_rule_id ON public.rule_set_rule USING btree (rule_id);


--
-- Name: i_rule_set_rule_rule_set_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_rule_rule_set_id ON public.rule_set_rule USING btree (rule_set_id);


--
-- Name: i_rule_set_rule_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_rule_status_id ON public.rule_set_rule USING btree (status_id);


--
-- Name: i_rule_set_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_status_id ON public.rule_set USING btree (status_id);


--
-- Name: i_rule_set_study_event_definition_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_study_event_definition_id ON public.rule_set USING btree (study_event_definition_id);


--
-- Name: i_rule_set_study_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_set_study_id ON public.rule_set USING btree (study_id);


--
-- Name: i_rule_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_rule_status_id ON public.rule USING btree (status_id);


--
-- Name: i_section_ordinal; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_section_ordinal ON public.section USING btree (ordinal);


--
-- Name: i_section_parent_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_section_parent_id ON public.section USING btree (parent_id);


--
-- Name: i_section_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_section_status_id ON public.section USING btree (status_id);


--
-- Name: i_study_event_date_end; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_event_date_end ON public.study_event USING btree (date_end);


--
-- Name: i_study_event_date_start; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_event_date_start ON public.study_event USING btree (date_start);


--
-- Name: i_study_event_definition_oc_oid; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_event_definition_oc_oid ON public.study_event_definition USING btree (oc_oid);


--
-- Name: i_study_event_definition_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_event_definition_status_id ON public.study_event_definition USING btree (status_id);


--
-- Name: i_study_event_definition_update_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_event_definition_update_id ON public.study_event_definition USING btree (update_id);


--
-- Name: i_study_event_sample_ordinal; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_event_sample_ordinal ON public.study_event USING btree (sample_ordinal);


--
-- Name: i_study_event_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_event_status_id ON public.study_event USING btree (status_id);


--
-- Name: i_study_event_subject_event_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_event_subject_event_status_id ON public.study_event USING btree (subject_event_status_id);


--
-- Name: i_study_group_class_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_group_class_status_id ON public.study_group_class USING btree (status_id);


--
-- Name: i_study_group_class_study_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_group_class_study_id ON public.study_group_class USING btree (study_id);


--
-- Name: i_study_oc_oid; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_oc_oid ON public.study USING btree (oc_oid);


--
-- Name: i_study_owner_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_owner_id ON public.study USING btree (owner_id);


--
-- Name: i_study_parameter_value_study_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_parameter_value_study_id ON public.study_parameter_value USING btree (study_id);


--
-- Name: i_study_parent_study_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_parent_study_id ON public.study USING btree (parent_study_id);


--
-- Name: i_study_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_status_id ON public.study USING btree (status_id);


--
-- Name: i_study_subject_label; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_subject_label ON public.study_subject USING btree (label);


--
-- Name: i_study_subject_oc_oid; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_subject_oc_oid ON public.study_subject USING btree (oc_oid);


--
-- Name: i_study_subject_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_subject_status_id ON public.study_subject USING btree (status_id);


--
-- Name: i_study_type_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_type_id ON public.study USING btree (type_id);


--
-- Name: i_study_unique_identifier; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_unique_identifier ON public.study USING btree (name);


--
-- Name: i_study_user_role_user_name; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_study_user_role_user_name ON public.study_user_role USING btree (user_name);


--
-- Name: i_subject_date_created; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_subject_date_created ON public.subject USING btree (date_created);


--
-- Name: i_subject_date_of_birth; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_subject_date_of_birth ON public.subject USING btree (date_of_birth);


--
-- Name: i_subject_gender; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_subject_gender ON public.subject USING btree (gender);


--
-- Name: i_subject_group_map_status_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_subject_group_map_status_id ON public.subject_group_map USING btree (status_id);


--
-- Name: i_subject_group_map_study_group_class_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_subject_group_map_study_group_class_id ON public.subject_group_map USING btree (study_group_class_id);


--
-- Name: i_subject_unique_identifier; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_subject_unique_identifier ON public.subject USING btree (unique_identifier);


--
-- Name: i_user_account_user_name; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_user_account_user_name ON public.user_account USING btree (user_name);


--
-- Name: i_versioning_map_crf_version_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_versioning_map_crf_version_id ON public.versioning_map USING btree (crf_version_id);


--
-- Name: i_versioning_map_item_id; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX i_versioning_map_item_id ON public.versioning_map USING btree (item_id);


--
-- Name: ix1_study; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX ix1_study ON public.study USING btree (mail_notification);


--
-- Name: ix1_user_account; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX ix1_user_account ON public.user_account USING btree (authtype);


--
-- Name: ix2_user_account; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX ix2_user_account ON public.user_account USING btree (authsecret);


--
-- Name: study_event_idx_study_event_definition; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX study_event_idx_study_event_definition ON public.study_event USING btree (study_event_definition_id);


--
-- Name: study_subject_idx_study; Type: INDEX; Schema: public; Owner: clinica
--

CREATE INDEX study_subject_idx_study ON public.study_subject USING btree (study_id);


--
-- Name: dn_item_data_map didm_update; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER didm_update AFTER INSERT ON public.dn_item_data_map FOR EACH ROW EXECUTE FUNCTION public.populate_ssid_in_didm_trigger();


--
-- Name: event_crf event_crf_initial; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER event_crf_initial AFTER INSERT ON public.event_crf FOR EACH ROW EXECUTE FUNCTION public.event_crf_initial_trigger();


--
-- Name: event_crf event_crf_update; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER event_crf_update AFTER UPDATE ON public.event_crf FOR EACH ROW EXECUTE FUNCTION public.event_crf_trigger();


--
-- Name: event_crf event_crf_update_1; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER event_crf_update_1 AFTER UPDATE ON public.event_crf FOR EACH ROW EXECUTE FUNCTION public.event_crf_version_change_trigger();


--
-- Name: event_definition_crf event_definition_crf_update; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER event_definition_crf_update AFTER UPDATE ON public.event_definition_crf FOR EACH ROW EXECUTE FUNCTION public.event_definition_crf_trigger();


--
-- Name: subject global_subject_insert_update; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER global_subject_insert_update AFTER INSERT OR UPDATE ON public.subject FOR EACH ROW EXECUTE FUNCTION public.global_subject_trigger();


--
-- Name: item_data item_data_initial; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER item_data_initial AFTER INSERT ON public.item_data FOR EACH ROW EXECUTE FUNCTION public.item_data_initial_trigger();


--
-- Name: item_data item_data_update; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER item_data_update AFTER DELETE OR UPDATE ON public.item_data FOR EACH ROW EXECUTE FUNCTION public.item_data_trigger();


--
-- Name: item_data repeating_data_insert; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER repeating_data_insert AFTER INSERT ON public.item_data FOR EACH ROW EXECUTE FUNCTION public.repeating_item_data_trigger();


--
-- Name: study_event study_event_insert_update; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER study_event_insert_update AFTER UPDATE ON public.study_event FOR EACH ROW EXECUTE FUNCTION public.study_event_trigger_new();


--
-- Name: study_subject study_subject_insert_updare; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER study_subject_insert_updare AFTER INSERT OR UPDATE ON public.study_subject FOR EACH ROW EXECUTE FUNCTION public.study_subject_trigger();


--
-- Name: subject_group_map subject_group_map_insert_update; Type: TRIGGER; Schema: public; Owner: clinica
--

CREATE TRIGGER subject_group_map_insert_update AFTER INSERT OR UPDATE ON public.subject_group_map FOR EACH ROW EXECUTE FUNCTION public.subject_group_assignment_trigger();


--
-- Name: dataset dataset_fk_dataset_item_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset
    ADD CONSTRAINT dataset_fk_dataset_item_status FOREIGN KEY (dataset_item_status_id) REFERENCES public.dataset_item_status(dataset_item_status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: discrepancy_note discrepancy_note_asn_u_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.discrepancy_note
    ADD CONSTRAINT discrepancy_note_asn_u_id_fkey FOREIGN KEY (assigned_user_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: discrepancy_note discrepancy_note_owner_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.discrepancy_note
    ADD CONSTRAINT discrepancy_note_owner_id_fkey FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: discrepancy_note discrepancy_note_study_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.discrepancy_note
    ADD CONSTRAINT discrepancy_note_study_id_fkey FOREIGN KEY (study_id) REFERENCES public.study(study_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: discrepancy_note dn_discrepancy_note_type_id_fk; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.discrepancy_note
    ADD CONSTRAINT dn_discrepancy_note_type_id_fk FOREIGN KEY (discrepancy_note_type_id) REFERENCES public.discrepancy_note_type(discrepancy_note_type_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_event_crf_map dn_event_crf_map_dn_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_event_crf_map
    ADD CONSTRAINT dn_event_crf_map_dn_id_fkey FOREIGN KEY (discrepancy_note_id) REFERENCES public.discrepancy_note(discrepancy_note_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_event_crf_map dn_evnt_crf_map_evnt_crf_id_fk; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_event_crf_map
    ADD CONSTRAINT dn_evnt_crf_map_evnt_crf_id_fk FOREIGN KEY (event_crf_id) REFERENCES public.event_crf(event_crf_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_item_data_map dn_item_data_map_dn_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_item_data_map
    ADD CONSTRAINT dn_item_data_map_dn_id_fkey FOREIGN KEY (discrepancy_note_id) REFERENCES public.discrepancy_note(discrepancy_note_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_item_data_map dn_itm_data_map_itm_data_id_fk; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_item_data_map
    ADD CONSTRAINT dn_itm_data_map_itm_data_id_fk FOREIGN KEY (item_data_id) REFERENCES public.item_data(item_data_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: discrepancy_note dn_resolution_status_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.discrepancy_note
    ADD CONSTRAINT dn_resolution_status_id_fkey FOREIGN KEY (resolution_status_id) REFERENCES public.resolution_status(resolution_status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_study_event_map dn_sem_study_event_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_study_event_map
    ADD CONSTRAINT dn_sem_study_event_id_fkey FOREIGN KEY (study_event_id) REFERENCES public.study_event(study_event_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_study_subject_map dn_ssm_study_subject_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_study_subject_map
    ADD CONSTRAINT dn_ssm_study_subject_id_fkey FOREIGN KEY (study_subject_id) REFERENCES public.study_subject(study_subject_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_study_event_map dn_study_event_map_dn_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_study_event_map
    ADD CONSTRAINT dn_study_event_map_dn_id_fkey FOREIGN KEY (discrepancy_note_id) REFERENCES public.discrepancy_note(discrepancy_note_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_study_subject_map dn_study_subject_map_dn_id_fk; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_study_subject_map
    ADD CONSTRAINT dn_study_subject_map_dn_id_fk FOREIGN KEY (discrepancy_note_id) REFERENCES public.discrepancy_note(discrepancy_note_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_subject_map dn_subject_map_dn_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_subject_map
    ADD CONSTRAINT dn_subject_map_dn_id_fkey FOREIGN KEY (discrepancy_note_id) REFERENCES public.discrepancy_note(discrepancy_note_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dn_subject_map dn_subject_map_subject_id_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dn_subject_map
    ADD CONSTRAINT dn_subject_map_subject_id_fkey FOREIGN KEY (subject_id) REFERENCES public.subject(subject_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item_data fk_answer_reference_item; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data
    ADD CONSTRAINT fk_answer_reference_item FOREIGN KEY (item_id) REFERENCES public.item(item_id) ON UPDATE RESTRICT;


--
-- Name: archived_dataset_file fk_archived_reference_dataset; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.archived_dataset_file
    ADD CONSTRAINT fk_archived_reference_dataset FOREIGN KEY (dataset_id) REFERENCES public.dataset(dataset_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: archived_dataset_file fk_archived_reference_export_f; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.archived_dataset_file
    ADD CONSTRAINT fk_archived_reference_export_f FOREIGN KEY (export_format_id) REFERENCES public.export_format(export_format_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: audit_event_context fk_audit_ev_reference_audit_ev; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_event_context
    ADD CONSTRAINT fk_audit_ev_reference_audit_ev FOREIGN KEY (audit_id) REFERENCES public.audit_event(audit_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: audit_event_values fk_audit_lo_ref_audit_lo; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_event_values
    ADD CONSTRAINT fk_audit_lo_ref_audit_lo FOREIGN KEY (audit_id) REFERENCES public.audit_event(audit_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: audit_user_login fk_audit_user_login_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.audit_user_login
    ADD CONSTRAINT fk_audit_user_login_id FOREIGN KEY (user_account_id) REFERENCES public.user_account(user_id);


--
-- Name: completion_status fk_completi_fk_comple_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.completion_status
    ADD CONSTRAINT fk_completi_fk_comple_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: crf fk_crf_crf_user_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf
    ADD CONSTRAINT fk_crf_crf_user_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: crf fk_crf_fk_crf_fk_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf
    ADD CONSTRAINT fk_crf_fk_crf_fk_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item_group_metadata fk_crf_metadata; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group_metadata
    ADD CONSTRAINT fk_crf_metadata FOREIGN KEY (crf_version_id) REFERENCES public.crf_version(crf_version_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: crf_version fk_crf_vers_crf_versi_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf_version
    ADD CONSTRAINT fk_crf_vers_crf_versi_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: crf_version fk_crf_vers_fk_crf_ve_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf_version
    ADD CONSTRAINT fk_crf_vers_fk_crf_ve_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: crf_version_media fk_crf_version_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf_version_media
    ADD CONSTRAINT fk_crf_version_id FOREIGN KEY (crf_version_id) REFERENCES public.crf_version(crf_version_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dataset_crf_version_map fk_dataset__ref_event_event_de; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset_crf_version_map
    ADD CONSTRAINT fk_dataset__ref_event_event_de FOREIGN KEY (event_definition_crf_id) REFERENCES public.event_definition_crf(event_definition_crf_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dataset_crf_version_map fk_dataset_crf_ref_dataset; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset_crf_version_map
    ADD CONSTRAINT fk_dataset_crf_ref_dataset FOREIGN KEY (dataset_id) REFERENCES public.dataset(dataset_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dataset fk_dataset_fk_datase_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset
    ADD CONSTRAINT fk_dataset_fk_datase_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dataset fk_dataset_fk_datase_study; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset
    ADD CONSTRAINT fk_dataset_fk_datase_study FOREIGN KEY (study_id) REFERENCES public.study(study_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dataset fk_dataset_fk_datase_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset
    ADD CONSTRAINT fk_dataset_fk_datase_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dataset_study_group_class_map fk_dataset_ref_study_grp_class; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset_study_group_class_map
    ADD CONSTRAINT fk_dataset_ref_study_grp_class FOREIGN KEY (study_group_class_id) REFERENCES public.study_group_class(study_group_class_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dataset_filter_map fk_dataset_reference_dataset; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset_filter_map
    ADD CONSTRAINT fk_dataset_reference_dataset FOREIGN KEY (dataset_id) REFERENCES public.dataset(dataset_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dataset_filter_map fk_dataset_reference_filter; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset_filter_map
    ADD CONSTRAINT fk_dataset_reference_filter FOREIGN KEY (filter_id) REFERENCES public.filter(filter_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dataset_study_group_class_map fk_dataset_study_ref_dataset; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dataset_study_group_class_map
    ADD CONSTRAINT fk_dataset_study_ref_dataset FOREIGN KEY (dataset_id) REFERENCES public.dataset(dataset_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_computed_event fk_dc_compu_fk_dc_com_dc_event; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_computed_event
    ADD CONSTRAINT fk_dc_compu_fk_dc_com_dc_event FOREIGN KEY (dc_event_id) REFERENCES public.dc_event(dc_event_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_event fk_dc_event_fk_dc_eve_decision; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_event
    ADD CONSTRAINT fk_dc_event_fk_dc_eve_decision FOREIGN KEY (decision_condition_id) REFERENCES public.decision_condition(decision_condition_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_primitive fk_dc_primi_fk_dc_pri_decision; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_primitive
    ADD CONSTRAINT fk_dc_primi_fk_dc_pri_decision FOREIGN KEY (decision_condition_id) REFERENCES public.decision_condition(decision_condition_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_primitive fk_dc_primi_fk_dc_pri_item; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_primitive
    ADD CONSTRAINT fk_dc_primi_fk_dc_pri_item FOREIGN KEY (dynamic_value_item_id) REFERENCES public.item(item_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_primitive fk_dc_primi_fk_item_i_item; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_primitive
    ADD CONSTRAINT fk_dc_primi_fk_item_i_item FOREIGN KEY (item_id) REFERENCES public.item(item_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_section_event fk_dc_secti_fk_dc_sec_dc_event; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_section_event
    ADD CONSTRAINT fk_dc_secti_fk_dc_sec_dc_event FOREIGN KEY (dc_event_id) REFERENCES public.dc_event(dc_event_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_send_email_event fk_dc_send__dc_send_e_dc_event; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_send_email_event
    ADD CONSTRAINT fk_dc_send__dc_send_e_dc_event FOREIGN KEY (dc_event_id) REFERENCES public.dc_event(dc_event_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_substitution_event fk_dc_subst_fk_dc_sub_dc_event; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_substitution_event
    ADD CONSTRAINT fk_dc_subst_fk_dc_sub_dc_event FOREIGN KEY (dc_event_id) REFERENCES public.dc_event(dc_event_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_substitution_event fk_dc_subst_fk_dc_sub_item; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_substitution_event
    ADD CONSTRAINT fk_dc_subst_fk_dc_sub_item FOREIGN KEY (item_id) REFERENCES public.item(item_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_summary_item_map fk_dc_summa_fk_dc_sum_dc_compu; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_summary_item_map
    ADD CONSTRAINT fk_dc_summa_fk_dc_sum_dc_compu FOREIGN KEY (dc_summary_event_id) REFERENCES public.dc_computed_event(dc_summary_event_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: dc_summary_item_map fk_dc_summa_fk_dc_sum_item; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.dc_summary_item_map
    ADD CONSTRAINT fk_dc_summa_fk_dc_sum_item FOREIGN KEY (item_id) REFERENCES public.item(item_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: decision_condition fk_decision_fk_decisi_crf_vers; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.decision_condition
    ADD CONSTRAINT fk_decision_fk_decisi_crf_vers FOREIGN KEY (crf_version_id) REFERENCES public.crf_version(crf_version_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: decision_condition fk_decision_fk_decisi_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.decision_condition
    ADD CONSTRAINT fk_decision_fk_decisi_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: decision_condition fk_decision_fk_decisi_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.decision_condition
    ADD CONSTRAINT fk_decision_fk_decisi_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_crf fk_event_cr_fk_event__completi; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf
    ADD CONSTRAINT fk_event_cr_fk_event__completi FOREIGN KEY (completion_status_id) REFERENCES public.completion_status(completion_status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_crf fk_event_cr_fk_event__status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf
    ADD CONSTRAINT fk_event_cr_fk_event__status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_crf fk_event_cr_fk_event__study_ev; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf
    ADD CONSTRAINT fk_event_cr_fk_event__study_ev FOREIGN KEY (study_event_id) REFERENCES public.study_event(study_event_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_crf fk_event_cr_fk_event__user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf
    ADD CONSTRAINT fk_event_cr_fk_event__user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_crf fk_event_cr_reference_study_su; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf
    ADD CONSTRAINT fk_event_cr_reference_study_su FOREIGN KEY (study_subject_id) REFERENCES public.study_subject(study_subject_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_definition_crf fk_event_de_fk_study__status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf
    ADD CONSTRAINT fk_event_de_fk_study__status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_definition_crf fk_event_de_reference_study_ev; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf
    ADD CONSTRAINT fk_event_de_reference_study_ev FOREIGN KEY (study_event_definition_id) REFERENCES public.study_event_definition(study_event_definition_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_definition_crf fk_event_de_study_crf_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf
    ADD CONSTRAINT fk_event_de_study_crf_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: filter_crf_version_map fk_filter_c_reference_crf_vers; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.filter_crf_version_map
    ADD CONSTRAINT fk_filter_c_reference_crf_vers FOREIGN KEY (crf_version_id) REFERENCES public.crf_version(crf_version_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: filter_crf_version_map fk_filter_c_reference_filter; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.filter_crf_version_map
    ADD CONSTRAINT fk_filter_c_reference_filter FOREIGN KEY (filter_id) REFERENCES public.filter(filter_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: filter fk_filter_fk_query__status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.filter
    ADD CONSTRAINT fk_filter_fk_query__status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: filter fk_filter_fk_query__user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.filter
    ADD CONSTRAINT fk_filter_fk_query__user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_group fk_group_class_study_group; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_group
    ADD CONSTRAINT fk_group_class_study_group FOREIGN KEY (study_group_class_id) REFERENCES public.study_group_class(study_group_class_id) ON UPDATE RESTRICT ON DELETE SET NULL;


--
-- Name: item_group_metadata fk_item; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group_metadata
    ADD CONSTRAINT fk_item FOREIGN KEY (item_id) REFERENCES public.item(item_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item_data fk_item_dat_fk_item_d_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data
    ADD CONSTRAINT fk_item_dat_fk_item_d_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item_data fk_item_dat_fk_item_d_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data
    ADD CONSTRAINT fk_item_dat_fk_item_d_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item fk_item_fk_item_f_item_ref; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item
    ADD CONSTRAINT fk_item_fk_item_f_item_ref FOREIGN KEY (item_reference_type_id) REFERENCES public.item_reference_type(item_reference_type_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item fk_item_fk_item_i_item_dat; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item
    ADD CONSTRAINT fk_item_fk_item_i_item_dat FOREIGN KEY (item_data_type_id) REFERENCES public.item_data_type(item_data_type_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item fk_item_fk_item_s_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item
    ADD CONSTRAINT fk_item_fk_item_s_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item fk_item_fk_item_u_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item
    ADD CONSTRAINT fk_item_fk_item_u_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item_group fk_item_gro_fk_item_g_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group
    ADD CONSTRAINT fk_item_gro_fk_item_g_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item_group fk_item_gro_fk_item_g_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group
    ADD CONSTRAINT fk_item_gro_fk_item_g_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item_group_metadata fk_item_group; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group_metadata
    ADD CONSTRAINT fk_item_group FOREIGN KEY (item_group_id) REFERENCES public.item_group(item_group_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item_group fk_item_group_crf; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_group
    ADD CONSTRAINT fk_item_group_crf FOREIGN KEY (crf_id) REFERENCES public.crf(crf_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: item_form_metadata fk_item_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_form_metadata
    ADD CONSTRAINT fk_item_id FOREIGN KEY (item_id) REFERENCES public.item(item_id) ON UPDATE RESTRICT;


--
-- Name: item_data fk_item_reference_subject; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_data
    ADD CONSTRAINT fk_item_reference_subject FOREIGN KEY (event_crf_id) REFERENCES public.event_crf(event_crf_id) ON UPDATE RESTRICT;


--
-- Name: study fk_old_status_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study
    ADD CONSTRAINT fk_old_status_id FOREIGN KEY (old_status_id) REFERENCES public.status(status_id);


--
-- Name: study_user_role fk_person_role_study_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_user_role
    ADD CONSTRAINT fk_person_role_study_id FOREIGN KEY (study_id) REFERENCES public.study(study_id) ON UPDATE RESTRICT;


--
-- Name: role_privilege_map fk_priv_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.role_privilege_map
    ADD CONSTRAINT fk_priv_id FOREIGN KEY (priv_id) REFERENCES public.privilege(priv_id) ON UPDATE RESTRICT;


--
-- Name: study_subject fk_project__reference_study2; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_subject
    ADD CONSTRAINT fk_project__reference_study2 FOREIGN KEY (study_id) REFERENCES public.study(study_id) ON UPDATE RESTRICT;


--
-- Name: response_set fk_response_fk_respon_response; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.response_set
    ADD CONSTRAINT fk_response_fk_respon_response FOREIGN KEY (response_type_id) REFERENCES public.response_type(response_type_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: role_privilege_map fk_role_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.role_privilege_map
    ADD CONSTRAINT fk_role_id FOREIGN KEY (role_id) REFERENCES public.user_role(role_id) ON UPDATE RESTRICT;


--
-- Name: item_form_metadata fk_rs_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_form_metadata
    ADD CONSTRAINT fk_rs_id FOREIGN KEY (response_set_id) REFERENCES public.response_set(response_set_id) ON UPDATE RESTRICT;


--
-- Name: item_form_metadata fk_sec_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.item_form_metadata
    ADD CONSTRAINT fk_sec_id FOREIGN KEY (section_id) REFERENCES public.section(section_id) ON UPDATE RESTRICT;


--
-- Name: section fk_section_fk_sectio_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.section
    ADD CONSTRAINT fk_section_fk_sectio_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: section fk_section_fk_sectio_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.section
    ADD CONSTRAINT fk_section_fk_sectio_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: section fk_section_version; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.section
    ADD CONSTRAINT fk_section_version FOREIGN KEY (crf_version_id) REFERENCES public.crf_version(crf_version_id) ON UPDATE RESTRICT;


--
-- Name: crf fk_source_study_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf
    ADD CONSTRAINT fk_source_study_id FOREIGN KEY (source_study_id) REFERENCES public.study(study_id);


--
-- Name: study_event fk_study_ev_fk_study__status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event
    ADD CONSTRAINT fk_study_ev_fk_study__status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_event_definition fk_study_ev_fk_study__study; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event_definition
    ADD CONSTRAINT fk_study_ev_fk_study__study FOREIGN KEY (study_id) REFERENCES public.study(study_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_event fk_study_ev_fk_study__study_ev; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event
    ADD CONSTRAINT fk_study_ev_fk_study__study_ev FOREIGN KEY (study_event_definition_id) REFERENCES public.study_event_definition(study_event_definition_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_event fk_study_ev_fk_study__user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event
    ADD CONSTRAINT fk_study_ev_fk_study__user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_event_definition fk_study_ev_fk_studye_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event_definition
    ADD CONSTRAINT fk_study_ev_fk_studye_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_event_definition fk_study_ev_fk_studye_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event_definition
    ADD CONSTRAINT fk_study_ev_fk_studye_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_event fk_study_ev_reference_study_su; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_event
    ADD CONSTRAINT fk_study_ev_reference_study_su FOREIGN KEY (study_subject_id) REFERENCES public.study_subject(study_subject_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study fk_study_fk_study__status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study
    ADD CONSTRAINT fk_study_fk_study__status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study fk_study_fk_study__user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study
    ADD CONSTRAINT fk_study_fk_study__user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_group_class fk_study_gr_fk_study__group_ty; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_group_class
    ADD CONSTRAINT fk_study_gr_fk_study__group_ty FOREIGN KEY (group_class_type_id) REFERENCES public.group_class_types(group_class_type_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_group_class fk_study_gr_fk_study__status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_group_class
    ADD CONSTRAINT fk_study_gr_fk_study__status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_group_class fk_study_gr_fk_study__user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_group_class
    ADD CONSTRAINT fk_study_gr_fk_study__user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_definition_crf fk_study_inst_reference; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf
    ADD CONSTRAINT fk_study_inst_reference FOREIGN KEY (crf_id) REFERENCES public.crf(crf_id) ON UPDATE RESTRICT;


--
-- Name: study_module_status fk_study_module_study_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_module_status
    ADD CONSTRAINT fk_study_module_study_id FOREIGN KEY (study_id) REFERENCES public.study(study_id);


--
-- Name: event_definition_crf fk_study_reference_instrument; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf
    ADD CONSTRAINT fk_study_reference_instrument FOREIGN KEY (study_id) REFERENCES public.study(study_id) ON UPDATE RESTRICT;


--
-- Name: study_subject fk_study_reference_subject; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_subject
    ADD CONSTRAINT fk_study_reference_subject FOREIGN KEY (subject_id) REFERENCES public.subject(subject_id) ON UPDATE RESTRICT ON DELETE SET NULL;


--
-- Name: study_subject fk_study_su_fk_study__status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_subject
    ADD CONSTRAINT fk_study_su_fk_study__status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_subject fk_study_su_fk_study__user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_subject
    ADD CONSTRAINT fk_study_su_fk_study__user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study fk_study_type; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study
    ADD CONSTRAINT fk_study_type FOREIGN KEY (type_id) REFERENCES public.study_type(study_type_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_user_role fk_study_us_fk_study__status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_user_role
    ADD CONSTRAINT fk_study_us_fk_study__status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_user_role fk_study_us_study_use_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_user_role
    ADD CONSTRAINT fk_study_us_study_use_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: subject_group_map fk_subject__fk_sub_gr_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject_group_map
    ADD CONSTRAINT fk_subject__fk_sub_gr_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: subject_group_map fk_subject__fk_subjec_group_ro; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject_group_map
    ADD CONSTRAINT fk_subject__fk_subjec_group_ro FOREIGN KEY (study_group_id) REFERENCES public.study_group(study_group_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: subject_group_map fk_subject__fk_subjec_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject_group_map
    ADD CONSTRAINT fk_subject__fk_subjec_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: subject_group_map fk_subject__fk_subjec_study_gr; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject_group_map
    ADD CONSTRAINT fk_subject__fk_subjec_study_gr FOREIGN KEY (study_group_class_id) REFERENCES public.study_group_class(study_group_class_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: subject_group_map fk_subject__subject_g_study_su; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject_group_map
    ADD CONSTRAINT fk_subject__subject_g_study_su FOREIGN KEY (study_subject_id) REFERENCES public.study_subject(study_subject_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: subject fk_subject_fk_subjec_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject
    ADD CONSTRAINT fk_subject_fk_subjec_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: subject fk_subject_fk_subjec_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject
    ADD CONSTRAINT fk_subject_fk_subjec_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: event_crf fk_subject_referenc_instrument; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_crf
    ADD CONSTRAINT fk_subject_referenc_instrument FOREIGN KEY (crf_version_id) REFERENCES public.crf_version(crf_version_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: user_account fk_user_acc_fk_user_f_user_acc; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.user_account
    ADD CONSTRAINT fk_user_acc_fk_user_f_user_acc FOREIGN KEY (owner_id) REFERENCES public.user_account(user_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: user_account fk_user_acc_ref_user__user_typ; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.user_account
    ADD CONSTRAINT fk_user_acc_ref_user__user_typ FOREIGN KEY (user_type_id) REFERENCES public.user_type(user_type_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: user_account fk_user_acc_status_re_status; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.user_account
    ADD CONSTRAINT fk_user_acc_status_re_status FOREIGN KEY (status_id) REFERENCES public.status(status_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: versioning_map fk_versioni_fk_versio_crf_vers; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.versioning_map
    ADD CONSTRAINT fk_versioni_fk_versio_crf_vers FOREIGN KEY (crf_version_id) REFERENCES public.crf_version(crf_version_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: versioning_map fk_versioni_fk_versio_item; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.versioning_map
    ADD CONSTRAINT fk_versioni_fk_versio_item FOREIGN KEY (item_id) REFERENCES public.item(item_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: crf_version fk_versioni_reference_instrume; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.crf_version
    ADD CONSTRAINT fk_versioni_reference_instrume FOREIGN KEY (crf_id) REFERENCES public.crf(crf_id) ON UPDATE RESTRICT;


--
-- Name: event_definition_crf fk_versioning_study_inst; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.event_definition_crf
    ADD CONSTRAINT fk_versioning_study_inst FOREIGN KEY (default_version_id) REFERENCES public.crf_version(crf_version_id) ON UPDATE RESTRICT ON DELETE SET NULL;


--
-- Name: subject has_father; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject
    ADD CONSTRAINT has_father FOREIGN KEY (father_id) REFERENCES public.subject(subject_id) ON UPDATE RESTRICT ON DELETE SET NULL;


--
-- Name: subject has_mother; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.subject
    ADD CONSTRAINT has_mother FOREIGN KEY (mother_id) REFERENCES public.subject(subject_id) ON UPDATE RESTRICT ON DELETE SET NULL;


--
-- Name: oc_qrtz_blob_triggers oc_qrtz_blob_triggers_trg_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_blob_triggers
    ADD CONSTRAINT oc_qrtz_blob_triggers_trg_fkey FOREIGN KEY (trigger_name, trigger_group) REFERENCES public.oc_qrtz_triggers(trigger_name, trigger_group);


--
-- Name: oc_qrtz_cron_triggers oc_qrtz_cron_triggers_trg_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_cron_triggers
    ADD CONSTRAINT oc_qrtz_cron_triggers_trg_fkey FOREIGN KEY (trigger_name, trigger_group) REFERENCES public.oc_qrtz_triggers(trigger_name, trigger_group);


--
-- Name: oc_qrtz_job_listeners oc_qrtz_job_listeners_job_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_job_listeners
    ADD CONSTRAINT oc_qrtz_job_listeners_job_fkey FOREIGN KEY (job_name, job_group) REFERENCES public.oc_qrtz_job_details(job_name, job_group);


--
-- Name: oc_qrtz_simple_triggers oc_qrtz_simple_trigs_trg_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_simple_triggers
    ADD CONSTRAINT oc_qrtz_simple_trigs_trg_fkey FOREIGN KEY (trigger_name, trigger_group) REFERENCES public.oc_qrtz_triggers(trigger_name, trigger_group);


--
-- Name: oc_qrtz_trigger_listeners oc_qrtz_trigger_lsnrs_trg_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_trigger_listeners
    ADD CONSTRAINT oc_qrtz_trigger_lsnrs_trg_fkey FOREIGN KEY (trigger_name, trigger_group) REFERENCES public.oc_qrtz_triggers(trigger_name, trigger_group);


--
-- Name: oc_qrtz_triggers oc_qrtz_triggers_job_name_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.oc_qrtz_triggers
    ADD CONSTRAINT oc_qrtz_triggers_job_name_fkey FOREIGN KEY (job_name, job_group) REFERENCES public.oc_qrtz_job_details(job_name, job_group);


--
-- Name: study project_is_contained_within_pa; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study
    ADD CONSTRAINT project_is_contained_within_pa FOREIGN KEY (parent_study_id) REFERENCES public.study(study_id) ON UPDATE RESTRICT ON DELETE SET NULL;


--
-- Name: scd_item_metadata scd_meta_fk_control_meta_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.scd_item_metadata
    ADD CONSTRAINT scd_meta_fk_control_meta_id FOREIGN KEY (control_item_form_metadata_id) REFERENCES public.item_form_metadata(item_form_metadata_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: scd_item_metadata scd_meta_fk_scd_form_meta_id; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.scd_item_metadata
    ADD CONSTRAINT scd_meta_fk_scd_form_meta_id FOREIGN KEY (scd_item_form_metadata_id) REFERENCES public.item_form_metadata(item_form_metadata_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_parameter_value study_param_value_param_fkey; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_parameter_value
    ADD CONSTRAINT study_param_value_param_fkey FOREIGN KEY (parameter) REFERENCES public.study_parameter(handle) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- Name: study_parameter_value study_param_value_study_id_fk; Type: FK CONSTRAINT; Schema: public; Owner: clinica
--

ALTER TABLE ONLY public.study_parameter_value
    ADD CONSTRAINT study_param_value_study_id_fk FOREIGN KEY (study_id) REFERENCES public.study(study_id) ON UPDATE RESTRICT ON DELETE RESTRICT;


--
-- PostgreSQL database dump complete
--

